No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 5z1bB, 0.7144, 2.60, 0.041, 620, 97, STRUCTURE OF BIFIDOBACTERIUM DENTIUM BETA-GLUCURONIDASE COMPLEXED WITH COUMARIN-3-O-GLUCURONIDE 
2, 5z1bC, 0.7122, 2.68, 0.051, 624, 98, STRUCTURE OF BIFIDOBACTERIUM DENTIUM BETA-GLUCURONIDASE COMPLEXED WITH COUMARIN-3-O-GLUCURONIDE 
3, 5z1bA, 0.7117, 2.69, 0.051, 627, 98, STRUCTURE OF BIFIDOBACTERIUM DENTIUM BETA-GLUCURONIDASE COMPLEXED WITH COUMARIN-3-O-GLUCURONIDE 
4, 5z1bD, 0.7091, 2.49, 0.042, 622, 95, STRUCTURE OF BIFIDOBACTERIUM DENTIUM BETA-GLUCURONIDASE COMPLEXED WITH COUMARIN-3-O-GLUCURONIDE 
5, 6cvmD, 0.7042, 2.73, 0.020, 1021, 99, ATOMIC RESOLUTION CRYO-EM STRUCTURE OF BETA-GALACTOSIDASE 
6, 6cvmC, 0.7042, 2.73, 0.020, 1021, 99, ATOMIC RESOLUTION CRYO-EM STRUCTURE OF BETA-GALACTOSIDASE 
7, 6cvmB, 0.7042, 2.73, 0.020, 1021, 99, ATOMIC RESOLUTION CRYO-EM STRUCTURE OF BETA-GALACTOSIDASE 
8, 6cvmA, 0.7042, 2.73, 0.020, 1021, 99, ATOMIC RESOLUTION CRYO-EM STRUCTURE OF BETA-GALACTOSIDASE 
9, 6drvD, 0.7041, 2.74, 0.020, 1024, 99, BETA-GALACTOSIDASE 
10, 6drvC, 0.7041, 2.74, 0.020, 1024, 99, BETA-GALACTOSIDASE 
11, 6drvB, 0.7041, 2.74, 0.020, 1024, 99, BETA-GALACTOSIDASE 
12, 6drvA, 0.7041, 2.74, 0.020, 1024, 99, BETA-GALACTOSIDASE 
13, 3t09A, 0.7032, 2.75, 0.020, 1015, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (S796A) GALACTONOLACTONE COMPLEX
14, 3dypC, 0.7026, 2.75, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (H418N)
15, 3t0aC, 0.7022, 2.75, 0.020, 1015, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (S796T)
16, 3j7hD, 0.7021, 2.67, 0.020, 1022, 98, STRUCTURE OF BETA-GALACTOSIDASE AT 3.2-A RESOLUTION OBTAINED BY CRYO- ELECTRON MICROSCOPY
17, 3j7hC, 0.7021, 2.67, 0.020, 1022, 98, STRUCTURE OF BETA-GALACTOSIDASE AT 3.2-A RESOLUTION OBTAINED BY CRYO- ELECTRON MICROSCOPY
18, 3j7hB, 0.7021, 2.67, 0.020, 1022, 98, STRUCTURE OF BETA-GALACTOSIDASE AT 3.2-A RESOLUTION OBTAINED BY CRYO- ELECTRON MICROSCOPY
19, 3j7hA, 0.7021, 2.67, 0.020, 1022, 98, STRUCTURE OF BETA-GALACTOSIDASE AT 3.2-A RESOLUTION OBTAINED BY CRYO- ELECTRON MICROSCOPY
20, 1jz2A, 0.7021, 2.76, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE-TRAPPED 2-F-GALACTOSYL- ENZYME INTERMEDIATE (ORTHORHOMBIC)
21, 1hn1D, 0.7021, 2.75, 0.020, 1011, 99, E. COLI (LAC Z) BETA-GALACTOSIDASE (ORTHORHOMBIC)
22, 3vd5A, 0.7019, 2.75, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (N460S)
23, 1px3C, 0.7019, 2.76, 0.020, 1007, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (G794A)
24, 3t08C, 0.7017, 2.75, 0.020, 1015, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (S796A) IPTG COMPLEX
25, 3iapC, 0.7016, 2.77, 0.030, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (E416Q)
26, 3t2pB, 0.7015, 2.76, 0.020, 1015, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (S796D) IN COMPLEX WITH IPTG
27, 1px3A, 0.7015, 2.77, 0.030, 1010, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (G794A)
28, 1dp0C, 0.7015, 2.76, 0.020, 1011, 99, E. COLI BETA-GALACTOSIDASE AT 1.7 ANGSTROM
29, 3vd5C, 0.7014, 2.77, 0.030, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (N460S)
30, 3iaqC, 0.7014, 2.76, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (E416V)
31, 3t2pA, 0.7013, 2.76, 0.020, 1014, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (S796D) IN COMPLEX WITH IPTG
32, 3iapB, 0.7013, 2.77, 0.030, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (E416Q)
33, 3vd4C, 0.7012, 2.76, 0.020, 1015, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (N460D) IN COMPLEX WITH IPTG
34, 1jz3C, 0.7012, 2.76, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE-TRAPPED 2-DEOXY- GALACTOSYL ENZYME INTERMEDIATE
35, 1px4C, 0.7011, 2.76, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (G794A) WITH IPTG BOUND
36, 1px4A, 0.7011, 2.77, 0.030, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (G794A) WITH IPTG BOUND
37, 3vd3A, 0.7010, 2.77, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (N460D)
38, 3t2pC, 0.7010, 2.75, 0.020, 1015, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (S796D) IN COMPLEX WITH IPTG
39, 3mv03, 0.7010, 2.76, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (R599A) IN COMPLEX WITH D- GALCTOPYRANOSYL-1-ONE
40, 1jz8C, 0.7010, 2.76, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH ALLOLACTOSE
41, 1jz4C, 0.7010, 2.76, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE-TRAPPED 2-DEOXY- GALACTOSYL-ENZYME INTERMEDIATE (LOW BIS-TRIS)
42, 1jynC, 0.7010, 2.76, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH LACTOSE
43, 3vd9C, 0.7009, 2.77, 0.020, 1015, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (N460S) IN COMPLEX WITH IPTG
44, 3t2oC, 0.7009, 2.76, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (S796D)
45, 3sepC, 0.7009, 2.77, 0.020, 1015, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (S796A)
46, 3i3bC, 0.7009, 2.76, 0.020, 1011, 99, E.COLI (LACZ) BETA-GALACTOSIDASE (M542A) IN COMPLEX WITH D- GALACTOPYRANOSYL-1-ON
47, 1jywC, 0.7009, 2.76, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH PNPG
48, 1jywA, 0.7009, 2.76, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH PNPG
49, 4v40E, 0.7008, 2.79, 0.030, 1021, 99, 
50, 3muy3, 0.7008, 2.77, 0.030, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (R599A)
51, 1jz5C, 0.7008, 2.76, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH D-GALCTOPYRANOSYL-1- ON
52, 4duxA, 0.7007, 2.76, 0.020, 1015, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (N460S) IN COMPLEX WITH L-RIBOSE
53, 4duwC, 0.7007, 2.77, 0.020, 1015, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (G974A) IN COMPLEX WITH ALLOLACTOSE
54, 3vdbC, 0.7007, 2.76, 0.020, 1015, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (N460T) IN COMPLEX WITH GALACTONOLACTONE
55, 1jz8A, 0.7007, 2.77, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH ALLOLACTOSE
56, 1jz4A, 0.7007, 2.78, 0.030, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE-TRAPPED 2-DEOXY- GALACTOSYL-ENZYME INTERMEDIATE (LOW BIS-TRIS)
57, 3dypA, 0.7006, 2.78, 0.030, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (H418N)
58, 1jz2B, 0.7006, 2.77, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE-TRAPPED 2-F-GALACTOSYL- ENZYME INTERMEDIATE (ORTHORHOMBIC)
59, 1jz2D, 0.7005, 2.76, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE-TRAPPED 2-F-GALACTOSYL- ENZYME INTERMEDIATE (ORTHORHOMBIC)
60, 1jynA, 0.7005, 2.77, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH LACTOSE
61, 3vdcC, 0.7004, 2.77, 0.020, 1015, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (N460T) IN COMPLEX WITH IPTG
62, 4duvA, 0.7003, 2.77, 0.020, 1019, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (G974A) 2-DEOXY-GALACTOSYL-ENZYME AND BIS-TRIS COMPLEX
63, 3t0aB, 0.7003, 2.77, 0.020, 1015, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (S796T)
64, 3t0aA, 0.7003, 2.76, 0.020, 1015, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (S796T)
65, 3t09D, 0.7003, 2.76, 0.020, 1015, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (S796A) GALACTONOLACTONE COMPLEX
66, 1jz5B, 0.7003, 2.77, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH D-GALCTOPYRANOSYL-1- ON
67, 4duxC, 0.7002, 2.78, 0.030, 1015, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (N460S) IN COMPLEX WITH L-RIBOSE
68, 3t2oA, 0.7002, 2.76, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (S796D)
69, 1dp0A, 0.7002, 2.77, 0.020, 1011, 99, E. COLI BETA-GALACTOSIDASE AT 1.7 ANGSTROM
70, 3vd9A, 0.7001, 2.76, 0.020, 1015, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (N460S) IN COMPLEX WITH IPTG
71, 3i3eA, 0.7001, 2.77, 0.030, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (M542A)
72, 3i3bB, 0.7001, 2.78, 0.030, 1011, 99, E.COLI (LACZ) BETA-GALACTOSIDASE (M542A) IN COMPLEX WITH D- GALACTOPYRANOSYL-1-ON
73, 3czjC, 0.7001, 2.77, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (N460T) IN COMPLEX WITH D- GALCTOPYRANOSYL-1-ONE
74, 1jz4B, 0.7001, 2.77, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE-TRAPPED 2-DEOXY- GALACTOSYL-ENZYME INTERMEDIATE (LOW BIS-TRIS)
75, 3dymB, 0.7000, 2.77, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (H418E)
76, 4v40P, 0.6999, 2.81, 0.030, 1021, 99, 
77, 4v40B, 0.6999, 2.77, 0.020, 1021, 99, 
78, 4duvC, 0.6999, 2.77, 0.020, 1018, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (G974A) 2-DEOXY-GALACTOSYL-ENZYME AND BIS-TRIS COMPLEX
79, 3vd4A, 0.6999, 2.77, 0.020, 1015, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (N460D) IN COMPLEX WITH IPTG
80, 3t2qC, 0.6999, 2.77, 0.020, 1015, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (S796D) IN COMPLEX WITH GALACTONOLACTONE
81, 3iapA, 0.6999, 2.78, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (E416Q)
82, 3i3dA, 0.6999, 2.76, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (M542A) IN COMPLEX WITH IPTG
83, 3vdbB, 0.6998, 2.77, 0.020, 1015, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (N460T) IN COMPLEX WITH GALACTONOLACTONE
84, 3t0dC, 0.6998, 2.77, 0.020, 1015, 99, E.COLI (LACZ) BETA-GALACTOSIDASE (S796T) IN COMPLEX WITH GALACTONOLACTONE
85, 3iaqA, 0.6998, 2.77, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (E416V)
86, 1jyxC, 0.6998, 2.77, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH IPTG
87, 3t09B, 0.6997, 2.77, 0.020, 1015, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (S796A) GALACTONOLACTONE COMPLEX
88, 4duxB, 0.6996, 2.79, 0.030, 1015, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (N460S) IN COMPLEX WITH L-RIBOSE
89, 3t0bC, 0.6996, 2.78, 0.020, 1015, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (S796T) IPTG COMPLEX
90, 3t09C, 0.6996, 2.78, 0.020, 1015, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (S796A) GALACTONOLACTONE COMPLEX
91, 3t08A, 0.6996, 2.76, 0.020, 1015, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (S796A) IPTG COMPLEX
92, 3sepA, 0.6996, 2.77, 0.020, 1015, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (S796A)
93, 3muy2, 0.6996, 2.77, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (R599A)
94, 3i3eC, 0.6996, 2.77, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (M542A)
95, 3i3dC, 0.6996, 2.77, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (M542A) IN COMPLEX WITH IPTG
96, 3i3bA, 0.6996, 2.79, 0.030, 1011, 99, E.COLI (LACZ) BETA-GALACTOSIDASE (M542A) IN COMPLEX WITH D- GALACTOPYRANOSYL-1-ON
97, 3dyoC, 0.6996, 2.77, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (H418N) IN COMPLEX WITH IPTG
98, 1jz6C, 0.6996, 2.77, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH GALACTO- TETRAZOLE
99, 3vdcB, 0.6995, 2.76, 0.020, 1015, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (N460T) IN COMPLEX WITH IPTG
100, 3vd5D, 0.6995, 2.75, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (N460S)
101, 1jyvA, 0.6995, 2.77, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH ONPG
102, 3t08B, 0.6994, 2.77, 0.020, 1015, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (S796A) IPTG COMPLEX
103, 3sepB, 0.6994, 2.78, 0.020, 1015, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (S796A)
104, 3muz3, 0.6994, 2.78, 0.020, 1011, 99, E.COLI (LACZ) BETA-GALACTOSIDASE (R599A) IN COMPLEX WITH IPTG
105, 3dyoA, 0.6994, 2.77, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (H418N) IN COMPLEX WITH IPTG
106, 3czjB, 0.6994, 2.77, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (N460T) IN COMPLEX WITH D- GALCTOPYRANOSYL-1-ONE
107, 3t0dA, 0.6993, 2.77, 0.020, 1015, 99, E.COLI (LACZ) BETA-GALACTOSIDASE (S796T) IN COMPLEX WITH GALACTONOLACTONE
108, 3mv02, 0.6993, 2.77, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (R599A) IN COMPLEX WITH D- GALCTOPYRANOSYL-1-ONE
109, 3muz1, 0.6993, 2.77, 0.020, 1011, 99, E.COLI (LACZ) BETA-GALACTOSIDASE (R599A) IN COMPLEX WITH IPTG
110, 1jywB, 0.6993, 2.79, 0.030, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH PNPG
111, 3vd9B, 0.6992, 2.78, 0.020, 1016, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (N460S) IN COMPLEX WITH IPTG
112, 3dymA, 0.6992, 2.77, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (H418E)
113, 1jz3A, 0.6992, 2.79, 0.030, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE-TRAPPED 2-DEOXY- GALACTOSYL ENZYME INTERMEDIATE
114, 3t0bA, 0.6991, 2.76, 0.020, 1014, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (S796T) IPTG COMPLEX
115, 4ttgC, 0.6990, 2.77, 0.020, 1014, 99, BETA-GALACTOSIDASE (E. COLI) IN THE PRESENCE OF POTASSIUM CHLORIDE.
116, 4duwA, 0.6990, 2.77, 0.020, 1015, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (G974A) IN COMPLEX WITH ALLOLACTOSE
117, 3vd7C, 0.6990, 2.79, 0.030, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (N460S) IN COMPLEX WITH GALACTOTETRAZOLE
118, 3dypB, 0.6990, 2.78, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (H418N)
119, 4v44O, 0.6989, 2.79, 0.030, 1018, 99, 
120, 4v44N, 0.6989, 2.79, 0.030, 1018, 99, 
121, 4v44M, 0.6989, 2.79, 0.030, 1018, 99, 
122, 4v44K, 0.6989, 2.79, 0.030, 1018, 99, 
123, 4v44J, 0.6989, 2.79, 0.030, 1018, 99, 
124, 4v44E, 0.6989, 2.79, 0.030, 1018, 99, 
125, 4v44D, 0.6989, 2.79, 0.030, 1018, 99, 
126, 4v44B, 0.6989, 2.79, 0.030, 1018, 99, 
127, 4v44A, 0.6989, 2.79, 0.030, 1018, 99, 
128, 3t2oD, 0.6989, 2.79, 0.030, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (S796D)
129, 3iapD, 0.6989, 2.79, 0.030, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (E416Q)
130, 4v44P, 0.6988, 2.79, 0.030, 1018, 99, 
131, 4v44L, 0.6988, 2.79, 0.030, 1018, 99, 
132, 4v44I, 0.6988, 2.79, 0.030, 1018, 99, 
133, 4v44H, 0.6988, 2.79, 0.030, 1018, 99, 
134, 4v44G, 0.6988, 2.79, 0.030, 1018, 99, 
135, 4v44F, 0.6988, 2.79, 0.030, 1018, 99, 
136, 4v44C, 0.6988, 2.79, 0.030, 1018, 99, 
137, 3mv13, 0.6988, 2.78, 0.030, 1011, 99, E.COLI (LACZ) BETA-GALACTOSIDASE (R599A) IN COMPLEX WITH GUANIDINIUM
138, 3dyoD, 0.6988, 2.78, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (H418N) IN COMPLEX WITH IPTG
139, 1jz8B, 0.6988, 2.82, 0.030, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH ALLOLACTOSE
140, 3vdcA, 0.6987, 2.77, 0.020, 1015, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (N460T) IN COMPLEX WITH IPTG
141, 3vdbA, 0.6987, 2.77, 0.020, 1015, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (N460T) IN COMPLEX WITH GALACTONOLACTONE
142, 3vd4B, 0.6987, 2.78, 0.020, 1015, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (N460D) IN COMPLEX WITH IPTG
143, 3t2qB, 0.6987, 2.78, 0.020, 1015, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (S796D) IN COMPLEX WITH GALACTONOLACTONE
144, 3t2pD, 0.6987, 2.77, 0.020, 1015, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (S796D) IN COMPLEX WITH IPTG
145, 3muy1, 0.6987, 2.78, 0.030, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (R599A)
146, 4duvB, 0.6986, 2.78, 0.020, 1018, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (G974A) 2-DEOXY-GALACTOSYL-ENZYME AND BIS-TRIS COMPLEX
147, 4ckdD, 0.6986, 2.78, 0.020, 1021, 99, MODEL OF COMPLEX BETWEEN THE E.COLI ENZYME BETA-GALACTOSIDASE AND FOUR SINGLE CHAIN FV ANTIBODY DOMAINS SCFV13R4.
148, 4ckdC, 0.6986, 2.78, 0.020, 1021, 99, MODEL OF COMPLEX BETWEEN THE E.COLI ENZYME BETA-GALACTOSIDASE AND FOUR SINGLE CHAIN FV ANTIBODY DOMAINS SCFV13R4.
149, 4ckdB, 0.6986, 2.78, 0.020, 1021, 99, MODEL OF COMPLEX BETWEEN THE E.COLI ENZYME BETA-GALACTOSIDASE AND FOUR SINGLE CHAIN FV ANTIBODY DOMAINS SCFV13R4.
150, 4ckdA, 0.6986, 2.78, 0.020, 1021, 99, MODEL OF COMPLEX BETWEEN THE E.COLI ENZYME BETA-GALACTOSIDASE AND FOUR SINGLE CHAIN FV ANTIBODY DOMAINS SCFV13R4.
151, 1jz2C, 0.6986, 2.78, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE-TRAPPED 2-F-GALACTOSYL- ENZYME INTERMEDIATE (ORTHORHOMBIC)
152, 1jyvB, 0.6986, 2.78, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH ONPG
153, 1f4aD, 0.6986, 2.78, 0.020, 1021, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (NCS CONSTRAINED MONOMER- ORTHORHOMBIC)
154, 1f4aC, 0.6986, 2.78, 0.020, 1021, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (NCS CONSTRAINED MONOMER- ORTHORHOMBIC)
155, 1f4aB, 0.6986, 2.78, 0.020, 1021, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (NCS CONSTRAINED MONOMER- ORTHORHOMBIC)
156, 1f4aA, 0.6986, 2.78, 0.020, 1021, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (NCS CONSTRAINED MONOMER- ORTHORHOMBIC)
157, 1dp0B, 0.6986, 2.79, 0.030, 1011, 99, E. COLI BETA-GALACTOSIDASE AT 1.7 ANGSTROM
158, 4duwB, 0.6985, 2.78, 0.020, 1015, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (G974A) IN COMPLEX WITH ALLOLACTOSE
159, 3t2oB, 0.6985, 2.78, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (S796D)
160, 3mv01, 0.6985, 2.77, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (R599A) IN COMPLEX WITH D- GALCTOPYRANOSYL-1-ONE
161, 1px3B, 0.6985, 2.78, 0.020, 1009, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (G794A)
162, 3t0dB, 0.6984, 2.78, 0.020, 1015, 99, E.COLI (LACZ) BETA-GALACTOSIDASE (S796T) IN COMPLEX WITH GALACTONOLACTONE
163, 3dymD, 0.6984, 2.78, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (H418E)
164, 3czjA, 0.6984, 2.77, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (N460T) IN COMPLEX WITH D- GALCTOPYRANOSYL-1-ONE
165, 1f4hC, 0.6984, 2.78, 0.020, 1021, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (ORTHORHOMBIC)
166, 1f4hB, 0.6984, 2.79, 0.030, 1021, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (ORTHORHOMBIC)
167, 4duvD, 0.6983, 2.78, 0.020, 1018, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (G974A) 2-DEOXY-GALACTOSYL-ENZYME AND BIS-TRIS COMPLEX
168, 3t2qA, 0.6983, 2.78, 0.020, 1015, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (S796D) IN COMPLEX WITH GALACTONOLACTONE
169, 1px4B, 0.6983, 2.78, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (G794A) WITH IPTG BOUND
170, 1jyxA, 0.6983, 2.78, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH IPTG
171, 1f4hD, 0.6983, 2.77, 0.020, 1021, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (ORTHORHOMBIC)
172, 3vd3C, 0.6982, 2.78, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (N460D)
173, 1jynB, 0.6982, 2.79, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH LACTOSE
174, 5a1aD, 0.6981, 2.80, 0.030, 1022, 99, 2.2 A RESOLUTION CRYO-EM STRUCTURE OF BETA-GALACTOSIDASE IN COMPLEX WITH A CELL-PERMEANT INHIBITOR
175, 5a1aC, 0.6981, 2.80, 0.030, 1022, 99, 2.2 A RESOLUTION CRYO-EM STRUCTURE OF BETA-GALACTOSIDASE IN COMPLEX WITH A CELL-PERMEANT INHIBITOR
176, 5a1aB, 0.6981, 2.80, 0.030, 1022, 99, 2.2 A RESOLUTION CRYO-EM STRUCTURE OF BETA-GALACTOSIDASE IN COMPLEX WITH A CELL-PERMEANT INHIBITOR
177, 5a1aA, 0.6981, 2.80, 0.030, 1022, 99, 2.2 A RESOLUTION CRYO-EM STRUCTURE OF BETA-GALACTOSIDASE IN COMPLEX WITH A CELL-PERMEANT INHIBITOR
178, 4v45P, 0.6981, 2.80, 0.030, 1018, 99, 
179, 4v45O, 0.6981, 2.80, 0.030, 1018, 99, 
180, 4v45N, 0.6981, 2.80, 0.030, 1018, 99, 
181, 4v45M, 0.6981, 2.80, 0.030, 1018, 99, 
182, 4v45L, 0.6981, 2.80, 0.030, 1018, 99, 
183, 4v45K, 0.6981, 2.80, 0.030, 1018, 99, 
184, 4v45J, 0.6981, 2.80, 0.030, 1018, 99, 
185, 4v45I, 0.6981, 2.80, 0.030, 1018, 99, 
186, 4v45H, 0.6981, 2.80, 0.030, 1018, 99, 
187, 4v45G, 0.6981, 2.80, 0.030, 1018, 99, 
188, 4v45F, 0.6981, 2.80, 0.030, 1018, 99, 
189, 4v45E, 0.6981, 2.80, 0.030, 1018, 99, 
190, 4v45D, 0.6981, 2.80, 0.030, 1018, 99, 
191, 4v45C, 0.6981, 2.80, 0.030, 1018, 99, 
192, 4v45B, 0.6981, 2.80, 0.030, 1018, 99, 
193, 4v45A, 0.6981, 2.80, 0.030, 1018, 99, 
194, 3t0bB, 0.6981, 2.78, 0.020, 1015, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (S796T) IPTG COMPLEX
195, 3dypD, 0.6981, 2.78, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (H418N)
196, 3i3eD, 0.6980, 2.79, 0.030, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (M542A)
197, 4v40G, 0.6979, 2.79, 0.030, 1021, 99, 
198, 3t0aD, 0.6979, 2.78, 0.020, 1015, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (S796T)
199, 3mv11, 0.6979, 2.78, 0.020, 1011, 99, E.COLI (LACZ) BETA-GALACTOSIDASE (R599A) IN COMPLEX WITH GUANIDINIUM
200, 3i3eB, 0.6979, 2.79, 0.030, 1010, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (M542A)
201, 1jz4D, 0.6979, 2.80, 0.030, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE-TRAPPED 2-DEOXY- GALACTOSYL-ENZYME INTERMEDIATE (LOW BIS-TRIS)
202, 1jyvD, 0.6979, 2.80, 0.030, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH ONPG
203, 1hn1B, 0.6979, 2.78, 0.020, 1011, 99, E. COLI (LAC Z) BETA-GALACTOSIDASE (ORTHORHOMBIC)
204, 3vd9D, 0.6978, 2.80, 0.030, 1015, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (N460S) IN COMPLEX WITH IPTG
205, 1jz5D, 0.6978, 2.78, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH D-GALCTOPYRANOSYL-1- ON
206, 1jywD, 0.6978, 2.78, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH PNPG
207, 1dp0D, 0.6978, 2.78, 0.020, 1011, 99, E. COLI BETA-GALACTOSIDASE AT 1.7 ANGSTROM
208, 3vd4D, 0.6977, 2.79, 0.020, 1015, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (N460D) IN COMPLEX WITH IPTG
209, 3muz2, 0.6977, 2.79, 0.020, 1011, 99, E.COLI (LACZ) BETA-GALACTOSIDASE (R599A) IN COMPLEX WITH IPTG
210, 3iaqB, 0.6977, 2.78, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (E416V)
211, 1px4D, 0.6977, 2.78, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (G794A) WITH IPTG BOUND
212, 1jz7C, 0.6977, 2.78, 0.020, 1010, 99, E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH GALACTOSE
213, 1jz3B, 0.6977, 2.79, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE-TRAPPED 2-DEOXY- GALACTOSYL ENZYME INTERMEDIATE
214, 3vd3D, 0.6976, 2.80, 0.030, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (N460D)
215, 3mv12, 0.6976, 2.80, 0.030, 1011, 99, E.COLI (LACZ) BETA-GALACTOSIDASE (R599A) IN COMPLEX WITH GUANIDINIUM
216, 1jz3D, 0.6976, 2.78, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE-TRAPPED 2-DEOXY- GALACTOSYL ENZYME INTERMEDIATE
217, 1jynD, 0.6976, 2.78, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH LACTOSE
218, 1hn1C, 0.6976, 2.78, 0.020, 1011, 99, E. COLI (LAC Z) BETA-GALACTOSIDASE (ORTHORHOMBIC)
219, 4v40A, 0.6975, 2.79, 0.030, 1021, 99, 
220, 3i3dD, 0.6975, 2.80, 0.030, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (M542A) IN COMPLEX WITH IPTG
221, 4v41P, 0.6974, 2.80, 0.030, 1018, 99, 
222, 4v41O, 0.6974, 2.80, 0.030, 1018, 99, 
223, 4v41N, 0.6974, 2.80, 0.030, 1018, 99, 
224, 4v41M, 0.6974, 2.80, 0.030, 1018, 99, 
225, 4v41L, 0.6974, 2.80, 0.030, 1018, 99, 
226, 4v41K, 0.6974, 2.80, 0.030, 1018, 99, 
227, 4v41J, 0.6974, 2.80, 0.030, 1018, 99, 
228, 4v41I, 0.6974, 2.80, 0.030, 1018, 99, 
229, 4v41H, 0.6974, 2.80, 0.030, 1018, 99, 
230, 4v41G, 0.6974, 2.80, 0.030, 1018, 99, 
231, 4v41F, 0.6974, 2.80, 0.030, 1018, 99, 
232, 4v41E, 0.6974, 2.80, 0.030, 1018, 99, 
233, 4v41D, 0.6974, 2.80, 0.030, 1018, 99, 
234, 4v41C, 0.6974, 2.80, 0.030, 1018, 99, 
235, 4v41B, 0.6974, 2.80, 0.030, 1018, 99, 
236, 4v41A, 0.6974, 2.80, 0.030, 1018, 99, 
237, 4ttgA, 0.6974, 2.78, 0.020, 1014, 99, BETA-GALACTOSIDASE (E. COLI) IN THE PRESENCE OF POTASSIUM CHLORIDE.
238, 1jz8D, 0.6974, 2.79, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH ALLOLACTOSE
239, 1hn1A, 0.6974, 2.78, 0.020, 1011, 99, E. COLI (LAC Z) BETA-GALACTOSIDASE (ORTHORHOMBIC)
240, 3muz4, 0.6973, 2.79, 0.020, 1011, 99, E.COLI (LACZ) BETA-GALACTOSIDASE (R599A) IN COMPLEX WITH IPTG
241, 3i3dB, 0.6973, 2.79, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (M542A) IN COMPLEX WITH IPTG
242, 1px3D, 0.6973, 2.78, 0.020, 1008, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (G794A)
243, 4v40K, 0.6972, 2.80, 0.020, 1021, 99, 
244, 4v40J, 0.6972, 2.81, 0.030, 1021, 99, 
245, 4v40C, 0.6972, 2.80, 0.030, 1021, 99, 
246, 4duxD, 0.6972, 2.78, 0.020, 1015, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (N460S) IN COMPLEX WITH L-RIBOSE
247, 3t08D, 0.6972, 2.78, 0.020, 1015, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (S796A) IPTG COMPLEX
248, 3muy4, 0.6972, 2.78, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (R599A)
249, 3dyoB, 0.6972, 2.79, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (H418N) IN COMPLEX WITH IPTG
250, 1jz6B, 0.6972, 2.80, 0.030, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH GALACTO- TETRAZOLE
251, 4v40H, 0.6971, 2.79, 0.020, 1021, 99, 
252, 3vd7B, 0.6971, 2.81, 0.030, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (N460S) IN COMPLEX WITH GALACTOTETRAZOLE
253, 3t0dD, 0.6971, 2.79, 0.020, 1015, 99, E.COLI (LACZ) BETA-GALACTOSIDASE (S796T) IN COMPLEX WITH GALACTONOLACTONE
254, 4v40O, 0.6970, 2.79, 0.020, 1021, 99, 
255, 4duwD, 0.6970, 2.79, 0.020, 1015, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (G974A) IN COMPLEX WITH ALLOLACTOSE
256, 1f4hA, 0.6970, 2.79, 0.020, 1021, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (ORTHORHOMBIC)
257, 4v40D, 0.6969, 2.80, 0.020, 1021, 99, 
258, 3vd3B, 0.6969, 2.81, 0.030, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (N460D)
259, 3vd7A, 0.6968, 2.79, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (N460S) IN COMPLEX WITH GALACTOTETRAZOLE
260, 4v40M, 0.6967, 2.80, 0.020, 1021, 99, 
261, 3mv04, 0.6967, 2.79, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (R599A) IN COMPLEX WITH D- GALCTOPYRANOSYL-1-ONE
262, 3sepD, 0.6966, 2.80, 0.020, 1015, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (S796A)
263, 3vdbD, 0.6965, 2.79, 0.020, 1015, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (N460T) IN COMPLEX WITH GALACTONOLACTONE
264, 3vd7D, 0.6964, 2.79, 0.030, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (N460S) IN COMPLEX WITH GALACTOTETRAZOLE
265, 3t0bD, 0.6963, 2.79, 0.020, 1015, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (S796T) IPTG COMPLEX
266, 4v40I, 0.6962, 2.81, 0.020, 1021, 99, 
267, 1jz6A, 0.6962, 2.80, 0.030, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH GALACTO- TETRAZOLE
268, 3t2qD, 0.6961, 2.79, 0.020, 1015, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (S796D) IN COMPLEX WITH GALACTONOLACTONE
269, 3e1f3, 0.6961, 2.81, 0.030, 1011, 99, E.COLI (LACZ) BETA-GALACTOSIDASE (H418E) IN COMPLEX WITH GALACTOSE
270, 3czjD, 0.6961, 2.79, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (N460T) IN COMPLEX WITH D- GALCTOPYRANOSYL-1-ONE
271, 1jz6D, 0.6961, 2.81, 0.030, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH GALACTO- TETRAZOLE
272, 1jyxD, 0.6961, 2.79, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH IPTG
273, 4ttgB, 0.6960, 2.79, 0.020, 1014, 99, BETA-GALACTOSIDASE (E. COLI) IN THE PRESENCE OF POTASSIUM CHLORIDE.
274, 3iaqD, 0.6960, 2.79, 0.020, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (E416V)
275, 3e1f4, 0.6959, 2.81, 0.030, 1011, 99, E.COLI (LACZ) BETA-GALACTOSIDASE (H418E) IN COMPLEX WITH GALACTOSE
276, 3e1f2, 0.6959, 2.81, 0.030, 1011, 99, E.COLI (LACZ) BETA-GALACTOSIDASE (H418E) IN COMPLEX WITH GALACTOSE
277, 3e1f1, 0.6959, 2.82, 0.030, 1011, 99, E.COLI (LACZ) BETA-GALACTOSIDASE (H418E) IN COMPLEX WITH GALACTOSE
278, 3mv14, 0.6957, 2.79, 0.020, 1011, 99, E.COLI (LACZ) BETA-GALACTOSIDASE (R599A) IN COMPLEX WITH GUANIDINIUM
279, 3vdaB, 0.6956, 2.81, 0.030, 1015, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (N460T)
280, 4ttgD, 0.6955, 2.79, 0.020, 1014, 99, BETA-GALACTOSIDASE (E. COLI) IN THE PRESENCE OF POTASSIUM CHLORIDE.
281, 3i3bD, 0.6954, 2.80, 0.020, 1011, 99, E.COLI (LACZ) BETA-GALACTOSIDASE (M542A) IN COMPLEX WITH D- GALACTOPYRANOSYL-1-ON
282, 3vdaC, 0.6953, 2.82, 0.030, 1015, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (N460T)
283, 4v40N, 0.6951, 2.83, 0.030, 1021, 99, 
284, 3vdcD, 0.6951, 2.79, 0.020, 1015, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (N460T) IN COMPLEX WITH IPTG
285, 1jz7D, 0.6947, 2.79, 0.020, 1010, 99, E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH GALACTOSE
286, 1jz7B, 0.6943, 2.80, 0.020, 1010, 99, E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH GALACTOSE
287, 3d87D, 0.6938, 2.75, 0.083, 296, 96, CRYSTAL STRUCTURE OF INTERLEUKIN-23
288, 3vdaD, 0.6930, 2.84, 0.030, 1015, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (N460T)
289, 4v40F, 0.6923, 2.84, 0.030, 1021, 99, 
290, 3d87B, 0.6923, 3.06, 0.082, 298, 98, CRYSTAL STRUCTURE OF INTERLEUKIN-23
291, 4v40L, 0.6921, 2.82, 0.020, 1021, 99, 
292, 3vdaA, 0.6919, 2.82, 0.020, 1015, 99, E. COLI (LACZ) BETA-GALACTOSIDASE (N460T)
293, 5mj3A, 0.6897, 2.76, 0.083, 302, 96, INTERLEUKIN-23 COMPLEX WITH AN ANTAGONISTIC ALPHABODY CRYSTAL FORM 1
294, 4oe8A, 0.6897, 2.76, 0.083, 302, 96, INTERLEUKIN-23 COMPLEX WITH AN ANTAGONISTIC ALPHABODY CRYSTAL FORM 1
295, 6mvhB, 0.6894, 2.75, 0.042, 638, 96, CRYSTAL STRUCTURE OF FMN-BINDING BETA-GLUCURONIDASE FROM ROSEBURIA HOMINIS 
296, 6mvhA, 0.6884, 2.76, 0.042, 639, 96, CRYSTAL STRUCTURE OF FMN-BINDING BETA-GLUCURONIDASE FROM ROSEBURIA HOMINIS 
297, 6mvfA, 0.6884, 2.76, 0.083, 643, 96, CRYSTAL STRUCTURE OF FMN-BINDING BETA-GLUCURONIDASE FROM FACAELIBACTERIUM PRAUSNITZII L2-6 
298, 3fn9B, 0.6881, 3.05, 0.050, 672, 100, CRYSTAL STRUCTURE OF PUTATIVE BETA-GALACTOSIDASE FROM BACTEROIDES FRAGILIS
299, 6mvhC, 0.6879, 2.77, 0.042, 638, 96, CRYSTAL STRUCTURE OF FMN-BINDING BETA-GLUCURONIDASE FROM ROSEBURIA HOMINIS 
300, 3duhB, 0.6874, 2.79, 0.083, 294, 96, STRUCTURE OF INTERLEUKIN-23
301, 5mj4A, 0.6873, 2.80, 0.083, 289, 96, INTERLEUKIN-23 COMPLEX WITH AN ANTAGONISTIC ALPHABODY CRYSTAL FORM 2
302, 6mvfE, 0.6872, 2.77, 0.083, 643, 96, CRYSTAL STRUCTURE OF FMN-BINDING BETA-GLUCURONIDASE FROM FACAELIBACTERIUM PRAUSNITZII L2-6 
303, 4og9A, 0.6872, 2.80, 0.083, 289, 96, INTERLEUKIN-23 COMPLEX WITH AN ANTAGONISTIC ALPHABODY CRYSTAL FORM 2
304, 6mvfB, 0.6869, 2.76, 0.073, 643, 96, CRYSTAL STRUCTURE OF FMN-BINDING BETA-GLUCURONIDASE FROM FACAELIBACTERIUM PRAUSNITZII L2-6 
305, 3d85D, 0.6869, 2.77, 0.083, 290, 96, CRYSTAL STRUCTURE OF IL-23 IN COMPLEX WITH NEUTRALIZING FAB
306, 6mvfC, 0.6868, 2.78, 0.083, 643, 96, CRYSTAL STRUCTURE OF FMN-BINDING BETA-GLUCURONIDASE FROM FACAELIBACTERIUM PRAUSNITZII L2-6 
307, 3hmxA, 0.6868, 2.91, 0.082, 295, 97, CRYSTAL STRUCTURE OF USTEKINUMAB FAB/IL-12 COMPLEX
308, 6mvfD, 0.6866, 2.77, 0.083, 643, 96, CRYSTAL STRUCTURE OF FMN-BINDING BETA-GLUCURONIDASE FROM FACAELIBACTERIUM PRAUSNITZII L2-6 
309, 3fn9D, 0.6859, 3.05, 0.050, 666, 100, CRYSTAL STRUCTURE OF PUTATIVE BETA-GALACTOSIDASE FROM BACTEROIDES FRAGILIS
310, 4c54A, 0.6855, 2.74, 0.053, 210, 95, CRYSTAL STRUCTURE OF RECOMBINANT HUMAN IGG4 FC
311, 3fn9A, 0.6853, 3.07, 0.050, 672, 100, CRYSTAL STRUCTURE OF PUTATIVE BETA-GALACTOSIDASE FROM BACTEROIDES FRAGILIS
312, 5njdC, 0.6852, 2.81, 0.083, 294, 96, STRUCTURE OF INTERLEUKIN 23 IN COMPLEX WITH BRIAKINUMAB FAB
313, 5njdA, 0.6852, 2.81, 0.083, 298, 96, STRUCTURE OF INTERLEUKIN 23 IN COMPLEX WITH BRIAKINUMAB FAB
314, 5njdE, 0.6847, 2.80, 0.083, 294, 96, STRUCTURE OF INTERLEUKIN 23 IN COMPLEX WITH BRIAKINUMAB FAB
315, 5lg1A, 0.6844, 2.77, 0.053, 209, 95, ROOM TEMPERATURE STRUCTURE OF HUMAN IGG4-FC FROM CRYSTALS ANALYSED IN SITU
316, 3duhA, 0.6840, 2.84, 0.083, 300, 96, STRUCTURE OF INTERLEUKIN-23
317, 4grwD, 0.6837, 3.04, 0.082, 292, 97, STRUCTURE OF A COMPLEX OF HUMAN IL-23 WITH 3 NANOBODIES (LLAMA VHHS)
318, 4c54B, 0.6837, 2.77, 0.053, 209, 95, CRYSTAL STRUCTURE OF RECOMBINANT HUMAN IGG4 FC
319, 5njdK, 0.6832, 2.81, 0.083, 297, 96, STRUCTURE OF INTERLEUKIN 23 IN COMPLEX WITH BRIAKINUMAB FAB
320, 6mvfF, 0.6831, 2.73, 0.083, 643, 96, CRYSTAL STRUCTURE OF FMN-BINDING BETA-GLUCURONIDASE FROM FACAELIBACTERIUM PRAUSNITZII L2-6 
321, 5njdI, 0.6828, 2.81, 0.083, 292, 96, STRUCTURE OF INTERLEUKIN 23 IN COMPLEX WITH BRIAKINUMAB FAB
322, 3fn9C, 0.6827, 3.07, 0.050, 673, 100, CRYSTAL STRUCTURE OF PUTATIVE BETA-GALACTOSIDASE FROM BACTEROIDES FRAGILIS
323, 3qwrA, 0.6826, 2.79, 0.083, 295, 96, CRYSTAL STRUCTURE OF IL-23 IN COMPLEX WITH AN ADNECTIN
324, 2vuoB, 0.6826, 2.54, 0.074, 214, 95, CRYSTAL STRUCTURE OF THE RABBIT IGG FC FRAGMENT
325, 6mvgA, 0.6814, 2.83, 0.052, 637, 96, CRYSTAL STRUCTURE OF FMN-BINDING BETA-GLUCURONIDASE FROM RUMINOCOCCUS GNAVUS 
326, 5mxaA, 0.6807, 3.09, 0.082, 301, 98, STRUCTURE OF UNBOUND INTERLEUKIN-23
327, 2rcjS, 0.6807, 2.94, 0.051, 523, 98, SOLUTION STRUCTURE OF HUMAN IMMUNOGLOBULIN M
328, 2rcjG, 0.6805, 2.94, 0.051, 523, 98, SOLUTION STRUCTURE OF HUMAN IMMUNOGLOBULIN M
329, 6mvgC, 0.6804, 2.81, 0.052, 637, 96, CRYSTAL STRUCTURE OF FMN-BINDING BETA-GLUCURONIDASE FROM RUMINOCOCCUS GNAVUS 
330, 2rcjK, 0.6803, 2.94, 0.051, 523, 98, SOLUTION STRUCTURE OF HUMAN IMMUNOGLOBULIN M
331, 2rcjC, 0.6799, 2.95, 0.051, 523, 98, SOLUTION STRUCTURE OF HUMAN IMMUNOGLOBULIN M
332, 3dymC, 0.6794, 2.93, 0.050, 1011, 100, E. COLI (LACZ) BETA-GALACTOSIDASE (H418E)
333, 6mvgB, 0.6789, 2.83, 0.052, 636, 96, CRYSTAL STRUCTURE OF FMN-BINDING BETA-GLUCURONIDASE FROM RUMINOCOCCUS GNAVUS 
334, 2rcjO, 0.6789, 2.96, 0.051, 523, 98, SOLUTION STRUCTURE OF HUMAN IMMUNOGLOBULIN M
335, 4c55A, 0.6784, 2.75, 0.053, 208, 94, CRYSTAL STRUCTURE OF SERUM-DERIVED HUMAN IGG4 FC
336, 1jyvC, 0.6775, 2.94, 0.050, 1011, 100, E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH ONPG
337, 1jz5A, 0.6773, 2.94, 0.060, 1011, 100, E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH D-GALCTOPYRANOSYL-1- ON
338, 4grwB, 0.6768, 2.76, 0.084, 293, 95, STRUCTURE OF A COMPLEX OF HUMAN IL-23 WITH 3 NANOBODIES (LLAMA VHHS)
339, 1t83A, 0.6767, 2.76, 0.042, 210, 95, CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR IN COMPLEX WITH AN FC FRAGMENT OF IGG1 (ORTHORHOMBIC)
340, 1jz7A, 0.6767, 2.94, 0.060, 1010, 100, E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH GALACTOSE
341, 1f45A, 0.6766, 3.17, 0.082, 282, 98, HUMAN INTERLEUKIN-12
342, 3wn5B, 0.6763, 2.62, 0.053, 210, 95, CRYSTAL STRUCTURE OF ASYMMETRICALLY ENGINEERED FC VARIANT IN COMPLEX WITH FCGRIIIA
343, 4c55B, 0.6761, 2.73, 0.054, 206, 93, CRYSTAL STRUCTURE OF SERUM-DERIVED HUMAN IGG4 FC
344, 1t89B, 0.6759, 2.76, 0.052, 213, 96, CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR IN COMPLEX WITH AN FC FRAGMENT OF IGG1 (HEXAGONAL)
345, 3vd5B, 0.6758, 2.95, 0.060, 1011, 100, E. COLI (LACZ) BETA-GALACTOSIDASE (N460S)
346, 1jyxB, 0.6757, 2.89, 0.051, 1011, 99, E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH IPTG
347, 5dvoA, 0.6755, 2.75, 0.042, 205, 95, FC K392D/K409D HOMODIMER
348, 1igyB, 0.6755, 2.91, 0.051, 434, 99, STRUCTURE OF IMMUNOGLOBULIN
349, 5dvoB, 0.6750, 2.76, 0.042, 205, 95, FC K392D/K409D HOMODIMER
350, 1hzhK, 0.6745, 2.79, 0.052, 444, 97, CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN
351, 2rcjH, 0.6742, 2.93, 0.041, 523, 97, SOLUTION STRUCTURE OF HUMAN IMMUNOGLOBULIN M
352, 6gfeK, 0.6741, 2.60, 0.054, 426, 93, HIGH-RESOLUTION STRUCTURE OF A THERAPEUTIC FULL-LENGTH ANTI-NPRA ANTIBODY WITH EXCEPTIONAL CONFORMATIONAL DIVERSITY 
353, 5w5nB, 0.6741, 2.97, 0.072, 211, 97, CRYSTAL STRUCTURE OF HUMAN IGG4-SIGMA2 FC FRAGMENT
354, 3wknD, 0.6741, 2.74, 0.043, 209, 94, CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG
355, 2rcjL, 0.6733, 2.93, 0.041, 523, 97, SOLUTION STRUCTURE OF HUMAN IMMUNOGLOBULIN M
356, 5u4yB, 0.6732, 2.68, 0.063, 212, 95, IGG FC BOUND TO 3 HELIX OF THE B-DOMAIN FROM PROTEIN A
357, 2rcjT, 0.6729, 2.89, 0.041, 523, 97, SOLUTION STRUCTURE OF HUMAN IMMUNOGLOBULIN M
358, 2rcjD, 0.6724, 2.92, 0.041, 523, 97, SOLUTION STRUCTURE OF HUMAN IMMUNOGLOBULIN M
359, 2atyB, 0.6724, 3.00, 0.061, 376, 99, COMPLEMENT RECEPTOR CHIMAERIC CONJUGATE CR2-IG
360, 2rcjP, 0.6723, 2.91, 0.052, 523, 97, SOLUTION STRUCTURE OF HUMAN IMMUNOGLOBULIN M
361, 2dtsA, 0.6718, 2.73, 0.043, 211, 94, CRYSTAL STRUCTURE OF THE DEFUCOSYLATED FC FRAGMENT FROM HUMAN IMMUNOGLOBULIN G1
362, 5w5nA, 0.6717, 2.77, 0.054, 206, 93, CRYSTAL STRUCTURE OF HUMAN IGG4-SIGMA2 FC FRAGMENT
363, 5mzvA, 0.6717, 3.16, 0.093, 303, 97, IL-23:IL-23R:NB22E11 COMPLEX
364, 5hvwA, 0.6717, 2.71, 0.053, 210, 94, MONOMERIC IGG4 FC
365, 1t83B, 0.6713, 2.92, 0.042, 212, 96, CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR IN COMPLEX WITH AN FC FRAGMENT OF IGG1 (ORTHORHOMBIC)
366, 2atyA, 0.6710, 3.04, 0.061, 376, 99, COMPLEMENT RECEPTOR CHIMAERIC CONJUGATE CR2-IG
367, 3hn3B, 0.6708, 2.79, 0.055, 609, 91, HUMAN BETA-GLUCURONIDASE AT 1.7 A RESOLUTION
368, 5c70B, 0.6703, 2.59, 0.055, 584, 91, THE STRUCTURE OF ASPERGILLUS ORYZAE BETA-GLUCURONIDASE
369, 3sgjA, 0.6702, 2.90, 0.052, 219, 97, UNIQUE CARBOHYDRATE-CARBOHYDRATE INTERACTIONS ARE REQUIRED FOR HIGH AFFINITY BINDING BETWEEN FCGIII AND ANTIBODIES LACKING CORE FUCOSE
370, 5v4eH, 0.6701, 2.74, 0.062, 216, 96, ENGINEERED HUMAN IGG FC DOMAIN GLYCO801 (FC801)
371, 5c70A, 0.6701, 2.61, 0.055, 588, 91, THE STRUCTURE OF ASPERGILLUS ORYZAE BETA-GLUCURONIDASE
372, 3hn3A, 0.6700, 2.73, 0.056, 608, 90, HUMAN BETA-GLUCURONIDASE AT 1.7 A RESOLUTION
373, 5dk3B, 0.6699, 2.89, 0.052, 441, 96, CRYSTAL STRUCTURE OF PEMBROLIZUMAB A FULL LENGTH IGG4 ANTIBODY
374, 5w5mA, 0.6697, 2.84, 0.064, 207, 94, CRYSTAL STRUCTURE OF HUMAN IGG4-SIGMA1 FC FRAGMENT
375, 5o4eB, 0.6696, 2.62, 0.053, 216, 94, CRYSTAL STRUCTURE OF VEGF IN COMPLEX WITH HETERODIMERIC FCAB JANUSCT6
376, 3hn3E, 0.6696, 2.79, 0.055, 606, 91, HUMAN BETA-GLUCURONIDASE AT 1.7 A RESOLUTION
377, 3fjtB, 0.6691, 2.94, 0.042, 209, 95, CRYSTAL STRUCTURE OF A HUMAN FC FRAGMENT ENGINEERED FOR EXTENDED SERUM HALF-LIFE
378, 4hdiL, 0.6690, 2.67, 0.043, 219, 93, CRYSTAL STRUCTURE OF 3E5 IGG3 FAB FROM MUS MUSCULUS
379, 2vuoA, 0.6689, 3.07, 0.061, 215, 98, CRYSTAL STRUCTURE OF THE RABBIT IGG FC FRAGMENT
380, 1zvoD, 0.6689, 3.06, 0.072, 512, 97, SEMI-EXTENDED SOLUTION STRUCTURE OF HUMAN MYELOMA IMMUNOGLOBULIN D DETERMINED BY CONSTRAINED X-RAY SCATTERING
381, 1zvoC, 0.6689, 3.06, 0.072, 512, 97, SEMI-EXTENDED SOLUTION STRUCTURE OF HUMAN MYELOMA IMMUNOGLOBULIN D DETERMINED BY CONSTRAINED X-RAY SCATTERING
382, 5o4eA, 0.6688, 2.65, 0.053, 209, 94, CRYSTAL STRUCTURE OF VEGF IN COMPLEX WITH HETERODIMERIC FCAB JANUSCT6
383, 3hn3D, 0.6687, 2.62, 0.066, 607, 91, HUMAN BETA-GLUCURONIDASE AT 1.7 A RESOLUTION
384, 1igyD, 0.6685, 3.05, 0.051, 434, 99, STRUCTURE OF IMMUNOGLOBULIN
385, 4q9bA, 0.6684, 2.43, 0.089, 101, 90, IGNAR ANTIBODY DOMAIN C2
386, 5w5mB, 0.6682, 2.88, 0.063, 209, 95, CRYSTAL STRUCTURE OF HUMAN IGG4-SIGMA1 FC FRAGMENT
387, 1f42A, 0.6681, 2.76, 0.085, 297, 94, THE P40 DOMAIN OF HUMAN INTERLEUKIN-12
388, 5c71C, 0.6679, 2.62, 0.055, 583, 91, THE STRUCTURE OF ASPERGILLUS ORYZAE A-GLUCURONIDASE COMPLEXED WITH GLYCYRRHETINIC ACID MONOGLUCURONIDE
389, 3dj9A, 0.6679, 2.85, 0.043, 107, 94, CRYSTAL STRUCTURE OF AN ISOLATED UNGLYCOSYLATED ANTIBODY CH2 DOMAIN
390, 1oqxA, 0.6679, 2.80, 0.043, 210, 94, G-2 GLYCOVARIANT OF HUMAN IGG FC BOUND TO MINIMIZED VERSION OF PROTEIN A CALLED Z34C
391, 5c71B, 0.6678, 2.62, 0.055, 582, 91, THE STRUCTURE OF ASPERGILLUS ORYZAE A-GLUCURONIDASE COMPLEXED WITH GLYCYRRHETINIC ACID MONOGLUCURONIDE
392, 5njdG, 0.6677, 3.09, 0.082, 293, 98, STRUCTURE OF INTERLEUKIN 23 IN COMPLEX WITH BRIAKINUMAB FAB
393, 5bw7B, 0.6672, 2.91, 0.052, 215, 97, CRYSTAL STRUCTURE OF NONFUCOSYLATED FC Y296W MUTANT COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA
394, 5k65A, 0.6669, 2.67, 0.053, 215, 94, CRYSTAL STRUCTURE OF VEGF BINDING IGG1-FC (FCAB CT6)
395, 5mevL, 0.6668, 2.63, 0.055, 213, 91, MCL1 FAB COMPLEX IN COMPLEX WITH COMPOUND 21
396, 5c71D, 0.6667, 2.66, 0.055, 582, 91, THE STRUCTURE OF ASPERGILLUS ORYZAE A-GLUCURONIDASE COMPLEXED WITH GLYCYRRHETINIC ACID MONOGLUCURONIDE
397, 5hyfA, 0.6664, 3.16, 0.041, 209, 97, GLYCOSYLATED KNOB-KNOB FC FRAGMENT (P6122)
398, 5xjfB, 0.6663, 2.91, 0.052, 215, 97, CRYSTAL STRUCTURE OF FUCOSYLATED IGG FC Y296W MUTANT COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA
399, 3aveA, 0.6663, 2.89, 0.042, 211, 95, CRYSTAL STRUCTURE OF THE FUCOSYLATED FC FRAGMENT FROM HUMAN IMMUNOGLOBULIN G1
400, 1nfdE, 0.6661, 2.69, 0.043, 212, 92, AN ALPHA-BETA T CELL RECEPTOR (TCR) HETERODIMER IN COMPLEX WITH AN ANTI-TCR FAB FRAGMENT DERIVED FROM A MITOGENIC ANTIBODY
401, 5xjfA, 0.6660, 2.87, 0.052, 215, 97, CRYSTAL STRUCTURE OF FUCOSYLATED IGG FC Y296W MUTANT COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA
402, 3wknM, 0.6660, 3.00, 0.042, 209, 96, CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG
403, 3wknB, 0.6660, 2.93, 0.042, 210, 95, CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG
404, 3wknI, 0.6659, 3.05, 0.042, 209, 96, CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG
405, 1bhgA, 0.6659, 2.70, 0.066, 611, 91, HUMAN BETA-GLUCURONIDASE AT 2.6 A RESOLUTION
406, 6fczK, 0.6656, 2.80, 0.052, 210, 96, MODEL OF GC1Q-FC COMPLEX BASED ON 7A EM MAP
407, 6e9iB, 0.6656, 2.74, 0.043, 215, 93, THE CRYSTAL STRUCTURE OF BOVINE ULTRALONG ANTIBODY BOV-4 
408, 3ay4B, 0.6656, 2.92, 0.052, 216, 97, CRYSTAL STRUCTURE OF NONFUCOSYLATED FC COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA
409, 5xjeA, 0.6655, 2.87, 0.052, 213, 97, CRYSTAL STRUCTURE OF FUCOSYLATED IGG1 FC COMPLEXED WITH BIS- GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA
410, 3ay4A, 0.6655, 2.84, 0.052, 215, 96, CRYSTAL STRUCTURE OF NONFUCOSYLATED FC COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA
411, 5xjeB, 0.6652, 2.93, 0.052, 215, 97, CRYSTAL STRUCTURE OF FUCOSYLATED IGG1 FC COMPLEXED WITH BIS- GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA
412, 3wknC, 0.6651, 2.95, 0.042, 209, 95, CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG
413, 5j13B, 0.6650, 2.70, 0.087, 213, 92, STRUCTURAL BASIS FOR TSLP ANTAGONISM BY THE THERAPEUTIC ANTIBODY TEZEPELUMAB (MEDI9929 / AMG-157)
414, 4q6yA, 0.6650, 2.80, 0.053, 208, 95, CRYSTAL STRUCTURE OF A CHEMOENZYMATIC GLYCOENGINEERED DISIALYLATED FC (DI-SFC)
415, 4o5lL, 0.6649, 2.86, 0.054, 215, 93, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY F045-092
416, 5c71A, 0.6648, 2.61, 0.055, 583, 91, THE STRUCTURE OF ASPERGILLUS ORYZAE A-GLUCURONIDASE COMPLEXED WITH GLYCYRRHETINIC ACID MONOGLUCURONIDE
417, 4bswA, 0.6646, 3.03, 0.042, 210, 96, HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 2
418, 5vaaB, 0.6645, 2.75, 0.096, 206, 94, CRYSTAL STRUCTURE OF MOUSE IGG2A FC T370K MUTANT
419, 4bm7A, 0.6644, 2.91, 0.043, 207, 94, CRYSTAL STRUCTURE OF IGG FC F241A MUTANT WITH NATIVE GLYCOSYLATION
420, 3aveB, 0.6643, 2.72, 0.053, 208, 94, CRYSTAL STRUCTURE OF THE FUCOSYLATED FC FRAGMENT FROM HUMAN IMMUNOGLOBULIN G1
421, 3dnkA, 0.6641, 2.76, 0.043, 209, 94, ENZYME DEGLYCOSYLATED HUMAN IGG1 FC FRAGMENT
422, 1oqxB, 0.6640, 2.80, 0.043, 209, 94, G-2 GLYCOVARIANT OF HUMAN IGG FC BOUND TO MINIMIZED VERSION OF PROTEIN A CALLED Z34C
423, 1nc4C, 0.6640, 2.76, 0.054, 215, 93, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 2D12.5 FAB COMPLEXED WITH GD- DOTA
424, 3wn5E, 0.6639, 2.91, 0.073, 210, 96, CRYSTAL STRUCTURE OF ASYMMETRICALLY ENGINEERED FC VARIANT IN COMPLEX WITH FCGRIIIA
425, 6chfA, 0.6638, 3.25, 0.041, 211, 97, CRYSTAL STRUCTURE OF A FC FRAGMENT LALA MUTANT (L234A; L235A) OF HUMAN IGG1 (CRYSTAL FORM 1) 
426, 5d6dB, 0.6638, 2.99, 0.042, 208, 95, CRYSTAL STRUCTURE OF GASDALIE IGG1 FC IN COMPLEX WITH FCGRIIIA
427, 3s7gB, 0.6638, 2.81, 0.043, 207, 94, AGLYCOSYLATED HUMAN IGG1 FC FRAGMENT
428, 5bw7A, 0.6637, 2.86, 0.052, 212, 96, CRYSTAL STRUCTURE OF NONFUCOSYLATED FC Y296W MUTANT COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA
429, 4q74A, 0.6637, 2.84, 0.053, 214, 95, F241A FC
430, 5y56A, 0.6636, 3.01, 0.052, 208, 97, FC MUTANT (K392D/K409D/D399K)
431, 3fjtA, 0.6635, 2.81, 0.043, 209, 94, CRYSTAL STRUCTURE OF A HUMAN FC FRAGMENT ENGINEERED FOR EXTENDED SERUM HALF-LIFE
432, 4n0uE, 0.6634, 2.95, 0.052, 209, 96, TERNARY COMPLEX BETWEEN NEONATAL FC RECEPTOR SERUM ALBUMIN AND FC
433, 5l6yL, 0.6633, 2.72, 0.065, 212, 92, IL13 IN COMPLEX WITH TRALOKINUMAB
434, 5iw6A, 0.6633, 2.81, 0.043, 209, 94, ANTI-CD20 MONOCLONAL ANTIBODY FC FRAGMENT
435, 2brrL, 0.6631, 2.97, 0.064, 215, 94, COMPLEX OF THE NEISSERIAL PORA P1.4 EPITOPE PEPTIDE AND TWO FAB-FRAGMENTS (ANTIBODY MN20B9.34)
436, 1igtB, 0.6629, 2.92, 0.084, 444, 95, STRUCTURE OF IMMUNOGLOBULIN
437, 5k64B, 0.6628, 2.71, 0.053, 213, 94, CRYSTAL STRUCTURE OF VEGF BINDING IGG1-FC (FCAB 448)
438, 5hyiD, 0.6628, 2.63, 0.053, 209, 94, GLYCOSYLATED DISULFIDE-LINKED HOLE-HOLE FC FRAGMENT
439, 4hagA, 0.6628, 2.82, 0.053, 208, 94, CRYSTAL STRUCTURE OF FC-FRAGMENT OF HUMAN IGG2 ANTIBODY (CENTERED CRYSTAL FORM)
440, 1ymhA, 0.6627, 3.05, 0.053, 220, 94, ANTI-HCV FAB 19D9D6 COMPLEXED WITH PROTEIN L (PPL) MUTANT A66W
441, 6bhqA, 0.6626, 2.82, 0.074, 208, 95, MOUSE IMMUNOGLOBULIN G 2C FC FRAGMENT WITH COMPLEX-TYPE GLYCAN
442, 6glxL, 0.6625, 2.82, 0.087, 213, 92, STRUCTURE OF GALECTIN-10 IN COMPLEX WITH THE FAB FRAGMENT OF A CHARCOT-LEYDEN CRYSTAL SOLUBILIZING ANTIBODY; 4E8 
443, 2bihA, 0.6625, 3.16, 0.041, 453, 98, CRYSTAL STRUCTURE OF THE MOLYBDENUM-CONTAINING NITRATE REDUCING FRAGMENT OF PICHIA ANGUSTA ASSIMILATORY NITRATE REDUCTASE
444, 1oqoB, 0.6625, 2.81, 0.043, 208, 94, COMPLEX BETWEEN G0 VERSION OF AN FC BOUND TO A MINIMIZED VERSION OF PROTEIN A CALLED MINI-Z
445, 5v43B, 0.6624, 2.96, 0.043, 202, 94, ENGINEERED HUMAN IGG FC DOMAIN AGLYCO801
446, 5d6dA, 0.6623, 2.81, 0.043, 209, 94, CRYSTAL STRUCTURE OF GASDALIE IGG1 FC IN COMPLEX WITH FCGRIIIA
447, 5alcL, 0.6623, 2.67, 0.056, 210, 90, TICAGRELOR ANTIDOTE CANDIDATE FAB 72 IN COMPLEX WITH TICAGRELOR
448, 3wn5D, 0.6623, 2.99, 0.062, 212, 97, CRYSTAL STRUCTURE OF ASYMMETRICALLY ENGINEERED FC VARIANT IN COMPLEX WITH FCGRIIIA
449, 6glxD, 0.6622, 2.78, 0.087, 213, 92, STRUCTURE OF GALECTIN-10 IN COMPLEX WITH THE FAB FRAGMENT OF A CHARCOT-LEYDEN CRYSTAL SOLUBILIZING ANTIBODY; 4E8 
450, 5vu0A, 0.6620, 2.89, 0.052, 215, 97, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN AFUCOSYLATED/GALACTOSYLATED HUMAN IGG1 FC AND FC GAMMA RECEPTOR IIIA (CD16A) WITH MAN5 N-GLYCANS 
451, 2j6eA, 0.6618, 2.80, 0.053, 209, 95, CRYSTAL STRUCTURE OF AN AUTOIMMUNE COMPLEX BETWEEN A HUMAN IGM RHEUMATOID FACTOR AND IGG1 FC REVEALS A NOVEL FC EPITOPE AND EVIDENCE FOR AFFINITY MATURATION
452, 1nc2C, 0.6618, 2.78, 0.054, 215, 93, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 2D12.5 FAB COMPLEXED WITH Y- DOTA
453, 6d4iB, 0.6617, 2.88, 0.042, 209, 95, CRYSTAL STRUCTURE OF A FC FRAGMENT OF RHESUS MACAQUE (MACACA MULATTA) IGG2 
454, 3wjjA, 0.6616, 2.96, 0.052, 212, 96, CRYSTAL STRUCTURE OF IIB SELECTIVE FC VARIANT FC(P238D) IN COMPLEX WITH FCGRIIB
455, 3dnkB, 0.6616, 2.97, 0.042, 210, 95, ENZYME DEGLYCOSYLATED HUMAN IGG1 FC FRAGMENT
456, 2pf6B, 0.6616, 3.19, 0.115, 231, 96, LUTHERAN GLYCOPROTEIN N-TERMINAL DOMAINS 1 AND 2
457, 5mv3S, 0.6615, 3.06, 0.064, 218, 94, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
458, 6bf4C, 0.6614, 2.93, 0.054, 219, 93, CRYSTAL STRUCTURE OF HIV-1 CLADE AE STRAIN CNE55 GP120 CORE IN COMPLEX WITH NEUTRALIZING ANTIBODY VRC-PG05 THAT TARGETS THE CENTER OF THE SILENT FACE ON THE OUTER DOMAIN OF GP120
459, 5yc5B, 0.6614, 3.13, 0.051, 213, 98, CRYSTAL STRUCTURE OF HUMAN IGG-FC IN COMPLEX WITH AGLYCAN AND OPTIMIZED FC GAMMA RECEPTOR IIIA
460, 4m61A, 0.6613, 2.96, 0.042, 219, 95, CRYSTAL STRUCTURE OF UNLIGANDED ANTI-DNA FAB A52
461, 2brrX, 0.6613, 2.82, 0.054, 214, 93, COMPLEX OF THE NEISSERIAL PORA P1.4 EPITOPE PEPTIDE AND TWO FAB-FRAGMENTS (ANTIBODY MN20B9.34)
462, 1kcvL, 0.6613, 2.85, 0.043, 214, 93, CRYSTAL STRUCTURE OF ANTIBODY PC282
463, 1nfdG, 0.6612, 2.74, 0.043, 212, 92, AN ALPHA-BETA T CELL RECEPTOR (TCR) HETERODIMER IN COMPLEX WITH AN ANTI-TCR FAB FRAGMENT DERIVED FROM A MITOGENIC ANTIBODY
464, 5yc5A, 0.6611, 2.88, 0.052, 211, 97, CRYSTAL STRUCTURE OF HUMAN IGG-FC IN COMPLEX WITH AGLYCAN AND OPTIMIZED FC GAMMA RECEPTOR IIIA
465, 1l6xA, 0.6611, 2.97, 0.043, 207, 94, FC FRAGMENT OF RITUXIMAB BOUND TO A MINIMIZED VERSION OF THE B-DOMAIN FROM PROTEIN A CALLED Z34C
466, 3sgkB, 0.6610, 3.17, 0.041, 212, 97, UNIQUE CARBOHYDRATE/CARBOHYDRATE INTERACTIONS ARE REQUIRED FOR HIGH AFFINITY BINDING OF FCGIII AND ANTIBODIES LACKING CORE FUCOSE
467, 4at6L, 0.6609, 2.62, 0.044, 212, 90, FAB FRAGMENT OF ANTIPORPHYRIN ANTIBODY 14H7
468, 5y56B, 0.6608, 2.82, 0.053, 208, 95, FC MUTANT (K392D/K409D/D399K)
469, 4odsL, 0.6608, 2.78, 0.043, 218, 93, UNLIGANDED FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY S55-3
470, 5w08R, 0.6607, 2.65, 0.088, 212, 91, A/TEXAS/50/2012(H3N2) INFLUENZA HEMAGGLUTININ IN COMPLEX WITH K03.12 FAB
471, 5dk2E, 0.6607, 2.86, 0.043, 159, 93, FC HETERODIMER E356K/D399K + K392D/K409D
472, 3zl4L, 0.6606, 2.73, 0.087, 214, 92, ANTIBODY STRUCTURAL ORGANIZATION: ROLE OF KAPPA -  LAMBDA CHAIN CONSTANT DOMAIN SWITCH IN CATALYTIC FUNCTIONALITY
473, 5jsaB, 0.6604, 2.80, 0.078, 204, 90, UNCLEAVED PREFUSION OPTIMIZED GP140 TRIMER WITH AN ENGINEERED 10- RESIDUE HR1 TURN BOUND TO BROADLY NEUTRALIZING ANTIBODIES 8ANC195 AND PGT128
474, 4l4jA, 0.6604, 2.98, 0.053, 208, 95, CRYSTAL STRUCTURE OF FC-FRAGMENT OF HUMAN IGG2-SIGMA ANTIBODY
475, 4k3eL, 0.6604, 2.80, 0.032, 215, 93, CRYSTAL STRUCTURE OF BOVINE ANTIBODY BLV5B8 WITH ULTRALONG CDR H3
476, 3mj9L, 0.6604, 2.68, 0.078, 209, 90, CRYSTAL STRUCTURE OF JAML IN COMPLEX WITH THE STIMULATORY ANTIBODY HL4E10
477, 4wi9A, 0.6603, 2.77, 0.043, 208, 93, STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION I253A/H310A
478, 4j12A, 0.6603, 2.99, 0.052, 209, 97, MONOMERIC FC
479, 3sgkA, 0.6603, 2.85, 0.043, 209, 94, UNIQUE CARBOHYDRATE/CARBOHYDRATE INTERACTIONS ARE REQUIRED FOR HIGH AFFINITY BINDING OF FCGIII AND ANTIBODIES LACKING CORE FUCOSE
480, 5u52B, 0.6602, 2.91, 0.042, 209, 95, HELIX MINIMIZED VERSION OF THE B-DOMAIN FROM PROTEIN A (Z34C0 BOUND TO IGG1 FC (MONOCLINIC FORM)
481, 5k64A, 0.6601, 2.74, 0.053, 213, 94, CRYSTAL STRUCTURE OF VEGF BINDING IGG1-FC (FCAB 448)
482, 4llqB, 0.6601, 2.65, 0.089, 101, 90, STRUCTURE OF REDESIGNED IGG1 FIRST CONSTANT AND LAMBDA DOMAINS (CH1:CLAMBDA CONSTANT REDESIGN 2 BETA CRD2B) AT 1.42A
483, 3wn5A, 0.6601, 3.14, 0.061, 212, 98, CRYSTAL STRUCTURE OF ASYMMETRICALLY ENGINEERED FC VARIANT IN COMPLEX WITH FCGRIIIA
484, 3wknA, 0.6601, 2.99, 0.042, 209, 95, CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG
485, 6e9iD, 0.6600, 2.77, 0.065, 214, 92, THE CRYSTAL STRUCTURE OF BOVINE ULTRALONG ANTIBODY BOV-4 
486, 5kvfL, 0.6600, 2.81, 0.054, 220, 93, ZIKA SPECIFIC ANTIBODY ZV-64 BOUND TO ZIKA ENVELOPE DIII
487, 5c7kB, 0.6600, 2.82, 0.078, 204, 90, CRYSTAL STRUCTURE BG505 SOSIP GP140 HIV-1 ENV TRIMER BOUND TO BROADLY NEUTRALIZING ANTIBODIES PGT128 AND 8ANC195
488, 6e9qF, 0.6599, 2.80, 0.043, 215, 93, THE CRYSTAL STRUCTURE OF BOVINE ULTRALONG ANTIBODY BOV-6 
489, 6bf7F, 0.6599, 2.95, 0.076, 211, 92, CRYO-EM STRUCTURE OF HUMAN INSULIN DEGRADING ENZYME IN COMPLEX WITH FAB H11-E HEAVY CHAIN FAB H11-E LIGHT CHAIN
490, 2dtsB, 0.6599, 2.78, 0.053, 208, 94, CRYSTAL STRUCTURE OF THE DEFUCOSYLATED FC FRAGMENT FROM HUMAN IMMUNOGLOBULIN G1
491, 5njdS, 0.6598, 2.74, 0.088, 214, 91, STRUCTURE OF INTERLEUKIN 23 IN COMPLEX WITH BRIAKINUMAB FAB
492, 6anaL, 0.6597, 2.93, 0.065, 217, 93, LL2 FAB IN COMPLEX WITH ANTI-KAPPA VHH DOMAIN
493, 4ztpL, 0.6597, 2.71, 0.066, 216, 91, FAB STRUCTURE OF RABBIT MONOCLONAL ANTIBODY R53 TARGETING AN EPITOPE IN HIV-1 GP120 C4 REGION
494, 6foeB, 0.6596, 3.04, 0.064, 214, 94, BAXB01 FAB FRAGMENT
495, 6ayzC, 0.6596, 2.92, 0.054, 213, 93, CRYSTAL STRUCTURE OF ASF1-FAB 12E COMPLEX
496, 1etzL, 0.6596, 2.85, 0.043, 215, 93, THE THREE-DIMENSIONAL STRUCTURE OF AN ANTI-SWEETENER FAB NC10.14 SHOWS THE EXTENT OF STRUCTURAL DIVERSITY IN ANTIGEN RECOGNITION BY IMMUNOGLOBULINS
497, 5mu2D, 0.6594, 3.13, 0.063, 218, 95, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
498, 5jdrB, 0.6594, 2.31, 0.057, 209, 88, STRUCTURE OF PD-L1
499, 5xmhA, 0.6593, 2.65, 0.054, 208, 93, CRYSTAL STRUCTURE OF AN IGM RHEUMATOID FACTOR YES8C IN COMPLEX WITH IGG1 FC
500, 4zncD, 0.6593, 2.72, 0.043, 207, 92, FC FRAGMENT OF HUMAN IGG IN COMPLEX WITH THE C DOMAIN OF STAPHYLOCOCCAL PROTEIN A MUTANT - Q9W
501, 4q74B, 0.6593, 2.92, 0.043, 207, 94, F241A FC
502, 2biiB, 0.6593, 3.18, 0.041, 415, 98, CRYSTAL STRUCTURE OF NITRATE-REDUCING FRAGMENT OF ASSIMILATORY NITRATE REDUCTASE FROM PICHIA ANGUSTA
503, 2biiA, 0.6593, 3.18, 0.041, 415, 98, CRYSTAL STRUCTURE OF NITRATE-REDUCING FRAGMENT OF ASSIMILATORY NITRATE REDUCTASE FROM PICHIA ANGUSTA
504, 1oqoA, 0.6593, 2.80, 0.043, 208, 93, COMPLEX BETWEEN G0 VERSION OF AN FC BOUND TO A MINIMIZED VERSION OF PROTEIN A CALLED MINI-Z
505, 4odhL, 0.6592, 2.79, 0.043, 210, 92, CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.UCA A POTENT V1V2- DIRECTED HIV-1 NEUTRALIZING ANTIBODY
506, 4jkmA, 0.6592, 2.64, 0.056, 602, 90, CRYSTAL STRUCTURE OF CLOSTRIDIUM PERFRINGENS BETA-GLUCURONIDASE
507, 3sgjB, 0.6592, 2.97, 0.052, 217, 96, UNIQUE CARBOHYDRATE-CARBOHYDRATE INTERACTIONS ARE REQUIRED FOR HIGH AFFINITY BINDING BETWEEN FCGIII AND ANTIBODIES LACKING CORE FUCOSE
508, 1t89A, 0.6592, 2.83, 0.052, 210, 96, CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR IN COMPLEX WITH AN FC FRAGMENT OF IGG1 (HEXAGONAL)
509, 3fn3B, 0.6590, 2.38, 0.056, 211, 89, DIMERIC STRUCTURE OF PD-L1
510, 6eaqB, 0.6589, 3.05, 0.041, 212, 97, GLYCOSYLATED FCGR3B / CD16B IN COMPLEX WITH AFUCOSYLATED IGG1 FC 
511, 2iqaL, 0.6589, 2.87, 0.054, 219, 93, PFA2 FAB FRAGMENT MONOCLINIC APO FORM
512, 4at6F, 0.6588, 2.63, 0.044, 212, 90, FAB FRAGMENT OF ANTIPORPHYRIN ANTIBODY 14H7
513, 5w08P, 0.6587, 2.68, 0.088, 212, 91, A/TEXAS/50/2012(H3N2) INFLUENZA HEMAGGLUTININ IN COMPLEX WITH K03.12 FAB
514, 5w08J, 0.6587, 2.77, 0.087, 213, 92, A/TEXAS/50/2012(H3N2) INFLUENZA HEMAGGLUTININ IN COMPLEX WITH K03.12 FAB
515, 5k33A, 0.6587, 2.69, 0.065, 213, 93, CRYSTAL STRUCTURE OF EXTRACELLULAR DOMAIN OF HER2 IN COMPLEX WITH FCAB STAB19
516, 6e9uB, 0.6586, 2.80, 0.043, 215, 93, THE CRYSTAL STRUCTURE OF BOVINE ULTRALONG ANTIBODY BOV-7 
517, 1igtD, 0.6586, 3.02, 0.093, 444, 97, STRUCTURE OF IMMUNOGLOBULIN
518, 5n2kA, 0.6584, 2.67, 0.065, 216, 92, STRUCTURE OF UNBOUND BRIAKINUMAB FAB
519, 3bisB, 0.6584, 2.39, 0.056, 212, 89, CRYSTAL STRUCTURE OF THE PD-L1
520, 6fgoC, 0.6583, 2.67, 0.054, 208, 93, FC IN COMPLEX WITH ENGINEERED CALCIUM BINDING DOMAIN Z 
521, 5z19E, 0.6583, 2.65, 0.100, 597, 90, THE CRYSTAL STRUCTURE OF RUMINOCOCCUS GNAVUS BETA-GLUCURONIDASE IN COMPLEX WITH URONIC ISOFAGOMINE 
522, 5js9B, 0.6583, 2.65, 0.079, 204, 89, UNCLEAVED PREFUSION OPTIMIZED GP140 TRIMER WITH AN ENGINEERED 8- RESIDUE HR1 TURN BOUND TO BROADLY NEUTRALIZING ANTIBODIES 8ANC195 AND PGT128
523, 4m1dL, 0.6583, 2.68, 0.065, 216, 92, CRYSTAL STRUCTURE OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 CYCLIC PEPTIDE MN
524, 4bsvB, 0.6583, 3.07, 0.042, 210, 95, HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 1
525, 5vgpB, 0.6582, 2.84, 0.043, 209, 94, FC FRAGMENT OF HUMAN IGG1 ANTIBODY; FROM NIST MAB 
526, 5od0L, 0.6582, 2.68, 0.055, 213, 91, CRYSTAL STRUCTURE OF ACPA E4 
527, 5dk0B, 0.6582, 2.78, 0.043, 206, 93, FC HETERODIMER DESIGN 20.8.34 Y349S/T366M/K370Y/K409V + E356G/E357D/S364Q/Y407A
528, 4bswB, 0.6582, 2.88, 0.043, 210, 94, HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 2
529, 5z19B, 0.6581, 2.66, 0.100, 601, 90, THE CRYSTAL STRUCTURE OF RUMINOCOCCUS GNAVUS BETA-GLUCURONIDASE IN COMPLEX WITH URONIC ISOFAGOMINE 
530, 5z18F, 0.6581, 2.67, 0.100, 582, 90, THE CRYSTAL STRUCTURE OF RUMINOCOCCUS GNAVUS BETA-GLUCURONIDASE 
531, 5njdQ, 0.6581, 2.67, 0.089, 213, 90, STRUCTURE OF INTERLEUKIN 23 IN COMPLEX WITH BRIAKINUMAB FAB
532, 5djdA, 0.6581, 2.79, 0.043, 208, 93, FC HETERODIMER DESIGN 5.1 T366V + Y407F
533, 4wi5B, 0.6581, 2.78, 0.053, 208, 95, STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION H310A
534, 4wi5A, 0.6581, 2.78, 0.053, 208, 95, STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION H310A
535, 4d2nD, 0.6581, 2.94, 0.062, 209, 96, CRYSTAL STRUCTURE OF DEGLYCOSYLATED SERUM-DERIVED HUMAN IGG4 FC
536, 3zo0A, 0.6581, 2.72, 0.086, 208, 93, MOUSE IGG2A IN COMPLEX WITH MOUSE TRIM21 PRYSPRY
537, 2rgsA, 0.6581, 2.73, 0.075, 206, 93, FC-FRAGMENT OF MONOCLONAL ANTIBODY IGG2B FROM MUS MUSCULUS
538, 6fczH, 0.6580, 3.12, 0.051, 216, 99, MODEL OF GC1Q-FC COMPLEX BASED ON 7A EM MAP
539, 5mesL, 0.6580, 2.70, 0.055, 213, 91, MCL1 FAB COMPLEX IN COMPLEX WITH COMPOUND 29
540, 4toyL, 0.6580, 2.71, 0.076, 214, 92, STRUCTURE OF 35O22 FAB A HIV-1 NEUTRALIZING ANTIBODY
541, 4k3dL, 0.6580, 2.88, 0.065, 215, 93, CRYSTAL STRUCTURE OF BOVINE ANTIBODY BLV1H12 WITH ULTRALONG CDR H3
542, 4b7iA, 0.6580, 2.97, 0.043, 208, 94, CRYSTAL STRUCTURE OF HUMAN IGG FC BEARING HYBRID-TYPE GLYCANS
543, 5z19D, 0.6579, 2.66, 0.100, 596, 90, THE CRYSTAL STRUCTURE OF RUMINOCOCCUS GNAVUS BETA-GLUCURONIDASE IN COMPLEX WITH URONIC ISOFAGOMINE 
544, 4m61C, 0.6579, 2.87, 0.054, 219, 93, CRYSTAL STRUCTURE OF UNLIGANDED ANTI-DNA FAB A52
545, 3lmjL, 0.6578, 2.70, 0.066, 215, 91, STRUCTURE OF HUMAN ANTI HIV 21C FAB
546, 6e9hB, 0.6577, 2.82, 0.043, 215, 93, THE CRYSTAL STRUCTURE OF BOVINE ULTRALONG ANTIBODY BOV-3 
547, 5myoA, 0.6577, 3.03, 0.064, 219, 94, STRUCTURE OF PYROGLUTAMATE-ABETA-SPECIFIC FAB C 6 IN COMPLEX WITH HUMAN ABETA-PE3-12-PEGB
548, 5djcE, 0.6577, 2.79, 0.043, 207, 93, FC HETERODIMER DESIGN 8.1 L368V/Y407A + T366V/K409F
549, 6cxsA, 0.6576, 2.63, 0.056, 598, 90, CRYSTAL STRUCTURE OF CLOSTRIDIUM PERFRINGENS BETA-GLUCURONIDASE BOUND WITH A NOVEL; POTENT INHIBITOR 4-(8-(PIPERAZIN-1-YL)-1;2;3;4- TETRAHYDRO-[1;2;3]TRIAZINO[4 ;5 :4;5]THIENO[2;3-C]ISOQUINOLIN-5-YL) MORPHOLINE 
550, 6ct7B, 0.6576, 2.67, 0.056, 211, 90, FAB OF ANTI-A-SYNUCLEIN ANTIBODY BIIB054 IN COMPLEX WITH ACETYLATED A- SYNUCLEIN PEPTIDE (1-10) 
551, 5hyiA, 0.6576, 2.65, 0.054, 209, 93, GLYCOSYLATED DISULFIDE-LINKED HOLE-HOLE FC FRAGMENT
552, 5hyeA, 0.6575, 2.83, 0.043, 208, 94, GLYCOSYLATED KNOB-KNOB FC FRAGMENT (P212121)
553, 2rgsB, 0.6575, 2.74, 0.075, 207, 93, FC-FRAGMENT OF MONOCLONAL ANTIBODY IGG2B FROM MUS MUSCULUS
554, 5i8oL, 0.6574, 3.07, 0.064, 217, 94, HMM5 FAB IN COMPLEX WITH DISACCHARIDE
555, 4w4oB, 0.6574, 2.91, 0.052, 209, 97, HIGH-RESOLUTION CRYSTAL STRUCTURE OF FC BOUND TO ITS HUMAN RECEPTOR FC-GAMMA-RI
556, 4w4oA, 0.6574, 3.17, 0.051, 215, 99, HIGH-RESOLUTION CRYSTAL STRUCTURE OF FC BOUND TO ITS HUMAN RECEPTOR FC-GAMMA-RI
557, 4r97B, 0.6574, 2.79, 0.054, 214, 92, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF KKO
558, 4ku1A, 0.6574, 3.07, 0.042, 207, 95, ROLE OF THE HINGE AND C-GAMMA-2/C-GAMMA-3 INTERFACE IN IMMUNOGLOBIN G1 FC DOMAIN MOTIONS: IMPLICATIONS FOR FC ENGINEERING
559, 1i1cA, 0.6574, 2.59, 0.055, 205, 91, NON-FCRN BINDING FC FRAGMENT OF RAT IGG2A
560, 6bhyA, 0.6573, 2.98, 0.064, 209, 94, MOUSE IMMUNOGLOBULIN G 2C FC FRAGMENT WITH SINGLE GLCNAC
561, 4at6K, 0.6573, 2.64, 0.044, 212, 90, FAB FRAGMENT OF ANTIPORPHYRIN ANTIBODY 14H7
562, 3twcL, 0.6573, 2.80, 0.054, 208, 92, CRYSTAL STRUCTURE OF BROAD AND POTENT HIV-1 NEUTRALIZING ANTIBODY PGT127 IN COMPLEX WITH MAN9
563, 6bz4A, 0.6571, 2.82, 0.043, 207, 93, HUMAN IGG1 LACKING COMPLEMENT-DEPENDENT CYTOTOXICITY: HU3S193 FC MUTANT K322A 
564, 5z18C, 0.6571, 2.66, 0.100, 588, 90, THE CRYSTAL STRUCTURE OF RUMINOCOCCUS GNAVUS BETA-GLUCURONIDASE 
565, 5ywyL, 0.6571, 2.97, 0.054, 214, 93, CRYSTAL STRUCTURE OF THE CLINICALLY IMPORTANT GPCR IN COMPLEX WITH FUNCTIONAL ANTIBODY. 
566, 5njdU, 0.6571, 2.74, 0.088, 215, 91, STRUCTURE OF INTERLEUKIN 23 IN COMPLEX WITH BRIAKINUMAB FAB
567, 6ec6B, 0.6570, 2.68, 0.100, 600, 90, RUMINOCOCCUS GNAVUS BETA-GLUCURONIDASE 
568, 5lg1B, 0.6570, 2.81, 0.064, 208, 94, ROOM TEMPERATURE STRUCTURE OF HUMAN IGG4-FC FROM CRYSTALS ANALYSED IN SITU
569, 3of6E, 0.6570, 2.84, 0.075, 104, 93, HUMAN PRE-T CELL RECEPTOR CRYSTAL STRUCTURE
570, 1ntlA, 0.6570, 2.98, 0.071, 551, 98, MODEL OF MOUSE CRRY-IG DETERMINED BY SOLUTION SCATTERING CURVE FITTING AND HOMOLOGY MODELLING
571, 6fs0L, 0.6568, 2.70, 0.055, 213, 91, INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN FABCOMPLEX IN COMPLEX WITH AZD5991 
572, 6cjxB, 0.6568, 2.93, 0.043, 209, 93, CRYSTAL STRUCTURE OF A FC FRAGMENT LALA MUTANT (L234A; L235A) OF HUMAN IGG1 (CRYSTAL FORM 2) 
573, 5ijvL, 0.6568, 2.78, 0.065, 213, 92, CRYSTAL STRUCTURE OF BOVINE FAB E03
574, 3oklA, 0.6568, 2.83, 0.054, 219, 93, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.8)KDO
575, 3d6gA, 0.6568, 2.84, 0.043, 210, 94, FC FRAGMENT OF IGG1 (HERCEPTIN) WITH PROTEIN-A MIMETIC PEPTIDE DENDRIMER LIGAND.
576, 2xa8L, 0.6568, 2.92, 0.054, 218, 93, CRYSTAL STRUCTURE OF THE FAB DOMAIN OF OMALIZUMAB AT 2.41A
577, 6eaqA, 0.6567, 2.88, 0.052, 210, 96, GLYCOSYLATED FCGR3B / CD16B IN COMPLEX WITH AFUCOSYLATED IGG1 FC 
578, 6cjxA, 0.6567, 2.81, 0.043, 208, 94, CRYSTAL STRUCTURE OF A FC FRAGMENT LALA MUTANT (L234A; L235A) OF HUMAN IGG1 (CRYSTAL FORM 2) 
579, 6a4kO, 0.6567, 2.80, 0.087, 216, 92, HUMAN ANTIBODY 32D6 FAB IN COMPLEX WITH H1N1 INFLUENZA A VIRUS HA1 
580, 5w08N, 0.6567, 2.69, 0.088, 212, 91, A/TEXAS/50/2012(H3N2) INFLUENZA HEMAGGLUTININ IN COMPLEX WITH K03.12 FAB
581, 5ifjH, 0.6567, 2.60, 0.090, 213, 89, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E01 FAB FRAGMENT IN COMPLEX OF PEPTIDE PLQPEQPFP
582, 5djyB, 0.6567, 2.80, 0.043, 207, 93, FC HETERODIMER DESIGN 20.8 Y349S/T366V/K370Y/K409V + E357D/S364Q/Y407A
583, 4jklB, 0.6567, 2.74, 0.067, 587, 90, CRYSTAL STRUCTURE OF STREPTOCOCCUS AGALACTIAE BETA-GLUCURONIDASE IN SPACE GROUP P21212
584, 4c2iN, 0.6567, 2.76, 0.078, 211, 90, CRYO-EM STRUCTURE OF DENGUE VIRUS SEROTYPE 1 COMPLEXED WITH FAB FRAGMENTS OF HUMAN ANTIBODY 1F4
585, 5ocyL, 0.6566, 2.71, 0.055, 213, 91, CRYSTAL STRUCTURE OF ACPA E4 IN COMPLEX WITH CII-C-48-CIT 
586, 5grjA, 0.6566, 2.51, 0.056, 213, 89, CRYSTAL STRUCTURE OF HUMAN PD-L1 WITH MONOCLONAL ANTIBODY AVELUMAB
587, 1z3gM, 0.6566, 2.86, 0.054, 213, 93, CRYSTAL STRUCTURE OF COMPLEX BETWEEN PVS25 AND FAB FRAGMENT OF MALARIA TRANSMISSION BLOCKING ANTIBODY 2A8
588, 1cr9L, 0.6566, 2.95, 0.043, 219, 93, CRYSTAL STRUCTURE OF THE ANTI-PRION FAB 3F4
589, 5yhlL, 0.6565, 2.97, 0.054, 214, 93, CRYSTAL STRUCTURE OF THE CLINICALLY IMPORTANT GPCR IN COMPLEX WITH FUNCTIONAL ANTIBODY. 
590, 5ocxL, 0.6565, 3.05, 0.043, 216, 94, CRYSTAL STRUCTURE OF ACPA E4 IN COMPLEX WITH CII-C-13-CIT 
591, 5iw3A, 0.6565, 2.85, 0.043, 208, 94, ANTI-CD20 MONOCLONAL ANTIBODY FC FRAGMENT
592, 3sy0A, 0.6565, 2.84, 0.054, 219, 93, S25-2- A(2-8)-A(2-4)KDO TRISACCHARIDE COMPLEX
593, 6dlbL, 0.6564, 2.70, 0.078, 210, 90, CRYSTAL STRUCTURE OF AN INFLUENZA A HEMAGGLUTININ ANTIBODY FAB CH65:1203D4 CHIMERA 
594, 5z19F, 0.6564, 2.68, 0.100, 600, 90, THE CRYSTAL STRUCTURE OF RUMINOCOCCUS GNAVUS BETA-GLUCURONIDASE IN COMPLEX WITH URONIC ISOFAGOMINE 
595, 5z18A, 0.6564, 2.68, 0.100, 586, 90, THE CRYSTAL STRUCTURE OF RUMINOCOCCUS GNAVUS BETA-GLUCURONIDASE 
596, 5wccB, 0.6564, 2.83, 0.065, 214, 92, CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING INFLUENZA A ANTIBODY VRC 315 02-1F07 FAB.
597, 5vgpA, 0.6564, 2.85, 0.043, 209, 94, FC FRAGMENT OF HUMAN IGG1 ANTIBODY; FROM NIST MAB 
598, 5myoC, 0.6564, 2.97, 0.053, 219, 94, STRUCTURE OF PYROGLUTAMATE-ABETA-SPECIFIC FAB C 6 IN COMPLEX WITH HUMAN ABETA-PE3-12-PEGB
599, 5ijvC, 0.6564, 2.76, 0.065, 213, 92, CRYSTAL STRUCTURE OF BOVINE FAB E03
600, 4o5iP, 0.6564, 2.68, 0.078, 213, 90, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY F045-092 IN COMPLEX WITH A/VICTORIA/361/2011 (H3N2) INFLUENZA HEMAGGLUTININ
601, 4m6nL, 0.6564, 2.78, 0.087, 216, 92, CRYSTAL STRUCTURE OF ANTI-IL-23 ANTIBODY CNTO1959 AT PH 6.5
602, 3v95A, 0.6564, 2.84, 0.043, 212, 94, CRYSTAL STRUCTURE OF MONOCLONAL HUMAN ANTI-RHESUS D FC AND IGG1 T125(YB2/0) IN THE PRESENCE OF EDTA
603, 3u0tA, 0.6564, 2.92, 0.054, 218, 93, FAB-ANTIBODY COMPLEX
604, 5w08H, 0.6563, 2.76, 0.087, 212, 92, A/TEXAS/50/2012(H3N2) INFLUENZA HEMAGGLUTININ IN COMPLEX WITH K03.12 FAB
605, 4wi9B, 0.6563, 2.99, 0.053, 208, 95, STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION I253A/H310A
606, 4q7dB, 0.6563, 2.85, 0.043, 208, 94, WILD TYPE FC (WTFC)
607, 3s7gA, 0.6563, 2.83, 0.053, 208, 95, AGLYCOSYLATED HUMAN IGG1 FC FRAGMENT
608, 5yupL, 0.6562, 2.94, 0.043, 215, 93, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF FVIIA ANTIBODY MAB4F5 
609, 5djxB, 0.6562, 2.97, 0.043, 207, 94, FC HETERODIMER DESIGN 2.9 L368M/K370E + E357A/S364G
610, 3n9gL, 0.6562, 3.04, 0.053, 220, 94, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE HUMAN NEUTRALIZING ANTI- WEST NILE VIRUS MAB CR4354
611, 3iywM, 0.6562, 3.04, 0.053, 220, 94, WEST NILE VIRUS IN COMPLEX WITH FAB FRAGMENTS OF MAB CR4354 (FITTED COORDINATES OF ENVELOPE PROTEINS AND FAB FRAGMENTS OF ONE ICOSAHEDRAL ASU)
612, 3iywL, 0.6562, 3.04, 0.053, 220, 94, WEST NILE VIRUS IN COMPLEX WITH FAB FRAGMENTS OF MAB CR4354 (FITTED COORDINATES OF ENVELOPE PROTEINS AND FAB FRAGMENTS OF ONE ICOSAHEDRAL ASU)
613, 6cxsB, 0.6561, 2.66, 0.056, 599, 90, CRYSTAL STRUCTURE OF CLOSTRIDIUM PERFRINGENS BETA-GLUCURONIDASE BOUND WITH A NOVEL; POTENT INHIBITOR 4-(8-(PIPERAZIN-1-YL)-1;2;3;4- TETRAHYDRO-[1;2;3]TRIAZINO[4 ;5 :4;5]THIENO[2;3-C]ISOQUINOLIN-5-YL) MORPHOLINE 
614, 5z19C, 0.6561, 2.68, 0.100, 600, 90, THE CRYSTAL STRUCTURE OF RUMINOCOCCUS GNAVUS BETA-GLUCURONIDASE IN COMPLEX WITH URONIC ISOFAGOMINE 
615, 5uhyI, 0.6561, 3.08, 0.053, 214, 94, A HUMAN ANTIBODY AGAINST ZIKA VIRUS CROSSLINKS THE E PROTEIN TO PREVENT INFECTION
616, 5uhyG, 0.6561, 3.08, 0.053, 214, 94, A HUMAN ANTIBODY AGAINST ZIKA VIRUS CROSSLINKS THE E PROTEIN TO PREVENT INFECTION
617, 5njdW, 0.6561, 2.72, 0.088, 214, 91, STRUCTURE OF INTERLEUKIN 23 IN COMPLEX WITH BRIAKINUMAB FAB
618, 5kvgL, 0.6561, 3.08, 0.053, 214, 94, ZIKA SPECIFIC ANTIBODY ZV-67 BOUND TO ZIKA ENVELOPE DIII
619, 5ihuL, 0.6561, 2.78, 0.033, 213, 92, CRYSTAL STRUCTURE OF BOVINE FAB B11
620, 5e99L, 0.6561, 2.78, 0.033, 213, 92, BOVINE FAB FRAGMENT F08_B11
621, 5dk2B, 0.6561, 2.88, 0.043, 208, 94, FC HETERODIMER E356K/D399K + K392D/K409D
622, 4at6B, 0.6561, 2.65, 0.044, 212, 90, FAB FRAGMENT OF ANTIPORPHYRIN ANTIBODY 14H7
623, 3u0tC, 0.6561, 2.92, 0.054, 219, 93, FAB-ANTIBODY COMPLEX
624, 3rpiB, 0.6561, 3.06, 0.054, 203, 93, CRYSTAL STRUCTURE OF FAB FROM 3BNC60 HIGHLY POTENT ANTI-HIV ANTIBODY
625, 1nldL, 0.6561, 3.06, 0.043, 219, 93, FAB FRAGMENT OF A NEUTRALIZING ANTIBODY DIRECTED AGAINST AN EPITOPE OF GP41 FROM HIV-1
626, 1i9jL, 0.6561, 2.97, 0.054, 219, 93, TESTOSTERONE COMPLEX STRUCTURE OF THE RECOMBINANT MONOCLONAL WILD TYPE ANTI-TESTOSTERONE FAB FRAGMENT
627, 5dj8B, 0.6560, 2.80, 0.043, 207, 93, FC HETERODIMER DESIGN 7.7 D399M/Y407A + T366V/K409I
628, 4o5iN, 0.6560, 2.65, 0.089, 213, 90, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY F045-092 IN COMPLEX WITH A/VICTORIA/361/2011 (H3N2) INFLUENZA HEMAGGLUTININ
629, 3rpiL, 0.6560, 3.06, 0.054, 203, 93, CRYSTAL STRUCTURE OF FAB FROM 3BNC60 HIGHLY POTENT ANTI-HIV ANTIBODY
630, 6e9kB, 0.6559, 2.81, 0.065, 214, 92, THE CRYSTAL STRUCTURE OF BOVINE ULTRALONG ANTIBODY BOV-5 
631, 5v4eA, 0.6559, 2.93, 0.062, 218, 96, ENGINEERED HUMAN IGG FC DOMAIN GLYCO801 (FC801)
632, 4zneJ, 0.6559, 2.87, 0.043, 209, 94, IGG1 FC-FCGAMMARI ECD COMPLEX
633, 6chfB, 0.6558, 2.93, 0.043, 208, 93, CRYSTAL STRUCTURE OF A FC FRAGMENT LALA MUTANT (L234A; L235A) OF HUMAN IGG1 (CRYSTAL FORM 1) 
634, 5u15L, 0.6558, 2.67, 0.089, 211, 90, CRYSTAL STRUCTURE OF DH270.UCA3 (UNLIGANDED) FROM THE DH270 BROADLY NEUTRALIZING N332-GLYCAN DEPENDENT LINEAGE
635, 5i8kL, 0.6558, 2.91, 0.054, 216, 93, HHH1 FAB FRAGMENT
636, 1bhgB, 0.6558, 2.86, 0.044, 611, 90, HUMAN BETA-GLUCURONIDASE AT 2.6 A RESOLUTION
637, 5nj3F, 0.6557, 2.83, 0.054, 210, 92, STRUCTURE OF AN ABC TRANSPORTER: COMPLETE STRUCTURE
638, 5nj3D, 0.6557, 2.83, 0.054, 210, 92, STRUCTURE OF AN ABC TRANSPORTER: COMPLETE STRUCTURE
639, 5kvlL, 0.6557, 2.91, 0.065, 214, 93, HUMANIZED 10G4 ANTI-LEUKOTRIENE C4 ANTIBODY FAB FRAGMENT IN COMPLEX WITH LEUKOTRIENE C4
640, 4dvbB, 0.6557, 2.89, 0.054, 215, 93, THE CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF PRO-UPA ANTIBODY MAB-112
641, 3okdA, 0.6557, 2.84, 0.054, 219, 93, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO
642, 2wahB, 0.6557, 2.82, 0.043, 209, 93, CRYSTAL STRUCTURE OF AN IGG1 FC GLYCOFORM (MAN9GLCNAC2)
643, 4wuuD, 0.6556, 2.70, 0.089, 212, 90, STRUCTURE OF ESK1 IN COMPLEX WITH HLA-A*0201/WT1
644, 5vmeA, 0.6555, 2.84, 0.053, 207, 95, CRYSTAL STRUCTURE OF HUMAN IGG1 FC K248E T437R MUTANT
645, 3v8cA, 0.6555, 2.81, 0.043, 212, 94, CRYSTAL STRUCTURE OF MONOCLONAL HUMAN ANTI-RHESUS D FC IGG1 T125(YB2/0) DOUBLE MUTANT (H310 AND H435 IN K)
646, 3v7aG, 0.6555, 2.93, 0.054, 215, 93, STRUCTURAL BASIS FOR BROAD DETECTION OF GENOGROUP II NOROVIRUSES BY A MONOCLONAL ANTIBODY THAT BINDS TO A SITE OCCLUDED IN THE VIRAL PARTICLE
647, 2v17L, 0.6555, 2.81, 0.054, 214, 92, STRUCTURE OF THE COMPLEX OF ANTIBODY MN423 WITH A FRAGMENT OF TAU PROTEIN
648, 5z19A, 0.6554, 2.62, 0.090, 593, 89, THE CRYSTAL STRUCTURE OF RUMINOCOCCUS GNAVUS BETA-GLUCURONIDASE IN COMPLEX WITH URONIC ISOFAGOMINE 
649, 5mu2B, 0.6554, 3.00, 0.053, 218, 94, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
650, 4x4mC, 0.6554, 2.96, 0.062, 212, 97, STRUCTURE OF FCGAMMARI IN COMPLEX WITH FC REVEALS THE IMPORTANCE OF GLYCAN RECOGNITION FOR HIGH AFFINITY IGG BINDING
651, 4x4mA, 0.6554, 2.96, 0.062, 218, 97, STRUCTURE OF FCGAMMARI IN COMPLEX WITH FC REVEALS THE IMPORTANCE OF GLYCAN RECOGNITION FOR HIGH AFFINITY IGG BINDING
652, 4d2nC, 0.6554, 2.67, 0.054, 205, 92, CRYSTAL STRUCTURE OF DEGLYCOSYLATED SERUM-DERIVED HUMAN IGG4 FC
653, 3mlvL, 0.6554, 2.70, 0.078, 218, 90, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH AN NOF V3 PEPTIDE
654, 3mlrL, 0.6554, 2.69, 0.089, 219, 90, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A NY5 V3 PEPTIDE
655, 6fy0L, 0.6553, 2.76, 0.065, 211, 92, CRYSTAL STRUCTURE OF A V2-DIRECTED; RV144 VACCINE-LIKE ANTIBODY FROM HIV-1 INFECTION; CAP228-16H; BOUND TO A HETEROLOGOUS V2 PEPTIDE 
656, 6cjcB, 0.6553, 2.97, 0.043, 207, 94, CRYSTAL STRUCTURE OF A FC FRAGMENT LALA MUTANT (L234A; L235A) OF HUMAN IGG1 (CRYSTAL FORM 3) 
657, 5ye3A, 0.6553, 3.00, 0.054, 213, 93, CRYSTAL STRUCTURE OF THE COMPLEX OF DI-ACETYLATED HISTONE H4 AND 2A7D9 FAB FRAGMENT 
658, 5wccL, 0.6553, 2.84, 0.065, 209, 92, CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING INFLUENZA A ANTIBODY VRC 315 02-1F07 FAB.
659, 3v7aH, 0.6553, 2.93, 0.054, 215, 93, STRUCTURAL BASIS FOR BROAD DETECTION OF GENOGROUP II NOROVIRUSES BY A MONOCLONAL ANTIBODY THAT BINDS TO A SITE OCCLUDED IN THE VIRAL PARTICLE
660, 2vxsO, 0.6553, 2.76, 0.088, 214, 91, STRUCTURE OF IL-17A IN COMPLEX WITH A POTENT FULLY HUMAN NEUTRALISING ANTIBODY
661, 6ii9Q, 0.6552, 2.67, 0.089, 212, 90, CRYSTAL STRUCTURE OF H7 HEMAGGLUTININ FROM A/ANHUI/1/2013 IN COMPLEX WITH A HUMAN NEUTRALIZING ANTIBODY L3A-44 
662, 5vu0B, 0.6552, 3.04, 0.051, 216, 98, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN AFUCOSYLATED/GALACTOSYLATED HUMAN IGG1 FC AND FC GAMMA RECEPTOR IIIA (CD16A) WITH MAN5 N-GLYCANS 
663, 5jnyD, 0.6552, 2.76, 0.054, 214, 92, CRYSTAL STRUCTURE OF 10E8 FAB
664, 3okkA, 0.6552, 2.94, 0.043, 220, 94, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.4)KDO
665, 3ghbM, 0.6552, 2.74, 0.087, 216, 92, CRYSTAL STRUCTURE OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 PEPTIDE W2RW020
666, 1h3wM, 0.6552, 2.78, 0.043, 206, 93, STRUCTURAL ANALYSIS OF HUMAN IGG-FC GLYCOFORMS REVEALS A CORRELATION BETWEEN GLYCOSYLATION AND STRUCTURAL INTEGRITY
667, 1ct8A, 0.6552, 2.90, 0.054, 214, 93, CATALYTIC ANTIBODY 7C8 COMPLEX
668, 6foeL, 0.6551, 2.82, 0.055, 214, 91, BAXB01 FAB FRAGMENT
669, 6azzB, 0.6551, 2.71, 0.078, 212, 90, CRYSTAL STRUCTURE OF PFS25 IN COMPLEX WITH THE TRANSMISSION BLOCKING ANTIBODY 1190
670, 5ea0L, 0.6551, 2.87, 0.054, 219, 92, STRUCTURE OF THE ANTIBODY 7968 WITH HUMAN COMPLEMENT FACTOR H-DERIVED PEPTIDE
671, 4yaqB, 0.6551, 2.71, 0.054, 214, 92, CRYSTAL STRUCTURE OF A COMPUTATIONALLY OPTIMIZED PG9 MUTANT
672, 4o5iR, 0.6551, 2.65, 0.089, 213, 90, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY F045-092 IN COMPLEX WITH A/VICTORIA/361/2011 (H3N2) INFLUENZA HEMAGGLUTININ
673, 1h3uB, 0.6551, 2.64, 0.054, 206, 92, CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENTGLYCOFORM (M3N2F)2
674, 5x4gB, 0.6550, 2.94, 0.054, 213, 93, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-CD147 MONOCLONAL ANTIBODY 6H8
675, 5di8B, 0.6550, 2.80, 0.043, 207, 93, FC KNOB-HOLE HETERODIMER T366W + T366S/L368A/Y407V
676, 5cezL, 0.6550, 2.72, 0.089, 211, 90, CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH AN EARLY PUTATIVE PRECURSOR OF THE PGT121 FAMILY AT 3.0 ANGSTROM
677, 4orgF, 0.6550, 2.74, 0.077, 209, 91, CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.04 A POTENT V1V2-DIRECTED HIV-1 NEUTRALIZING ANTIBODY
678, 4bsvA, 0.6550, 2.89, 0.042, 210, 95, HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 1
679, 3vfgL, 0.6550, 2.81, 0.054, 211, 93, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 3F8 FAB FRAGMENT THAT BINDS TO GD2 GANGLIOSIDE
680, 3fctA, 0.6550, 2.88, 0.054, 213, 92, MATURE METAL CHELATASE CATALYTIC ANTIBODY WITH HAPTEN
681, 6dc7L, 0.6549, 3.03, 0.064, 218, 94, APO FAB STRUCTURE OF MOUSE MONOCLONAL ANTIBODY 8B2 
682, 6azzE, 0.6549, 2.72, 0.078, 212, 90, CRYSTAL STRUCTURE OF PFS25 IN COMPLEX WITH THE TRANSMISSION BLOCKING ANTIBODY 1190
683, 5vaaA, 0.6549, 2.98, 0.074, 207, 95, CRYSTAL STRUCTURE OF MOUSE IGG2A FC T370K MUTANT
684, 5ugyN, 0.6549, 2.68, 0.089, 210, 90, INFLUENZA HEMAGGLUTININ IN COMPLEX WITH A NEUTRALIZING ANTIBODY
685, 4kmtL, 0.6549, 2.95, 0.054, 214, 93, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY 5-51/O12
686, 6e9iL, 0.6548, 2.79, 0.065, 213, 92, THE CRYSTAL STRUCTURE OF BOVINE ULTRALONG ANTIBODY BOV-4 
687, 6dl8L, 0.6548, 2.87, 0.100, 204, 90, CRYSTAL STRUCTURE OF AN INFLUENZA A HEMAGGLUTININ ANTIBODY FAB VARIANT CH67:1203D4 CHIMERA 
688, 5z18E, 0.6548, 2.68, 0.100, 586, 90, THE CRYSTAL STRUCTURE OF RUMINOCOCCUS GNAVUS BETA-GLUCURONIDASE 
689, 4xzuB, 0.6548, 3.01, 0.053, 213, 94, CRYSTAL STRUCTURE OF THE HUMAN FACTOR VIII C2 DOMAIN IN COMPLEX WITH MURINE 3E6 INHIBITORY ANTIBODY
690, 4fqkL, 0.6548, 2.77, 0.087, 214, 92, INFLUENZA B/BRISBANE/60/2008 HEMAGGLUTININ FAB CR8059 COMPLEX
691, 4fqjL, 0.6548, 2.77, 0.087, 215, 92, INFLUENZA B/FLORIDA/4/2006 HEMAGGLUTININ FAB CR8071 COMPLEX
692, 6gkuL, 0.6547, 2.68, 0.055, 214, 91, STRUCTURE OF GALECTIN-10 IN COMPLEX WITH THE FAB FRAGMENT OF A CHARCOT-LEYDEN CRYSTAL SOLUBILIZING ANTIBODY; 6F5 
693, 6cezL, 0.6547, 2.79, 0.066, 212, 91, CRYSTAL STRUCTURE OF RABBIT ANTI-HIV-1 GP120 V2 FAB 16C2 IN COMPLEX WITH V2 PEPTIDE CONB 
694, 5utyL, 0.6547, 2.71, 0.089, 208, 90, CRYSTAL STRUCTURE OF A STABILIZED DS-SOSIP.MUT4 BG505 GP140 HIV-1 ENV TRIMER CONTAINING MUTATIONS I201C-P433C (DS) L154M N300M N302M T320L IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 4.1 ANGSTROM
695, 5djzA, 0.6547, 3.00, 0.042, 209, 95, FC HETERODIMER DESIGN 7.8 D399M/Y407A + T366V/K409V
696, 4jkkA, 0.6547, 2.73, 0.056, 588, 90, CRYSTAL STRUCTURE OF STREPTOCOCCUS AGALACTIAE BETA-GLUCURONIDASE IN SPACE GROUP I222
697, 1t3fA, 0.6547, 2.96, 0.054, 214, 93, THREE DIMENSIONAL STRUCTURE OF A HUMANIZED ANTI-IFN-GAMMA FAB (HUZAF) IN P21 21 21 SPACE GROUP
698, 1hezA, 0.6547, 3.07, 0.064, 214, 94, ANTIBODY-ANTIGEN COMPLEX
699, 5z18D, 0.6546, 2.67, 0.100, 591, 90, THE CRYSTAL STRUCTURE OF RUMINOCOCCUS GNAVUS BETA-GLUCURONIDASE 
700, 5ugyM, 0.6546, 2.68, 0.089, 210, 90, INFLUENZA HEMAGGLUTININ IN COMPLEX WITH A NEUTRALIZING ANTIBODY
701, 5dk0A, 0.6546, 2.82, 0.043, 207, 93, FC HETERODIMER DESIGN 20.8.34 Y349S/T366M/K370Y/K409V + E356G/E357D/S364Q/Y407A
702, 5dj0B, 0.6546, 2.81, 0.043, 207, 93, FC HETERODIMER DESIGN 11.2 Y349S/K370Y + E357D/S364Q
703, 4xptL, 0.6546, 2.83, 0.043, 214, 92, X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER WITH SUBSITEB MUTATIONS D121G/S426M AND EL2 DELETION OF 162-201 IN COMPLEX WITH SUBSTRATE ANALOGUE 34 DICHLOROPHEN ETHYLAMINE
704, 4wi7B, 0.6546, 2.99, 0.043, 208, 94, STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION H435A
705, 4nghL, 0.6546, 2.94, 0.054, 215, 93, CRYSTAL STRUCTURE OF THE HIV-1 NEUTRALIZING ANTIBODY 4E10 FAB FRAGMENT IN COMPLEX WITH A HYDROCARBON-STAPLED PEPTIDE CONTAINING THE 4E10 EPITOPE ON GP41 AND A TETHERED PHOSPHATE MOIETY.
706, 4m6mL, 0.6546, 2.81, 0.054, 216, 92, CRYSTAL STRUCTURE OF ANTI-IL-23 ANTIBODY CNTO1959 AT PH 9.5
707, 4j4pD, 0.6546, 2.84, 0.065, 215, 92, THE COMPLEX OF HUMAN IGE-FC WITH TWO BOUND FAB FRAGMENTS
708, 4edxL, 0.6546, 2.79, 0.054, 214, 92, NERVE GROWTH FACTOR IN COMPLEX WITH FAB FROM MOUSE MAB 911
709, 3m8oL, 0.6546, 2.90, 0.065, 219, 93, HUMAN IGA1 FAB FRAGMENT
710, 6cjcA, 0.6545, 2.98, 0.052, 207, 96, CRYSTAL STRUCTURE OF A FC FRAGMENT LALA MUTANT (L234A; L235A) OF HUMAN IGG1 (CRYSTAL FORM 3) 
711, 5v43A, 0.6545, 2.93, 0.062, 209, 96, ENGINEERED HUMAN IGG FC DOMAIN AGLYCO801
712, 5ik3B, 0.6545, 3.11, 0.064, 220, 94, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E03 FAB FRAGMENT
713, 5bv7B, 0.6545, 2.77, 0.076, 212, 92, CRYSTAL STRUCTURE OF HUMAN LCAT (L4F N5D) IN COMPLEX WITH FAB OF AN AGONISTIC ANTIBODY
714, 4dz8A, 0.6545, 2.83, 0.043, 209, 94, HUMAN IGG1 FC FRAGMENT HETERODIMER
715, 4at6N, 0.6545, 2.67, 0.056, 212, 90, FAB FRAGMENT OF ANTIPORPHYRIN ANTIBODY 14H7
716, 2xqyK, 0.6545, 2.89, 0.043, 218, 93, CRYSTAL STRUCTURE OF PSEUDORABIES CORE FRAGMENT OF GLYCOPROTEIN H IN COMPLEX WITH FAB D6.3
717, 2gj7A, 0.6545, 2.80, 0.043, 207, 93, CRYSTAL STRUCTURE OF A GE-GI/FC COMPLEX
718, 2g2rA, 0.6545, 2.97, 0.054, 219, 93, GREEN-FLUORESCENT ANTIBODY 11G10 IN COMPLEX WITH ITS HAPTEN (NITRO-STILBENE DERIVATIVE)
719, 2fd6L, 0.6545, 3.07, 0.053, 214, 94, STRUCTURE OF HUMAN UROKINASE PLASMINOGEN ACTIVATOR IN COMPLEX WITH UROKINASE RECEPTOR AND AN ANTI-UPAR ANTIBODY AT 1.9 A
720, 1dn2A, 0.6545, 2.80, 0.043, 207, 93, FC FRAGMENT OF HUMAN IGG1 IN COMPLEX WITH AN ENGINEERED 13 RESIDUE PEPTIDE DCAWHLGELVWCT-NH2
721, 5tfwL, 0.6544, 2.72, 0.065, 213, 92, CRYSTAL STRUCTURE OF 10E8 FAB LIGHT CHAIN MUTANT2 AGAINST THE MPER REGION OF THE HIV-1 ENV IN COMPLEX WITH T117V2 EPITOPE SCAFFOLD
722, 5anmC, 0.6544, 2.69, 0.089, 213, 90, CRYSTAL STRUCTURE OF IGE FC IN COMPLEX WITH A NEUTRALIZING ANTIBODY
723, 4q6yB, 0.6544, 2.90, 0.054, 206, 93, CRYSTAL STRUCTURE OF A CHEMOENZYMATIC GLYCOENGINEERED DISIALYLATED FC (DI-SFC)
724, 4o5iT, 0.6544, 2.67, 0.089, 213, 90, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY F045-092 IN COMPLEX WITH A/VICTORIA/361/2011 (H3N2) INFLUENZA HEMAGGLUTININ
725, 1um4L, 0.6544, 3.02, 0.053, 219, 94, CATALYTIC ANTIBODY 21H3 WITH HAPTEN
726, 5drnB, 0.6543, 2.57, 0.067, 215, 90, CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU24 IN COMPLEX WITH HYPUSINE
727, 4x7sL, 0.6543, 2.76, 0.054, 218, 92, STRUCTURE OF OMALIZUMAB FAB FRAGMENT CRYSTAL FORM 1
728, 4l5fL, 0.6543, 2.83, 0.043, 213, 92, CRYSTAL STRUCTURE OF DENV1-E106 FAB BOUND TO DENV-1 ENVELOPE PROTEIN DIII
729, 3mlzL, 0.6543, 2.77, 0.054, 214, 92, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 3074 IN COMPLEX WITH A VI191 V3 PEPTIDE
730, 2g2rL, 0.6543, 2.96, 0.054, 219, 93, GREEN-FLUORESCENT ANTIBODY 11G10 IN COMPLEX WITH ITS HAPTEN (NITRO-STILBENE DERIVATIVE)
731, 2aj3A, 0.6543, 2.90, 0.054, 212, 92, CRYSTAL STRUCTURE OF A CROSS-REACTIVE HIV-1 NEUTRALIZING CD4-BINDING SITE ANTIBODY FAB M18
732, 1xf2A, 0.6543, 2.98, 0.054, 213, 93, STRUCTURE OF FAB DNA-1 COMPLEXED WITH DT3
733, 1q9wC, 0.6543, 2.84, 0.054, 219, 93, S45-18 FAB PENTASACCHARIDE BISPHOSPHATE COMPLEX
734, 6mdtL, 0.6542, 2.73, 0.089, 211, 90, CRYSTAL STRUCTURE OF THE B41 SOSIP.664 ENV TRIMER WITH PGT124 AND 35O22 FABS; IN P63 SPACE GROUP 
735, 5nscB, 0.6542, 3.07, 0.042, 210, 96, FC DEKK HETERODIMER VARIANT
736, 5iltL, 0.6542, 2.80, 0.033, 213, 92, CRYSTAL STRUCTURE OF BOVINE FAB A01
737, 5djcA, 0.6542, 2.79, 0.053, 207, 94, FC HETERODIMER DESIGN 8.1 L368V/Y407A + T366V/K409F
738, 4yaqL, 0.6542, 2.76, 0.087, 214, 92, CRYSTAL STRUCTURE OF A COMPUTATIONALLY OPTIMIZED PG9 MUTANT
739, 4o5iV, 0.6542, 2.67, 0.089, 213, 90, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY F045-092 IN COMPLEX WITH A/VICTORIA/361/2011 (H3N2) INFLUENZA HEMAGGLUTININ
740, 4nqsA, 0.6542, 2.85, 0.053, 210, 95, KNOB-INTO-HOLE IGG FC
741, 4lluB, 0.6542, 2.72, 0.089, 210, 90, STRUCTURE OF PERTUZUMAB FAB WITH LIGHT CHAIN CLAMBDA AT 2.16A
742, 3gi8L, 0.6542, 2.86, 0.043, 220, 93, CRYSTAL STRUCTURE OF APCT K158A TRANSPORTER BOUND TO 7F11 MONOCLONAL FAB FRAGMENT
743, 6d58A, 0.6541, 2.81, 0.043, 207, 93, CRYSTAL STRUCTURE OF A FC FRAGMENT OF HUMAN IGG3 
744, 5dj6B, 0.6541, 2.82, 0.043, 207, 93, FC HETERODIMER DESIGN 6.1 F405W/Y407A + T366M
745, 4qgtB, 0.6541, 2.81, 0.053, 207, 95, THE CRYSTAL STRUCTURE OF HUMAN IGG FC DOMAIN WITH ENHANCED AROMATIC SEQUON
746, 4hafA, 0.6541, 2.90, 0.053, 209, 94, CRYSTAL STRUCTURE OF FC-FRAGMENT OF HUMAN IGG2 ANTIBODY (PRIMITIVE CRYSTAL FORM)
747, 4gxuR, 0.6541, 2.70, 0.089, 213, 90, CRYSTAL STRUCTURE OF ANTIBODY 1F1 BOUND TO THE 1918 INFLUENZA HEMAGGLUTININ
748, 4edxA, 0.6541, 2.87, 0.043, 214, 93, NERVE GROWTH FACTOR IN COMPLEX WITH FAB FROM MOUSE MAB 911
749, 3c2aL, 0.6541, 2.77, 0.087, 216, 92, ANTIBODY FAB FRAGMENT 447-52D IN COMPLEX WITH UG1033 PEPTIDE
750, 2vdkL, 0.6541, 3.03, 0.053, 214, 94, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE
751, 2r8sL, 0.6541, 2.94, 0.054, 214, 93, HIGH RESOLUTION STRUCTURE OF A SPECIFIC SYNTHETIC FAB BOUND TO P4-P6 RNA RIBOZYME DOMAIN
752, 2oldA, 0.6541, 2.73, 0.054, 216, 92, BENCE JONES KWR PROTEIN- IMMUNOGLOBULIN LIGHT CHAIN DIMER P3(2)21 CRYSTAL FORM
753, 5vkdL, 0.6540, 2.98, 0.054, 213, 93, CRYSTAL STRUCTURE OF C-TERMINAL DOMAIN OF EBOLA (BUNDIBUGYO) NUCLEOPROTEIN IN COMPLEX WITH FAB FRAGMENT 
754, 5njdM, 0.6540, 2.70, 0.089, 213, 90, STRUCTURE OF INTERLEUKIN 23 IN COMPLEX WITH BRIAKINUMAB FAB
755, 5jdrA, 0.6540, 2.41, 0.056, 209, 89, STRUCTURE OF PD-L1
756, 4m5zL, 0.6540, 2.73, 0.088, 212, 91, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY 5J8 BOUND TO 2009 PANDEMIC INFLUENZA HEMAGGLUTININ HA1 SUBUNIT
757, 3mltG, 0.6540, 2.64, 0.090, 213, 89, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A UG1033 V3 PEPTIDE
758, 1nj9L, 0.6540, 2.70, 0.056, 212, 90, COCAINE HYDROLYTIC ANTIBODY 15A10
759, 6fgoB, 0.6539, 2.82, 0.053, 209, 94, FC IN COMPLEX WITH ENGINEERED CALCIUM BINDING DOMAIN Z 
760, 5dj2B, 0.6539, 2.82, 0.043, 207, 93, FC HETERODIMER DESIGN 7.4 Y407A + T366V/K409V
761, 3muhL, 0.6539, 2.74, 0.078, 212, 90, CRYSTAL STRUCTURE OF PG9 LIGHT CHAIN
762, 3mlvM, 0.6539, 2.72, 0.078, 219, 90, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH AN NOF V3 PEPTIDE
763, 3do3B, 0.6539, 2.87, 0.053, 210, 95, HUMAN 1GG1 FC FRAGMENT 2.5 ANGSTROM STRUCTURE
764, 2r2eA, 0.6539, 2.95, 0.054, 219, 93, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
765, 1fc1B, 0.6539, 2.63, 0.044, 206, 91, CRYSTALLOGRAPHIC REFINEMENT AND ATOMIC MODELS OF A HUMAN FC FRAGMENT AND ITS COMPLEX WITH FRAGMENT B OF PROTEIN A FROM STAPHYLOCOCCUS AUREUS AT 2.9-AND 2.8-ANGSTROMS RESOLUTION
766, 5u3oL, 0.6538, 2.98, 0.054, 216, 93, CRYSTAL STRUCTURE OF DH511.2_K3 FAB IN COMPLEX WITH HIV-1 GP41 MPER PEPTIDE
767, 5hyiB, 0.6538, 3.03, 0.052, 209, 96, GLYCOSYLATED DISULFIDE-LINKED HOLE-HOLE FC FRAGMENT
768, 5dt1L, 0.6538, 2.73, 0.077, 215, 91, CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.25 A POTENT V1V2-DIRECTED HIV-1 BROADLY NEUTRALIZING ANTIBODY
769, 3t65A, 0.6538, 2.86, 0.054, 219, 93, S25-2- A(2-8)KDO DISACCHARIDE COMPLEX
770, 1um5L, 0.6538, 3.07, 0.053, 216, 94, CATALYTIC ANTIBODY 21H3 WITH ALCOHOL SUBSTRATE
771, 1adqL, 0.6538, 2.92, 0.075, 213, 93, CRYSTAL STRUCTURE OF A HUMAN IGM RHEUMATOID FACTOR FAB IN COMPLEX WITH ITS AUTOANTIGEN IGG FC
772, 6chbL, 0.6537, 2.87, 0.076, 205, 92, CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND IOMA 
773, 5w6dL, 0.6537, 2.73, 0.089, 211, 90, CRYSTAL STRUCTURE OF BG505-SOSIP.V4.1-GT1-N137A IN COMPLEX WITH FABS 35022 AND 9H/109L
774, 5ugyL, 0.6537, 2.69, 0.089, 210, 90, INFLUENZA HEMAGGLUTININ IN COMPLEX WITH A NEUTRALIZING ANTIBODY
775, 5n2kC, 0.6537, 2.77, 0.087, 215, 92, STRUCTURE OF UNBOUND BRIAKINUMAB FAB
776, 5dscB, 0.6537, 2.58, 0.067, 212, 90, CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU24.B IN COMPLEX WITH HYPUSINE
777, 4k3dM, 0.6537, 2.83, 0.065, 213, 92, CRYSTAL STRUCTURE OF BOVINE ANTIBODY BLV1H12 WITH ULTRALONG CDR H3
778, 4c83D, 0.6537, 2.86, 0.054, 213, 93, CRYSTAL STRUCTURE OF THE IGG2A LPT3 IN COMPLEX WITH AN 8- SUGAR INNER CORE ANALOGUE OF NEISSERIA MENINGITIDIS
779, 2b4cL, 0.6537, 3.05, 0.074, 215, 94, CRYSTAL STRUCTURE OF HIV-1 JR-FL GP120 CORE PROTEIN CONTAINING THE THIRD VARIABLE REGION (V3) COMPLEXED WITH CD4 AND THE X5 ANTIBODY
780, 1ynkL, 0.6537, 3.12, 0.042, 219, 95, IDENTIFICATION OF KEY RESIDUES OF THE NC6.8 FAB ANTIBODY FRAGMENT BINDING TO SYNTHETIC SWEETENERS: CRYSTAL STRUCTURE OF NC6.8 CO-CRYSTALIZED WITH HIGH POTENCY SWEETENER COMPOUND SC45647
781, 1cu4L, 0.6537, 2.88, 0.054, 219, 93, CRYSTAL STRUCTURE OF THE ANTI-PRION FAB 3F4 IN COMPLEX WITH ITS PEPTIDE EPITOPE
782, 1ct8C, 0.6537, 2.91, 0.043, 214, 93, CATALYTIC ANTIBODY 7C8 COMPLEX
783, 6k7oC, 0.6536, 3.11, 0.064, 218, 94, COMPLEX STRUCTURE OF LILRB4 AND H128-3 ANTIBODY 
784, 5z18B, 0.6536, 2.69, 0.100, 586, 90, THE CRYSTAL STRUCTURE OF RUMINOCOCCUS GNAVUS BETA-GLUCURONIDASE 
785, 5jikA, 0.6536, 2.84, 0.043, 201, 93, CRYSTAL STRUCTURE OF HER2 BINDING IGG1-FC (FCAB H10-03-6)
786, 4ydjL, 0.6536, 2.77, 0.076, 205, 92, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY 44- VRC13.01 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057 GP120
787, 2vdlL, 0.6536, 3.04, 0.053, 214, 94, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE
788, 5wawL, 0.6535, 2.90, 0.054, 218, 92, FCABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION-MAKING IN ANTIBODY DRUG DISCOVERY
789, 5mvjL, 0.6535, 2.99, 0.054, 219, 93, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACE-GROUP P1 
790, 3ulsA, 0.6535, 2.79, 0.087, 211, 92, CRYSTAL STRUCTURE OF FAB12
791, 3t4yA, 0.6535, 2.75, 0.054, 219, 92, S25-2- KDO MONOSACCHARIDE COMPLEX
792, 2qhrL, 0.6535, 2.65, 0.055, 218, 91, CRYSTAL STRUCTURE OF THE 13F6-1-2 FAB FRAGMENT BOUND TO ITS EBOLA VIRUS GLYCOPROTEIN PEPTIDE EPITOPE.
793, 6d58B, 0.6534, 2.80, 0.053, 207, 94, CRYSTAL STRUCTURE OF A FC FRAGMENT OF HUMAN IGG3 
794, 6d4mA, 0.6534, 3.02, 0.063, 208, 95, CRYSTAL STRUCTURE OF A FC FRAGMENT OF RHESUS MACAQUE (MACACA MULATTA) IGG3 
795, 6bzwH, 0.6534, 2.99, 0.054, 218, 93, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE GL PRECURSOR OF THE BROADLY NEUTRALIZING ANTIBODY AP33 
796, 4zncE, 0.6534, 2.76, 0.054, 207, 93, FC FRAGMENT OF HUMAN IGG IN COMPLEX WITH THE C DOMAIN OF STAPHYLOCOCCAL PROTEIN A MUTANT - Q9W
797, 4z8fL, 0.6534, 2.94, 0.054, 214, 93, FAB STRUCTURE OF ANTIBODY S1-15 IN COMPLEX WITH SSDNA DNA 5 -P5(DT)P- 3 
798, 4rrpF, 0.6534, 3.13, 0.064, 214, 94, CRYSTAL STRUCTURE OF THE FAB COMPLEXED WITH ANTIGEN ASF1P NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET PDR16
799, 1ntlB, 0.6534, 3.09, 0.061, 551, 98, MODEL OF MOUSE CRRY-IG DETERMINED BY SOLUTION SCATTERING CURVE FITTING AND HOMOLOGY MODELLING
800, 6r8xB, 0.6533, 2.72, 0.089, 211, 90, COAGULATION FACTOR XI CATALYTIC DOMAIN IN COMPLEX WITH FAB-PORTION OF MAA868 
801, 6njmJ, 0.6533, 3.00, 0.000, 213, 93, STRUCTURE OF A COMPLEX 
802, 5mykA, 0.6533, 3.02, 0.053, 219, 94, STRUCTURE OF PYROGLUTAMATE-ABETA-SPECIFIC FAB C 17 IN COMPLEX WITH MURINE ABETA-PE3-18PEGB
803, 5kg9L, 0.6533, 2.70, 0.089, 218, 90, CRYSTAL STRUCTURE OF THE GP120 V2 ANTIBODY RE505-22 FAB FROM IGH- AND IGK-HUMANIZED MOUSE
804, 5ihzL, 0.6533, 2.76, 0.088, 215, 91, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E01 FAB FRAGMENT
805, 4ocrL, 0.6533, 2.96, 0.054, 216, 93, CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.01 A POTENT V1V2-DIRECTED HIV-1 NEUTRALIZING ANTIBODY
806, 4dcqA, 0.6533, 2.74, 0.054, 218, 92, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF 3B5H10 AN ANTIBODY-SPECIFIC FOR EXTENDED POLYGLUTAMINE REPEATS (ORTHORHOMBIC FORM)
807, 4d9rL, 0.6533, 3.02, 0.054, 214, 93, INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D
808, 6rcuC, 0.6532, 2.68, 0.078, 211, 90, PFRH5 BOUND TO MONOCLONAL ANTIBODIES R5.004 AND R5.016 
809, 5t5bL, 0.6532, 2.76, 0.088, 212, 91, CRYSTAL STRUCTURE OF THE COMPLEX OF 10E8 FAB LIGHT CHAIN MUTANT5 AND T117V2 HIV-1 MPER SCAFFOLD
810, 5kg9B, 0.6532, 2.71, 0.089, 218, 90, CRYSTAL STRUCTURE OF THE GP120 V2 ANTIBODY RE505-22 FAB FROM IGH- AND IGK-HUMANIZED MOUSE
811, 5jnyB, 0.6532, 2.80, 0.088, 212, 91, CRYSTAL STRUCTURE OF 10E8 FAB
812, 5hysB, 0.6532, 3.07, 0.065, 217, 93, STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB
813, 4dqoL, 0.6532, 2.73, 0.055, 214, 91, CRYSTAL STRUCTURE OF PG16 FAB IN COMPLEX WITH V1V2 REGION FROM HIV-1 STRAIN ZM109
814, 4d9rD, 0.6532, 2.92, 0.054, 213, 92, INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D
815, 2g75B, 0.6532, 2.73, 0.066, 211, 91, CRYSTAL STRUCTURE OF ANTI-SARS M396 ANTIBODY
816, 1xf5A, 0.6532, 3.04, 0.053, 220, 94, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (H74C Y64W)IN SPACE GROUP P21212
817, 5v4eG, 0.6531, 2.97, 0.062, 219, 97, ENGINEERED HUMAN IGG FC DOMAIN GLYCO801 (FC801)
818, 5mu2N, 0.6531, 3.03, 0.053, 218, 94, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
819, 5lspT, 0.6531, 2.82, 0.056, 212, 90, 107_A07 FAB IN COMPLEX WITH FRAGMENT OF THE MET RECEPTOR
820, 4wi7A, 0.6531, 2.90, 0.043, 208, 94, STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION H435A
821, 2vc2L, 0.6531, 3.04, 0.053, 214, 94, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST L-739758
822, 2g75D, 0.6531, 2.73, 0.066, 211, 91, CRYSTAL STRUCTURE OF ANTI-SARS M396 ANTIBODY
823, 6ii9L, 0.6530, 2.70, 0.078, 212, 90, CRYSTAL STRUCTURE OF H7 HEMAGGLUTININ FROM A/ANHUI/1/2013 IN COMPLEX WITH A HUMAN NEUTRALIZING ANTIBODY L3A-44 
824, 6dc9M, 0.6530, 3.21, 0.053, 215, 95, FAB/EPITOPE COMPLEX OF HUMAN CHIMERIC MONOCLONAL ANTIBODY H4E6 TARGETING A PHOSPHORYLATED TAU EPITOPE. 
825, 5wavA, 0.6530, 2.86, 0.043, 207, 93, FC ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION-MAKING IN ANTIBODY DRUG DISCOVERY.
826, 4q6iD, 0.6530, 2.96, 0.053, 218, 94, CRYSTAL STRUCTURE OF MURINE 2D5 FAB A POTENT ANTI-CD4 HIV-1- NEUTRALIZING ANTIBODY IN COMPLEX WITH CD4
827, 4d9lO, 0.6530, 2.55, 0.044, 215, 90, FAB STRUCTURE OF ANTI-HIV-1 GP120 V2 MAB 697
828, 3mlyM, 0.6530, 2.80, 0.076, 214, 92, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 3074 IN COMPLEX WITH A UR29 V3 PEPTIDE
829, 2j6eM, 0.6530, 2.77, 0.076, 215, 92, CRYSTAL STRUCTURE OF AN AUTOIMMUNE COMPLEX BETWEEN A HUMAN IGM RHEUMATOID FACTOR AND IGG1 FC REVEALS A NOVEL FC EPITOPE AND EVIDENCE FOR AFFINITY MATURATION
830, 5mu0L, 0.6529, 3.15, 0.064, 217, 94, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (IA03)
831, 4z95L, 0.6529, 2.94, 0.054, 214, 93, FAB STRUCTURE OF ANTIBODY S1-15 IN COMPLEX WITH SSDNA DNA 5 -5(DT)-P- 3 
832, 4qciA, 0.6529, 2.69, 0.055, 206, 91, PDGF-B BLOCKING ANTIBODY BOUND TO PDGF-BB
833, 2vdmL, 0.6529, 3.05, 0.053, 214, 94, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST TIROFIBAN
834, 2blfA, 0.6529, 2.91, 0.053, 373, 94, SULFITE DEHYDROGENASE FROM STARKEYA NOVELLA
835, 6k7oG, 0.6528, 3.10, 0.064, 218, 94, COMPLEX STRUCTURE OF LILRB4 AND H128-3 ANTIBODY 
836, 6ce0E, 0.6528, 2.89, 0.054, 213, 92, CRYSTAL STRUCTURE OF A HIV-1 CLADE B TIER-3 ISOLATE H078.14 UFO-BG ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING FABS PGT124 AND 35O22 AT 4.6 ANGSTROM 
837, 5w4lE, 0.6528, 3.01, 0.065, 213, 92, CRYSTAL STRUCTURE OF THE NON-NEUTRALIZING AND ADCC-POTENT C11-LIKE ANTIBODY N12-I3 IN COMPLEX WITH HIV-1 CLADE A/E GP120 THE CD4 MIMETIC M48U1 AND THE ANTIBODY N5-I5.
838, 5ivzC, 0.6528, 3.10, 0.065, 213, 93, CETUXIMAB FAB IN COMPLEX WITH ARG8CIR MEDITOPE VARIANT
839, 5fehC, 0.6528, 3.04, 0.064, 214, 94, CRYSTAL STRUCTURE OF PCT64_35B A BROADLY NEUTRALIZING ANTI-HIV ANTIBODY
840, 5dk2A, 0.6528, 2.88, 0.053, 207, 95, FC HETERODIMER E356K/D399K + K392D/K409D
841, 4n9gB, 0.6528, 3.13, 0.064, 214, 94, CRYSTAL STRUCTURE OF A COMPUTATIONALLY DESIGNED RSV-PRESENTING EPITOPE SCAFFOLD AND ITS ELICITED ANTIBODY 17HD9
842, 6idgL, 0.6527, 2.58, 0.044, 217, 90, ANTIBODY 64M-5 FAB IN COMPLEX WITH DT(6-4)T 
843, 5xjmL, 0.6527, 3.06, 0.054, 212, 93, COMPLEX STRUCTURE OF ANGIOTENSIN II TYPE 2 RECEPTOR WITH FAB 
844, 5w6dE, 0.6527, 2.88, 0.054, 213, 92, CRYSTAL STRUCTURE OF BG505-SOSIP.V4.1-GT1-N137A IN COMPLEX WITH FABS 35022 AND 9H/109L
845, 5mubD, 0.6527, 2.87, 0.043, 217, 92, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (CG05)
846, 5jorA, 0.6527, 2.82, 0.054, 218, 92, CRYSTAL STRUCTURE OF UNBOUND ANTI-GLYCAN ANTIBODY FAB14.22 AT 2.2 A
847, 4ztoM, 0.6527, 2.74, 0.066, 216, 91, FAB/EPITOPE COMPLEX STRUCTURE OF RABBIT MONOCLONAL ANTIBODY R53 TARGETING AN EPITOPE IN HIV-1 GP120 C4 REGION
848, 4wi8A, 0.6527, 2.68, 0.055, 208, 91, STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION Y436A
849, 4q6iF, 0.6527, 2.96, 0.053, 218, 94, CRYSTAL STRUCTURE OF MURINE 2D5 FAB A POTENT ANTI-CD4 HIV-1- NEUTRALIZING ANTIBODY IN COMPLEX WITH CD4
850, 3ujjL, 0.6527, 2.91, 0.076, 213, 92, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 4025 IN COMPLEX WITH CON A PEPTIDE
851, 2fb4L, 0.6527, 2.93, 0.054, 216, 93, DIR PRIMAERSTRUKTUR DES KRISTALLISIERBAREN MONOKLONALEN IMMUNOGLOBULINS IGG1 KOL. II. AMINOSAEURESEQUENZ DER L- KETTE LAMBDA-TYP SUBGRUPPE I (GERMAN)
852, 6ii9N, 0.6526, 2.74, 0.078, 212, 90, CRYSTAL STRUCTURE OF H7 HEMAGGLUTININ FROM A/ANHUI/1/2013 IN COMPLEX WITH A HUMAN NEUTRALIZING ANTIBODY L3A-44 
853, 6h3hB, 0.6526, 2.81, 0.054, 215, 92, FAB FRAGMENT OF ANTIBODY AGAINST FULLERENE C60 
854, 5wduS, 0.6526, 2.74, 0.089, 210, 90, HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB 35O22 FAB AND NIH45-46 SCFV
855, 5w08L, 0.6526, 2.76, 0.088, 211, 91, A/TEXAS/50/2012(H3N2) INFLUENZA HEMAGGLUTININ IN COMPLEX WITH K03.12 FAB
856, 4byhB, 0.6526, 3.12, 0.042, 209, 96, CRYSTAL STRUCTURE OF SIALYLATED IGG FC
857, 3j1sL, 0.6526, 2.87, 0.054, 214, 93, STRUCTURE OF ADENO-ASSOCIATED VIRUS-2 IN COMPLEX WITH NEUTRALIZING MONOCLONAL ANTIBODY A20
858, 3d6gB, 0.6526, 3.00, 0.053, 209, 95, FC FRAGMENT OF IGG1 (HERCEPTIN) WITH PROTEIN-A MIMETIC PEPTIDE DENDRIMER LIGAND.
859, 1ospL, 0.6526, 2.87, 0.054, 214, 93, CRYSTAL STRUCTURE OF OUTER SURFACE PROTEIN A OF BORRELIA BURGDORFERI COMPLEXED WITH A MURINE MONOCLONAL ANTIBODY FAB
860, 6njmN, 0.6525, 2.85, 0.000, 213, 92, STRUCTURE OF A COMPLEX 
861, 6bzwD, 0.6525, 2.83, 0.054, 216, 92, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE GL PRECURSOR OF THE BROADLY NEUTRALIZING ANTIBODY AP33 
862, 4wi6B, 0.6525, 3.00, 0.043, 208, 94, STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION N434A
863, 3s37L, 0.6525, 2.97, 0.054, 212, 92, STRUCTURAL BASIS FOR THE FUNCTION OF TWO ANTI-VEGF RECEPTOR ANTIBODIES
864, 2y7qB, 0.6525, 3.32, 0.061, 287, 99, THE HIGH-AFFINITY COMPLEX BETWEEN IGE AND ITS RECEPTOR FC EPSILON RI
865, 2p8pA, 0.6525, 2.85, 0.066, 214, 91, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE LELDKWASLW[N-AC]
866, 1i1cB, 0.6525, 2.57, 0.066, 205, 91, NON-FCRN BINDING FC FRAGMENT OF RAT IGG2A
867, 5mv3M, 0.6524, 2.86, 0.043, 218, 93, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
868, 5esqC, 0.6524, 2.72, 0.055, 213, 91, CETUXIMAB FAB IN COMPLEX WITH CYCLIC BETA-ALANINE-LINKED MEDITOPE
869, 4wi2B, 0.6524, 3.01, 0.053, 208, 95, STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC (WILD-TYPE)
870, 4wi2A, 0.6524, 2.81, 0.043, 208, 93, STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC (WILD-TYPE)
871, 4isvA, 0.6524, 2.67, 0.056, 217, 90, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF 1C2 A MONOCLONAL ANTIBODY SPECIFIC FOR POLY-GLUTAMINE
872, 3levL, 0.6524, 3.02, 0.054, 214, 93, HIV-1 ANTIBODY 2F5 IN COMPLEX WITH EPITOPE SCAFFOLD ES2
873, 2bpbA, 0.6524, 2.91, 0.053, 373, 94, SULFITE DEHYDROGENASE FROM STARKEYA NOVELLA
874, 1etzA, 0.6524, 2.77, 0.054, 215, 92, THE THREE-DIMENSIONAL STRUCTURE OF AN ANTI-SWEETENER FAB NC10.14 SHOWS THE EXTENT OF STRUCTURAL DIVERSITY IN ANTIGEN RECOGNITION BY IMMUNOGLOBULINS
875, 6fxnG, 0.6523, 2.72, 0.089, 210, 90, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
876, 6bzwF, 0.6523, 2.95, 0.054, 217, 92, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE GL PRECURSOR OF THE BROADLY NEUTRALIZING ANTIBODY AP33 
877, 5o4gA, 0.6523, 2.92, 0.065, 214, 92, HER2 IN COMPLEX WITH FAB MF3958 
878, 4xp4L, 0.6523, 3.01, 0.054, 214, 93, X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER IN COMPLEX WITH COCAINE
879, 4rnrB, 0.6523, 2.76, 0.088, 212, 91, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTI-HIV ANTIBODY PGT130
880, 4m5yM, 0.6523, 2.69, 0.089, 211, 90, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING FAB 5J8
881, 2vxsM, 0.6523, 2.97, 0.086, 215, 93, STRUCTURE OF IL-17A IN COMPLEX WITH A POTENT FULLY HUMAN NEUTRALISING ANTIBODY
882, 1jvkB, 0.6523, 2.68, 0.066, 214, 91, THREE-DIMENSIONAL STRUCTURE OF AN IMMUNOGLOBULIN LIGHT CHAIN DIMER ACTING AS A LETHAL AMYLOID PRECURSOR
883, 6dlaL, 0.6522, 2.72, 0.078, 210, 90, CRYSTAL STRUCTURES OF AN INFLUENZA A HEMAGGLUTININ ANTIBODY FAB CH65:7969D2 
884, 5um8L, 0.6522, 2.69, 0.067, 211, 90, CRYSTAL STRUCTURE OF HIV-1 ENVELOPE TRIMER 16055 NFL TD CC (T569G) IN COMPLEX WITH FABS 35022 AND PGT124
885, 5mv3J, 0.6522, 3.13, 0.043, 218, 94, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
886, 5mu2J, 0.6522, 3.03, 0.064, 218, 94, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
887, 2orbM, 0.6522, 2.89, 0.054, 210, 93, THE STRUCTURE OF THE ANTI-C-MYC ANTIBODY 9E10 FAB FRAGMENT
888, 2dd8L, 0.6522, 2.83, 0.087, 212, 92, CRYSTAL STRUCTURE OF SARS-COV SPIKE RECEPTOR-BINDING DOMAIN COMPLEXED WITH NEUTRALIZING ANTIBODY
889, 1xctC, 0.6522, 2.91, 0.054, 220, 93, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55A L57H Y64W) IN SPACE GROUP P21212
890, 6jfiI, 0.6521, 2.72, 0.078, 214, 90, THE SYMMETRIC-RECONSTRUCTED CRYO-EM STRUCTURE OF ZIKA VIRUS-FABZK2B10 COMPLEX 
891, 6jfhI, 0.6521, 2.72, 0.078, 214, 90, THE ASYMMETRIC-RECONSTRUCTED CRYO-EM STRUCTURE OF ZIKA VIRUS-FABZK2B10 COMPLEX 
892, 6jepI, 0.6521, 2.72, 0.078, 214, 90, STRUCTURE OF A NEUTRALIZING ANTIBODY BOUND TO THE ZIKA ENVELOPE PROTEIN DOMAIN III 
893, 6glwD, 0.6521, 2.74, 0.088, 213, 91, STRUCTURE OF GALECTIN-10 IN COMPLEX WITH THE FAB FRAGMENT OF A CHARCOT-LEYDEN CRYSTAL SOLUBILIZING ANTIBODY; 1D11 
894, 6g1eA, 0.6521, 2.99, 0.043, 207, 94, BEAT FC WITH IMPROVED HETERODIMERIZATION (Q3A-D84.4Q) 
895, 6d8kA, 0.6521, 2.72, 0.043, 570, 92, BACTEROIDES MULTIPLE SPECIES BETA-GLUCURONIDASE 
896, 5wduB, 0.6521, 2.68, 0.067, 210, 90, HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB 35O22 FAB AND NIH45-46 SCFV
897, 4xnuL, 0.6521, 2.98, 0.054, 214, 93, X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER IN COMPLEX WITH NISOXETINE
898, 4odtL, 0.6521, 2.76, 0.054, 214, 92, FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY S1-15 IN COMPLEX WITH LIPID A CARBOHYDRATE BACKBONE
899, 4ki5D, 0.6521, 2.81, 0.055, 211, 91, CYSTAL STRUCTURE OF HUMAN FACTOR VIII C2 DOMAIN IN A TERNARY COMPLEX WITH MURINE INHBITORY ANTIBODIES 3E6 AND G99
900, 4gw5C, 0.6521, 2.93, 0.065, 213, 92, CQYN MEDITOPE - CETUXIMAB FAB
901, 3i2cL, 0.6521, 2.91, 0.043, 218, 93, CRYSTAL STRUCTURE OF ANTI-IL-23 ANTIBODY CNTO4088
902, 6rcoB, 0.6520, 2.79, 0.088, 214, 91, PFRH5-BINDING MONOCLONAL ANTIBODY R5.004 
903, 6n4qK, 0.6520, 2.96, 0.054, 215, 93, CRYOEM STRUCTURE OF NAV1.7 VSD2 (ACTIVED STATE) IN COMPLEX WITH THE GATING MODIFIER TOXIN PROTX2 
904, 6n4qI, 0.6520, 2.96, 0.054, 215, 93, CRYOEM STRUCTURE OF NAV1.7 VSD2 (ACTIVED STATE) IN COMPLEX WITH THE GATING MODIFIER TOXIN PROTX2 
905, 6ec6A, 0.6520, 2.65, 0.090, 594, 89, RUMINOCOCCUS GNAVUS BETA-GLUCURONIDASE 
906, 6e9gB, 0.6520, 2.86, 0.065, 214, 92, THE CRYSTAL STRUCTURE OF BOVINE ULTRALONG ANTIBODY BOV-2 
907, 5zv3L, 0.6520, 2.93, 0.054, 219, 92, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-28.1 IN COMPLEX WITH ITS TAU PEPTIDE 
908, 5u4yA, 0.6520, 2.85, 0.053, 207, 94, IGG FC BOUND TO 3 HELIX OF THE B-DOMAIN FROM PROTEIN A
909, 5tpsA, 0.6520, 2.81, 0.043, 207, 92, STRUCTURE OF A FC HETERODIMER
910, 5i17A, 0.6520, 2.93, 0.054, 214, 92, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV1-69/IGKV3-20
911, 4g6aL, 0.6520, 3.00, 0.054, 218, 93, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY AP33
912, 4g6aD, 0.6520, 2.99, 0.054, 218, 93, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY AP33
913, 1qbmL, 0.6520, 3.04, 0.054, 214, 93, FAB E8B ANTIBODY X-RAY STRUCTURE AT 2.37 ANGSTROMS RESOLUTION
914, 1q9oA, 0.6520, 2.91, 0.054, 219, 93, S45-18 FAB UNLIGANDED
915, 1q0xL, 0.6520, 2.77, 0.067, 212, 90, ANTI-MORPHINE ANTIBODY 9B1 UNLIGANDED FORM
916, 6dc9L, 0.6519, 2.99, 0.054, 215, 93, FAB/EPITOPE COMPLEX OF HUMAN CHIMERIC MONOCLONAL ANTIBODY H4E6 TARGETING A PHOSPHORYLATED TAU EPITOPE. 
917, 5nbwL, 0.6519, 3.02, 0.053, 214, 94, CRYSTAL STRUCTURE OF THE FAB FRAGMENT 22F12 IN COMPLEX WITH 3- HYDROXYBENZO[A]PYRENE
918, 5anmA, 0.6519, 2.68, 0.067, 213, 90, CRYSTAL STRUCTURE OF IGE FC IN COMPLEX WITH A NEUTRALIZING ANTIBODY
919, 4dkeL, 0.6519, 3.12, 0.064, 214, 94, CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-34 BOUND TO FAB1.1
920, 3c2aM, 0.6519, 2.76, 0.087, 216, 92, ANTIBODY FAB FRAGMENT 447-52D IN COMPLEX WITH UG1033 PEPTIDE
921, 2vdrL, 0.6519, 3.20, 0.063, 214, 95, INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO A CHIMERIC FIBRINOGEN GAMMA CHAIN PEPTIDE LGGAKQRGDV
922, 2vdqL, 0.6519, 3.06, 0.053, 214, 94, INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO A CHIMERIC FIBRINOGEN GAMMA CHAIN PEPTIDE HHLGGAKQRGDV
923, 2pf6A, 0.6519, 3.29, 0.104, 231, 96, LUTHERAN GLYCOPROTEIN N-TERMINAL DOMAINS 1 AND 2
924, 1ad9A, 0.6519, 2.98, 0.054, 219, 93, IGG-FAB FRAGMENT OF ENGINEERED HUMAN MONOCLONAL ANTIBODY CTM01
925, 6mcoL, 0.6518, 2.73, 0.089, 211, 90, CRYSTAL STRUCTURE OF THE B41 SOSIP.664 ENV TRIMER WITH PGT124 AND 35O22 FABS; IN P23 SPACE GROUP 
926, 5x2qL, 0.6518, 2.88, 0.054, 217, 92, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH GLYCINE
927, 5t3sE, 0.6518, 2.89, 0.054, 213, 92, HIV GP140 TRIMER MD39-10MUTA IN COMPLEX WITH FABS PGT124 AND 35022
928, 5nbwA, 0.6518, 2.88, 0.054, 214, 93, CRYSTAL STRUCTURE OF THE FAB FRAGMENT 22F12 IN COMPLEX WITH 3- HYDROXYBENZO[A]PYRENE
929, 5muqL, 0.6518, 2.91, 0.043, 219, 93, CRYSTAL STRUCTURE OF DC8E8 FAB AT PH 7.0 CONTAINING A ZN ATOM 
930, 5kaqR, 0.6518, 2.94, 0.054, 213, 93, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 31.A.83 IN COMPLEX WITH HEMAGGLUTININ HONG KONG 1968.
931, 5itfC, 0.6518, 3.05, 0.065, 213, 93, CETUXIMAB FAB IN COMPLEX WITH 2-BROMOPHENYLALANINE MEDITOPE VARIANT
932, 5djcD, 0.6518, 2.83, 0.053, 207, 94, FC HETERODIMER DESIGN 8.1 L368V/Y407A + T366V/K409F
933, 3wjlB, 0.6518, 2.98, 0.043, 208, 94, CRYSTAL STRUCTURE OF IIB SELECTIVE FC VARIANT FC(V12) IN COMPLEX WITH FCGRIIB
934, 6erxG, 0.6517, 2.73, 0.089, 210, 90, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
935, 6dkjL, 0.6517, 2.95, 0.054, 213, 92, HUMAN GIPR ECD AND FAB COMPLEX 
936, 5gsqC, 0.6517, 2.86, 0.043, 208, 93, CRYSTAL STRUCTURE OF IGG FC WITH A HOMOGENEOUS GLYCOFORM AND ANTIBODY- DEPENDENT CELLULAR CYTOTOXICITY
937, 4q6iA, 0.6517, 2.97, 0.053, 218, 94, CRYSTAL STRUCTURE OF MURINE 2D5 FAB A POTENT ANTI-CD4 HIV-1- NEUTRALIZING ANTIBODY IN COMPLEX WITH CD4
938, 4nqsG, 0.6517, 2.71, 0.054, 208, 93, KNOB-INTO-HOLE IGG FC
939, 3sgeL, 0.6517, 2.82, 0.054, 219, 92, CRYSTAL STRUCTURE OF MAB 17.2 IN COMPLEX WITH R13 PEPTIDE
940, 1qblL, 0.6517, 3.03, 0.054, 214, 93, FAB E8 (FABE8A) X-RAY STRUCTURE AT 2.26 ANGSTROM RESOLUTION
941, 1q0yL, 0.6517, 2.69, 0.056, 212, 90, ANTI-MORPHINE ANTIBODY 9B1 COMPLEXED WITH MORPHINE
942, 5utzK, 0.6516, 2.79, 0.076, 215, 92, HUMAN IL-2/FAB COMPLEX 
943, 5dvkA, 0.6516, 2.83, 0.043, 208, 93, FC DESIGN 7.7 B CHAIN HOMODIMER T366V/K409I
944, 5dj0A, 0.6516, 2.83, 0.053, 208, 94, FC HETERODIMER DESIGN 11.2 Y349S/K370Y + E357D/S364Q
945, 4uimD, 0.6516, 3.05, 0.053, 214, 94, CRYSTAL STRUCTURE OF QUININE-DEPENDENT FAB 314.3
946, 4o9hL, 0.6516, 2.64, 0.090, 211, 89, STRUCTURE OF INTERLEUKIN-6 IN COMPLEX WITH A CAMELID FAB FRAGMENT
947, 4n9gF, 0.6516, 3.07, 0.075, 214, 93, CRYSTAL STRUCTURE OF A COMPUTATIONALLY DESIGNED RSV-PRESENTING EPITOPE SCAFFOLD AND ITS ELICITED ANTIBODY 17HD9
948, 4at6P, 0.6516, 2.69, 0.056, 212, 90, FAB FRAGMENT OF ANTIPORPHYRIN ANTIBODY 14H7
949, 2r2hA, 0.6516, 2.77, 0.054, 219, 92, STRUCTURE OF S25-2 IN COMPLEX WITH KO
950, 5muqB, 0.6515, 2.92, 0.043, 219, 93, CRYSTAL STRUCTURE OF DC8E8 FAB AT PH 7.0 CONTAINING A ZN ATOM 
951, 5m6aC, 0.6515, 2.69, 0.056, 211, 90, CRYSTAL STRUCTURE OF CARDIOTOXIC BENCE-JONES LIGHT CHAIN DIMER H9
952, 5it2L, 0.6515, 2.96, 0.054, 215, 93, STRUCTURE OF A TRANSGLUTAMINASE 2-SPECIFIC AUTOANTIBODY 693-10-B06 FAB FRAGMENT
953, 5ir1C, 0.6515, 3.05, 0.065, 213, 93, CETUXIMAB FAB IN COMPLEX WITH 3-BROMOPHENYLALANINE MEDITOPE VARIANT
954, 5djyA, 0.6515, 2.80, 0.053, 208, 94, FC HETERODIMER DESIGN 20.8 Y349S/T366V/K370Y/K409V + E357D/S364Q/Y407A
955, 4xpaL, 0.6515, 2.85, 0.043, 214, 92, X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER BOUND TO 3 4DICHLOROPHENETHYLAMINE
956, 4ubdD, 0.6515, 2.92, 0.054, 213, 92, CRYSTAL STRUCTURE OF A NEUTRALIZING HUMAN MONOCLONAL ANTIBODY WITH 1968 H3 HA
957, 4q6iL, 0.6515, 2.98, 0.053, 218, 94, CRYSTAL STRUCTURE OF MURINE 2D5 FAB A POTENT ANTI-CD4 HIV-1- NEUTRALIZING ANTIBODY IN COMPLEX WITH CD4
958, 4o5iX, 0.6515, 2.81, 0.055, 213, 91, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY F045-092 IN COMPLEX WITH A/VICTORIA/361/2011 (H3N2) INFLUENZA HEMAGGLUTININ
959, 6fgoD, 0.6514, 2.74, 0.065, 208, 93, FC IN COMPLEX WITH ENGINEERED CALCIUM BINDING DOMAIN Z 
960, 5t4zL, 0.6514, 2.81, 0.076, 213, 92, STRUCTURE OF THE ANTI-HIV ANTIBODY DH501 THAT BINDS GP120 V3 GLYCAN AND THE BASE OF V3 WITH FREE MAN9 GLYCAN
961, 4nzrL, 0.6514, 2.98, 0.054, 214, 93, CRYSTAL STRUCTURE OF THE ANTIBODY-BINDING REGION OF PROTEIN M (PROTEIN M TD) IN COMPLEX WITH ANTI-HIV ANTIBODY PGT135 FAB
962, 4glrK, 0.6514, 2.71, 0.089, 207, 90, STRUCTURE OF THE ANTI-PTAU FAB (PT231/PS235_1) IN COMPLEX WITH PHOSPHOEPITOPE PT231/PS235
963, 3qa3J, 0.6514, 3.10, 0.053, 220, 94, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
964, 3mlsO, 0.6514, 2.72, 0.089, 219, 90, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 MAB 2557 FAB IN COMPLEX WITH A HIV- 1 GP120 V3 MIMOTOPE
965, 3leyL, 0.6514, 2.96, 0.065, 216, 92, 2F5 EPITOPE SCAFFOLD ELICITED ANTI-HIV-1 MONOCLONAL ANTIBODY 6A7 IN COMPLEX WITH HIV-1 GP41
966, 1mreL, 0.6514, 2.93, 0.033, 218, 92, PREPARATION CHARACTERIZATION AND CRYSTALLIZATION OF AN ANTIBODY FAB FRAGMENT THAT RECOGNIZES RNA. CRYSTAL STRUCTURES OF NATIVE FAB AND THREE FAB-MONONUCLEOTIDE COMPLEXES
967, 1kcsL, 0.6514, 2.92, 0.043, 214, 93, CRYSTAL STRUCTURE OF ANTIBODY PC282 IN COMPLEX WITH PS1 PEPTIDE
968, 6f2zA, 0.6513, 2.89, 0.053, 209, 95, STRUCTURE OF A FC MUTATNT 
969, 6e9qB, 0.6513, 2.89, 0.065, 215, 93, THE CRYSTAL STRUCTURE OF BOVINE ULTRALONG ANTIBODY BOV-6 
970, 6ca9C, 0.6513, 2.82, 0.056, 212, 90, CRYSTAL STRUCTURE OF FAB PCT64_LMCA (SAR); THE LEAST MUTATED COMMON ANCESTOR OF THE HIV-1 BROADLY NEUTRALIZING ANTIBODY LINEAGE PCT64 
971, 6ca9A, 0.6513, 2.81, 0.056, 212, 90, CRYSTAL STRUCTURE OF FAB PCT64_LMCA (SAR); THE LEAST MUTATED COMMON ANCESTOR OF THE HIV-1 BROADLY NEUTRALIZING ANTIBODY LINEAGE PCT64 
972, 5djaA, 0.6513, 2.82, 0.053, 208, 94, FC HETERODIMER DESIGN 9.1 Y407M + T366I
973, 4ubdX, 0.6513, 2.92, 0.054, 213, 92, CRYSTAL STRUCTURE OF A NEUTRALIZING HUMAN MONOCLONAL ANTIBODY WITH 1968 H3 HA
974, 4n9gN, 0.6513, 2.78, 0.055, 214, 91, CRYSTAL STRUCTURE OF A COMPUTATIONALLY DESIGNED RSV-PRESENTING EPITOPE SCAFFOLD AND ITS ELICITED ANTIBODY 17HD9
975, 4edwL, 0.6513, 2.98, 0.054, 214, 93, NERVE GROWTH FACTOR IN COMPLEX WITH FAB FROM HUMANIZED VERSION OF MOUSE MAB 911 (TANEZUMAB)
976, 1rzgD, 0.6513, 2.98, 0.054, 214, 93, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120 REACTIVE ANTIBODY 412D
977, 6mdtE, 0.6512, 2.91, 0.054, 213, 92, CRYSTAL STRUCTURE OF THE B41 SOSIP.664 ENV TRIMER WITH PGT124 AND 35O22 FABS; IN P63 SPACE GROUP 
978, 5ywpQ, 0.6512, 3.05, 0.053, 215, 94, JEV-2H4 FAB COMPLEX 
979, 5uelL, 0.6512, 3.15, 0.064, 216, 94, CRYSTAL STRUCTURE OF 354NC102 FAB
980, 5dj6A, 0.6512, 2.81, 0.053, 208, 94, FC HETERODIMER DESIGN 6.1 F405W/Y407A + T366M
981, 5cezE, 0.6512, 2.90, 0.054, 213, 92, CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH AN EARLY PUTATIVE PRECURSOR OF THE PGT121 FAMILY AT 3.0 ANGSTROM
982, 4s1qL, 0.6512, 2.94, 0.054, 209, 92, CRYSTAL STRUCTURE OF A VRC01-LINEAGE ANTIBODY 45-VRC01.H03+06.D- 001739 IN COMPLEX WITH CLADE A/E HIV-1 GP120 CORE
983, 4gw1C, 0.6512, 2.88, 0.054, 213, 92, CQFD MEDITOPE
984, 4f33G, 0.6512, 2.70, 0.056, 211, 90, CRYSTAL STRUCTURE OF THERAPEUTIC ANTIBODY MORAB-009
985, 3skjM, 0.6512, 3.15, 0.064, 214, 94, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF AN AGONISTIC ANTI-HUMAN EPHA2 MONOCLONAL ANTIBODY
986, 1ikfL, 0.6512, 2.99, 0.054, 214, 93, A CONFORMATION OF CYCLOSPORIN A IN AQUEOUS ENVIRONMENT REVEALED BY THE X-RAY STRUCTURE OF A CYCLOSPORIN-FAB COMPLEX
987, 1dqdL, 0.6512, 3.11, 0.053, 214, 95, CRYSTAL STRUCTURE OF FAB HGR-2 F6 A COMPETITIVE ANTAGONIST OF THE GLUCAGON RECEPTOR
988, 6f7tL, 0.6511, 2.59, 0.056, 218, 90, CRYSTAL STRUCTURE OF AN FAB FRAGMENT IN COMPLEX WITH A PEPTIDE FROM BACILLUS SUBTILIS RNASE Y 
989, 6e62C, 0.6511, 2.68, 0.067, 213, 90, CRYSTAL STRUCTURE OF MALARIA TRANSMISSION-BLOCKING ANTIGEN PFS48/45 6C IN COMPLEX WITH ANTIBODY 85RF45.1 
990, 5wduK, 0.6511, 2.87, 0.088, 210, 91, HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB 35O22 FAB AND NIH45-46 SCFV
991, 5ud9L, 0.6511, 2.82, 0.065, 205, 92, CRYSTAL STRUCTURE OF 354BG18 FAB
992, 5t80L, 0.6511, 2.91, 0.087, 212, 92, CRYSTAL STRUCTURE OF 10E8 FAB IN COMPLEX WITH THE MPER EPITOPE SCAFFOLD T117V2 AND PHOSPHATIDIC ACID (06:0 PA)
993, 5m63L, 0.6511, 2.79, 0.066, 215, 91, CRYSTAL STRUCTURE OF GROUP B STREPTOCOCCUS TYPE III DP2 OLIGOSACCHARIDE BOUND TO FAB NVS-1-19-5
994, 5f6hL, 0.6511, 2.71, 0.089, 212, 90, CRYSTAL STRUCTURE OF TIER 2 NEUTRALIZING ANTIBODY DH427 FROM A RHESUS MACAQUE
995, 5adoL, 0.6511, 2.99, 0.054, 213, 93, CRYSTAL STRUCTURE OF THE PARAOXON-MODIFIED A.17 ANTIBODY FAB FRAGMENT - LIGHT CHAIN S35R MUTANT
996, 4i0pE, 0.6511, 2.76, 0.022, 188, 92, HLA-DO IN COMPLEX WITH HLA-DM
997, 4hs6A, 0.6511, 3.14, 0.064, 218, 94, HEPATITUS C ENVELOPE GLYCOPROTEIN E2 FRAGMENT 412-423 WITH HUMANIZED AND AFFINITY-MATURED ANTIBODY MRCT10.V362
998, 3tnnF, 0.6511, 2.72, 0.089, 212, 90, CRYSTAL STRUCTURE OF N5-I5 FAB AN ADCC MEDIATING AND NON-NEUTRALIZING CD4I ANTI-HIV- 1 ANTIBODY.
999, 6n9tB, 0.6510, 2.81, 0.053, 207, 94, STRUCTURE OF A PEPTIDE-BASED PHOTO-AFFINITY CROSS-LINKER WITH HERCEPTIN FC 
1000, 6k7oE, 0.6510, 2.99, 0.054, 218, 93, COMPLEX STRUCTURE OF LILRB4 AND H128-3 ANTIBODY 
1001, 6d4nA, 0.6510, 2.82, 0.054, 208, 93, CRYSTAL STRUCTURE OF A FC FRAGMENT OF RHESUS MACAQUE (MACACA MULATTA) IGG4 
1002, 5w5lB, 0.6510, 2.90, 0.053, 210, 95, CRYSTAL STRUCTURE OF HUMAN IGG1-SIGMA FC FRAGMENT
1003, 5u3jL, 0.6510, 3.00, 0.054, 215, 92, CRYSTAL STRUCTURE OF DH511.1 FAB IN COMPLEX WITH HIV-1 GP41 MPER PEPTIDE
1004, 5gguB, 0.6510, 2.93, 0.054, 213, 92, CRYSTAL STRUCTURE OF TREMELIMUMAB FAB
1005, 5dk3A, 0.6510, 2.94, 0.065, 218, 93, CRYSTAL STRUCTURE OF PEMBROLIZUMAB A FULL LENGTH IGG4 ANTIBODY
1006, 5dj8A, 0.6510, 2.83, 0.053, 208, 94, FC HETERODIMER DESIGN 7.7 D399M/Y407A + T366V/K409I
1007, 5d4qB, 0.6510, 2.81, 0.053, 208, 94, CRYSTAL STRUCTURE OF GASDALIE IGG1 FC
1008, 5d4qA, 0.6510, 2.81, 0.043, 208, 93, CRYSTAL STRUCTURE OF GASDALIE IGG1 FC
1009, 4wukL, 0.6510, 2.74, 0.089, 210, 90, CRYSTAL STRUCTURE OF APO CH65 FAB
1010, 4i0pA, 0.6510, 2.79, 0.022, 188, 92, HLA-DO IN COMPLEX WITH HLA-DM
1011, 3v4uL, 0.6510, 2.91, 0.054, 218, 93, STRUCTURE OF A MONOCLONAL ANTIBODY COMPLEXED WITH ITS MHC-I ANTIGEN
1012, 2jixL, 0.6510, 3.00, 0.054, 214, 93, CRYSTAL STRUCTURE OF ABT-007 FAB FRAGMENT WITH THE SOLUBLE DOMAIN OF EPO RECEPTOR
1013, 6n9tA, 0.6509, 2.83, 0.053, 207, 94, STRUCTURE OF A PEPTIDE-BASED PHOTO-AFFINITY CROSS-LINKER WITH HERCEPTIN FC 
1014, 6ev1J, 0.6509, 2.89, 0.065, 212, 92, CRYSTAL STRUCTURE OF ANTIBODY AGAINST SCHIZOPHYLLAN 
1015, 5sy8L, 0.6509, 2.78, 0.087, 211, 92, CRYSTAL STRUCTURE OF THE COMPLEX OF 10E8 FAB LIGHT CHAIN MUTANT1 AND T117V2 HIV-1 MPER SCAFFOLD
1016, 5fuoL, 0.6509, 3.12, 0.064, 217, 94, EXTENDING THE HALF-LIFE OF A FAB FRAGMENT THROUGH GENERATION OF A HUMANISED ANTI-HUMAN SERUM ALBUMIN (HSA) FV DOMAIN: AN INVESTIGATION INTO THE CORRELATION BETWEEN AFFINITY AND SERUM HALF-LIFE
1017, 4rnrD, 0.6509, 2.78, 0.088, 212, 91, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTI-HIV ANTIBODY PGT130
1018, 4ot1L, 0.6509, 2.83, 0.087, 214, 92, STRUCTURAL BASIS FOR THE RECOGNITION OF HUMAN CYTOMEGALOVIRUS GLYCOPROTEIN B BY THE NEUTRALIZING HUMAN ANTIBODY SM5-1
1019, 3gjeL, 0.6509, 2.74, 0.089, 212, 90, RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES
1020, 2vdpL, 0.6509, 3.06, 0.053, 214, 94, INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO FIBRINOGEN GAMMA CHAIN PEPTIDELGGAKQAGDV
1021, 2qqlL, 0.6509, 3.18, 0.064, 214, 94, NEUROPILIN-2 A1A2B1B2 DOMAINS IN COMPLEX WITH A SEMAPHORIN-BLOCKING FAB
1022, 2gj7B, 0.6509, 2.80, 0.053, 207, 94, CRYSTAL STRUCTURE OF A GE-GI/FC COMPLEX
1023, 2dquL, 0.6509, 2.92, 0.054, 219, 92, CRYSTAL FORM II: HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX OF THE HYDROLYTIC ANTIBODY FAB 6D9 AND A TRANSITION-STATE ANALOG
1024, 1nj9A, 0.6509, 2.73, 0.044, 212, 90, COCAINE HYDROLYTIC ANTIBODY 15A10
1025, 1dn2B, 0.6509, 2.80, 0.053, 207, 94, FC FRAGMENT OF HUMAN IGG1 IN COMPLEX WITH AN ENGINEERED 13 RESIDUE PEPTIDE DCAWHLGELVWCT-NH2
1026, 6g1eB, 0.6508, 3.02, 0.043, 206, 94, BEAT FC WITH IMPROVED HETERODIMERIZATION (Q3A-D84.4Q) 
1027, 5t1lC, 0.6508, 3.08, 0.065, 213, 93, CETUXIMAB FAB IN COMPLEX WITH CQA(PH)2DLSTRRLKC PEPTIDE
1028, 5ijvE, 0.6508, 2.81, 0.065, 213, 92, CRYSTAL STRUCTURE OF BOVINE FAB E03
1029, 5f6jF, 0.6508, 2.72, 0.089, 212, 90, CRYSTAL STRUCTURE OF TIER 2 NEUTRALIZING ANTIBODY DH427 FROM A RHESUS MACAQUE IN COMPLEX WITH HIV-1 GP120 CORE
1030, 5di8A, 0.6508, 2.83, 0.053, 208, 94, FC KNOB-HOLE HETERODIMER T366W + T366S/L368A/Y407V
1031, 4ydkL, 0.6508, 2.91, 0.054, 214, 92, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY C38- VRC16.01 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057 GP120
1032, 4uikL, 0.6508, 3.09, 0.043, 213, 93, CRYSTAL STRUCTURE OF QUININE-DEPENDENT FAB 314.1
1033, 4m48L, 0.6508, 2.83, 0.043, 214, 92, X-RAY STRUCTURE OF DOPAMINE TRANSPORTER ELUCIDATES ANTIDEPRESSANT MECHANISM
1034, 1fc2D, 0.6508, 2.92, 0.043, 206, 93, CRYSTALLOGRAPHIC REFINEMENT AND ATOMIC MODELS OF A HUMAN FC FRAGMENT AND ITS COMPLEX WITH FRAGMENT B OF PROTEIN A FROM STAPHYLOCOCCUS AUREUS AT 2.9-AND 2.8-ANGSTROMS RESOLUTION
1035, 1dn0C, 0.6508, 2.97, 0.054, 215, 93, STRUCTURE OF THE FAB FRAGMENT FROM A HUMAN IGM COLD AGGLUTININ
1036, 6qn7L, 0.6507, 2.84, 0.065, 213, 92, STRUCTURE OF BOVINE ANTI-RSV HYBRID FAB B4HC-B13LC 
1037, 6hygA, 0.6507, 2.96, 0.063, 416, 95, HETEROMERIC TANDEM IGG4/IGG1 FC 
1038, 5ibtL, 0.6507, 2.93, 0.054, 215, 92, UCA FAB (UNBOUND) FROM 6515 LINEAGE
1039, 4s1dF, 0.6507, 3.05, 0.043, 213, 93, STRUCTURE OF IGG1 FAB FRAGMENT IN COMPLEX WITH BIOTINCYTIDINAMIDE
1040, 4q2zL, 0.6507, 2.65, 0.090, 212, 89, FAB FRAGMENT OF HIV VACCINE-ELICITED CD4BS-DIRECTED ANTIBODY GE356 FROM A NON-HUMAN PRIMATE
1041, 4fqkF, 0.6507, 2.75, 0.088, 213, 91, INFLUENZA B/BRISBANE/60/2008 HEMAGGLUTININ FAB CR8059 COMPLEX
1042, 3mlyL, 0.6507, 2.88, 0.043, 214, 92, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 3074 IN COMPLEX WITH A UR29 V3 PEPTIDE
1043, 1n0xL, 0.6507, 2.98, 0.054, 215, 93, CRYSTAL STRUCTURE OF A BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY IN COMPLEX WITH A PEPTIDE MIMOTOPE
1044, 1c5bL, 0.6507, 2.89, 0.065, 214, 92, DECARBOXYLASE CATALYTIC ANTIBODY 21D8 UNLIGANDED FORM
1045, 6iqhB, 0.6506, 2.82, 0.053, 207, 94, X-RAY CRYSTAL STRUCTURE OF COVALENT-BONDED COMPLEX OF FC AND PEPTIDE 
1046, 6cdpB, 0.6506, 3.07, 0.054, 219, 93, VACCINE-ELICITED HIV-1 NEUTRALIZING ANTIBODY VFP20.01 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519 
1047, 6blaL, 0.6506, 2.98, 0.043, 215, 93, STRUCTURE OF AMM01 FAB; AN ANTI EBV GH/GL NEUTRALIZING ANTIBODY 
1048, 6axpC, 0.6506, 2.87, 0.067, 212, 90, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-OCTYLARGININE MEDITOPE VARIANT
1049, 5v7uL, 0.6506, 3.14, 0.064, 219, 94, CYRSTAL STRUCTURE OF ANTI-TAU ANTIBODY CBTAU-22.1 FAB
1050, 5n2kK, 0.6506, 2.72, 0.066, 214, 91, STRUCTURE OF UNBOUND BRIAKINUMAB FAB
1051, 4w4nB, 0.6506, 2.85, 0.043, 207, 93, CRYSTAL STRUCTURE OF HUMAN FC AT 1.80 A
1052, 4d9lM, 0.6506, 2.77, 0.044, 215, 91, FAB STRUCTURE OF ANTI-HIV-1 GP120 V2 MAB 697
1053, 3v6oF, 0.6506, 2.93, 0.054, 212, 93, LEPTIN RECEPTOR-ANTIBODY COMPLEX
1054, 3c2sA, 0.6506, 3.15, 0.042, 210, 96, STRUCTURAL CHARACTERIZATION OF A HUMAN FC FRAGMENT ENGINEERED FOR LACK OF EFFECTOR FUNCTIONS
1055, 2ig2L, 0.6506, 2.78, 0.087, 216, 92, DIR PRIMAERSTRUKTUR DES KRISTALLISIERBAREN MONOKLONALEN IMMUNOGLOBULINS IGG1 KOL. II. AMINOSAEURESEQUENZ DER L- KETTE LAMBDA-TYP SUBGRUPPE I (GERMAN)
1056, 2i9lG, 0.6506, 2.86, 0.054, 219, 93, STRUCTURE OF FAB 7D11 FROM A NEUTRALIZING ANTIBODY AGAINST THE POXVIRUS L1 PROTEIN
1057, 6ieaL, 0.6505, 2.71, 0.089, 218, 90, STRUCTURE OF RVFV GN AND HUMAN MONOCLONAL ANTIBODY R13 
1058, 5mhgL, 0.6505, 2.89, 0.054, 213, 93, CRYSTAL STRUCTURE OF ANTI-T4 FAB FRAGMENT WITH TETRAIODOBPA 
1059, 5ijvA, 0.6505, 2.80, 0.065, 213, 92, CRYSTAL STRUCTURE OF BOVINE FAB E03
1060, 5gsqA, 0.6505, 3.05, 0.052, 208, 96, CRYSTAL STRUCTURE OF IGG FC WITH A HOMOGENEOUS GLYCOFORM AND ANTIBODY- DEPENDENT CELLULAR CYTOTOXICITY
1061, 5ghwL, 0.6505, 2.74, 0.089, 211, 90, CRYSTAL STRUCTURE OF BROAD NEUTRALIZING ANTIBODY 10E8 WITH LONG EPITOPE BOUND
1062, 5djaB, 0.6505, 2.82, 0.043, 207, 93, FC HETERODIMER DESIGN 9.1 Y407M + T366I
1063, 4uimF, 0.6505, 2.86, 0.054, 214, 92, CRYSTAL STRUCTURE OF QUININE-DEPENDENT FAB 314.3
1064, 4nm4L, 0.6505, 2.88, 0.055, 219, 91, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR8043
1065, 4m7jL, 0.6505, 2.92, 0.054, 219, 93, CRYSTAL STRUCTURE OF S25-26 IN COMPLEX WITH KDO(2.8)KDO(2.4)KDO TRISACCHARIDE
1066, 4f57L, 0.6505, 2.72, 0.089, 213, 90, FAB STRUCTURE OF A NEUTRALIZING ANTIBODY L1 FROM AN EARLY SUBTYPE A HIV-1 INFECTED PATIENT
1067, 2iwgA, 0.6505, 2.84, 0.053, 207, 94, COMPLEX BETWEEN THE PRYSPRY DOMAIN OF TRIM21 AND IGG FC
1068, 2i9lA, 0.6505, 2.86, 0.054, 219, 93, STRUCTURE OF FAB 7D11 FROM A NEUTRALIZING ANTIBODY AGAINST THE POXVIRUS L1 PROTEIN
1069, 6qn8L, 0.6504, 2.87, 0.065, 213, 92, STRUCTURE OF BOVINE ANTI-RSV FAB B13 
1070, 6meiL, 0.6504, 3.07, 0.054, 214, 93, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
1071, 6bzwB, 0.6504, 2.90, 0.054, 217, 92, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE GL PRECURSOR OF THE BROADLY NEUTRALIZING ANTIBODY AP33 
1072, 5ye4D, 0.6504, 2.76, 0.054, 212, 92, CRYSTAL STRUCTURE OF THE COMPLEX OF DI-ACETYLATED HISTONE H4 AND 1A9D7 FAB FRAGMENT 
1073, 5iczA, 0.6504, 2.92, 0.065, 213, 92, CETUXIMAB FAB IN COMPLEX WITH GQFDLSTRRLKG PEPTIDE
1074, 5i1jL, 0.6504, 2.93, 0.054, 214, 92, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV5-51/IGKV3-11
1075, 5azeL, 0.6504, 2.72, 0.066, 206, 91, FAB FRAGMENT OF CALCIUM-DEPENDENT ANTIGEN BINDING ANTIBODY 6RL 9
1076, 4r9yM, 0.6504, 3.06, 0.053, 214, 94, CRYSTAL STRUCTURE OF KKOFAB IN COMPLEX WITH PLATELET FACTOR 4
1077, 4m5yL, 0.6504, 2.71, 0.089, 211, 90, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING FAB 5J8
1078, 4jb9L, 0.6504, 2.81, 0.043, 209, 92, CRYSTAL STRUCTURE OF ANTIBODY VRC06 IN COMPLEX WITH HIV-1 GP120 CORE
1079, 4hh9A, 0.6504, 3.02, 0.054, 214, 93, ANTI-HUMAN CYTOMEGALOVIRUS (HCMV) FAB KE5
1080, 3v52L, 0.6504, 2.95, 0.054, 218, 93, STRUCTURE OF A MONOCLONAL ANTIBODY COMPLEXED WITH ITS MHC-I ANTIGEN
1081, 3uluE, 0.6504, 2.92, 0.054, 215, 92, STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM1)
1082, 3q6fK, 0.6504, 2.88, 0.098, 212, 92, CRYSTAL STRUCTURE OF FAB OF HUMAN MAB 2909 SPECIFIC FOR QUATERNARY NEUTRALIZING EPITOPE OF HIV-1 GP120
1083, 3mlxL, 0.6504, 2.71, 0.078, 211, 90, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 3074 IN COMPLEX WITH AN MN V3 PEPTIDE
1084, 2vdoL, 0.6504, 3.21, 0.063, 214, 95, INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO FIBRINOGEN GAMMA CHAIN PEPTIDE HHLGGAKQAGDV
1085, 2r1xA, 0.6504, 2.90, 0.054, 219, 93, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
1086, 2oldB, 0.6504, 2.56, 0.067, 216, 90, BENCE JONES KWR PROTEIN- IMMUNOGLOBULIN LIGHT CHAIN DIMER P3(2)21 CRYSTAL FORM
1087, 2i9lE, 0.6504, 2.86, 0.054, 219, 93, STRUCTURE OF FAB 7D11 FROM A NEUTRALIZING ANTIBODY AGAINST THE POXVIRUS L1 PROTEIN
1088, 2i9lC, 0.6504, 2.86, 0.054, 219, 93, STRUCTURE OF FAB 7D11 FROM A NEUTRALIZING ANTIBODY AGAINST THE POXVIRUS L1 PROTEIN
1089, 1q9wA, 0.6504, 2.91, 0.043, 219, 93, S45-18 FAB PENTASACCHARIDE BISPHOSPHATE COMPLEX
1090, 1hh9A, 0.6504, 3.04, 0.053, 214, 94, ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH A PEPTIDE
1091, 1ehlL, 0.6504, 2.84, 0.043, 217, 92, 64M-2 ANTIBODY FAB COMPLEXED WITH D(5HT)(6-4)T
1092, 6qn8K, 0.6503, 2.88, 0.065, 213, 92, STRUCTURE OF BOVINE ANTI-RSV FAB B13 
1093, 6fxnN, 0.6503, 2.75, 0.089, 210, 90, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
1094, 6fgoA, 0.6503, 2.86, 0.053, 209, 94, FC IN COMPLEX WITH ENGINEERED CALCIUM BINDING DOMAIN Z 
1095, 6e9qD, 0.6503, 2.68, 0.044, 214, 91, THE CRYSTAL STRUCTURE OF BOVINE ULTRALONG ANTIBODY BOV-6 
1096, 5xlib, 0.6503, 2.84, 0.054, 213, 92, STRUCTURE OF ANTI-ANGIOTENSIN II TYPE2 RECEPTOR ANTIBODY (D5711-4A03) 
1097, 5fhbL, 0.6503, 2.72, 0.066, 208, 91, CRYSTAL STRUCTURE OF PROTECTIVE EBOLA VIRUS ANTIBODY 100
1098, 5f6jA, 0.6503, 2.72, 0.089, 212, 90, CRYSTAL STRUCTURE OF TIER 2 NEUTRALIZING ANTIBODY DH427 FROM A RHESUS MACAQUE IN COMPLEX WITH HIV-1 GP120 CORE
1099, 4zneE, 0.6503, 3.07, 0.051, 215, 98, IGG1 FC-FCGAMMARI ECD COMPLEX
1100, 4o58L, 0.6503, 2.72, 0.089, 213, 90, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY F045-092 IN COMPLEX WITH A/VICTORIA/3/1975 (H3N2) INFLUENZA HEMAGGLUTININ
1101, 4fqxC, 0.6503, 2.62, 0.022, 186, 91, CRYSTAL STRUCTURE OF HLA-DM BOUND TO HLA-DR1
1102, 3gheL, 0.6503, 2.72, 0.089, 214, 90, CRYSTAL STRUCTURE OF ANTI-HIV-1 FAB 537-10D IN COMPLEX WITH V3 PEPTIDE MN
1103, 2petA, 0.6503, 3.15, 0.116, 231, 95, LUTHERAN GLYCOPROTEIN N-TERMINAL DOMAINS 1 AND 2.
1104, 2oz4L, 0.6503, 2.88, 0.043, 214, 92, STRUCTURAL PLASTICITY IN IGSF DOMAIN 4 OF ICAM-1 MEDIATES CELL SURFACE DIMERIZATION
1105, 2iwgD, 0.6503, 2.84, 0.053, 207, 94, COMPLEX BETWEEN THE PRYSPRY DOMAIN OF TRIM21 AND IGG FC
1106, 1i8mA, 0.6503, 3.01, 0.054, 213, 93, CRYSTAL STRUCTURE OF A RECOMBINANT ANTI-SINGLE-STRANDED DNA ANTIBODY FRAGMENT COMPLEXED WITH DT5
1107, 6qn8B, 0.6502, 2.86, 0.065, 213, 92, STRUCTURE OF BOVINE ANTI-RSV FAB B13 
1108, 6ev1L, 0.6502, 2.84, 0.066, 211, 91, CRYSTAL STRUCTURE OF ANTIBODY AGAINST SCHIZOPHYLLAN 
1109, 6dfiL, 0.6502, 2.96, 0.054, 215, 92, CRYSTAL STRUCTURE OF ANTI-ZIKA ANTIBODY Z021 BOUND TO ZIKA VIRUS ENVELOPE PROTEIN DIII 
1110, 6d2pL, 0.6502, 2.72, 0.066, 210, 91, CRYSTAL STRUCTURE OF IOMA-CLASS CLK31 FAB FROM AN HIV-1 NAIVE DONOR IN COMPLEX WITH A GERMLINE-TARGETING GP120 ENGINEERED OUTER DOMAIN EOD- GT8 AT 2.6 A 
1111, 5u52A, 0.6502, 2.85, 0.053, 207, 94, HELIX MINIMIZED VERSION OF THE B-DOMAIN FROM PROTEIN A (Z34C0 BOUND TO IGG1 FC (MONOCLINIC FORM)
1112, 4xp5L, 0.6502, 2.83, 0.044, 213, 91, X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER BOUND TO COCAINE ANALOGUE-RTI55
1113, 4jy4A, 0.6502, 2.78, 0.088, 208, 91, CRYSTAL STRUCTURE OF HUMAN FAB PGT121 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
1114, 4dgyL, 0.6502, 2.94, 0.054, 212, 92, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY HCV1 C2 FORM
1115, 4acpB, 0.6502, 2.87, 0.053, 208, 95, DEACTIVATION OF HUMAN IGG1 FC BY ENDOGLYCOSIDASE TREATMENT
1116, 3s7gC, 0.6502, 2.87, 0.053, 208, 95, AGLYCOSYLATED HUMAN IGG1 FC FRAGMENT
1117, 2xwtB, 0.6502, 2.78, 0.088, 213, 91, CRYSTAL STRUCTURE OF THE TSH RECEPTOR IN COMPLEX WITH A BLOCKING TYPE TSHR AUTOANTIBODY
1118, 2vdnL, 0.6502, 3.06, 0.053, 213, 94, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST EPTIFIBATIDE
1119, 6erxN, 0.6501, 2.76, 0.089, 210, 90, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
1120, 6b3dL, 0.6501, 2.75, 0.066, 207, 91, CRYSTAL STRUCTURE OF ANTI-HIV ANTIBODY PGT128 IN COMPLEX WITH A BACTERIALLY DERIVED SYNTHETIC MIMETIC OF MAN9.
1121, 5t1mA, 0.6501, 2.94, 0.054, 213, 92, CETUXIMAB FAB IN COMPLEX WITH CQYDLSTRRLKC
1122, 5ocaL, 0.6501, 2.75, 0.089, 214, 90, PCSK9:FAB COMPLEX WITH DEXTRAN SULFATE
1123, 5i8hL, 0.6501, 2.76, 0.089, 210, 90, CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH V3 LOOP-TARGETING ANTIBODY PGT122 FAB AND FUSION PEPTIDE-TARGETING ANTIBODY VRC34.01 FAB
1124, 5i1kL, 0.6501, 2.89, 0.055, 213, 91, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV5-51/IGKV3-20
1125, 4jg1L, 0.6501, 2.93, 0.054, 214, 92, STRUCTURE OF PHOSPHOSERINE/THREONINE (PSTAB) SCAFFOLD BOUND TO PTHR PEPTIDE
1126, 1rhhC, 0.6501, 3.02, 0.054, 215, 93, CRYSTAL STRUCTURE OF THE BROADLY HIV-1 NEUTRALIZING FAB X5 AT 1.90 ANGSTROM RESOLUTION
1127, 1dn0A, 0.6501, 2.94, 0.054, 215, 92, STRUCTURE OF THE FAB FRAGMENT FROM A HUMAN IGM COLD AGGLUTININ
1128, 5mvzB, 0.6500, 2.93, 0.065, 214, 93, FAB 4AB007 BOUND TO INTERLEUKIN-1-BETA
1129, 5hyqC, 0.6500, 3.05, 0.065, 213, 93, CETUXIMAB FAB IN COMPLEX WITH AMIDATED MEDITOPE
1130, 4qf1L, 0.6500, 2.69, 0.056, 211, 90, CRYSTAL STRUCTURE OF UNLIGANDED CH59UA THE INFERRED UNMUTATED ANCESTOR OF THE RV144 ANTI-HIV ANTIBODY LINEAGE PRODUCING CH59
1131, 3x3gL, 0.6500, 3.17, 0.064, 214, 94, FAB FRAGMENT FROM ANTI TRAIL-R2 HUMAN AGONIST ANTIBODY KMTR2
1132, 3ulsL, 0.6500, 2.83, 0.087, 211, 92, CRYSTAL STRUCTURE OF FAB12
1133, 1yy8A, 0.6500, 2.74, 0.055, 213, 91, CRYSTAL STRUCTURE OF THE FAB FRAGMENT FROM THE MONOCLONAL ANTIBODY CETUXIMAB/ERBITUX/IMC-C225
1134, 1sbsL, 0.6500, 2.96, 0.043, 220, 93, CRYSTAL STRUCTURE OF AN ANTI-HCG FAB
1135, 6a0xB, 0.6499, 3.04, 0.053, 214, 94, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY 13D4 
1136, 5vigL, 0.6499, 2.92, 0.054, 212, 92, CRYSTAL STRUCTURE OF ANTI-ZIKA ANTIBODY Z006 BOUND TO ZIKA VIRUS ENVELOPE PROTEIN DIII
1137, 5vigB, 0.6499, 2.92, 0.054, 212, 92, CRYSTAL STRUCTURE OF ANTI-ZIKA ANTIBODY Z006 BOUND TO ZIKA VIRUS ENVELOPE PROTEIN DIII
1138, 5mu2L, 0.6499, 3.22, 0.063, 218, 95, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
1139, 5lqbL, 0.6499, 3.09, 0.053, 217, 94, COMPLEX STRUCTURE OF HUMAN IL2 MUTANT PROLEUKIN WITH FAB FRAGMENT OF NARA1 ANTIBODY
1140, 4xwoJ, 0.6499, 3.13, 0.064, 215, 94, STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF SEC22
1141, 4ubdL, 0.6499, 2.93, 0.054, 213, 92, CRYSTAL STRUCTURE OF A NEUTRALIZING HUMAN MONOCLONAL ANTIBODY WITH 1968 H3 HA
1142, 4f33E, 0.6499, 2.71, 0.056, 211, 90, CRYSTAL STRUCTURE OF THERAPEUTIC ANTIBODY MORAB-009
1143, 3uyrL, 0.6499, 2.95, 0.054, 218, 93, STRUCTURE OF A MONOCLONAL ANTIBODY COMPLEXED WITH ITS MHC-I ANTIGEN
1144, 2op4L, 0.6499, 2.69, 0.056, 212, 90, CRYSTAL STRUCTURE OF QUORUM-QUENCHING ANTIBODY 1G9
1145, 1rhhA, 0.6499, 2.99, 0.054, 215, 93, CRYSTAL STRUCTURE OF THE BROADLY HIV-1 NEUTRALIZING FAB X5 AT 1.90 ANGSTROM RESOLUTION
1146, 1i7zC, 0.6499, 2.95, 0.054, 219, 92, ANTIBODY GNC92H2 BOUND TO LIGAND
1147, 6rcoD, 0.6498, 2.80, 0.088, 215, 91, PFRH5-BINDING MONOCLONAL ANTIBODY R5.004 
1148, 5mudB, 0.6498, 2.67, 0.067, 212, 90, CRYSTAL STRUCTURE OF AN AMYLOIDOGENIC LIGHT CHAIN DIMER H6
1149, 5dj2A, 0.6498, 2.83, 0.053, 208, 94, FC HETERODIMER DESIGN 7.4 Y407A + T366V/K409V
1150, 4nhcL, 0.6498, 2.96, 0.054, 215, 93, CRYSTAL STRUCTURE OF THE HIV-1 NEUTRALIZING ANTIBODY 4E10 FAB FRAGMENT IN COMPLEX WITH A HYDROCARBON-STAPLED PEPTIDE CONTAINING THE 4E10 EPITOPE ON GP41.
1151, 3vrlF, 0.6498, 2.93, 0.043, 214, 93, CRYSTAL STRUCTURE OF BMJ4 P24 CAPSID PROTEIN IN COMPLEX WITH A10F9 FAB
1152, 3do3A, 0.6498, 2.92, 0.043, 209, 94, HUMAN 1GG1 FC FRAGMENT 2.5 ANGSTROM STRUCTURE
1153, 1q9oC, 0.6498, 2.87, 0.054, 219, 93, S45-18 FAB UNLIGANDED
1154, 5uslL, 0.6497, 2.69, 0.100, 210, 90, STRUCTURE OF VACCINIA VIRUS D8 PROTEIN BOUND TO HUMAN FAB VV304
1155, 5umnF, 0.6497, 2.93, 0.065, 213, 92, CRYSTAL STRUCTURE OF C05 VPGSGW MUTANT BOUND TO H3 INFLUENZA HEMAGGLUTININ HA1 SUBUNIT
1156, 5tl5L, 0.6497, 2.95, 0.054, 217, 92, COMPLEX BETWEEN HUMAN CD27 AND ANTIBODY M2177
1157, 5itfA, 0.6497, 2.92, 0.065, 213, 92, CETUXIMAB FAB IN COMPLEX WITH 2-BROMOPHENYLALANINE MEDITOPE VARIANT
1158, 4ubdP, 0.6497, 2.93, 0.054, 213, 92, CRYSTAL STRUCTURE OF A NEUTRALIZING HUMAN MONOCLONAL ANTIBODY WITH 1968 H3 HA
1159, 4pw3D, 0.6497, 3.06, 0.083, 365, 96, CRYSTAL STRUCTURE OF THE SULFITE DEHYDROGENASE SORT FROM SINORHIZOBIUM MELILOTI
1160, 4pw3B, 0.6497, 3.06, 0.083, 363, 96, CRYSTAL STRUCTURE OF THE SULFITE DEHYDROGENASE SORT FROM SINORHIZOBIUM MELILOTI
1161, 3wknJ, 0.6497, 3.12, 0.052, 209, 97, CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG
1162, 3l5wL, 0.6497, 2.93, 0.054, 213, 92, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN IL-13 AND C836 FAB
1163, 1sy6L, 0.6497, 3.08, 0.064, 213, 94, CRYSTAL STRUCTURE OF CD3GAMMAEPSILON HETERODIMER IN COMPLEX WITH OKT3 FAB FRAGMENT
1164, 1rupL, 0.6497, 2.89, 0.043, 219, 93, CRYSTAL STRUCTURE (G) OF NATIVE CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 8.5 WITH A DATA SET COLLECTED AT APS BEAMLINE 19-ID
1165, 6iqhA, 0.6496, 2.74, 0.053, 207, 94, X-RAY CRYSTAL STRUCTURE OF COVALENT-BONDED COMPLEX OF FC AND PEPTIDE 
1166, 6fy2Y, 0.6496, 2.73, 0.089, 209, 90, CRYSTAL STRUCTURE OF A V2P-REACTIVE RV144 VACCINE-LIKE ANTIBODY; CAP228-16H; IN COMPLEX WITH A HETEROLOGOUS CAP225 V1V2 
1167, 6aodA, 0.6496, 3.08, 0.054, 207, 93, FXIA ANTIBODY COMPLEX
1168, 6al4A, 0.6496, 2.94, 0.054, 218, 93, CRYSTAL STRUCTURE OF ANTI-CD19 ANTIBODY B43 FAB
1169, 5t6lB, 0.6496, 2.70, 0.066, 212, 91, CRYSTAL STRUCTURE OF 10E8 FAB IN COMPLEX WITH THE MPER EPITOPE SCAFFOLD T117V2
1170, 5t1mC, 0.6496, 3.08, 0.065, 213, 93, CETUXIMAB FAB IN COMPLEX WITH CQYDLSTRRLKC
1171, 4pw3C, 0.6496, 3.06, 0.083, 365, 96, CRYSTAL STRUCTURE OF THE SULFITE DEHYDROGENASE SORT FROM SINORHIZOBIUM MELILOTI
1172, 4pw3A, 0.6496, 3.06, 0.083, 365, 96, CRYSTAL STRUCTURE OF THE SULFITE DEHYDROGENASE SORT FROM SINORHIZOBIUM MELILOTI
1173, 4osuL, 0.6496, 2.75, 0.078, 212, 90, CRYSTAL STRUCTURE OF HCMV GB-NEUTRALIZING SM5-1 FAB FRAGMENT
1174, 3q6fA, 0.6496, 2.87, 0.098, 212, 92, CRYSTAL STRUCTURE OF FAB OF HUMAN MAB 2909 SPECIFIC FOR QUATERNARY NEUTRALIZING EPITOPE OF HIV-1 GP120
1175, 3mlwM, 0.6496, 2.77, 0.089, 215, 90, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 1006-15D IN COMPLEX WITH AN MN V3 PEPTIDE
1176, 2z4qA, 0.6496, 2.92, 0.043, 219, 93, CRYSTAL STRUCTURE OF A MURINE ANTIBODY FAB 528
1177, 1xcqA, 0.6496, 2.94, 0.043, 220, 93, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55AL57HY64W) IN SPACE GROUP P21
1178, 1hi6A, 0.6496, 3.04, 0.053, 214, 94, ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH A PEPTIDE
1179, 1ad9L, 0.6496, 2.98, 0.054, 219, 93, IGG-FAB FRAGMENT OF ENGINEERED HUMAN MONOCLONAL ANTIBODY CTM01
1180, 6mcoE, 0.6495, 2.73, 0.055, 213, 91, CRYSTAL STRUCTURE OF THE B41 SOSIP.664 ENV TRIMER WITH PGT124 AND 35O22 FABS; IN P23 SPACE GROUP 
1181, 6ecaA, 0.6495, 2.74, 0.067, 590, 90, LACTOBACILLUS RHAMNOSUS BETA-GLUCURONIDASE 
1182, 6e64B, 0.6495, 2.76, 0.089, 213, 90, CRYSTAL STRUCTURE OF MALARIA TRANSMISSION-BLOCKING ANTIGEN PFS48/45 6C IN COMPLEX WITH ANTIBODY 85RF45.1 
1183, 6bftB, 0.6495, 3.04, 0.054, 214, 93, STRUCTURE OF BEVACIZUMAB FAB MUTANT IN COMPLEX WITH VEGF 
1184, 6aynC, 0.6495, 3.05, 0.076, 212, 92, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-(3- AMINOPROPYL)-L-ARGININE MEDITOPE VARIANT
1185, 5u3mL, 0.6495, 2.94, 0.054, 216, 92, CRYSTAL STRUCTURE OF DH511.11P FAB IN COMPLEX WITH HIV-1 GP41 MPER PEPTIDE
1186, 5mu2F, 0.6495, 2.99, 0.065, 217, 93, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
1187, 5m6iB, 0.6495, 2.74, 0.078, 212, 90, CRYSTAL STRUCTURE OF NON-CARDIOTOXIC BENCE-JONES LIGHT CHAIN DIMER M8
1188, 5djcB, 0.6495, 2.83, 0.053, 206, 94, FC HETERODIMER DESIGN 8.1 L368V/Y407A + T366V/K409F
1189, 5a16H, 0.6495, 2.97, 0.054, 218, 93, CRYSTAL STRUCTURE OF FAB4201 RAISED AGAINST HUMAN ERYTHROCYTE ANION EXCHANGER 1
1190, 4x7tL, 0.6495, 3.00, 0.054, 218, 93, STRUCTURE OF OMALIZUMAB FAB FRAGMENT CRYSTAL FORM 2
1191, 4llwB, 0.6495, 2.90, 0.044, 207, 91, CRYSTAL STRUCTURE OF PERTUZUMAB CLAMBDA FAB WITH VARIABLE DOMAIN REDESIGN (VRD2) AT 1.95A
1192, 4jg0L, 0.6495, 2.95, 0.054, 214, 92, STRUCTURE OF PHOSPHOSERINE/THREONINE (PSTAB) SCAFFOLD BOUND TO PSER PEPTIDE
1193, 4f58O, 0.6495, 2.69, 0.067, 213, 90, FAB STRUCTURE OF A NEUTRALIZING ANTIBODY L3 FROM AN EARLY SUBTYPE A HIV-1 INFECTED PATIENT
1194, 3zknL, 0.6495, 3.02, 0.054, 217, 93, BACE2 FAB INHIBITOR COMPLEX
1195, 3v7mA, 0.6495, 2.95, 0.042, 209, 95, CRYSTAL STRUCTURE OF MONOCLONAL HUMAN ANTI-RHESUS D FC IGG1 T125(YB2/0) IN THE PRESENCE OF ZN2+
1196, 3qhfL, 0.6495, 2.75, 0.088, 214, 91, CRYSTAL STRUCTURE OF FAB DEL2D1 A DELETION VARIANT OF ANTI-INFLUENZA ANTIBODY 2D1
1197, 3idiA, 0.6495, 2.85, 0.066, 213, 91, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 FAB  FRAGMENT IN COMPLEX WITH GP41 PEPTIDE ALDKWNQ
1198, 3eyoA, 0.6495, 3.01, 0.066, 213, 91, CRYSTAL STRUCTURE OF ANTI-HUMAN CYTOMEGALOVIRUS ANTIBODY 8F9
1199, 3dggA, 0.6495, 3.09, 0.043, 217, 94, CRYSTAL STRUCTURE OF FABOX108
1200, 3bisA, 0.6495, 2.44, 0.056, 212, 89, CRYSTAL STRUCTURE OF THE PD-L1
1201, 2x7lD, 0.6495, 3.00, 0.054, 217, 93, IMPLICATIONS OF THE HIV-1 REV DIMER STRUCTURE AT 3.2A RESOLUTION FOR MULTIMERIC BINDING TO THE REV RESPONSE ELEMENT
1202, 2pr4L, 0.6495, 2.85, 0.066, 213, 91, CRYSTAL STRUCTURE OF FAB  FROM THE HIV-1 NEUTRALIZING ANTIBODY 2F5
1203, 2f5aL, 0.6495, 2.85, 0.066, 213, 91, CRYSTAL STRUCTURE OF FAB  FROM THE HIV-1 NEUTRALIZING ANTIBODY 2F5
1204, 1mamL, 0.6495, 2.93, 0.043, 214, 93, CRYSTAL STRUCTURE TO 2.45 A RESOLUTION OF A MONOCLONAL FAB SPECIFIC FOR THE BRUCELLA A CELL WALL POLYSACCHARIDE ANTIGEN
1205, 1h0dA, 0.6495, 2.88, 0.054, 216, 92, CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN IN COMPLEX WITH FAB FRAGMENT OF ITS MONOCLONAL ANTIBODY MAB 26-2F
1206, 1eapA, 0.6495, 2.91, 0.043, 213, 93, CRYSTAL STRUCTURE OF A CATALYTIC ANTIBODY WITH A SERINE PROTEASE ACTIVE SITE
1207, 6mehL, 0.6494, 2.97, 0.054, 213, 92, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
1208, 6ieqE, 0.6494, 2.92, 0.054, 213, 92, CRYSTAL STRUCTURE OF HIV-1 ENV CONM SOSIP.V7 IN COMPLEX WITH BNAB PGT124 AND 35O22 
1209, 6e63L, 0.6494, 2.77, 0.065, 215, 92, CRYSTAL STRUCTURE OF MALARIA TRANSMISSION-BLOCKING ANTIGEN PFS48/45 6C IN COMPLEX WITH ANTIBODY TB31F 
1210, 5yfiL, 0.6494, 3.09, 0.053, 214, 94, CRYSTAL STRUCTURE OF THE CLINICALLY IMPORTANT GPCR IN COMPLEX WITH FUNCTIONAL ANTIBODY 
1211, 5xrqL, 0.6494, 2.93, 0.054, 213, 92, CRYSTAL STRUCTURE OF HUMAN MONOCLONAL ANTIBODY H3V-47 
1212, 5wa0B, 0.6494, 3.05, 0.083, 365, 96, CRYSTAL STRUCTURE OF THE SULFITE DEHYDROGENASE SORT R78Q MUTANT FROM SINORHIZOBIUM MELILOTI
1213, 5nsgA, 0.6494, 2.92, 0.043, 206, 94, FC DEDE HOMODIMER VARIANT
1214, 5l9dL, 0.6494, 2.93, 0.054, 214, 93, AFAMIN ANTIBODY FRAGMENT N14 FAB L1- GLYCOSYLATED CRYSTAL FORM I PARSIMONIOUS MODEL
1215, 5eukC, 0.6494, 2.88, 0.065, 213, 92, CETUXIMAB FAB IN COMPLEX WITH F3H MEDITOPE VARIANT
1216, 4ku1B, 0.6494, 2.85, 0.043, 208, 93, ROLE OF THE HINGE AND C-GAMMA-2/C-GAMMA-3 INTERFACE IN IMMUNOGLOBIN G1 FC DOMAIN MOTIONS: IMPLICATIONS FOR FC ENGINEERING
1217, 4g6fD, 0.6494, 2.74, 0.089, 211, 90, CRYSTAL STRUCTURE OF 10E8 FAB IN COMPLEX WITH AN HIV-1 GP41 PEPTIDE
1218, 4fzeL, 0.6494, 2.72, 0.066, 209, 91, CRYSTAL STRUCTURE OF N26_I1 FAB AN ADCC MEDIATING ANTI-HIV-1 ANTIBODY.
1219, 4f58N, 0.6494, 2.70, 0.056, 213, 90, FAB STRUCTURE OF A NEUTRALIZING ANTIBODY L3 FROM AN EARLY SUBTYPE A HIV-1 INFECTED PATIENT
1220, 3gjeA, 0.6494, 2.76, 0.089, 212, 90, RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES
1221, 3gi9L, 0.6494, 2.82, 0.043, 219, 92, CRYSTAL STRUCTURE OF APCT TRANSPORTER BOUND TO 7F11 MONOCLONAL FAB FRAGMENT
1222, 1nlbL, 0.6494, 2.94, 0.054, 220, 93, CRYSTAL STRUCTURE OF ANTI-HCV MONOCLONAL ANTIBODY 19D9D6
1223, 1ngzA, 0.6494, 2.90, 0.055, 213, 91, CHIMERIC GERMLINE FAB 7G12-APO
1224, 1cz8L, 0.6494, 2.94, 0.054, 213, 92, VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH AN AFFINITY MATURED ANTIBODY
1225, 6a67D, 0.6493, 2.74, 0.089, 212, 90, CRYSTAL STRUCTURE OF INFLUENZA A VIRUS H5 HEMAGGLUTININ GLOBULAR HEAD IN COMPLEX WITH THE FAB OF ANTIBODY FLD21.140 
1226, 5tkkL, 0.6493, 3.04, 0.065, 213, 93, STRUCTURE OF MOUSE VACCINATION-ELICITED HIV NEUTRALIZING ANTIBODY VFP5.01 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519
1227, 5t1kC, 0.6493, 3.09, 0.065, 213, 93, CETUXIMAB FAB IN COMPLEX WITH CQFDA(PH)2STRRLKC
1228, 5sx5K, 0.6493, 2.93, 0.055, 213, 91, CRYSTAL STRUCTURE OF PANITUMUMAB IN COMPLEX WITH EPIDERMAL GROWTH FACTOR RECEPTOR DOMAIN 3 MUTANT S468R.
1229, 5mu2H, 0.6493, 3.17, 0.064, 217, 94, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
1230, 5m63N, 0.6493, 2.96, 0.065, 216, 92, CRYSTAL STRUCTURE OF GROUP B STREPTOCOCCUS TYPE III DP2 OLIGOSACCHARIDE BOUND TO FAB NVS-1-19-5
1231, 5lgkC, 0.6493, 2.85, 0.093, 306, 97, CRYSTAL STRUCTURE OF THE HUMAN IGE-FC BOUND TO ITS B CELL RECEPTOR DERCD23
1232, 5iczC, 0.6493, 3.08, 0.065, 213, 93, CETUXIMAB FAB IN COMPLEX WITH GQFDLSTRRLKG PEPTIDE
1233, 5i2iC, 0.6493, 3.07, 0.065, 213, 93, STRUCTURE OF CETUXIMAB FAB WITH CYCLIC F3Q VARIANT OF THE MEDITOPE
1234, 4xh2F, 0.6493, 2.95, 0.054, 209, 93, CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD4 MOTIF IN COMPLEX WITH FAB FRAGMENT
1235, 4hxbL, 0.6493, 2.87, 0.054, 219, 92, CRYSTAL STRUCTURE OF 6B9 FAB
1236, 3se9L, 0.6493, 2.99, 0.054, 208, 93, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC- PG04 IN COMPLEX WITH HIV-1 GP120
1237, 3ojdA, 0.6493, 2.96, 0.054, 214, 93, ANTI-INDOLICIDIN MONOCLONAL ANTIBODY V2D2 (FAB FRAGMENT)
1238, 3ggwA, 0.6493, 2.83, 0.054, 218, 92, CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A CARBOHYDRATE-MIMETIC PEPTIDE
1239, 3eoaL, 0.6493, 3.03, 0.054, 214, 93, CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB IN COMPLEX WITH LFA-1 I DOMAIN FORM I
1240, 2hkfL, 0.6493, 2.94, 0.054, 219, 93, CRYSTAL STRUCTURE OF THE COMPLEX FAB M75- PEPTIDE
1241, 1xctA, 0.6493, 3.06, 0.053, 220, 94, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55A L57H Y64W) IN SPACE GROUP P21212
1242, 6db7M, 0.6492, 2.75, 0.089, 210, 90, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 1334 IN COMPLEX WITH A HIV-1 GP120 V3 PEPTIDE FROM MN STRAIN 
1243, 6au5C, 0.6492, 3.08, 0.065, 213, 93, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-BUTYLARGININE MEDITOPE VARIANT
1244, 5y9fS, 0.6492, 2.84, 0.044, 218, 91, CRYSTAL STRUCTURE OF HPV59 PENTAMER IN COMPLEX WITH THE FAB FRAGMENT OF ANTIBODY 28F10
1245, 5u66A, 0.6492, 2.91, 0.053, 207, 95, MODIFIED SINGLE HELIX FROM THE B-DOMAIN OF PROTEIN A BOUND TO IGG1 FC
1246, 5mheL, 0.6492, 2.74, 0.055, 212, 91, CRYSTAL STRUCTURE OF ANTI-T4 FAB FRAGMENT WITH T4 
1247, 5l88L, 0.6492, 2.93, 0.054, 215, 93, AFAMIN ANTIBODY FRAGMENT N14 FAB L1- GLYCOSILATED CRYSTAL FORM I NON-PARSIMONIOUS MODEL
1248, 5i1cL, 0.6492, 3.13, 0.064, 215, 94, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-23/IGKV3-20
1249, 4tnvK, 0.6492, 2.77, 0.056, 212, 90, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
1250, 4qhkP, 0.6492, 2.71, 0.067, 209, 90, UCA (UNBOUND) FROM CH103 LINEAGE
1251, 4jn1L, 0.6492, 2.90, 0.054, 219, 92, AN ANTIDOTE FOR DABIGATRAN
1252, 4f33A, 0.6492, 2.71, 0.056, 211, 90, CRYSTAL STRUCTURE OF THERAPEUTIC ANTIBODY MORAB-009
1253, 3tnnD, 0.6492, 2.66, 0.101, 212, 89, CRYSTAL STRUCTURE OF N5-I5 FAB AN ADCC MEDIATING AND NON-NEUTRALIZING CD4I ANTI-HIV- 1 ANTIBODY.
1254, 3chnD, 0.6492, 3.21, 0.053, 475, 94, SOLUTION STRUCTURE OF HUMAN SECRETORY IGA1
1255, 3chnB, 0.6492, 3.21, 0.053, 475, 94, SOLUTION STRUCTURE OF HUMAN SECRETORY IGA1
1256, 3chnA, 0.6492, 3.21, 0.053, 475, 94, SOLUTION STRUCTURE OF HUMAN SECRETORY IGA1
1257, 2x7lL, 0.6492, 3.01, 0.054, 217, 93, IMPLICATIONS OF THE HIV-1 REV DIMER STRUCTURE AT 3.2A RESOLUTION FOR MULTIMERIC BINDING TO THE REV RESPONSE ELEMENT
1258, 2qtjC, 0.6492, 3.21, 0.053, 475, 94, SOLUTION STRUCTURE OF HUMAN DIMERIC IMMUNOGLOBULIN A
1259, 2qtjB, 0.6492, 3.21, 0.053, 475, 94, SOLUTION STRUCTURE OF HUMAN DIMERIC IMMUNOGLOBULIN A
1260, 2qtjA, 0.6492, 3.21, 0.053, 475, 94, SOLUTION STRUCTURE OF HUMAN DIMERIC IMMUNOGLOBULIN A
1261, 2esgB, 0.6492, 3.21, 0.053, 475, 94, SOLUTION STRUCTURE OF THE COMPLEX BETWEEN IMMUNOGLOBULIN IGA1 AND HUMAN SERUM ALBUMIN
1262, 1igaB, 0.6492, 3.21, 0.053, 475, 94, MODEL OF HUMAN IGA1 DETERMINED BY SOLUTION SCATTERING CURVE- FITTING AND HOMOLOGY MODELLING
1263, 1igaA, 0.6492, 3.21, 0.053, 475, 94, MODEL OF HUMAN IGA1 DETERMINED BY SOLUTION SCATTERING CURVE- FITTING AND HOMOLOGY MODELLING
1264, 6ieqL, 0.6491, 2.77, 0.089, 210, 90, CRYSTAL STRUCTURE OF HIV-1 ENV CONM SOSIP.V7 IN COMPLEX WITH BNAB PGT124 AND 35O22 
1265, 6glwL, 0.6491, 2.99, 0.086, 216, 93, STRUCTURE OF GALECTIN-10 IN COMPLEX WITH THE FAB FRAGMENT OF A CHARCOT-LEYDEN CRYSTAL SOLUBILIZING ANTIBODY; 1D11 
1266, 6b0hA, 0.6491, 2.94, 0.054, 213, 92, CRYSTAL STRUCTURE OF PFS25 IN COMPLEX WITH THE TRANSMISSION BLOCKING ANTIBODY 1262
1267, 6a0xD, 0.6491, 3.06, 0.053, 214, 94, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY 13D4 
1268, 5mv4G, 0.6491, 3.24, 0.063, 218, 95, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED CII616-639 EPITOPE OF COLLAGEN TYPE II (PTM23)
1269, 5icxC, 0.6491, 2.87, 0.066, 212, 91, CETUXIMAB FAB IN COMPLEX WITH CQFDLSTRRLRCGGSK MEDITOPE
1270, 5fb8A, 0.6491, 3.15, 0.064, 218, 94, STRUCTURE OF INTERLEUKIN-16 BOUND TO THE 14.1 ANTIBODY
1271, 5etuC, 0.6491, 3.07, 0.065, 213, 93, CETUXIMAB FAB IN COMPLEX WITH L5E MEDITOPE VARIANT
1272, 4x7tB, 0.6491, 2.97, 0.065, 218, 93, STRUCTURE OF OMALIZUMAB FAB FRAGMENT CRYSTAL FORM 2
1273, 4hxaL, 0.6491, 2.90, 0.054, 213, 93, CRYSTAL STRUCTURE OF 13D9 FAB
1274, 3uo1L, 0.6491, 2.96, 0.054, 218, 93, STRUCTURE OF A MONOCLONAL ANTIBODY COMPLEXED WITH ITS MHC-I ANTIGEN
1275, 3chnC, 0.6491, 3.21, 0.053, 475, 94, SOLUTION STRUCTURE OF HUMAN SECRETORY IGA1
1276, 2vxsL, 0.6491, 2.73, 0.089, 213, 90, STRUCTURE OF IL-17A IN COMPLEX WITH A POTENT FULLY HUMAN NEUTRALISING ANTIBODY
1277, 2vweJ, 0.6491, 3.14, 0.064, 214, 94, CRYSTAL STRUCTURE OF VASCULAR ENDOTHELIAL GROWTH FACTOR-B IN COMPLEX WITH A NEUTRALIZING ANTIBODY FAB FRAGMENT
1278, 2qtjD, 0.6491, 3.21, 0.053, 475, 94, SOLUTION STRUCTURE OF HUMAN DIMERIC IMMUNOGLOBULIN A
1279, 2ql1A, 0.6491, 2.99, 0.042, 209, 95, STRUCTURAL CHARACTERIZATION OF A MUTATED ADCC-ENHANCED HUMAN FC FRAGMENT
1280, 2dtmL, 0.6491, 2.84, 0.054, 218, 92, THERMODYNAMIC AND STRUCTURAL ANALYSES OF HYDROLYTIC MECHANISM BY CATALYTIC ANTIBODIES
1281, 1xf5C, 0.6491, 2.90, 0.054, 220, 93, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (H74C Y64W)IN SPACE GROUP P21212
1282, 1mjjA, 0.6491, 2.83, 0.054, 218, 92, HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS6-12 AND A TRANSITION- STATE ANALOG
1283, 1cf8L, 0.6491, 2.96, 0.054, 215, 93, CONVERGENCE OF CATALYTIC ANTIBODY AND TERPENE CYCLASE MECHANISMS: POLYENE CYCLIZATION DIRECTED BY CARBOCATION-PI INTERACTIONS
1284, 6bf7D, 0.6490, 2.87, 0.066, 211, 91, CRYO-EM STRUCTURE OF HUMAN INSULIN DEGRADING ENZYME IN COMPLEX WITH FAB H11-E HEAVY CHAIN FAB H11-E LIGHT CHAIN
1285, 6b0sL, 0.6490, 2.82, 0.087, 210, 92, CRYSTAL STRUCTURE OF CIRCUMSPOROZOITE PROTEIN ATSR DOMAIN IN COMPLEX WITH 1710 ANTIBODY
1286, 5gznD, 0.6490, 2.74, 0.066, 214, 91, STRUCTURE OF NEUTRALIZING ANTIBODY BOUND TO ZIKA ENVELOPE PROTEIN
1287, 5ff6C, 0.6490, 3.09, 0.065, 213, 93, CETUXIMAB FAB IN COMPLEX WITH L10Q MEDITOPE VARIANT
1288, 4x80L, 0.6490, 2.86, 0.043, 213, 92, CRYSTAL STRUCTURE OF MURINE 7B4 FAB MONOCLONAL ANTIBODY AGAINST ADAMTS5
1289, 4qhuA, 0.6490, 2.71, 0.089, 209, 90, CRYSTAL STRUCTURE OF IL-17A/FAB6785 COMPLEX
1290, 4qhkL, 0.6490, 2.71, 0.067, 209, 90, UCA (UNBOUND) FROM CH103 LINEAGE
1291, 4j4pL, 0.6490, 2.75, 0.055, 215, 91, THE COMPLEX OF HUMAN IGE-FC WITH TWO BOUND FAB FRAGMENTS
1292, 3q6fI, 0.6490, 2.88, 0.098, 212, 92, CRYSTAL STRUCTURE OF FAB OF HUMAN MAB 2909 SPECIFIC FOR QUATERNARY NEUTRALIZING EPITOPE OF HIV-1 GP120
1293, 2p8lA, 0.6490, 2.94, 0.065, 214, 92, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELLELDKWASLWN
1294, 2bc4C, 0.6490, 2.63, 0.022, 195, 91, CRYSTAL STRUCTURE OF HLA-DM
1295, 6ocbL, 0.6489, 3.10, 0.065, 213, 93, CRYSTAL STRUCTURE OF FLUA-20 FAB IN COMPLEX WITH THE HEAD DOMAIN OF H3 (A/HONG KONG/1/1968) 
1296, 6b5sL, 0.6489, 2.72, 0.089, 212, 90, STRUCTURE OF PFCSP PEPTIDE 25 WITH HUMAN ANTIBODY CIS42
1297, 5xhvL, 0.6489, 3.06, 0.054, 214, 93, CRYSTAL STRUCTURE OF FAB S40 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ HA1 SUBUNIT.
1298, 5vr9B, 0.6489, 2.96, 0.054, 210, 92, CH1/CKAPPA FAB BASED ON MATUZUMAB
1299, 5nscA, 0.6489, 2.93, 0.052, 209, 96, FC DEKK HETERODIMER VARIANT
1300, 5k65B, 0.6489, 2.62, 0.055, 212, 91, CRYSTAL STRUCTURE OF VEGF BINDING IGG1-FC (FCAB CT6)
1301, 5i66B, 0.6489, 2.84, 0.054, 213, 92, X-RAY STRUCTURE OF THE FAB FRAGMENT OF 8B6 A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR THE HUMAN SEROTONIN TRANSPORTER
1302, 4xphL, 0.6489, 2.86, 0.043, 214, 92, X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER WITH SUBSITEB MUTATIONS (D121G/S426M) BOUND TO 34DICHLOROPHENETHYLAMINE
1303, 4gxvM, 0.6489, 2.74, 0.089, 213, 90, CRYSTAL STRUCTURE OF ANTI-INFLUENZA VIRUS ANTIBODY 1F1
1304, 3ghbL, 0.6489, 2.77, 0.065, 216, 92, CRYSTAL STRUCTURE OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 PEPTIDE W2RW020
1305, 2ombC, 0.6489, 2.97, 0.065, 216, 93, BENCE JONES KWR PROTEIN- IMMUNOGLOBULIN LIGHT CHAIN DIMER P3(1)21 CRYSTAL FORM
1306, 1za3L, 0.6489, 2.85, 0.054, 213, 92, THE CRYSTAL STRUCTURE OF THE YSD1 FAB BOUND TO DR5
1307, 1q9kA, 0.6489, 3.06, 0.053, 219, 94, S25-2 FAB UNLIGANDED 1
1308, 6qnaL, 0.6488, 2.82, 0.066, 211, 91, STRUCTURE OF BOVINE ANTI-RSV HYBRID FAB B13HC-B4LC 
1309, 6azmC, 0.6488, 2.93, 0.054, 219, 92, CRYSTAL STRUCTURE OF THE 580 GERMLINE ANTIBODY BOUND TO CIRCUMSPOROZOITE PROTEIN NANP 5-MER
1310, 5ywoQ, 0.6488, 3.12, 0.043, 215, 94, STRUCTURE OF JEV-2F2 FAB COMPLEX
1311, 5ywoM, 0.6488, 3.12, 0.043, 215, 94, STRUCTURE OF JEV-2F2 FAB COMPLEX
1312, 5tzuL, 0.6488, 3.04, 0.065, 213, 92, CRYSTAL STRUCTURE OF HUMAN CD47 ECD BOUND TO FAB OF B6H12.2
1313, 5mu0B, 0.6488, 3.02, 0.054, 217, 93, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (IA03)
1314, 5mp5L, 0.6488, 2.85, 0.043, 218, 92, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 6.5 
1315, 5jorC, 0.6488, 3.04, 0.043, 218, 93, CRYSTAL STRUCTURE OF UNBOUND ANTI-GLYCAN ANTIBODY FAB14.22 AT 2.2 A
1316, 5i2iA, 0.6488, 2.96, 0.054, 213, 92, STRUCTURE OF CETUXIMAB FAB WITH CYCLIC F3Q VARIANT OF THE MEDITOPE
1317, 5cszB, 0.6488, 2.96, 0.054, 214, 92, CRYSTAL STRUCTURE OF GANTENERUMAB FAB FRAGMENT IN COMPLEX WITH ABETA 1-11
1318, 4o51C, 0.6488, 2.94, 0.065, 214, 92, CRYSTAL STRUCTURE OF THE QAA VARIANT OF ANTI-HINGE RABBIT ANTIBODY 2095-2 IN COMPLEX WITH IDES HINGE PEPTIDE
1319, 4n9gL, 0.6488, 3.16, 0.064, 214, 94, CRYSTAL STRUCTURE OF A COMPUTATIONALLY DESIGNED RSV-PRESENTING EPITOPE SCAFFOLD AND ITS ELICITED ANTIBODY 17HD9
1320, 4imlH, 0.6488, 3.05, 0.054, 234, 92, CROSSFAB BINDING TO HUMAN ANGIOPOIETIN 2
1321, 4cdhB, 0.6488, 3.00, 0.053, 208, 95, CRYSTALLOGRAPHIC STRUCTURE OF THE HUMAN IGG1 ALPHA 2-6 SIALILATED FC-FRAGMENT
1322, 3q6fC, 0.6488, 2.86, 0.098, 212, 92, CRYSTAL STRUCTURE OF FAB OF HUMAN MAB 2909 SPECIFIC FOR QUATERNARY NEUTRALIZING EPITOPE OF HIV-1 GP120
1323, 2bc4A, 0.6488, 2.62, 0.022, 188, 91, CRYSTAL STRUCTURE OF HLA-DM
1324, 6qn8F, 0.6487, 2.86, 0.065, 213, 92, STRUCTURE OF BOVINE ANTI-RSV FAB B13 
1325, 6njmO, 0.6487, 2.96, 0.044, 211, 91, STRUCTURE OF A COMPLEX 
1326, 6ii8L, 0.6487, 2.76, 0.089, 213, 90, CRYSTAL STRUCTURE OF H7 HEMAGGLUTININ FROM A/ANHUI/1/2013 IN COMPLEX WITH A HUMAN NEUTRALIZING ANTIBODY L4B-18 
1327, 6ddrA, 0.6487, 3.02, 0.054, 214, 93, CRYSTAL STRUCTURE ANALYSIS OF THE EPITOPE OF AN ANTI-MICA ANTIBODY 
1328, 5ziaB, 0.6487, 3.12, 0.065, 217, 92, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-24.1 IN COMPLEX WITH ITS PHOSPHORYLATED TAU PEPTIDE 
1329, 5vj6R, 0.6487, 2.92, 0.055, 214, 91, BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PG9 AND 8ANC195
1330, 5vj6P, 0.6487, 2.92, 0.055, 214, 91, BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PG9 AND 8ANC195
1331, 5vj6N, 0.6487, 2.92, 0.055, 214, 91, BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PG9 AND 8ANC195
1332, 5u7mL, 0.6487, 2.74, 0.089, 208, 90, CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-378806 IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 3.8 ANGSTROM
1333, 5iv2C, 0.6487, 2.80, 0.055, 213, 91, CETUXIMAB FAB IN COMPLEX WITH ARG9CIR MEDITOPE VARIANT
1334, 5hysL, 0.6487, 2.95, 0.054, 217, 92, STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB
1335, 5hy9A, 0.6487, 3.11, 0.042, 207, 95, GLYCOSYLATED DISULFIDE-LINKED KNOB-INTO-HOLE FC FRAGMENT
1336, 5f88C, 0.6487, 2.94, 0.065, 213, 92, CETUXIMAB FAB IN COMPLEX WITH L5Y MEDITOPE VARIANT
1337, 5cjxE, 0.6487, 2.92, 0.055, 214, 91, CRYSTAL STRUCTURE OF 8ANC195 FAB IN COMPLEX WITH BG505 SOSIP.664 HIV-1 ENV TRIMER
1338, 4xnxL, 0.6487, 2.89, 0.043, 214, 92, X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER IN COMPLEX WITH REBOXETINE
1339, 4wv1D, 0.6487, 3.14, 0.064, 214, 94, CRYSTAL STRUCTURE OF THE FGFR2 D2 DOMAIN IN COMPLEX WITH FAB 2B.1.3
1340, 4tvpL, 0.6487, 2.77, 0.089, 210, 90, CRYSTAL STRUCTURE OF THE HIV-1 BG505 SOSIP.664 ENV TRIMER ECTODOMAIN COMPRISING ATOMIC-LEVEL DEFINITION OF PRE-FUSION GP120 AND GP41 IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22
1341, 4ocsL, 0.6487, 2.75, 0.078, 212, 90, CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.10 A POTENT V1V2-DIRECTED HIV-1 NEUTRALIZING ANTIBODY
1342, 4hc1L, 0.6487, 2.98, 0.054, 213, 93, CRYSTAL STRUCTURE OF A LOOP DELETED MUTANT OF HUMAN MADCAM-1 D1D2 COMPLEXED WITH FAB 10G3
1343, 4cniB, 0.6487, 2.98, 0.054, 214, 93, CRYSTAL STRUCTURE OF THE FAB PORTION OF OLOKIZUMAB IN COMPLEX WITH IL-6
1344, 3q6fG, 0.6487, 2.89, 0.098, 212, 92, CRYSTAL STRUCTURE OF FAB OF HUMAN MAB 2909 SPECIFIC FOR QUATERNARY NEUTRALIZING EPITOPE OF HIV-1 GP120
1345, 2x7lK, 0.6487, 3.01, 0.054, 217, 93, IMPLICATIONS OF THE HIV-1 REV DIMER STRUCTURE AT 3.2A RESOLUTION FOR MULTIMERIC BINDING TO THE REV RESPONSE ELEMENT
1346, 2x7lI, 0.6487, 3.01, 0.054, 217, 93, IMPLICATIONS OF THE HIV-1 REV DIMER STRUCTURE AT 3.2A RESOLUTION FOR MULTIMERIC BINDING TO THE REV RESPONSE ELEMENT
1347, 1um6L, 0.6487, 3.11, 0.053, 219, 94, CATALYTIC ANTIBODY 21H3
1348, 6ii8I, 0.6486, 2.75, 0.089, 213, 90, CRYSTAL STRUCTURE OF H7 HEMAGGLUTININ FROM A/ANHUI/1/2013 IN COMPLEX WITH A HUMAN NEUTRALIZING ANTIBODY L4B-18 
1349, 6azkC, 0.6486, 3.06, 0.076, 212, 92, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-(3- HYDROXYPROPYL)-L-ARGININE MEDITOPE VARIANT
1350, 6apdO, 0.6486, 2.64, 0.090, 213, 89, CRYSTAL STRUCTURE OF RSV F BOUND BY AM22 AND THE INFANT ANTIBODY ADI- 19425
1351, 5xf1D, 0.6486, 2.95, 0.065, 214, 93, STRUCTURE OF THE FULL-LENGTH GLUCAGON CLASS B G PROTEIN-COUPLED RECEPTOR
1352, 5th2A, 0.6486, 3.09, 0.065, 213, 93, CETUXIMAB FAB IN COMPLEX WITH L5Q MEDITOPE VARIANT
1353, 5te4L, 0.6486, 2.99, 0.054, 210, 93, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING VRC01-CLASS ANTIBODY N6 IN COMPLEX WITH HIV-1 CLADE G STRAIN X2088 GP120 CORE
1354, 5o4eD, 0.6486, 2.89, 0.053, 214, 94, CRYSTAL STRUCTURE OF VEGF IN COMPLEX WITH HETERODIMERIC FCAB JANUSCT6
1355, 5jo5F, 0.6486, 2.76, 0.066, 212, 91, CRYSTAL STRUCTURE OF 10E8 GHV-GLV ANTIGEN-BINDING FRAGMENT.
1356, 5jiiA, 0.6486, 2.86, 0.043, 207, 93, CRYSTAL STRUCTURE OF HUMAN IGG1-FC
1357, 5icyC, 0.6486, 2.88, 0.066, 212, 91, CETUXIMAB FAB IN COMPLEX WITH LINEAR MEDITOPE
1358, 5esqA, 0.6486, 2.93, 0.065, 213, 92, CETUXIMAB FAB IN COMPLEX WITH CYCLIC BETA-ALANINE-LINKED MEDITOPE
1359, 5dscF, 0.6486, 2.64, 0.067, 211, 90, CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU24.B IN COMPLEX WITH HYPUSINE
1360, 4xpgL, 0.6486, 2.85, 0.043, 214, 92, X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER WITH SUBSITEB MUTATIONS (D121G/S426M) BOUND TO BETA-CFT OR WIN35428
1361, 4jfzL, 0.6486, 2.95, 0.054, 214, 92, STRUCTURE OF PHOSPHOSERINE (PSAB) SCAFFOLD BOUND TO PSER PEPTIDE
1362, 3zkmL, 0.6486, 2.91, 0.054, 217, 92, BACE2 FAB COMPLEX
1363, 3idjA, 0.6486, 2.94, 0.065, 214, 92, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 FAB  FRAGMENT IN COMPLEX WITH GP41 PEPTIDE ANALOG ELD(ORN)WAS
1364, 3hr5Q, 0.6486, 3.03, 0.054, 219, 93, M1PRIME PEPTIDE FROM IGE BOUND BY HUMANIZED ANTIBODY 47H4 FAB
1365, 3drqA, 0.6486, 2.86, 0.066, 213, 91, CRYSTAL STRUCTURE OF THE HIV-1 BROADLY NEUTRALIZING ANTIBODY 2F5 IN COMPLEX WITH THE GP41 FP-MPER HYB3K CONSTRUCT 514GIGALFLGFLGAAGS528KK-AHX-655KNEQELLELDKWASLWN671 SOAKED IN PEG/2- PROPANOL SOLUTION
1366, 1i1aC, 0.6486, 2.96, 0.054, 205, 93, CRYSTAL STRUCTURE OF THE NEONATAL FC RECEPTOR COMPLEXED WITH A HETERODIMERIC FC
1367, 6qnaB, 0.6485, 2.82, 0.066, 211, 91, STRUCTURE OF BOVINE ANTI-RSV HYBRID FAB B13HC-B4LC 
1368, 6qn9L, 0.6485, 2.79, 0.066, 210, 91, STRUCTURE OF BOVINE ANTI-RSV FAB B4 
1369, 5wnbL, 0.6485, 3.11, 0.065, 213, 93, STRUCTURE OF ANTIBODY 3D3 BOUND TO THE LINEAR EPITOPE OF RSV G
1370, 5u3nL, 0.6485, 2.93, 0.054, 215, 92, CRYSTAL STRUCTURE OF DH511.12P FAB IN COMPLEX WITH HIV-1 GP41 MPER PEPTIDE
1371, 5mubJ, 0.6485, 2.87, 0.054, 217, 92, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (CG05)
1372, 5mu0H, 0.6485, 3.04, 0.054, 217, 93, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (IA03)
1373, 5jihA, 0.6485, 2.85, 0.043, 212, 93, CRYSTAL STRUCTURE OF HER2 BINDING IGG1-FC (FCAB STAB19)
1374, 5ivzA, 0.6485, 2.95, 0.065, 213, 92, CETUXIMAB FAB IN COMPLEX WITH ARG8CIR MEDITOPE VARIANT
1375, 5itbL, 0.6485, 3.04, 0.054, 215, 93, CRYSTAL STRUCTURE OF THE ANTI-RSV F FAB 14N4
1376, 5bq7B, 0.6485, 2.80, 0.088, 201, 91, CRYSTAL STRUCTURE OF CHIKUNGUNYA VIRUS-HUMAN FAB 5F-10 FRAGMENT
1377, 4npyL, 0.6485, 2.76, 0.089, 212, 90, CRYSTAL STRUCTURE OF GERMLINE FAB PGT121 A PUTATIVE PRECURSOR OF THE BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
1378, 4jreC, 0.6485, 2.80, 0.055, 211, 91, CRYSTAL STRUCTURE OF NITRATE/NITRITE EXCHANGER NARK WITH NITRITE BOUND
1379, 4c83B, 0.6485, 2.90, 0.054, 214, 93, CRYSTAL STRUCTURE OF THE IGG2A LPT3 IN COMPLEX WITH AN 8- SUGAR INNER CORE ANALOGUE OF NEISSERIA MENINGITIDIS
1380, 3wjlA, 0.6485, 3.08, 0.052, 212, 96, CRYSTAL STRUCTURE OF IIB SELECTIVE FC VARIANT FC(V12) IN COMPLEX WITH FCGRIIB
1381, 3sbwC, 0.6485, 2.57, 0.056, 208, 89, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE EXTRACELLULAR DOMAINS OF MOUSE PD-1 MUTANT AND HUMAN PD-L1
1382, 3oknA, 0.6485, 2.86, 0.043, 218, 92, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.4)KDO(2.4)KDO
1383, 3hnvL, 0.6485, 3.00, 0.043, 214, 93, CS-35 FAB COMPLEX WITH OLIGOARABINOFURANOSYL TETRASACCHARIDE (BRANCH PART OF HEXASACCHARIDE)
1384, 3fo9L, 0.6485, 2.95, 0.054, 219, 93, CRYSTAL STRUCTURE OF ALDOLASE ANTIBODY 33F12 FAB  IN COMPLEX WITH HAPTEN 13-DIKETONE
1385, 2pw1A, 0.6485, 2.95, 0.065, 214, 92, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKWNSL
1386, 1ncwL, 0.6485, 2.94, 0.043, 219, 93, CATIONIC CYCLIZATION ANTIBODY 4C6 IN COMPLEX WITH BENZOIC ACID
1387, 6qn7B, 0.6484, 2.84, 0.065, 213, 92, STRUCTURE OF BOVINE ANTI-RSV HYBRID FAB B4HC-B13LC 
1388, 6nz7I, 0.6484, 3.09, 0.054, 214, 93, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 429 B01 IN COMPLEX WITH HEMAGGLUTININ HONG KONG 1968 
1389, 6iekF, 0.6484, 2.59, 0.067, 218, 90, STRUCTURE OF RVFV GN AND HUMAN MONOCLONAL ANTIBODY R12 
1390, 6b9yA, 0.6484, 3.17, 0.064, 214, 94, TRASTUZUMAB FAB V3 IN COMPLEX WITH 5-PHENYL MEDITOPE VARIANT 
1391, 5wa0A, 0.6484, 3.07, 0.083, 365, 96, CRYSTAL STRUCTURE OF THE SULFITE DEHYDROGENASE SORT R78Q MUTANT FROM SINORHIZOBIUM MELILOTI
1392, 5o14D, 0.6484, 3.15, 0.064, 215, 94, CO-CRYSTAL STRUCTURE OF A CROSS-REACTIVE BACTERICIDAL HUMAN ANTIBODY TARGETING MENINGOCOCCAL VACCINE ANTIGEN FACTOR H BINDING PROTEIN
1393, 5lghL, 0.6484, 2.93, 0.054, 214, 92, AFAMIN ANTIBODY FRAGMENT N14 FAB L1- GLYCOSILATED CRYSTAL FORM II SAME AS 5L7X BUT ISOMORPHOUS SETTING INDEXED SAME AS 5L88 5L9D
1394, 5l7xL, 0.6484, 2.93, 0.054, 214, 92, AFAMIN ANTIBODY FRAGMENT N14 FAB L1- GLYCOSYLATED CRYSTAL FORM II
1395, 5hpmC, 0.6484, 2.74, 0.055, 213, 91, CETUXIMAB FAB IN COMPLEX WITH CYCLIC LINKED MEDITOPE
1396, 5g64L, 0.6484, 3.08, 0.075, 216, 93, THE COMPLEX BETWEEN HUMAN IGE-FC AND TWO ANTI-IGE FAB FRAGMENTS
1397, 4janB, 0.6484, 2.72, 0.078, 206, 90, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH103 IN COMPLEX WITH HIV-1 GP120
1398, 4f33C, 0.6484, 2.73, 0.056, 211, 90, CRYSTAL STRUCTURE OF THERAPEUTIC ANTIBODY MORAB-009
1399, 3n85L, 0.6484, 3.06, 0.075, 214, 93, CRYSTALLOGRAPHIC TRIMER OF HER2 EXTRACELLULAR REGIONS IN COMPLEX WITH TRYPTOPHAN-RICH ANTIBODY FRAGMENT
1400, 3l7eL, 0.6484, 2.98, 0.054, 213, 92, CRYSTAL STRUCTURE OF ANTI-IL-13 ANTIBODY C836
1401, 3b9kC, 0.6484, 3.13, 0.043, 213, 94, CRYSTAL STRUCTURE OF CD8ALPHA-BETA IN COMPLEX WITH YTS 156.7 FAB
1402, 2x7lB, 0.6484, 3.02, 0.054, 217, 93, IMPLICATIONS OF THE HIV-1 REV DIMER STRUCTURE AT 3.2A RESOLUTION FOR MULTIMERIC BINDING TO THE REV RESPONSE ELEMENT
1403, 2wucL, 0.6484, 2.97, 0.065, 214, 93, CRYSTAL STRUCTURE OF HGFA IN COMPLEX WITH THE ALLOSTERIC NON- INHIBITORY ANTIBODY FAB40.DELTATRP AND AC-KQLR-CHLOROMETHYLKETONE
1404, 1s5iL, 0.6484, 2.97, 0.043, 219, 93, FAB (LNKB-2) OF MONOCLONAL ANTIBODY TO HUMAN INTERLEUKIN-2 CRYSTAL STRUCTURE
1405, 6nnjL, 0.6483, 2.70, 0.067, 210, 90, CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO CH31 SCFV IN COMPLEX WITH CRYSTALLIZATION CHAPERONES 3H109L FAB AND 35O22 SCFV AT 3.1 ANGSTROM 
1406, 6njmK, 0.6483, 2.96, 0.044, 211, 91, STRUCTURE OF A COMPLEX 
1407, 6mg5B, 0.6483, 2.84, 0.054, 215, 92, STRUCTURE OF FULL-LENGTH HUMAN LAMBDA-6A LIGHT CHAIN JTO IN COMPLEX WITH COUMARIN 1 
1408, 6chbR, 0.6483, 2.91, 0.098, 205, 92, CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND IOMA 
1409, 6ccbE, 0.6483, 2.86, 0.087, 211, 92, CRYSTAL STRUCTURE OF 253-11 SOSIP TRIMER IN COMPLEX WITH 10-1074 FAB
1410, 6axlB, 0.6483, 2.96, 0.054, 213, 92, CRYSTAL STRUCTURE OF FAB317 COMPLEX
1411, 5y9jL, 0.6483, 2.74, 0.089, 210, 90, BAFF IN COMPLEX WITH BELIMUMAB
1412, 5wa0D, 0.6483, 3.07, 0.083, 365, 96, CRYSTAL STRUCTURE OF THE SULFITE DEHYDROGENASE SORT R78Q MUTANT FROM SINORHIZOBIUM MELILOTI
1413, 5tkjE, 0.6483, 3.05, 0.054, 219, 93, STRUCTURE OF VACCINE-ELICITED DIVERSE HIV-1 NEUTRALIZING ANTIBODY VFP1.01 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519
1414, 5kaqL, 0.6483, 2.97, 0.054, 213, 93, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 31.A.83 IN COMPLEX WITH HEMAGGLUTININ HONG KONG 1968.
1415, 5iopC, 0.6483, 3.08, 0.065, 213, 93, CETUXIMAB FAB IN COMPLEX WITH 4-BROMOPHENYLALANINE MEDITOPE VARIANT
1416, 5dfvD, 0.6483, 2.85, 0.054, 217, 92, CRYSTAL STRUCTURE OF HUMAN CD81 LARGE EXTRACELLULAR LOOP IN COMPLEX WITH MURINE FAB FRAGMENT K04
1417, 4ub0L, 0.6483, 2.96, 0.054, 214, 93, NEW DESIGN FOR MONOVALENT BISPECIFIC IGG THROUGH CYSTEINE ENGINEERING OF THE CH1-CL INTERFACE
1418, 4tnvO, 0.6483, 2.68, 0.056, 211, 89, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
1419, 4jdvB, 0.6483, 3.09, 0.065, 208, 93, CRYSTAL STRUCTURE OF GERM-LINE PRECURSOR OF NIH45-46 FAB
1420, 4hg4O, 0.6483, 3.06, 0.054, 214, 93, CRYSTAL STRUCTURE OF FAB 2G1 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ
1421, 3h0tA, 0.6483, 2.96, 0.065, 216, 93, HEPCIDIN-FAB COMPLEX
1422, 3fo9A, 0.6483, 2.90, 0.054, 219, 92, CRYSTAL STRUCTURE OF ALDOLASE ANTIBODY 33F12 FAB  IN COMPLEX WITH HAPTEN 13-DIKETONE
1423, 3difC, 0.6483, 2.97, 0.054, 214, 93, CRYSTAL STRUCTURE OF FABOX117
1424, 2v7nA, 0.6483, 3.04, 0.066, 213, 91, UNUSUAL TWINNING IN CRYSTALS OF THE CITS BINDING ANTIBODY FAB FRAGMENT F3P4
1425, 1q1jM, 0.6483, 2.73, 0.066, 215, 91, CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 PEPTIDE
1426, 1jgvL, 0.6483, 2.96, 0.054, 220, 93, STRUCTURAL BASIS FOR DISFAVORED ELIMINATION REACTION IN CATALYTIC ANTIBODY 1D4
1427, 6nm6L, 0.6482, 2.71, 0.067, 210, 90, CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO N6 FR3-03 SCFV IN COMPLEX WITH CRYSTALLIZATION CHAPERONES 3H109L FAB AND 35O22 SCFV AT 3.2 ANGSTROM 
1428, 6gfeH, 0.6482, 2.94, 0.054, 429, 93, HIGH-RESOLUTION STRUCTURE OF A THERAPEUTIC FULL-LENGTH ANTI-NPRA ANTIBODY WITH EXCEPTIONAL CONFORMATIONAL DIVERSITY 
1429, 6fxnE, 0.6482, 2.76, 0.089, 209, 90, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
1430, 6eayL, 0.6482, 3.01, 0.066, 211, 91, STRUCTURAL BASIS FOR BROAD NEUTRALIZATION OF EBOLAVIRUSES BY AN ANTIBODY TARGETING THE GLYCOPROTEIN FUSION LOOP 
1431, 6b0hC, 0.6482, 2.94, 0.054, 213, 92, CRYSTAL STRUCTURE OF PFS25 IN COMPLEX WITH THE TRANSMISSION BLOCKING ANTIBODY 1262
1432, 6arpA, 0.6482, 2.76, 0.055, 213, 91, STRUCTURE OF A MUTANT CETUXIMAB FAB FRAGMENT 
1433, 5y2kB, 0.6482, 2.76, 0.089, 208, 90, A HUMAN ANTIBODY AF4H1L1 
1434, 5wuxL, 0.6482, 2.95, 0.054, 213, 92, TNFALPHA-CERTOLIZUMAB FAB
1435, 5wduN, 0.6482, 2.95, 0.054, 213, 92, HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB 35O22 FAB AND NIH45-46 SCFV
1436, 5w3pL, 0.6482, 2.91, 0.054, 210, 92, ANTIBODY C706 IN COMPLEX WTH BETA-AMYLOID PEPTIDE 1-16
1437, 5t33L, 0.6482, 2.82, 0.065, 212, 92, CRYSTAL STRUCTURE OF STRAIN-SPECIFIC GLYCAN-DEPENDENT CD4 BINDING SITE-DIRECTED NEUTRALIZING ANTIBODY CAP257-RH1 IN COMPLEX WITH HIV-1 STRAIN RHPA GP120 CORE WITH AN OLIGOMANNOSE N276 GLYCAN.
1438, 5mu2P, 0.6482, 3.02, 0.054, 217, 93, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
1439, 5id0C, 0.6482, 2.87, 0.066, 212, 91, CETUXIMAB FAB IN COMPLEX WITH AMINOHEPTANOIC ACID-LINKED MEDITOPE
1440, 5f88A, 0.6482, 2.96, 0.054, 213, 92, CETUXIMAB FAB IN COMPLEX WITH L5Y MEDITOPE VARIANT
1441, 5djxA, 0.6482, 2.85, 0.053, 208, 94, FC HETERODIMER DESIGN 2.9 L368M/K370E + E357A/S364G
1442, 3tnnL, 0.6482, 2.73, 0.089, 212, 90, CRYSTAL STRUCTURE OF N5-I5 FAB AN ADCC MEDIATING AND NON-NEUTRALIZING CD4I ANTI-HIV- 1 ANTIBODY.
1443, 3phoA, 0.6482, 3.13, 0.053, 216, 94, CRYSTAL STRUCTURE OF S64-4 IN COMPLEX WITH PSBP
1444, 3mugC, 0.6482, 2.80, 0.078, 212, 90, CRYSTAL STRUCTURE OF HUMAN FAB PG16 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
1445, 3k2uL, 0.6482, 3.05, 0.054, 208, 93, CRYSTAL STRUCTURE OF HGFA IN COMPLEX WITH THE ALLOSTERIC INHIBITORY ANTIBODY FAB40
1446, 1za6A, 0.6482, 2.99, 0.054, 220, 93, THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY
1447, 1v7nO, 0.6482, 3.00, 0.054, 213, 93, HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB
1448, 1uwgX, 0.6482, 2.95, 0.054, 213, 92, MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9
1449, 1mnuL, 0.6482, 3.09, 0.053, 219, 94, UNLIGANDED BACTERICIDAL ANTIBODY AGAINST NEISSERIA MENINGITIDIS
1450, 1f11C, 0.6482, 2.89, 0.054, 216, 92, F124 FAB FRAGMENT FROM A MONOCLONAL ANTI-PRES2 ANTIBODY
1451, 1emtL, 0.6482, 3.05, 0.054, 214, 93, FAB ANTIBODY FRAGMENT OF AN C60 ANTIFULLERENE ANTIBODY
1452, 6erxE, 0.6481, 2.76, 0.089, 209, 90, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
1453, 5uddP, 0.6481, 2.86, 0.056, 212, 90, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
1454, 5mubG, 0.6481, 2.90, 0.043, 217, 92, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (CG05)
1455, 5b71A, 0.6481, 2.96, 0.065, 217, 93, CRYSTAL STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH SKY59
1456, 4tsbL, 0.6481, 2.85, 0.088, 214, 91, STRUCTURE OF A LYSOZYME ANTIBODY COMPLEX
1457, 4tnvL, 0.6481, 2.71, 0.056, 211, 89, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
1458, 4ma1F, 0.6481, 3.09, 0.053, 219, 94, UNLIGANDED 3 CRYSTAL STRUCTURE OF S25-26 FAB
1459, 4k9eL, 0.6481, 2.93, 0.054, 221, 92, CRYSTAL STRUCTURE OF KIT D4D5 FRAGMENT IN COMPLEX WITH ANTI-KIT ANTIBODIES FAB79D
1460, 4d9lN, 0.6481, 2.80, 0.077, 215, 91, FAB STRUCTURE OF ANTI-HIV-1 GP120 V2 MAB 697
1461, 3u1sL, 0.6481, 2.91, 0.054, 217, 92, CRYSTAL STRUCTURE OF HUMAN FAB PGT145 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
1462, 3o41L, 0.6481, 3.08, 0.053, 218, 94, CRYSTAL STRUCTURE OF 101F FAB BOUND TO 15-MER PEPTIDE EPITOPE
1463, 1xf4A, 0.6481, 2.94, 0.054, 213, 92, STRUCTURE OF LIGAND-FREE FAB DNA-1 IN SPACE GROUP P321 SOLVED FROM CRYSTALS WITH PERFECT HEMIHEDRAL TWINNING
1464, 1q1jL, 0.6481, 2.73, 0.066, 215, 91, CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 PEPTIDE
1465, 1aifL, 0.6481, 3.10, 0.064, 215, 94, ANTI-IDIOTYPIC FAB 409.5.3 (IGG2A) FAB FROM MOUSE
1466, 6ncwC, 0.6480, 2.89, 0.096, 559, 94, CRYSTAL STRUCTURE OF A GH2 BETA-GALACTURONIDASE FROM EISENBERGIELLA TAYI BOUND TO GLYCEROL 
1467, 6blhL, 0.6480, 2.77, 0.078, 211, 90, RSV G CENTRAL CONSERVED REGION BOUND TO FAB CB017.5
1468, 5u7oL, 0.6480, 2.74, 0.089, 208, 90, CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-626529 IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 3.8 ANGSTROM
1469, 5occL, 0.6480, 2.84, 0.054, 216, 92, CRYSTAL STRUCTURE OF CD32B (FC GAMMA RECEPTOR IIB) IN COMPLEX WITH HUMAN IGG1 FAB FRAGMENT (6G08) 
1470, 5d93E, 0.6480, 2.96, 0.054, 212, 92, OXIDOREDUCTASE FRAGMENT OF MOUSE QSOX1 IN COMPLEX WITH A FAB FRAGMENT FROM A MOUSE QSOX1-SPECIFIC ANTIBODY
1471, 3oayK, 0.6480, 2.79, 0.055, 213, 91, A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY
1472, 3hzvA, 0.6480, 2.93, 0.054, 218, 92, CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.8) KDO(2.4)KDO
1473, 3hnsL, 0.6480, 2.98, 0.054, 214, 93, CS-35 FAB COMPLEX WITH OLIGOARABINOFURANOSYL HEXASACCHARIDE
1474, 3g04A, 0.6480, 2.66, 0.079, 212, 89, CRYSTAL STRUCTURE OF THE TSH RECEPTOR IN COMPLEX WITH A THYROID- STIMULATING AUTOANTIBODY
1475, 3eyfA, 0.6480, 2.70, 0.056, 215, 90, CRYSTAL STRUCTURE OF ANTI-HUMAN CYTOMEGALOVIRUS ANTIBODY 8F9 PLUS GB PEPTIDE
1476, 3eoaA, 0.6480, 3.00, 0.054, 214, 93, CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB IN COMPLEX WITH LFA-1 I DOMAIN FORM I
1477, 3d85A, 0.6480, 2.95, 0.054, 213, 92, CRYSTAL STRUCTURE OF IL-23 IN COMPLEX WITH NEUTRALIZING FAB
1478, 1h3tA, 0.6480, 2.78, 0.043, 207, 92, CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENTGLYCOFORM (MN2F)2
1479, 1f90L, 0.6480, 2.98, 0.054, 219, 93, FAB FRAGMENT OF MONOCLONAL ANTIBODY (LNKB-2) AGAINST HUMAN INTERLEUKIN-2 IN COMPLEX WITH ANTIGENIC PEPTIDE
1480, 6mejL, 0.6479, 2.94, 0.054, 213, 92, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
1481, 6cxlK, 0.6479, 2.99, 0.054, 213, 92, ANTI-HIV-1 FAB 2G12 IN COMPLEX WITH GLYCOPEPTIDE 10F5 
1482, 6cwtB, 0.6479, 3.03, 0.065, 214, 92, HEPATITIS B CORE-ANTIGEN IN COMPLEX WITH FAB E21 
1483, 6b5tL, 0.6479, 2.74, 0.089, 212, 90, STRUCTURE OF PFCSP PEPTIDE 29 WITH HUMAN ANTIBODY CIS42
1484, 6anpA, 0.6479, 2.76, 0.055, 214, 91, CAT192 FAB INSERTION MUTANT H5/L0
1485, 5utzL, 0.6479, 2.96, 0.054, 215, 93, HUMAN IL-2/FAB COMPLEX 
1486, 5mthL, 0.6479, 2.94, 0.054, 219, 93, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACEGROUP P21 
1487, 5iq7L, 0.6479, 2.84, 0.088, 212, 91, CRYSTAL STRUCTURE OF 10E8-S74W FAB IN COMPLEX WITH AN HIV-1 GP41 PEPTIDE.
1488, 5dqjL, 0.6479, 3.07, 0.054, 217, 93, STRUCTURE OF UNLIGANDED S55-5 FAB
1489, 4wv1A, 0.6479, 3.14, 0.064, 214, 94, CRYSTAL STRUCTURE OF THE FGFR2 D2 DOMAIN IN COMPLEX WITH FAB 2B.1.3
1490, 4qhkN, 0.6479, 2.72, 0.067, 209, 90, UCA (UNBOUND) FROM CH103 LINEAGE
1491, 4lkxB, 0.6479, 2.98, 0.065, 219, 93, HUMANIZED ANTIBODY 4B12 FAB COMPLEXED WITH A CEMX SEGMENT
1492, 4f58M, 0.6479, 2.71, 0.056, 213, 90, FAB STRUCTURE OF A NEUTRALIZING ANTIBODY L3 FROM AN EARLY SUBTYPE A HIV-1 INFECTED PATIENT
1493, 3sgeI, 0.6479, 2.98, 0.054, 219, 93, CRYSTAL STRUCTURE OF MAB 17.2 IN COMPLEX WITH R13 PEPTIDE
1494, 3modL, 0.6479, 3.01, 0.054, 214, 92, CRYSTAL STRUCTURE OF THE NEUTRALIZING HIV ANTIBODY 2F5 FAB FRAGMENT (RECOMBINANTLY PRODUCED IGG) WITH 11 AA GP41 MPER-DERIVED PEPTIDE
1495, 3g5zA, 0.6479, 2.76, 0.055, 213, 91, ANTIBODIES SPECIFICALLY TARGETING A LOCALLY MISFOLDED REGION OF TUMOR ASSOCIATED EGFR
1496, 1xf2L, 0.6479, 2.94, 0.054, 213, 92, STRUCTURE OF FAB DNA-1 COMPLEXED WITH DT3
1497, 1jfqL, 0.6479, 3.21, 0.053, 215, 95, ANTIGEN-BINDING FRAGMENT OF THE MURINE ANTI-PHENYLARSONATE ANTIBODY 36-71 FAB 36-71
1498, 6d4iA, 0.6478, 2.84, 0.053, 209, 94, CRYSTAL STRUCTURE OF A FC FRAGMENT OF RHESUS MACAQUE (MACACA MULATTA) IGG2 
1499, 5udcG, 0.6478, 3.00, 0.054, 213, 92, CRYSTAL STRUCTURE OF RSV F A2 BOUND TO MEDI8897
1500, 5tudB, 0.6478, 2.87, 0.056, 211, 90, STRUCTURAL INSIGHTS INTO THE EXTRACELLULAR RECOGNITION OF THE HUMAN SEROTONIN 2B RECEPTOR BY AN ANTIBODY
1501, 5e08L, 0.6478, 3.18, 0.064, 215, 94, SPECIFIC RECOGNITION OF A SINGLE-STRANDED RNA SEQUENCE BY AN ENGINEERED SYNTHETIC ANTIBODY FRAGMENT
1502, 4zfoL, 0.6478, 2.99, 0.054, 214, 93, J22.9-XI: CHIMERIC MOUSE/HUMAN ANTIBODY AGAINST HUMAN BCMA (CD269)
1503, 4m7lL, 0.6478, 3.14, 0.064, 220, 94, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN HUMAN TISSUE FACTOR EXTRACELLULAR DOMAIN AND ANTIBODY 10H10 FAB FRAGMENT
1504, 4hcrA, 0.6478, 2.98, 0.042, 194, 95, CRYSTAL STRUCTURE OF HUMAN MADCAM-1 D1D2 COMPLEXED WITH FAB PF-547659
1505, 3kdmA, 0.6478, 3.12, 0.064, 216, 94, CRYSTAL STRUCTURE OF HUMAN ANTI-STEROID FAB 5F2 IN COMPLEX WITH TESTOSTERONE
1506, 3agvB, 0.6478, 2.85, 0.053, 208, 94, CRYSTAL STRUCTURE OF A HUMAN IGG-APTAMER COMPLEX
1507, 2ny7L, 0.6478, 2.96, 0.054, 215, 92, HIV-1 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH THE BROADLY NEUTRALIZING CD4-BINDING-SITE ANTIBODY B12
1508, 2aabL, 0.6478, 3.01, 0.054, 217, 93, STRUCTURAL BASIS OF ANTIGEN MIMICRY IN A CLINICALLY RELEVANT MELANOMA ANTIGEN SYSTEM
1509, 1rz7L, 0.6478, 2.90, 0.054, 211, 92, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 48D
1510, 1rukL, 0.6478, 2.92, 0.043, 219, 93, CRYSTAL STRUCTURE (C) OF NATIVE CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 4.6 WITH A DATA SET COLLECTED AT SSRL BEAMLINE 9-1
1511, 1h3uA, 0.6478, 2.81, 0.043, 207, 92, CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENTGLYCOFORM (M3N2F)2
1512, 1aifA, 0.6478, 3.11, 0.064, 215, 94, ANTI-IDIOTYPIC FAB 409.5.3 (IGG2A) FAB FROM MOUSE
1513, 6n7jL, 0.6477, 2.93, 0.055, 214, 91, BDBV223 FAB BOUND TO SYNTHETIC PEPTIDE OF BUNDIBUGYO VIRUS GLYCOPROTEIN STALK 
1514, 6ev2B, 0.6477, 3.02, 0.065, 217, 93, CRYSTAL STRUCTURE OF ANTIBODY AGAINST SCHIZOPHYLLAN IN COMPLEX WITH LAMINARIHEXAOSE 
1515, 6apdE, 0.6477, 3.21, 0.075, 213, 93, CRYSTAL STRUCTURE OF RSV F BOUND BY AM22 AND THE INFANT ANTIBODY ADI- 19425
1516, 5wa0C, 0.6477, 3.07, 0.083, 365, 96, CRYSTAL STRUCTURE OF THE SULFITE DEHYDROGENASE SORT R78Q MUTANT FROM SINORHIZOBIUM MELILOTI
1517, 4ydjB, 0.6477, 2.85, 0.076, 205, 92, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY 44- VRC13.01 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057 GP120
1518, 4xwoX, 0.6477, 2.78, 0.055, 216, 91, STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF SEC22
1519, 4xwoF, 0.6477, 3.16, 0.064, 215, 94, STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF SEC22
1520, 4uimB, 0.6477, 2.93, 0.043, 214, 93, CRYSTAL STRUCTURE OF QUININE-DEPENDENT FAB 314.3
1521, 4rirL, 0.6477, 2.77, 0.088, 214, 91, STRUCTURAL ANALYSIS OF THE UNMUTATED ANCESTOR OF THE HIV-1 ENVELOPE V2 REGION ANTIBODY CH58 ISOLATED FROM AN RV144 HIV-1 VACCINE EFFICACY TRIAL VACCINEE AND ASSOCIATED WITH DECREASED TRANSMISSION RISK
1522, 4nkiL, 0.6477, 2.78, 0.089, 212, 90, CRYSTAL STRUCTURE OF A FAB
1523, 3sgdL, 0.6477, 2.86, 0.054, 218, 92, CRYSTAL STRUCTURE OF THE MOUSE MAB 17.2
1524, 3nh7L, 0.6477, 2.75, 0.089, 210, 90, CRYSTAL STRUCTURE OF THE NEUTRALIZING FAB FRAGMENT ABD1556 BOUND TO THE BMP TYPE I RECEPTOR IA
1525, 3ijyC, 0.6477, 2.83, 0.054, 217, 92, STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)KDO
1526, 3ggwC, 0.6477, 2.96, 0.054, 219, 93, CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A CARBOHYDRATE-MIMETIC PEPTIDE
1527, 3egsA, 0.6477, 2.88, 0.066, 213, 91, CRYSTAL STRUCTURE OF THE HIV-1 BROADLY NEUTRALIZING ANTIBODY 2F5 IN COMPLEX WITH THE GP41 SCRAMBLEDFP-MPER SCRHYB3K CONSTRUCT GIGAFGLLGFLAAGSKK-AHX-K656NEQELLELDKWASLWN671 SOAKED IN AMMONIUM SULFATE
1528, 3bquA, 0.6477, 2.95, 0.078, 211, 90, CRYSTAL STRUCTURE OF THE 2F5 FAB -3H6 FAB COMPLEX
1529, 2x7lF, 0.6477, 3.03, 0.054, 217, 93, IMPLICATIONS OF THE HIV-1 REV DIMER STRUCTURE AT 3.2A RESOLUTION FOR MULTIMERIC BINDING TO THE REV RESPONSE ELEMENT
1530, 1ngwL, 0.6477, 2.88, 0.054, 213, 92, CHIMERIC AFFINITY MATURED FAB 7G12 COMPLEXED WITH MESOPORPHYRIN
1531, 1mj7L, 0.6477, 2.90, 0.043, 218, 92, CRYSTAL STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS5-393 AND A TRANSITION-STATE ANALOG
1532, 1hdmA, 0.6477, 2.64, 0.022, 184, 91, HISTOCOMPATIBILITY ANTIGEN HLA-DM
1533, 6azlC, 0.6476, 2.75, 0.056, 212, 90, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N- CARBOXYETHYLARGININE MEDITOPE VARIANT
1534, 5wl2L, 0.6476, 2.74, 0.089, 211, 90, VH1-69 GERMLINE ANTIBODY WITH CDR H3 SEQUENCE OF CR9114 
1535, 5wl2B, 0.6476, 2.75, 0.089, 211, 90, VH1-69 GERMLINE ANTIBODY WITH CDR H3 SEQUENCE OF CR9114 
1536, 5n7wL, 0.6476, 2.73, 0.089, 211, 90, COMPUTATIONALLY DESIGNED FUNCTIONAL ANTIBODY 
1537, 5jopD, 0.6476, 2.85, 0.043, 218, 92, CRYSTAL STRUCTURE OF ANTI-GLYCAN ANTIBODY FAB14.22 IN COMPLEX WITH STREPTOCOCCUS PNEUMONIAE SEROTYPE 14 TETRASACCHARIDE AT 1.75 A
1538, 5esvB, 0.6476, 2.86, 0.056, 213, 90, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH03 ISOLATED FROM DONOR CH0219 IN COMPLEX WITH SCAFFOLDED TRIMERIC HIV-1 ENV V1V2 DOMAIN FROM THE CLADE C SUPERINFECTING STRAIN OF DONOR CAP256.
1539, 5dvmA, 0.6476, 2.87, 0.053, 207, 94, FC DESIGN 20.8.37 B CHAIN HOMODIMER E357D/S364R/Y407A
1540, 4wi3B, 0.6476, 2.92, 0.053, 208, 95, STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION I253A
1541, 4ubdT, 0.6476, 2.95, 0.054, 213, 92, CRYSTAL STRUCTURE OF A NEUTRALIZING HUMAN MONOCLONAL ANTIBODY WITH 1968 H3 HA
1542, 4ubdH, 0.6476, 2.95, 0.054, 213, 92, CRYSTAL STRUCTURE OF A NEUTRALIZING HUMAN MONOCLONAL ANTIBODY WITH 1968 H3 HA
1543, 6rcvB, 0.6475, 2.83, 0.088, 211, 91, PFRH5 BOUND TO MONOCLONAL ANTIBODIES R5.011 AND R5.016 
1544, 6mtnL, 0.6475, 2.90, 0.066, 211, 91, CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR COMPOUND 484 IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.0 ANGSTROM 
1545, 6jfiL, 0.6475, 2.77, 0.078, 214, 90, THE SYMMETRIC-RECONSTRUCTED CRYO-EM STRUCTURE OF ZIKA VIRUS-FABZK2B10 COMPLEX 
1546, 6jfhN, 0.6475, 2.77, 0.078, 214, 90, THE ASYMMETRIC-RECONSTRUCTED CRYO-EM STRUCTURE OF ZIKA VIRUS-FABZK2B10 COMPLEX 
1547, 6jfhL, 0.6475, 2.77, 0.078, 214, 90, THE ASYMMETRIC-RECONSTRUCTED CRYO-EM STRUCTURE OF ZIKA VIRUS-FABZK2B10 COMPLEX 
1548, 6jepL, 0.6475, 2.77, 0.078, 214, 90, STRUCTURE OF A NEUTRALIZING ANTIBODY BOUND TO THE ZIKA ENVELOPE PROTEIN DOMAIN III 
1549, 6bi2M, 0.6475, 2.98, 0.054, 214, 93, TRASTUZUMAB FAB D185A (LIGHT CHAIN) MUTANT BIOTIN CONJUGATION.
1550, 5mubM, 0.6475, 2.92, 0.043, 217, 92, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (CG05)
1551, 5k8aE, 0.6475, 2.99, 0.054, 213, 93, NIST FAB
1552, 5ir1A, 0.6475, 2.94, 0.065, 213, 92, CETUXIMAB FAB IN COMPLEX WITH 3-BROMOPHENYLALANINE MEDITOPE VARIANT
1553, 5fgcB, 0.6475, 2.96, 0.065, 214, 93, THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING HUMAN ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 FAB FRAGMENT HC33.8
1554, 5cjsL, 0.6475, 2.68, 0.079, 211, 89, CRYSTAL STRUCTURE OF A MONOMERIC INFLUENZA HEMAGGLUTININ STEM IN COMPLEX WITH AN BROADLY NEUTRALIZING ANTIBODY CR9114
1555, 4wi3A, 0.6475, 2.92, 0.053, 208, 95, STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION I253A
1556, 4tnwg, 0.6475, 2.68, 0.056, 211, 89, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
1557, 4r96E, 0.6475, 2.94, 0.054, 221, 92, STRUCTURE OF A LLAMA GLAMA FAB 48A2 AGAINST HUMAN CMET
1558, 4nqsB, 0.6475, 2.92, 0.053, 207, 95, KNOB-INTO-HOLE IGG FC
1559, 4ma1L, 0.6475, 3.10, 0.053, 219, 94, UNLIGANDED 3 CRYSTAL STRUCTURE OF S25-26 FAB
1560, 4jr9L, 0.6475, 2.97, 0.065, 211, 92, CRYSTAL STRUCTURE OF NITRATE/NITRITE EXCHANGER NARK
1561, 4glrI, 0.6475, 2.77, 0.089, 207, 90, STRUCTURE OF THE ANTI-PTAU FAB (PT231/PS235_1) IN COMPLEX WITH PHOSPHOEPITOPE PT231/PS235
1562, 3o45L, 0.6475, 3.10, 0.053, 218, 94, CRYSTAL STRUCTURE OF 101F FAB BOUND TO 17-MER PEPTIDE EPITOPE
1563, 3nh7M, 0.6475, 2.75, 0.089, 210, 90, CRYSTAL STRUCTURE OF THE NEUTRALIZING FAB FRAGMENT ABD1556 BOUND TO THE BMP TYPE I RECEPTOR IA
1564, 3eyoC, 0.6475, 3.04, 0.065, 214, 92, CRYSTAL STRUCTURE OF ANTI-HUMAN CYTOMEGALOVIRUS ANTIBODY 8F9
1565, 3eobL, 0.6475, 2.77, 0.055, 214, 91, CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB IN COMPLEX WITH LFA-1 I DOMAIN FORM II
1566, 1y18C, 0.6475, 2.93, 0.054, 216, 92, FAB FRAGMENT OF CATALYTIC ELIMINATION ANTIBODY 34E4 E(H50)D MUTANT IN COMPLEX WITH HAPTEN
1567, 1mcsA, 0.6475, 2.82, 0.065, 216, 92, PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
1568, 1bm3L, 0.6475, 2.96, 0.054, 214, 93, IMMUNOGLOBULIN OPG2 FAB-PEPTIDE COMPLEX
1569, 6qn8I, 0.6474, 2.87, 0.065, 213, 92, STRUCTURE OF BOVINE ANTI-RSV FAB B13 
1570, 6eluI, 0.6474, 2.94, 0.054, 217, 92, STRUCTURE OF SERUM RESISTANCE ASSOCIATED PROTEIN FROM T. B. RHODESIENSE
1571, 6bliH, 0.6474, 2.96, 0.054, 214, 92, RSV G PEPTIDE BOUND TO FAB CB002.5
1572, 5wduV, 0.6474, 2.97, 0.043, 213, 92, HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB 35O22 FAB AND NIH45-46 SCFV
1573, 5mp5D, 0.6474, 2.86, 0.043, 218, 92, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 6.5 
1574, 5bv7L, 0.6474, 2.77, 0.089, 210, 90, CRYSTAL STRUCTURE OF HUMAN LCAT (L4F N5D) IN COMPLEX WITH FAB OF AN AGONISTIC ANTIBODY
1575, 5bk1D, 0.6474, 3.03, 0.065, 209, 93, CRYSTAL STRUCTURE OF MALTOSE BINDING PROTEIN IN COMPLEX WITH AN ENDOSTERIC SYNTHETIC ANTIBODY
1576, 4wi6A, 0.6474, 2.85, 0.053, 208, 95, STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION N434A
1577, 4o51A, 0.6474, 2.95, 0.065, 214, 92, CRYSTAL STRUCTURE OF THE QAA VARIANT OF ANTI-HINGE RABBIT ANTIBODY 2095-2 IN COMPLEX WITH IDES HINGE PEPTIDE
1578, 4gw5A, 0.6474, 2.70, 0.056, 212, 89, CQYN MEDITOPE - CETUXIMAB FAB
1579, 3nh7O, 0.6474, 2.75, 0.089, 210, 90, CRYSTAL STRUCTURE OF THE NEUTRALIZING FAB FRAGMENT ABD1556 BOUND TO THE BMP TYPE I RECEPTOR IA
1580, 3droA, 0.6474, 3.08, 0.076, 213, 92, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELLELDKWASLWN GROWN IN AMMONIUM SULFATE
1581, 2vweC, 0.6474, 3.31, 0.063, 214, 95, CRYSTAL STRUCTURE OF VASCULAR ENDOTHELIAL GROWTH FACTOR-B IN COMPLEX WITH A NEUTRALIZING ANTIBODY FAB FRAGMENT
1582, 1qlrA, 0.6474, 2.84, 0.054, 215, 92, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A HUMAN MONOCLONAL IGM COLD AGGLUTININ
1583, 6novD, 0.6473, 2.95, 0.054, 219, 92, A FAB DERIVED FROM IXEKIZUMAB 
1584, 6mhrB, 0.6473, 2.96, 0.055, 215, 91, STRUCTURE OF THE HUMAN 4-1BB / URELUMAB FAB COMPLEX 
1585, 6hf1E, 0.6473, 2.70, 0.056, 212, 90, MUTANT OXIDOREDUCTASE FRAGMENT OF MOUSE QSOX1 IN COMPLEX WITH AN ANTIBODY FAB 
1586, 5otjL, 0.6473, 2.74, 0.089, 213, 90, MONOMERIC POLCALCIN (PHL P 7) IN COMPLEX WITH TWO IDENTICAL ALLERGEN- SPECIFIC ANTIBODIES 
1587, 5mubB, 0.6473, 2.91, 0.043, 217, 92, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (CG05)
1588, 5jikB, 0.6473, 2.88, 0.053, 204, 94, CRYSTAL STRUCTURE OF HER2 BINDING IGG1-FC (FCAB H10-03-6)
1589, 5etuA, 0.6473, 3.12, 0.075, 213, 93, CETUXIMAB FAB IN COMPLEX WITH L5E MEDITOPE VARIANT
1590, 4ma7L, 0.6473, 3.06, 0.043, 213, 93, CRYSTAL STRUCTURE OF MOUSE PRION PROTEIN COMPLEXED WITH PROMAZINE
1591, 4k7pL, 0.6473, 3.03, 0.054, 214, 93, GENERATION AND CHARACTERIZATION OF A UNIQUE REAGENT THAT RECOGNIZES A PANEL OF RECOMBINANT HUMAN MONOCLONAL ANTIBODY THERAPEUTICS IN THE PRESENCE OF ENDOGENOUS HUMAN IGG
1592, 4j6rL, 0.6473, 2.97, 0.054, 210, 92, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC23 IN COMPLEX WITH HIV-1 GP120
1593, 3p30L, 0.6473, 2.71, 0.090, 211, 89, CRYSTAL STRUCTURE OF THE CLUSTER II FAB 1281 IN COMPLEX WITH HIV-1 GP41 ECTODOMAIN
1594, 3mlxM, 0.6473, 2.75, 0.078, 211, 90, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 3074 IN COMPLEX WITH AN MN V3 PEPTIDE
1595, 3mlsN, 0.6473, 2.73, 0.089, 219, 90, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 MAB 2557 FAB IN COMPLEX WITH A HIV- 1 GP120 V3 MIMOTOPE
1596, 2q8aL, 0.6473, 2.84, 0.054, 214, 92, STRUCTURE OF THE MALARIA ANTIGEN AMA1 IN COMPLEX WITH A GROWTH- INHIBITORY ANTIBODY
1597, 2pw2A, 0.6473, 3.01, 0.065, 214, 93, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKWKSL
1598, 1z3gL, 0.6473, 2.81, 0.054, 213, 92, CRYSTAL STRUCTURE OF COMPLEX BETWEEN PVS25 AND FAB FRAGMENT OF MALARIA TRANSMISSION BLOCKING ANTIBODY 2A8
1599, 1yy8C, 0.6473, 2.95, 0.054, 213, 92, CRYSTAL STRUCTURE OF THE FAB FRAGMENT FROM THE MONOCLONAL ANTIBODY CETUXIMAB/ERBITUX/IMC-C225
1600, 1vpoL, 0.6473, 3.06, 0.053, 219, 94, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-TESTOSTERONE FAB IN COMPLEX WITH TESTOSTERONE
1601, 1cicC, 0.6473, 2.97, 0.054, 214, 93, IDIOTOPE-ANTI-IDIOTOPE FAB-FAB COMPLEX; D1.3-E225
1602, 6n5dD, 0.6472, 2.75, 0.089, 212, 90, BROADLY PROTECTIVE ANTIBODIES DIRECTED TO A SUBDOMINANT INFLUENZA HEMAGGLUTININ EPITOPE 
1603, 6ecaB, 0.6472, 2.77, 0.067, 592, 90, LACTOBACILLUS RHAMNOSUS BETA-GLUCURONIDASE 
1604, 6e64L, 0.6472, 2.76, 0.089, 213, 90, CRYSTAL STRUCTURE OF MALARIA TRANSMISSION-BLOCKING ANTIGEN PFS48/45 6C IN COMPLEX WITH ANTIBODY 85RF45.1 
1605, 6d01F, 0.6472, 3.04, 0.065, 212, 92, CRYSTAL STRUCTURE OF 1210 FAB IN COMPLEX WITH CIRCUMSPOROZOITE PROTEIN NANP5 
1606, 6btjL, 0.6472, 2.90, 0.066, 213, 91, CRYSTAL STRUCTURE OF PAN-H7; ANTI-HEMAGGLUTININ MONOCLONAL ANTIBODY H7.5 (FAB FRAGMENT) 
1607, 6bliE, 0.6472, 2.96, 0.054, 214, 92, RSV G PEPTIDE BOUND TO FAB CB002.5
1608, 5yslF, 0.6472, 3.01, 0.054, 213, 92, CRYSTAL STRUCTURE OF ANTIBODY 1H1 FAB
1609, 5v4eE, 0.6472, 3.05, 0.062, 208, 96, ENGINEERED HUMAN IGG FC DOMAIN GLYCO801 (FC801)
1610, 5u1fL, 0.6472, 2.92, 0.054, 214, 92, CRYOEM STRUCTURE OF BG505 DS SOSIP TRIMER IN COMPLEX WITH CD4 AND PGT145
1611, 4tvpE, 0.6472, 2.89, 0.054, 213, 92, CRYSTAL STRUCTURE OF THE HIV-1 BG505 SOSIP.664 ENV TRIMER ECTODOMAIN COMPRISING ATOMIC-LEVEL DEFINITION OF PRE-FUSION GP120 AND GP41 IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22
1612, 4orgL, 0.6472, 2.64, 0.079, 211, 89, CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.04 A POTENT V1V2-DIRECTED HIV-1 NEUTRALIZING ANTIBODY
1613, 4lspL, 0.6472, 2.86, 0.056, 208, 90, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC- CH31 IN COMPLEX WITH HIV-1 CLADE A/E GP120 93TH057
1614, 4gbxC, 0.6472, 2.57, 0.022, 189, 90, CRYSTAL STRUCTURE OF AN IMMUNE COMPLEX AT PH 6.5
1615, 4d9qD, 0.6472, 2.94, 0.055, 213, 91, INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D
1616, 3nh7N, 0.6472, 2.75, 0.089, 210, 90, CRYSTAL STRUCTURE OF THE NEUTRALIZING FAB FRAGMENT ABD1556 BOUND TO THE BMP TYPE I RECEPTOR IA
1617, 3lrsD, 0.6472, 2.73, 0.089, 211, 90, STRUCTURE OF PG16 AN ANTIBODY WITH BROAD AND POTENT NEUTRALIZATION OF HIV-1
1618, 2v7hL, 0.6472, 2.96, 0.054, 214, 93, CRYSTAL STRUCTURE OF AN IMMUNOGEN SPECIFIC ANTI- MANNOPYRANOSIDE MONOCLONAL ANTIBODY FAB FRAGMENT
1619, 2r0lL, 0.6472, 3.07, 0.054, 214, 93, SHORT FORM HGFA WITH INHIBITORY FAB75
1620, 2ok0L, 0.6472, 3.15, 0.043, 219, 94, FAB ED10-DNA COMPLEX
1621, 1hh6A, 0.6472, 3.06, 0.053, 214, 94, ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH A PEPTIDE
1622, 1dclB, 0.6472, 2.83, 0.054, 216, 92, MCG A LAMBDA V TYPE LIGHT-CHAIN DIMER (BENCE-JONES PROTEIN) CRYSTALLIZED FROM AMMONIUM SULFATE
1623, 6qnaD, 0.6471, 2.83, 0.066, 211, 91, STRUCTURE OF BOVINE ANTI-RSV HYBRID FAB B13HC-B4LC 
1624, 6oc3D, 0.6471, 2.96, 0.054, 213, 92, CRYSTAL STRUCTURE OF FLUA-20 FAB IN COMPLEX WITH THE HEAD DOMAIN OF H1 (A/SOLOMON ISLANDS/3/2006) 
1625, 6nnfL, 0.6471, 2.72, 0.067, 211, 90, CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO VRC01 FR3-03 SCFV IN COMPLEX WITH CRYSTALLIZATION CHAPERONES 3H109L FAB AND 35O22 SCFV AT 3.5 ANGSTROM 
1626, 6dkjB, 0.6471, 3.07, 0.065, 213, 92, HUMAN GIPR ECD AND FAB COMPLEX 
1627, 6c5kB, 0.6471, 3.15, 0.043, 219, 94, S25-23 FAB IN COMPLEX WITH CHLAMYDIACEAE LPS (CRYSTAL FORM 2) 
1628, 6baeA, 0.6471, 3.02, 0.054, 214, 93, TRASTUZUMAB FAB V3 IN COMPLEX WITH CQFDLSTRRLKC 
1629, 6apdL, 0.6471, 2.65, 0.090, 213, 89, CRYSTAL STRUCTURE OF RSV F BOUND BY AM22 AND THE INFANT ANTIBODY ADI- 19425
1630, 5wkzL, 0.6471, 2.77, 0.089, 212, 90, VH1-69 GERMLINE ANTIBODY PREDICTED FROM CR6261 
1631, 5vr9L, 0.6471, 2.97, 0.054, 212, 92, CH1/CKAPPA FAB BASED ON MATUZUMAB
1632, 5jxaL, 0.6471, 3.15, 0.064, 209, 94, CRYSTAL STRUCTURE OF LIGAND-FREE VRC03 ANTIGEN-BINDING FRAGMENT.
1633, 5id1C, 0.6471, 2.75, 0.056, 212, 90, CETUXIMAB FAB IN COMPLEX WITH MPT-CYS MEDITOPE
1634, 5i18L, 0.6471, 2.86, 0.056, 219, 90, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV1-69/IGKV4-1
1635, 5f6hJ, 0.6471, 2.75, 0.089, 212, 90, CRYSTAL STRUCTURE OF TIER 2 NEUTRALIZING ANTIBODY DH427 FROM A RHESUS MACAQUE
1636, 4rrpE, 0.6471, 2.95, 0.054, 214, 92, CRYSTAL STRUCTURE OF THE FAB COMPLEXED WITH ANTIGEN ASF1P NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET PDR16
1637, 4qhnB, 0.6471, 2.76, 0.089, 208, 90, I2 (UNBOUND) FROM CH103 LINEAGE
1638, 4o51E, 0.6471, 2.95, 0.065, 214, 92, CRYSTAL STRUCTURE OF THE QAA VARIANT OF ANTI-HINGE RABBIT ANTIBODY 2095-2 IN COMPLEX WITH IDES HINGE PEPTIDE
1639, 4njaL, 0.6471, 2.91, 0.054, 217, 92, CRYSTAL STRUCTURE OF FAB 6C8 IN COMPLEX WITH MPTS
1640, 4hbcL, 0.6471, 2.79, 0.066, 213, 91, CRYSTAL STRUCTURE OF A CONFORMATION-DEPENDENT RABBIT IGG FAB SPECIFIC FOR AMYLOID PREFIBRILLAR OLIGOMERS
1641, 2oslB, 0.6471, 3.04, 0.054, 213, 93, CRYSTAL STRUCTURE OF RITUXIMAB FAB IN COMPLEX WITH AN EPITOPE PEPTIDE
1642, 1mcoH, 0.6471, 3.12, 0.042, 428, 96, THREE-DIMENSIONAL STRUCTURE OF A HUMAN IMMUNOGLOBULIN WITH A HINGE DELETION
1643, 1f11A, 0.6471, 2.88, 0.054, 216, 92, F124 FAB FRAGMENT FROM A MONOCLONAL ANTI-PRES2 ANTIBODY
1644, 6qexB, 0.6470, 2.96, 0.054, 220, 92, NANODISC RECONSTITUTED HUMAN ABCB1 IN COMPLEX WITH UIC2 FAB AND TAXOL 
1645, 6oc3B, 0.6470, 3.11, 0.065, 213, 93, CRYSTAL STRUCTURE OF FLUA-20 FAB IN COMPLEX WITH THE HEAD DOMAIN OF H1 (A/SOLOMON ISLANDS/3/2006) 
1646, 6njnM, 0.6470, 2.87, 0.000, 213, 92, STRUCTURE OF A COMPLEX 
1647, 6mamF, 0.6470, 3.01, 0.054, 216, 92, CLEAVED EBOLA GP IN COMPLEX WITH A BROADLY NEUTRALIZING HUMAN ANTIBODY; ADI-15946 
1648, 5te6L, 0.6470, 3.03, 0.054, 210, 93, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING VRC01-CLASS ANTIBODY N6 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057 GP120 CORE
1649, 5sx5L, 0.6470, 2.90, 0.056, 212, 90, CRYSTAL STRUCTURE OF PANITUMUMAB IN COMPLEX WITH EPIDERMAL GROWTH FACTOR RECEPTOR DOMAIN 3 MUTANT S468R.
1650, 5nmvL, 0.6470, 2.95, 0.054, 212, 92, CRYSTAL STRUCTURE OF 2F22 FAB FRAGMENT AGAINST TFPI1
1651, 5njdO, 0.6470, 2.78, 0.089, 213, 90, STRUCTURE OF INTERLEUKIN 23 IN COMPLEX WITH BRIAKINUMAB FAB
1652, 5djdB, 0.6470, 2.85, 0.053, 207, 94, FC HETERODIMER DESIGN 5.1 T366V + Y407F
1653, 5cexC, 0.6470, 2.79, 0.088, 213, 91, CRYSTAL STRUCTURE OF FAB 32H+109L A PUTATIVE PRECURSOR OF THE PGT121 FAMILY OF POTENT HIV-1 ANTIBODIES
1654, 4u6gB, 0.6470, 2.82, 0.088, 211, 91, CRYSTAL STRUCTURE OF 10E8 FAB IN COMPLEX WITH A HYDROCARBON-STAPLED HIV-1 GP41 MPER PEPTIDE
1655, 4rwyL, 0.6470, 3.01, 0.054, 213, 93, CRYSTAL STRUCTURE OF VH1-46 GERMLINE-DERIVED CD4-BINDING SITE-DIRECTED ANTIBODY 8ANC131 IN COMPLEX WITH HIV-1 CLADE B YU2 GP120
1656, 4od1L, 0.6470, 2.62, 0.079, 211, 89, CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.03 A POTENT V1V2-DIRECTED HIV-1 NEUTRALIZING ANTIBODY
1657, 4kzeL, 0.6470, 3.04, 0.054, 215, 93, CRYSTAL STRUCTURE OF AN RNA APTAMER IN COMPLEX WITH FAB
1658, 4cniL, 0.6470, 2.95, 0.054, 214, 92, CRYSTAL STRUCTURE OF THE FAB PORTION OF OLOKIZUMAB IN COMPLEX WITH IL-6
1659, 3qq9C, 0.6470, 2.93, 0.065, 217, 92, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-HUMAN RSV (RESPIRATORY SYNCYTIAL VIRUS) F PROTEIN MAB 101F
1660, 3o11A, 0.6470, 3.00, 0.054, 211, 93, ANTI-BETA-AMYLOID ANTIBODY C706 FAB IN SPACE GROUP C2
1661, 3l5wA, 0.6470, 3.02, 0.054, 213, 92, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN IL-13 AND C836 FAB
1662, 3dsfL, 0.6470, 2.99, 0.065, 213, 93, CRYSTAL STRUCTURE OF ANTI-OSTEOPONTIN ANTIBODY 23C3 IN COMPLEX WITH W43A MUTATED EPITOPE PEPTIDE
1663, 2qscL, 0.6470, 2.84, 0.054, 215, 92, CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 V3-FAB F425-B4E8 IN COMPLEX WITH A V3-PEPTIDE
1664, 2hrpM, 0.6470, 3.13, 0.053, 218, 94, ANTIGEN-ANTIBODY COMPLEX
1665, 1lhzB, 0.6470, 2.70, 0.067, 213, 90, STRUCTURE OF A HUMAN BENCE-JONES DIMER CRYSTALLIZED IN U.S. SPACE SHUTTLE MISSION STS-95: 293K
1666, 6nb8L, 0.6469, 2.83, 0.054, 219, 92, CRYSTAL STRUCTURE OF ANTI- SARS-COV HUMAN NEUTRALIZING S230 ANTIBODY FAB FRAGMENT 
1667, 6iqgA, 0.6469, 2.83, 0.053, 207, 94, X-RAY CRYSTAL STRUCTURE OF FC AND PEPTIDE COMPLEX 
1668, 6iekC, 0.6469, 2.59, 0.067, 218, 90, STRUCTURE OF RVFV GN AND HUMAN MONOCLONAL ANTIBODY R12 
1669, 6gc2L, 0.6469, 2.83, 0.054, 214, 92, ABLIFT: ANTIBODY STABILITY AND AFFINITY OPTIMIZATION BY COMPUTATIONAL DESIGN OF THE VARIABLE LIGHT-HEAVY CHAIN INTERFACE 
1670, 6chbK, 0.6469, 2.88, 0.054, 205, 92, CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND IOMA 
1671, 6b08B, 0.6469, 2.77, 0.089, 210, 90, CRYSTAL STRUCTURE OF PFS25 IN COMPLEX WITH THE TRANSMISSION BLOCKING ANTIBODY 1276
1672, 6arpC, 0.6469, 2.98, 0.054, 213, 92, STRUCTURE OF A MUTANT CETUXIMAB FAB FRAGMENT 
1673, 5uknL, 0.6469, 2.78, 0.078, 211, 90, STRUCTURE OF UNLIGANDED ANTI-GP120 CD4BS ANTIBODY DH522UCA FAB
1674, 5k8aA, 0.6469, 3.07, 0.054, 213, 93, NIST FAB
1675, 5iopA, 0.6469, 3.13, 0.075, 213, 93, CETUXIMAB FAB IN COMPLEX WITH 4-BROMOPHENYLALANINE MEDITOPE VARIANT
1676, 5dmgD, 0.6469, 2.98, 0.054, 217, 92, X-RAY STRUCTURE OF THE FAB FRAGMENT OF THE ANTI TAU ANTIBODY RB86 IN COMPLEX WITH THE PHOSPHORYLATED TAU PEPTIDE (416-430)
1677, 5a16D, 0.6469, 3.10, 0.053, 218, 94, CRYSTAL STRUCTURE OF FAB4201 RAISED AGAINST HUMAN ERYTHROCYTE ANION EXCHANGER 1
1678, 4ypgL, 0.6469, 2.92, 0.065, 215, 92, STRUCTURAL INSIGHTS INTO THE NEUTRALIZATION PROPERTIES OF A HUMAN ANTI-INTERFERON MONOCLONAL ANTIBODY
1679, 4xx1L, 0.6469, 2.74, 0.089, 210, 90, LOW RESOLUTION STRUCTURE OF LCAT IN COMPLEX WITH FAB1
1680, 4x98A, 0.6469, 3.12, 0.042, 208, 95, IMMUNOGLOBULIN FC HETERODIMER VARIANT
1681, 4nhhJ, 0.6469, 2.81, 0.043, 207, 92, STRUCTURE OF 2G12 IGG DIMER
1682, 4nhhC, 0.6469, 2.81, 0.043, 207, 92, STRUCTURE OF 2G12 IGG DIMER
1683, 4nhhA, 0.6469, 2.81, 0.043, 207, 92, STRUCTURE OF 2G12 IGG DIMER
1684, 4nhgX, 0.6469, 2.81, 0.043, 207, 92, CRYSTAL STRUCTURE OF 2G12 IGG DIMER
1685, 4nhgO, 0.6469, 2.81, 0.043, 207, 92, CRYSTAL STRUCTURE OF 2G12 IGG DIMER
1686, 4nhgJ, 0.6469, 2.81, 0.043, 207, 92, CRYSTAL STRUCTURE OF 2G12 IGG DIMER
1687, 3vrlL, 0.6469, 3.14, 0.043, 214, 94, CRYSTAL STRUCTURE OF BMJ4 P24 CAPSID PROTEIN IN COMPLEX WITH A10F9 FAB
1688, 3qnzA, 0.6469, 3.05, 0.065, 219, 93, ORTHORHOMBIC FORM OF IGG1 FAB FRAGMENT (IN COMPLEX WITH ANTIGENIC TUBULIN PEPTIDE) SHARING SAME FV AS IGA
1689, 3mlwL, 0.6469, 2.78, 0.078, 215, 90, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 1006-15D IN COMPLEX WITH AN MN V3 PEPTIDE
1690, 3idnA, 0.6469, 2.94, 0.065, 214, 92, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 FAB  FRAGMENT IN COMPLEX WITH GP41 PEPTIDE ANALOG ELD(PAF)WAS
1691, 3eo0C, 0.6469, 2.92, 0.054, 215, 92, STRUCTURE OF THE TRANSFORMING GROWTH FACTOR-BETA NEUTRALIZING ANTIBODY GC-1008
1692, 32c2A, 0.6469, 2.98, 0.043, 217, 93, STRUCTURE OF AN ACTIVITY SUPPRESSING FAB FRAGMENT TO CYTOCHROME P450 AROMATASE
1693, 2xqyL, 0.6469, 3.04, 0.054, 218, 93, CRYSTAL STRUCTURE OF PSEUDORABIES CORE FRAGMENT OF GLYCOPROTEIN H IN COMPLEX WITH FAB D6.3
1694, 2ombA, 0.6469, 2.83, 0.054, 216, 92, BENCE JONES KWR PROTEIN- IMMUNOGLOBULIN LIGHT CHAIN DIMER P3(1)21 CRYSTAL FORM
1695, 1y18A, 0.6469, 3.15, 0.064, 216, 94, FAB FRAGMENT OF CATALYTIC ELIMINATION ANTIBODY 34E4 E(H50)D MUTANT IN COMPLEX WITH HAPTEN
1696, 1rzgB, 0.6469, 2.92, 0.054, 213, 92, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120 REACTIVE ANTIBODY 412D
1697, 1ngwA, 0.6469, 2.90, 0.054, 213, 92, CHIMERIC AFFINITY MATURED FAB 7G12 COMPLEXED WITH MESOPORPHYRIN
1698, 1h3xA, 0.6469, 2.81, 0.043, 207, 92, CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENTGLYCOFORM (G0F)2
1699, 1fc1A, 0.6469, 2.95, 0.043, 206, 93, CRYSTALLOGRAPHIC REFINEMENT AND ATOMIC MODELS OF A HUMAN FC FRAGMENT AND ITS COMPLEX WITH FRAGMENT B OF PROTEIN A FROM STAPHYLOCOCCUS AUREUS AT 2.9-AND 2.8-ANGSTROMS RESOLUTION
1700, 1cicA, 0.6469, 3.15, 0.053, 214, 94, IDIOTOPE-ANTI-IDIOTOPE FAB-FAB COMPLEX; D1.3-E225
1701, 6mugL, 0.6468, 2.72, 0.067, 211, 90, CRYSTAL STRUCTURE OF HIV-1 B41 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-386150 IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.8 ANGSTROM 
1702, 6fxnI, 0.6468, 2.77, 0.089, 210, 90, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
1703, 6e65L, 0.6468, 2.78, 0.066, 214, 91, CRYSTAL STRUCTURE OF MALARIA TRANSMISSION-BLOCKING ANTIGEN PFS48/45 6C IN COMPLEX WITH ANTIBODY 85RF45.1 
1704, 5vz1C, 0.6468, 2.88, 0.066, 196, 91, CRYSTAL STRUCTURE OF THE APO ANTIBODY FRAGMENT (FAB) RAISED AGAINST C- TERMINAL DOMAIN OF EBOLA NUCLEOPROTEIN (EBOV; TAFV; BDBV STRAINS) 
1705, 5mubV, 0.6468, 2.92, 0.043, 217, 92, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (CG05)
1706, 5i8hJ, 0.6468, 2.79, 0.089, 210, 90, CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH V3 LOOP-TARGETING ANTIBODY PGT122 FAB AND FUSION PEPTIDE-TARGETING ANTIBODY VRC34.01 FAB
1707, 5gjtL, 0.6468, 3.03, 0.044, 211, 91, CRYSTAL STRUCTURE OF H1 HEMAGGLUTININ FROM A/WASHINGTON/05/2011 IN COMPLEX WITH A NEUTRALIZING ANTIBODY 3E1
1708, 5fgbB, 0.6468, 2.87, 0.056, 212, 90, THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING HUMAN ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 FAB FRAGMENT HC33.4
1709, 5fgbA, 0.6468, 2.95, 0.054, 213, 92, THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING HUMAN ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 FAB FRAGMENT HC33.4
1710, 5c8jB, 0.6468, 3.15, 0.064, 214, 94, A YIDC-LIKE PROTEIN IN THE ARCHAEAL PLASMA MEMBRANE
1711, 4xh2L, 0.6468, 3.01, 0.054, 209, 93, CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD4 MOTIF IN COMPLEX WITH FAB FRAGMENT
1712, 4q0xL, 0.6468, 2.92, 0.054, 218, 92, CRYSTAL STRUCTURE OF NON-NEUTRALIZING ANTIBODY IN COMPLEX WITH EPITOPE II OF HCV E2
1713, 4jznB, 0.6468, 3.03, 0.054, 213, 93, THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING HUMAN ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 FAB FRAGMENT HC84-1
1714, 4jo2M, 0.6468, 2.86, 0.066, 216, 91, CRYSTAL STRUCTURE OF RABBIT MAB R56 FAB IN COMPLEX WITH V3 CROWN OF HIV-1 CONSENSUS A GP120
1715, 4imkC, 0.6468, 3.00, 0.065, 213, 93, UNCROSSED FAB BINDING TO HUMAN ANGIOPOIETIN 2
1716, 4gxvL, 0.6468, 2.74, 0.089, 213, 90, CRYSTAL STRUCTURE OF ANTI-INFLUENZA VIRUS ANTIBODY 1F1
1717, 4g6fL, 0.6468, 2.76, 0.066, 212, 91, CRYSTAL STRUCTURE OF 10E8 FAB IN COMPLEX WITH AN HIV-1 GP41 PEPTIDE
1718, 3eo0A, 0.6468, 2.92, 0.054, 215, 92, STRUCTURE OF THE TRANSFORMING GROWTH FACTOR-BETA NEUTRALIZING ANTIBODY GC-1008
1719, 2vxsN, 0.6468, 2.74, 0.089, 213, 90, STRUCTURE OF IL-17A IN COMPLEX WITH A POTENT FULLY HUMAN NEUTRALISING ANTIBODY
1720, 2cgrL, 0.6468, 2.87, 0.043, 219, 92, LOCAL AND TRANSMITTED CONFORMATIONAL CHANGES ON COMPLEXATION OF AN ANTI-SWEETENER FAB
1721, 1lo3X, 0.6468, 3.00, 0.054, 219, 93, RETRO-DIELS-ALDERASE CATALYTIC ANTIBODY: PRODUCT ANALOGUE
1722, 1i8mL, 0.6468, 3.06, 0.054, 213, 93, CRYSTAL STRUCTURE OF A RECOMBINANT ANTI-SINGLE-STRANDED DNA ANTIBODY FRAGMENT COMPLEXED WITH DT5
1723, 1c5dL, 0.6468, 2.96, 0.043, 213, 92, THE CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A RAT MONOCLONAL ANTIBODY AGAINST THE MAIN IMMUNOGENIC REGION OF THE HUMAN MUSCLE ACETYLCHOLINE RECEPTOR
1724, 6n7uB, 0.6467, 2.76, 0.055, 214, 91, APO-BDBV223 FAB 
1725, 6amjA, 0.6467, 3.04, 0.054, 214, 93, CAT192 FAB WILD TYPE
1726, 5v7jL, 0.6467, 2.75, 0.089, 211, 90, CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER WITH FOUR GLYCANS (N197 N276 N362 AND N462) REMOVED IN COMPLEX WITH NEUTRALIZING ANTIBODIES 3H+109L AND 35O22.
1727, 5t29L, 0.6467, 2.77, 0.089, 211, 90, CRYSTAL STRUCTURE OF 10E8 FAB LIGHT CHAIN MUTANT3 AGAINST THE MPER REGION OF THE HIV-1 ENV IN COMPLEX WITH THE MPER EPITOPE SCAFFOLD T117V2
1728, 5k8aM, 0.6467, 3.02, 0.065, 213, 93, NIST FAB
1729, 5jiiB, 0.6467, 2.89, 0.053, 208, 95, CRYSTAL STRUCTURE OF HUMAN IGG1-FC
1730, 4wi8B, 0.6467, 2.83, 0.053, 208, 94, STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION Y436A
1731, 4kq4L, 0.6467, 3.01, 0.054, 214, 93, CRYSTAL STRUCTURE OF ANTI-IL-17A ANTIBODY CNTO7357
1732, 4jreL, 0.6467, 2.81, 0.055, 211, 91, CRYSTAL STRUCTURE OF NITRATE/NITRITE EXCHANGER NARK WITH NITRITE BOUND
1733, 4i77L, 0.6467, 2.88, 0.054, 218, 92, LEBRIKIZUMAB FAB BOUND TO IL-13
1734, 4dtgL, 0.6467, 2.99, 0.054, 219, 93, HEMOSTATIC EFFECT OF A MONOCLONAL ANTIBODY MAB 2021 BLOCKING THE INTERACTION BETWEEN FXA AND TFPI IN A RABBIT HEMOPHILIA MODEL
1735, 3q6fE, 0.6467, 2.68, 0.077, 212, 91, CRYSTAL STRUCTURE OF FAB OF HUMAN MAB 2909 SPECIFIC FOR QUATERNARY NEUTRALIZING EPITOPE OF HIV-1 GP120
1736, 3lrsF, 0.6467, 2.75, 0.078, 211, 90, STRUCTURE OF PG16 AN ANTIBODY WITH BROAD AND POTENT NEUTRALIZATION OF HIV-1
1737, 1y18E, 0.6467, 3.16, 0.064, 216, 94, FAB FRAGMENT OF CATALYTIC ELIMINATION ANTIBODY 34E4 E(H50)D MUTANT IN COMPLEX WITH HAPTEN
1738, 1qlrC, 0.6467, 2.84, 0.054, 215, 92, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A HUMAN MONOCLONAL IGM COLD AGGLUTININ
1739, 6erxI, 0.6466, 2.77, 0.089, 210, 90, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
1740, 5nb5M, 0.6466, 3.03, 0.054, 218, 93, PRINCIPLES FOR COMPUTATIONAL DESIGN OF ANTIBODIES
1741, 5k8aL, 0.6466, 3.00, 0.054, 213, 93, NIST FAB
1742, 5bzdA, 0.6466, 2.97, 0.054, 213, 92, CRYSTAL STRUCTURE OF PCDN-27A AN ANTIBODY FROM THE PCDN FAMILY OF HIV-1 ANTIBODIES
1743, 4o51L, 0.6466, 2.95, 0.065, 214, 92, CRYSTAL STRUCTURE OF THE QAA VARIANT OF ANTI-HINGE RABBIT ANTIBODY 2095-2 IN COMPLEX WITH IDES HINGE PEPTIDE
1744, 4f58L, 0.6466, 2.71, 0.056, 213, 90, FAB STRUCTURE OF A NEUTRALIZING ANTIBODY L3 FROM AN EARLY SUBTYPE A HIV-1 INFECTED PATIENT
1745, 3d0lA, 0.6466, 2.95, 0.065, 213, 92, CRYSTAL STRUCTURE OF THE HIV-1 BROADLY NEUTRALIZING ANTIBODY 2F5 IN COMPLEX WITH THE GP41 FP-MPER HYB3K CONSTRUCT 514GIGALFLGFLGAAGS528KK-AHX-655KNEQELLELDKWASLWN671
1746, 2fl5E, 0.6466, 2.74, 0.089, 209, 90, COFACTOR-CONTAINING ANTIBODIES: CRYSTAL STRUCTURE OF THE ORIGINAL YELLOW ANTIBODY
1747, 1u8jA, 0.6466, 2.95, 0.065, 214, 92, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKWAG
1748, 1q9lC, 0.6466, 3.02, 0.054, 219, 93, S25-2 FAB UNLIGANDED 2
1749, 1fccA, 0.6466, 2.65, 0.054, 206, 92, CRYSTAL STRUCTURE OF THE C2 FRAGMENT OF STREPTOCOCCAL PROTEIN G IN COMPLEX WITH THE FC DOMAIN OF HUMAN IGG
1750, 6fy1L, 0.6465, 2.85, 0.065, 211, 92, CRYSTAL STRUCTURE OF A V2P-REACTIVE RV144 VACCINE-LIKE ANTIBODY; CAP228-16H; IN COMPLEX WITH A SCAFFOLDED AUTOLOGOUS V1V2 
1751, 5wcdL, 0.6465, 2.73, 0.078, 212, 90, CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING INFLUENZA A ANTIBODY VRC 315 04-1D02 FAB.
1752, 5u4rL, 0.6465, 3.14, 0.064, 214, 94, CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING INFLUENZA A ANTIBODY VRC 315 53-1A09 FAB.
1753, 5t1lA, 0.6465, 2.95, 0.065, 213, 92, CETUXIMAB FAB IN COMPLEX WITH CQA(PH)2DLSTRRLKC PEPTIDE
1754, 5t1kA, 0.6465, 2.96, 0.065, 213, 92, CETUXIMAB FAB IN COMPLEX WITH CQFDA(PH)2STRRLKC
1755, 4oawA, 0.6465, 2.83, 0.054, 214, 92, FAB STRUCTURE OF ANTI-HIV GP120 V2 MAB 2158
1756, 4lsrL, 0.6465, 2.86, 0.056, 208, 90, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC- CH31 IN COMPLEX WITH HIV-1 CLADE A/E STRAN 93TH057 GP120 WITH LOOP D AND LOOP V5 FROM CLADE A STRAIN KER_2018_11
1757, 4kteL, 0.6465, 2.68, 0.090, 216, 89, FAB FRAGMENT OF HIV VACCINE-ELICITED CD4BS-DIRECTED ANTIBODY GE148 FROM NON-HUMAN PRIMATE
1758, 4fqrh, 0.6465, 3.08, 0.065, 213, 92, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
1759, 3j5mK, 0.6465, 2.96, 0.055, 208, 91, CRYO-EM STRUCTURE OF THE BG505 SOSIP.664 HIV-1 ENV TRIMER WITH 3 PGV04 FABS
1760, 3j5mG, 0.6465, 2.96, 0.055, 208, 91, CRYO-EM STRUCTURE OF THE BG505 SOSIP.664 HIV-1 ENV TRIMER WITH 3 PGV04 FABS
1761, 3j5mC, 0.6465, 2.96, 0.055, 208, 91, CRYO-EM STRUCTURE OF THE BG505 SOSIP.664 HIV-1 ENV TRIMER WITH 3 PGV04 FABS
1762, 2p8mA, 0.6465, 2.90, 0.066, 213, 91, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELLELDKWASLWN IN NEW CRYSTAL FORM
1763, 2gcyA, 0.6465, 2.92, 0.055, 216, 91, HUMANIZED ANTIBODY C25 FAB FRAGMENT
1764, 1u8qA, 0.6465, 2.94, 0.065, 214, 92, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELEKWAS
1765, 1u8mA, 0.6465, 2.95, 0.065, 214, 92, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKYAS
1766, 1orqA, 0.6465, 2.97, 0.054, 215, 93, X-RAY STRUCTURE OF A VOLTAGE-DEPENDENT POTASSIUM CHANNEL IN COMPLEX WITH AN FAB
1767, 1m7dA, 0.6465, 2.63, 0.045, 215, 89, CRYSTAL STRUCTURE OF A MONOCLONAL FAB SPECIFIC FOR SHIGELLA FLEXNERI Y LIPOPOLYSACCHARIDE COMPLEXED WITH A TRISACCHARIDE
1768, 1lgvB, 0.6465, 2.69, 0.067, 213, 90, STRUCTURE OF A HUMAN BENCE-JONES DIMER CRYSTALLIZED IN U.S. SPACE SHUTTLE MISSION STS-95: 100K
1769, 1fccB, 0.6465, 2.65, 0.054, 206, 92, CRYSTAL STRUCTURE OF THE C2 FRAGMENT OF STREPTOCOCCAL PROTEIN G IN COMPLEX WITH THE FC DOMAIN OF HUMAN IGG
1770, 6n4rK, 0.6464, 2.98, 0.043, 215, 93, CRYOEM STRUCTURE OF NAV1.7 VSD2 (DEACTIVED STATE) IN COMPLEX WITH THE GATING MODIFIER TOXIN PROTX2 
1771, 6n4rI, 0.6464, 2.98, 0.043, 215, 93, CRYOEM STRUCTURE OF NAV1.7 VSD2 (DEACTIVED STATE) IN COMPLEX WITH THE GATING MODIFIER TOXIN PROTX2 
1772, 6h5nB, 0.6464, 2.73, 0.044, 212, 90, PLASMODIUM FALCIPARUM PFS48/45 C-TERMINAL DOMAIN BOUND TO MONOCLONAL ANTIBODY 85RF45.1 
1773, 6ellL, 0.6464, 2.95, 0.055, 213, 91, FAB FRAGMENT. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN ANTIBODY DRUG DISCOVERY
1774, 6apdM, 0.6464, 2.83, 0.089, 213, 90, CRYSTAL STRUCTURE OF RSV F BOUND BY AM22 AND THE INFANT ANTIBODY ADI- 19425
1775, 5ziaL, 0.6464, 3.02, 0.077, 217, 91, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-24.1 IN COMPLEX WITH ITS PHOSPHORYLATED TAU PEPTIDE 
1776, 5xajC, 0.6464, 2.83, 0.088, 214, 91, STRUCTURAL MIMICRY OF THE DENGUE VIRUS ENVELOPE GLYCOPROTEIN REVEALED BY THE CRYSTALLOGRAPHIC STUDY OF AN IDIOTYPE-ANTI-IDIOTYPE FAB COMPLEX.
1777, 5utfE, 0.6464, 2.72, 0.055, 213, 91, CRYSTAL STRUCTURE OF A STABILIZED DS-SOSIP.6MUT BG505 GP140 HIV-1 ENV TRIMER CONTAINING MUTATIONS I201C-P433C (DS) L154M Y177W N300M N302M T320L I420M IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 4.3 A
1778, 5mvjD, 0.6464, 2.92, 0.054, 218, 92, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACE-GROUP P1 
1779, 5mu0D, 0.6464, 3.04, 0.054, 217, 93, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (IA03)
1780, 5kaqG, 0.6464, 2.95, 0.054, 213, 93, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 31.A.83 IN COMPLEX WITH HEMAGGLUTININ HONG KONG 1968.
1781, 5k9kB, 0.6464, 3.08, 0.054, 215, 93, CRYSTAL STRUCTURE OF MULTIDONOR HV6-1-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 56.A.09 IN COMPLEX WITH HEMAGGLUTININ HONG KONG 1968.
1782, 5d72L, 0.6464, 2.67, 0.090, 206, 89, CRYSTAL STRUCTURE OF MOR04252 A NEUTRALIZING ANTI-HUMAN GM-CSF ANTIBODY FAB FRAGMENT IN COMPLEX WITH HUMAN GM-CSF
1783, 4u6gL, 0.6464, 2.85, 0.088, 212, 91, CRYSTAL STRUCTURE OF 10E8 FAB IN COMPLEX WITH A HYDROCARBON-STAPLED HIV-1 GP41 MPER PEPTIDE
1784, 4oiiM, 0.6464, 2.82, 0.054, 213, 92, WEST NILE VIRUS NS1 IN COMPLEX WITH NEUTRALIZING 22NS1 ANTIBODY FAB
1785, 4oiiL, 0.6464, 2.82, 0.054, 213, 92, WEST NILE VIRUS NS1 IN COMPLEX WITH NEUTRALIZING 22NS1 ANTIBODY FAB
1786, 4n8cM, 0.6464, 2.99, 0.054, 220, 93, THREE-DIMENSIONAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF MATRIX PROTEIN 2 OF INFLUENZA A VIRUS
1787, 4jznP, 0.6464, 2.94, 0.054, 213, 92, THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING HUMAN ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 FAB FRAGMENT HC84-1
1788, 3l7eA, 0.6464, 3.01, 0.054, 213, 92, CRYSTAL STRUCTURE OF ANTI-IL-13 ANTIBODY C836
1789, 3g6aA, 0.6464, 2.76, 0.089, 210, 90, CRYSTAL STRUCTURE OF ANTI-IL-13 ANTIBODY CNTO607
1790, 1u8pA, 0.6464, 2.95, 0.065, 214, 92, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ECDKWCS
1791, 6fabL, 0.6463, 2.98, 0.054, 214, 93, THREE-DIMENSIONAL STRUCTURE OF MURINE ANTI-P- AZOPHENYLARSONATE FAB 36-71. 1. X-RAY CRYSTALLOGRAPHY SITE-DIRECTED MUTAGENESIS AND MODELING OF THE COMPLEX WITH HAPTEN
1792, 6b6zC, 0.6463, 2.89, 0.066, 198, 91, CRYSTAL STRUCTURE OF THE APO ANTIBODY FRAGMENT (FAB) RAISED AGAINST C- TERMINAL DOMAIN OF EBOLA NUCLEOPROTEIN (EBOV; TAFV; BDBV STRAINS) 
1793, 5y9fY, 0.6463, 2.86, 0.044, 217, 91, CRYSTAL STRUCTURE OF HPV59 PENTAMER IN COMPLEX WITH THE FAB FRAGMENT OF ANTIBODY 28F10
1794, 5vebB, 0.6463, 2.88, 0.055, 215, 91, CRYSTAL STRUCTURE OF A FAB BINDING TO EXTRACELLULAR DOMAIN 5 OF CADHERIN-6
1795, 5sx4I, 0.6463, 2.98, 0.054, 213, 92, CRYSTAL STRUCTURE OF PANITUMUMAB IN COMPLEX WITH EPIDERMAL GROWTH FACTOR RECEPTOR DOMAIN 3.
1796, 5mubP, 0.6463, 2.92, 0.043, 217, 92, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (CG05)
1797, 5ezjB, 0.6463, 2.85, 0.054, 213, 92, CRYSTAL STRUCTURE OF FAB OF PARASITE INVASION INHIBITORY ANTIBODY C1 - ORTHORHOMBIC FORM
1798, 5cmaA, 0.6463, 2.95, 0.055, 213, 91, ANTI-B7-H3 MONOCLONAL ANTIBODY CH8H9 FAB FRAGMENT
1799, 5bzdC, 0.6463, 3.03, 0.054, 214, 93, CRYSTAL STRUCTURE OF PCDN-27A AN ANTIBODY FROM THE PCDN FAMILY OF HIV-1 ANTIBODIES
1800, 4xh2B, 0.6463, 2.99, 0.065, 210, 93, CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD4 MOTIF IN COMPLEX WITH FAB FRAGMENT
1801, 4ht1L, 0.6463, 2.98, 0.054, 217, 92, HUMAN TWEAK IN COMPLEX WITH THE FAB FRAGMENT OF A NEUTRALIZING ANTIBODY
1802, 3u7wL, 0.6463, 3.00, 0.054, 210, 93, CRYSTAL STRUCTURE OF NIH45-46 FAB
1803, 3mckL, 0.6463, 2.94, 0.054, 219, 92, CRYSTAL STRUCTURE OF ANTI-BETA-AMYLOID ANTIBODY C705
1804, 3ifoB, 0.6463, 2.89, 0.054, 218, 92, X-RAY STRUCTURE OF AMYLOID BETA PEPTIDE:ANTIBODY (ABETA1-7:10D5) COMPLEX
1805, 2vxvL, 0.6463, 2.77, 0.055, 214, 91, CRYSTAL STRUCTURE OF HUMAN IGG ABT-325 FAB FRAGMENT
1806, 2fl5C, 0.6463, 2.73, 0.089, 209, 90, COFACTOR-CONTAINING ANTIBODIES: CRYSTAL STRUCTURE OF THE ORIGINAL YELLOW ANTIBODY
1807, 6eluC, 0.6462, 2.86, 0.054, 217, 92, STRUCTURE OF SERUM RESISTANCE ASSOCIATED PROTEIN FROM T. B. RHODESIENSE
1808, 6c6xD, 0.6462, 2.83, 0.065, 214, 92, CRYSTAL STRUCTURE OF MIDDLE-EAST RESPIRATORY SYNDROME (MERS) CORONAVIRUS NEUTRALIZING ANTIBODY JC57-14 ISOLATED FROM A VACCINATED RHESUS MACAQUE.
1809, 5x0tB, 0.6462, 2.92, 0.054, 213, 92, CRYSTAL STRUCTURE OF CD147 C2 DOMAIN IN COMPLEX WITH FAB OF ITS MONOCLONAL ANTIBODY 6H8
1810, 5ukoL, 0.6462, 2.71, 0.079, 211, 89, STRUCTURE OF UNLIGANDED ANTI-GP120 CD4BS ANTIBODY DH522IA FAB
1811, 5te7L, 0.6462, 3.03, 0.054, 210, 93, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING VRC01-CLASS ANTIBODY N6 IN COMPLEX WITH HIV-1 CLADE C STRAIN DU172.17 GP120 CORE
1812, 5t5bB, 0.6462, 2.93, 0.054, 210, 92, CRYSTAL STRUCTURE OF THE COMPLEX OF 10E8 FAB LIGHT CHAIN MUTANT5 AND T117V2 HIV-1 MPER SCAFFOLD
1813, 5mp6L, 0.6462, 2.99, 0.075, 224, 93, STRUCTURE OF THE UNLIGANDED FAB FROM HIV-1 NEUTRALIZING ANTIBODY CAP248-2B THAT BINDS TO THE GP120 C-TERMINUS - GP41 INTERFACE AT TWO ANGSTROM RESOLUTION.
1814, 5d9qE, 0.6462, 2.73, 0.056, 208, 90, CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46
1815, 4xvuD, 0.6462, 3.02, 0.054, 216, 93, STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF NYV1
1816, 4qhlD, 0.6462, 2.74, 0.078, 209, 90, I3.2 (UNBOUND) FROM CH103 LINEAGE
1817, 4ki5F, 0.6462, 2.53, 0.045, 209, 88, CYSTAL STRUCTURE OF HUMAN FACTOR VIII C2 DOMAIN IN A TERNARY COMPLEX WITH MURINE INHBITORY ANTIBODIES 3E6 AND G99
1818, 4dgiL, 0.6462, 3.05, 0.043, 213, 93, STRUCTURE OF POM1 FAB FRAGMENT COMPLEXED WITH HUMAN PRPC FRAGMENT 120- 230
1819, 3ulvL, 0.6462, 2.82, 0.054, 214, 92, STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM2)
1820, 3ulvE, 0.6462, 3.09, 0.065, 215, 93, STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM2)
1821, 3uluC, 0.6462, 2.76, 0.066, 210, 91, STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM1)
1822, 3oz9L, 0.6462, 2.82, 0.054, 211, 92, CRYSTAL STRUCTURE OF ANTI-GP41 FAB NC-1
1823, 3fn3A, 0.6462, 2.45, 0.056, 215, 89, DIMERIC STRUCTURE OF PD-L1
1824, 3cfjE, 0.6462, 2.95, 0.054, 215, 92, CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4 ORTHORHOMBIC CRYSTAL FORM
1825, 2vxuL, 0.6462, 3.10, 0.053, 214, 94, CRYSTAL STRUCTURE OF MURINE REFERENCE ANTIBODY 125-2H FAB FRAGMENT
1826, 1zanL, 0.6462, 2.90, 0.043, 213, 92, CRYSTAL STRUCTURE OF ANTI-NGF AD11 FAB
1827, 1tzgM, 0.6462, 2.92, 0.054, 214, 92, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH A 13-RESIDUE PEPTIDE CONTAINING THE 4E10 EPITOPE ON GP41
1828, 1ngxL, 0.6462, 2.98, 0.043, 213, 92, CHIMERIC GERMLINE FAB 7G12 WITH JEFFAMINE FRAGMENT BOUND
1829, 1fnsL, 0.6462, 3.13, 0.053, 214, 94, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR (VWF) A1 DOMAIN I546V MUTANT IN COMPLEX WITH THE FUNCTION BLOCKING FAB NMC4
1830, 6mhrE, 0.6461, 2.97, 0.055, 215, 91, STRUCTURE OF THE HUMAN 4-1BB / URELUMAB FAB COMPLEX 
1831, 6gfeL, 0.6461, 2.84, 0.054, 215, 92, HIGH-RESOLUTION STRUCTURE OF A THERAPEUTIC FULL-LENGTH ANTI-NPRA ANTIBODY WITH EXCEPTIONAL CONFORMATIONAL DIVERSITY 
1832, 6d01H, 0.6461, 3.17, 0.064, 213, 94, CRYSTAL STRUCTURE OF 1210 FAB IN COMPLEX WITH CIRCUMSPOROZOITE PROTEIN NANP5 
1833, 5y9fM, 0.6461, 2.91, 0.044, 217, 91, CRYSTAL STRUCTURE OF HPV59 PENTAMER IN COMPLEX WITH THE FAB FRAGMENT OF ANTIBODY 28F10
1834, 5y2kF, 0.6461, 2.67, 0.101, 208, 89, A HUMAN ANTIBODY AF4H1L1 
1835, 5vlpL, 0.6461, 2.90, 0.054, 214, 92, PCSK9 COMPLEX WITH LDLR ANTAGONIST PEPTIDE AND FAB7G7
1836, 5u7mE, 0.6461, 2.90, 0.054, 213, 92, CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-378806 IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 3.8 ANGSTROM
1837, 5th9M, 0.6461, 2.95, 0.054, 214, 92, STRUCTURE DETERMINATION OF A POTENT SELECTIVE ANTIBODY INHIBITOR OF HUMAN MMP9 (GS-5745 BOUND TO MMP-9)
1838, 5mv4P, 0.6461, 3.26, 0.063, 218, 95, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED CII616-639 EPITOPE OF COLLAGEN TYPE II (PTM23)
1839, 5gguL, 0.6461, 2.98, 0.054, 213, 92, CRYSTAL STRUCTURE OF TREMELIMUMAB FAB
1840, 5djxE, 0.6461, 2.94, 0.053, 207, 95, FC HETERODIMER DESIGN 2.9 L368M/K370E + E357A/S364G
1841, 5bzwA, 0.6461, 2.92, 0.055, 213, 91, CRYSTAL STRUCTURE OF PCDN-27B AN ANTIBODY FROM THE PCDN FAMILY OF HIV-1 ANTIBODIES
1842, 4xp1L, 0.6461, 2.90, 0.043, 214, 92, X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER BOUND TO NEUROTRANSMITTER DOPAMINE
1843, 4wwiF, 0.6461, 2.79, 0.054, 207, 93, CRYSTAL STRUCTURE OF THE C DOMAIN OF STAPHYLOCOCCAL PROTEIN A IN COMPLEX WITH THE FC FRAGMENT OF HUMAN IGG AT 2.3 ANGSTROM RESOLUTION
1844, 4orgD, 0.6461, 2.77, 0.078, 208, 90, CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.04 A POTENT V1V2-DIRECTED HIV-1 NEUTRALIZING ANTIBODY
1845, 4idjL, 0.6461, 2.82, 0.054, 214, 92, S.AUREUS A-HEMOLYSIN MONOMER IN COMPLEX WITH FAB
1846, 3nzhL, 0.6461, 2.82, 0.054, 214, 92, CRYSTAL STRUCTURE OF ANTI-EMMPRIN ANTIBODY 5F6 FAB
1847, 3idyL, 0.6461, 2.93, 0.054, 214, 92, CRYSTAL STRUCTURE OF HIV-GP120 CORE IN COMPLEX WITH CD4-BINDING SITE ANTIBODY B13 SPACE GROUP C2221
1848, 3h42L, 0.6461, 2.78, 0.089, 214, 90, CRYSTAL STRUCTURE OF PCSK9 IN COMPLEX WITH FAB FROM LDLR COMPETITIVE ANTIBODY
1849, 1ynlL, 0.6461, 3.09, 0.053, 219, 94, IDENTIFICATION OF KEY RESIDUES OF THE NC6.8 FAB ANTIBODY FRAGMENT BINDING TO SYNTHETIC SWEETERNERS: CRYSTAL STRUCTURE OF NC6.8 CO- CRYSTALIZED WITH HIGH POTENCY SWEETENER COMPOUND SC45647
1850, 1u8kA, 0.6461, 3.01, 0.065, 214, 93, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE LELDKWASL
1851, 1fdlL, 0.6461, 2.73, 0.044, 214, 91, CRYSTALLOGRAPHIC REFINEMENT OF THE THREE-DIMENSIONAL STRUCTURE OF THE FAB D1.3-LYSOZYME COMPLEX AT 2.5- ANGSTROMS RESOLUTION
1852, 6qnaF, 0.6460, 2.92, 0.065, 211, 92, STRUCTURE OF BOVINE ANTI-RSV HYBRID FAB B13HC-B4LC 
1853, 6mu7L, 0.6460, 2.71, 0.067, 211, 90, CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-818251 IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.1 ANGSTROM 
1854, 6fy0M, 0.6460, 2.68, 0.090, 208, 89, CRYSTAL STRUCTURE OF A V2-DIRECTED; RV144 VACCINE-LIKE ANTIBODY FROM HIV-1 INFECTION; CAP228-16H; BOUND TO A HETEROLOGOUS V2 PEPTIDE 
1855, 6bp2L, 0.6460, 2.81, 0.088, 215, 91, THERAPEUTIC HUMAN MONOCLONAL ANTIBODY MR191 BOUND TO A MARBURGVIRUS GLYCOPROTEIN
1856, 5ywpM, 0.6460, 3.25, 0.053, 215, 95, JEV-2H4 FAB COMPLEX 
1857, 5utfL, 0.6460, 2.81, 0.078, 208, 90, CRYSTAL STRUCTURE OF A STABILIZED DS-SOSIP.6MUT BG505 GP140 HIV-1 ENV TRIMER CONTAINING MUTATIONS I201C-P433C (DS) L154M Y177W N300M N302M T320L I420M IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 4.3 A
1858, 5myxA, 0.6460, 2.97, 0.054, 219, 93, STRUCTURE OF PYROGLUTAMATE-ABETA-SPECIFIC FAB C 24 IN COMPLEX WITH HUMAN ABETA-PE3-18
1859, 5mx3L, 0.6460, 2.88, 0.054, 218, 92, STRUCTURE OF DC8E8 FAB CRYSTALLIZED AT PH 8.5
1860, 5mv4V, 0.6460, 3.10, 0.064, 218, 94, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED CII616-639 EPITOPE OF COLLAGEN TYPE II (PTM23)
1861, 5ikcL, 0.6460, 2.86, 0.044, 211, 91, X-RAY STRUCTURE OF THE N-TERMINAL DOMAIN OF HUMAN DOUBLECORTIN IN COMPLEX WITH FAB
1862, 5ceyA, 0.6460, 2.80, 0.089, 211, 90, CRYSTAL STRUCTURE OF FAB 9H+3L A PUTATIVE PRECURSOR OF THE PGT121 FAMILY OF POTENT HIV-1 ANTIBODIES
1863, 4s1dL, 0.6460, 3.06, 0.054, 213, 93, STRUCTURE OF IGG1 FAB FRAGMENT IN COMPLEX WITH BIOTINCYTIDINAMIDE
1864, 4hjjL, 0.6460, 2.96, 0.054, 327, 92, STRUCTURE REVEALS FUNCTION OF THE DUAL VARIABLE DOMAIN IMMUNOGLOBULIN (DVD-IG) MOLECULE
1865, 3skjL, 0.6460, 3.02, 0.054, 214, 93, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF AN AGONISTIC ANTI-HUMAN EPHA2 MONOCLONAL ANTIBODY
1866, 3i02A, 0.6460, 2.97, 0.054, 219, 93, CRYSTAL STRUCTURE OF S54-10 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO(2.4)KDO
1867, 3hr5P, 0.6460, 3.02, 0.054, 219, 93, M1PRIME PEPTIDE FROM IGE BOUND BY HUMANIZED ANTIBODY 47H4 FAB
1868, 1mcsB, 0.6460, 2.90, 0.054, 216, 92, PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
1869, 1mcdA, 0.6460, 2.84, 0.065, 216, 92, PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
1870, 6megL, 0.6459, 2.52, 0.057, 213, 88, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
1871, 6gfeM, 0.6459, 2.99, 0.065, 215, 93, HIGH-RESOLUTION STRUCTURE OF A THERAPEUTIC FULL-LENGTH ANTI-NPRA ANTIBODY WITH EXCEPTIONAL CONFORMATIONAL DIVERSITY 
1872, 6anpL, 0.6459, 2.72, 0.056, 214, 90, CAT192 FAB INSERTION MUTANT H5/L0
1873, 5xf1L, 0.6459, 2.99, 0.054, 214, 93, STRUCTURE OF THE FULL-LENGTH GLUCAGON CLASS B G PROTEIN-COUPLED RECEPTOR
1874, 5wk2L, 0.6459, 2.99, 0.054, 219, 92, CRYSTAL STRUCTURE OF ANTI-CCL17 ANTIBODY M116
1875, 5o7pA, 0.6459, 2.94, 0.055, 213, 91, HER3 IN COMPLEX WITH FAB MF3178 
1876, 5mubS, 0.6459, 2.92, 0.043, 217, 92, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (CG05)
1877, 5kmvI, 0.6459, 3.17, 0.064, 219, 94, CRYSTAL STRUCTURE OF CRENEZUMAB FAB
1878, 5h35B, 0.6459, 2.85, 0.044, 217, 91, CRYSTAL STRUCTURES OF THE TRIC TRIMERIC INTRACELLULAR CATION CHANNEL ORTHOLOGUE FROM SULFOLOBUS SOLFATARICUS
1879, 5gznL, 0.6459, 2.77, 0.089, 213, 90, STRUCTURE OF NEUTRALIZING ANTIBODY BOUND TO ZIKA ENVELOPE PROTEIN
1880, 4yhlL, 0.6459, 3.00, 0.054, 218, 92, REVERSAL AGENT FOR DABIGATRAN
1881, 4oz4L, 0.6459, 2.88, 0.054, 218, 92, X-RAY STRUCTURE OF THE DC8E8 FAB APO-FORM CRYSTALLIZED AT PH 8.5 AND REFINED TO 3.0 A.
1882, 4oqtL, 0.6459, 2.91, 0.055, 214, 91, LINGO-1/LI81 FAB COMPLEX
1883, 4i3rL, 0.6459, 2.97, 0.054, 208, 92, CRYSTAL STRUCTURE OF THE OUTER DOMAIN OF HIV-1 GP120 IN COMPLEX WITH VRC-PG04 SPACE GROUP P3221
1884, 4h88L, 0.6459, 3.05, 0.043, 213, 93, STRUCTURE OF POM1 FAB FRAGMENT COMPLEXED WITH MOUSE PRPC FRAGMENT 120- 230
1885, 3r1gL, 0.6459, 3.01, 0.054, 214, 93, STRUCTURE BASIS OF ALLOSTERIC INHIBITION OF BACE1 BY AN EXOSITE- BINDING ANTIBODY
1886, 3qhzM, 0.6459, 2.73, 0.089, 211, 90, CRYSTAL STRUCTURE OF HUMAN ANTI-INFLUENZA FAB 2D1
1887, 3mltL, 0.6459, 2.76, 0.089, 216, 90, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A UG1033 V3 PEPTIDE
1888, 3mlsM, 0.6459, 2.74, 0.089, 219, 90, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 MAB 2557 FAB IN COMPLEX WITH A HIV- 1 GP120 V3 MIMOTOPE
1889, 3cxdL, 0.6459, 3.03, 0.054, 213, 93, CRYSTAL STRUCTURE OF ANTI-OSTEOPONTIN ANTIBODY 23C3 IN COMPLEX WITH ITS EPITOPE PEPTIDE
1890, 2or9M, 0.6459, 2.94, 0.054, 218, 93, THE STRUCTURE OF THE ANTI-C-MYC ANTIBODY 9E10 FAB FRAGMENT/EPITOPE PEPTIDE COMPLEX REVEALS A NOVEL BINDING MODE DOMINATED BY THE HEAVY CHAIN HYPERVARIABLE LOOPS
1891, 1vgeL, 0.6459, 2.79, 0.055, 214, 91, TR1.9 FAB FRAGMENT OF A HUMAN IGG1 KAPPA AUTOANTIBODY
1892, 1t04A, 0.6459, 3.01, 0.054, 214, 93, THREE DIMENSIONAL STRUCTURE OF A HUMANIZED ANTI-IFN-GAMMA FAB IN C2 SPACE GROUP
1893, 1q9lA, 0.6459, 2.96, 0.054, 219, 93, S25-2 FAB UNLIGANDED 2
1894, 1pz5A, 0.6459, 2.74, 0.056, 215, 90, STRUCTURAL BASIS OF PEPTIDE-CARBOHYDRATE MIMICRY IN AN ANTIBODY COMBINING SITE
1895, 1h3pL, 0.6459, 3.04, 0.053, 219, 94, STRUCTURAL CHARACTERISATION OF A MONOCLONAL ANTIBODY SPECIFIC FOR THE PRES1 REGION OF THE HEPATITIS B VIRUS
1896, 6icfL, 0.6458, 2.82, 0.043, 213, 92, THE NZ-1 FAB COMPLEXED WITH THE PDZ TANDEM FRAGMENT OF A. AEOLICUS S2P HOMOLOG WITH THE PA12 TAG INSERTED BETWEEN THE RESIDUES 263 AND 266 
1897, 5w0kF, 0.6458, 2.90, 0.055, 212, 91, CRYSTAL STRUCTURE OF EBV GHGL/CL40/GP42 N-DOMAIN
1898, 5mv4S, 0.6458, 3.10, 0.064, 218, 94, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED CII616-639 EPITOPE OF COLLAGEN TYPE II (PTM23)
1899, 5i1dL, 0.6458, 3.04, 0.054, 220, 93, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-23/IGKV4-1
1900, 5fhcB, 0.6458, 2.70, 0.067, 207, 90, CRYSTAL STRUCTURE OF PROTECTIVE HUMAN ANTIBODIES 100 AND 114 IN COMPLEX WITH EBOLA VIRUS FUSION GLYCOPROTEIN (GP)
1901, 5f6hN, 0.6458, 2.79, 0.089, 212, 90, CRYSTAL STRUCTURE OF TIER 2 NEUTRALIZING ANTIBODY DH427 FROM A RHESUS MACAQUE
1902, 5d9qL, 0.6458, 2.74, 0.056, 208, 90, CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46
1903, 5cp7E, 0.6458, 2.76, 0.033, 218, 91, CRYSTAL STRUCTURE OF AN ANTIGEN-BINDING FRAGMENT OF MONOCLONAL ANTIBODY AGAINST SULFONAMIDES
1904, 5chnB, 0.6458, 2.95, 0.054, 218, 92, FAB FRAGMENTS OF CHIKUNGUNYA VIRUS NEUTRALIZING HUMAN MONOCLONAL ANTIBODY 5M16
1905, 4xvtL, 0.6458, 2.98, 0.054, 208, 93, CRYSTAL STRUCTURE OF HIV-1 93TH057 COREE GP120 WITH ANTIBODY 45- VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995)
1906, 4xh2D, 0.6458, 2.99, 0.054, 210, 93, CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD4 MOTIF IN COMPLEX WITH FAB FRAGMENT
1907, 4rrpB, 0.6458, 2.99, 0.054, 216, 93, CRYSTAL STRUCTURE OF THE FAB COMPLEXED WITH ANTIGEN ASF1P NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET PDR16
1908, 4rgnE, 0.6458, 2.99, 0.054, 220, 93, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO TWO NEUTRALIZING ANTIBODIES 14G8 AND 6D3
1909, 4rbpK, 0.6458, 2.98, 0.054, 213, 92, CRYSTAL STRUCTURE OF HIV NEUTRALIZING ANTIBODY 2G12 IN COMPLEX WITH A BACTERIAL OLIGOSACCHARIDE ANALOG OF MAMMALIAN OLIGOMANOSE
1910, 4ps4L, 0.6458, 2.73, 0.056, 213, 90, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN IL-13 AND M1295 FAB
1911, 4nujA, 0.6458, 2.96, 0.055, 218, 91, CRYSTAL STRUCTURE OF HIV-1 BROADLY NEUTRALIZING ANTIBODY PGT152
1912, 3jwdL, 0.6458, 2.90, 0.055, 212, 91, STRUCTURE OF HIV-1 GP120 WITH GP41-INTERACTIVE REGION: LAYERED ARCHITECTURE AND BASIS OF CONFORMATIONAL MOBILITY
1913, 2fl5A, 0.6458, 2.79, 0.089, 209, 90, COFACTOR-CONTAINING ANTIBODIES: CRYSTAL STRUCTURE OF THE ORIGINAL YELLOW ANTIBODY
1914, 1za3A, 0.6458, 2.98, 0.054, 213, 92, THE CRYSTAL STRUCTURE OF THE YSD1 FAB BOUND TO DR5
1915, 1ngyA, 0.6458, 2.94, 0.054, 213, 92, CHIMERIC MATURE FAB 7G12-APO
1916, 6obdA, 0.6457, 2.70, 0.056, 216, 89, CRYSTAL STRUCTURE OF ANTI-GLD52 FAB COMPLEX WITH HUMAN GLD52 PEPTIDE MIMETIC 
1917, 6mufL, 0.6457, 2.73, 0.067, 211, 90, CRYSTAL STRUCTURE OF HIV-1 B41 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.4 ANGSTROM 
1918, 6mu3L, 0.6457, 2.88, 0.056, 211, 90, ANTI-HIV-1 FAB 2G12 + MAN7 RE-REFINEMENT 
1919, 6m87G, 0.6457, 3.05, 0.054, 208, 92, FAB 10A6 IN COMPLEX WITH MPTS 
1920, 6fxnP, 0.6457, 2.76, 0.089, 210, 90, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
1921, 6cmiC, 0.6457, 2.91, 0.065, 213, 92, CRYSTAL STRUCTURE OF THE HENDRA VIRUS ATTACHMENT G GLYCOPROTEIN BOUND TO A POTENT CROSS-REACTIVE NEUTRALIZING HUMAN MONOCLONAL ANTIBODY M102.3 
1922, 5vh4B, 0.6457, 3.12, 0.065, 213, 92, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-TNFA ANTIBODY INFLIXIMAB IN AN I-CENTERED ORTHORHOMBIC CRYSTAL FORM
1923, 5uslC, 0.6457, 2.73, 0.100, 210, 90, STRUCTURE OF VACCINIA VIRUS D8 PROTEIN BOUND TO HUMAN FAB VV304
1924, 5m6aB, 0.6457, 2.65, 0.066, 214, 91, CRYSTAL STRUCTURE OF CARDIOTOXIC BENCE-JONES LIGHT CHAIN DIMER H9
1925, 4z18A, 0.6457, 2.47, 0.056, 212, 89, CRYSTAL STRUCTURE OF HUMAN PD-L1
1926, 4yhmL, 0.6457, 2.98, 0.054, 219, 93, REVERSAL AGENT FOR DABIGATRAN
1927, 4nwtL, 0.6457, 3.12, 0.065, 220, 93, CRYSTAL STRUCTURE OF THE ANTI-HUMAN NGF FAB APE1531
1928, 4lsuL, 0.6457, 2.87, 0.065, 203, 92, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC- PG20 IN COMPLEX WITH HIV-1 CLADE A/E 93TH057 GP120
1929, 4hh9C, 0.6457, 3.10, 0.065, 214, 93, ANTI-HUMAN CYTOMEGALOVIRUS (HCMV) FAB KE5
1930, 3opzL, 0.6457, 2.94, 0.043, 212, 92, CRYSTAL STRUCTURE OF TRANS-SIALIDASE IN COMPLEX WITH THE FAB FRAGMENT OF A NEUTRALIZING MONOCLONAL IGG ANTIBODY
1931, 3idmA, 0.6457, 2.96, 0.065, 214, 92, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 FAB  FRAGMENT IN COMPLEX WITH GP41 PEPTIDE ANALOG ELD(NRG)WAS
1932, 3ffdB, 0.6457, 2.69, 0.056, 217, 90, STRUCTURE OF PARATHYROID HORMONE-RELATED PROTEIN COMPLEXED TO A NEUTRALIZING MONOCLONAL ANTIBODY
1933, 3drtA, 0.6457, 2.89, 0.066, 213, 91, CRYSTAL STRUCTURE OF THE HIV-1 BROADLY NEUTRALIZING ANTIBODY 2F5 IN COMPLEX WITH THE GP41 SCRAMBLEDFP-MPER SCRHYB3K CONSTRUCT GIGAFGLLGFLAAGSKK-AHX-K656NEQELLELDKWASLWN671
1934, 3chnO, 0.6457, 2.80, 0.055, 214, 91, SOLUTION STRUCTURE OF HUMAN SECRETORY IGA1
1935, 3chnN, 0.6457, 2.80, 0.055, 214, 91, SOLUTION STRUCTURE OF HUMAN SECRETORY IGA1
1936, 3chnM, 0.6457, 2.80, 0.055, 214, 91, SOLUTION STRUCTURE OF HUMAN SECRETORY IGA1
1937, 3chnL, 0.6457, 2.80, 0.055, 214, 91, SOLUTION STRUCTURE OF HUMAN SECRETORY IGA1
1938, 2qtjO, 0.6457, 2.80, 0.055, 214, 91, SOLUTION STRUCTURE OF HUMAN DIMERIC IMMUNOGLOBULIN A
1939, 2qtjN, 0.6457, 2.80, 0.055, 214, 91, SOLUTION STRUCTURE OF HUMAN DIMERIC IMMUNOGLOBULIN A
1940, 2qtjM, 0.6457, 2.80, 0.055, 214, 91, SOLUTION STRUCTURE OF HUMAN DIMERIC IMMUNOGLOBULIN A
1941, 2qtjL, 0.6457, 2.80, 0.055, 214, 91, SOLUTION STRUCTURE OF HUMAN DIMERIC IMMUNOGLOBULIN A
1942, 2oqjJ, 0.6457, 2.88, 0.056, 211, 90, CRYSTAL STRUCTURE ANALYSIS OF FAB 2G12 IN COMPLEX WITH PEPTIDE 2G12.1
1943, 2esgM, 0.6457, 2.80, 0.055, 214, 91, SOLUTION STRUCTURE OF THE COMPLEX BETWEEN IMMUNOGLOBULIN IGA1 AND HUMAN SERUM ALBUMIN
1944, 2esgL, 0.6457, 2.80, 0.055, 214, 91, SOLUTION STRUCTURE OF THE COMPLEX BETWEEN IMMUNOGLOBULIN IGA1 AND HUMAN SERUM ALBUMIN
1945, 2aj3C, 0.6457, 2.89, 0.055, 212, 91, CRYSTAL STRUCTURE OF A CROSS-REACTIVE HIV-1 NEUTRALIZING CD4-BINDING SITE ANTIBODY FAB M18
1946, 1igaD, 0.6457, 2.80, 0.055, 214, 91, MODEL OF HUMAN IGA1 DETERMINED BY SOLUTION SCATTERING CURVE- FITTING AND HOMOLOGY MODELLING
1947, 1igaC, 0.6457, 2.80, 0.055, 214, 91, MODEL OF HUMAN IGA1 DETERMINED BY SOLUTION SCATTERING CURVE- FITTING AND HOMOLOGY MODELLING
1948, 6ncwB, 0.6456, 3.09, 0.083, 560, 96, CRYSTAL STRUCTURE OF A GH2 BETA-GALACTURONIDASE FROM EISENBERGIELLA TAYI BOUND TO GLYCEROL 
1949, 6h06F, 0.6456, 2.92, 0.055, 218, 91, FAB CBTAU-22.1 IN COMPLEX WITH TAU PEPTIDE V1088-5 
1950, 6erxP, 0.6456, 2.76, 0.089, 210, 90, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
1951, 6d8kC, 0.6456, 2.77, 0.043, 569, 92, BACTEROIDES MULTIPLE SPECIES BETA-GLUCURONIDASE 
1952, 6btjB, 0.6456, 2.98, 0.054, 213, 92, CRYSTAL STRUCTURE OF PAN-H7; ANTI-HEMAGGLUTININ MONOCLONAL ANTIBODY H7.5 (FAB FRAGMENT) 
1953, 5y9fK, 0.6456, 2.89, 0.044, 217, 91, CRYSTAL STRUCTURE OF HPV59 PENTAMER IN COMPLEX WITH THE FAB FRAGMENT OF ANTIBODY 28F10
1954, 5u5mA, 0.6456, 3.07, 0.054, 214, 93, CRYSTAL STRUCTURE OF I83E MEDITOPE-ENABLED TRASTUZUMAB WITH AZIDO- MEDITOPE
1955, 5cszL, 0.6456, 2.93, 0.055, 213, 91, CRYSTAL STRUCTURE OF GANTENERUMAB FAB FRAGMENT IN COMPLEX WITH ABETA 1-11
1956, 4xcnK, 0.6456, 2.96, 0.054, 214, 92, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA); 2.9 A RESOLUTION
1957, 4rx4L, 0.6456, 3.07, 0.054, 212, 93, CRYSTAL STRUCTURE OF VH1-46 GERMLINE-DERIVED CD4-BINDING SITE-DIRECTED ANTIBODY 8ANC134 IN COMPLEX WITH HIV-1 CLADE A Q842.D12 GP120
1958, 4pw9A, 0.6456, 3.07, 0.083, 363, 96, CRYSTAL STRUCTURE OF THE ELECTRON-TRANSFER COMPLEX FORMED BETWEEN A SULFITE DEHYDROGENASE AND A C-TYPE CYTOCHROME FROM SINORHIZOBIUM MELILOTI
1959, 4jo1M, 0.6456, 2.87, 0.066, 216, 91, CRYSTAL STRUCTURE OF RABBIT MAB R56 FAB IN COMPLEX WITH V3 CROWN OF HIV-1 JR-FL GP120
1960, 4jm4L, 0.6456, 2.79, 0.055, 214, 91, CRYSTAL STRUCTURE OF PGT 135 FAB
1961, 4g3yL, 0.6456, 3.02, 0.054, 214, 93, CRYSTAL STRUCTURE OF TNF-ALPHA IN COMPLEX WITH INFLIXIMAB FAB FRAGMENT
1962, 4fqqL, 0.6456, 2.88, 0.087, 213, 92, CRYSTAL STRUCTURE OF GERMLINE ANTIBODY PGT121-GL FAB
1963, 3mugK, 0.6456, 2.84, 0.088, 212, 91, CRYSTAL STRUCTURE OF HUMAN FAB PG16 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
1964, 3mbxL, 0.6456, 3.09, 0.043, 220, 94, CRYSTAL STRUCTURE OF CHIMERIC ANTIBODY X836
1965, 3j42L, 0.6456, 2.89, 0.044, 212, 91, OBSTRUCTION OF DENGUE VIRUS MATURATION BY FAB FRAGMENTS OF THE 2H2 ANTIBODY
1966, 3j42J, 0.6456, 2.89, 0.044, 212, 91, OBSTRUCTION OF DENGUE VIRUS MATURATION BY FAB FRAGMENTS OF THE 2H2 ANTIBODY
1967, 3j42H, 0.6456, 2.89, 0.044, 212, 91, OBSTRUCTION OF DENGUE VIRUS MATURATION BY FAB FRAGMENTS OF THE 2H2 ANTIBODY
1968, 3bz4C, 0.6456, 2.87, 0.054, 218, 92, CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A SHIGELLA FLEXNERI 2A O-AG DECASACCHARIDE
1969, 2hwzL, 0.6456, 2.76, 0.055, 210, 91, FAB FRAGMENT OF HUMANIZED ANTI-VIRAL ANTIBODY MEDI-493 (SYNAGIS TM)
1970, 1deeE, 0.6456, 2.99, 0.054, 214, 93, CRYSTAL STRUCTURE AT 2.7A RESOLUTION OF A COMPLEX BETWEEN A STAPHYLOCOCCUS AUREUS DOMAIN AND A FAB FRAGMENT OF A HUMAN IGM ANTIBODY
1971, 1deeC, 0.6456, 2.99, 0.054, 214, 93, CRYSTAL STRUCTURE AT 2.7A RESOLUTION OF A COMPLEX BETWEEN A STAPHYLOCOCCUS AUREUS DOMAIN AND A FAB FRAGMENT OF A HUMAN IGM ANTIBODY
1972, 6n5dN, 0.6455, 2.70, 0.067, 212, 90, BROADLY PROTECTIVE ANTIBODIES DIRECTED TO A SUBDOMINANT INFLUENZA HEMAGGLUTININ EPITOPE 
1973, 6hkgB, 0.6455, 2.97, 0.054, 214, 92, STRUCTURE OF FISW84 FAB FRAGMENT 
1974, 6df1L, 0.6455, 2.72, 0.056, 213, 90, ANTI-PHOSPHOTYROSINE ANTIBODY 4G10-4D5 FAB COMPLEXED WITH SULFATE 
1975, 6b0aL, 0.6455, 2.96, 0.054, 211, 92, CRYSTAL STRUCTURE OF PFS25 IN COMPLEX WITH THE TRANSMISSION BLOCKING ANTIBODY 1269
1976, 5y2kD, 0.6455, 2.74, 0.089, 208, 90, A HUMAN ANTIBODY AF4H1L1 
1977, 5xhvQ, 0.6455, 3.12, 0.064, 214, 94, CRYSTAL STRUCTURE OF FAB S40 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ HA1 SUBUNIT.
1978, 5tr8L, 0.6455, 2.81, 0.055, 212, 91, CRYSTAL STRUCTURE OF VACCINE-ELICITED PAN- INFLUENZA H1N1 NEUTRALIZING MURINE ANTIBODY 441D6. 
1979, 5sx4L, 0.6455, 2.95, 0.065, 213, 92, CRYSTAL STRUCTURE OF PANITUMUMAB IN COMPLEX WITH EPIDERMAL GROWTH FACTOR RECEPTOR DOMAIN 3.
1980, 5mtlD, 0.6455, 2.70, 0.079, 200, 89, CRYSTAL STRUCTURE OF AN AMYLOIDOGENIC LIGHT CHAIN
1981, 5mthB, 0.6455, 2.88, 0.054, 218, 92, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACEGROUP P21 
1982, 5mo9L, 0.6455, 2.94, 0.065, 219, 92, STRUCTURE OF HUMAN TRKB RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH THE FAB FRGMENT OF ANTIBODY AB20
1983, 5k9qT, 0.6455, 3.02, 0.065, 214, 93, CRYSTAL STRUCTURE OF MULTIDONOR HV1-18-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 16.A.26 IN COMPLEX WITH A/HONG KONG/1-4-MA21- 1/1968 (H3N2) HEMAGGLUTININ
1984, 5k59F, 0.6455, 2.92, 0.055, 212, 91, CRYSTAL STRUCTURE OF LUKGH FROM STAPHYLOCOCCUS AUREUS IN COMPLEX WITH A NEUTRALISING ANTIBODY
1985, 5i73C, 0.6455, 2.93, 0.043, 214, 93, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH S-CITALOPRAM AT THE CENTRAL AND ALLOSTERIC SITES
1986, 5hyiC, 0.6455, 2.84, 0.053, 208, 94, GLYCOSYLATED DISULFIDE-LINKED HOLE-HOLE FC FRAGMENT
1987, 5hhxL, 0.6455, 2.79, 0.089, 213, 90, INHIBITING COMPLEX IL-17A AND IL-17RA INTERACTIONS WITH A LINEAR PEPTIDE
1988, 5gksD, 0.6455, 2.72, 0.079, 209, 89, CRYSTAL STRUCTURE OF SLE PATIENT-DERIVED ANTI-DNA ANTIBODY
1989, 5dd6B, 0.6455, 3.00, 0.076, 213, 92, CRYSTAL STRUCTURES IN AN ANTI-HIV ANTIBODY LINEAGE FROM IMMUNIZATION OF RHESUS MACAQUES
1990, 4yhzL, 0.6455, 2.96, 0.054, 211, 92, CRYSTAL STRUCTURE OF 304M3-B FAB IN COMPLEX WITH H3K4ME3 PEPTIDE
1991, 4x8jB, 0.6455, 3.16, 0.053, 214, 94, CRYSTAL STRUCTURE OF MURINE 12F4 FAB MONOCLONAL ANTIBODY AGAINST ADAMTS5
1992, 4nqsH, 0.6455, 2.93, 0.053, 207, 95, KNOB-INTO-HOLE IGG FC
1993, 4jfxA, 0.6455, 3.05, 0.054, 214, 93, STRUCTURE OF PHOSPHOTYROSINE (PTYR) SCAFFOLD BOUND TO PTYR PEPTIDE
1994, 4jamB, 0.6455, 2.78, 0.078, 205, 90, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY CH103
1995, 4fqrv, 0.6455, 2.92, 0.055, 213, 91, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
1996, 3v6oE, 0.6455, 2.94, 0.043, 213, 93, LEPTIN RECEPTOR-ANTIBODY COMPLEX
1997, 3v6fL, 0.6455, 2.83, 0.044, 219, 91, CRYSTAL STRUCTURE OF AN ANTI-HBV E-ANTIGEN MONOCLONAL FAB FRAGMENT (E6) UNBOUND
1998, 3tjeL, 0.6455, 2.80, 0.089, 213, 90, CRYSTAL STRUCTURE OF FAS RECEPTOR EXTRACELLULAR DOMAIN IN COMPLEX WITH FAB E09
1999, 3macL, 0.6455, 2.79, 0.078, 210, 90, CRYSTAL STRUCTURE OF GP41-DERIVED PROTEIN COMPLEXED WITH FAB 8062
2000, 3l1oL, 0.6455, 2.99, 0.054, 214, 93, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY MN423 FAB FRAGMENT WITH FREE COMBINING SITE CRYSTALLIZED IN THE PRESENCE OF ZINC
2001, 2uylA, 0.6455, 2.87, 0.043, 218, 92, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
2002, 2orbL, 0.6455, 2.89, 0.054, 212, 92, THE STRUCTURE OF THE ANTI-C-MYC ANTIBODY 9E10 FAB FRAGMENT
2003, 2fjhL, 0.6455, 3.09, 0.075, 214, 93, STRUCTURE OF THE B20-4 FAB A PHAGE DERIVED FAB FRAGMENT IN COMPLEX WITH VEGF
2004, 1uywL, 0.6455, 2.85, 0.044, 212, 91, CRYSTAL STRUCTURE OF THE ANTIFLAVIVIRUS FAB4G2
2005, 1deeA, 0.6455, 2.99, 0.054, 214, 93, CRYSTAL STRUCTURE AT 2.7A RESOLUTION OF A COMPLEX BETWEEN A STAPHYLOCOCCUS AUREUS DOMAIN AND A FAB FRAGMENT OF A HUMAN IGM ANTIBODY
2006, 6o3bE, 0.6454, 2.75, 0.056, 213, 90, CRYSTAL STRUCTURE OF FRIZZLED 7 CRD IN COMPLEX WITH F6 FAB 
2007, 6dwiM, 0.6454, 2.84, 0.056, 207, 89, STRUCTURE OF THE 4462 ANTIBODY FAB FRAGMENT BOUND TO A STAPHYLOCOCCUS AUREUS WALL TECHOIC ACID ANALOG 
2008, 6b0eA, 0.6454, 2.91, 0.056, 217, 90, CRYSTAL STRUCTURE OF PFS25 IN COMPLEX WITH THE TRANSMISSION BLOCKING ANTIBODY 1260
2009, 5um8E, 0.6454, 2.99, 0.054, 213, 92, CRYSTAL STRUCTURE OF HIV-1 ENVELOPE TRIMER 16055 NFL TD CC (T569G) IN COMPLEX WITH FABS 35022 AND PGT124
2010, 5u7oE, 0.6454, 2.90, 0.054, 213, 92, CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-626529 IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 3.8 ANGSTROM
2011, 5mp1G, 0.6454, 2.88, 0.043, 218, 92, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 7.5 
2012, 5jo5L, 0.6454, 2.78, 0.066, 212, 91, CRYSTAL STRUCTURE OF 10E8 GHV-GLV ANTIGEN-BINDING FRAGMENT.
2013, 5ggvL, 0.6454, 2.96, 0.054, 213, 92, CTLA-4 IN COMPLEX WITH TREMELIMUMAB FAB
2014, 5dk3F, 0.6454, 3.17, 0.064, 218, 94, CRYSTAL STRUCTURE OF PEMBROLIZUMAB A FULL LENGTH IGG4 ANTIBODY
2015, 5d1qA, 0.6454, 2.77, 0.055, 214, 91, ISDB NEAT2 BOUND BY CLONE D2-06
2016, 4qxuL, 0.6454, 3.13, 0.053, 219, 94, NOVEL INHIBITION MECHANISM OF MEMBRANE METALLOPROTEASE BY AN EXOSITE- SWIVELING CONFORMATIONAL ANTIBODY
2017, 4kzdL, 0.6454, 3.06, 0.054, 215, 93, CRYSTAL STRUCTURE OF AN RNA APTAMER IN COMPLEX WITH FLUOROPHORE AND FAB
2018, 4fz8L, 0.6454, 2.87, 0.056, 215, 90, CRYSTAL STRUCTURE OF C11 FAB AN ADCC MEDIATING ANTI-HIV-1 ANTIBODY.
2019, 3u9uB, 0.6454, 2.95, 0.054, 219, 93, CRYSTAL STRUCTURE OF EXTRACELLULAR DOMAIN OF HUMAN ERBB4/HER4 IN COMPLEX WITH THE FAB FRAGMENT OF MAB1479
2020, 3u2sL, 0.6454, 2.69, 0.090, 211, 89, CRYSTAL STRUCTURE OF PG9 FAB IN COMPLEX WITH V1V2 REGION FROM HIV-1 STRAIN ZM109
2021, 3phqA, 0.6454, 3.02, 0.043, 216, 93, CRYSTAL STRUCTURE OF S64-4 IN COMPLEX WITH KDO
2022, 3mckA, 0.6454, 3.19, 0.043, 219, 94, CRYSTAL STRUCTURE OF ANTI-BETA-AMYLOID ANTIBODY C705
2023, 3ijhC, 0.6454, 2.85, 0.054, 217, 92, STRUCTURE OF S67-27 IN COMPLEX WITH KO
2024, 3fzuD, 0.6454, 2.78, 0.055, 213, 91, IGG1 FAB CHARACTERIZED BY H/D EXCHANGE
2025, 3f12C, 0.6454, 2.97, 0.065, 213, 92, GERMLINE V-GENES SCULPT THE BINDING SITE OF A FAMILY OF ANTIBODIES NEUTRALIZING HUMAN CYTOMEGALOVIRUS
2026, 1y18L, 0.6454, 3.16, 0.064, 216, 94, FAB FRAGMENT OF CATALYTIC ELIMINATION ANTIBODY 34E4 E(H50)D MUTANT IN COMPLEX WITH HAPTEN
2027, 1y0lL, 0.6454, 2.97, 0.054, 216, 92, CATALYTIC ELIMINATION ANTIBODY 34E4 IN COMPLEX WITH HAPTEN
2028, 1n8zA, 0.6454, 3.00, 0.054, 214, 93, CRYSTAL STRUCTURE OF EXTRACELLULAR DOMAIN OF HUMAN HER2 COMPLEXED WITH HERCEPTIN FAB
2029, 1jguL, 0.6454, 2.94, 0.054, 220, 93, STRUCTURAL BASIS FOR DISFAVORED ELIMINATION REACTION IN CATALYTIC ANTIBODY 1D4
2030, 1cftA, 0.6454, 3.20, 0.053, 214, 94, ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH AN EPITOPE-UNRELATED D-PEPTIDE
2031, 6c6yB, 0.6453, 2.94, 0.065, 214, 92, CRYSTAL STRUCTURE OF MIDDLE-EAST RESPIRATORY SYNDROME (MERS) CORONAVIRUS NEUTRALIZING ANTIBODY JC57-14 ISOLATED FROM A VACCINATED RHESUS MACAQUE IN COMPLEX WITH MERS RECEPTOR BINDING DOMAIN
2032, 6b14L, 0.6453, 2.86, 0.054, 215, 92, CRYSTAL STRUCTURE OF SPINACH RNA APTAMER IN COMPLEX WITH FAB BL3-6S97N
2033, 5tudE, 0.6453, 2.91, 0.056, 211, 90, STRUCTURAL INSIGHTS INTO THE EXTRACELLULAR RECOGNITION OF THE HUMAN SEROTONIN 2B RECEPTOR BY AN ANTIBODY
2034, 5kw9L, 0.6453, 2.93, 0.054, 219, 92, STRUCTURAL BASIS FOR NOROVIRUS NEUTRALIZATION BY A HBGA BLOCKING HUMAN IGA ANTIBODY
2035, 5k9kL, 0.6453, 3.04, 0.054, 215, 93, CRYSTAL STRUCTURE OF MULTIDONOR HV6-1-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 56.A.09 IN COMPLEX WITH HEMAGGLUTININ HONG KONG 1968.
2036, 5i71C, 0.6453, 2.93, 0.043, 214, 93, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH S-CITALOPRAM AT THE CENTRAL SITE
2037, 5hyeC, 0.6453, 3.05, 0.053, 207, 95, GLYCOSYLATED KNOB-KNOB FC FRAGMENT (P212121)
2038, 5d9qM, 0.6453, 2.74, 0.056, 208, 90, CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46
2039, 4z18B, 0.6453, 2.40, 0.057, 210, 88, CRYSTAL STRUCTURE OF HUMAN PD-L1
2040, 4rgnG, 0.6453, 2.99, 0.054, 220, 93, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO TWO NEUTRALIZING ANTIBODIES 14G8 AND 6D3
2041, 4mwfB, 0.6453, 2.96, 0.054, 211, 92, STRUCTURE OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 CORE BOUND TO BROADLY NEUTRALIZING ANTIBODY AR3C
2042, 4k3eM, 0.6453, 2.85, 0.065, 213, 92, CRYSTAL STRUCTURE OF BOVINE ANTIBODY BLV5B8 WITH ULTRALONG CDR H3
2043, 4jzjB, 0.6453, 3.01, 0.054, 219, 92, CRYSTAL STRUCTURE OF RECEPTOR-FAB COMPLEX
2044, 4hjgA, 0.6453, 3.03, 0.054, 214, 93, MEDITOPE-ENABLED TRASTUZUMAB
2045, 3wihL, 0.6453, 2.87, 0.054, 213, 92, CRYSTAL STRUCTURE OF THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1 IN COMPLEX WITH THE FAB FRAGMENT OF MURINE MONOCLONAL ANTIBODY B2212A.
2046, 3ru8L, 0.6453, 2.87, 0.056, 213, 90, STRUCTURE OF AN HIV EPITOPE SCAFFOLD IN COMPLEX WITH NEUTRALIZING ANTIBODY B12 FAB
2047, 1pskL, 0.6453, 2.98, 0.054, 213, 93, THE CRYSTAL STRUCTURE OF AN FAB FRAGMENT THAT BINDS TO THE MELANOMA-ASSOCIATED GD2 GANGLIOSIDE
2048, 1mjuL, 0.6453, 3.01, 0.043, 219, 93, 1.22 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS6-12
2049, 1mckA, 0.6453, 2.85, 0.065, 216, 92, PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
2050, 6bkcL, 0.6452, 2.96, 0.055, 214, 91, STRUCTURE OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 CORE FROM GENOTYPE 6A BOUND TO BROADLY NEUTRALIZING ANTIBODY AR3B 
2051, 6b0wL, 0.6452, 2.81, 0.088, 209, 91, CRYSTAL STRUCTURE OF THE ANTI-CIRCUMSPOROZOITE PROTEIN 1710 ANTIBODY
2052, 6a77L, 0.6452, 3.12, 0.065, 211, 92, CRYSTAL STRUCTURE OF THE FIFTH IMMUNOGLOBULIN DOMAIN (IG5) OF HUMAN ROBO1 IN COMPLEX WITH THE FAB FRAGMENT OF MURINE MONOCLONAL ANTIBODY B5209B 
2053, 5uy3B, 0.6452, 2.89, 0.056, 216, 90, CRYSTAL STRUCTURE OF HUMAN FAB PGT144 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
2054, 5k9qL, 0.6452, 3.07, 0.054, 214, 93, CRYSTAL STRUCTURE OF MULTIDONOR HV1-18-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 16.A.26 IN COMPLEX WITH A/HONG KONG/1-4-MA21- 1/1968 (H3N2) HEMAGGLUTININ
2055, 4uimL, 0.6452, 3.10, 0.054, 214, 93, CRYSTAL STRUCTURE OF QUININE-DEPENDENT FAB 314.3
2056, 4r7dD, 0.6452, 3.07, 0.065, 211, 92, FAB HU 15C1
2057, 4fqrd, 0.6452, 2.95, 0.054, 213, 92, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
2058, 3mltD, 0.6452, 2.75, 0.089, 213, 90, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A UG1033 V3 PEPTIDE
2059, 3j8dD, 0.6452, 2.86, 0.044, 425, 91, CRYOELECTRON MICROSCOPY OF DENGUE-FAB E104 COMPLEX AT PH 5.5
2060, 3j8dA, 0.6452, 2.86, 0.044, 425, 91, CRYOELECTRON MICROSCOPY OF DENGUE-FAB E104 COMPLEX AT PH 5.5
2061, 3d0vA, 0.6452, 3.02, 0.065, 214, 93, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE LLELDKWASLW
2062, 2mklC, 0.6452, 3.09, 0.097, 105, 93, SOLUTION STRUCTURE OF THE FOURTH CONSTANT IMMUNOGLOBULIN DOMAIN OF NURSE SHARK IGNAR
2063, 2hfgL, 0.6452, 3.12, 0.065, 213, 93, CRYSTAL STRUCTURE OF HBR3 BOUND TO CB3S-FAB
2064, 6n32M, 0.6451, 2.78, 0.055, 213, 91, ANTI-HIV-1 FAB 2G12 RE-REFINEMENT 
2065, 6mtjL, 0.6451, 2.73, 0.067, 211, 90, CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-378806 IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 2.9 ANGSTROM 
2066, 5tkjB, 0.6451, 2.99, 0.054, 218, 92, STRUCTURE OF VACCINE-ELICITED DIVERSE HIV-1 NEUTRALIZING ANTIBODY VFP1.01 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519
2067, 5od8B, 0.6451, 2.97, 0.054, 213, 92, CRYSTAL STRUCTURE OF THE RA-ASSOCIATED MAB B2 (FAB FRAGMENT) 
2068, 4ydiL, 0.6451, 2.95, 0.055, 208, 91, CRYSTAL STRUCTURE OF BROAD AND POTENTLY NEUTRALIZING VRC01-CLASS ANTIBODY Z258-VRC27.01 ISOLATED FROM HUMAN DONOR Z258 IN COMPLEX WITH HIV-1 GP120 FROM CLADE A STRAIN Q23.17
2069, 4xnzL, 0.6451, 2.74, 0.056, 207, 90, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC06B IN COMPLEX WITH HIV-1 CLADE A/E STRAIN 93TH057 GP120
2070, 4hgwA, 0.6451, 2.87, 0.054, 217, 92, CRYSTAL STRUCTURE OF S25-2 IN COMPLEX WITH A 56-DEHYDRO-KDO DISACCHARIDE
2071, 4fqrp, 0.6451, 2.95, 0.054, 213, 92, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
2072, 4ffzY, 0.6451, 2.72, 0.044, 216, 90, CRYSTAL STRUCTURE OF DENV1-E111 FAB FRAGMENT BOUND TO DENV-1 DIII (WESTERN PACIFIC-74 STRAIN).
2073, 4ffzL, 0.6451, 2.72, 0.044, 216, 90, CRYSTAL STRUCTURE OF DENV1-E111 FAB FRAGMENT BOUND TO DENV-1 DIII (WESTERN PACIFIC-74 STRAIN).
2074, 3uluL, 0.6451, 2.98, 0.054, 214, 93, STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM1)
2075, 3u0wL, 0.6451, 2.98, 0.054, 213, 92, AD RELATED MURINE ANTIBODY FRAGMENT
2076, 3cfcL, 0.6451, 3.08, 0.054, 219, 93, HIGH-RESOLUTION STRUCTURE OF BLUE FLUORESCENT ANTIBODY EP2-19G2
2077, 2hkhL, 0.6451, 3.12, 0.053, 219, 94, CRYSTAL STRUCTURE OF THE FAB M75
2078, 1kb5L, 0.6451, 2.99, 0.043, 214, 93, MURINE T-CELL RECEPTOR VARIABLE DOMAIN/FAB COMPLEX
2079, 6mg4A, 0.6450, 2.84, 0.088, 215, 91, STRUCTURE OF FULL-LENGTH HUMAN LAMBDA-6A LIGHT CHAIN JTO 
2080, 6e3hL, 0.6450, 3.03, 0.065, 219, 93, CRYSTAL STRUCTURE OF S9-3-37 BOUND TO H5 INFLUENZA HEMAGGLUTININ 
2081, 6cyfL, 0.6450, 2.98, 0.054, 214, 92, PCRV FRAGMENT WITH BOUND FAB 
2082, 6al5L, 0.6450, 2.95, 0.065, 217, 92, COMPLEX BETWEEN CD19 (N138Q MUTANT) AND B43 FAB
2083, 5u6aA, 0.6450, 3.03, 0.054, 214, 93, CRYSTAL STRUCTURE OF I83E MEDITOPE-ENABLED TRASTUZUMAB WITH AZIDO- PEG3-MEDITOPE
2084, 5u0rL, 0.6450, 2.87, 0.088, 209, 91, CRYSTAL STRUCTURE OF DH270.UCA1 (UNLIGANDED) FROM THE DH270 BROADLY NEUTRALIZING N332-GLYCAN DEPENDENT LINEAGE
2085, 5ockL, 0.6450, 2.98, 0.054, 214, 92, CRYSTAL STRUCTURE OF ACPA E4 IN COMPLEX WITH CEP1 
2086, 5ifjK, 0.6450, 2.71, 0.090, 213, 89, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E01 FAB FRAGMENT IN COMPLEX OF PEPTIDE PLQPEQPFP
2087, 5ibuL, 0.6450, 2.93, 0.055, 214, 91, FAB (UNBOUND)
2088, 5i75C, 0.6450, 2.94, 0.043, 214, 93, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH S-CITALOPRAM AT THE CENTRAL SITE AND BR-CITALOPRAM AT THE ALLOSTERIC SITE
2089, 5dvnA, 0.6450, 2.87, 0.053, 208, 94, FC K392D/K409D HOMODIMER
2090, 5do2D, 0.6450, 2.94, 0.054, 214, 92, COMPLEX STRUCTURE OF MERS-RBD BOUND WITH 4C2 ANTIBODY
2091, 4yzfL, 0.6450, 3.00, 0.054, 218, 93, CRYSTAL STRUCTURE OF THE ANION EXCHANGER DOMAIN OF HUMAN ERYTHROCYTE BAND 3
2092, 4xvuJ, 0.6450, 2.78, 0.055, 215, 91, STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF NYV1
2093, 4x99A, 0.6450, 3.14, 0.042, 208, 95, IMMUNOGLOBULIN FC HETERODIMERS VARIANT
2094, 4whyL, 0.6450, 2.99, 0.032, 218, 93, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11 P21 CRYSTAL FORM
2095, 4trpL, 0.6450, 3.13, 0.043, 219, 93, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY AGAINST NEUROBLASTOMA ASSOCIATED ANTIGEN.
2096, 4risL, 0.6450, 2.77, 0.089, 213, 90, STRUCTURAL ANALYSIS OF THE UNMUTATED ANCESTOR OF THE HIV-1 ENVELOPE V2 REGION ANTIBODY CH58 ISOLATED FROM AN RV144 HIV-1 VACCINE EFFICACY TRIAL VACCINEE AND ASSOCIATED WITH DECREASED TRANSMISSION RISK
2097, 4r2gC, 0.6450, 2.84, 0.078, 210, 90, CRYSTAL STRUCTURE OF PGT124 FAB BOUND TO HIV-1 JRCSF GP120 CORE AND TO CD4
2098, 4q9cA, 0.6450, 2.85, 0.043, 105, 92, IGNAR ANTIBODY DOMAIN C3
2099, 4oluL, 0.6450, 2.90, 0.055, 208, 91, CRYSTAL STRUCTURE OF ANTIBODY VRC07 IN COMPLEX WITH CLADE A/E 93TH057 HIV-1 GP120 CORE
2100, 4lu5L, 0.6450, 2.83, 0.054, 219, 92, STRUCTURE OF MURINE IGG2A A20G2-FAB IN COMPLEX WITH VACCINIA ANTIGEN A33R AT THE RESOLUTION OF 2.9 ANGSTROMS
2101, 4jo1L, 0.6450, 2.88, 0.066, 216, 91, CRYSTAL STRUCTURE OF RABBIT MAB R56 FAB IN COMPLEX WITH V3 CROWN OF HIV-1 JR-FL GP120
2102, 4gxuN, 0.6450, 2.77, 0.089, 213, 90, CRYSTAL STRUCTURE OF ANTIBODY 1F1 BOUND TO THE 1918 INFLUENZA HEMAGGLUTININ
2103, 4g6kL, 0.6450, 2.89, 0.056, 212, 90, CRYSTAL STRUCTURE OF THE THERAPEUTIC ANTIBODY BINDING FRAGMENT OF GEVOKIZUMAB IN ITS UNBOUND STATE
2104, 3mugG, 0.6450, 2.79, 0.089, 212, 90, CRYSTAL STRUCTURE OF HUMAN FAB PG16 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
2105, 3k46A, 0.6450, 2.78, 0.056, 597, 89, CRYSTAL STRUCTURE OF FULL-LENGTH E. COLI BETA-GLUCURONIDASE
2106, 3eobA, 0.6450, 2.81, 0.055, 214, 91, CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB IN COMPLEX WITH LFA-1 I DOMAIN FORM II
2107, 3eo9L, 0.6450, 2.77, 0.055, 213, 91, CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB
2108, 2r1yA, 0.6450, 2.98, 0.054, 217, 93, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
2109, 6h3hD, 0.6449, 2.91, 0.054, 215, 93, FAB FRAGMENT OF ANTIBODY AGAINST FULLERENE C60 
2110, 6attL, 0.6449, 3.03, 0.054, 220, 93, 39S FAB BOUND TO HER2 ECD 
2111, 6andL, 0.6449, 2.89, 0.055, 212, 91, PINATUZUMAB FAB IN COMPLEX WITH ANTI-KAPPA VHH DOMAIN
2112, 5ye4B, 0.6449, 2.78, 0.055, 211, 91, CRYSTAL STRUCTURE OF THE COMPLEX OF DI-ACETYLATED HISTONE H4 AND 1A9D7 FAB FRAGMENT 
2113, 5ubzL, 0.6449, 2.79, 0.089, 213, 90, FAB STRUCTURE OF HIV GP120 SPECIFIC MAB 1E12
2114, 5tdnC, 0.6449, 3.16, 0.064, 213, 94, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-HER2 ANTIBODY 4D5 WITH REDESIGNED HEAVY AND LIGHT CHAIN INTERFACES
2115, 5mv4J, 0.6449, 2.89, 0.054, 218, 92, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED CII616-639 EPITOPE OF COLLAGEN TYPE II (PTM23)
2116, 5jw3L, 0.6449, 3.00, 0.054, 206, 92, STRUCTURE OF MEDI8852 FAB FRAGMENT IN COMPLEX WITH H7 HA
2117, 5jorL, 0.6449, 2.95, 0.054, 218, 92, CRYSTAL STRUCTURE OF UNBOUND ANTI-GLYCAN ANTIBODY FAB14.22 AT 2.2 A
2118, 5iv2A, 0.6449, 2.97, 0.065, 213, 92, CETUXIMAB FAB IN COMPLEX WITH ARG9CIR MEDITOPE VARIANT
2119, 4jvuB, 0.6449, 2.62, 0.034, 97, 89, IGM C2-DOMAIN FROM MOUSE
2120, 4hpyL, 0.6449, 2.77, 0.066, 213, 91, CRYSTAL STRUCTURE OF RV144-ELICITED ANTIBODY CH59 IN COMPLEX WITH V2 PEPTIDE
2121, 3ks0J, 0.6449, 2.76, 0.056, 212, 90, CRYSTAL STRUCTURE OF THE HEME DOMAIN OF FLAVOCYTOCHROME B2 IN COMPLEX WITH FAB B2B4
2122, 3cfjA, 0.6449, 2.96, 0.054, 215, 92, CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4 ORTHORHOMBIC CRYSTAL FORM
2123, 3bikA, 0.6449, 2.39, 0.057, 212, 88, CRYSTAL STRUCTURE OF THE PD-1/PD-L1 COMPLEX
2124, 2ai0O, 0.6449, 2.93, 0.054, 217, 92, ANTI-COCAINE ANTIBODY 7.5.21 CRYSTAL FORM III
2125, 1za6E, 0.6449, 3.03, 0.054, 220, 93, THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY
2126, 1rzfL, 0.6449, 2.73, 0.089, 213, 90, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY E51
2127, 1h3vB, 0.6449, 2.81, 0.043, 206, 92, CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENTGLYCOFORM (G2F)2SG P212121
2128, 1e4wL, 0.6449, 3.13, 0.053, 214, 94, CROSSREACTIVE BINDING OF A CIRCULARIZED PEPTIDE TO AN ANTI-TGFALPHA ANTIBODY FAB-FRAGMENT
2129, 6mnfL, 0.6448, 2.98, 0.054, 213, 92, ANTI-HIV-1 FAB 2G12 + MAN8 RE-REFINEMENT 
2130, 6meeD, 0.6448, 2.96, 0.055, 213, 91, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
2131, 6db6L, 0.6448, 2.86, 0.076, 213, 92, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 311-11D IN COMPLEX WITH A HIV-1 GP120 V3 PEPTIDE FROM MN STRAIN 
2132, 6b5pL, 0.6448, 2.68, 0.090, 211, 89, STRUCTURE OF PFCSP PEPTIDE 20 WITH HUMAN ANTIBODY CIS42
2133, 5wthD, 0.6448, 2.99, 0.054, 212, 93, CRYO-EM STRUCTURE FOR HEPATITIS A VIRUS COMPLEXED WITH FAB
2134, 5kvdL, 0.6448, 2.98, 0.043, 220, 93, ZIKA SPECIFIC ANTIBODY ZV-2 BOUND TO ZIKA ENVELOPE DIII
2135, 5jw4N, 0.6448, 2.98, 0.054, 206, 92, STRUCTURE OF MEDI8852 FAB FRAGMENT IN COMPLEX WITH H5 HA
2136, 5jo5D, 0.6448, 2.81, 0.055, 212, 91, CRYSTAL STRUCTURE OF 10E8 GHV-GLV ANTIGEN-BINDING FRAGMENT.
2137, 5i6xC, 0.6448, 2.90, 0.054, 214, 93, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH PAROXETINE AT THE CENTRAL SITE
2138, 5eukA, 0.6448, 2.73, 0.056, 212, 89, CETUXIMAB FAB IN COMPLEX WITH F3H MEDITOPE VARIANT
2139, 4k7pX, 0.6448, 3.07, 0.054, 213, 93, GENERATION AND CHARACTERIZATION OF A UNIQUE REAGENT THAT RECOGNIZES A PANEL OF RECOMBINANT HUMAN MONOCLONAL ANTIBODY THERAPEUTICS IN THE PRESENCE OF ENDOGENOUS HUMAN IGG
2140, 4d2nA, 0.6448, 2.93, 0.064, 208, 94, CRYSTAL STRUCTURE OF DEGLYCOSYLATED SERUM-DERIVED HUMAN IGG4 FC
2141, 3l7fL, 0.6448, 2.96, 0.055, 213, 91, STRUCTURE OF IL-13 ANTIBODY H2L6 A HUMANIZED VARIANT OF C836
2142, 3kr3L, 0.6448, 2.97, 0.054, 214, 92, CRYSTAL STRUCTURE OF IGF-II ANTIBODY COMPLEX
2143, 3ikcA, 0.6448, 2.87, 0.043, 217, 92, STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)-7-O-METHYL-KDO
2144, 3ijhA, 0.6448, 2.89, 0.043, 217, 92, STRUCTURE OF S67-27 IN COMPLEX WITH KO
2145, 3idyC, 0.6448, 2.93, 0.054, 214, 92, CRYSTAL STRUCTURE OF HIV-GP120 CORE IN COMPLEX WITH CD4-BINDING SITE ANTIBODY B13 SPACE GROUP C2221
2146, 3hntL, 0.6448, 3.04, 0.043, 214, 93, CS-35 FAB COMPLEX WITH A LINEAR TERMINAL OLIGOARABINOFURANOSYL TETRASACCHARIDE FROM LIPOARABINOMANNAN
2147, 3gjfK, 0.6448, 2.77, 0.089, 212, 90, RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES
2148, 2f5bL, 0.6448, 3.03, 0.065, 214, 93, CRYSTAL STRUCTURE OF FAB  FROM THE HIV-1 NEUTRALIZING ANTIBODY 2F5 IN COMPLEX WITH ITS GP41 EPITOPE
2149, 1zlvL, 0.6448, 2.90, 0.056, 211, 90, FAB 2G12 + MAN7
2150, 1y0lC, 0.6448, 3.01, 0.054, 216, 93, CATALYTIC ELIMINATION ANTIBODY 34E4 IN COMPLEX WITH HAPTEN
2151, 1uweX, 0.6448, 2.91, 0.055, 213, 91, MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9
2152, 1s78E, 0.6448, 3.03, 0.054, 214, 93, INSIGHTS INTO ERBB SIGNALING FROM THE STRUCTURE OF THE ERBB2- PERTUZUMAB COMPLEX
2153, 1lgvA, 0.6448, 2.88, 0.055, 213, 91, STRUCTURE OF A HUMAN BENCE-JONES DIMER CRYSTALLIZED IN U.S. SPACE SHUTTLE MISSION STS-95: 100K
2154, 1fskK, 0.6448, 3.12, 0.053, 214, 94, COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1
2155, 1bbdL, 0.6448, 2.93, 0.043, 219, 92, THREE DIMENSIONAL STRUCTURE OF THE FAB FRAGMENT OF A NEUTRALIZING ANTIBODY TO HUMAN RHINOVIRUS SEROTYPE 2
2156, 6ncxB, 0.6447, 2.92, 0.096, 559, 94, CRYSTAL STRUCTURE OF GH2 BETA-GALACTURONIDASE FROM EISENBERGIELLA TAYI BOUND TO GALACTURONATE 
2157, 6cxlL, 0.6447, 3.00, 0.054, 213, 92, ANTI-HIV-1 FAB 2G12 IN COMPLEX WITH GLYCOPEPTIDE 10F5 
2158, 6al4C, 0.6447, 2.74, 0.056, 217, 90, CRYSTAL STRUCTURE OF ANTI-CD19 ANTIBODY B43 FAB
2159, 5i19L, 0.6447, 2.90, 0.055, 213, 91, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-23/IGKV1-39
2160, 5ff6A, 0.6447, 2.97, 0.065, 213, 92, CETUXIMAB FAB IN COMPLEX WITH L10Q MEDITOPE VARIANT
2161, 5c0rL, 0.6447, 3.03, 0.043, 214, 93, CRYSTAL STRUCTURE OF A GENERATION 3 INFLUENZA HEMAGGLUTININ STABILIZED STEM COMPLEXED WITH THE BROADLY NEUTRALIZING ANTIBODY C179
2162, 5a16F, 0.6447, 2.94, 0.054, 218, 93, CRYSTAL STRUCTURE OF FAB4201 RAISED AGAINST HUMAN ERYTHROCYTE ANION EXCHANGER 1
2163, 4z5rJ, 0.6447, 2.97, 0.054, 217, 92, RONTALIZUMAB FAB BOUND TO INTERFERON-A2
2164, 4yzfH, 0.6447, 3.00, 0.054, 218, 93, CRYSTAL STRUCTURE OF THE ANION EXCHANGER DOMAIN OF HUMAN ERYTHROCYTE BAND 3
2165, 4ioiA, 0.6447, 3.04, 0.054, 214, 93, MEDITOPE-ENABLED TRASTUZUMAB IN COMPLEX WITH CQFDLSTRRLKC
2166, 4dagL, 0.6447, 3.00, 0.065, 213, 93, STRUCTURE OF THE HUMAN METAPNEUMOVIRUS FUSION PROTEIN WITH NEUTRALIZING ANTIBODY IDENTIFIES A PNEUMOVIRUS ANTIGENIC SITE
2167, 3u4eL, 0.6447, 2.84, 0.088, 214, 91, CRYSTAL STRUCTURE OF PG9 FAB IN COMPLEX WITH V1V2 REGION FROM HIV-1 STRAIN CAP45
2168, 3mj8A, 0.6447, 2.71, 0.079, 209, 89, CRYSTAL STRUCTURE OF HL4E10 FAB A HAMSTER AB STIMULATORY FOR GAMMADELTA T CELLS
2169, 3lrsB, 0.6447, 2.78, 0.089, 211, 90, STRUCTURE OF PG16 AN ANTIBODY WITH BROAD AND POTENT NEUTRALIZATION OF HIV-1
2170, 3kdmL, 0.6447, 3.03, 0.054, 216, 93, CRYSTAL STRUCTURE OF HUMAN ANTI-STEROID FAB 5F2 IN COMPLEX WITH TESTOSTERONE
2171, 1fskH, 0.6447, 3.12, 0.053, 214, 94, COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1
2172, 1fskE, 0.6447, 3.12, 0.053, 214, 94, COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1
2173, 1fskB, 0.6447, 3.12, 0.053, 214, 94, COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1
2174, 6obzL, 0.6446, 2.95, 0.055, 213, 91, CRYSTAL STRUCTURE OF FLUA-20 FAB 
2175, 6njnN, 0.6446, 3.01, 0.044, 211, 91, STRUCTURE OF A COMPLEX 
2176, 6id4L, 0.6446, 2.68, 0.090, 216, 89, COMPLEX OF HLA-A*11:01 BINDING TO ALLOANTIBODY 2E3 
2177, 6ccbL, 0.6446, 2.90, 0.087, 211, 92, CRYSTAL STRUCTURE OF 253-11 SOSIP TRIMER IN COMPLEX WITH 10-1074 FAB
2178, 5xlia, 0.6446, 2.80, 0.055, 213, 91, STRUCTURE OF ANTI-ANGIOTENSIN II TYPE2 RECEPTOR ANTIBODY (D5711-4A03) 
2179, 5u5fA, 0.6446, 3.04, 0.054, 214, 93, MEDITOPE ENABLED TRASTUZUMAB I83E VARIANT IN COMPLEX WITH (AC) CQFDA(PH)2STRRLRCGGSK
2180, 5t78A, 0.6446, 2.96, 0.055, 216, 91, CRYSTAL STRUCTURE OF THERAPEUTIC MAB AR20.5 IN COMPLEX WITH MUC1 PEPTIDE
2181, 5jw4V, 0.6446, 2.98, 0.054, 206, 92, STRUCTURE OF MEDI8852 FAB FRAGMENT IN COMPLEX WITH H5 HA
2182, 5djxD, 0.6446, 2.93, 0.053, 208, 95, FC HETERODIMER DESIGN 2.9 L368M/K370E + E357A/S364G
2183, 5c0sL, 0.6446, 2.83, 0.088, 212, 91, CRYSTAL STRUCTURE OF A GENERATION 4 INFLUENZA HEMAGGLUTININ STABILIZED STEM IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODY CR6261
2184, 4r9yL, 0.6446, 2.95, 0.054, 214, 93, CRYSTAL STRUCTURE OF KKOFAB IN COMPLEX WITH PLATELET FACTOR 4
2185, 4m6oL, 0.6446, 2.81, 0.055, 214, 91, CRYSTAL STRUCTURE OF ANTI-NGF ANTIBODY CNTO7309
2186, 4jkmB, 0.6446, 2.63, 0.056, 602, 89, CRYSTAL STRUCTURE OF CLOSTRIDIUM PERFRINGENS BETA-GLUCURONIDASE
2187, 3uajD, 0.6446, 3.10, 0.054, 214, 93, CRYSTAL STRUCTURE OF THE ENVELOPE GLYCOPROTEIN ECTODOMAIN FROM DENGUE VIRUS SEROTYPE 4 IN COMPLEX WITH THE FAB FRAGMENT OF THE CHIMPANZEE MONOCLONAL ANTIBODY 5H2
2188, 3t77A, 0.6446, 2.84, 0.054, 219, 92, S25-2- A(2-4)KDO DISACCHARIDE COMPLEX
2189, 3mmeB, 0.6446, 2.80, 0.089, 211, 90, STRUCTURE AND FUNCTIONAL DISSECTION OF PG16 AN ANTIBODY WITH BROAD AND POTENT NEUTRALIZATION OF HIV-1
2190, 3ks0L, 0.6446, 2.76, 0.056, 212, 90, CRYSTAL STRUCTURE OF THE HEME DOMAIN OF FLAVOCYTOCHROME B2 IN COMPLEX WITH FAB B2B4
2191, 1om3M, 0.6446, 2.95, 0.054, 212, 92, FAB 2G12 UNLIGANDED
2192, 1ngxA, 0.6446, 2.83, 0.055, 213, 91, CHIMERIC GERMLINE FAB 7G12 WITH JEFFAMINE FRAGMENT BOUND
2193, 1mchA, 0.6446, 2.88, 0.065, 216, 92, PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
2194, 1clyL, 0.6446, 2.93, 0.054, 217, 92, IGG FAB (HUMAN IGG1 KAPPA) CHIMERIC FRAGMENT (CBR96) COMPLEXED WITH LEWIS Y NONOATE METHYL ESTER
2195, 6nz7L, 0.6445, 2.92, 0.044, 214, 91, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 429 B01 IN COMPLEX WITH HEMAGGLUTININ HONG KONG 1968 
2196, 6ncpB, 0.6445, 2.95, 0.055, 212, 91, CRYSTAL STRUCTURE OF HIV-1 BROADLY NEUTRALIZING ANTIBODY ACS202 
2197, 6c6zD, 0.6445, 2.93, 0.056, 215, 90, CRYSTAL STRUCTURE OF POTENT NEUTRALIZING ANTIBODY CDC2-C2 IN COMPLEX WITH MERS-COV S1 RBD
2198, 5w06L, 0.6445, 2.96, 0.054, 219, 92, HUMAN TISSUE FACTOR IN COMPLEX WITH ANTIBODY M1587
2199, 5th2C, 0.6445, 2.97, 0.065, 213, 92, CETUXIMAB FAB IN COMPLEX WITH L5Q MEDITOPE VARIANT
2200, 5t3sL, 0.6445, 2.79, 0.089, 210, 90, HIV GP140 TRIMER MD39-10MUTA IN COMPLEX WITH FABS PGT124 AND 35022
2201, 5nivA, 0.6445, 2.79, 0.055, 212, 91, CRYSTAL STRUCTURE OF 5D3 FAB
2202, 5mvjB, 0.6445, 2.95, 0.043, 218, 92, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACE-GROUP P1 
2203, 5jueL, 0.6445, 3.06, 0.054, 220, 93, CRYSTAL STRUCTURE OF UIC2 FAB
2204, 5girL, 0.6445, 2.97, 0.054, 212, 92, CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH ITS LIGAND PEPTIDE
2205, 4xnyL, 0.6445, 3.12, 0.054, 211, 93, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC08C IN COMPLEX WITH HIV-1 CLADE A STRAIN Q842.D12 GP120
2206, 4qxgL, 0.6445, 2.96, 0.054, 214, 92, ANTIGEN BINDING FRAGMENT OF AN ANTI IFNAR1 ANTIBODY
2207, 4liqL, 0.6445, 3.02, 0.054, 213, 93, STRUCTURE OF THE EXTRACELLULAR DOMAIN OF HUMAN CSF-1 RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF RG7155
2208, 4dvbL, 0.6445, 2.95, 0.054, 215, 92, THE CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF PRO-UPA ANTIBODY MAB-112
2209, 4cdhA, 0.6445, 2.83, 0.043, 206, 92, CRYSTALLOGRAPHIC STRUCTURE OF THE HUMAN IGG1 ALPHA 2-6 SIALILATED FC-FRAGMENT
2210, 3ngbC, 0.6445, 2.91, 0.055, 210, 91, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC01 IN COMPLEX WITH HIV-1 GP120
2211, 3mugI, 0.6445, 2.81, 0.089, 212, 90, CRYSTAL STRUCTURE OF HUMAN FAB PG16 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
2212, 3lrsL, 0.6445, 2.77, 0.089, 211, 90, STRUCTURE OF PG16 AN ANTIBODY WITH BROAD AND POTENT NEUTRALIZATION OF HIV-1
2213, 3l5xL, 0.6445, 3.02, 0.054, 214, 93, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN IL-13 AND H2L6 FAB
2214, 3k4dA, 0.6445, 2.88, 0.045, 596, 89, CRYSTAL STRUCTURE OF E. COLI BETA-GLUCURONIDASE WITH THE GLUCARO-D- LACTAM INHIBITOR BOUND
2215, 2ymxL, 0.6445, 3.02, 0.043, 213, 92, CRYSTAL STRUCTURE OF INHIBITORY ANTI-ACHE FAB408
2216, 2agjL, 0.6445, 3.20, 0.064, 215, 94, CRYSTAL STRUCTURE OF A GLYCOSYLATED FAB FROM AN IGM CRYOGLOBULIN WITH PROPERTIES OF A NATURAL PROTEOLYTIC ANTIBODY
2217, 1uywN, 0.6445, 3.16, 0.065, 211, 92, CRYSTAL STRUCTURE OF THE ANTIFLAVIVIRUS FAB4G2
2218, 1uwgL, 0.6445, 2.96, 0.054, 213, 92, MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9
2219, 1u8lA, 0.6445, 3.03, 0.065, 214, 93, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE DLDRWAS
2220, 1u8iA, 0.6445, 3.03, 0.065, 214, 93, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKWAN
2221, 1lo3L, 0.6445, 2.97, 0.054, 219, 92, RETRO-DIELS-ALDERASE CATALYTIC ANTIBODY: PRODUCT ANALOGUE
2222, 1lo2X, 0.6445, 3.12, 0.053, 219, 94, RETRO-DIELS-ALDERASE CATALYTIC ANTIBODY
2223, 6h0eL, 0.6444, 2.89, 0.055, 218, 91, FAB DMCBTAU-22.1 IN COMPLEX WITH TAU PEPTIDE V1088-23 
2224, 6h06D, 0.6444, 2.89, 0.056, 217, 90, FAB CBTAU-22.1 IN COMPLEX WITH TAU PEPTIDE V1088-5 
2225, 6e4zL, 0.6444, 2.99, 0.054, 218, 92, ANTI-PCSK9 FAB 6E2 BOUND TO THE MODIFIED N-TERMINAL PEPTIDE FROM PCSK9 
2226, 6db7L, 0.6444, 2.79, 0.089, 211, 90, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 1334 IN COMPLEX WITH A HIV-1 GP120 V3 PEPTIDE FROM MN STRAIN 
2227, 6cxgK, 0.6444, 2.99, 0.054, 213, 92, ANTI-HIV-1 FAB 2G12 IN COMPLEX WITH GLYCOPEPTIDE 10V1S 
2228, 6aniM, 0.6444, 2.92, 0.056, 209, 90, COLTUXIMAB FAB IN COMPLEX WITH ANTI-KAPPA VHH DOMAIN
2229, 5ur8B, 0.6444, 3.11, 0.053, 215, 94, HUMAN ANTIBODY FRAGMENT (FAB) TO MENINGOCOCCAL FACTOR H BINDING PROTEIN
2230, 5ukpL, 0.6444, 2.73, 0.079, 210, 89, STRUCTURE OF UNLIGANDED ANTI-GP120 CD4BS ANTIBODY DH522.1 FAB
2231, 5ubyL, 0.6444, 2.80, 0.089, 211, 90, FAB STRUCTURE OF ANTI-HIV-1 GP120 MAB 1A8
2232, 5u4rB, 0.6444, 2.88, 0.056, 212, 90, CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING INFLUENZA A ANTIBODY VRC 315 53-1A09 FAB.
2233, 5u3dA, 0.6444, 3.03, 0.054, 214, 93, STRUCTURE OF MEDITOPE ENABLED TRASTUZUMAB I83E VARIANT
2234, 5k9qY, 0.6444, 3.02, 0.054, 214, 93, CRYSTAL STRUCTURE OF MULTIDONOR HV1-18-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 16.A.26 IN COMPLEX WITH A/HONG KONG/1-4-MA21- 1/1968 (H3N2) HEMAGGLUTININ
2235, 5k9qV, 0.6444, 2.87, 0.054, 214, 92, CRYSTAL STRUCTURE OF MULTIDONOR HV1-18-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 16.A.26 IN COMPLEX WITH A/HONG KONG/1-4-MA21- 1/1968 (H3N2) HEMAGGLUTININ
2236, 5jr1L, 0.6444, 2.83, 0.089, 211, 90, CRYSTAL STRUCTURE OF 10E8 GHV-MATUREL ANTIGEN-BINDING FRAGMENT.
2237, 5ifjB, 0.6444, 2.70, 0.090, 213, 89, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E01 FAB FRAGMENT IN COMPLEX OF PEPTIDE PLQPEQPFP
2238, 5iblL, 0.6444, 3.13, 0.054, 215, 93, HUMAN ANTIBODY 6639 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ H1 X-181
2239, 5g64B, 0.6444, 2.86, 0.085, 306, 94, THE COMPLEX BETWEEN HUMAN IGE-FC AND TWO ANTI-IGE FAB FRAGMENTS
2240, 5eszB, 0.6444, 2.99, 0.054, 211, 92, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH04 ISOLATED FROM DONOR CH0219 IN COMPLEX WITH SCAFFOLDED TRIMERIC HIV-1 ENV V1V2 DOMAIN FROM THE CLADE AE STRAIN A244
2241, 5e8dL, 0.6444, 2.89, 0.054, 210, 92, CRYSTAL STRUCTURE OF HUMAN EPIREGULIN IN COMPLEX WITH THE FAB FRAGMENT OF MURINE MONOCLONAL ANTIBODY 9E5
2242, 5b3jL, 0.6444, 3.16, 0.054, 212, 93, ACTIVATION OF NMDA RECEPTORS AND THE MECHANISM OF INHIBITION BY IFENPRODIL
2243, 5adpL, 0.6444, 3.07, 0.053, 217, 94, CRYSTAL STRUCTURE OF THE A.17 ANTIBODY FAB FRAGMENT - LIGHT CHAIN S35R MUTANT
2244, 4wcyL, 0.6444, 3.04, 0.054, 217, 93, FAB FRAGMENT OF MOUSE AZ130 MONOCLONAL ANTIBODY
2245, 4tscL, 0.6444, 2.78, 0.089, 214, 90, STRUCTURE OF A LYSOZYME ANTIBODY COMPLEX
2246, 4qnpF, 0.6444, 2.89, 0.054, 212, 92, CRYSTAL STRUCTURE OF THE 2009 PANDEMIC H1N1 INFLUENZA VIRUS NEURAMINIDASE WITH A NEUTRALIZING ANTIBODY
2247, 4lkcA, 0.6444, 2.75, 0.056, 213, 90, AN ANTIBODY AGAINST THE C-TERMINAL DOMAIN OF PCSK9 LOWERS LDL CHOLESTEROL LEVELS IN VIVO
2248, 4kvcL, 0.6444, 2.90, 0.055, 212, 91, 2H2 FAB FRAGMENT OF IMMATURE DENGUE VIRUS
2249, 4jfxL, 0.6444, 2.81, 0.055, 214, 91, STRUCTURE OF PHOSPHOTYROSINE (PTYR) SCAFFOLD BOUND TO PTYR PEPTIDE
2250, 3qo1A, 0.6444, 3.13, 0.054, 219, 93, MONOCLINIC FORM OF IGG1 FAB FRAGMENT (APO FORM) SHARING SAME FV AS IGA
2251, 2vxuM, 0.6444, 3.12, 0.053, 214, 94, CRYSTAL STRUCTURE OF MURINE REFERENCE ANTIBODY 125-2H FAB FRAGMENT
2252, 1n64L, 0.6444, 3.15, 0.053, 220, 94, CRYSTAL STRUCTURE ANALYSIS OF THE IMMUNODOMINANT ANTIGENIC SITE ON HEPATITIS C VIRUS PROTEIN BOUND TO MAB 19D9D6
2253, 1mcnA, 0.6444, 2.83, 0.065, 216, 92, PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
2254, 1bjmB, 0.6444, 2.93, 0.054, 215, 93, LOC NAKS A LAMBDA 1 TYPE LIGHT-CHAIN DIMER (BENCE-JONES PROTEIN) CRYSTALLIZED IN NAKSO4
2255, 6mnfK, 0.6443, 2.98, 0.054, 213, 92, ANTI-HIV-1 FAB 2G12 + MAN8 RE-REFINEMENT 
2256, 6mi2B, 0.6443, 2.69, 0.090, 210, 89, STRUCTURE OF THE HUMAN 4-1BB / UTOMILUMAB FAB COMPLEX 
2257, 6k7oL, 0.6443, 3.01, 0.054, 218, 93, COMPLEX STRUCTURE OF LILRB4 AND H128-3 ANTIBODY 
2258, 6bkbL, 0.6443, 2.88, 0.056, 211, 90, STRUCTURE OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 CORE FROM GENOTYPE 6A BOUND TO BROADLY NEUTRALIZING ANTIBODY AR3A 
2259, 6bahA, 0.6443, 3.08, 0.054, 214, 93, TRASTUZUMAB FAB V3 WITH 5-DIPHENYL MEDITOPE VARIANT 
2260, 6b5rL, 0.6443, 2.68, 0.067, 212, 89, STRUCTURE OF PFCSP PEPTIDE 21 WITH HUMAN ANTIBODY CIS42
2261, 6b0nL, 0.6443, 2.78, 0.089, 210, 90, CRYSTAL STRUCTURE OF THE CLEAVAGE-INDEPENDENT PREFUSION HIV ENV GLYCOPROTEIN TRIMER OF THE CLADE A BG505 ISOLATE (NFL CONSTRUCT) IN COMPLEX WITH FABS PGT122 AND PGV19 AT 3.39 A 
2262, 6ammL, 0.6443, 2.98, 0.054, 215, 92, CAT192 FAB INSERTION MUTANT H0/L1
2263, 5ziaP, 0.6443, 2.88, 0.067, 217, 90, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-24.1 IN COMPLEX WITH ITS PHOSPHORYLATED TAU PEPTIDE 
2264, 5vzxI, 0.6443, 2.88, 0.054, 219, 92, CRYSTAL STRUCTURE OF CRENEZUMAB FAB
2265, 5th9L, 0.6443, 2.97, 0.054, 214, 92, STRUCTURE DETERMINATION OF A POTENT SELECTIVE ANTIBODY INHIBITOR OF HUMAN MMP9 (GS-5745 BOUND TO MMP-9)
2266, 5n2kE, 0.6443, 2.77, 0.089, 214, 90, STRUCTURE OF UNBOUND BRIAKINUMAB FAB
2267, 5mu0J, 0.6443, 2.77, 0.055, 217, 91, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (IA03)
2268, 5m76A, 0.6443, 2.81, 0.078, 211, 90, CRYSTAL STRUCTURE OF CARDIOTOXIC BENCE-JONES LIGHT CHAIN DIMER H10
2269, 5kzpJ, 0.6443, 2.92, 0.055, 212, 91, STRUCTURE OF THE HCV1-C1 ANTIBODY-ANTIGEN COMPLEX
2270, 5k59L, 0.6443, 2.94, 0.055, 212, 91, CRYSTAL STRUCTURE OF LUKGH FROM STAPHYLOCOCCUS AUREUS IN COMPLEX WITH A NEUTRALISING ANTIBODY
2271, 5ifjE, 0.6443, 2.70, 0.090, 213, 89, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E01 FAB FRAGMENT IN COMPLEX OF PEPTIDE PLQPEQPFP
2272, 5e94C, 0.6443, 3.00, 0.065, 214, 93, ANTIBODY-BOUND GLUCAGON-LIKE PEPTIDE-1 RECEPTOR EXTRACELLULAR DOMAIN
2273, 5cexA, 0.6443, 2.80, 0.089, 207, 90, CRYSTAL STRUCTURE OF FAB 32H+109L A PUTATIVE PRECURSOR OF THE PGT121 FAMILY OF POTENT HIV-1 ANTIBODIES
2274, 5b6fC, 0.6443, 3.16, 0.065, 217, 93, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF AN ANTI-LEUKOTRIENE C4 MONOCLONAL ANTIBODY COMPLEXED WITH LTC4
2275, 4r7dJ, 0.6443, 2.71, 0.056, 212, 89, FAB HU 15C1
2276, 4qhkJ, 0.6443, 2.75, 0.067, 209, 90, UCA (UNBOUND) FROM CH103 LINEAGE
2277, 4nm4M, 0.6443, 2.99, 0.054, 219, 92, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR8043
2278, 4llyB, 0.6443, 2.69, 0.067, 209, 89, CRYSTAL STRUCTURE OF PERTUZUMAB CLAMBDA FAB WITH VARIABLE AND CONSTANT DOMAIN REDESIGNS (VRD2 AND CRD2) AT 1.6A
2279, 4lf3A, 0.6443, 3.02, 0.054, 214, 93, INHIBITORY MECHANISM OF AN ALLOSTERIC ANTIBODY TARGETING THE GLUCAGON RECEPTOR
2280, 4kxzI, 0.6443, 2.97, 0.055, 212, 91, CRYSTAL STRUCTURE OF TGFB2 IN COMPLEX WITH GC2008.
2281, 4jvuA, 0.6443, 2.95, 0.033, 110, 92, IGM C2-DOMAIN FROM MOUSE
2282, 4jamL, 0.6443, 2.77, 0.078, 206, 90, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY CH103
2283, 3ulvC, 0.6443, 2.92, 0.088, 210, 91, STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM2)
2284, 3l95L, 0.6443, 3.07, 0.076, 212, 92, CRYSTAL STRUCTURE OF THE HUMAN NOTCH1 NEGATIVE REGULATORY REGION (NRR) BOUND TO THE FAB FRAGMENT OF AN ANTAGONIST ANTIBODY
2285, 2oqjD, 0.6443, 2.92, 0.056, 211, 90, CRYSTAL STRUCTURE ANALYSIS OF FAB 2G12 IN COMPLEX WITH PEPTIDE 2G12.1
2286, 1zvoB, 0.6443, 2.98, 0.054, 214, 93, SEMI-EXTENDED SOLUTION STRUCTURE OF HUMAN MYELOMA IMMUNOGLOBULIN D DETERMINED BY CONSTRAINED X-RAY SCATTERING
2287, 1zvoA, 0.6443, 2.98, 0.054, 214, 93, SEMI-EXTENDED SOLUTION STRUCTURE OF HUMAN MYELOMA IMMUNOGLOBULIN D DETERMINED BY CONSTRAINED X-RAY SCATTERING
2288, 1u95A, 0.6443, 3.03, 0.065, 214, 93, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDHWAS
2289, 1u92A, 0.6443, 3.03, 0.065, 214, 93, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ANALOG E-[DAP]- DKWQS (CYCLIC)
2290, 1u91A, 0.6443, 3.03, 0.065, 214, 93, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ANALOG ENDKW- [DAP]-S (CYCLIC)
2291, 1u8hA, 0.6443, 3.03, 0.065, 214, 93, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ALDKWAS
2292, 1u6aL, 0.6443, 2.98, 0.054, 214, 92, CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV FAB F105
2293, 1hq4A, 0.6443, 3.16, 0.053, 215, 94, STRUCTURE OF NATIVE CATALYTIC ANTIBODY HA5-19A4
2294, 1a5fL, 0.6443, 2.99, 0.043, 220, 93, FAB FRAGMENT OF A MONOCLONAL ANTI-E-SELECTIN ANTIBODY
2295, 6fxnR, 0.6442, 2.69, 0.090, 209, 89, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
2296, 6dcvL, 0.6442, 2.99, 0.054, 220, 93, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-27.1 
2297, 5whjL, 0.6442, 2.72, 0.090, 211, 89, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-FCRN ANTIBODY DX-2507
2298, 5t78C, 0.6442, 2.97, 0.055, 216, 91, CRYSTAL STRUCTURE OF THERAPEUTIC MAB AR20.5 IN COMPLEX WITH MUC1 PEPTIDE
2299, 5mp3B, 0.6442, 3.04, 0.054, 218, 93, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 30-MER TAU PEPTIDE AT PH 6.5 
2300, 5jo5B, 0.6442, 2.83, 0.088, 212, 91, CRYSTAL STRUCTURE OF 10E8 GHV-GLV ANTIGEN-BINDING FRAGMENT.
2301, 5id1A, 0.6442, 2.97, 0.066, 212, 91, CETUXIMAB FAB IN COMPLEX WITH MPT-CYS MEDITOPE
2302, 5d72N, 0.6442, 2.70, 0.079, 201, 89, CRYSTAL STRUCTURE OF MOR04252 A NEUTRALIZING ANTI-HUMAN GM-CSF ANTIBODY FAB FRAGMENT IN COMPLEX WITH HUMAN GM-CSF
2303, 5a3iH, 0.6442, 2.78, 0.056, 218, 90, CRYSTAL STRUCTURE OF A COMPLEX FORMED BETWEEN FLD194 FAB AND TRANSMISSIBLE MUTANT H5 HAEMAGGLUTININ
2304, 4qthL, 0.6442, 3.14, 0.053, 214, 94, CRYSTAL STRUCTURE OF ANTI-UPAR FAB 8B12
2305, 4qhuL, 0.6442, 2.75, 0.089, 209, 90, CRYSTAL STRUCTURE OF IL-17A/FAB6785 COMPLEX
2306, 3qo0A, 0.6442, 3.11, 0.054, 219, 93, MONOCLINIC FORM OF IGG1 FAB FRAGMENT (IN COMPLEX WITH ANTIGENIC PEPTIDE) SHARING SAME FV AS IGA
2307, 3qnxA, 0.6442, 3.11, 0.065, 219, 93, ORTHORHOMBIC FORM OF HUMAN IGA1 FAB FRAGMENT SHARING SAME FV AS IGG
2308, 3qcvM, 0.6442, 2.99, 0.054, 218, 92, CRYSTAL STRUCTURE OF THE LT3015 ANTIBODY FAB FRAGMENT IN COMPLEX WITH LYSOPHOSPHATIDIC ACID (18:2)
2309, 3o41B, 0.6442, 3.04, 0.054, 217, 93, CRYSTAL STRUCTURE OF 101F FAB BOUND TO 15-MER PEPTIDE EPITOPE
2310, 2wahA, 0.6442, 2.82, 0.043, 207, 92, CRYSTAL STRUCTURE OF AN IGG1 FC GLYCOFORM (MAN9GLCNAC2)
2311, 2j4wL, 0.6442, 3.15, 0.053, 212, 94, STRUCTURE OF A PLASMODIUM VIVAX APICAL MEMBRANE ANTIGEN 1- FAB F8.12.19 COMPLEX
2312, 1u93A, 0.6442, 3.03, 0.065, 214, 93, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ANALOG EQDKW- [DAP]-S (CYCLIC)
2313, 1u8oA, 0.6442, 3.03, 0.065, 214, 93, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKHAS
2314, 1iaiL, 0.6442, 2.95, 0.043, 214, 93, IDIOTYPE-ANTI-IDIOTYPE FAB COMPLEX
2315, 1hklL, 0.6442, 3.00, 0.054, 214, 93, FREE AND LIGANDED FORM OF AN ESTEROLYTIC CATALYTIC ANTIBODY
2316, 6mu8L, 0.6441, 2.74, 0.067, 211, 90, CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-386150 IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.5 ANGSTROM 
2317, 6mejB, 0.6441, 2.71, 0.090, 212, 89, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
2318, 6f2zB, 0.6441, 2.87, 0.053, 208, 94, STRUCTURE OF A FC MUTATNT 
2319, 6db8L, 0.6441, 2.77, 0.056, 212, 90, STRUCTURAL BASIS FOR PROMISCUOUS BINDING AND ACTIVATION OF FLUOROGENIC DYES BY DIR2S RNA APTAMER 
2320, 6axlC, 0.6441, 2.84, 0.055, 213, 91, CRYSTAL STRUCTURE OF FAB317 COMPLEX
2321, 5x2qK, 0.6441, 2.91, 0.055, 216, 91, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH GLYCINE
2322, 5x2pK, 0.6441, 2.92, 0.055, 216, 91, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-GLUTAMATE
2323, 5x0tD, 0.6441, 2.94, 0.054, 213, 92, CRYSTAL STRUCTURE OF CD147 C2 DOMAIN IN COMPLEX WITH FAB OF ITS MONOCLONAL ANTIBODY 6H8
2324, 5w0dC, 0.6441, 2.76, 0.089, 202, 90, INFERRED PRECURSOR (UCA) OF THE HUMAN ANTIBODY LINEAGE K03.12 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ H1 SOLOMON ISLANDS/03/2006
2325, 5vk2L, 0.6441, 2.67, 0.090, 212, 89, STRUCTURAL BASIS FOR ANTIBODY-MEDIATED NEUTRALIZATION OF LASSA VIRUS
2326, 5tdoC, 0.6441, 3.18, 0.064, 213, 94, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-HER2 ANTIBODY 4D5 WITH REDESIGNED HEAVY AND LIGHT CHAIN INTERFACES
2327, 5i6zC, 0.6441, 2.93, 0.043, 214, 93, X-RAY STRUCTURE OF THE TS2 HUMAN SEROTONIN TRANSPORTER
2328, 5h35I, 0.6441, 3.03, 0.043, 217, 92, CRYSTAL STRUCTURES OF THE TRIC TRIMERIC INTRACELLULAR CATION CHANNEL ORTHOLOGUE FROM SULFOLOBUS SOLFATARICUS
2329, 5dlmM, 0.6441, 2.93, 0.055, 217, 91, COMPLEX OF INFLUENZA M2E AND ANTIBODY
2330, 5cp7G, 0.6441, 2.78, 0.033, 218, 91, CRYSTAL STRUCTURE OF AN ANTIGEN-BINDING FRAGMENT OF MONOCLONAL ANTIBODY AGAINST SULFONAMIDES
2331, 5bjzH, 0.6441, 2.98, 0.054, 213, 92, CRYSTAL STRUCTURE OF MALTOSE BINDING PROTEIN IN COMPLEX WITH AN ALLOSTERIC SYNTHETIC ANTIBODY
2332, 4xwoL, 0.6441, 3.02, 0.054, 215, 93, STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF SEC22
2333, 4rrpC, 0.6441, 2.88, 0.056, 212, 90, CRYSTAL STRUCTURE OF THE FAB COMPLEXED WITH ANTIGEN ASF1P NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET PDR16
2334, 4ocwL, 0.6441, 2.76, 0.056, 211, 90, CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.06 A POTENT V1V2-DIRECTED HIV-1 NEUTRALIZING ANTIBODY
2335, 4ebqL, 0.6441, 3.09, 0.065, 211, 93, FAB STRUCTURE OF ANTI-VACCINIA VIRUS D8L ANTIGEN MOUSE IGG2A LA5
2336, 3so3B, 0.6441, 2.98, 0.054, 216, 92, STRUCTURES OF FAB-PROTEASE COMPLEXES REVEAL A HIGHLY SPECIFIC NON- CANONICAL MECHANISM OF INHIBITION.
2337, 3qrgL, 0.6441, 2.91, 0.055, 217, 91, CRYSTAL STRUCTURE OF ANTIRSVF FAB B21M
2338, 3opzM, 0.6441, 3.01, 0.043, 212, 92, CRYSTAL STRUCTURE OF TRANS-SIALIDASE IN COMPLEX WITH THE FAB FRAGMENT OF A NEUTRALIZING MONOCLONAL IGG ANTIBODY
2339, 3mmeD, 0.6441, 2.84, 0.089, 211, 90, STRUCTURE AND FUNCTIONAL DISSECTION OF PG16 AN ANTIBODY WITH BROAD AND POTENT NEUTRALIZATION OF HIV-1
2340, 3lqaL, 0.6441, 2.74, 0.078, 213, 90, CRYSTAL STRUCTURE OF CLADE C GP120 IN COMPLEX WITH SCD4 AND 21C FAB
2341, 3idgA, 0.6441, 3.03, 0.065, 214, 93, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ALDKWD
2342, 3hi6L, 0.6441, 2.90, 0.067, 210, 90, CRYSTAL STRUCTURE OF INTERMEDIATE AFFINITY I DOMAIN OF INTEGRIN LFA-1 WITH THE FAB FRAGMENT OF ITS ANTIBODY AL-57
2343, 3g5xA, 0.6441, 2.98, 0.043, 214, 93, ANTIBODIES SPECIFICALLY TARGETING A LOCALLY MISFOLDED REGION OF TUMOR ASSOCIATED EGFR
2344, 3dvgA, 0.6441, 2.90, 0.056, 210, 90, CRYSTAL STRUCTURE OF K63-SPECIFIC FAB APU.3A8 BOUND TO K63-LINKED DI- UBIQUITIN
2345, 3bdyL, 0.6441, 2.98, 0.054, 217, 92, DUAL SPECIFIC BH1 FAB IN COMPLEX WITH VEGF
2346, 1u8nA, 0.6441, 3.03, 0.065, 214, 93, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKFAS
2347, 1h3yB, 0.6441, 2.84, 0.043, 206, 92, CRYSTAL STRUCTURE OF A HUMAN IGG1 FC-FRAGMENTHIGH SALT CONDITION
2348, 1b2wL, 0.6441, 2.87, 0.054, 214, 92, COMPARISON OF THE THREE-DIMENSIONAL STRUCTURES OF A HUMANIZED AND A CHIMERIC FAB OF AN ANTI-GAMMA-INTERFERON ANTIBODY
2349, 6rcvG, 0.6440, 2.80, 0.089, 210, 90, PFRH5 BOUND TO MONOCLONAL ANTIBODIES R5.011 AND R5.016 
2350, 6mg4B, 0.6440, 2.84, 0.054, 215, 92, STRUCTURE OF FULL-LENGTH HUMAN LAMBDA-6A LIGHT CHAIN JTO 
2351, 6erxR, 0.6440, 2.70, 0.090, 209, 89, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
2352, 6cjkA, 0.6440, 2.87, 0.066, 216, 91, ANTI HIV FAB 10A 
2353, 6bqbL, 0.6440, 2.96, 0.054, 219, 92, MGG4 FAB IN COMPLEX WITH PEPTIDE
2354, 6bf4L, 0.6440, 2.97, 0.054, 218, 92, CRYSTAL STRUCTURE OF HIV-1 CLADE AE STRAIN CNE55 GP120 CORE IN COMPLEX WITH NEUTRALIZING ANTIBODY VRC-PG05 THAT TARGETS THE CENTER OF THE SILENT FACE ON THE OUTER DOMAIN OF GP120
2355, 6azlA, 0.6440, 2.74, 0.056, 212, 89, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N- CARBOXYETHYLARGININE MEDITOPE VARIANT
2356, 5x2oK, 0.6440, 2.92, 0.055, 216, 91, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-ARGININE
2357, 5wcaL, 0.6440, 2.69, 0.056, 211, 90, CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING INFLUENZA A ANTIBODY VRC 315 27-1C08 FAB.
2358, 5wb9L, 0.6440, 2.97, 0.066, 200, 91, CRYSTAL STRUCTURE OF CD4 BINDING SITE ANTIBODY N60P23 IN COMPLEX WITH HIV-1 CLADE A/E STRAIN 93TH057 GP120 CORE 
2359, 5i76A, 0.6440, 2.96, 0.054, 213, 92, CRYSTAL STRUCTURE OF FM318 A RECOMBINANT FAB ADOPTED FROM CETUXIMAB
2360, 5esvD, 0.6440, 2.85, 0.055, 214, 91, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH03 ISOLATED FROM DONOR CH0219 IN COMPLEX WITH SCAFFOLDED TRIMERIC HIV-1 ENV V1V2 DOMAIN FROM THE CLADE C SUPERINFECTING STRAIN OF DONOR CAP256.
2361, 4odwB, 0.6440, 2.78, 0.033, 214, 91, UNLIGANDED FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY A6
2362, 4ma1C, 0.6440, 3.12, 0.053, 219, 94, UNLIGANDED 3 CRYSTAL STRUCTURE OF S25-26 FAB
2363, 3wihM, 0.6440, 2.90, 0.043, 213, 92, CRYSTAL STRUCTURE OF THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1 IN COMPLEX WITH THE FAB FRAGMENT OF MURINE MONOCLONAL ANTIBODY B2212A.
2364, 3tnnB, 0.6440, 2.75, 0.089, 212, 90, CRYSTAL STRUCTURE OF N5-I5 FAB AN ADCC MEDIATING AND NON-NEUTRALIZING CD4I ANTI-HIV- 1 ANTIBODY.
2365, 3moaL, 0.6440, 3.05, 0.054, 213, 93, CRYSTAL STRUCTURE OF THE NEUTRALIZING HIV ANTIBODY 2F5 FAB FRAGMENT (RECOMBINANTLY PRODUCED FAB) WITH 17 AA GP41 MPER-DERIVED PEPTIDE
2366, 2b1aL, 0.6440, 2.77, 0.089, 215, 90, CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 V3 FAB 2219 IN COMPLEX WITH UG1033 PEPTIDE
2367, 1y0lA, 0.6440, 3.01, 0.054, 216, 93, CATALYTIC ELIMINATION ANTIBODY 34E4 IN COMPLEX WITH HAPTEN
2368, 1v7mM, 0.6440, 2.95, 0.054, 212, 93, HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB
2369, 1nsnL, 0.6440, 2.90, 0.043, 217, 92, THE CRYSTAL STRUCTURE OF ANTIBODY N10-STAPHYLOCOCCAL NUCLEASE COMPLEX AT 2.9 ANGSTROMS RESOLUTION
2370, 1l7tL, 0.6440, 2.95, 0.054, 219, 93, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-TESTOSTERONE FAB FRAGMENT
2371, 1hq4C, 0.6440, 2.94, 0.054, 215, 92, STRUCTURE OF NATIVE CATALYTIC ANTIBODY HA5-19A4
2372, 1c5cL, 0.6440, 3.02, 0.065, 214, 93, DECARBOXYLASE CATALYTIC ANTIBODY 21D8-HAPTEN COMPLEX
2373, 6njlM, 0.6439, 3.00, 0.044, 211, 91, STRUCTURE OF A COMPLEX 
2374, 6iqgB, 0.6439, 2.87, 0.053, 207, 95, X-RAY CRYSTAL STRUCTURE OF FC AND PEPTIDE COMPLEX 
2375, 5ziaE, 0.6439, 3.12, 0.076, 218, 92, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-24.1 IN COMPLEX WITH ITS PHOSPHORYLATED TAU PEPTIDE 
2376, 5wnaL, 0.6439, 2.92, 0.056, 211, 90, STRUCTURE OF ANTIBODY 3D3 BOUND TO THE CENTRAL CONSERVED REGION OF RSV 2 G
2377, 5nb5L, 0.6439, 3.04, 0.054, 218, 93, PRINCIPLES FOR COMPUTATIONAL DESIGN OF ANTIBODIES
2378, 5jw4X, 0.6439, 2.99, 0.054, 206, 92, STRUCTURE OF MEDI8852 FAB FRAGMENT IN COMPLEX WITH H5 HA
2379, 5jw4P, 0.6439, 2.99, 0.054, 206, 92, STRUCTURE OF MEDI8852 FAB FRAGMENT IN COMPLEX WITH H5 HA
2380, 5iblD, 0.6439, 3.13, 0.054, 215, 93, HUMAN ANTIBODY 6639 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ H1 X-181
2381, 5drxL, 0.6439, 2.90, 0.055, 221, 91, CRYSTAL STRUCTURE OF THE BCR FAB FRAGMENT FROM SUBSET  4 CASE CLL240
2382, 5d1zE, 0.6439, 2.97, 0.055, 213, 91, ISDB NEAT1 BOUND BY CLONE D4-10
2383, 4nrxL, 0.6439, 3.00, 0.054, 213, 92, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66 IN COMPLEX WITH GP41 MPER PEPTIDE
2384, 4ij3B, 0.6439, 3.13, 0.053, 214, 94, OXIDOREDUCTASE FRAGMENT OF HUMAN QSOX1 IN COMPLEX WITH A FAB FRAGMENT FROM AN ANTI- HUMAN QSOX1 ANTIBODY
2385, 4fqrb, 0.6439, 3.13, 0.065, 213, 93, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
2386, 4dw2L, 0.6439, 2.77, 0.044, 214, 91, THE CRYSTAL STRUCTURE OF UPA IN COMPLEX WITH THE FAB FRAGMENT OF MAB- 112
2387, 3pnwS, 0.6439, 2.89, 0.067, 214, 90, CRYSTAL STRUCTURE OF THE TUDOR DOMAIN OF HUMAN TDRD3 IN COMPLEX WITH AN ANTI-TDRD3 FAB
2388, 3eyvA, 0.6439, 2.93, 0.054, 219, 92, ANTI-LEWIS Y FAB FRAGMENT WITH LEWIS Y ANTIGEN IN THE PRESENCE OF ZINC IONS
2389, 1c5dA, 0.6439, 3.00, 0.032, 213, 93, THE CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A RAT MONOCLONAL ANTIBODY AGAINST THE MAIN IMMUNOGENIC REGION OF THE HUMAN MUSCLE ACETYLCHOLINE RECEPTOR
2390, 1bjmA, 0.6439, 2.90, 0.065, 215, 92, LOC NAKS A LAMBDA 1 TYPE LIGHT-CHAIN DIMER (BENCE-JONES PROTEIN) CRYSTALLIZED IN NAKSO4
2391, 6oe5C, 0.6438, 2.93, 0.066, 211, 91, SPLAYED OPEN PREFUSION RSV F CAPTURED BY CR9501 AND MOTAVIZUMAB FABS 
2392, 6mv5L, 0.6438, 2.98, 0.054, 218, 92, ANTI-PCSK9 FAB 6E2 BOUND TO THE N-TERMINAL PEPTIDE FROM PCSK9 (E32K) 
2393, 6id4D, 0.6438, 2.70, 0.079, 215, 89, COMPLEX OF HLA-A*11:01 BINDING TO ALLOANTIBODY 2E3 
2394, 6c6xF, 0.6438, 2.85, 0.065, 214, 92, CRYSTAL STRUCTURE OF MIDDLE-EAST RESPIRATORY SYNDROME (MERS) CORONAVIRUS NEUTRALIZING ANTIBODY JC57-14 ISOLATED FROM A VACCINATED RHESUS MACAQUE.
2395, 5xmhL, 0.6438, 2.95, 0.055, 214, 91, CRYSTAL STRUCTURE OF AN IGM RHEUMATOID FACTOR YES8C IN COMPLEX WITH IGG1 FC
2396, 5vzyL, 0.6438, 2.99, 0.054, 218, 92, CRYSTAL STRUCTURE OF CRENEZUMAB FAB IN COMPLEX WITH ABETA
2397, 5vkkL, 0.6438, 2.95, 0.054, 219, 92, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-CD22 EPRATUZUMAB
2398, 5bk5A, 0.6438, 2.84, 0.054, 219, 92, CRYSTAL STRUCTURE OF THE ANTI-CIRCUMSPOROZOITE PROTEIN 663 GERMLINE ANTIBODY
2399, 4jn2A, 0.6438, 2.81, 0.055, 219, 91, AN ANTIDOTE FOR DABIGATRAN
2400, 3wiiL, 0.6438, 2.90, 0.054, 213, 92, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF B2212A A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1.
2401, 3s36L, 0.6438, 3.12, 0.043, 214, 93, STRUCTURAL BASIS FOR THE FUNCTION OF TWO ANTI-VEGF RECEPTOR ANTIBODIES
2402, 3qpqC, 0.6438, 3.10, 0.065, 215, 93, CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB
2403, 2oqjG, 0.6438, 2.92, 0.056, 211, 90, CRYSTAL STRUCTURE ANALYSIS OF FAB 2G12 IN COMPLEX WITH PEPTIDE 2G12.1
2404, 1xf4L, 0.6438, 2.93, 0.043, 213, 92, STRUCTURE OF LIGAND-FREE FAB DNA-1 IN SPACE GROUP P321 SOLVED FROM CRYSTALS WITH PERFECT HEMIHEDRAL TWINNING
2405, 1rz8A, 0.6438, 2.71, 0.056, 214, 89, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 17B
2406, 1hezC, 0.6438, 3.07, 0.054, 214, 93, ANTIBODY-ANTIGEN COMPLEX
2407, 6qn8D, 0.6437, 2.91, 0.065, 213, 92, STRUCTURE OF BOVINE ANTI-RSV FAB B13 
2408, 6obzB, 0.6437, 2.96, 0.055, 213, 91, CRYSTAL STRUCTURE OF FLUA-20 FAB 
2409, 6d01D, 0.6437, 3.01, 0.054, 212, 92, CRYSTAL STRUCTURE OF 1210 FAB IN COMPLEX WITH CIRCUMSPOROZOITE PROTEIN NANP5 
2410, 6c6xL, 0.6437, 2.81, 0.066, 214, 91, CRYSTAL STRUCTURE OF MIDDLE-EAST RESPIRATORY SYNDROME (MERS) CORONAVIRUS NEUTRALIZING ANTIBODY JC57-14 ISOLATED FROM A VACCINATED RHESUS MACAQUE.
2411, 6b9jL, 0.6437, 2.98, 0.054, 209, 92, STRUCTURE OF VACCINIA VIRUS D8 PROTEIN BOUND TO HUMAN FAB VV138
2412, 5wkoJ, 0.6437, 2.89, 0.056, 213, 90, CRYSTAL STRUCTURE OF ANTIBODY 27F3 RECOGNIZING THE HA FROM A/CALIFORNIA/04/2009 (H1N1) INFLUENZA VIRUS
2413, 5vxrL, 0.6437, 2.95, 0.054, 217, 92, THE ANTIGEN-BINDING FRAGMENT OF MAB24 IN COMPLEX WITH A PEPTIDE FROM HEPATITIS C VIRUS E2 EPITOPE I (412-423)
2414, 5knaL, 0.6437, 2.99, 0.054, 218, 92, CRYSTAL STRUCTURE OF CRENEZUMAB FAB IN COMPLEX WITH ABETA
2415, 5hysD, 0.6437, 2.98, 0.054, 217, 92, STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB
2416, 5ezlB, 0.6437, 2.94, 0.054, 213, 92, CRYSTAL STRUCTURE OF FAB OF PARASITE INVASION INHIBITORY ANTIBODY C1 - MONOCLINIC FORM
2417, 5do2L, 0.6437, 3.17, 0.043, 214, 94, COMPLEX STRUCTURE OF MERS-RBD BOUND WITH 4C2 ANTIBODY
2418, 5dfvF, 0.6437, 2.89, 0.043, 217, 92, CRYSTAL STRUCTURE OF HUMAN CD81 LARGE EXTRACELLULAR LOOP IN COMPLEX WITH MURINE FAB FRAGMENT K04
2419, 5chnL, 0.6437, 2.98, 0.054, 218, 92, FAB FRAGMENTS OF CHIKUNGUNYA VIRUS NEUTRALIZING HUMAN MONOCLONAL ANTIBODY 5M16
2420, 4xvsL, 0.6437, 3.04, 0.054, 210, 93, CRYSTAL STRUCTURE OF HIV-1 DONOR 45 D45-01DG5 COREE GP120 WITH ANTIBODY 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995)
2421, 4onfL, 0.6437, 2.97, 0.054, 218, 92, FAB FRAGMENT OF 3D6 IN COMPLEX WITH AMYLOID BETA 1-7
2422, 4n8cL, 0.6437, 2.94, 0.054, 219, 92, THREE-DIMENSIONAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF MATRIX PROTEIN 2 OF INFLUENZA A VIRUS
2423, 4irzL, 0.6437, 3.02, 0.066, 208, 91, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB NATALIZUMAB
2424, 4fqcL, 0.6437, 2.67, 0.090, 206, 89, CRYSTAL STRUCTURE OF PGT121 FAB BOUND TO A COMPLEX-TYPE SIALYLATED N- GLYCAN
2425, 3zkmD, 0.6437, 2.90, 0.043, 217, 92, BACE2 FAB COMPLEX
2426, 3tv3L, 0.6437, 2.72, 0.090, 205, 89, CRYSTAL STRUCTURE OF BROAD AND POTENT HIV-1 NEUTRALIZING ANTIBODY PGT128 IN COMPLEX WITH MAN9
2427, 3q3gJ, 0.6437, 3.09, 0.054, 220, 93, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
2428, 2xtsC, 0.6437, 3.11, 0.021, 389, 97, CRYSTAL STRUCTURE OF THE SULFANE DEHYDROGENASE SOXCD FROM PARACOCCUS PANTOTROPHUS
2429, 2gjzA, 0.6437, 2.99, 0.054, 217, 92, STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 13G5 FROM A CRYSTAL IN SPACE GROUP P2(1)
2430, 1h3yA, 0.6437, 2.85, 0.043, 206, 92, CRYSTAL STRUCTURE OF A HUMAN IGG1 FC-FRAGMENTHIGH SALT CONDITION
2431, 6flaL, 0.6436, 2.84, 0.055, 216, 91, 3H5 FAB BOUND TO EDIII OF DENV 2 XTAL FORM 1 
2432, 6eynA, 0.6436, 2.91, 0.056, 214, 90, STRUCTURE OF THE 8D6 (ANTI-IGE) FAB 
2433, 6ev2D, 0.6436, 3.04, 0.065, 217, 93, CRYSTAL STRUCTURE OF ANTIBODY AGAINST SCHIZOPHYLLAN IN COMPLEX WITH LAMINARIHEXAOSE 
2434, 6bfqF, 0.6436, 2.80, 0.055, 213, 91, THE MECHANISM OF GM-CSF INHIBITION BY HUMAN GM-CSF AUTO-ANTIBODIES 
2435, 5wkoF, 0.6436, 2.89, 0.056, 213, 90, CRYSTAL STRUCTURE OF ANTIBODY 27F3 RECOGNIZING THE HA FROM A/CALIFORNIA/04/2009 (H1N1) INFLUENZA VIRUS
2436, 5vqmL, 0.6436, 2.84, 0.055, 214, 91, CLOSTRIDIUM DIFFICILE TCDB-GTD BOUND TO PA41 FAB
2437, 5kjrL, 0.6436, 2.69, 0.090, 212, 89, CRYSTAL STRUCTURE OF THE ADCC-POTENT ANTIBODY N60-I3 FAB IN COMPLEX WITH HIV-1 CLADE A/E GP120 W69A/S115W MUTANT AND M48U1.
2438, 5hpmA, 0.6436, 2.97, 0.065, 213, 92, CETUXIMAB FAB IN COMPLEX WITH CYCLIC LINKED MEDITOPE
2439, 5gsqB, 0.6436, 2.90, 0.053, 208, 94, CRYSTAL STRUCTURE OF IGG FC WITH A HOMOGENEOUS GLYCOFORM AND ANTIBODY- DEPENDENT CELLULAR CYTOTOXICITY
2440, 5d7sL, 0.6436, 2.78, 0.089, 205, 90, CRYSTAL STRUCTURE OF MOR04357 A NEUTRALIZING ANTI-HUMAN GM-CSF ANTIBODY FAB FRAGMENT
2441, 4yzfJ, 0.6436, 3.11, 0.053, 218, 94, CRYSTAL STRUCTURE OF THE ANION EXCHANGER DOMAIN OF HUMAN ERYTHROCYTE BAND 3
2442, 4x4mB, 0.6436, 3.06, 0.052, 216, 97, STRUCTURE OF FCGAMMARI IN COMPLEX WITH FC REVEALS THE IMPORTANCE OF GLYCAN RECOGNITION FOR HIGH AFFINITY IGG BINDING
2443, 4hqqL, 0.6436, 2.73, 0.090, 212, 89, CRYSTAL STRUCTURE OF RV144-ELICITED ANTIBODY CH58
2444, 4hbqB, 0.6436, 3.43, 0.040, 206, 99, CRYSTAL STRUCTURE OF A LOOP DELETED MUTANT OF HUMAN MADCAM-1 D1D2
2445, 4gmtL, 0.6436, 3.12, 0.054, 213, 93, CRYSTAL STRUCTURE OF HETEROSUBTYPIC FAB S139/1
2446, 3u4bL, 0.6436, 2.91, 0.066, 214, 91, CH04H/CH02L FAB P4
2447, 3opzN, 0.6436, 3.02, 0.043, 212, 92, CRYSTAL STRUCTURE OF TRANS-SIALIDASE IN COMPLEX WITH THE FAB FRAGMENT OF A NEUTRALIZING MONOCLONAL IGG ANTIBODY
2448, 3oauL, 0.6436, 3.05, 0.054, 212, 92, ANTIBODY 2G12 RECOGNIZES DI-MANNOSE EQUIVALENTLY IN DOMAIN- AND NON- DOMAIN-EXCHANGED FORMS BUT ONLY BINDS THE HIV-1 GLYCAN SHIELD IF DOMAIN-EXCHANGED
2449, 2xtjC, 0.6436, 2.99, 0.054, 105, 92, THE CRYSTAL STRUCTURE OF PCSK9 IN COMPLEX WITH 1D05 FAB
2450, 2fbjL, 0.6436, 3.06, 0.043, 213, 93, REFINED CRYSTAL STRUCTURE OF THE GALACTAN-BINDING IMMUNOGLOBULIN FAB J539 AT 1.95-ANGSTROMS RESOLUTION
2451, 2a6jL, 0.6436, 2.99, 0.054, 214, 93, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-ARSONATE GERMLINE ANTIBODY 36- 65
2452, 1y0lE, 0.6436, 3.02, 0.054, 216, 93, CATALYTIC ELIMINATION ANTIBODY 34E4 IN COMPLEX WITH HAPTEN
2453, 1uweU, 0.6436, 2.93, 0.055, 213, 91, MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9
2454, 1afvL, 0.6436, 3.06, 0.054, 217, 93, HIV-1 CAPSID PROTEIN (P24) COMPLEX WITH FAB25.3
2455, 6jmrF, 0.6435, 2.84, 0.054, 218, 92, CD98HC EXTRACELLULAR DOMAIN BOUND TO HBJ127 FAB AND MEM-108 FAB 
2456, 6b9jB, 0.6435, 2.98, 0.054, 213, 92, STRUCTURE OF VACCINIA VIRUS D8 PROTEIN BOUND TO HUMAN FAB VV138
2457, 5x2oL, 0.6435, 2.95, 0.055, 216, 91, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-ARGININE
2458, 5t85L, 0.6435, 2.76, 0.089, 212, 90, CRYSTAL STRUCTURE OF 10E8 FAB IN COMPLEX WITH THE MPER EPITOPE SCAFFOLD T117V2 AND PHOSPHATIDYLGLYCEROL (06:0 PG)
2459, 5jw4T, 0.6435, 3.00, 0.054, 206, 92, STRUCTURE OF MEDI8852 FAB FRAGMENT IN COMPLEX WITH H5 HA
2460, 5ibuB, 0.6435, 3.20, 0.064, 215, 94, FAB (UNBOUND)
2461, 5eiiB, 0.6435, 2.91, 0.056, 212, 90, STRUCTURAL DETERMINATION OF AN PROTEIN COMPLEX OF A FAB WITH INCREASED SOLUBILITY
2462, 5d1zH, 0.6435, 3.04, 0.054, 214, 93, ISDB NEAT1 BOUND BY CLONE D4-10
2463, 4oawC, 0.6435, 3.00, 0.065, 214, 93, FAB STRUCTURE OF ANTI-HIV GP120 V2 MAB 2158
2464, 4nrzB, 0.6435, 2.91, 0.056, 212, 90, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66.6
2465, 4gq9L, 0.6435, 2.85, 0.054, 212, 92, CHIKUNGUNYA VIRUS NEUTRALIZING ANTIBODY 9.8B FAB FRAGMENT
2466, 4cc8L, 0.6435, 2.97, 0.055, 208, 91, PRE-FUSION STRUCTURE OF TRIMERIC HIV-1 ENVELOPE GLYCOPROTEIN DETERMINED BY CRYO-ELECTRON MICROSCOPY
2467, 4cc8K, 0.6435, 2.97, 0.055, 208, 91, PRE-FUSION STRUCTURE OF TRIMERIC HIV-1 ENVELOPE GLYCOPROTEIN DETERMINED BY CRYO-ELECTRON MICROSCOPY
2468, 4cc8J, 0.6435, 2.97, 0.055, 208, 91, PRE-FUSION STRUCTURE OF TRIMERIC HIV-1 ENVELOPE GLYCOPROTEIN DETERMINED BY CRYO-ELECTRON MICROSCOPY
2469, 3se8L, 0.6435, 2.97, 0.055, 208, 91, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC03 IN COMPLEX WITH HIV-1 GP120
2470, 3p0vM, 0.6435, 3.08, 0.076, 212, 92, ANTI-EGFR/HER3 FAB DL11 ALONE
2471, 3o11L, 0.6435, 3.01, 0.065, 211, 93, ANTI-BETA-AMYLOID ANTIBODY C706 FAB IN SPACE GROUP C2
2472, 3j2zG, 0.6435, 2.85, 0.054, 212, 92, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M10
2473, 3j2zE, 0.6435, 2.85, 0.054, 212, 92, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M10
2474, 3j2zC, 0.6435, 2.85, 0.054, 212, 92, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M10
2475, 3j2zA, 0.6435, 2.85, 0.054, 212, 92, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M10
2476, 3j2yG, 0.6435, 2.85, 0.054, 212, 92, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB 9.8B
2477, 3j2yE, 0.6435, 2.85, 0.054, 212, 92, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB 9.8B
2478, 3j2yC, 0.6435, 2.85, 0.054, 212, 92, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB 9.8B
2479, 3j2yA, 0.6435, 2.85, 0.054, 212, 92, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB 9.8B
2480, 3hmxL, 0.6435, 2.88, 0.054, 214, 92, CRYSTAL STRUCTURE OF USTEKINUMAB FAB/IL-12 COMPLEX
2481, 3aazL, 0.6435, 3.26, 0.053, 228, 95, CRYSTAL STRUCTURE OF THE HUMANIZED RECOMBINANT FAB FRAGMENT OF A MURINE; ANTIBODY
2482, 2dqtL, 0.6435, 3.01, 0.054, 219, 92, HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX OF THE HYDROLYTIC ANTIBODY FAB 6D9 AND A TRANSITION-STATE ANALOG
2483, 2a9aB, 0.6435, 3.35, 0.083, 359, 96, CRYSTAL STRUCTURE OF RECOMBINANT CHICKEN SULFITE OXIDASE WITH THE BOUND PRODUCT SULFATE AT THE ACTIVE SITE
2484, 2a6kA, 0.6435, 2.94, 0.054, 214, 92, CRYSTAL STRUCTURE ANALYSIS OF THE GERMLINE ANTIBODY 36-65 FAB IN COMPLEX WITH THE DODECAPEPTIDE SLGDNLTNHNLR
2485, 1n0xM, 0.6435, 3.06, 0.054, 215, 93, CRYSTAL STRUCTURE OF A BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY IN COMPLEX WITH A PEPTIDE MIMOTOPE
2486, 1jptL, 0.6435, 2.93, 0.054, 213, 92, CRYSTAL STRUCTURE OF FAB D3H44
2487, 1iarB, 0.6435, 2.64, 0.079, 188, 89, INTERLEUKIN-4 / RECEPTOR ALPHA CHAIN COMPLEX
2488, 6dc7M, 0.6434, 3.00, 0.054, 218, 93, APO FAB STRUCTURE OF MOUSE MONOCLONAL ANTIBODY 8B2 
2489, 6au5A, 0.6434, 2.97, 0.066, 212, 91, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-BUTYLARGININE MEDITOPE VARIANT
2490, 5v7rL, 0.6434, 3.02, 0.054, 215, 93, CYRSTAL STRUCTURE OF ANTI-TAU ANTIBODY CBTAU-7.1 FAB
2491, 5uweL, 0.6434, 2.76, 0.056, 213, 89, CRYSTAL STRUCTURE OF THE ADCC-POTENT; WEAKLY NEUTRALIZING HIV ENV CO- RECEPTOR BINDING SITE ANTIBODY N12-I2 FAB IN COMPLEX WITH HIV-1 CLADE A/E GP120 AND M48U1 
2492, 5n4jL, 0.6434, 2.69, 0.090, 211, 89, HUMAN FAB FRAGMENT 10C3 AGAINST NHBA FROM NEISSERIA MENINGITIDIS
2493, 5mv3G, 0.6434, 2.89, 0.043, 217, 92, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
2494, 5i74C, 0.6434, 2.94, 0.043, 214, 93, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH BR-CITALOPRAM AT THE CENTRAL SITE
2495, 5eiiL, 0.6434, 2.74, 0.056, 212, 89, STRUCTURAL DETERMINATION OF AN PROTEIN COMPLEX OF A FAB WITH INCREASED SOLUBILITY
2496, 4llyD, 0.6434, 2.69, 0.067, 209, 89, CRYSTAL STRUCTURE OF PERTUZUMAB CLAMBDA FAB WITH VARIABLE AND CONSTANT DOMAIN REDESIGNS (VRD2 AND CRD2) AT 1.6A
2497, 4fqqA, 0.6434, 2.80, 0.089, 211, 90, CRYSTAL STRUCTURE OF GERMLINE ANTIBODY PGT121-GL FAB
2498, 4evnJ, 0.6434, 2.86, 0.088, 213, 91, CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN)
2499, 3qq9L, 0.6434, 2.96, 0.054, 217, 92, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-HUMAN RSV (RESPIRATORY SYNCYTIAL VIRUS) F PROTEIN MAB 101F
2500, 3p0vL, 0.6434, 3.08, 0.076, 212, 92, ANTI-EGFR/HER3 FAB DL11 ALONE
2501, 3hr5L, 0.6434, 2.82, 0.055, 219, 91, M1PRIME PEPTIDE FROM IGE BOUND BY HUMANIZED ANTIBODY 47H4 FAB
2502, 3hbgA, 0.6434, 3.32, 0.083, 353, 96, STRUCTURE OF RECOMBINANT CHICKEN LIVER SULFITE OXIDASE MUTANT C185S
2503, 3grwL, 0.6434, 3.02, 0.054, 214, 93, FGFR3 IN COMPLEX WITH A FAB
2504, 3gbmL, 0.6434, 2.83, 0.088, 208, 91, CRYSTAL STRUCTURE OF FAB CR6261 IN COMPLEX WITH A H5N1 INFLUENZA VIRUS HEMAGGLUTININ.
2505, 3fctC, 0.6434, 2.87, 0.055, 213, 91, MATURE METAL CHELATASE CATALYTIC ANTIBODY WITH HAPTEN
2506, 3cfjL, 0.6434, 2.98, 0.054, 215, 92, CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4 ORTHORHOMBIC CRYSTAL FORM
2507, 2xtsA, 0.6434, 3.12, 0.021, 389, 97, CRYSTAL STRUCTURE OF THE SULFANE DEHYDROGENASE SOXCD FROM PARACOCCUS PANTOTROPHUS
2508, 2oqjA, 0.6434, 2.90, 0.056, 211, 90, CRYSTAL STRUCTURE ANALYSIS OF FAB 2G12 IN COMPLEX WITH PEPTIDE 2G12.1
2509, 2bdnL, 0.6434, 2.99, 0.043, 214, 93, CRYSTAL STRUCTURE OF HUMAN MCP-1 BOUND TO A BLOCKING ANTIBODY 11K2
2510, 1za6H, 0.6434, 3.26, 0.126, 324, 95, THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY
2511, 1rz8C, 0.6434, 2.73, 0.056, 214, 89, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 17B
2512, 1jnhE, 0.6434, 2.56, 0.045, 208, 89, CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES
2513, 6mu6L, 0.6433, 2.74, 0.067, 211, 90, CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-814508 IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.2 ANGSTROM 
2514, 6medB, 0.6433, 2.78, 0.056, 213, 90, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
2515, 6dwaL, 0.6433, 2.99, 0.065, 219, 92, STRUCTURE OF THE 4497 ANTIBODY FAB FRAGMENT BOUND TO A STAPHYLOCOCCUS AUREUS WALL TECHOIC ACID ANALOG 
2516, 6bliK, 0.6433, 2.81, 0.055, 214, 91, RSV G PEPTIDE BOUND TO FAB CB002.5
2517, 6bfqD, 0.6433, 2.82, 0.056, 213, 90, THE MECHANISM OF GM-CSF INHIBITION BY HUMAN GM-CSF AUTO-ANTIBODIES 
2518, 6b0gC, 0.6433, 3.00, 0.054, 218, 92, CRYSTAL STRUCTURE OF PFS25 IN COMPLEX WITH THE TRANSMISSION BLOCKING ANTIBODY 1245
2519, 5u3lL, 0.6433, 2.73, 0.056, 214, 89, CRYSTAL STRUCTURE OF DH511.2 FAB IN COMPLEX WITH HIV-1 GP41 MPER 670- 683 PEPTIDE
2520, 5u3kL, 0.6433, 2.90, 0.056, 214, 90, CRYSTAL STRUCTURE OF DH511.2 FAB IN COMPLEX WITH HIV-1 GP41 MPER 662- 683 PEPTIDE
2521, 5tpnL, 0.6433, 3.17, 0.064, 214, 94, CRYSTAL STRUCTURE OF RSV F IN COMPLEX WITH HUMAN ANTIBODY HRSV90
2522, 5t3xL, 0.6433, 2.89, 0.087, 211, 92, 3.9 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074.
2523, 4yhnL, 0.6433, 2.97, 0.054, 218, 92, DABIGATRAN REVERSAL AGENT
2524, 4wi4B, 0.6433, 2.86, 0.043, 207, 92, STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION S254A
2525, 4q9qL, 0.6433, 3.05, 0.054, 215, 93, CRYSTAL STRUCTURE OF AN RNA APTAMER BOUND TO BROMO-LIGAND ANALOG IN COMPLEX WITH FAB
2526, 4lldB, 0.6433, 2.70, 0.090, 101, 89, STRUCTURE OF WILD-TYPE IGG1 ANTIBODY HEAVY CHAIN CONSTANT DOMAIN 1 AND LIGHT CHAIN LAMBDA CONSTANT DOMAIN (IGG1 CH1:CLAMBDA) AT 1.19A
2527, 4jvwC, 0.6433, 3.12, 0.065, 108, 93, IGM C4-DOMAIN FROM MOUSE
2528, 4fqrn, 0.6433, 3.14, 0.065, 213, 93, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
2529, 3s7gD, 0.6433, 2.82, 0.054, 207, 93, AGLYCOSYLATED HUMAN IGG1 FC FRAGMENT
2530, 3s34L, 0.6433, 3.09, 0.043, 214, 93, STRUCTURE OF THE 1121B FAB FRAGMENT
2531, 3dvnL, 0.6433, 3.03, 0.054, 212, 93, CRYSTAL STRUCTURE OF K63-SPECIFIC FAB APU2.16 BOUND TO K63-LINKED DI- UBIQUITIN
2532, 2iptL, 0.6433, 3.12, 0.053, 219, 94, PFA1 FAB FRAGMENT
2533, 2eh8L, 0.6433, 2.96, 0.054, 218, 92, CRYSTAL STRUCTURE OF THE COMPLEX OF HUMANIZED KR127 FAB AND PRES1 PEPTIDE EPITOPE
2534, 1wcbL, 0.6433, 3.02, 0.043, 213, 93, PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH ITS HAPTEN
2535, 1h3vA, 0.6433, 2.80, 0.043, 207, 92, CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENTGLYCOFORM (G2F)2SG P212121
2536, 1fl5A, 0.6433, 3.09, 0.065, 217, 92, THE UNLIGANDED GERMLINE PRECURSOR TO THE SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4.
2537, 1f8tL, 0.6433, 2.85, 0.054, 219, 92, FAB (LNKB-2) OF MONOCLONAL ANTIBODY CRYSTAL STRUCTURE
2538, 6njnJ, 0.6432, 3.01, 0.044, 211, 91, STRUCTURE OF A COMPLEX 
2539, 6dwcL, 0.6432, 3.05, 0.054, 220, 93, STRUCTURE OF THE APO 4497 ANTIBODY FAB FRAGMENT 
2540, 6bzuF, 0.6432, 2.96, 0.055, 214, 91, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 19B3 
2541, 5ziaM, 0.6432, 2.72, 0.056, 217, 89, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-24.1 IN COMPLEX WITH ITS PHOSPHORYLATED TAU PEPTIDE 
2542, 5y9fa, 0.6432, 2.91, 0.044, 217, 91, CRYSTAL STRUCTURE OF HPV59 PENTAMER IN COMPLEX WITH THE FAB FRAGMENT OF ANTIBODY 28F10
2543, 5x2pL, 0.6432, 3.15, 0.054, 217, 93, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-GLUTAMATE
2544, 5wtgA, 0.6432, 3.01, 0.054, 212, 93, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-HAV ANTIBODY R10
2545, 5vjqF, 0.6432, 2.95, 0.055, 212, 91, COMPLEX BETWEEN HYHEL10 FAB FRAGMENT HEAVY CHAIN MUTANT (I29F; S52T; Y53F) AND PEKIN DUCK EGG LYSOZYME ISOFORM I (DEL-I) 
2546, 5vh4L, 0.6432, 2.97, 0.055, 213, 91, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-TNFA ANTIBODY INFLIXIMAB IN AN I-CENTERED ORTHORHOMBIC CRYSTAL FORM
2547, 5utzG, 0.6432, 2.77, 0.089, 213, 90, HUMAN IL-2/FAB COMPLEX 
2548, 5tdpC, 0.6432, 2.85, 0.054, 213, 92, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-HER2 ANTIBODY 4D5 WITH REDESIGNED HEAVY AND LIGHT CHAIN INTERFACES
2549, 5odbB, 0.6432, 2.70, 0.045, 207, 89, CRYSTAL STRUCTURE OF THE RA-ASSOCIATED MAB D10 (CHIMERIC FAB FRAGMENT) 
2550, 5gkrB, 0.6432, 2.81, 0.089, 213, 90, CRYSTAL STRUCTURE OF SLE PATIENT-DERIVED ANTI-DNA ANTIBODY IN COMPLEX WITH OLIGONUCLEOTIDE
2551, 5f3bB, 0.6432, 2.95, 0.055, 213, 91, STRUCTURE OF MYOSTATIN IN COMPLEX WITH CHIMERIC RK35 ANTIBODY
2552, 5dlmL, 0.6432, 2.94, 0.055, 217, 91, COMPLEX OF INFLUENZA M2E AND ANTIBODY
2553, 5bo1L, 0.6432, 2.84, 0.055, 214, 91, CRYSTAL STRUCTURE OF A HUMAN JAG1 FRAGMENT IN COMPLEX WITH AN ANTI- JAG1 FAB
2554, 4yzfF, 0.6432, 3.11, 0.053, 218, 94, CRYSTAL STRUCTURE OF THE ANION EXCHANGER DOMAIN OF HUMAN ERYTHROCYTE BAND 3
2555, 4xp6L, 0.6432, 2.87, 0.044, 213, 91, X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER BOUND TO PSYCHOSTIMULANT METHAMPHETAMINE
2556, 3zknD, 0.6432, 2.95, 0.054, 217, 92, BACE2 FAB INHIBITOR COMPLEX
2557, 3qcuL, 0.6432, 2.93, 0.055, 218, 91, CRYSTAL STRUCTURE OF THE LT3015 ANTIBODY FAB FRAGMENT IN COMPLEX WITH LYSOPHOSPHATIDIC ACID (14:0)
2558, 2nyyC, 0.6432, 2.77, 0.056, 216, 90, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY CR1
2559, 2h32B, 0.6432, 2.75, 0.079, 117, 89, CRYSTAL STRUCTURE OF THE PRE-B CELL RECEPTOR
2560, 2a6jA, 0.6432, 2.96, 0.043, 214, 93, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-ARSONATE GERMLINE ANTIBODY 36- 65
2561, 1il1B, 0.6432, 2.85, 0.054, 219, 92, CRYSTAL STRUCTURE OF G3-519 AN ANTI-HIV MONOCLONAL ANTIBODY
2562, 1afvM, 0.6432, 3.06, 0.054, 217, 93, HIV-1 CAPSID PROTEIN (P24) COMPLEX WITH FAB25.3
2563, 6n7jB, 0.6431, 2.98, 0.054, 214, 92, BDBV223 FAB BOUND TO SYNTHETIC PEPTIDE OF BUNDIBUGYO VIRUS GLYCOPROTEIN STALK 
2564, 6eluF, 0.6431, 2.96, 0.054, 217, 92, STRUCTURE OF SERUM RESISTANCE ASSOCIATED PROTEIN FROM T. B. RHODESIENSE
2565, 6axpA, 0.6431, 2.97, 0.055, 212, 91, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-OCTYLARGININE MEDITOPE VARIANT
2566, 5y2mJ, 0.6431, 2.90, 0.056, 212, 90, CRYSTAL STRUCTURE OF A GROUP 2 HA BINDING ANTIBODY AF4H1K1 FAB IN COMPLEX WITH THE H4N6 DUCK ISOLATE (H4-CZ/56) HEMAGGLUTININ 
2567, 5w6cL, 0.6431, 2.68, 0.090, 214, 89, UCA FAB (UNBOUND) FROM 6649 LINEAGE
2568, 5v2aL, 0.6431, 3.03, 0.054, 221, 93, CRYSTAL STRUCTURE OF FAB H7.167 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/SHANGHAI/02/2013 (H7N9)
2569, 5n2kG, 0.6431, 2.65, 0.067, 212, 89, STRUCTURE OF UNBOUND BRIAKINUMAB FAB
2570, 5jw5L, 0.6431, 3.01, 0.054, 209, 92, STRUCTURE OF MEDI8852 FAB FRAGMENT
2571, 5eu7D, 0.6431, 2.93, 0.055, 213, 91, CRYSTAL STRUCTURE OF HIV-1 INTEGRASE CATALYTIC CORE IN COMPLEX WITH FAB
2572, 5dscD, 0.6431, 2.84, 0.066, 212, 91, CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU24.B IN COMPLEX WITH HYPUSINE
2573, 5d1xA, 0.6431, 2.94, 0.055, 218, 91, ISDB NEAT2 BOUND BY D4-30
2574, 4xbgI, 0.6431, 2.94, 0.055, 214, 91, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA): 2.73 A RESOLUTION
2575, 4r7dN, 0.6431, 2.75, 0.056, 211, 89, FAB HU 15C1
2576, 4k8rL, 0.6431, 2.80, 0.089, 214, 90, AN ANTIBODY AGAINST THE C-TERMINAL DOMAIN OF PCSK9 LOWERS LDL CHOLESTEROL LEVELS IN VIVO
2577, 4h8wL, 0.6431, 2.74, 0.079, 212, 89, CRYSTAL STRUCTURE OF NON-NEUTRALIZING AND ADCC-POTENT ANTIBODY N5-I5 IN COMPLEX WITH HIV-1 CLADE A/E GP120 AND SCD4.
2578, 4fqrx, 0.6431, 3.14, 0.065, 213, 93, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
2579, 3okeA, 0.6431, 2.97, 0.055, 217, 91, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KO
2580, 3ngbL, 0.6431, 3.01, 0.054, 208, 93, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC01 IN COMPLEX WITH HIV-1 GP120
2581, 3l95A, 0.6431, 2.72, 0.056, 212, 89, CRYSTAL STRUCTURE OF THE HUMAN NOTCH1 NEGATIVE REGULATORY REGION (NRR) BOUND TO THE FAB FRAGMENT OF AN ANTAGONIST ANTIBODY
2582, 3iu4L, 0.6431, 2.79, 0.055, 213, 91, ANTI NEUGCGM3 GANGLIOSIDE CHIMERIC ANTIBODY CHP3
2583, 3idxL, 0.6431, 3.01, 0.054, 214, 92, CRYSTAL STRUCTURE OF HIV-GP120 CORE IN COMPLEX WITH CD4-BINDING SITE ANTIBODY B13 SPACE GROUP C222
2584, 3cfbA, 0.6431, 3.06, 0.054, 218, 93, HIGH-RESOLUTION STRUCTURE OF BLUE FLUORESCENT ANTIBODY EP2-19G2 IN COMPLEX WITH STILBENE HAPTEN AT 100K
2585, 2a6dL, 0.6431, 2.93, 0.054, 214, 92, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-ARSONATE GERMLINE ANTIBODY 36-65 IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE RLLIADPPSPRE
2586, 1ymhC, 0.6431, 3.20, 0.043, 220, 94, ANTI-HCV FAB 19D9D6 COMPLEXED WITH PROTEIN L (PPL) MUTANT A66W
2587, 1uweL, 0.6431, 2.91, 0.055, 213, 91, MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9
2588, 1opgL, 0.6431, 2.97, 0.043, 214, 93, OPG2 FAB FRAGMENT
2589, 1ae6L, 0.6431, 3.08, 0.065, 219, 92, IGG-FAB FRAGMENT OF MOUSE MONOCLONAL ANTIBODY CTM01
2590, 6meeB, 0.6430, 2.99, 0.055, 213, 91, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
2591, 6ck9L, 0.6430, 2.82, 0.089, 211, 90, CRYSTAL STRUCTURE OF HIV-1 CONC_BASE0 PREFUSION ENV TRIMER IN COMPLEX WITH HUMAN ANTIBODY FRAGMENT 3H109L AND 35O22 VARIANTS AT 3.5 ANGSTROM 
2592, 6c6yL, 0.6430, 2.84, 0.066, 214, 91, CRYSTAL STRUCTURE OF MIDDLE-EAST RESPIRATORY SYNDROME (MERS) CORONAVIRUS NEUTRALIZING ANTIBODY JC57-14 ISOLATED FROM A VACCINATED RHESUS MACAQUE IN COMPLEX WITH MERS RECEPTOR BINDING DOMAIN
2593, 6b3sD, 0.6430, 3.00, 0.055, 213, 91, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF NECITUMUMAB (FAB11F8) IN COMPLEX WITH DOMAIN III FROM A CETUXIMAB RESISTANT VARIANT OF EGFR (SEGFRD3-S468R)
2594, 5wt9L, 0.6430, 2.81, 0.055, 216, 91, COMPLEX STRUCTURE OF PD-1 AND NIVOLUMAB-FAB
2595, 5vebL, 0.6430, 3.03, 0.054, 215, 93, CRYSTAL STRUCTURE OF A FAB BINDING TO EXTRACELLULAR DOMAIN 5 OF CADHERIN-6
2596, 5mp3L, 0.6430, 2.88, 0.054, 218, 92, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 30-MER TAU PEPTIDE AT PH 6.5 
2597, 5ceyC, 0.6430, 2.81, 0.089, 207, 90, CRYSTAL STRUCTURE OF FAB 9H+3L A PUTATIVE PRECURSOR OF THE PGT121 FAMILY OF POTENT HIV-1 ANTIBODIES
2598, 4xcnF, 0.6430, 2.92, 0.055, 214, 91, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA); 2.9 A RESOLUTION
2599, 4x4mD, 0.6430, 3.08, 0.052, 214, 97, STRUCTURE OF FCGAMMARI IN COMPLEX WITH FC REVEALS THE IMPORTANCE OF GLYCAN RECOGNITION FOR HIGH AFFINITY IGG BINDING
2600, 4rirB, 0.6430, 2.81, 0.088, 214, 91, STRUCTURAL ANALYSIS OF THE UNMUTATED ANCESTOR OF THE HIV-1 ENVELOPE V2 REGION ANTIBODY CH58 ISOLATED FROM AN RV144 HIV-1 VACCINE EFFICACY TRIAL VACCINEE AND ASSOCIATED WITH DECREASED TRANSMISSION RISK
2601, 4hc1A, 0.6430, 3.39, 0.031, 198, 98, CRYSTAL STRUCTURE OF A LOOP DELETED MUTANT OF HUMAN MADCAM-1 D1D2 COMPLEXED WITH FAB 10G3
2602, 4fqhL, 0.6430, 2.67, 0.101, 212, 89, CRYSTAL STRUCTURE OF FAB CR9114
2603, 3u4eB, 0.6430, 2.71, 0.101, 212, 89, CRYSTAL STRUCTURE OF PG9 FAB IN COMPLEX WITH V1V2 REGION FROM HIV-1 STRAIN CAP45
2604, 3q3gC, 0.6430, 3.16, 0.043, 220, 94, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
2605, 3hbpA, 0.6430, 3.35, 0.083, 373, 96, THE CRYSTAL STRUCTURE OF C185S MUTANT OF RECOMBINANT SULFITE OXIDASE WITH BOUND SUBSTRATE SULFITE AT THE ACTIVE SITE
2606, 3cfkE, 0.6430, 2.92, 0.055, 215, 91, CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4 TRICLINIC CRYSTAL FORM
2607, 2wubL, 0.6430, 3.04, 0.065, 214, 93, CRYSTAL STRUCTURE OF HGFA IN COMPLEX WITH THE ALLOSTERIC NON-INHIBITORY ANTIBODY FAB40.DELTATRP
2608, 1wejL, 0.6430, 3.13, 0.053, 214, 94, IGG1 FAB FRAGMENT (OF E8 ANTIBODY) COMPLEXED WITH HORSE CYTOCHROME C AT 1.8 A RESOLUTION
2609, 1uz8A, 0.6430, 2.91, 0.054, 218, 92, ANTI-LEWIS X FAB FRAGMENT IN COMPLEX WITH LEWIS X
2610, 1nc4A, 0.6430, 2.80, 0.079, 211, 89, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 2D12.5 FAB COMPLEXED WITH GD- DOTA
2611, 1flrL, 0.6430, 3.02, 0.054, 219, 93, 4-4-20 FAB FRAGMENT
2612, 1b4jL, 0.6430, 3.09, 0.054, 214, 93, COMPARISON OF THE THREE-DIMENSIONAL STRUCTURES OF A HUMANIZED AND A CHIMERIC FAB OF AN ANTI-GAMMA-INTERFERON ANTIBODY
2613, 6mamB, 0.6429, 2.98, 0.054, 215, 92, CLEAVED EBOLA GP IN COMPLEX WITH A BROADLY NEUTRALIZING HUMAN ANTIBODY; ADI-15946 
2614, 6jbtL, 0.6429, 3.12, 0.065, 218, 92, COMPLEX STRUCTURE OF TORIPALIMAB-FAB AND PD-1 
2615, 6ghgL, 0.6429, 2.94, 0.054, 215, 92, VARIABLE HEAVY - VARIABLE LIGHT DOMAIN AND FAB-ARM CROSSMABS WITH CHARGED RESIDUE EXCHANGES 
2616, 6ddmA, 0.6429, 3.06, 0.054, 215, 93, CRYSTAL STRUCTURE ANALYSIS OF THE EPITOPE OF AN ANTI-MICA ANTIBODY 
2617, 6b9zA, 0.6429, 3.09, 0.054, 214, 93, TRASTUZUMAB FAB V3 
2618, 6aynA, 0.6429, 2.98, 0.066, 212, 91, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-(3- AMINOPROPYL)-L-ARGININE MEDITOPE VARIANT
2619, 5yslH, 0.6429, 3.05, 0.054, 213, 92, CRYSTAL STRUCTURE OF ANTIBODY 1H1 FAB
2620, 5w4lL, 0.6429, 2.70, 0.090, 212, 89, CRYSTAL STRUCTURE OF THE NON-NEUTRALIZING AND ADCC-POTENT C11-LIKE ANTIBODY N12-I3 IN COMPLEX WITH HIV-1 CLADE A/E GP120 THE CD4 MIMETIC M48U1 AND THE ANTIBODY N5-I5.
2621, 5w1gL, 0.6429, 2.81, 0.055, 221, 91, CR1-07 UNLIGANDED FAB 
2622, 5vsiL, 0.6429, 2.99, 0.054, 212, 92, CH1/CKAPPA FAB MUTANT 15.1
2623, 5i1hL, 0.6429, 2.99, 0.054, 214, 92, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-53/IGKV3-20
2624, 5i17L, 0.6429, 2.93, 0.056, 213, 90, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV1-69/IGKV3-20
2625, 4tsaL, 0.6429, 2.70, 0.090, 210, 89, STRUCTURE OF A LYSOZYME FAB COMPLEX
2626, 4qhlB, 0.6429, 2.81, 0.089, 209, 90, I3.2 (UNBOUND) FROM CH103 LINEAGE
2627, 4om1L, 0.6429, 2.91, 0.055, 210, 91, CRYSTAL STRUCTURE OF ANTIBODY VRC07-I30Q G54W S58N IN COMPLEX WITH CLADE A/E 93TH057 HIV-1 GP120 CORE
2628, 4lu5M, 0.6429, 2.98, 0.043, 219, 93, STRUCTURE OF MURINE IGG2A A20G2-FAB IN COMPLEX WITH VACCINIA ANTIGEN A33R AT THE RESOLUTION OF 2.9 ANGSTROMS
2629, 3x3fL, 0.6429, 3.01, 0.065, 214, 93, TRAIL-R2 EXTRACELLULAR REGION COMPLEXED TO A FAB FRAGMENT FROM HUMAN AGONIST ANTIBODY KMTR2
2630, 3qnyC, 0.6429, 2.98, 0.065, 219, 92, MONOCLINIC FORM OF HUMAN IGA1 FAB FRAGMENT SHARING SAME FV AS IGG
2631, 3mobL, 0.6429, 3.07, 0.054, 213, 93, CRYSTAL STRUCTURE OF THE NEUTRALIZING HIV ANTIBODY 2F5 FAB FRAGMENT (RECOMBINANTLY PRODUCED FAB) WITH 11 AA GP41 MPER-DERIVED PEPTIDE
2632, 3l7fD, 0.6429, 2.95, 0.054, 213, 92, STRUCTURE OF IL-13 ANTIBODY H2L6 A HUMANIZED VARIANT OF C836
2633, 3ikcC, 0.6429, 2.88, 0.043, 217, 92, STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)-7-O-METHYL-KDO
2634, 3cfjC, 0.6429, 2.98, 0.054, 215, 92, CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4 ORTHORHOMBIC CRYSTAL FORM
2635, 2y06L, 0.6429, 2.71, 0.056, 211, 89, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-(4-HYDROXY-3- NITROPHENYL) -ACETYL MURINE GERMLINE ANTIBODY BBE6.12H3 FAB FRAGMENT IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE GDPRPSYISHLL
2636, 2vxqL, 0.6429, 2.95, 0.054, 213, 92, CRYSTAL STRUCTURE OF THE MAJOR GRASS POLLEN ALLERGEN PHL P 2 IN COMPLEX WITH ITS SPECIFIC IGE-FAB
2637, 1xgqA, 0.6429, 3.14, 0.054, 215, 93, STRUCTURE FOR ANTIBODY HYHEL-63 Y33V MUTANT COMPLEXED WITH HEN EGG LYSOZYME
2638, 1bogA, 0.6429, 3.24, 0.053, 214, 94, ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH AN EPITOPE-HOMOLOGOUS PEPTIDE
2639, 6o39A, 0.6428, 2.98, 0.055, 212, 91, CRYSTAL STRUCTURE OF FRIZZLED 5 CRD IN COMPLEX WITH F2.I FAB 
2640, 6ev2F, 0.6428, 2.92, 0.066, 213, 91, CRYSTAL STRUCTURE OF ANTIBODY AGAINST SCHIZOPHYLLAN IN COMPLEX WITH LAMINARIHEXAOSE 
2641, 6ea5R, 0.6428, 2.91, 0.067, 211, 90, STRUCTURE OF BDBV GPCL IN COMPLEX WITH THE PAN-EBOLAVIRUS MAB ADI- 15878 
2642, 6d4mB, 0.6428, 3.00, 0.062, 209, 96, CRYSTAL STRUCTURE OF A FC FRAGMENT OF RHESUS MACAQUE (MACACA MULATTA) IGG3 
2643, 6b3sK, 0.6428, 2.99, 0.055, 213, 91, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF NECITUMUMAB (FAB11F8) IN COMPLEX WITH DOMAIN III FROM A CETUXIMAB RESISTANT VARIANT OF EGFR (SEGFRD3-S468R)
2644, 6azkA, 0.6428, 2.74, 0.056, 212, 89, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-(3- HYDROXYPROPYL)-L-ARGININE MEDITOPE VARIANT
2645, 5wkoB, 0.6428, 2.90, 0.056, 213, 90, CRYSTAL STRUCTURE OF ANTIBODY 27F3 RECOGNIZING THE HA FROM A/CALIFORNIA/04/2009 (H1N1) INFLUENZA VIRUS
2646, 5c7xN, 0.6428, 2.70, 0.090, 201, 89, CRYSTAL STRUCTURE OF MOR04357 A NEUTRALIZING ANTI-HUMAN GM-CSF ANTIBODY FAB FRAGMENT IN COMPLEX WITH HUMAN GM-CSF
2647, 4ztoL, 0.6428, 2.84, 0.066, 216, 91, FAB/EPITOPE COMPLEX STRUCTURE OF RABBIT MONOCLONAL ANTIBODY R53 TARGETING AN EPITOPE IN HIV-1 GP120 C4 REGION
2648, 4zsoA, 0.6428, 3.05, 0.054, 214, 93, CRYSTAL STRUCTURE OF A COMPLEX BETWEEN B7-H6 A TUMOR CELL LIGAND FOR NATURAL CYTOTOXICITY RECEPTOR NKP30 AND AN INHIBITORY ANTIBODY
2649, 4u6vL, 0.6428, 3.02, 0.065, 213, 93, MECHANISMS OF NEUTRALIZATION OF A HUMAN ANTI-ALPHA TOXIN ANTIBODY
2650, 4r2gM, 0.6428, 2.83, 0.078, 210, 90, CRYSTAL STRUCTURE OF PGT124 FAB BOUND TO HIV-1 JRCSF GP120 CORE AND TO CD4
2651, 4evnN, 0.6428, 2.86, 0.088, 213, 91, CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN)
2652, 3tnmB, 0.6428, 2.70, 0.090, 210, 89, CRYSTAL STRUCTURE OF A32 FAB AN ADCC MEDIATING ANTI-HIV-1 ANTIBODY
2653, 3qhzL, 0.6428, 2.91, 0.065, 216, 92, CRYSTAL STRUCTURE OF HUMAN ANTI-INFLUENZA FAB 2D1
2654, 3mxvL, 0.6428, 2.95, 0.055, 212, 91, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-SHH 5E1 CHIMERA
2655, 3ijsC, 0.6428, 2.87, 0.055, 216, 91, STRUCTURE OF S67-27 IN COMPLEX WITH TSBP
2656, 3fzuL, 0.6428, 2.94, 0.055, 213, 91, IGG1 FAB CHARACTERIZED BY H/D EXCHANGE
2657, 3dvnA, 0.6428, 3.03, 0.054, 212, 93, CRYSTAL STRUCTURE OF K63-SPECIFIC FAB APU2.16 BOUND TO K63-LINKED DI- UBIQUITIN
2658, 3aazB, 0.6428, 3.19, 0.053, 229, 94, CRYSTAL STRUCTURE OF THE HUMANIZED RECOMBINANT FAB FRAGMENT OF A MURINE; ANTIBODY
2659, 1rjlA, 0.6428, 2.90, 0.055, 212, 91, STRUCTURE OF THE COMPLEX BETWEEN OSPB-CT AND BACTERICIDAL FAB-H6831
2660, 1mieL, 0.6428, 2.90, 0.054, 218, 92, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS5-393
2661, 1frtC, 0.6428, 2.93, 0.043, 205, 92, CRYSTAL STRUCTURE OF THE COMPLEX OF RAT NEONATAL FC RECEPTOR WITH FC
2662, 1e4xM, 0.6428, 3.15, 0.053, 214, 94, CROSSREACTIVE BINDING OF A CIRCULARIZED PEPTIDE TO AN ANTI-TGFALPHA ANTIBODY FAB-FRAGMENT
2663, 1e4xL, 0.6428, 3.04, 0.054, 214, 93, CROSSREACTIVE BINDING OF A CIRCULARIZED PEPTIDE TO AN ANTI-TGFALPHA ANTIBODY FAB-FRAGMENT
2664, 1bj1J, 0.6428, 2.98, 0.054, 213, 92, VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH A NEUTRALIZING ANTIBODY
2665, 6nb5L, 0.6427, 2.68, 0.090, 210, 89, CRYSTAL STRUCTURE OF ANTI- MERS-COV HUMAN NEUTRALIZING LCA60 ANTIBODY FAB FRAGMENT 
2666, 6bliB, 0.6427, 2.81, 0.055, 214, 91, RSV G PEPTIDE BOUND TO FAB CB002.5
2667, 6al4E, 0.6427, 2.99, 0.054, 217, 92, CRYSTAL STRUCTURE OF ANTI-CD19 ANTIBODY B43 FAB
2668, 5wuvL, 0.6427, 3.02, 0.054, 213, 92, CRYSTAL STRUCTURE OF CERTOLIZUMAB FAB
2669, 5vvfL, 0.6427, 3.15, 0.065, 213, 93, CRYSTAL STRUCTURE OF 354BG1 FAB
2670, 5vh5A, 0.6427, 2.90, 0.043, 207, 93, CRYSTAL STRUCTURE OF FC FRAGMENT OF ANTI-TNFA ANTIBODY INFLIXIMAB
2671, 5obfL, 0.6427, 2.92, 0.043, 217, 92, FAB. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION-MAKING IN ANTIBODY DRUG DISCOVERY.
2672, 5mtlA, 0.6427, 2.74, 0.079, 194, 89, CRYSTAL STRUCTURE OF AN AMYLOIDOGENIC LIGHT CHAIN
2673, 5jofL, 0.6427, 3.08, 0.054, 211, 93, CRYSTAL STRUCTURE OF VRC03 GHVGLV ANTIGEN-BINDING FRAGMENT.
2674, 5d6cL, 0.6427, 2.77, 0.056, 219, 90, STRUCTURE OF 4497 FAB BOUND TO SYNTHETIC WALL TEICHOIC ACID FRAGMENT
2675, 5awnL, 0.6427, 2.77, 0.100, 212, 90, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 BROADLY NEUTRALIZING ANTIBODY 3BC176 FAB
2676, 4z7nF, 0.6427, 2.98, 0.054, 214, 92, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE
2677, 4rfnL, 0.6427, 2.75, 0.090, 210, 89, CRYSTAL STRUCTURE OF ADCC-POTENT RHESUS MACAQUE ANTIBODY JR4 IN COMPLEX WITH HIV-1 CLADE A/E GP120 AND M48
2678, 4hg4M, 0.6427, 3.08, 0.054, 214, 93, CRYSTAL STRUCTURE OF FAB 2G1 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ
2679, 4gw1A, 0.6427, 2.75, 0.056, 212, 89, CQFD MEDITOPE
2680, 4f3fA, 0.6427, 2.90, 0.055, 211, 91, CRYSTAL STRUCTURE OF MSLN7-64 MORAB-009 FAB COMPLEX
2681, 3qcuM, 0.6427, 2.98, 0.054, 218, 92, CRYSTAL STRUCTURE OF THE LT3015 ANTIBODY FAB FRAGMENT IN COMPLEX WITH LYSOPHOSPHATIDIC ACID (14:0)
2682, 3csyF, 0.6427, 2.84, 0.056, 216, 89, CRYSTAL STRUCTURE OF THE TRIMERIC PREFUSION EBOLA VIRUS GLYCOPROTEIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY FROM A HUMAN SURVIVOR
2683, 2fx8L, 0.6427, 2.91, 0.055, 214, 91, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH AN AIB-INDUCED PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41
2684, 1nakL, 0.6427, 2.84, 0.055, 217, 91, IGG1 FAB FRAGMENT (83.1) COMPLEX WITH 16-RESIDUE PEPTIDE (RESIDUES 304-321 OF HIV-1 GP120 (MN ISOLATE))
2685, 1m7iA, 0.6427, 2.80, 0.044, 215, 90, CRYSTAL STRUCTURE OF A MONOCLONAL FAB SPECIFIC FOR SHIGELLA FLEXNERI Y LIPOPOLYSACCHARIDE COMPLEXED WITH A PENTASACCHARIDE
2686, 1lo2L, 0.6427, 3.06, 0.054, 219, 93, RETRO-DIELS-ALDERASE CATALYTIC ANTIBODY
2687, 1i7zA, 0.6427, 3.02, 0.054, 219, 93, ANTIBODY GNC92H2 BOUND TO LIGAND
2688, 1hzhM, 0.6427, 3.03, 0.054, 215, 93, CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN
2689, 1hzhL, 0.6427, 3.19, 0.064, 215, 94, CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN
2690, 1dqqC, 0.6427, 2.94, 0.054, 214, 93, CRYSTAL STRUCTURE OF ANTI-LYSOZYME ANTIBODY HYHEL-63
2691, 1bqsA, 0.6427, 3.30, 0.031, 209, 97, THE CRYSTAL STRUCTURE OF MUCOSAL ADDRESSIN CELL ADHESION MOLECULE-1 (MADCAM-1)
2692, 6njlJ, 0.6426, 3.00, 0.044, 211, 91, STRUCTURE OF A COMPLEX 
2693, 6mubL, 0.6426, 2.91, 0.056, 212, 90, ANTI-HIV-1 FAB 2G12 + MAN5 RE-REFINEMENT 
2694, 6h0eF, 0.6426, 2.98, 0.054, 218, 92, FAB DMCBTAU-22.1 IN COMPLEX WITH TAU PEPTIDE V1088-23 
2695, 6dznL, 0.6426, 2.85, 0.055, 213, 91, PAN-EBOLAVIRUS HUMAN ANTIBODY ADI-15878 FAB 
2696, 6df2A, 0.6426, 2.98, 0.054, 215, 92, IMPROVED ANTI-PHOSPHOTYROSINE ANTIBODY 4G10-S5-4D5 FAB COMPLEXED WITH PHOSPHOTYROSINE PEPTIDE 
2697, 5y9fQ, 0.6426, 2.90, 0.044, 217, 91, CRYSTAL STRUCTURE OF HPV59 PENTAMER IN COMPLEX WITH THE FAB FRAGMENT OF ANTIBODY 28F10
2698, 5hyqA, 0.6426, 2.98, 0.065, 213, 92, CETUXIMAB FAB IN COMPLEX WITH AMIDATED MEDITOPE
2699, 5gzoL, 0.6426, 2.82, 0.055, 213, 91, STRUCTURE OF NEUTRALIZING ANTIBODY BOUND TO ZIKA ENVELOPE PROTEIN
2700, 5bk1L, 0.6426, 3.02, 0.065, 210, 93, CRYSTAL STRUCTURE OF MALTOSE BINDING PROTEIN IN COMPLEX WITH AN ENDOSTERIC SYNTHETIC ANTIBODY
2701, 4z7oF, 0.6426, 2.99, 0.054, 214, 92, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE
2702, 4yc2C, 0.6426, 2.87, 0.067, 210, 90, CRYSTAL STRUCTURE OF THE STABILIZED INNER DOMAIN OF CLADE A/E HIV-1 GP120 FROM E. COLI IN COMPLEX WITH THE ANTIBODY A32.
2703, 4r90L, 0.6426, 2.72, 0.090, 210, 89, ANTI CD70 LLAMA GLAMA FAB 27B3
2704, 4r2gP, 0.6426, 2.85, 0.089, 210, 90, CRYSTAL STRUCTURE OF PGT124 FAB BOUND TO HIV-1 JRCSF GP120 CORE AND TO CD4
2705, 4mwfL, 0.6426, 2.97, 0.054, 212, 92, STRUCTURE OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 CORE BOUND TO BROADLY NEUTRALIZING ANTIBODY AR3C
2706, 4kxzP, 0.6426, 2.97, 0.055, 213, 91, CRYSTAL STRUCTURE OF TGFB2 IN COMPLEX WITH GC2008.
2707, 4fqrt, 0.6426, 2.97, 0.054, 213, 92, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
2708, 4fqrj, 0.6426, 3.14, 0.065, 213, 93, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
2709, 4evnP, 0.6426, 2.86, 0.088, 213, 91, CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN)
2710, 4evnL, 0.6426, 2.86, 0.088, 213, 91, CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN)
2711, 3nacL, 0.6426, 3.06, 0.054, 214, 93, CRYSTAL STRUCTURE OF FAB15 MUT7
2712, 3g5vA, 0.6426, 2.89, 0.044, 212, 91, ANTIBODIES SPECIFICALLY TARGETING A LOCALLY MISFOLDED REGION OF TUMOR ASSOCIATED EGFR
2713, 3csyB, 0.6426, 2.84, 0.056, 216, 89, CRYSTAL STRUCTURE OF THE TRIMERIC PREFUSION EBOLA VIRUS GLYCOPROTEIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY FROM A HUMAN SURVIVOR
2714, 3cfkM, 0.6426, 2.93, 0.055, 215, 91, CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4 TRICLINIC CRYSTAL FORM
2715, 2ca4A, 0.6426, 3.00, 0.042, 373, 95, SULFITE DEHYDROGENASE FROM STARKEYA NOVELLA MUTANT
2716, 1jglL, 0.6426, 3.07, 0.054, 213, 93, CRYSTAL STRUCTURE OF IMMUNOGLOBULIN FAB FRAGMENT COMPLEXED WITH 17-BETA-ESTRADIOL
2717, 6ncxC, 0.6425, 3.11, 0.083, 559, 96, CRYSTAL STRUCTURE OF GH2 BETA-GALACTURONIDASE FROM EISENBERGIELLA TAYI BOUND TO GALACTURONATE 
2718, 6dg2D, 0.6425, 2.86, 0.056, 211, 89, ANTIGEN BINDING FRAGMENT OF THE PAN-EBOLAVIRUS MONOCLONAL ANTIBODY 6D6 
2719, 6dg2B, 0.6425, 2.90, 0.056, 212, 90, ANTIGEN BINDING FRAGMENT OF THE PAN-EBOLAVIRUS MONOCLONAL ANTIBODY 6D6 
2720, 5tqaL, 0.6425, 2.80, 0.089, 211, 90, CRYSTAL STRUCTURE OF DH270.6 (UNLIGANDED) FROM THE DH270 BROADLY NEUTRALIZING N332-GLYCAN DEPENDENT LINEAGE
2721, 5mvjF, 0.6425, 2.98, 0.054, 218, 92, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACE-GROUP P1 
2722, 5k9qK, 0.6425, 3.04, 0.054, 214, 93, CRYSTAL STRUCTURE OF MULTIDONOR HV1-18-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 16.A.26 IN COMPLEX WITH A/HONG KONG/1-4-MA21- 1/1968 (H3N2) HEMAGGLUTININ
2723, 5hhvL, 0.6425, 2.81, 0.089, 213, 90, INHIBITING COMPLEX IL-17A AND IL-17RA INTERACTIONS WITH A LINEAR PEPTIDE
2724, 5dd1L, 0.6425, 3.14, 0.065, 213, 92, CRYSTAL STRUCTURES IN AN ANTI-HIV ANTIBODY LINEAGE FROM IMMUNIZATION OF RHESUS MACAQUES
2725, 5bvjA, 0.6425, 3.01, 0.054, 214, 92, THE MOLECULAR MODE OF ACTION AND SPECIES SPECIFICITY OF CANAKINUMAB A HUMAN MONOCLONAL ANTIBODY NEUTRALIZING IL-1BETA
2726, 5b3jF, 0.6425, 3.04, 0.054, 211, 92, ACTIVATION OF NMDA RECEPTORS AND THE MECHANISM OF INHIBITION BY IFENPRODIL
2727, 4yblC, 0.6425, 2.71, 0.067, 210, 89, CRYSTAL STRUCTURE OF THE STABILIZED INNER DOMAIN OF CLADE A/E HIV-1 GP120 IN COMPLEX WITH THE ADCC MEDIATING ANTI-HIV-1 ANTIBODY A32
2728, 4xtrF, 0.6425, 3.02, 0.054, 216, 93, STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF PEP12
2729, 4xbgD, 0.6425, 2.97, 0.055, 214, 91, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA): 2.73 A RESOLUTION
2730, 4r7nR, 0.6425, 3.00, 0.065, 213, 92, FAB C2E3
2731, 4nnpL, 0.6425, 2.93, 0.056, 213, 90, CRYSTAL STRUCTURE OF APO MANGANESE ABC TRANSPORTER MNTC FROM STAPHYLOCOCCUS AUREUS BOUND TO AN ANTAGONISTIC FAB FRAGMENT
2732, 4m7kL, 0.6425, 3.00, 0.054, 220, 92, CRYSTAL STRUCTURE OF ANTI-TISSUE FACTOR ANTIBODY 10H10
2733, 4jznD, 0.6425, 2.98, 0.054, 212, 92, THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING HUMAN ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 FAB FRAGMENT HC84-1
2734, 4jn2L, 0.6425, 2.81, 0.055, 219, 91, AN ANTIDOTE FOR DABIGATRAN
2735, 4i3sL, 0.6425, 3.06, 0.065, 208, 93, CRYSTAL STRUCTURE OF THE OUTER DOMAIN OF HIV-1 GP120 IN COMPLEX WITH VRC-PG04 SPACE GROUP P21
2736, 3w2dL, 0.6425, 3.04, 0.043, 215, 93, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL EENTEROTOXIN B IN COMPLEX WITH A NOVEL NEUTRALIZATION MONOCLONAL ANTIBODY FAB FRAGMENT
2737, 3sobL, 0.6425, 2.96, 0.055, 213, 91, THE STRUCTURE OF THE FIRST YWTD BETA PROPELLER DOMAIN OF LRP6 IN COMPLEX WITH A FAB
2738, 3o45B, 0.6425, 3.05, 0.054, 217, 93, CRYSTAL STRUCTURE OF 101F FAB BOUND TO 17-MER PEPTIDE EPITOPE
2739, 3mj8L, 0.6425, 2.74, 0.079, 209, 89, CRYSTAL STRUCTURE OF HL4E10 FAB A HAMSTER AB STIMULATORY FOR GAMMADELTA T CELLS
2740, 3bpoB, 0.6425, 2.76, 0.078, 198, 90, CRYSTAL STRUCTURE OF THE IL13-IL4R-IL13RA TERNARY COMPLEX
2741, 3b9kL, 0.6425, 3.16, 0.043, 213, 94, CRYSTAL STRUCTURE OF CD8ALPHA-BETA IN COMPLEX WITH YTS 156.7 FAB
2742, 2zpkL, 0.6425, 2.76, 0.056, 211, 90, CRYSTAL STRUCTURE OF P20.1 FAB FRAGMENT IN COMPLEX WITH ITS ANTIGEN PEPTIDE
2743, 2nz9E, 0.6425, 2.90, 0.056, 216, 90, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY AR2
2744, 2ca3A, 0.6425, 2.90, 0.032, 373, 94, SULFITE DEHYDROGENASE FROM STARKEYA NOVELLA R55M MUTANT
2745, 1ztxL, 0.6425, 2.93, 0.044, 212, 91, WEST NILE VIRUS ENVELOPE PROTEIN DIII IN COMPLEX WITH NEUTRALIZING E16 ANTIBODY FAB
2746, 1tjiL, 0.6425, 3.07, 0.054, 213, 92, CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY 2F5 IN COMPLEX WITH A GP41 17MER EPITOPE
2747, 1tjhL, 0.6425, 2.97, 0.055, 213, 91, CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY 2F5 IN COMPLEX WITH A GP41 11MER EPITOPE
2748, 1nd0E, 0.6425, 3.03, 0.054, 219, 93, CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG
2749, 1nd0C, 0.6425, 3.03, 0.054, 219, 93, CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG
2750, 1nd0A, 0.6425, 3.03, 0.054, 219, 93, CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG
2751, 1fl5L, 0.6425, 3.10, 0.065, 217, 92, THE UNLIGANDED GERMLINE PRECURSOR TO THE SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4.
2752, 1bj1L, 0.6425, 3.00, 0.054, 213, 92, VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH A NEUTRALIZING ANTIBODY
2753, 6oe5L, 0.6424, 2.93, 0.056, 212, 90, SPLAYED OPEN PREFUSION RSV F CAPTURED BY CR9501 AND MOTAVIZUMAB FABS 
2754, 6d4nB, 0.6424, 2.89, 0.064, 208, 94, CRYSTAL STRUCTURE OF A FC FRAGMENT OF RHESUS MACAQUE (MACACA MULATTA) IGG4 
2755, 6cyfE, 0.6424, 3.04, 0.065, 214, 93, PCRV FRAGMENT WITH BOUND FAB 
2756, 6c6xB, 0.6424, 2.82, 0.067, 213, 90, CRYSTAL STRUCTURE OF MIDDLE-EAST RESPIRATORY SYNDROME (MERS) CORONAVIRUS NEUTRALIZING ANTIBODY JC57-14 ISOLATED FROM A VACCINATED RHESUS MACAQUE.
2757, 6bitK, 0.6424, 3.11, 0.043, 211, 92, SIRPALPHA ANTIBODY COMPLEX
2758, 6b3kL, 0.6424, 3.03, 0.054, 215, 93, CRYSTAL STRUCTURE OF MUTANT SPINACH RNA APTAMER IN COMPLEX WITH FAB BL3-6
2759, 5y2mL, 0.6424, 2.90, 0.056, 212, 90, CRYSTAL STRUCTURE OF A GROUP 2 HA BINDING ANTIBODY AF4H1K1 FAB IN COMPLEX WITH THE H4N6 DUCK ISOLATE (H4-CZ/56) HEMAGGLUTININ 
2760, 5vzrB, 0.6424, 3.06, 0.054, 208, 93, CRYSTAL STRUCTURE OF MERS-COV NEUTRALIZING ANTIBODY G4 FAB
2761, 5tjdL, 0.6424, 3.07, 0.054, 215, 93, COMPUTER-BASED RATIONAL DESIGN OF IMPROVED FUNCTIONALITY FOR ANTIBODY CATALYSTS TOWARD ORGANOPHOSPHORUS COMPOUNDS 
2762, 5k9qI, 0.6424, 3.04, 0.054, 214, 93, CRYSTAL STRUCTURE OF MULTIDONOR HV1-18-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 16.A.26 IN COMPLEX WITH A/HONG KONG/1-4-MA21- 1/1968 (H3N2) HEMAGGLUTININ
2763, 5jopL, 0.6424, 3.11, 0.065, 218, 93, CRYSTAL STRUCTURE OF ANTI-GLYCAN ANTIBODY FAB14.22 IN COMPLEX WITH STREPTOCOCCUS PNEUMONIAE SEROTYPE 14 TETRASACCHARIDE AT 1.75 A
2764, 5f3bF, 0.6424, 2.96, 0.055, 213, 91, STRUCTURE OF MYOSTATIN IN COMPLEX WITH CHIMERIC RK35 ANTIBODY
2765, 5czxL, 0.6424, 3.01, 0.054, 213, 92, CRYSTAL STRUCTURE OF NOTCH3 NRR IN COMPLEX WITH 20358 FAB
2766, 5bk0C, 0.6424, 3.05, 0.054, 214, 92, CRYSTAL STRUCTURE OF 663 FAB BOUND TO CIRCUMSPOROZOITE PROTEIN NANP 5- MER
2767, 4nugL, 0.6424, 2.95, 0.055, 218, 91, CRYSTAL STRUCTURE OF HIV-1 BROADLY NEUTRALIZING ANTIBODY PGT151
2768, 4mauL, 0.6424, 2.89, 0.056, 216, 90, CRYSTAL STRUCTURE OF ANTI-ST2L ANTIBODY C2244
2769, 4m1dM, 0.6424, 2.75, 0.089, 213, 90, CRYSTAL STRUCTURE OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 CYCLIC PEPTIDE MN
2770, 4hc1B, 0.6424, 3.39, 0.031, 198, 98, CRYSTAL STRUCTURE OF A LOOP DELETED MUTANT OF HUMAN MADCAM-1 D1D2 COMPLEXED WITH FAB 10G3
2771, 3v6zD, 0.6424, 2.84, 0.055, 219, 91, CRYSTAL STRUCTURE OF HEPATITIS B VIRUS E-ANTIGEN
2772, 3g6jG, 0.6424, 3.05, 0.054, 214, 93, C3B IN COMPLEX WITH A C3B SPECIFIC FAB
2773, 2iqaA, 0.6424, 3.06, 0.054, 219, 93, PFA2 FAB FRAGMENT MONOCLINIC APO FORM
2774, 2fl5L, 0.6424, 2.81, 0.089, 209, 90, COFACTOR-CONTAINING ANTIBODIES: CRYSTAL STRUCTURE OF THE ORIGINAL YELLOW ANTIBODY
2775, 2a9bA, 0.6424, 3.34, 0.083, 372, 96, CRYSTAL STRUCTURE OF R138Q MUTANT OF RECOMBINANT SULFITE OXIDASE AT RESTING STATE
2776, 1gigL, 0.6424, 2.48, 0.057, 210, 87, REFINED THREE-DIMENSIONAL STRUCTURE OF THE FAB FRAGMENT OF A MURINE IGG1 LAMBDA ANTIBODY
2777, 1dqqA, 0.6424, 3.06, 0.054, 214, 93, CRYSTAL STRUCTURE OF ANTI-LYSOZYME ANTIBODY HYHEL-63
2778, 1cz8X, 0.6424, 3.00, 0.054, 213, 92, VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH AN AFFINITY MATURED ANTIBODY
2779, 1ad0A, 0.6424, 2.97, 0.054, 213, 92, FAB FRAGMENT OF ENGINEERED HUMAN MONOCLONAL ANTIBODY A5B7
2780, 6ev1F, 0.6423, 2.79, 0.055, 212, 91, CRYSTAL STRUCTURE OF ANTIBODY AGAINST SCHIZOPHYLLAN 
2781, 5w1kM, 0.6423, 3.03, 0.054, 213, 92, JUNV GP1 CR1-10 FAB CR1-28 FAB COMPLEX 
2782, 5umnD, 0.6423, 3.01, 0.054, 213, 92, CRYSTAL STRUCTURE OF C05 VPGSGW MUTANT BOUND TO H3 INFLUENZA HEMAGGLUTININ HA1 SUBUNIT
2783, 5mv3B, 0.6423, 3.01, 0.043, 218, 93, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
2784, 5ig7K, 0.6423, 2.73, 0.090, 213, 89, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E01 FAB FRAGMENT IN COMPLEX OF PEPTIDE PLQPQQPFP
2785, 5gz0A, 0.6423, 2.97, 0.054, 213, 92, CRYSTAL STRUCTURE OF FM329 A RECOMBINANT FAB ADOPTED FROM CETUXIMAB
2786, 4xcnD, 0.6423, 2.98, 0.055, 214, 91, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA); 2.9 A RESOLUTION
2787, 4olxL, 0.6423, 2.91, 0.055, 208, 91, CRYSTAL STRUCTURE OF ANTIBODY VRC07-G54L IN COMPLEX WITH CLADE A/E 93TH057 HIV-1 GP120 CORE
2788, 4ma3A, 0.6423, 2.94, 0.055, 218, 91, CRYSTAL STRUCTURE OF ANTI-HINGE RABBIT ANTIBODY C2095
2789, 4jzoB, 0.6423, 2.92, 0.056, 211, 90, THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING HUMAN ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 FAB FRAGMENT HC84-27
2790, 4evnH, 0.6423, 2.86, 0.088, 213, 91, CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN)
2791, 4evnF, 0.6423, 2.86, 0.088, 213, 91, CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN)
2792, 4d9lL, 0.6423, 2.83, 0.078, 214, 90, FAB STRUCTURE OF ANTI-HIV-1 GP120 V2 MAB 697
2793, 4aeiL, 0.6423, 3.12, 0.043, 218, 93, CRYSTAL STRUCTURE OF THE AAHII-FAB4C1 COMPLEX
2794, 3uajL, 0.6423, 3.01, 0.054, 213, 92, CRYSTAL STRUCTURE OF THE ENVELOPE GLYCOPROTEIN ECTODOMAIN FROM DENGUE VIRUS SEROTYPE 4 IN COMPLEX WITH THE FAB FRAGMENT OF THE CHIMPANZEE MONOCLONAL ANTIBODY 5H2
2795, 3ob8C, 0.6423, 3.03, 0.063, 1024, 95, STRUCTURE OF THE BETA-GALACTOSIDASE FROM KLUYVEROMYCES LACTIS IN COMPLEX WITH GALACTOSE
2796, 3oazK, 0.6423, 2.75, 0.056, 213, 90, A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY
2797, 3nabL, 0.6423, 3.05, 0.054, 214, 93, CRYSTAL STRUCTURE OF FAB15 MUT6
2798, 3naaL, 0.6423, 2.88, 0.054, 214, 92, CRYSTAL STRUCTURE OF FAB15 MUT5
2799, 3csyD, 0.6423, 2.67, 0.057, 216, 88, CRYSTAL STRUCTURE OF THE TRIMERIC PREFUSION EBOLA VIRUS GLYCOPROTEIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY FROM A HUMAN SURVIVOR
2800, 3cfkL, 0.6423, 2.93, 0.055, 215, 91, CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4 TRICLINIC CRYSTAL FORM
2801, 1v7nL, 0.6423, 3.01, 0.054, 213, 93, HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB
2802, 1mjjL, 0.6423, 2.79, 0.056, 216, 90, HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS6-12 AND A TRANSITION- STATE ANALOG
2803, 1kcrL, 0.6423, 3.02, 0.032, 213, 93, CRYSTAL STRUCTURE OF ANTIBODY PC283 IN COMPLEX WITH PS1 PEPTIDE
2804, 1cfnA, 0.6423, 3.23, 0.053, 214, 94, ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH AN EPITOPE-RELATED PEPTIDE
2805, 6flaB, 0.6422, 2.87, 0.044, 216, 91, 3H5 FAB BOUND TO EDIII OF DENV 2 XTAL FORM 1 
2806, 6apcL, 0.6422, 2.71, 0.090, 213, 89, CRYSTAL STRUCTURE OF INFANT ANTIBODY ADI-19425
2807, 6apbL, 0.6422, 2.91, 0.056, 212, 90, CRYSTAL STRUCTURE OF NON-NEUTRALIZING INFANT ANTIBODY ADI-14359 IN COMPLEX WITH POSTFUSION RSV F GLYCOPROTEIN
2808, 5xajL, 0.6422, 3.06, 0.054, 214, 93, STRUCTURAL MIMICRY OF THE DENGUE VIRUS ENVELOPE GLYCOPROTEIN REVEALED BY THE CRYSTALLOGRAPHIC STUDY OF AN IDIOTYPE-ANTI-IDIOTYPE FAB COMPLEX.
2809, 5w5lA, 0.6422, 3.01, 0.053, 209, 95, CRYSTAL STRUCTURE OF HUMAN IGG1-SIGMA FC FRAGMENT
2810, 5t6lL, 0.6422, 2.82, 0.066, 212, 91, CRYSTAL STRUCTURE OF 10E8 FAB IN COMPLEX WITH THE MPER EPITOPE SCAFFOLD T117V2
2811, 5nuzL, 0.6422, 2.97, 0.054, 219, 92, JUNIN VIRUS GP1 GLYCOPROTEIN IN COMPLEX WITH AN ANTIBODY FAB FRAGMENT
2812, 5muhB, 0.6422, 2.78, 0.056, 182, 90, CRYSTAL STRUCTURE OF AN AMYLOIDOGENIC LIGHT CHAIN DIMER H7
2813, 5mp5B, 0.6422, 3.04, 0.054, 217, 92, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 6.5 
2814, 5jihB, 0.6422, 2.93, 0.053, 212, 94, CRYSTAL STRUCTURE OF HER2 BINDING IGG1-FC (FCAB STAB19)
2815, 5eocM, 0.6422, 3.06, 0.054, 215, 92, CRYSTAL STRUCTURE OF FAB C2 IN COMPLEX WITH A CYCLIC VARIANT OF HEPATITIS C VIRUS E2 EPITOPE I
2816, 5b6fG, 0.6422, 3.18, 0.065, 217, 93, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF AN ANTI-LEUKOTRIENE C4 MONOCLONAL ANTIBODY COMPLEXED WITH LTC4
2817, 4x8jL, 0.6422, 3.06, 0.054, 214, 93, CRYSTAL STRUCTURE OF MURINE 12F4 FAB MONOCLONAL ANTIBODY AGAINST ADAMTS5
2818, 4r26L, 0.6422, 2.84, 0.089, 210, 90, CRYSTAL STRUCTURE OF HUMAN FAB PGT124 A BROADLY NEUTRALIZING AND POTENT HIV-1 NEUTRALIZING ANTIBODY
2819, 4kxzL, 0.6422, 2.96, 0.055, 213, 91, CRYSTAL STRUCTURE OF TGFB2 IN COMPLEX WITH GC2008.
2820, 4i18L, 0.6422, 2.78, 0.056, 216, 90, CRYSTAL STRUCTURE OF HUMAN PROLACTIN RECEPTOR COMPLEXED WITH FAB FRAGMENT
2821, 4evnD, 0.6422, 2.86, 0.088, 213, 91, CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN)
2822, 4dkeM, 0.6422, 2.71, 0.056, 212, 89, CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-34 BOUND TO FAB1.1
2823, 3wkmL, 0.6422, 2.98, 0.055, 215, 91, THE PERIPLASMIC PDZ TANDEM FRAGMENT OF THE RSEP HOMOLOGUE FROM AQUIFEX AEOLICUS IN COMPLEX WITH THE FAB FRAGMENT
2824, 3u30E, 0.6422, 2.88, 0.056, 211, 90, CRYSTAL STRUCTURE OF A LINEAR-SPECIFIC UBIQUITIN FAB BOUND TO LINEAR UBIQUITIN
2825, 3mluL, 0.6422, 2.72, 0.067, 218, 90, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A ZAM18 V3 PEPTIDE
2826, 3cfkO, 0.6422, 2.93, 0.055, 215, 91, CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4 TRICLINIC CRYSTAL FORM
2827, 2fx8O, 0.6422, 2.99, 0.054, 214, 92, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH AN AIB-INDUCED PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41
2828, 1mcqA, 0.6422, 2.86, 0.054, 216, 92, PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
2829, 1jhkL, 0.6422, 3.06, 0.054, 213, 93, CRYSTAL STRUCTURE OF THE ANTI-ESTRADIOL ANTIBODY 57-2
2830, 6novB, 0.6421, 2.99, 0.054, 218, 92, A FAB DERIVED FROM IXEKIZUMAB 
2831, 6gk8L, 0.6421, 3.01, 0.054, 219, 92, CRYSTAL STRUCTURE OF ANTI-TAU ANTIBODY DMCBTAU-28.1; DOUBLE MUTANT (S32R; E35K) OF CBTAU-28.1; IN COMPLEX WITH TAU PEPTIDE A7731 (RESIDUES 52-71) 
2832, 6bdzL, 0.6421, 3.01, 0.054, 215, 93, ADAM10 EXTRACELLULAR DOMAIN BOUND BY THE 11G2 FAB
2833, 5x2mL, 0.6421, 2.94, 0.043, 217, 92, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-GLUTAMINE
2834, 5lcvL, 0.6421, 2.83, 0.089, 212, 90, STRUCTURAL BASIS OF ZIKA AND DENGUE VIRUS POTENT ANTIBODY CROSS- NEUTRALIZATION
2835, 5kzpL, 0.6421, 2.95, 0.066, 212, 91, STRUCTURE OF THE HCV1-C1 ANTIBODY-ANTIGEN COMPLEX
2836, 5j3dD, 0.6421, 3.21, 0.064, 215, 94, CRYSTAL STRUCTURE OF HUMAN FAB 14N4 IN COMPLEX WITH POST-FUSION RSV F
2837, 4s1dD, 0.6421, 2.86, 0.056, 211, 90, STRUCTURE OF IGG1 FAB FRAGMENT IN COMPLEX WITH BIOTINCYTIDINAMIDE
2838, 4rx4D, 0.6421, 3.01, 0.054, 213, 92, CRYSTAL STRUCTURE OF VH1-46 GERMLINE-DERIVED CD4-BINDING SITE-DIRECTED ANTIBODY 8ANC134 IN COMPLEX WITH HIV-1 CLADE A Q842.D12 GP120
2839, 4hs6L, 0.6421, 3.19, 0.064, 218, 94, HEPATITUS C ENVELOPE GLYCOPROTEIN E2 FRAGMENT 412-423 WITH HUMANIZED AND AFFINITY-MATURED ANTIBODY MRCT10.V362
2840, 4hkzA, 0.6421, 3.03, 0.054, 213, 92, TRASTUZUMAB FAB COMPLEXED WITH PROTEIN L AND PROTEIN A FRAGMENTS
2841, 4hd9A, 0.6421, 3.26, 0.051, 198, 98, CRYSTAL STRUCTURE OF NATIVE HUMAN MADCAM-1 D1D2 DOMAIN
2842, 4fqvN, 0.6421, 2.71, 0.090, 211, 89, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR9114 BOUND TO H7 INFLUENZA HEMAGGLUTININ
2843, 4fqrl, 0.6421, 2.98, 0.054, 213, 92, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
2844, 3ze0F, 0.6421, 2.99, 0.054, 214, 92, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
2845, 3v6zB, 0.6421, 2.85, 0.055, 219, 91, CRYSTAL STRUCTURE OF HEPATITIS B VIRUS E-ANTIGEN
2846, 3hi1A, 0.6421, 3.05, 0.054, 215, 93, STRUCTURE OF HIV-1 GP120 (CORE WITH V3) IN COMPLEX WITH CD4-BINDING- SITE ANTIBODY F105
2847, 3hc0L, 0.6421, 2.95, 0.055, 212, 91, BHA10 IGG1 WILD-TYPE FAB - ANTIBODY DIRECTED AT HUMAN LTBR
2848, 3difA, 0.6421, 2.79, 0.055, 213, 91, CRYSTAL STRUCTURE OF FABOX117
2849, 2jixG, 0.6421, 3.08, 0.065, 214, 93, CRYSTAL STRUCTURE OF ABT-007 FAB FRAGMENT WITH THE SOLUBLE DOMAIN OF EPO RECEPTOR
2850, 1nd0G, 0.6421, 3.03, 0.054, 219, 93, CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG
2851, 1l7iL, 0.6421, 3.02, 0.065, 214, 93, CRYSTAL STRUCTURE OF THE ANTI-ERBB2 FAB2C4
2852, 1knoC, 0.6421, 3.00, 0.043, 214, 93, CRYSTAL STRUCTURE OF THE COMPLEX OF A CATALYTIC ANTIBODY FAB WITH A TRANSITION STATE ANALOG: STRUCTURAL SIMILARITIES IN ESTERASE-LIKE ABZYMES
2853, 1jnhA, 0.6421, 2.58, 0.045, 208, 89, CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES
2854, 1ad0C, 0.6421, 2.98, 0.054, 213, 92, FAB FRAGMENT OF ENGINEERED HUMAN MONOCLONAL ANTIBODY A5B7
2855, 6e4xY, 0.6420, 2.94, 0.056, 208, 90, HUMAN ANTIBODY S5V2-29 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ A/TEXAS/50/2012 (H3N2) 
2856, 6ce0L, 0.6420, 2.87, 0.089, 211, 90, CRYSTAL STRUCTURE OF A HIV-1 CLADE B TIER-3 ISOLATE H078.14 UFO-BG ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING FABS PGT124 AND 35O22 AT 4.6 ANGSTROM 
2857, 6b3sL, 0.6420, 3.01, 0.055, 213, 91, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF NECITUMUMAB (FAB11F8) IN COMPLEX WITH DOMAIN III FROM A CETUXIMAB RESISTANT VARIANT OF EGFR (SEGFRD3-S468R)
2858, 6a4kN, 0.6420, 3.09, 0.053, 216, 94, HUMAN ANTIBODY 32D6 FAB IN COMPLEX WITH H1N1 INFLUENZA A VIRUS HA1 
2859, 5ziaI, 0.6420, 2.83, 0.056, 217, 89, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-24.1 IN COMPLEX WITH ITS PHOSPHORYLATED TAU PEPTIDE 
2860, 5wnaD, 0.6420, 2.92, 0.056, 211, 90, STRUCTURE OF ANTIBODY 3D3 BOUND TO THE CENTRAL CONSERVED REGION OF RSV 2 G
2861, 5vagB, 0.6420, 2.83, 0.055, 214, 91, CRYSTAL STRUCTURE OF H7-SPECIFIC ANTIBODY M826 IN COMPLEX WITH THE HA1 DOMAIN OF HEMAGGLUTININ FROM H7N9 INFLUENZA VIRUS
2862, 5nbiL, 0.6420, 2.75, 0.056, 216, 89, PRINCIPLES FOR COMPUTATIONAL DESIGN OF ANTIBODIES
2863, 5erwB, 0.6420, 3.14, 0.053, 213, 94, STRUCTURE OF HCV E2 GLYCOPROTEIN ANTIGENIC EPITOPE II BOUND TO THE BROADLY NEUTRALIZING ANTIBODY HC84-26
2864, 5dvlA, 0.6420, 2.90, 0.053, 208, 94, FC DESIGN 20.8.37 A CHAIN HOMODIMER Y349S/T366M/K370Y/K409V
2865, 5dmiL, 0.6420, 2.97, 0.054, 213, 92, STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE CD40 IN COMPLEX WITH CHI220 FAB
2866, 4ypgA, 0.6420, 3.20, 0.064, 215, 94, STRUCTURAL INSIGHTS INTO THE NEUTRALIZATION PROPERTIES OF A HUMAN ANTI-INTERFERON MONOCLONAL ANTIBODY
2867, 4xpbL, 0.6420, 2.90, 0.043, 214, 92, X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER WITH SUBSITEB MUTATIONS (D121G/S426M) BOUND TO COCAINE
2868, 4fq2L, 0.6420, 2.94, 0.087, 211, 92, CRYSTAL STRUCTURE OF 10-1074 FAB
2869, 3zdzF, 0.6420, 2.99, 0.054, 214, 92, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
2870, 3qa3A, 0.6420, 3.16, 0.053, 220, 94, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
2871, 3nz8L, 0.6420, 2.95, 0.043, 218, 92, CRYSTAL STRUCTURE OF THE HIV-2 NEUTRALIZING FAB FRAGMENT 7C8
2872, 3na9L, 0.6420, 3.06, 0.054, 214, 93, CRYSTAL STRUCTURE OF FAB15
2873, 3hi1L, 0.6420, 3.05, 0.054, 215, 93, STRUCTURE OF HIV-1 GP120 (CORE WITH V3) IN COMPLEX WITH CD4-BINDING- SITE ANTIBODY F105
2874, 3cfkJ, 0.6420, 2.93, 0.055, 215, 91, CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4 TRICLINIC CRYSTAL FORM
2875, 3c6sC, 0.6420, 2.90, 0.054, 218, 92, CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A SHIGELLA FLEXNERI 2A O-AG PENTADECASACCHARIDE
2876, 2r0kL, 0.6420, 3.05, 0.054, 214, 93, PROTEASE DOMAIN OF HGFA WITH INHIBITOR FAB58
2877, 2gjzL, 0.6420, 2.85, 0.044, 217, 91, STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 13G5 FROM A CRYSTAL IN SPACE GROUP P2(1)
2878, 2gfbM, 0.6420, 2.99, 0.043, 214, 93, CRYSTAL STRUCTURE OF A CATALYTIC FAB HAVING ESTERASE-LIKE ACTIVITY
2879, 2gfbA, 0.6420, 3.00, 0.043, 214, 93, CRYSTAL STRUCTURE OF A CATALYTIC FAB HAVING ESTERASE-LIKE ACTIVITY
2880, 1nl0L, 0.6420, 2.76, 0.067, 213, 90, CRYSTAL STRUCTURE OF HUMAN FACTOR IX GLA DOMAIN IN COMPLEX OF AN INHIBITORY ANTIBODY 10C12
2881, 1bafL, 0.6420, 3.01, 0.043, 214, 93, 2.9 ANGSTROMS RESOLUTION STRUCTURE OF AN ANTI-DINITROPHENYL-SPIN-LABEL MONOCLONAL ANTIBODY FAB FRAGMENT WITH BOUND HAPTEN
2882, 6de7L, 0.6419, 2.78, 0.067, 208, 90, CRYSTAL STRUCTURE AT 4.3 A RESOLUTION OF GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER WITH INTERDOMAIN STABILIZATION 113C-429GCG IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122 AND 35O22 
2883, 6ca6L, 0.6419, 2.98, 0.054, 213, 92, CRYSTAL STRUCTURE OF PCT64_35S; A BROADLY NEUTRALIZING ANTI-HIV ANTIBODY. 
2884, 5y2lJ, 0.6419, 2.91, 0.056, 212, 90, CRYSTAL STRUCTURE OF A GROUP 2 HA BINDING ANTIBODY AF4H1K1 FAB IN COMPLEX WITH THE 1968 H3N2 PANDEMIC (H3-AC/68) HEMAGGLUTININ 
2885, 5xrqB, 0.6419, 2.96, 0.055, 212, 91, CRYSTAL STRUCTURE OF HUMAN MONOCLONAL ANTIBODY H3V-47 
2886, 5w38A, 0.6419, 3.14, 0.052, 209, 97, 1.80A RESOLUTION STRUCTURE OF HUMAN IGG3 FC (N392K)
2887, 5kqvQ, 0.6419, 2.99, 0.043, 214, 93, INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1CRL2 FNIII-1 AND ALPHACT PEPTIDE IN COMPLEX WITH BOVINE INSULIN AND FAB 83-14 (REVISED STRUCTURE)
2888, 5kqvD, 0.6419, 2.99, 0.043, 214, 93, INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1CRL2 FNIII-1 AND ALPHACT PEPTIDE IN COMPLEX WITH BOVINE INSULIN AND FAB 83-14 (REVISED STRUCTURE)
2889, 5ihzD, 0.6419, 2.71, 0.090, 213, 89, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E01 FAB FRAGMENT
2890, 5ggsD, 0.6419, 3.01, 0.055, 217, 91, PD-1 IN COMPLEX WITH PEMBROLIZUMAB FAB
2891, 5cd3D, 0.6419, 2.84, 0.056, 206, 89, STRUCTURE OF IMMATURE VRC01-CLASS ANTIBODY DRVIA7
2892, 5a16B, 0.6419, 3.04, 0.054, 218, 93, CRYSTAL STRUCTURE OF FAB4201 RAISED AGAINST HUMAN ERYTHROCYTE ANION EXCHANGER 1
2893, 4xh2K, 0.6419, 3.06, 0.054, 210, 93, CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD4 MOTIF IN COMPLEX WITH FAB FRAGMENT
2894, 4orgB, 0.6419, 2.69, 0.079, 208, 89, CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.04 A POTENT V1V2-DIRECTED HIV-1 NEUTRALIZING ANTIBODY
2895, 4nwuL, 0.6419, 3.06, 0.054, 220, 93, CRYSTAL STRUCTURE OF APE1551 AN ANTI-HUMAN NGF FAB WITH A NINE AMINO ACID INSERTION IN CDR H1
2896, 4llmB, 0.6419, 2.74, 0.090, 101, 89, STRUCTURE OF REDESIGNED IGG1 FIRST CONSTANT AND LAMBDA DOMAINS (CH1:CLAMBDA CONSTANT REDESIGN 1 CRD1) AT 1.75A
2897, 4d9qL, 0.6419, 3.01, 0.054, 213, 92, INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D
2898, 3r08L, 0.6419, 2.90, 0.044, 213, 91, CRYSTAL STRUCTURE OF MOUSE CD3EPSILON IN COMPLEX WITH ANTIBODY 2C11 FAB
2899, 3qpqE, 0.6419, 3.10, 0.054, 215, 93, CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB
2900, 3pp3K, 0.6419, 3.02, 0.054, 219, 93, EPITOPE CHARACTERIZATION AND CRYSTAL STRUCTURE OF GA101 PROVIDE INSIGHTS INTO THE MOLECULAR BASIS FOR THE TYPE I / TYPE II DISTINCTION OF ANTI- CD20 ANTIBODIES
2901, 3ncjL, 0.6419, 3.06, 0.054, 214, 93, CRYSTAL STRUCTURE OF FAB15 MUT8
2902, 3cfkC, 0.6419, 2.93, 0.055, 215, 91, CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4 TRICLINIC CRYSTAL FORM
2903, 2ai0N, 0.6419, 2.89, 0.044, 216, 91, ANTI-COCAINE ANTIBODY 7.5.21 CRYSTAL FORM III
2904, 2a99A, 0.6419, 3.34, 0.083, 372, 96, CRYSTAL STRUCTURE OF RECOMBINANT CHICKEN SULFITE OXIDASE AT RESTING STATE
2905, 1knoE, 0.6419, 3.00, 0.043, 214, 93, CRYSTAL STRUCTURE OF THE COMPLEX OF A CATALYTIC ANTIBODY FAB WITH A TRANSITION STATE ANALOG: STRUCTURAL SIMILARITIES IN ESTERASE-LIKE ABZYMES
2906, 6h0eB, 0.6418, 2.98, 0.054, 218, 92, FAB DMCBTAU-22.1 IN COMPLEX WITH TAU PEPTIDE V1088-23 
2907, 5x8lK, 0.6418, 3.01, 0.054, 213, 92, PD-L1 IN COMPLEX WITH ATEZOLIZUMAB
2908, 5wkoH, 0.6418, 2.92, 0.056, 213, 90, CRYSTAL STRUCTURE OF ANTIBODY 27F3 RECOGNIZING THE HA FROM A/CALIFORNIA/04/2009 (H1N1) INFLUENZA VIRUS
2909, 5t3zL, 0.6418, 2.88, 0.087, 211, 92, 3.5 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074
2910, 5cp3A, 0.6418, 2.97, 0.043, 218, 92, CRYSTAL STRUCTURE OF AN ANTIGEN-BINDING FRAGMENT OF MONOCLONAL ANTIBODY AGAINST SULFONAMIDES IN COMPLEX WITH SULFATHIAZOLE
2911, 5c8jD, 0.6418, 3.21, 0.064, 212, 94, A YIDC-LIKE PROTEIN IN THE ARCHAEAL PLASMA MEMBRANE
2912, 5c7xL, 0.6418, 2.71, 0.079, 206, 89, CRYSTAL STRUCTURE OF MOR04357 A NEUTRALIZING ANTI-HUMAN GM-CSF ANTIBODY FAB FRAGMENT IN COMPLEX WITH HUMAN GM-CSF
2913, 4z5rV, 0.6418, 2.82, 0.055, 217, 91, RONTALIZUMAB FAB BOUND TO INTERFERON-A2
2914, 4uv4L, 0.6418, 3.01, 0.055, 217, 91, CRYSTAL STRUCTURE OF ANTI-FPR FPRO0165 FAB FRAGMENT
2915, 4tnvg, 0.6418, 2.69, 0.056, 211, 89, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2916, 4lf3D, 0.6418, 3.07, 0.054, 214, 93, INHIBITORY MECHANISM OF AN ALLOSTERIC ANTIBODY TARGETING THE GLUCAGON RECEPTOR
2917, 4gw4B, 0.6418, 2.85, 0.056, 199, 89, CRYSTAL STRUCTURE OF 3BNC60 FAB WITH P61A MUTATION
2918, 4fqrr, 0.6418, 3.14, 0.065, 213, 93, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
2919, 4fp8N, 0.6418, 3.00, 0.054, 213, 92, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ HA1 SUBUNIT
2920, 3ujiL, 0.6418, 2.68, 0.090, 208, 89, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2558 IN COMPLEX WITH MN PEPTIDE
2921, 3u46B, 0.6418, 3.03, 0.054, 214, 92, CH04H/CH02L P212121
2922, 3pp4L, 0.6418, 3.05, 0.054, 219, 93, EPITOPE CHARACTERIZATION AND CRYSTAL STRUCTURE OF GA101 PROVIDE INSIGHTS INTO THE MOLECULAR BASIS FOR THE TYPE I / TYPE II DISTINCTION OF ANTI- CD20 ANTIBODIES
2923, 3ivkB, 0.6418, 2.83, 0.056, 213, 90, CRYSTAL STRUCTURE OF THE CATALYTIC CORE OF AN RNA POLYMERASE RIBOZYME COMPLEXED WITH AN ANTIGEN BINDING ANTIBODY FRAGMENT
2924, 3ietA, 0.6418, 3.02, 0.054, 215, 92, CRYSTAL STRUCTURE OF 237MAB WITH ANTIGEN
2925, 3hbqA, 0.6418, 3.34, 0.083, 373, 96, STRUCTURE OF RECOMBINANT CHICKEN LIVER SULFITE OXIDASE MUTANT CYS 185 ALA
2926, 1za6F, 0.6418, 3.03, 0.108, 324, 93, THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY
2927, 1rziO, 0.6418, 2.97, 0.054, 211, 92, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 47E FAB
2928, 1qgc4, 0.6418, 2.98, 0.043, 217, 92, STRUCTURE OF THE COMPLEX OF A FAB FRAGMENT OF A NEUTRALIZING ANTIBODY WITH FOOT AND MOUTH DISEASE VIRUS
2929, 1mclA, 0.6418, 2.70, 0.066, 216, 91, PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
2930, 1lo0X, 0.6418, 3.02, 0.054, 219, 93, CATALYTIC RETRO-DIELS-ALDERASE TRANSITION STATE ANALOGUE COMPLEX
2931, 1jnhC, 0.6418, 2.59, 0.045, 208, 89, CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES
2932, 7fabL, 0.6417, 2.71, 0.090, 204, 89, CRYSTAL STRUCTURE OF HUMAN IMMUNOGLOBULIN FRAGMENT FAB NEW REFINED AT 2.0 ANGSTROMS RESOLUTION
2933, 6okqE, 0.6417, 2.80, 0.055, 210, 91, CRYSTAL STRUCTURE OF THE SF12 FAB 
2934, 6me1B, 0.6417, 2.93, 0.056, 212, 90, CRYSTAL STRUCTURE OF THE CLADE B ISOLATE B41 MUTANT FUSION PEPTIDE (RESIDUES 512-521) IN COMPLEX WITH VRC34.01 
2935, 5x2nK, 0.6417, 3.07, 0.054, 216, 92, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-ALANINE
2936, 5wtgC, 0.6417, 2.96, 0.043, 212, 93, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-HAV ANTIBODY R10
2937, 5w2bL, 0.6417, 2.97, 0.055, 210, 91, CRYSTAL STRUCTURE OF C-TERMINAL DOMAIN OF EBOLA (RESTON) NUCLEOPROTEIN IN COMPLEX WITH FAB FRAGMENT 
2938, 5vgaA, 0.6417, 2.98, 0.054, 214, 92, ALTERNATIVE MODEL FOR FAB 36-65
2939, 5utzC, 0.6417, 2.77, 0.089, 213, 90, HUMAN IL-2/FAB COMPLEX 
2940, 5o14L, 0.6417, 2.84, 0.056, 212, 89, CO-CRYSTAL STRUCTURE OF A CROSS-REACTIVE BACTERICIDAL HUMAN ANTIBODY TARGETING MENINGOCOCCAL VACCINE ANTIGEN FACTOR H BINDING PROTEIN
2941, 5mvzL, 0.6417, 3.09, 0.064, 215, 94, FAB 4AB007 BOUND TO INTERLEUKIN-1-BETA
2942, 5mv3D, 0.6417, 2.90, 0.054, 217, 92, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
2943, 5ig7B, 0.6417, 2.75, 0.090, 213, 89, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E01 FAB FRAGMENT IN COMPLEX OF PEPTIDE PLQPQQPFP
2944, 4ywgM, 0.6417, 3.07, 0.054, 215, 93, CRYSTAL STRUCTURE OF 830A IN COMPLEX WITH V1V2
2945, 4rqsC, 0.6417, 2.95, 0.056, 214, 90, CRYSTAL STRUCTURE OF FULLY GLYCOSYLATED HIV-1 GP120 CORE BOUND TO CD4 AND 17B FAB
2946, 4nrzL, 0.6417, 3.01, 0.054, 213, 92, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66.6
2947, 4lstL, 0.6417, 3.18, 0.064, 210, 94, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC01 IN COMPLEX WITH HIV-1 CLADE C STRAIN ZM176.66 GP120
2948, 4lqfL, 0.6417, 2.98, 0.054, 219, 92, STRUCTURE OF MURINE IGG2B A2C7-FAB IN COMPLEX WITH VACCINIA ANTIGEN A33R AT THE RESOLUTION OF 2.3 ANGSTROMS
2949, 4fqvM, 0.6417, 2.71, 0.090, 211, 89, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR9114 BOUND TO H7 INFLUENZA HEMAGGLUTININ
2950, 3sdyL, 0.6417, 3.03, 0.054, 215, 93, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR8020 BOUND TO THE INFLUENZA A H3 HEMAGGLUTININ
2951, 3ivkL, 0.6417, 2.83, 0.056, 213, 90, CRYSTAL STRUCTURE OF THE CATALYTIC CORE OF AN RNA POLYMERASE RIBOZYME COMPLEXED WITH AN ANTIGEN BINDING ANTIBODY FRAGMENT
2952, 3g6jE, 0.6417, 3.06, 0.054, 214, 93, C3B IN COMPLEX WITH A C3B SPECIFIC FAB
2953, 3eyfC, 0.6417, 2.97, 0.054, 215, 92, CRYSTAL STRUCTURE OF ANTI-HUMAN CYTOMEGALOVIRUS ANTIBODY 8F9 PLUS GB PEPTIDE
2954, 2r2bA, 0.6417, 2.89, 0.054, 217, 92, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
2955, 2gfbE, 0.6417, 2.99, 0.043, 214, 93, CRYSTAL STRUCTURE OF A CATALYTIC FAB HAVING ESTERASE-LIKE ACTIVITY
2956, 1zluL, 0.6417, 2.75, 0.056, 211, 89, FAB 2G12 + MAN5
2957, 6rcqB, 0.6416, 2.70, 0.090, 209, 89, PFRH5-BINDING MONOCLONAL ANTIBODY R5.011 
2958, 6o3bA, 0.6416, 3.01, 0.054, 213, 92, CRYSTAL STRUCTURE OF FRIZZLED 7 CRD IN COMPLEX WITH F6 FAB 
2959, 6i9iB, 0.6416, 2.85, 0.066, 216, 91, RIFT VALLEY FEVER VIRUS GN IN COMPLEX WITH A NEUTRALIZING ANTIBODY FRAGMENT 
2960, 6dcvA, 0.6416, 3.01, 0.054, 220, 93, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-27.1 
2961, 6cbjL, 0.6416, 2.79, 0.089, 212, 90, CRYSTAL STRUCTURE OF DH270.3 FAB IN COMPLEX WITH MAN9
2962, 6bftL, 0.6416, 2.97, 0.054, 213, 92, STRUCTURE OF BEVACIZUMAB FAB MUTANT IN COMPLEX WITH VEGF 
2963, 5x2mK, 0.6416, 2.95, 0.055, 216, 91, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-GLUTAMINE
2964, 5w6gL, 0.6416, 2.80, 0.089, 214, 90, HUMAN ANTIBODY 6649 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ H1 SOLOMON ISLANDS
2965, 5vzxL, 0.6416, 3.00, 0.054, 218, 92, CRYSTAL STRUCTURE OF CRENEZUMAB FAB
2966, 5vjqB, 0.6416, 3.01, 0.054, 212, 92, COMPLEX BETWEEN HYHEL10 FAB FRAGMENT HEAVY CHAIN MUTANT (I29F; S52T; Y53F) AND PEKIN DUCK EGG LYSOZYME ISOFORM I (DEL-I) 
2967, 5f96L, 0.6416, 2.93, 0.056, 211, 90, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING VH1-46 GERMLINE-DERIVED CD4- BINDING SITE-DIRECTED ANTIBODY CH235.12 IN COMPLEX WITH HIV-1 CLADE A/E 93TH057 GP120
2968, 4xxdA, 0.6416, 3.00, 0.055, 218, 91, CRYSTAL STRUCTURE OF MID-REGION AMYLOID BETA CAPTURE BY SOLANEZUMAB
2969, 4xmpL, 0.6416, 3.05, 0.054, 211, 93, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC08 IN COMPLEX WITH HIV-1 CLADE A STRAIN Q842.D12 GP120
2970, 4xgzK, 0.6416, 3.03, 0.065, 210, 93, CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD2 MOTIF IN COMPLEX WITH FAB FRAGMENT
2971, 4u6vM, 0.6416, 3.06, 0.065, 213, 93, MECHANISMS OF NEUTRALIZATION OF A HUMAN ANTI-ALPHA TOXIN ANTIBODY
2972, 4gsdL, 0.6416, 2.86, 0.088, 207, 91, H5.3 FAB STRUCTURE
2973, 3rkdL, 0.6416, 2.98, 0.054, 213, 92, HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE I) IN COMPLEX WITH A NEUTRALIZING ANTIBODY
2974, 3of6D, 0.6416, 2.72, 0.079, 100, 89, HUMAN PRE-T CELL RECEPTOR CRYSTAL STRUCTURE
2975, 3ncyW, 0.6416, 3.03, 0.054, 211, 92, X-RAY CRYSTAL STRUCTURE OF AN ARGININE AGMATINE ANTIPORTER (ADIC) IN COMPLEX WITH A FAB FRAGMENT
2976, 3kymI, 0.6416, 2.76, 0.056, 213, 90, CRYSTAL STRUCTURE OF LI33 IGG2 DI-FAB
2977, 2zjsL, 0.6416, 2.83, 0.043, 214, 92, CRYSTAL STRUCTURE OF SECYE TRANSLOCON FROM THERMUS THERMOPHILUS WITH A FAB FRAGMENT
2978, 2qqnL, 0.6416, 3.09, 0.065, 214, 93, NEUROPILIN-1 B1 DOMAIN IN COMPLEX WITH A VEGF-BLOCKING FAB
2979, 2q8bL, 0.6416, 2.90, 0.043, 213, 92, STRUCTURE OF THE MALARIA ANTIGEN AMA1 IN COMPLEX WITH A GROWTH- INHIBITORY ANTIBODY
2980, 2gfbI, 0.6416, 3.00, 0.043, 214, 93, CRYSTAL STRUCTURE OF A CATALYTIC FAB HAVING ESTERASE-LIKE ACTIVITY
2981, 1xcqE, 0.6416, 2.99, 0.043, 220, 93, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55AL57HY64W) IN SPACE GROUP P21
2982, 1nakM, 0.6416, 2.89, 0.055, 217, 91, IGG1 FAB FRAGMENT (83.1) COMPLEX WITH 16-RESIDUE PEPTIDE (RESIDUES 304-321 OF HIV-1 GP120 (MN ISOLATE))
2983, 1n7mH, 0.6416, 3.00, 0.065, 213, 92, GERMLINE 7G12 WITH N-METHYLMESOPORPHYRIN
2984, 1mlcA, 0.6416, 3.00, 0.054, 214, 92, MONOCLONAL ANTIBODY FAB D44.1 RAISED AGAINST CHICKEN EGG- WHITE LYSOZYME COMPLEXED WITH LYSOZYME
2985, 1mhhA, 0.6416, 2.96, 0.054, 219, 92, ANTIBODY-ANTIGEN COMPLEX
2986, 1m71A, 0.6416, 2.68, 0.045, 215, 89, CRYSTAL STRUCTURE OF A MONOCLONAL FAB SPECIFIC FOR SHIGELLA FLEXNERI Y LIPOPOLYSACCHARIDE
2987, 6i9iL, 0.6415, 2.74, 0.067, 215, 90, RIFT VALLEY FEVER VIRUS GN IN COMPLEX WITH A NEUTRALIZING ANTIBODY FRAGMENT 
2988, 6d7fF, 0.6415, 2.63, 0.044, 579, 90, BACTEROIDES UNIFORMIS BETA-GLUCURONIDASE 1 BOUND TO THIOPHENYL-BETA-D- GLUCURONIDE 
2989, 6bhzM, 0.6415, 3.09, 0.054, 214, 93, TRASTUZUMAB FAB D185A (LIGHT CHAIN) MUTANT.
2990, 6be3L, 0.6415, 2.59, 0.102, 213, 88, CRYSTAL STRUCTURE OF A POLYSACCHARIDE-BINDING HUMAN FAB (F598) IN COMPLEX WITH N-ACETYL-D-GLUCOSAMINE (GLCNAC)
2991, 5ywfC, 0.6415, 3.09, 0.054, 215, 93, CRYSTAL STRUCTURE OF 2H4 FAB
2992, 5ywfA, 0.6415, 3.12, 0.054, 215, 93, CRYSTAL STRUCTURE OF 2H4 FAB
2993, 5xajD, 0.6415, 2.82, 0.066, 213, 91, STRUCTURAL MIMICRY OF THE DENGUE VIRUS ENVELOPE GLYCOPROTEIN REVEALED BY THE CRYSTALLOGRAPHIC STUDY OF AN IDIOTYPE-ANTI-IDIOTYPE FAB COMPLEX.
2994, 5vj6L, 0.6415, 2.71, 0.090, 211, 89, BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PG9 AND 8ANC195
2995, 5ushE, 0.6415, 2.72, 0.090, 212, 89, STRUCTURE OF VACCINIA VIRUS D8 PROTEIN BOUND TO HUMAN FAB VV66
2996, 5o1rL, 0.6415, 2.91, 0.056, 211, 90, HUMAN FAB 5H2 BOUND TO NHBA-C3 FROM NEISSERIA MENINGITIDIS SEROGROUP B 
2997, 5kmvL, 0.6415, 3.00, 0.054, 218, 92, CRYSTAL STRUCTURE OF CRENEZUMAB FAB
2998, 5i9qC, 0.6415, 3.06, 0.054, 206, 92, CRYSTAL STRUCTURE OF 3BNC55 FAB IN COMPLEX WITH 426C.TM4DELTAV1-3 GP120
2999, 4xxdD, 0.6415, 2.73, 0.056, 217, 89, CRYSTAL STRUCTURE OF MID-REGION AMYLOID BETA CAPTURE BY SOLANEZUMAB
3000, 4xmnL, 0.6415, 3.02, 0.054, 209, 93, STRUCTURE OF THE YEAST COAT NUCLEOPORIN COMPLEX SPACE GROUP P212121
3001, 4xgzI, 0.6415, 3.05, 0.065, 211, 93, CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD2 MOTIF IN COMPLEX WITH FAB FRAGMENT
3002, 4i2xC, 0.6415, 2.98, 0.043, 214, 93, CRYSTAL STRUCTURE OF SIGNAL REGULATORY PROTEIN GAMMA (SIRP-GAMMA) IN COMPLEX WITH FABOX117
3003, 4hweL, 0.6415, 2.99, 0.055, 210, 91, CRYSTAL STRUCTURE OF ECTODOMAIN 3 OF THE IL-13 RECEPTOR ALPHA1 IN COMPLEX WITH A HUMAN NEUTRALIZING MONOCLONAL ANTIBODY FRAGMENT
3004, 4fnlL, 0.6415, 3.15, 0.065, 213, 93, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05
3005, 3v95B, 0.6415, 2.87, 0.053, 209, 94, CRYSTAL STRUCTURE OF MONOCLONAL HUMAN ANTI-RHESUS D FC AND IGG1 T125(YB2/0) IN THE PRESENCE OF EDTA
3006, 3u36L, 0.6415, 2.71, 0.090, 211, 89, CRYSTAL STRUCTURE OF PG9 FAB
3007, 3u36D, 0.6415, 2.71, 0.090, 211, 89, CRYSTAL STRUCTURE OF PG9 FAB
3008, 3u36B, 0.6415, 2.71, 0.090, 211, 89, CRYSTAL STRUCTURE OF PG9 FAB
3009, 3pgfL, 0.6415, 3.03, 0.054, 214, 93, CRYSTAL STRUCTURE OF MALTOSE BOUND MBP WITH A CONFORMATIONALLY SPECIFIC SYNTHETIC ANTIGEN BINDER (SAB)
3010, 3cfkA, 0.6415, 2.99, 0.054, 215, 92, CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4 TRICLINIC CRYSTAL FORM
3011, 2xzcL, 0.6415, 2.98, 0.065, 214, 92, CRYSTAL STRUCTURE OF PHOSPHONATE-MODIFIED RECOMBINANT A.17 ANTIBODY FAB FRAGMENT
3012, 2h2pD, 0.6415, 2.89, 0.044, 211, 91, CRYSTAL STRUCTURE OF CLC-EC1 IN COMPLEX WITH FAB FRAGMENT IN SECN-
3013, 2fr4L, 0.6415, 3.11, 0.054, 212, 93, STRUCTURE OF FAB DNA-1 COMPLEXED WITH A STEM-LOOP DNA LIGAND
3014, 1fj1C, 0.6415, 2.90, 0.054, 213, 92, LYME DISEASE ANTIGEN OSPA IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB LA-2
3015, 1ahwA, 0.6415, 2.94, 0.054, 214, 92, A COMPLEX OF EXTRACELLULAR DOMAIN OF TISSUE FACTOR WITH AN INHIBITORY FAB (5G9)
3016, 5uy3L, 0.6414, 2.91, 0.056, 216, 90, CRYSTAL STRUCTURE OF HUMAN FAB PGT144 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
3017, 5tztL, 0.6414, 3.07, 0.054, 219, 93, CRYSTAL STRUCTURE OF HUMAN CD47 ECD BOUND TO FAB OF C47B161
3018, 5nyxL, 0.6414, 2.95, 0.055, 211, 91, HUMAN FAB FRAGMENT 5H2 AGAINST NHBA FROM NEISSERIA MENINGITIDIS 
3019, 5i9qL, 0.6414, 3.01, 0.055, 206, 91, CRYSTAL STRUCTURE OF 3BNC55 FAB IN COMPLEX WITH 426C.TM4DELTAV1-3 GP120
3020, 5drnL, 0.6414, 2.94, 0.067, 213, 90, CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU24 IN COMPLEX WITH HYPUSINE
3021, 4zsoC, 0.6414, 3.01, 0.054, 214, 93, CRYSTAL STRUCTURE OF A COMPLEX BETWEEN B7-H6 A TUMOR CELL LIGAND FOR NATURAL CYTOTOXICITY RECEPTOR NKP30 AND AN INHIBITORY ANTIBODY
3022, 4w4nA, 0.6414, 3.04, 0.053, 206, 94, CRYSTAL STRUCTURE OF HUMAN FC AT 1.80 A
3023, 4olyL, 0.6414, 2.92, 0.055, 208, 91, CRYSTAL STRUCTURE OF ANTIBODY VRC07-G54R IN COMPLEX WITH CLADE A/E 93TH057 HIV-1 GP120 CORE
3024, 4n0yL, 0.6414, 2.81, 0.089, 212, 90, STRUCTURE OF THE HEPATITIS C ENVELOPE GLYCOPROTEIN E1 ANTIGENIC REGION 314-324 BOUND TO THE CROSS-NEUTRALIZING ANTIBODY IGH526
3025, 4hcrB, 0.6414, 3.14, 0.042, 194, 96, CRYSTAL STRUCTURE OF HUMAN MADCAM-1 D1D2 COMPLEXED WITH FAB PF-547659
3026, 4fqlL, 0.6414, 3.03, 0.054, 215, 93, INFLUENZA B HA ANTIBODY (FAB) CR8033
3027, 3ze1F, 0.6414, 2.99, 0.054, 214, 92, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
3028, 3u36F, 0.6414, 2.71, 0.090, 211, 89, CRYSTAL STRUCTURE OF PG9 FAB
3029, 3sqoL, 0.6414, 2.82, 0.055, 213, 91, PCSK9 J16 FAB COMPLEX
3030, 3mnvA, 0.6414, 2.75, 0.056, 221, 90, CRYSTAL STRUCTURE OF THE NON-NEUTRALIZING HIV ANTIBODY 13H11 FAB FRAGMENT
3031, 3g5xC, 0.6414, 3.00, 0.043, 214, 93, ANTIBODIES SPECIFICALLY TARGETING A LOCALLY MISFOLDED REGION OF TUMOR ASSOCIATED EGFR
3032, 2mcg2, 0.6414, 2.88, 0.054, 215, 92, THREE-DIMENSIONAL STRUCTURE OF A LIGHT CHAIN DIMER CRYSTALLIZED IN WATER. CONFORMATIONAL FLEXIBILITY OF A MOLECULE IN TWO CRYSTAL FORMS
3033, 1pg7W, 0.6414, 2.63, 0.045, 210, 88, MURINE 6A6 FAB IN COMPLEX WITH HUMANIZED ANTI-TISSUE FACTOR D3H44 FAB
3034, 1knoA, 0.6414, 3.00, 0.043, 214, 93, CRYSTAL STRUCTURE OF THE COMPLEX OF A CATALYTIC ANTIBODY FAB WITH A TRANSITION STATE ANALOG: STRUCTURAL SIMILARITIES IN ESTERASE-LIKE ABZYMES
3035, 1indL, 0.6414, 2.77, 0.056, 211, 90, HOW THE ANTI-(METAL CHELATE) ANTIBODY CHA255 IS SPECIFIC FOR THE METAL ION OF ITS ANTIGEN: X-RAY STRUCTURES FOR TWO FAB (SLASH)HAPTEN COMPLEXES WITH DIFFERENT METALS IN THE CHELATE
3036, 1igyC, 0.6414, 2.98, 0.065, 213, 93, STRUCTURE OF IMMUNOGLOBULIN
3037, 6cyfT, 0.6413, 2.83, 0.055, 214, 91, PCRV FRAGMENT WITH BOUND FAB 
3038, 6c5iL, 0.6413, 3.16, 0.053, 219, 94, UNLIGANDED S25-5 FAB 
3039, 5x2nL, 0.6413, 2.95, 0.055, 216, 91, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-ALANINE
3040, 5w1kC, 0.6413, 3.04, 0.054, 213, 92, JUNV GP1 CR1-10 FAB CR1-28 FAB COMPLEX 
3041, 5vk2G, 0.6413, 2.70, 0.090, 211, 89, STRUCTURAL BASIS FOR ANTIBODY-MEDIATED NEUTRALIZATION OF LASSA VIRUS
3042, 5t6pA, 0.6413, 2.88, 0.056, 216, 90, CRYSTAL STRUCTURE OF THERAPEUTIC MAB AR20.5 IN COMPLEX WITH MUC1 PEPTIDE
3043, 5t3zE, 0.6413, 2.82, 0.078, 210, 90, 3.5 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074
3044, 5mudA, 0.6413, 2.80, 0.089, 212, 90, CRYSTAL STRUCTURE OF AN AMYLOIDOGENIC LIGHT CHAIN DIMER H6
3045, 5k3xA, 0.6413, 3.13, 0.072, 343, 97, CRYSTAL STRUCTURE OF THE SULFITE DEHYDROGENASE SORT R78K MUTANT FROM SINORHIZOBIUM MELILOTI
3046, 5hi3L, 0.6413, 2.83, 0.089, 213, 90, BINDING SITE ELUCIDATION AND STRUCTURE GUIDED DESIGN OF MACROCYCLIC IL-17A ANTAGONISTS
3047, 5fhaL, 0.6413, 2.93, 0.056, 212, 90, CRYSTAL STRUCTURE OF PROTECTIVE EBOLA VIRUS ANTIBODY 114
3048, 5e2uL, 0.6413, 2.96, 0.055, 203, 91, STRUCTURE OF ANTI-TAU AT8 FAB IN THE PRESENCE OF PHOSPHOPEPTIDE
3049, 5durL, 0.6413, 2.71, 0.090, 212, 89, INFLUENZA A VIRUS H5 HEMAGGLUTININ GLOBULAR HEAD IN COMPLEX WITH ANTIBODY 100F4
3050, 5bk5E, 0.6413, 3.15, 0.054, 217, 93, CRYSTAL STRUCTURE OF THE ANTI-CIRCUMSPOROZOITE PROTEIN 663 GERMLINE ANTIBODY
3051, 4z5rP, 0.6413, 2.81, 0.055, 217, 91, RONTALIZUMAB FAB BOUND TO INTERFERON-A2
3052, 4xmmL, 0.6413, 3.00, 0.054, 210, 93, STRUCTURE OF THE YEAST COAT NUCLEOPORIN COMPLEX SPACE GROUP C2
3053, 4xh2I, 0.6413, 3.11, 0.053, 209, 94, CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD4 MOTIF IN COMPLEX WITH FAB FRAGMENT
3054, 4uinL, 0.6413, 3.19, 0.053, 214, 94, CRYSTAL STRUCTURE OF QUININE-DEPENDENT FAB 314.3 WITH QUININE
3055, 4pubL, 0.6413, 3.09, 0.054, 212, 92, CRYSTAL STRUCTURE OF FAB DX-2930
3056, 4olwL, 0.6413, 2.92, 0.055, 208, 91, CRYSTAL STRUCTURE OF ANTIBODY VRC07-G54H IN COMPLEX WITH CLADE A/E 93TH057 HIV-1 GP120 CORE
3057, 4olvL, 0.6413, 2.92, 0.055, 208, 91, CRYSTAL STRUCTURE OF ANTIBODY VRC07-G54F IN COMPLEX WITH CLADE A/E 93TH057 HIV-1 GP120 CORE
3058, 4fqyL, 0.6413, 2.71, 0.090, 209, 89, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR9114 BOUND TO H3 INFLUENZA HEMAGGLUTININ
3059, 4fqvL, 0.6413, 2.71, 0.090, 211, 89, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR9114 BOUND TO H7 INFLUENZA HEMAGGLUTININ
3060, 4fqrf, 0.6413, 3.15, 0.065, 213, 93, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
3061, 3ls5L, 0.6413, 3.05, 0.054, 215, 93, ANTI-TETRAHYDROCANNABINOL FAB FRAGMENT FREE FORM
3062, 3j30G, 0.6413, 3.10, 0.054, 217, 93, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK152
3063, 3j30E, 0.6413, 3.10, 0.054, 217, 93, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK152
3064, 3j30C, 0.6413, 3.10, 0.054, 217, 93, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK152
3065, 3j30A, 0.6413, 3.10, 0.054, 217, 93, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK152
3066, 3j2xG, 0.6413, 3.10, 0.054, 217, 93, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M242
3067, 3j2xE, 0.6413, 3.10, 0.054, 217, 93, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M242
3068, 3j2xC, 0.6413, 3.10, 0.054, 217, 93, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M242
3069, 3j2xA, 0.6413, 3.10, 0.054, 217, 93, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M242
3070, 2omnA, 0.6413, 2.87, 0.054, 216, 92, BENCE JONES KWR PROTEIN- IMMUNOGLOBULIN LIGHT CHAIN DIMER P4(3)2(1)2 CRYSTAL FORM
3071, 2gfbO, 0.6413, 3.00, 0.043, 214, 93, CRYSTAL STRUCTURE OF A CATALYTIC FAB HAVING ESTERASE-LIKE ACTIVITY
3072, 2gfbC, 0.6413, 2.97, 0.054, 214, 93, CRYSTAL STRUCTURE OF A CATALYTIC FAB HAVING ESTERASE-LIKE ACTIVITY
3073, 1ucbL, 0.6413, 3.05, 0.054, 216, 93, STRUCTURE OF UNCOMPLEXED FAB COMPARED TO COMPLEX (1CLY 1CLZ)
3074, 1rumL, 0.6413, 3.06, 0.054, 218, 93, CRYSTAL STRUCTURE (F) OF H2O2-SOAKED CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 8.5 WITH A DATA SET COLLECTED AT SSRL BEAMLINE 9-1.
3075, 6d8kB, 0.6412, 2.78, 0.043, 571, 92, BACTEROIDES MULTIPLE SPECIES BETA-GLUCURONIDASE 
3076, 6be4L, 0.6412, 2.74, 0.090, 213, 89, CRYSTAL STRUCTURE OF A POLYSACCHARIDE-BINDING HUMAN FAB (F598) IN COMPLEX WITH NONA-N-ACETYL-D-GLUCOSAMINE (9NAC)
3077, 5y2kH, 0.6412, 2.82, 0.089, 208, 90, A HUMAN ANTIBODY AF4H1L1 
3078, 5w23L, 0.6412, 3.12, 0.043, 216, 92, CRYSTAL STRUCTURE OF RSV F IN COMPLEX WITH 5C4 FAB
3079, 5viyP, 0.6412, 3.05, 0.054, 214, 92, BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195
3080, 5viyN, 0.6412, 3.05, 0.054, 214, 92, BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195
3081, 5viyL, 0.6412, 3.05, 0.054, 214, 92, BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195
3082, 5ty6L, 0.6412, 2.88, 0.056, 212, 90, CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING INFLUENZA A ANTIBODY VRC 315 13-1B02 FAB.
3083, 5jqdB, 0.6412, 2.93, 0.055, 214, 91, ANTIBODY FAB FRAGMENT
3084, 5fhcL, 0.6412, 2.89, 0.056, 211, 90, CRYSTAL STRUCTURE OF PROTECTIVE HUMAN ANTIBODIES 100 AND 114 IN COMPLEX WITH EBOLA VIRUS FUSION GLYCOPROTEIN (GP)
3085, 5cjxL, 0.6412, 3.05, 0.054, 214, 92, CRYSTAL STRUCTURE OF 8ANC195 FAB IN COMPLEX WITH BG505 SOSIP.664 HIV-1 ENV TRIMER
3086, 4xp9L, 0.6412, 2.88, 0.044, 213, 91, X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER BOUND TO PSYCHOSTIMULANT D-AMPHETAMINE
3087, 4xgzP, 0.6412, 3.05, 0.054, 210, 93, CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD2 MOTIF IN COMPLEX WITH FAB FRAGMENT
3088, 4xcyF, 0.6412, 3.02, 0.054, 214, 92, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDYLGLYCEROL (06:0 PG)
3089, 4qhmD, 0.6412, 2.81, 0.089, 209, 90, I3.1 (UNBOUND) FROM CH103 LINEAGE
3090, 4py8J, 0.6412, 2.75, 0.056, 212, 89, CRYSTAL STRUCTURE OF FAB 3.1 IN COMPLEX WITH THE 1918 INFLUENZA VIRUS HEMAGGLUTININ
3091, 3dggC, 0.6412, 3.08, 0.054, 215, 92, CRYSTAL STRUCTURE OF FABOX108
3092, 3clfL, 0.6412, 3.02, 0.043, 214, 93, HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ23
3093, 3b2uX, 0.6412, 2.91, 0.055, 213, 91, CRYSTAL STRUCTURE OF ISOLATED DOMAIN III OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8
3094, 2ny4C, 0.6412, 2.94, 0.056, 214, 90, HIV-1 GP120 ENVELOPE GLYCOPROTEIN (K231C T257S E268C S334A S375W) COMPLEXED WITH CD4 AND ANTIBODY 17B
3095, 2gfbG, 0.6412, 3.00, 0.043, 214, 93, CRYSTAL STRUCTURE OF A CATALYTIC FAB HAVING ESTERASE-LIKE ACTIVITY
3096, 2eh7L, 0.6412, 2.85, 0.054, 219, 92, CRYSTAL STRUCTURE OF HUMANIZED KR127 FAB
3097, 1za6C, 0.6412, 3.05, 0.054, 220, 93, THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY
3098, 1p2cA, 0.6412, 2.91, 0.055, 212, 91, CRYSTAL STRUCTURE ANALYSIS OF AN ANTI-LYSOZYME ANTIBODY
3099, 1mlcC, 0.6412, 3.04, 0.054, 214, 93, MONOCLONAL ANTIBODY FAB D44.1 RAISED AGAINST CHICKEN EGG- WHITE LYSOZYME COMPLEXED WITH LYSOZYME
3100, 1lilB, 0.6412, 2.82, 0.065, 212, 92, BENCE JONES PROTEIN CLE A LAMBDA III IMMUNOGLOBULIN LIGHT- CHAIN DIMER
3101, 1fj1A, 0.6412, 2.90, 0.054, 213, 92, LYME DISEASE ANTIGEN OSPA IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB LA-2
3102, 6n5dF, 0.6411, 2.73, 0.067, 212, 90, BROADLY PROTECTIVE ANTIBODIES DIRECTED TO A SUBDOMINANT INFLUENZA HEMAGGLUTININ EPITOPE 
3103, 6mtrL, 0.6411, 2.71, 0.090, 210, 89, CRYSTAL STRUCTURE OF VRC43.01 FAB 
3104, 6ddvA, 0.6411, 2.91, 0.056, 217, 90, CRYSTAL STRUCTURE ANALYSIS OF THE EPITOPE OF AN ANTI-MICA ANTIBODY 
3105, 6cbvL, 0.6411, 2.76, 0.056, 213, 89, CRYSTAL STRUCTURE OF BRIL BOUND TO AN AFFINITY MATURED SYNTHETIC ANTIBODY. 
3106, 6bfsL, 0.6411, 3.01, 0.054, 212, 92, THE MECHANISM OF GM-CSF INHIBITION BY HUMAN GM-CSF AUTO-ANTIBODIES 
3107, 6azmA, 0.6411, 3.00, 0.054, 219, 92, CRYSTAL STRUCTURE OF THE 580 GERMLINE ANTIBODY BOUND TO CIRCUMSPOROZOITE PROTEIN NANP 5-MER
3108, 5v6lM, 0.6411, 2.86, 0.066, 215, 91, CRYSTAL STRUCTURE OF RABBIT ANTI-HIV-1 GP120 V3 FAB 10A37 IN COMPLEX WITH V3 PEPTIDE JR-FL
3109, 5n09L, 0.6411, 2.77, 0.067, 213, 90, CRYSTAL STRUCTURE OF L107C/A313C COVALENTLY LINKED DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN DIMER IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11
3110, 5mu0F, 0.6411, 3.03, 0.054, 216, 92, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (IA03)
3111, 5m6iA, 0.6411, 2.83, 0.089, 212, 90, CRYSTAL STRUCTURE OF NON-CARDIOTOXIC BENCE-JONES LIGHT CHAIN DIMER M8
3112, 5dumL, 0.6411, 2.92, 0.056, 211, 90, CRYSTAL STRUCTURE OF INFLUENZA A VIRUS H5 HEMAGGLUTININ GLOBULAR HEAD IN COMPLEX WITH THE FAB OF ANTIBODY 65C6
3113, 5cd3H, 0.6411, 2.85, 0.056, 206, 89, STRUCTURE OF IMMATURE VRC01-CLASS ANTIBODY DRVIA7
3114, 4yx2L, 0.6411, 3.11, 0.043, 213, 93, CRYSTAL STRUCTURE OF BOVINE PRION PROTEIN COMPLEXED WITH POM1 FAB
3115, 4xccL, 0.6411, 2.99, 0.055, 214, 91, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB CRYSTALIZED IN THE PRESENCE OF PHOSPHATIDYLCHOLINE (06:0 PC); I422 SPACE GROUP
3116, 4nhgK, 0.6411, 2.90, 0.056, 211, 90, CRYSTAL STRUCTURE OF 2G12 IGG DIMER
3117, 4jzoE, 0.6411, 2.93, 0.056, 211, 90, THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING HUMAN ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 FAB FRAGMENT HC84-27
3118, 4jpwL, 0.6411, 2.91, 0.056, 208, 90, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY 12A21 IN COMPLEX WITH HIV-1 STRAIN 93TH057 GP120 MUTANT
3119, 4gmtM, 0.6411, 3.06, 0.054, 213, 93, CRYSTAL STRUCTURE OF HETEROSUBTYPIC FAB S139/1
3120, 4g6mL, 0.6411, 3.01, 0.055, 213, 91, CRYSTAL STRUCTURE OF HUMAN IL-1BETA IN COMPLEX WITH THERAPEUTIC ANTIBODY BINDING FRAGMENT OF GEVOKIZUMAB
3121, 4d2nB, 0.6411, 2.89, 0.054, 206, 92, CRYSTAL STRUCTURE OF DEGLYCOSYLATED SERUM-DERIVED HUMAN IGG4 FC
3122, 3bpnB, 0.6411, 2.73, 0.089, 199, 90, CRYSTAL STRUCTURE OF THE IL4-IL4R-IL13RA TERNARY COMPLEX
3123, 3b2uG, 0.6411, 3.00, 0.065, 213, 92, CRYSTAL STRUCTURE OF ISOLATED DOMAIN III OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8
3124, 2c9xA, 0.6411, 2.90, 0.032, 373, 94, SULFITE DEHYDROGENASE FROM STARKEYA NOVELLA Y236F MUTANT
3125, 2a6dA, 0.6411, 2.98, 0.054, 214, 92, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-ARSONATE GERMLINE ANTIBODY 36-65 IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE RLLIADPPSPRE
3126, 1ogpB, 0.6411, 3.10, 0.043, 388, 94, THE CRYSTAL STRUCTURE OF PLANT SULFITE OXIDASE PROVIDES INSIGHT INTO SULFITE OXIDATION IN PLANTS AND ANIMALS
3127, 1ndgA, 0.6411, 3.02, 0.054, 214, 92, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTIBODY HYHEL-8 COMPLEXED WITH ITS ANTIGEN LYSOZYME
3128, 1mcfA, 0.6411, 2.88, 0.065, 216, 92, PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
3129, 1i9iL, 0.6411, 3.15, 0.053, 219, 94, NATIVE CRYSTAL STRUCTURE OF THE RECOMBINANT MONOCLONAL WILD TYPE ANTI-TESTOSTERONE FAB FRAGMENT
3130, 1a0qL, 0.6411, 2.99, 0.054, 211, 92, 29G11 COMPLEXED WITH PHENYL [1-(1-N-SUCCINYLAMINO)PENTYL] PHOSPHONATE
3131, 6mftB, 0.6410, 2.96, 0.065, 209, 92, CRYSTAL STRUCTURE OF GLYCOSYLATED 426C HIV-1 GP120 CORE G459C IN COMPLEX WITH GLVRC01 A60C HEAVY CHAIN 
3132, 6bfqB, 0.6410, 2.76, 0.056, 212, 89, THE MECHANISM OF GM-CSF INHIBITION BY HUMAN GM-CSF AUTO-ANTIBODIES 
3133, 6b5oL, 0.6410, 2.99, 0.054, 219, 92, STRUCTURE OF PFCSP PEPTIDE 29 WITH HUMAN PROTECTIVE ANTIBODY CIS43
3134, 6b3sG, 0.6410, 2.85, 0.055, 213, 91, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF NECITUMUMAB (FAB11F8) IN COMPLEX WITH DOMAIN III FROM A CETUXIMAB RESISTANT VARIANT OF EGFR (SEGFRD3-S468R)
3135, 6az2F, 0.6410, 2.85, 0.056, 211, 89, CRYSTAL STRUCTURE OF ASF1-FAB 12E COMPLEX
3136, 5xmhB, 0.6410, 2.87, 0.054, 207, 93, CRYSTAL STRUCTURE OF AN IGM RHEUMATOID FACTOR YES8C IN COMPLEX WITH IGG1 FC
3137, 5vkkB, 0.6410, 3.07, 0.054, 219, 93, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-CD22 EPRATUZUMAB
3138, 5v6mL, 0.6410, 3.03, 0.054, 219, 92, CRYSTAL STRUCTURE OF RABBIT ANTI-HIV-1 GP120 V3 FAB 10A3 IN COMPLEX WITH V3 PEPTIDE CONB
3139, 5otjA, 0.6410, 2.80, 0.089, 213, 90, MONOMERIC POLCALCIN (PHL P 7) IN COMPLEX WITH TWO IDENTICAL ALLERGEN- SPECIFIC ANTIBODIES 
3140, 5fykL, 0.6410, 2.74, 0.067, 210, 90, CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE B JR-FL SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122 35O22 AND VRC01
3141, 5cgyD, 0.6410, 2.82, 0.101, 212, 89, FAB FRAGMENT OF CHIKUNGUNYA VIRUS NEUTRALIZING HUMAN MONOCLONAL ANTIBODY 4J21
3142, 4xtrD, 0.6410, 3.03, 0.065, 216, 93, STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF PEP12
3143, 4xcnI, 0.6410, 3.02, 0.054, 214, 92, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA); 2.9 A RESOLUTION
3144, 4uilL, 0.6410, 2.96, 0.054, 213, 92, CRYSTAL STRUCTURE OF QUININE-DEPENDENT FAB 314.1 WITH QUININE
3145, 4okvB, 0.6410, 2.91, 0.054, 218, 92, CRYSTAL STRUCTURE OF ANOPHELINE ANTI-PLATELET PROTEIN WITH FAB ANTIBODY
3146, 4ogxL, 0.6410, 2.78, 0.056, 212, 90, CRYSTAL STRUCTURE OF FAB DX-2930 IN COMPLEX WITH HUMAN PLASMA KALLIKREIN AT 2.4 ANGSTROM RESOLUTION
3147, 4odwL, 0.6410, 2.97, 0.054, 214, 92, UNLIGANDED FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY A6
3148, 4nhgL, 0.6410, 2.90, 0.056, 211, 90, CRYSTAL STRUCTURE OF 2G12 IGG DIMER
3149, 4ma3L, 0.6410, 2.94, 0.055, 218, 91, CRYSTAL STRUCTURE OF ANTI-HINGE RABBIT ANTIBODY C2095
3150, 4bz1L, 0.6410, 2.96, 0.055, 218, 91, STRUCTURE OF DENGUE VIRUS EDIII IN COMPLEX WITH FAB 3E31
3151, 3zdyF, 0.6410, 3.07, 0.054, 214, 93, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
3152, 3zdxF, 0.6410, 3.17, 0.053, 214, 94, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
3153, 3rvtC, 0.6410, 2.92, 0.054, 213, 92, STRUCTURE OF 4C1 FAB IN P212121 SPACE GROUP
3154, 3qnyA, 0.6410, 2.82, 0.055, 218, 91, MONOCLINIC FORM OF HUMAN IGA1 FAB FRAGMENT SHARING SAME FV AS IGG
3155, 3lpfA, 0.6410, 2.80, 0.056, 590, 89, STRUCTURE OF E. COLI BETA-GLUCURONIDASE BOUND WITH A NOVEL POTENT INHIBITOR 1-((67-DIMETHYL-2-OXO-12-DIHYDROQUINOLIN-3-YL)METHYL)-1- (2-HYDROXYETHYL)-3-(3-METHOXYPHENYL)THIOUREA
3156, 3haeS, 0.6410, 2.73, 0.090, 211, 89, RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES
3157, 3bgfL, 0.6410, 2.89, 0.044, 212, 91, X-RAY CRYSTAL STRUCTURE OF THE SARS CORONAVIRUS SPIKE RECEPTOR BINDING DOMAIN IN COMPLEX WITH F26G19 FAB
3158, 1yeeL, 0.6410, 3.16, 0.053, 219, 94, STRUCTURE OF A CATALYTIC ANTIBODY IGG2A FAB FRAGMENT (D2.5)
3159, 1tziA, 0.6410, 3.01, 0.054, 214, 93, CRYSTAL STRUCTURE OF THE FAB YADS2 COMPLEXED WITH H-VEGF
3160, 6hf1B, 0.6409, 2.73, 0.056, 211, 89, MUTANT OXIDOREDUCTASE FRAGMENT OF MOUSE QSOX1 IN COMPLEX WITH AN ANTIBODY FAB 
3161, 6fhjA, 0.6409, 3.19, 0.074, 979, 94, STRUCTURAL DYNAMICS AND CATALYTIC PROPERTIES OF A MULTI-MODULAR XANTHANASE; NATIVE. 
3162, 6dcwL, 0.6409, 3.00, 0.054, 219, 92, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-27.1 FAB IN COMPLEX WITH A HUMAN TAU PEPTIDE 
3163, 6cr1H, 0.6409, 2.75, 0.077, 225, 91, ADALIMUMAB EFAB 
3164, 6bz4B, 0.6409, 2.80, 0.044, 206, 91, HUMAN IGG1 LACKING COMPLEMENT-DEPENDENT CYTOTOXICITY: HU3S193 FC MUTANT K322A 
3165, 6bfqL, 0.6409, 2.81, 0.056, 212, 90, THE MECHANISM OF GM-CSF INHIBITION BY HUMAN GM-CSF AUTO-ANTIBODIES 
3166, 6awnC, 0.6409, 3.10, 0.054, 214, 93, X-RAY STRUCTURE OF THE S439T HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH PAROXETINE AT THE CENTRAL SITE
3167, 5w05L, 0.6409, 3.06, 0.054, 219, 92, ANTI-TISSUE FACTOR ANTIBODY M59 A HUMANIZED VERSION OF 10H10
3168, 5vzrL, 0.6409, 3.16, 0.043, 209, 93, CRYSTAL STRUCTURE OF MERS-COV NEUTRALIZING ANTIBODY G4 FAB
3169, 5icxA, 0.6409, 2.76, 0.056, 212, 89, CETUXIMAB FAB IN COMPLEX WITH CQFDLSTRRLRCGGSK MEDITOPE
3170, 5dtfB, 0.6409, 2.88, 0.066, 214, 91, CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU98.61 IN COMPLEX WITH HYPUSINE
3171, 5dr5L, 0.6409, 3.08, 0.054, 215, 93, CRYSTAL STRUCTURE OF THE SCLEROSTIN-NEUTRALIZING FAB ABD09097
3172, 5bk5G, 0.6409, 2.96, 0.056, 217, 90, CRYSTAL STRUCTURE OF THE ANTI-CIRCUMSPOROZOITE PROTEIN 663 GERMLINE ANTIBODY
3173, 5az2L, 0.6409, 2.97, 0.043, 213, 93, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF 9E5 A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR HUMAN EPIREGULIN
3174, 4yhyC, 0.6409, 2.98, 0.055, 210, 91, CRYSTAL STRUCTURE OF 309M3-B IN COMPLEX WITH TRIMETHYLATED LYS
3175, 4ma8L, 0.6409, 3.10, 0.043, 213, 93, CRYSTAL STRUCTURE OF MOUSE PRION PROTEIN COMPLEXED WITH CHLORPROMAZINE
3176, 4ky1L, 0.6409, 3.00, 0.054, 213, 92, HUMANIZED HP1/2 FAB
3177, 4aeiM, 0.6409, 2.95, 0.055, 217, 91, CRYSTAL STRUCTURE OF THE AAHII-FAB4C1 COMPLEX
3178, 3wfcL, 0.6409, 2.97, 0.054, 213, 92, REDUCED AND CARBONMONOXIDE-BOUND CYTOCHROME C-DEPENDENT NITRIC OXIDE REDUCTASE (CNOR) FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH ANTIBODY FRAGMENT
3179, 3okoA, 0.6409, 2.79, 0.056, 217, 90, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.8)KDO(2.4)KDO
3180, 3ncyS, 0.6409, 3.03, 0.054, 211, 92, X-RAY CRYSTAL STRUCTURE OF AN ARGININE AGMATINE ANTIPORTER (ADIC) IN COMPLEX WITH A FAB FRAGMENT
3181, 3hzmA, 0.6409, 2.99, 0.054, 218, 92, CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO
3182, 2mpaL, 0.6409, 3.05, 0.043, 219, 93, BACTERICIDAL ANTIBODY AGAINST NEISSERIA MENINGITIDIS
3183, 1wcbA, 0.6409, 3.07, 0.054, 213, 93, PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH ITS HAPTEN
3184, 1v7mL, 0.6409, 2.90, 0.054, 212, 92, HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB
3185, 1t04C, 0.6409, 3.03, 0.054, 214, 93, THREE DIMENSIONAL STRUCTURE OF A HUMANIZED ANTI-IFN-GAMMA FAB IN C2 SPACE GROUP
3186, 1bfoC, 0.6409, 3.10, 0.054, 214, 93, CAMPATH-1G IGG2B RAT MONOCLONAL FAB
3187, 8fabA, 0.6408, 2.72, 0.090, 206, 89, CRYSTAL STRUCTURE OF THE FAB FRAGMENT FROM THE HUMAN MYELOMA IMMUNOGLOBULIN IGG HIL AT 1.8 ANGSTROMS RESOLUTION
3188, 6f7tA, 0.6408, 2.61, 0.056, 217, 89, CRYSTAL STRUCTURE OF AN FAB FRAGMENT IN COMPLEX WITH A PEPTIDE FROM BACILLUS SUBTILIS RNASE Y 
3189, 6cyfC, 0.6408, 3.06, 0.054, 214, 93, PCRV FRAGMENT WITH BOUND FAB 
3190, 5y9fc, 0.6408, 3.02, 0.043, 218, 92, CRYSTAL STRUCTURE OF HPV59 PENTAMER IN COMPLEX WITH THE FAB FRAGMENT OF ANTIBODY 28F10
3191, 5xkuB, 0.6408, 2.87, 0.056, 211, 90, CRYSTAL STRUCTURE OF HEMAGGLUTININ GLOBULAR HEAD FROM AN H7N9 INFLUENZA VIRUS IN COMPLEX WITH A NEUTRALIZING ANTIBODY HNIGGA6
3192, 5xezD, 0.6408, 3.04, 0.054, 214, 93, STRUCTURE OF THE FULL-LENGTH GLUCAGON CLASS B G PROTEIN-COUPLED RECEPTOR
3193, 5uixL, 0.6408, 2.97, 0.054, 213, 92, CRYSTAL STRUCTURE OF THE DH576 CD4BS FAB (UNLIGANDED) FROM THE RV305 HIV VACCINE TRIAL
3194, 5tqaB, 0.6408, 2.80, 0.089, 211, 90, CRYSTAL STRUCTURE OF DH270.6 (UNLIGANDED) FROM THE DH270 BROADLY NEUTRALIZING N332-GLYCAN DEPENDENT LINEAGE
3195, 5o4oA, 0.6408, 3.07, 0.054, 213, 92, HER3 IN COMPLEX WITH FAB MF3178 
3196, 5dd3L, 0.6408, 3.08, 0.065, 213, 92, CRYSTAL STRUCTURES IN AN ANTI-HIV ANTIBODY LINEAGE FROM IMMUNIZATION OF RHESUS MACAQUES
3197, 5bjzL, 0.6408, 3.05, 0.054, 213, 93, CRYSTAL STRUCTURE OF MALTOSE BINDING PROTEIN IN COMPLEX WITH AN ALLOSTERIC SYNTHETIC ANTIBODY
3198, 5a8hQ, 0.6408, 3.06, 0.054, 214, 92, CRYO-ET SUBTOMOGRAM AVERAGING OF BG505 SOSIP.664 IN COMPLEX WITH SCD4 17B AND 8ANC195
3199, 5a8hK, 0.6408, 3.06, 0.054, 214, 92, CRYO-ET SUBTOMOGRAM AVERAGING OF BG505 SOSIP.664 IN COMPLEX WITH SCD4 17B AND 8ANC195
3200, 5a8hE, 0.6408, 3.06, 0.054, 214, 92, CRYO-ET SUBTOMOGRAM AVERAGING OF BG505 SOSIP.664 IN COMPLEX WITH SCD4 17B AND 8ANC195
3201, 5a7xQ, 0.6408, 3.06, 0.054, 214, 92, NEGATIVE STAIN EM OF BG505 SOSIP.664 IN COMPLEX WITH SCD4 17B AND 8ANC195
3202, 5a7xO, 0.6408, 3.06, 0.054, 214, 92, NEGATIVE STAIN EM OF BG505 SOSIP.664 IN COMPLEX WITH SCD4 17B AND 8ANC195
3203, 5a7xM, 0.6408, 3.06, 0.054, 214, 92, NEGATIVE STAIN EM OF BG505 SOSIP.664 IN COMPLEX WITH SCD4 17B AND 8ANC195
3204, 4r7dB, 0.6408, 2.66, 0.057, 211, 88, FAB HU 15C1
3205, 4p9mL, 0.6408, 3.06, 0.054, 214, 92, CRYSTAL STRUCTURE OF 8ANC195 FAB
3206, 4nhgB, 0.6408, 2.90, 0.056, 211, 90, CRYSTAL STRUCTURE OF 2G12 IGG DIMER
3207, 4lmqL, 0.6408, 3.06, 0.054, 214, 93, DEVELOPMENT AND PRECLINICAL CHARACTERIZATION OF A HUMANIZED ANTIBODY TARGETING CXCL12
3208, 4kvnL, 0.6408, 2.98, 0.055, 213, 91, CRYSTAL STRUCTURE OF FAB 39.29 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ A/PERTH/16/2009 (H3N2)
3209, 4hbqA, 0.6408, 3.36, 0.020, 206, 98, CRYSTAL STRUCTURE OF A LOOP DELETED MUTANT OF HUMAN MADCAM-1 D1D2
3210, 4fqhB, 0.6408, 2.78, 0.089, 212, 90, CRYSTAL STRUCTURE OF FAB CR9114
3211, 4dkfL, 0.6408, 2.95, 0.066, 212, 91, CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-34 BOUND TO FAB2
3212, 3zdzL, 0.6408, 2.98, 0.054, 214, 92, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
3213, 3qcvL, 0.6408, 2.95, 0.055, 218, 91, CRYSTAL STRUCTURE OF THE LT3015 ANTIBODY FAB FRAGMENT IN COMPLEX WITH LYSOPHOSPHATIDIC ACID (18:2)
3214, 3qctL, 0.6408, 2.97, 0.054, 218, 92, CRYSTAL STRUCTURE OF THE HUMANIZED APO LT3015 ANTI-LYSOPHOSPHATIDIC ACID ANTIBODY FAB FRAGMENT
3215, 3mugA, 0.6408, 2.83, 0.089, 212, 90, CRYSTAL STRUCTURE OF HUMAN FAB PG16 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
3216, 3gnmL, 0.6408, 2.85, 0.044, 217, 91, THE CRYSTAL STRUCTURE OF THE JAA-F11 MONOCLONAL ANTIBODY FAB FRAGMENT
3217, 2r23A, 0.6408, 3.08, 0.054, 217, 93, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
3218, 1za6B, 0.6408, 3.28, 0.156, 324, 96, THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY
3219, 1fl6A, 0.6408, 2.93, 0.056, 217, 90, THE HAPTEN COMPLEXED GERMLINE PRECURSOR TO SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4
3220, 6c5kL, 0.6407, 3.04, 0.054, 219, 93, S25-23 FAB IN COMPLEX WITH CHLAMYDIACEAE LPS (CRYSTAL FORM 2) 
3221, 6bf9F, 0.6407, 3.02, 0.056, 210, 90, CRYO-EM STRUCTURE OF HUMAN INSULIN DEGRADING ENZYME IN COMPLEX WITH FAB H11-E HEAVY CHAIN FAB H11-E LIGHT CHAIN
3222, 5vh3B, 0.6407, 2.85, 0.055, 214, 91, CRYSTAL STRUCTURE OF FAB FRAGMENT OF THE ANTI-TNFA ANTIBODY INFLIXIMAB IN A C-CENTERED ORTHORHOMBIC CRYSTAL FORM
3223, 5ukqL, 0.6407, 2.81, 0.078, 213, 90, STRUCTURE OF UNLIGANDED ANTI-GP120 CD4BS ANTIBODY DH522.2 FAB
3224, 5o1rM, 0.6407, 3.00, 0.054, 212, 92, HUMAN FAB 5H2 BOUND TO NHBA-C3 FROM NEISSERIA MENINGITIDIS SEROGROUP B 
3225, 5n09M, 0.6407, 2.78, 0.067, 213, 90, CRYSTAL STRUCTURE OF L107C/A313C COVALENTLY LINKED DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN DIMER IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11
3226, 5lgkA, 0.6407, 2.89, 0.093, 307, 97, CRYSTAL STRUCTURE OF THE HUMAN IGE-FC BOUND TO ITS B CELL RECEPTOR DERCD23
3227, 5jofD, 0.6407, 2.99, 0.066, 210, 91, CRYSTAL STRUCTURE OF VRC03 GHVGLV ANTIGEN-BINDING FRAGMENT.
3228, 5icyA, 0.6407, 2.77, 0.056, 212, 89, CETUXIMAB FAB IN COMPLEX WITH LINEAR MEDITOPE
3229, 5i1lL, 0.6407, 3.11, 0.054, 220, 93, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV5-51/IGKV4-1
3230, 5hi3D, 0.6407, 2.81, 0.089, 213, 90, BINDING SITE ELUCIDATION AND STRUCTURE GUIDED DESIGN OF MACROCYCLIC IL-17A ANTAGONISTS
3231, 5guxL, 0.6407, 2.94, 0.054, 213, 92, CYTOCHROME C-DEPENDENT NITRIC OXIDE REDUCTASE (CNOR) FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH XENON
3232, 4xceB, 0.6407, 3.02, 0.054, 214, 92, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB CRYSTALIZED IN THE PRESENCE OF PHOSPHATIDYLCHOLINE (06:0 PC); C2 SPACE GROUP
3233, 4utbL, 0.6407, 2.79, 0.067, 213, 90, CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11
3234, 4rgmB, 0.6407, 2.94, 0.054, 213, 92, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO THE NEUTRALIZING ANTIBODY 20B1
3235, 4eowL, 0.6407, 2.71, 0.090, 211, 89, CRYSTAL STRUCTURE OF A DISEASE-ASSOCIATED ANTI-HUMAN GM-CSF AUTOANTIBODY MB007
3236, 4bh8A, 0.6407, 2.98, 0.054, 214, 92, CRYSTAL STRUCTURE OF GERMLINE ANTIBODY 36-65 IN COMPLEX WITH PEPTIDE GDPRPSYISHLL
3237, 3x2dG, 0.6407, 2.86, 0.056, 211, 90, CRYSTAL STRUCTURE OF MARBURG VIRUS GP IN COMPLEX WITH THE HUMAN SURVIVOR ANTIBODY MR78
3238, 3k4aB, 0.6407, 2.94, 0.056, 584, 90, CRYSTAL STRUCTURE OF SELENOMETHIONINE SUBSTITUTED E. COLI BETA- GLUCURONIDASE
3239, 3g6dL, 0.6407, 2.79, 0.089, 210, 90, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CNTO607 FAB AND IL-13
3240, 3cfkG, 0.6407, 3.00, 0.054, 215, 92, CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4 TRICLINIC CRYSTAL FORM
3241, 2v7nC, 0.6407, 3.01, 0.067, 212, 90, UNUSUAL TWINNING IN CRYSTALS OF THE CITS BINDING ANTIBODY FAB FRAGMENT F3P4
3242, 2v7hA, 0.6407, 3.02, 0.054, 214, 93, CRYSTAL STRUCTURE OF AN IMMUNOGEN SPECIFIC ANTI- MANNOPYRANOSIDE MONOCLONAL ANTIBODY FAB FRAGMENT
3243, 2a1wM, 0.6407, 2.93, 0.055, 216, 91, ANTI-COCAINE ANTIBODY 7.5.21 CRYSTAL FORM I
3244, 1rziM, 0.6407, 2.99, 0.065, 211, 92, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 47E FAB
3245, 1ru9L, 0.6407, 3.11, 0.054, 218, 93, CRYSTAL STRUCTURE (A) OF U.V.-IRRADIATED CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 4.6 WITH A DATA SET COLLECTED IN-HOUSE.
3246, 1om3L, 0.6407, 3.10, 0.054, 212, 92, FAB 2G12 UNLIGANDED
3247, 1jnhG, 0.6407, 2.57, 0.056, 208, 89, CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES
3248, 1beyL, 0.6407, 3.08, 0.064, 214, 94, ANTIBODY TO CAMPATH-1H HUMANIZED FAB
3249, 1aqkL, 0.6407, 3.10, 0.075, 215, 93, THREE-DIMENSIONAL STRUCTURE OF A HUMAN FAB WITH HIGH AFFINITY FOR TETANUS TOXOID
3250, 6ncpD, 0.6406, 2.93, 0.056, 212, 90, CRYSTAL STRUCTURE OF HIV-1 BROADLY NEUTRALIZING ANTIBODY ACS202 
3251, 6n6bL, 0.6406, 3.07, 0.054, 214, 93, THE COMPLEX CRYSTAL STRUCTURE OF NEURAMINIDASE FROM A/MINNESOTA/11/2010 WITH B10 ANTIBODY. 
3252, 6n35K, 0.6406, 2.82, 0.055, 213, 91, ANTI-HIV-1 FAB 2G12 + MAN1-2 RE-REFINEMENT 
3253, 6mamD, 0.6406, 3.02, 0.054, 215, 92, CLEAVED EBOLA GP IN COMPLEX WITH A BROADLY NEUTRALIZING HUMAN ANTIBODY; ADI-15946 
3254, 6m87C, 0.6406, 2.88, 0.044, 208, 91, FAB 10A6 IN COMPLEX WITH MPTS 
3255, 6dcaM, 0.6406, 2.79, 0.033, 215, 90, FAB/EPITOPE COMPLEX OF MOUSE MONOCLONAL ANTIBODY 6B2 TARGETING A NON- PHOSPHORYLATED TAU EPITOPE. 
3256, 6db5M, 0.6406, 2.80, 0.089, 211, 90, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB TA6 IN COMPLEX WITH A HIV-1 GP120 V3 PEPTIDE FROM NY5 STRAIN 
3257, 6c5vL, 0.6406, 2.82, 0.067, 212, 90, AN ANTI-GH/GL ANTIBODY THAT NEUTRALIZES DUAL-TROPIC INFECTION DEFINES A SITE OF VULNERABILITY ON EPSTEIN-BARR VIRUS 
3258, 6b5nL, 0.6406, 2.97, 0.054, 219, 92, STRUCTURE OF PFCSP PEPTIDE 25 WITH HUMAN PROTECTIVE ANTIBODY CIS43
3259, 5w1kH, 0.6406, 3.05, 0.054, 213, 92, JUNV GP1 CR1-10 FAB CR1-28 FAB COMPLEX 
3260, 5ggrL, 0.6406, 2.94, 0.056, 212, 90, PD-1 IN COMPLEX WITH NIVOLUMAB FAB
3261, 5czvL, 0.6406, 2.75, 0.056, 211, 89, CRYSTAL STRUCTURE OF NOTCH3 NRR IN COMPLEX WITH 20350 FAB
3262, 5bvjE, 0.6406, 2.91, 0.055, 214, 91, THE MOLECULAR MODE OF ACTION AND SPECIES SPECIFICITY OF CANAKINUMAB A HUMAN MONOCLONAL ANTIBODY NEUTRALIZING IL-1BETA
3263, 5a3iD, 0.6406, 3.00, 0.054, 218, 92, CRYSTAL STRUCTURE OF A COMPLEX FORMED BETWEEN FLD194 FAB AND TRANSMISSIBLE MUTANT H5 HAEMAGGLUTININ
3264, 4utaL, 0.6406, 2.98, 0.065, 215, 92, CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE1 C8
3265, 4lsqL, 0.6406, 2.96, 0.054, 209, 92, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC- CH31 IN COMPLEX WITH HIV-1 CLADE A/E GP120 93TH057 WITH LOOP D AND LOOP V5 FROM CLADE A STRAIN 3415_V1_C1
3266, 4jo2L, 0.6406, 2.84, 0.066, 216, 91, CRYSTAL STRUCTURE OF RABBIT MAB R56 FAB IN COMPLEX WITH V3 CROWN OF HIV-1 CONSENSUS A GP120
3267, 4h20L, 0.6406, 3.18, 0.053, 214, 94, CRYSTAL STRUCTURE AND COMPUTATIONAL MODELING OF THE FAB FRAGMENT FROM THE PROTECTIVE ANTI-RICIN MONOCLONAL ANTIBODY RAC18
3268, 3qa3C, 0.6406, 3.17, 0.053, 220, 94, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
3269, 3mlsL, 0.6406, 2.74, 0.056, 219, 90, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 MAB 2557 FAB IN COMPLEX WITH A HIV- 1 GP120 V3 MIMOTOPE
3270, 3lzfL, 0.6406, 2.72, 0.090, 212, 89, CRYSTAL STRUCTURE OF FAB 2D1 IN COMPLEX WITH THE 1918 INFLUENZA VIRUS HEMAGGLUTININ
3271, 3i9gL, 0.6406, 3.02, 0.054, 213, 92, CRYSTAL STRUCTURE OF THE LT1009 (SONEPCIZUMAB) ANTIBODY FAB FRAGMENT IN COMPLEX WITH SPHINGOSINE-1-PHOSPHATE
3272, 3ejyD, 0.6406, 2.89, 0.044, 211, 91, STRUCTURE OF E203H MUTANT OF E.COLI CL-/H+ ANTIPORTER CLC-EC1
3273, 3b2uL, 0.6406, 2.93, 0.055, 213, 91, CRYSTAL STRUCTURE OF ISOLATED DOMAIN III OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8
3274, 2w9eL, 0.6406, 3.01, 0.043, 212, 92, STRUCTURE OF ICSM 18 (ANTI-PRP THERAPEUTIC ANTIBODY) FAB FRAGMENT COMPLEXED WITH HUMAN PRP FRAGMENT 119-231
3275, 1za6D, 0.6406, 3.02, 0.108, 324, 93, THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY
3276, 6otcL, 0.6405, 2.98, 0.066, 215, 91, SYNTHETIC FAB BOUND TO MARBURG VIRUS VP35 INTERFERON INHIBITORY DOMAIN 
3277, 6o3aA, 0.6405, 3.00, 0.055, 212, 91, CRYSTAL STRUCTURE OF FRIZZLED 7 CRD IN COMPLEX WITH F7.B FAB 
3278, 5y9fU, 0.6405, 2.91, 0.044, 217, 91, CRYSTAL STRUCTURE OF HPV59 PENTAMER IN COMPLEX WITH THE FAB FRAGMENT OF ANTIBODY 28F10
3279, 5tdoA, 0.6405, 3.06, 0.054, 213, 93, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-HER2 ANTIBODY 4D5 WITH REDESIGNED HEAVY AND LIGHT CHAIN INTERFACES
3280, 5n2kM, 0.6405, 2.66, 0.067, 212, 89, STRUCTURE OF UNBOUND BRIAKINUMAB FAB
3281, 5jofF, 0.6405, 2.99, 0.055, 210, 91, CRYSTAL STRUCTURE OF VRC03 GHVGLV ANTIGEN-BINDING FRAGMENT.
3282, 5jo4B, 0.6405, 2.86, 0.054, 215, 92, ANTIBODY FAB FRAGMENT COMPLEX
3283, 5id0A, 0.6405, 2.83, 0.056, 212, 90, CETUXIMAB FAB IN COMPLEX WITH AMINOHEPTANOIC ACID-LINKED MEDITOPE
3284, 5hysJ, 0.6405, 2.97, 0.022, 214, 92, STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB
3285, 5cgyL, 0.6405, 2.69, 0.090, 213, 89, FAB FRAGMENT OF CHIKUNGUNYA VIRUS NEUTRALIZING HUMAN MONOCLONAL ANTIBODY 4J21
3286, 4z7oL, 0.6405, 2.98, 0.054, 214, 92, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE
3287, 4xpfL, 0.6405, 2.94, 0.043, 214, 92, X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER WITH SUBSITEB MUTATIONS (D121G/S426M) BOUND TO RTI-55
3288, 4jkpL, 0.6405, 3.00, 0.054, 207, 92, RESTRICTING HIV-1 PATHWAYS FOR ESCAPE USING RATIONALLY-DESIGNED ANTI- HIV-1 ANTIBODIES
3289, 4fp8O, 0.6405, 2.81, 0.055, 213, 91, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ HA1 SUBUNIT
3290, 3p0yL, 0.6405, 2.83, 0.055, 213, 91, ANTI-EGFR/HER3 FAB DL11 IN COMPLEX WITH DOMAIN III OF EGFR EXTRACELLULAR REGION
3291, 3ma9L, 0.6405, 2.72, 0.090, 209, 89, CRYSTAL STRUCTURE OF GP41 DERIVED PROTEIN COMPLEXED WITH FAB 8066
3292, 3kj4B, 0.6405, 3.00, 0.054, 219, 93, STRUCTURE OF RAT NOGO RECEPTOR BOUND TO 1D9 ANTAGONIST ANTIBODY
3293, 3haeL, 0.6405, 2.72, 0.090, 211, 89, RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES
3294, 3c5sC, 0.6405, 2.94, 0.055, 217, 91, CRYSTAL STRUCTURE OF MONOCLONAL FAB F22-4 SPECIFIC FOR SHIGELLA FLEXNERI 2A O-AG
3295, 1zlwK, 0.6405, 2.91, 0.056, 209, 90, FAB 2G12 + MAN8
3296, 1xgtA, 0.6405, 3.14, 0.054, 215, 93, STRUCTURE FOR ANTIBODY HYHEL-63 Y33L MUTANT COMPLEXED WITH HEN EGG LYSOZYME
3297, 1dqjA, 0.6405, 3.16, 0.054, 214, 93, CRYSTAL STRUCTURE OF THE ANTI-LYSOZYME ANTIBODY HYHEL-63 COMPLEXED WITH HEN EGG WHITE LYSOZYME
3298, 1bfoA, 0.6405, 3.13, 0.054, 214, 93, CAMPATH-1G IGG2B RAT MONOCLONAL FAB
3299, 6m87E, 0.6404, 2.89, 0.044, 210, 91, FAB 10A6 IN COMPLEX WITH MPTS 
3300, 5w1mA, 0.6404, 2.78, 0.056, 221, 90, MACV GP1 CR1-07 FAB COMPLEX 
3301, 5i1dA, 0.6404, 2.94, 0.056, 218, 90, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-23/IGKV4-1
3302, 5fcuL, 0.6404, 2.87, 0.089, 212, 90, CRYSTAL STRUCTURE OF THE INNER DOMAIN OF CLADE A/E HIV-1 GP120 IN COMPLEX WITH THE ADCC-POTENT RHESUS MACAQUE ANTIBODY JR4
3303, 4z5rR, 0.6404, 3.02, 0.054, 217, 92, RONTALIZUMAB FAB BOUND TO INTERFERON-A2
3304, 4xcnL, 0.6404, 2.98, 0.055, 214, 91, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA); 2.9 A RESOLUTION
3305, 4xbgL, 0.6404, 2.98, 0.055, 214, 91, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA): 2.73 A RESOLUTION
3306, 4tnwO, 0.6404, 2.73, 0.056, 211, 89, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
3307, 4qhmH, 0.6404, 2.82, 0.089, 209, 90, I3.1 (UNBOUND) FROM CH103 LINEAGE
3308, 4llwD, 0.6404, 2.72, 0.090, 209, 89, CRYSTAL STRUCTURE OF PERTUZUMAB CLAMBDA FAB WITH VARIABLE DOMAIN REDESIGN (VRD2) AT 1.95A
3309, 4fqiL, 0.6404, 2.72, 0.090, 211, 89, CRYSTAL STRUCTURE OF FAB CR9114 IN COMPLEX WITH A H5N1 INFLUENZA VIRUS HEMAGGLUTININ
3310, 4am0D, 0.6404, 2.92, 0.044, 212, 91, STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12
3311, 3zdxL, 0.6404, 2.98, 0.054, 214, 92, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
3312, 3u46L, 0.6404, 3.04, 0.054, 214, 92, CH04H/CH02L P212121
3313, 3thmL, 0.6404, 2.89, 0.088, 214, 91, CRYSTAL STRUCTURE OF FAS RECEPTOR EXTRACELLULAR DOMAIN IN COMPLEX WITH FAB EP6B_B01
3314, 3o0rL, 0.6404, 3.10, 0.054, 213, 93, CRYSTAL STRUCTURE OF NITRIC OXIDE REDUCTASE FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH ANTIBODY FRAGMENT
3315, 3jwdO, 0.6404, 2.78, 0.055, 212, 91, STRUCTURE OF HIV-1 GP120 WITH GP41-INTERACTIVE REGION: LAYERED ARCHITECTURE AND BASIS OF CONFORMATIONAL MOBILITY
3316, 2rcsL, 0.6404, 2.84, 0.055, 214, 91, IMMUNOGLOBULIN 48G7 GERMLINE FAB-AFFINITY MATURATION OF AN ESTEROLYTIC ANTIBODY
3317, 2nxyC, 0.6404, 2.95, 0.056, 214, 90, HIV-1 GP120 ENVELOPE GLYCOPROTEIN(S334A) COMPLEXED WITH CD4 AND ANTIBODY 17B
3318, 2ipuL, 0.6404, 3.15, 0.053, 219, 94, PFA1 FAB FRAGMENT COMPLEXED WITH ABETA 1-8 PEPTIDE
3319, 1ejoL, 0.6404, 2.97, 0.055, 216, 91, FAB FRAGMENT OF NEUTRALISING MONOCLONAL ANTIBODY 4C4 COMPLEXED WITH G-H LOOP FROM FMDV.
3320, 6mi2E, 0.6403, 2.72, 0.090, 210, 89, STRUCTURE OF THE HUMAN 4-1BB / UTOMILUMAB FAB COMPLEX 
3321, 6mh2A, 0.6403, 3.03, 0.054, 214, 93, STRUCTURE OF HERCEPTIN FAB WITHOUT ANTIGEN 
3322, 6i04D, 0.6403, 2.98, 0.055, 212, 91, CRYSTAL STRUCTURE OF SEMA DOMAIN OF THE MET RECEPTOR IN COMPLEX WITH FAB 
3323, 6h5nE, 0.6403, 2.83, 0.067, 212, 90, PLASMODIUM FALCIPARUM PFS48/45 C-TERMINAL DOMAIN BOUND TO MONOCLONAL ANTIBODY 85RF45.1 
3324, 6fy2L, 0.6403, 2.81, 0.089, 209, 90, CRYSTAL STRUCTURE OF A V2P-REACTIVE RV144 VACCINE-LIKE ANTIBODY; CAP228-16H; IN COMPLEX WITH A HETEROLOGOUS CAP225 V1V2 
3325, 6d4eA, 0.6403, 2.91, 0.054, 208, 93, CRYSTAL STRUCTURE OF A FC FRAGMENT OF RHESUS MACAQUE (MACACA MULATTA) IGG1. 
3326, 6d41B, 0.6403, 2.65, 0.044, 579, 90, BACTERIODES UNIFORMIS BETA-GLUCURONIDASE 1 BOUND TO D-GLUCARO-1;5- LACTONE 
3327, 6ca7L, 0.6403, 2.94, 0.055, 213, 91, CRYSTAL STRUCTURE OF PCT64_13C; A STRAIN SPECIFIC ANTI-HIV ANTIBODY 
3328, 6bzvF, 0.6403, 2.96, 0.055, 214, 91, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE GL PRECURSOR OF THE BROADLY NEUTRALIZING ANTIBODY 19B3 
3329, 6bi2L, 0.6403, 3.03, 0.054, 213, 92, TRASTUZUMAB FAB D185A (LIGHT CHAIN) MUTANT BIOTIN CONJUGATION.
3330, 5ucbL, 0.6403, 3.01, 0.055, 210, 91, STRUCTURE OF ANTIGEN-FAB COMPLEX WITH ENGINEERED SWITCH RESIDUE REGION.
3331, 5mo3L, 0.6403, 3.10, 0.054, 218, 93, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 8.5 
3332, 5ik3D, 0.6403, 2.85, 0.056, 218, 89, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E03 FAB FRAGMENT
3333, 5hi4L, 0.6403, 2.84, 0.089, 213, 90, BINDING SITE ELUCIDATION AND STRUCTURE GUIDED DESIGN OF MACROCYCLIC IL-17A ANTAGONISTS
3334, 5eocL, 0.6403, 2.85, 0.044, 216, 91, CRYSTAL STRUCTURE OF FAB C2 IN COMPLEX WITH A CYCLIC VARIANT OF HEPATITIS C VIRUS E2 EPITOPE I
3335, 5d1zA, 0.6403, 3.01, 0.054, 213, 92, ISDB NEAT1 BOUND BY CLONE D4-10
3336, 4z7nL, 0.6403, 2.99, 0.054, 214, 92, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE
3337, 4xvuL, 0.6403, 3.05, 0.054, 216, 93, STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF NYV1
3338, 4tukL, 0.6403, 3.12, 0.043, 218, 92, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY AGAINST NEUROBLASTOMA ASSOCIATED ANTIGEN.
3339, 4r96A, 0.6403, 2.93, 0.056, 219, 90, STRUCTURE OF A LLAMA GLAMA FAB 48A2 AGAINST HUMAN CMET
3340, 4q2zB, 0.6403, 2.73, 0.090, 212, 89, FAB FRAGMENT OF HIV VACCINE-ELICITED CD4BS-DIRECTED ANTIBODY GE356 FROM A NON-HUMAN PRIMATE
3341, 4hijC, 0.6403, 3.04, 0.067, 212, 90, ANTI-STREPTOCOCCUS PNEUMONIAE 23F FAB 023.102 WITH BOUND L-RHAMNOSE- (1-2)-ALPHA-D-GALACTOSE-(3-O)-PHOSPHATE-2-GLYCEROL
3342, 4g7vL, 0.6403, 2.86, 0.056, 211, 89, CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (R217E 2.5 A)
3343, 4al8L, 0.6403, 3.11, 0.054, 213, 93, STRUCTURE OF DENGUE VIRUS DIII IN COMPLEX WITH FAB 2H12
3344, 4aeiN, 0.6403, 3.06, 0.054, 217, 92, CRYSTAL STRUCTURE OF THE AAHII-FAB4C1 COMPLEX
3345, 3tygL, 0.6403, 2.87, 0.056, 206, 90, CRYSTAL STRUCTURE OF BROAD AND POTENT HIV-1 NEUTRALIZING ANTIBODY PGT128 IN COMPLEX WITH A GLYCOSYLATED ENGINEERED GP120 OUTER DOMAIN WITH MINIV3 (EODMV3)
3346, 3of6F, 0.6403, 2.82, 0.087, 103, 92, HUMAN PRE-T CELL RECEPTOR CRYSTAL STRUCTURE
3347, 3hi5L, 0.6403, 2.92, 0.056, 211, 90, CRYSTAL STRUCTURE OF FAB FRAGMENT OF AL-57
3348, 3eo1J, 0.6403, 3.16, 0.064, 215, 94, STRUCTURE OF THE FAB FRAGMENT OF GC-1008 IN COMPLEX WITH TRANSFORMING GROWTH FACTOR-BETA 3
3349, 3eo1D, 0.6403, 3.16, 0.064, 215, 94, STRUCTURE OF THE FAB FRAGMENT OF GC-1008 IN COMPLEX WITH TRANSFORMING GROWTH FACTOR-BETA 3
3350, 3bgaB, 0.6403, 3.26, 0.059, 980, 102, CRYSTAL STRUCTURE OF BETA-GALACTOSIDASE FROM BACTEROIDES THETAIOTAOMICRON VPI-5482
3351, 1lhzA, 0.6403, 2.76, 0.067, 213, 90, STRUCTURE OF A HUMAN BENCE-JONES DIMER CRYSTALLIZED IN U.S. SPACE SHUTTLE MISSION STS-95: 293K
3352, 1bfoE, 0.6403, 3.10, 0.054, 214, 93, CAMPATH-1G IGG2B RAT MONOCLONAL FAB
3353, 6n32L, 0.6402, 2.82, 0.056, 212, 90, ANTI-HIV-1 FAB 2G12 RE-REFINEMENT 
3354, 6jmqD, 0.6402, 3.14, 0.054, 219, 93, LAT1-CD98HC COMPLEX BOUND TO MEM-108 FAB 
3355, 6ev2H, 0.6402, 2.85, 0.055, 213, 91, CRYSTAL STRUCTURE OF ANTIBODY AGAINST SCHIZOPHYLLAN IN COMPLEX WITH LAMINARIHEXAOSE 
3356, 6e4yL, 0.6402, 3.02, 0.054, 218, 92, ANTI-PCSK9 FAB 6E2 BOUND TO THE N-TERMINAL PEPTIDE FROM PCSK9; UNMODIFIED 
3357, 6bzuB, 0.6402, 2.95, 0.055, 216, 91, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 19B3 
3358, 6bi0M, 0.6402, 3.08, 0.054, 213, 93, TRASTUZUMAB FAB N158A D185A K190A (LIGHT CHAIN) TRIPLE MUTANT.
3359, 5vshL, 0.6402, 2.99, 0.054, 213, 92, CH1/CLAMBDA FAB BASED ON PERTUZUMAB
3360, 5tgbL, 0.6402, 3.01, 0.054, 208, 92, STRUCTURE OF CHIMERIC 02-CB FAB A VRC01-LIKE GERMLINE ANTIBODY
3361, 5mvgB, 0.6402, 2.84, 0.089, 209, 90, CRYSTAL STRUCTURE OF NON-AMYLOIDOGENIC LIGHT CHAIN DIMER M7
3362, 5jrpL, 0.6402, 2.81, 0.056, 210, 90, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY MR78 FAB
3363, 5ig7H, 0.6402, 2.73, 0.090, 213, 89, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E01 FAB FRAGMENT IN COMPLEX OF PEPTIDE PLQPQQPFP
3364, 5hi5D, 0.6402, 2.81, 0.089, 213, 90, BINDING SITE ELUCIDATION AND STRUCTURE GUIDED DESIGN OF MACROCYCLIC IL-17A ANTAGONISTS
3365, 4zfoB, 0.6402, 3.02, 0.054, 213, 92, J22.9-XI: CHIMERIC MOUSE/HUMAN ANTIBODY AGAINST HUMAN BCMA (CD269)
3366, 4ydlC, 0.6402, 3.05, 0.054, 211, 93, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY C38- VRC18.02 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057GP120
3367, 4j4pA, 0.6402, 3.49, 0.061, 315, 99, THE COMPLEX OF HUMAN IGE-FC WITH TWO BOUND FAB FRAGMENTS
3368, 4hcrN, 0.6402, 2.81, 0.055, 218, 91, CRYSTAL STRUCTURE OF HUMAN MADCAM-1 D1D2 COMPLEXED WITH FAB PF-547659
3369, 3vg0L, 0.6402, 2.91, 0.054, 213, 92, ANTIBODY FAB FRAGMENT
3370, 3oayL, 0.6402, 3.01, 0.055, 213, 91, A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY
3371, 3hc0B, 0.6402, 3.10, 0.054, 213, 92, BHA10 IGG1 WILD-TYPE FAB - ANTIBODY DIRECTED AT HUMAN LTBR
3372, 2xzaL, 0.6402, 2.84, 0.055, 214, 91, CRYSTAL STRUCTURE OF RECOMBINANT A.17 ANTIBODY FAB FRAGMENT
3373, 1jpsL, 0.6402, 2.81, 0.055, 213, 91, CRYSTAL STRUCTURE OF TISSUE FACTOR IN COMPLEX WITH HUMANIZED FAB D3H44
3374, 1g9mL, 0.6402, 2.95, 0.044, 214, 90, HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
3375, 1fbiL, 0.6402, 3.06, 0.043, 214, 93, CRYSTAL STRUCTURE OF A CROSS-REACTION COMPLEX BETWEEN FAB F9.13.7 AND GUINEA-FOWL LYSOZYME
3376, 1aj7L, 0.6402, 3.03, 0.054, 214, 93, IMMUNOGLOBULIN 48G7 GERMLINE FAB ANTIBODY COMPLEXED WITH HAPTEN 5-(PARA-NITROPHENYL PHOSPHONATE)-PENTANOIC ACID. AFFINITY MATURATION OF AN ESTEROLYTIC ANTIBODY
3377, 6idhL, 0.6401, 3.10, 0.054, 217, 93, ANTIBODY 64M-5 FAB IN LIGAND-FREE FORM 
3378, 6fhnA, 0.6401, 3.19, 0.074, 978, 94, STRUCTURAL DYNAMICS AND CATALYTIC PROPERTIES OF A MULTI-MODULAR XANTHANASE (PT DERIVATIVE) 
3379, 6dwiO, 0.6401, 2.89, 0.067, 211, 89, STRUCTURE OF THE 4462 ANTIBODY FAB FRAGMENT BOUND TO A STAPHYLOCOCCUS AUREUS WALL TECHOIC ACID ANALOG 
3380, 5xj4A, 0.6401, 2.39, 0.058, 206, 86, COMPLEX STRUCTURE OF DURVALUMAB-SCFV/PD-L1 
3381, 5xezL, 0.6401, 2.99, 0.065, 214, 93, STRUCTURE OF THE FULL-LENGTH GLUCAGON CLASS B G PROTEIN-COUPLED RECEPTOR
3382, 5tdnA, 0.6401, 3.06, 0.054, 213, 93, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-HER2 ANTIBODY 4D5 WITH REDESIGNED HEAVY AND LIGHT CHAIN INTERFACES
3383, 5gsqD, 0.6401, 3.03, 0.132, 194, 91, CRYSTAL STRUCTURE OF IGG FC WITH A HOMOGENEOUS GLYCOFORM AND ANTIBODY- DEPENDENT CELLULAR CYTOTOXICITY
3384, 5e94A, 0.6401, 3.04, 0.065, 214, 93, ANTIBODY-BOUND GLUCAGON-LIKE PEPTIDE-1 RECEPTOR EXTRACELLULAR DOMAIN
3385, 5dqjB, 0.6401, 3.11, 0.054, 217, 93, STRUCTURE OF UNLIGANDED S55-5 FAB
3386, 4r7dP, 0.6401, 2.85, 0.056, 211, 90, FAB HU 15C1
3387, 4r2gI, 0.6401, 2.87, 0.078, 210, 90, CRYSTAL STRUCTURE OF PGT124 FAB BOUND TO HIV-1 JRCSF GP120 CORE AND TO CD4
3388, 4olzL, 0.6401, 3.09, 0.054, 208, 93, CRYSTAL STRUCTURE OF ANTIBODY VRC07-G54W IN COMPLEX WITH CLADE A/E 93TH057 HIV-1 GP120 CORE
3389, 3w9dD, 0.6401, 3.11, 0.054, 213, 92, STRUCTURE OF HUMAN MONOCLONAL ANTIBODY E317 FAB
3390, 1cfqA, 0.6401, 3.25, 0.053, 214, 94, ANTI-P24 (HIV-1) FAB FRAGMENT CB41
3391, 6n2xL, 0.6400, 2.85, 0.055, 213, 91, ANTI-HIV-1 FAB 2G12 + MAN9 RE-REFINEMENT 
3392, 6d0uL, 0.6400, 2.94, 0.066, 213, 91, CRYSTAL STRUCTURE OF C05 V110P/A117E MUTANT BOUND TO H3 INFLUENZA HEMAGGLUTININ; HA1 SUBUNIT 
3393, 6bhyB, 0.6400, 3.01, 0.065, 207, 93, MOUSE IMMUNOGLOBULIN G 2C FC FRAGMENT WITH SINGLE GLCNAC
3394, 6avnL, 0.6400, 2.81, 0.089, 205, 90, CRYSTAL STRUCTURE OF UNBOUND ANTI-HIV ANTIBODY FAB PGV19 AT 2.5 A 
3395, 5hi4D, 0.6400, 2.81, 0.089, 213, 90, BINDING SITE ELUCIDATION AND STRUCTURE GUIDED DESIGN OF MACROCYCLIC IL-17A ANTAGONISTS
3396, 5dmgL, 0.6400, 2.96, 0.066, 216, 91, X-RAY STRUCTURE OF THE FAB FRAGMENT OF THE ANTI TAU ANTIBODY RB86 IN COMPLEX WITH THE PHOSPHORYLATED TAU PEPTIDE (416-430)
3397, 5d6cA, 0.6400, 3.00, 0.054, 219, 92, STRUCTURE OF 4497 FAB BOUND TO SYNTHETIC WALL TEICHOIC ACID FRAGMENT
3398, 4tnwN, 0.6400, 2.74, 0.056, 211, 89, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
3399, 4r96C, 0.6400, 2.92, 0.056, 219, 90, STRUCTURE OF A LLAMA GLAMA FAB 48A2 AGAINST HUMAN CMET
3400, 4oz4B, 0.6400, 2.94, 0.054, 218, 92, X-RAY STRUCTURE OF THE DC8E8 FAB APO-FORM CRYSTALLIZED AT PH 8.5 AND REFINED TO 3.0 A.
3401, 4nhgF, 0.6400, 2.91, 0.056, 211, 90, CRYSTAL STRUCTURE OF 2G12 IGG DIMER
3402, 4k23L, 0.6400, 2.98, 0.054, 218, 92, STRUCTURE OF ANTI-UPAR FAB ATN-658
3403, 4hihC, 0.6400, 2.87, 0.067, 208, 89, ANTI-STREPTOCOCCUS PNEUMONIAE 23F FAB 023.102 WITH BOUND RHAMNOSE.
3404, 3rkdC, 0.6400, 2.99, 0.054, 213, 92, HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE I) IN COMPLEX WITH A NEUTRALIZING ANTIBODY
3405, 3ntcL, 0.6400, 2.95, 0.054, 219, 92, CRYSTAL STRUCTURE OF KD-247 FAB AN ANTI-V3 ANTIBODY THAT INHIBITS HIV-1 ENTRY
3406, 3kj4L, 0.6400, 3.20, 0.053, 219, 95, STRUCTURE OF RAT NOGO RECEPTOR BOUND TO 1D9 ANTAGONIST ANTIBODY
3407, 3b2uK, 0.6400, 2.84, 0.056, 213, 90, CRYSTAL STRUCTURE OF ISOLATED DOMAIN III OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8
3408, 2nxzC, 0.6400, 2.96, 0.056, 214, 90, HIV-1 GP120 ENVELOPE GLYCOPROTEIN (T257S S334A S375W) COMPLEXED WITH CD4 AND ANTIBODY 17B
3409, 1yehL, 0.6400, 3.27, 0.043, 219, 94, STRUCTURE OF IGG2A FAB FRAGMENT
3410, 1uj3A, 0.6400, 3.02, 0.054, 214, 92, CRYSTAL STRUCTURE OF A HUMANIZED FAB FRAGMENT OF ANTI- TISSUE-FACTOR ANTIBODY IN COMPLEX WITH TISSUE FACTOR
3411, 1dqmL, 0.6400, 3.06, 0.054, 214, 93, CRYSTAL STRUCTURE OF ANTI-LYSOZYME ANTIBODY
3412, 1bfoG, 0.6400, 3.10, 0.054, 214, 93, CAMPATH-1G IGG2B RAT MONOCLONAL FAB
3413, 6nb5M, 0.6399, 2.84, 0.089, 209, 90, CRYSTAL STRUCTURE OF ANTI- MERS-COV HUMAN NEUTRALIZING LCA60 ANTIBODY FAB FRAGMENT 
3414, 6h06B, 0.6399, 2.99, 0.054, 218, 92, FAB CBTAU-22.1 IN COMPLEX WITH TAU PEPTIDE V1088-5 
3415, 6dfjL, 0.6399, 2.94, 0.055, 214, 91, CRYSTAL STRUCTURE OF ANTI-ZIKA ANTIBODY Z021 BOUND TO DENV-1 ENVELOPE PROTEIN DIII 
3416, 5mx3B, 0.6399, 2.94, 0.054, 218, 92, STRUCTURE OF DC8E8 FAB CRYSTALLIZED AT PH 8.5
3417, 5kzpK, 0.6399, 3.07, 0.066, 211, 91, STRUCTURE OF THE HCV1-C1 ANTIBODY-ANTIGEN COMPLEX
3418, 5ihzF, 0.6399, 2.75, 0.090, 213, 89, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E01 FAB FRAGMENT
3419, 5dubB, 0.6399, 2.76, 0.067, 214, 90, CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU98 IN COMPLEX WITH DEOXYHYPUSINE
3420, 4zs6D, 0.6399, 2.97, 0.056, 210, 90, RECEPTOR BINDING DOMAIN AND FAB COMPLEX
3421, 4whtT, 0.6399, 2.91, 0.044, 215, 90, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11 P1 CRYSTAL FORM
3422, 4rfoL, 0.6399, 2.72, 0.090, 212, 89, CRYSTAL STRUCTURE OF THE ADCC-POTENT ANTIBODY N60-I3 FAB IN COMPLEX WITH HIV-1 CLADE A/E GP120 AND M48U1
3423, 3v6fD, 0.6399, 2.89, 0.044, 219, 91, CRYSTAL STRUCTURE OF AN ANTI-HBV E-ANTIGEN MONOCLONAL FAB FRAGMENT (E6) UNBOUND
3424, 3nigL, 0.6399, 2.99, 0.054, 214, 92, THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
3425, 3ifpD, 0.6399, 3.12, 0.054, 218, 93, X-RAY STRUCTURE OF AMYLOID BETA PEPTIDE:ANTIBODY (ABETA1-7:12B4) COMPLEX
3426, 3hr5A, 0.6399, 2.86, 0.055, 219, 91, M1PRIME PEPTIDE FROM IGE BOUND BY HUMANIZED ANTIBODY 47H4 FAB
3427, 3bplB, 0.6399, 2.78, 0.078, 202, 90, CRYSTAL STRUCTURE OF THE IL4-IL4R-COMMON GAMMA TERNARY COMPLEX
3428, 2b1hL, 0.6399, 2.81, 0.089, 215, 90, CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 V3 FAB 2219 IN COMPLEX WITH UG29 PEPTIDE
3429, 1ahwD, 0.6399, 2.80, 0.055, 214, 91, A COMPLEX OF EXTRACELLULAR DOMAIN OF TISSUE FACTOR WITH AN INHIBITORY FAB (5G9)
3430, 6m87A, 0.6398, 2.87, 0.044, 210, 91, FAB 10A6 IN COMPLEX WITH MPTS 
3431, 6avrL, 0.6398, 2.96, 0.055, 211, 91, HUMAN ALPHA-V BETA-3 INTEGRIN (INTERMEDIATE CONFORMATION) IN COMPLEX WITH THE THERAPEUTIC ANTIBODY LM609
3432, 6avqL, 0.6398, 2.96, 0.055, 211, 91, THE THERAPEUTIC ANTIBODY LM609 SELECTIVELY INHIBITS LIGAND BINDING TO HUMAN ALPHA-V BETA-3 INTEGRIN VIA STERIC HINDRANCE
3433, 6a0xH, 0.6398, 3.15, 0.053, 214, 94, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY 13D4 
3434, 5vk2E, 0.6398, 2.72, 0.090, 211, 89, STRUCTURAL BASIS FOR ANTIBODY-MEDIATED NEUTRALIZATION OF LASSA VIRUS
3435, 5i8hH, 0.6398, 2.97, 0.056, 212, 90, CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH V3 LOOP-TARGETING ANTIBODY PGT122 FAB AND FUSION PEPTIDE-TARGETING ANTIBODY VRC34.01 FAB
3436, 5d96I, 0.6398, 3.08, 0.054, 214, 93, OXIDOREDUCTASE FRAGMENT OF MOUSE QSOX1 IN COMPLEX WITH A FAB FRAGMENT FROM AN ANTIBODY TARGETING MOUSE AND HUMAN QSOX1
3437, 4yhnB, 0.6398, 3.01, 0.054, 218, 92, DABIGATRAN REVERSAL AGENT
3438, 4xgzD, 0.6398, 3.08, 0.065, 210, 93, CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD2 MOTIF IN COMPLEX WITH FAB FRAGMENT
3439, 4xceL, 0.6398, 3.14, 0.065, 212, 93, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB CRYSTALIZED IN THE PRESENCE OF PHOSPHATIDYLCHOLINE (06:0 PC); C2 SPACE GROUP
3440, 4xbpL, 0.6398, 2.95, 0.055, 214, 91, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB CRYSTALIZED IN THE PRESENCE OF PHOSPHATIDYLETHANOLAMINE (06:0 PE)
3441, 4r7dH, 0.6398, 2.87, 0.056, 212, 90, FAB HU 15C1
3442, 4jzjL, 0.6398, 3.01, 0.054, 219, 92, CRYSTAL STRUCTURE OF RECEPTOR-FAB COMPLEX
3443, 3wfdL, 0.6398, 2.98, 0.054, 213, 92, REDUCED AND ACETALDOXIME-BOUND CYTOCHROME C-DEPENDENT NITRIC OXIDE REDUCTASE (CNOR) FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH ANTIBODY FRAGMENT
3444, 3q3gA, 0.6398, 3.03, 0.043, 220, 93, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
3445, 3mugE, 0.6398, 2.82, 0.089, 211, 90, CRYSTAL STRUCTURE OF HUMAN FAB PG16 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
3446, 3ifpL, 0.6398, 3.12, 0.054, 218, 93, X-RAY STRUCTURE OF AMYLOID BETA PEPTIDE:ANTIBODY (ABETA1-7:12B4) COMPLEX
3447, 3ifpF, 0.6398, 3.12, 0.054, 218, 93, X-RAY STRUCTURE OF AMYLOID BETA PEPTIDE:ANTIBODY (ABETA1-7:12B4) COMPLEX
3448, 3i75A, 0.6398, 2.84, 0.033, 212, 90, ANTIBODY STRUCTURE
3449, 3eysL, 0.6398, 3.02, 0.054, 218, 92, PFA1 FAB FRAGMENT COMPLEXED WITH PYRO-GLU3-A-BETA (3-8)
3450, 2y5tB, 0.6398, 2.98, 0.043, 218, 93, CRYSTAL STRUCTURE OF THE PATHOGENIC AUTOANTIBODY CIIC1 IN COMPLEX WITH THE TRIPLE-HELICAL C1 PEPTIDE
3451, 2fx9L, 0.6398, 3.00, 0.055, 214, 91, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH A THIOETHER-LINKED PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41
3452, 2aj3E, 0.6398, 2.94, 0.055, 212, 91, CRYSTAL STRUCTURE OF A CROSS-REACTIVE HIV-1 NEUTRALIZING CD4-BINDING SITE ANTIBODY FAB M18
3453, 1xguA, 0.6398, 3.16, 0.054, 214, 93, STRUCTURE FOR ANTIBODY HYHEL-63 Y33F MUTANT COMPLEXED WITH HEN EGG LYSOZYME
3454, 1xf3L, 0.6398, 2.95, 0.054, 213, 92, STRUCTURE OF LIGAND-FREE FAB DNA-1 IN SPACE GROUP P65
3455, 1gsmA, 0.6398, 3.43, 0.040, 206, 99, A REASSESSMENT OF THE MADCAM-1 STRUCTURE AND ITS ROLE IN INTEGRIN RECOGNITION.
3456, 1b6dA, 0.6398, 2.72, 0.056, 212, 89, BENCE JONES PROTEIN DEL: AN ENTIRE IMMUNOGLOBULIN KAPPA LIGHT-CHAIN DIMER
3457, 1a8jL, 0.6398, 2.87, 0.055, 215, 91, IMMUNOGLOBULIN LAMBDA LIGHT CHAIN DIMER (MCG) COMPLEX WITH ASPARTAME
3458, 6oe4C, 0.6397, 2.97, 0.056, 212, 90, PREFUSION RSV F MONOMER BOUND BY NEUTRALIZING ANTIBODY CR9501 
3459, 6cw3D, 0.6397, 2.83, 0.055, 213, 91, CRYSTAL STRUCTURE OF A YEAST SAGA TRANSCRIPTIONAL COACTIVATOR ADA2/GCN5 HAT SUBCOMPLEX; CRYSTAL FORM 2 
3460, 5eszL, 0.6397, 3.04, 0.054, 214, 92, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH04 ISOLATED FROM DONOR CH0219 IN COMPLEX WITH SCAFFOLDED TRIMERIC HIV-1 ENV V1V2 DOMAIN FROM THE CLADE AE STRAIN A244
3461, 5cjsE, 0.6397, 2.73, 0.079, 211, 89, CRYSTAL STRUCTURE OF A MONOMERIC INFLUENZA HEMAGGLUTININ STEM IN COMPLEX WITH AN BROADLY NEUTRALIZING ANTIBODY CR9114
3462, 4xvuF, 0.6397, 3.02, 0.065, 216, 92, STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF NYV1
3463, 4nm8N, 0.6397, 2.87, 0.056, 217, 89, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR8043 BOUND TO H3 INFLUENZA HEMAGGLUTININ
3464, 4nhhP, 0.6397, 2.81, 0.056, 211, 90, STRUCTURE OF 2G12 IGG DIMER
3465, 4nhhK, 0.6397, 2.81, 0.056, 211, 90, STRUCTURE OF 2G12 IGG DIMER
3466, 4nhhF, 0.6397, 2.81, 0.056, 211, 90, STRUCTURE OF 2G12 IGG DIMER
3467, 4nhgG, 0.6397, 3.14, 0.065, 211, 92, CRYSTAL STRUCTURE OF 2G12 IGG DIMER
3468, 4nhgC, 0.6397, 3.14, 0.065, 211, 92, CRYSTAL STRUCTURE OF 2G12 IGG DIMER
3469, 4lmqI, 0.6397, 2.86, 0.055, 214, 91, DEVELOPMENT AND PRECLINICAL CHARACTERIZATION OF A HUMANIZED ANTIBODY TARGETING CXCL12
3470, 3v6fF, 0.6397, 2.86, 0.055, 219, 91, CRYSTAL STRUCTURE OF AN ANTI-HBV E-ANTIGEN MONOCLONAL FAB FRAGMENT (E6) UNBOUND
3471, 3t3pL, 0.6397, 2.99, 0.054, 214, 92, A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
3472, 3ifoL, 0.6397, 2.98, 0.043, 218, 92, X-RAY STRUCTURE OF AMYLOID BETA PEPTIDE:ANTIBODY (ABETA1-7:10D5) COMPLEX
3473, 2nz9C, 0.6397, 2.94, 0.056, 216, 90, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY AR2
3474, 1xgpA, 0.6397, 3.02, 0.054, 215, 92, STRUCTURE FOR ANTIBODY HYHEL-63 Y33A MUTANT COMPLEXED WITH HEN EGG LYSOZYME
3475, 1op3K, 0.6397, 2.81, 0.056, 211, 90, CRYSTAL STRUCTURE OF FAB 2G12 BOUND TO MAN1->2MAN
3476, 1nc2A, 0.6397, 2.56, 0.057, 211, 88, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 2D12.5 FAB COMPLEXED WITH Y- DOTA
3477, 6d0uF, 0.6396, 2.76, 0.056, 213, 90, CRYSTAL STRUCTURE OF C05 V110P/A117E MUTANT BOUND TO H3 INFLUENZA HEMAGGLUTININ; HA1 SUBUNIT 
3478, 6cxgL, 0.6396, 2.78, 0.056, 213, 90, ANTI-HIV-1 FAB 2G12 IN COMPLEX WITH GLYCOPEPTIDE 10V1S 
3479, 6be2L, 0.6396, 2.60, 0.102, 213, 88, CRYSTAL STRUCTURE OF A POLYSACCHARIDE-BINDING HUMAN FAB (F598)
3480, 6bb4L, 0.6396, 2.94, 0.055, 211, 91, FAB/EPITOPE COMPLEX OF MOUSE MONOCLONAL ANTIBODY C5.2 TARGETING A PHOSPHO-TAU EPITOPE. 
3481, 6avuL, 0.6396, 2.97, 0.055, 211, 91, HUMAN ALPHA-V BETA-3 INTEGRIN (OPEN CONFORMATION) IN COMPLEX WITH THE THERAPEUTIC ANTIBODY LM609
3482, 6a0xF, 0.6396, 3.14, 0.053, 214, 94, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY 13D4 
3483, 5mu0P, 0.6396, 3.10, 0.054, 216, 92, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (IA03)
3484, 5j3dB, 0.6396, 3.08, 0.054, 215, 93, CRYSTAL STRUCTURE OF HUMAN FAB 14N4 IN COMPLEX WITH POST-FUSION RSV F
3485, 5ihzB, 0.6396, 2.69, 0.090, 213, 89, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E01 FAB FRAGMENT
3486, 5hi5L, 0.6396, 2.85, 0.089, 213, 90, BINDING SITE ELUCIDATION AND STRUCTURE GUIDED DESIGN OF MACROCYCLIC IL-17A ANTAGONISTS
3487, 5gzoD, 0.6396, 2.85, 0.055, 213, 91, STRUCTURE OF NEUTRALIZING ANTIBODY BOUND TO ZIKA ENVELOPE PROTEIN
3488, 5cp7A, 0.6396, 3.08, 0.043, 218, 93, CRYSTAL STRUCTURE OF AN ANTIGEN-BINDING FRAGMENT OF MONOCLONAL ANTIBODY AGAINST SULFONAMIDES
3489, 5bo1M, 0.6396, 2.87, 0.055, 214, 91, CRYSTAL STRUCTURE OF A HUMAN JAG1 FRAGMENT IN COMPLEX WITH AN ANTI- JAG1 FAB
3490, 4zypE, 0.6396, 2.93, 0.056, 213, 90, CRYSTAL STRUCTURE OF MOTAVIZUMAB AND QUATERNARY-SPECIFIC RSV- NEUTRALIZING HUMAN ANTIBODY AM14 IN COMPLEX WITH PREFUSION RSV F GLYCOPROTEIN
3491, 4z5rT, 0.6396, 2.79, 0.056, 217, 90, RONTALIZUMAB FAB BOUND TO INTERFERON-A2
3492, 4xbgK, 0.6396, 2.85, 0.056, 212, 89, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA): 2.73 A RESOLUTION
3493, 4qhmF, 0.6396, 2.84, 0.089, 209, 90, I3.1 (UNBOUND) FROM CH103 LINEAGE
3494, 4qhmB, 0.6396, 2.83, 0.089, 209, 90, I3.1 (UNBOUND) FROM CH103 LINEAGE
3495, 4ktdL, 0.6396, 2.77, 0.079, 216, 89, FAB FRAGMENT OF HIV VACCINE-ELICITED CD4BS-DIRECTED ANTIBODY GE136 FROM NON-HUMAN PRIMATE
3496, 4jpkL, 0.6396, 2.95, 0.056, 208, 90, CRYSTAL STRUCTURE OF THE GERMLINE-TARGETING HIV-1 GP120 ENGINEERED OUTER DOMAIN EOD-GT6 IN COMPLEX WITH A PUTATIVE VRC01 GERMLINE PRECURSOR FAB
3497, 4jfyA, 0.6396, 2.85, 0.056, 211, 89, APO STRUCTURE OF PHOSPHOTYROSINE (PYAB) SCAFFOLD
3498, 4b53A, 0.6396, 2.96, 0.110, 103, 91, CRYSTAL STRUCTURE OF THE ISOLATED IGG4 CH3 DOMAIN
3499, 3o2wL, 0.6396, 3.00, 0.054, 218, 92, CRYSTAL STRUCTURE OF THE 1E9 PHEL89SER/LEUH47TRP/METH100BPHE FAB IN COMPLEX WITH A 39A11 TRANSITION STATE ANALOG
3500, 2iq9L, 0.6396, 3.04, 0.054, 219, 93, PFA2 FAB FRAGMENT TRICLINIC APO FORM
3501, 2h2sD, 0.6396, 2.93, 0.044, 211, 91, CRYSTAL STRUCTURE OF E148A MUTANT OF CLC-EC1 IN SECN-
3502, 2gfbK, 0.6396, 3.00, 0.043, 214, 93, CRYSTAL STRUCTURE OF A CATALYTIC FAB HAVING ESTERASE-LIKE ACTIVITY
3503, 1mj8L, 0.6396, 2.77, 0.045, 214, 89, HIGH RESOLUTION CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE ESTEROLYTIC ANTIBODY MS6-126
3504, 1lo0L, 0.6396, 3.07, 0.054, 219, 93, CATALYTIC RETRO-DIELS-ALDERASE TRANSITION STATE ANALOGUE COMPLEX
3505, 6n35L, 0.6395, 2.99, 0.055, 211, 91, ANTI-HIV-1 FAB 2G12 + MAN1-2 RE-REFINEMENT 
3506, 6n2xK, 0.6395, 3.02, 0.054, 213, 92, ANTI-HIV-1 FAB 2G12 + MAN9 RE-REFINEMENT 
3507, 6mtpL, 0.6395, 3.02, 0.054, 214, 92, CRYSTAL STRUCTURE OF VRC42.04 FAB IN COMPLEX WITH GP41 PEPTIDE 
3508, 6dc8L, 0.6395, 2.95, 0.043, 218, 92, FAB/EPITOPE COMPLEX OF MOUSE MONOCLONAL ANTIBODY 8B2 TARGETING A NON- PHOSPHORYLATED TAU EPITOPE. 
3509, 6cw3B, 0.6395, 3.02, 0.054, 213, 92, CRYSTAL STRUCTURE OF A YEAST SAGA TRANSCRIPTIONAL COACTIVATOR ADA2/GCN5 HAT SUBCOMPLEX; CRYSTAL FORM 2 
3510, 6ct7L, 0.6395, 2.86, 0.088, 212, 91, FAB OF ANTI-A-SYNUCLEIN ANTIBODY BIIB054 IN COMPLEX WITH ACETYLATED A- SYNUCLEIN PEPTIDE (1-10) 
3511, 5vobL, 0.6395, 3.02, 0.054, 214, 92, CRYSTAL STRUCTURE OF HCMV PENTAMER IN COMPLEX WITH NEUTRALIZING ANTIBODY 8I21
3512, 5vh3L, 0.6395, 2.87, 0.055, 214, 91, CRYSTAL STRUCTURE OF FAB FRAGMENT OF THE ANTI-TNFA ANTIBODY INFLIXIMAB IN A C-CENTERED ORTHORHOMBIC CRYSTAL FORM
3513, 5ukrL, 0.6395, 2.76, 0.079, 210, 89, STRUCTURE OF UNLIGANDED ANTI-GP120 CD4BS ANTIBODY DH522.2 FAB IN COMPLEX WITH A GP120 CORE
3514, 5tz2L, 0.6395, 2.93, 0.056, 212, 90, CRYSTAL STRUCTURE OF HUMAN CD47 ECD BOUND TO FAB OF C47B222
3515, 5tplL, 0.6395, 2.63, 0.090, 210, 89, CRYSTAL STRUCTURE OF DH270.3 (UNLIGANDED) FROM THE DH270 BROADLY NEUTRALIZING N332-GLYCAN DEPENDENT LINEAGE
3516, 5h2bB, 0.6395, 2.89, 0.056, 211, 90, STRUCTURE OF A NOVEL ANTIBODY G196
3517, 5epmF, 0.6395, 2.96, 0.043, 218, 92, CERATOTOXIN VARIANT IN COMPLEX WITH SPECIFIC ANTIBODY FAB FRAGMENT
3518, 5dd5L, 0.6395, 2.98, 0.066, 213, 91, CRYSTAL STRUCTURES IN AN ANTI-HIV ANTIBODY LINEAGE FROM IMMUNIZATION OF RHESUS MACAQUES
3519, 5bk2D, 0.6395, 3.05, 0.054, 216, 93, CRYSTAL STRUCTURE OF MALTOSE BINDING PROTEIN IN COMPLEX WITH A PERISTERIC SYNTHETIC ANTIBODY
3520, 4xmkL, 0.6395, 2.66, 0.057, 215, 88, CRYSTAL STRUCTURE OF FAB OF HIV-1 GP120 V3-SPECIFIC HUMAN MONOCLONAL ANTIBODY 2424 IN COMPLEX WITH JR-FL V3 PEPTIDE
3521, 4xgzT, 0.6395, 3.06, 0.054, 210, 93, CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD2 MOTIF IN COMPLEX WITH FAB FRAGMENT
3522, 4xgzN, 0.6395, 3.05, 0.054, 210, 93, CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD2 MOTIF IN COMPLEX WITH FAB FRAGMENT
3523, 4s1sL, 0.6395, 2.99, 0.054, 208, 92, CRYSTAL STRUCTURE OF A VRC01-LINEAGE ANTIBODY 45-VRC01.H5.F-185917 IN COMPLEX WITH CLADE A/E HIV-1 GP120 CORE
3524, 4ogyN, 0.6395, 3.03, 0.054, 212, 92, CRYSTAL STRUCTURE OF FAB DX-2930 IN COMPLEX WITH HUMAN PLASMA KALLIKREIN AT 2.1 ANGSTROM RESOLUTION
3525, 4ogyL, 0.6395, 2.78, 0.056, 212, 90, CRYSTAL STRUCTURE OF FAB DX-2930 IN COMPLEX WITH HUMAN PLASMA KALLIKREIN AT 2.1 ANGSTROM RESOLUTION
3526, 4o4yL, 0.6395, 2.92, 0.056, 218, 90, CRYSTAL STRUCTURE OF THE ANTI-HINGE RABBIT ANTIBODY 2095-2 IN COMPLEX WITH IDES HINGE PEPTIDE
3527, 4kk8D, 0.6395, 2.89, 0.044, 211, 91, STRUCTURE OF THE E148Q MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE
3528, 4fnlM, 0.6395, 3.17, 0.065, 213, 93, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05
3529, 3s35L, 0.6395, 3.12, 0.054, 217, 93, STRUCTURAL BASIS FOR THE FUNCTION OF TWO ANTI-VEGF RECEPTOR ANTIBODIES
3530, 3ifpB, 0.6395, 3.12, 0.054, 218, 93, X-RAY STRUCTURE OF AMYLOID BETA PEPTIDE:ANTIBODY (ABETA1-7:12B4) COMPLEX
3531, 3if1A, 0.6395, 2.92, 0.055, 215, 91, CRYSTAL STRUCTURE OF 237MAB IN COMPLEX WITH A GALNAC
3532, 2ntfA, 0.6395, 2.74, 0.056, 211, 89, CRYSTAL STRUCTURE OF A QUORUM-QUENCHING ANTIBODY IN COMPLEX WITH AN N- ACYL-L-HOMOSERINE LACTONE ANALOG
3533, 2i60Q, 0.6395, 2.94, 0.056, 214, 90, CRYSTAL STRUCTURE OF [PHE23]M47 A SCORPION-TOXIN MIMIC OF CD4 IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
3534, 2htkD, 0.6395, 2.90, 0.044, 211, 91, STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445A MUTANT AND FAB COMPLEX
3535, 1soxA, 0.6395, 3.34, 0.083, 463, 96, SULFITE OXIDASE FROM CHICKEN LIVER
3536, 1rzjL, 0.6395, 2.94, 0.056, 214, 90, HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
3537, 1d6vL, 0.6395, 2.70, 0.057, 211, 88, CONFORMATION EFFECTS IN BIOLOGICAL CATALYSIS INTRODUCED BY OXY-COPE ANTIBODY MATURATION
3538, 6mu3K, 0.6394, 2.95, 0.056, 211, 90, ANTI-HIV-1 FAB 2G12 + MAN7 RE-REFINEMENT 
3539, 6medI, 0.6394, 2.99, 0.054, 213, 92, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
3540, 6df2L, 0.6394, 2.98, 0.054, 215, 92, IMPROVED ANTI-PHOSPHOTYROSINE ANTIBODY 4G10-S5-4D5 FAB COMPLEXED WITH PHOSPHOTYROSINE PEPTIDE 
3541, 6d0uI, 0.6394, 3.01, 0.054, 213, 92, CRYSTAL STRUCTURE OF C05 V110P/A117E MUTANT BOUND TO H3 INFLUENZA HEMAGGLUTININ; HA1 SUBUNIT 
3542, 6awqC, 0.6394, 2.97, 0.043, 214, 93, ANOMALOUS CHLORIDE SIGNAL REVEALS THE POSITION OF SERTRALINE COMPLEXED WITH THE SEROTONIN TRANSPORTER AT THE CENTRAL SITE
3543, 6awpC, 0.6394, 3.11, 0.053, 214, 94, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH FLUVOXAMINE AT THE CENTRAL SITE
3544, 6awoC, 0.6394, 2.97, 0.043, 214, 93, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH SERTRALINE AT THE CENTRAL SITE
3545, 5tljE, 0.6394, 2.70, 0.057, 215, 88, COMPLEX BETWEEN HUMAN CD27 AND FAB FRAGMENTS OF ANTIBODIES M2177 AND M2191
3546, 5opyL, 0.6394, 3.01, 0.054, 212, 92, CRYSTAL STRUCTURE OF ANTI-ALPHAVBETA3 INTEGRIN FAB LM609
3547, 5n2kI, 0.6394, 2.82, 0.089, 214, 90, STRUCTURE OF UNBOUND BRIAKINUMAB FAB
3548, 5mvgA, 0.6394, 2.79, 0.056, 177, 90, CRYSTAL STRUCTURE OF NON-AMYLOIDOGENIC LIGHT CHAIN DIMER M7
3549, 5d1zC, 0.6394, 3.06, 0.066, 208, 91, ISDB NEAT1 BOUND BY CLONE D4-10
3550, 4uaoB, 0.6394, 3.05, 0.032, 214, 93, CRYSTAL STRUCTURE OF APICAL MEMBRANE ANTIGEN 1 FROM PLASMODIUM KNOWLESI IN COMPLEX WITH AN INVASION INHIBITORY ANTIBODY
3551, 4om0L, 0.6394, 3.08, 0.054, 208, 93, CRYSTAL STRUCTURE OF ANTIBODY VRC07-G54Y IN COMPLEX WITH CLADE A/E 93TH057 HIV-1 GP120 CORE
3552, 4oduB, 0.6394, 2.88, 0.044, 212, 91, UNLIGANDED FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY S1-15
3553, 3wfeL, 0.6394, 2.98, 0.054, 213, 92, REDUCED AND CYANIDE-BOUND CYTOCHROME C-DEPENDENT NITRIC OXIDE REDUCTASE (CNOR) FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH ANTIBODY FRAGMENT
3554, 3w14Q, 0.6394, 3.02, 0.043, 214, 93, INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1CRL2 FNIII-1 AND ALPHACT PEPTIDE IN COMPLEX WITH BOVINE INSULIN AND FAB 83-14
3555, 3v8cB, 0.6394, 2.92, 0.054, 209, 93, CRYSTAL STRUCTURE OF MONOCLONAL HUMAN ANTI-RHESUS D FC IGG1 T125(YB2/0) DOUBLE MUTANT (H310 AND H435 IN K)
3556, 3ob8B, 0.6394, 3.30, 0.061, 1024, 98, STRUCTURE OF THE BETA-GALACTOSIDASE FROM KLUYVEROMYCES LACTIS IN COMPLEX WITH GALACTOSE
3557, 3lpgA, 0.6394, 2.88, 0.056, 590, 89, STRUCTURE OF E. COLI BETA-GLUCURONIDASE BOUND WITH A NOVEL POTENT INHIBITOR 3-(2-FLUOROPHENYL)-1-(2-HYDROXYETHYL)-1-((6-METHYL-2-OXO-1 2-DIHYDROQUINOLIN-3-YL)METHYL)UREA
3558, 3hzkA, 0.6394, 2.99, 0.054, 218, 92, CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO
3559, 3bz4G, 0.6394, 2.82, 0.056, 216, 90, CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A SHIGELLA FLEXNERI 2A O-AG DECASACCHARIDE
3560, 2ny1C, 0.6394, 2.95, 0.056, 214, 90, HIV-1 GP120 ENVELOPE GLYCOPROTEIN (I109C T257S S334A S375W Q428C) COMPLEXED WITH CD4 AND ANTIBODY 17B
3561, 1s78C, 0.6394, 2.97, 0.065, 214, 93, INSIGHTS INTO ERBB SIGNALING FROM THE STRUCTURE OF THE ERBB2- PERTUZUMAB COMPLEX
3562, 1pkqA, 0.6394, 3.02, 0.054, 219, 92, MYELIN OLIGODENDROCYTE GLYCOPROTEIN-(8-18C5) FAB-COMPLEX
3563, 1kn4L, 0.6394, 3.01, 0.043, 219, 92, CATALYTIC ANTIBODY D2.3 COMPLEX
3564, 1fe8L, 0.6394, 2.88, 0.056, 211, 90, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A FAB FRAGMENT OF IGG RU5 THAT INHIBITS COLLAGEN BINDING
3565, 6b70D, 0.6393, 2.84, 0.056, 211, 89, CRYO-EM STRUCTURE OF HUMAN INSULIN DEGRADING ENZYME IN COMPLEX WITH FAB H11-E HEAVY CHAIN FAB H11-E LIGHT CHAIN AND INSULIN
3566, 5utyE, 0.6393, 2.95, 0.076, 213, 92, CRYSTAL STRUCTURE OF A STABILIZED DS-SOSIP.MUT4 BG505 GP140 HIV-1 ENV TRIMER CONTAINING MUTATIONS I201C-P433C (DS) L154M N300M N302M T320L IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 4.1 ANGSTROM
3567, 5mp1K, 0.6393, 2.97, 0.043, 218, 92, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 7.5 
3568, 5if0L, 0.6393, 2.76, 0.056, 206, 89, CRYSTAL STRUCTURE OF VRC01C-HUGL2 FAB FROM AN HIV-1 NAIVE DONOR IN COMPLEX WITH WITH A GERMLINE-TARGETING GP120 ENGINEERED OUTER DOMAIN EOD-GT8 AT 2.44 A
3569, 5i8hF, 0.6393, 2.98, 0.056, 212, 90, CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH V3 LOOP-TARGETING ANTIBODY PGT122 FAB AND FUSION PEPTIDE-TARGETING ANTIBODY VRC34.01 FAB
3570, 5ggsB, 0.6393, 2.79, 0.056, 217, 90, PD-1 IN COMPLEX WITH PEMBROLIZUMAB FAB
3571, 5fehE, 0.6393, 3.02, 0.054, 212, 92, CRYSTAL STRUCTURE OF PCT64_35B A BROADLY NEUTRALIZING ANTI-HIV ANTIBODY
3572, 5bk0A, 0.6393, 3.03, 0.065, 217, 92, CRYSTAL STRUCTURE OF 663 FAB BOUND TO CIRCUMSPOROZOITE PROTEIN NANP 5- MER
3573, 4zypG, 0.6393, 2.93, 0.056, 213, 90, CRYSTAL STRUCTURE OF MOTAVIZUMAB AND QUATERNARY-SPECIFIC RSV- NEUTRALIZING HUMAN ANTIBODY AM14 IN COMPLEX WITH PREFUSION RSV F GLYCOPROTEIN
3574, 4zykL, 0.6393, 3.01, 0.066, 213, 91, CRYSTAL STRUCTURE OF QUATERNARY-SPECIFIC RSV-NEUTRALIZING HUMAN ANTIBODY AM14
3575, 4tnwL, 0.6393, 2.76, 0.056, 211, 89, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
3576, 4r4nR, 0.6393, 2.70, 0.057, 210, 88, CRYSTAL STRUCTURE OF THE ANTI-HIV-1 ANTIBODY 2.2C IN COMPLEX WITH HIV- 1 93UG037 GP120
3577, 4nqtA, 0.6393, 2.91, 0.043, 208, 93, ANTI-PARALLEL FC-HOLE(T366S/L368A/Y407V) HOMODIMER
3578, 4k24L, 0.6393, 3.02, 0.043, 218, 92, STRUCTURE OF ANTI-UPAR FAB ATN-658 IN COMPLEX WITH UPAR
3579, 4hixL, 0.6393, 3.10, 0.054, 219, 93, CRYSTAL STRUCTURE OF A HUMANISED 3D6 FAB BOUND TO AMYLOID BETA PEPTIDE
3580, 3x2dO, 0.6393, 2.66, 0.056, 211, 89, CRYSTAL STRUCTURE OF MARBURG VIRUS GP IN COMPLEX WITH THE HUMAN SURVIVOR ANTIBODY MR78
3581, 3w14D, 0.6393, 3.02, 0.043, 214, 93, INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1CRL2 FNIII-1 AND ALPHACT PEPTIDE IN COMPLEX WITH BOVINE INSULIN AND FAB 83-14
3582, 3pnwM, 0.6393, 2.75, 0.056, 214, 89, CRYSTAL STRUCTURE OF THE TUDOR DOMAIN OF HUMAN TDRD3 IN COMPLEX WITH AN ANTI-TDRD3 FAB
3583, 3g5yA, 0.6393, 3.00, 0.054, 213, 92, ANTIBODIES SPECIFICALLY TARGETING A LOCALLY MISFOLDED REGION OF TUMOR ASSOCIATED EGFR
3584, 2v7nE, 0.6393, 2.93, 0.056, 213, 90, UNUSUAL TWINNING IN CRYSTALS OF THE CITS BINDING ANTIBODY FAB FRAGMENT F3P4
3585, 2ny3C, 0.6393, 2.96, 0.056, 214, 90, HIV-1 GP120 ENVELOPE GLYCOPROTEIN (K231C T257S E267C S334A S375W) COMPLEXED WITH CD4 AND ANTIBODY 17B
3586, 2ny2C, 0.6393, 2.96, 0.056, 214, 90, HIV-1 GP120 ENVELOPE GLYCOPROTEIN (T123C T257S S334A S375W G431C) COMPLEXED WITH CD4 AND ANTIBODY 17B
3587, 1p7kA, 0.6393, 3.11, 0.054, 214, 93, CRYSTAL STRUCTURE OF AN ANTI-SSDNA ANTIGEN-BINDING FRAGMENT (FAB) BOUND TO 4-(2-HYDROXYETHYL)PIPERAZINE-1-ETHANESULFONIC ACID (HEPES)
3588, 6eluL, 0.6392, 2.99, 0.054, 217, 92, STRUCTURE OF SERUM RESISTANCE ASSOCIATED PROTEIN FROM T. B. RHODESIENSE
3589, 6d7fD, 0.6392, 2.65, 0.044, 579, 90, BACTEROIDES UNIFORMIS BETA-GLUCURONIDASE 1 BOUND TO THIOPHENYL-BETA-D- GLUCURONIDE 
3590, 6axkB, 0.6392, 2.83, 0.089, 214, 90, CRYSTAL STRUCTURE OF FAB311 COMPLEX
3591, 5f6hP, 0.6392, 2.80, 0.089, 212, 90, CRYSTAL STRUCTURE OF TIER 2 NEUTRALIZING ANTIBODY DH427 FROM A RHESUS MACAQUE
3592, 5ezlL, 0.6392, 3.00, 0.054, 213, 92, CRYSTAL STRUCTURE OF FAB OF PARASITE INVASION INHIBITORY ANTIBODY C1 - MONOCLINIC FORM
3593, 5czxD, 0.6392, 3.05, 0.054, 213, 92, CRYSTAL STRUCTURE OF NOTCH3 NRR IN COMPLEX WITH 20358 FAB
3594, 4zs7L, 0.6392, 2.73, 0.090, 210, 89, STRUCTURAL MIMICRY OF RECEPTOR INTERACTION BY ANTAGONISTIC IL-6 ANTIBODIES
3595, 4xwgL, 0.6392, 2.82, 0.089, 210, 90, CRYSTAL STRUCTURE OF LCAT (C31Y) IN COMPLEX WITH FAB1
3596, 4xgzX, 0.6392, 3.08, 0.054, 210, 93, CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD2 MOTIF IN COMPLEX WITH FAB FRAGMENT
3597, 4od3L, 0.6392, 2.84, 0.078, 213, 90, CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.07 A POTENT V1V2-DIRECTED HIV-1 NEUTRALIZING ANTIBODY
3598, 4nylL, 0.6392, 3.02, 0.055, 211, 91, CRYSTAL STRUCTURE OF ADALIMUMAB FAB FRAGMENT
3599, 4lexL, 0.6392, 2.95, 0.056, 217, 90, UNLIGANDED CRYSTAL STRUCTURE OF MAB7
3600, 4ersL, 0.6392, 3.11, 0.054, 214, 93, A MOLECULAR BASIS FOR NEGATIVE REGULATION OF THE GLUCAGON RECEPTOR
3601, 3r18A, 0.6392, 3.35, 0.083, 373, 96, CHICKEN SULFITE OXIDASE DOUBLE MUTANT WITH ALTERED ACTIVITY AND SUBSTRATE AFFINITY
3602, 3pp3L, 0.6392, 3.05, 0.054, 219, 93, EPITOPE CHARACTERIZATION AND CRYSTAL STRUCTURE OF GA101 PROVIDE INSIGHTS INTO THE MOLECULAR BASIS FOR THE TYPE I / TYPE II DISTINCTION OF ANTI- CD20 ANTIBODIES
3603, 3ob8A, 0.6392, 3.30, 0.061, 1024, 98, STRUCTURE OF THE BETA-GALACTOSIDASE FROM KLUYVEROMYCES LACTIS IN COMPLEX WITH GALACTOSE
3604, 2vq1E, 0.6392, 2.84, 0.044, 216, 90, ANTI TRIMERIC LEWIS X FAB54-5C10-A
3605, 2ntfL, 0.6392, 2.75, 0.056, 211, 89, CRYSTAL STRUCTURE OF A QUORUM-QUENCHING ANTIBODY IN COMPLEX WITH AN N- ACYL-L-HOMOSERINE LACTONE ANALOG
3606, 2bmkL, 0.6392, 3.07, 0.054, 213, 93, FAB FRAGMENT OF PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH PHOSPHOPYRIDOXYL-D-ALANINE
3607, 2b0sL, 0.6392, 2.80, 0.089, 215, 90, CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 V3 FAB 2219 IN COMPLEX WITH MN PEPTIDE
3608, 1ruaL, 0.6392, 3.11, 0.054, 218, 93, CRYSTAL STRUCTURE (B) OF U.V.-IRRADIATED CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 4.6 WITH A DATA SET COLLECTED AT SSRL BEAMLINE 11-1.
3609, 1kn2L, 0.6392, 3.01, 0.043, 219, 92, CATALYTIC ANTIBODY D2.3 COMPLEX
3610, 1igtC, 0.6392, 3.05, 0.043, 214, 93, STRUCTURE OF IMMUNOGLOBULIN
3611, 5moiE, 0.6391, 3.00, 0.044, 200, 91, CRYSTAL STRUCTURE OF HUMAN IGE-FC EPSILON 3-4
3612, 4z5rA, 0.6391, 2.99, 0.054, 217, 92, RONTALIZUMAB FAB BOUND TO INTERFERON-A2
3613, 4ygvL, 0.6391, 3.00, 0.054, 218, 92, REVERSAL AGENT FOR DABIGATRAN
3614, 4ydlL, 0.6391, 3.06, 0.054, 211, 93, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY C38- VRC18.02 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057GP120
3615, 4xgzB, 0.6391, 3.08, 0.065, 210, 93, CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD2 MOTIF IN COMPLEX WITH FAB FRAGMENT
3616, 4nm8L, 0.6391, 2.87, 0.056, 217, 89, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR8043 BOUND TO H3 INFLUENZA HEMAGGLUTININ
3617, 4m7zC, 0.6391, 3.06, 0.054, 219, 93, UNLIGANDED 1 CRYSTAL STRUCTURE OF S25-26 FAB
3618, 4louD, 0.6391, 2.87, 0.055, 211, 91, STRUCTURE OF THE E148Q MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN THE ABSENCE OF HALIDE
3619, 3wfbL, 0.6391, 3.11, 0.054, 213, 93, REDUCED CYTOCHROME C-DEPENDENT NITRIC OXIDE REDUCTASE (CNOR) FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH ANTIBODY FRAGMENT
3620, 3vi4E, 0.6391, 2.99, 0.054, 219, 92, CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE IN COMPLEX WITH RGD PEPTIDE
3621, 3ob8D, 0.6391, 3.30, 0.061, 1024, 98, STRUCTURE OF THE BETA-GALACTOSIDASE FROM KLUYVEROMYCES LACTIS IN COMPLEX WITH GALACTOSE
3622, 3ob0L, 0.6391, 2.97, 0.055, 212, 91, A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY
3623, 3nidL, 0.6391, 3.02, 0.043, 214, 93, THE CLOSED HEADPIECE OF INTEGRIN ALPHAIIB BETA3 AND ITS COMPLEX WITH AN ALPAHIIB BETA3 -SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
3624, 3kymO, 0.6391, 2.86, 0.055, 213, 91, CRYSTAL STRUCTURE OF LI33 IGG2 DI-FAB
3625, 3j3oL, 0.6391, 3.15, 0.043, 219, 94, CONFORMATIONAL SHIFT OF A MAJOR POLIOVIRUS ANTIGEN CONFIRMED BY IMMUNO-CRYOGENIC ELECTRON MICROSCOPY: 160S POLIOVIRUS AND C3-FAB COMPLEX
3626, 3go1L, 0.6391, 2.76, 0.090, 209, 89, CRYSTAL STRUCTURE OF ANTI-HIV-1 FAB 268-D IN COMPLEX WITH V3 PEPTIDE MN
3627, 1igtA, 0.6391, 3.05, 0.043, 214, 93, STRUCTURE OF IMMUNOGLOBULIN
3628, 6bzvD, 0.6390, 2.88, 0.056, 215, 90, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE GL PRECURSOR OF THE BROADLY NEUTRALIZING ANTIBODY 19B3 
3629, 6bb4N, 0.6390, 2.96, 0.055, 211, 91, FAB/EPITOPE COMPLEX OF MOUSE MONOCLONAL ANTIBODY C5.2 TARGETING A PHOSPHO-TAU EPITOPE. 
3630, 5x8mC, 0.6390, 2.99, 0.065, 213, 92, PD-L1 IN COMPLEX WITH DURVALUMAB
3631, 5wkoD, 0.6390, 3.01, 0.055, 213, 91, CRYSTAL STRUCTURE OF ANTIBODY 27F3 RECOGNIZING THE HA FROM A/CALIFORNIA/04/2009 (H1N1) INFLUENZA VIRUS
3632, 5w24L, 0.6390, 3.08, 0.055, 215, 91, CRYSTAL STRUCTURE OF 5C4 FAB
3633, 5jxeF, 0.6390, 3.04, 0.067, 215, 90, HUMAN PD-1 ECTODOMAIN COMPLEXED WITH PEMBROLIZUMAB FAB
3634, 5g64M, 0.6390, 2.85, 0.067, 214, 89, THE COMPLEX BETWEEN HUMAN IGE-FC AND TWO ANTI-IGE FAB FRAGMENTS
3635, 5bk3F, 0.6390, 2.95, 0.044, 217, 90, CRYSTAL STRUCTURE OF THE NEUTRALIZING ANTI-CIRCUMSPOROZOITE PROTEIN 580 ANTIBODY
3636, 4qf1B, 0.6390, 2.74, 0.056, 210, 89, CRYSTAL STRUCTURE OF UNLIGANDED CH59UA THE INFERRED UNMUTATED ANCESTOR OF THE RV144 ANTI-HIV ANTIBODY LINEAGE PRODUCING CH59
3637, 4q9rL, 0.6390, 3.06, 0.054, 214, 92, CRYSTAL STRUCTURE OF AN RNA APTAMER BOUND TO TRIFLUOROETHYL-LIGAND ANALOG IN COMPLEX WITH FAB
3638, 4np4M, 0.6390, 2.93, 0.056, 213, 90, CLOSTRIDIUM DIFFICILE TOXIN B CROP DOMAIN IN COMPLEX WITH FAB DOMAINS OF NEUTRALIZING ANTIBODY BEZLOTOXUMAB
3639, 4kxzM, 0.6390, 3.00, 0.055, 213, 91, CRYSTAL STRUCTURE OF TGFB2 IN COMPLEX WITH GC2008.
3640, 4kjqD, 0.6390, 2.89, 0.044, 211, 91, STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE
3641, 4jfyL, 0.6390, 3.01, 0.054, 213, 92, APO STRUCTURE OF PHOSPHOTYROSINE (PYAB) SCAFFOLD
3642, 4etqL, 0.6390, 3.01, 0.054, 212, 92, VACCINIA VIRUS D8L IMV ENVELOPE PROTEIN IN COMPLEX WITH FAB OF MURINE IGG2A LA5
3643, 3ze0L, 0.6390, 2.99, 0.054, 214, 92, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
3644, 2xraL, 0.6390, 2.87, 0.056, 215, 90, CRYSTAL STRUCTURE OF THE HK20 FAB IN COMPLEX WITH A GP41 MIMETIC 5-HELIX
3645, 2q76C, 0.6390, 2.92, 0.055, 212, 91, MOUSE ANTI-HEN EGG WHITE LYSOZYME ANTIBODY F10.6.6 FAB FRAGMENT
3646, 2ht3D, 0.6390, 2.88, 0.044, 211, 91, STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445L MUTANT AND FAB COMPLEX
3647, 1zlvK, 0.6390, 2.78, 0.056, 211, 89, FAB 2G12 + MAN7
3648, 1tjgL, 0.6390, 3.09, 0.054, 213, 92, CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY 2F5 IN COMPLEX WITH A GP41 7MER EPITOPE
3649, 1s3kL, 0.6390, 2.89, 0.067, 216, 90, CRYSTAL STRUCTURE OF A HUMANIZED FAB (HU3S193) IN COMPLEX WITH THE LEWIS Y TETRASACCHARIDE
3650, 1pg7M, 0.6390, 3.01, 0.055, 213, 91, MURINE 6A6 FAB IN COMPLEX WITH HUMANIZED ANTI-TISSUE FACTOR D3H44 FAB
3651, 1ob1A, 0.6390, 3.06, 0.043, 215, 93, CRYSTAL STRUCTURE OF A FAB COMPLEX WHITH PLASMODIUM FALCIPARUM MSP1-19
3652, 8fabC, 0.6389, 2.75, 0.090, 206, 89, CRYSTAL STRUCTURE OF THE FAB FRAGMENT FROM THE HUMAN MYELOMA IMMUNOGLOBULIN IGG HIL AT 1.8 ANGSTROMS RESOLUTION
3653, 6fy3L, 0.6389, 2.73, 0.090, 214, 89, CRYSTAL STRUCTURE OF A V2-DIRECTED; RV144 VACCINE-LIKE ANTIBODY FROM HIV-1 INFECTION; CAP228-3D; BOUND TO A HETEROLOGOUS V2 PEPTIDE 
3654, 6eynL, 0.6389, 3.10, 0.054, 217, 92, STRUCTURE OF THE 8D6 (ANTI-IGE) FAB 
3655, 6ea7R, 0.6389, 2.98, 0.066, 211, 91, STRUCTURE OF EBOV GPCL IN COMPLEX WITH THE PAN-EBOLAVIRUS MAB ADI- 15878 
3656, 6c6zL, 0.6389, 2.77, 0.056, 215, 89, CRYSTAL STRUCTURE OF POTENT NEUTRALIZING ANTIBODY CDC2-C2 IN COMPLEX WITH MERS-COV S1 RBD
3657, 6bzuH, 0.6389, 2.99, 0.055, 215, 91, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 19B3 
3658, 6b6zA, 0.6389, 2.99, 0.065, 200, 92, CRYSTAL STRUCTURE OF THE APO ANTIBODY FRAGMENT (FAB) RAISED AGAINST C- TERMINAL DOMAIN OF EBOLA NUCLEOPROTEIN (EBOV; TAFV; BDBV STRAINS) 
3659, 6b3mN, 0.6389, 3.05, 0.054, 214, 92, THE CRYSTAL STRUCTURE OF A BROADLY-REACTIVE HUMAN ANTI-HEMAGGLUTININ STALK ANTIBODY (70-1F02) IN COMPLEX WITH H5 HEMAGGLUTININ 
3660, 5w23M, 0.6389, 2.86, 0.044, 215, 90, CRYSTAL STRUCTURE OF RSV F IN COMPLEX WITH 5C4 FAB
3661, 5vshB, 0.6389, 3.00, 0.054, 213, 92, CH1/CLAMBDA FAB BASED ON PERTUZUMAB
3662, 5usiL, 0.6389, 3.02, 0.054, 213, 92, STRUCTURE OF VACCINIA VIRUS D8 PROTEIN BOUND TO HUMAN FAB VV138
3663, 5uddR, 0.6389, 2.90, 0.056, 211, 89, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
3664, 5i1aL, 0.6389, 2.77, 0.056, 212, 89, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-23/IGKV3-11
3665, 5i1aA, 0.6389, 2.86, 0.056, 211, 89, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-23/IGKV3-11
3666, 5hysG, 0.6389, 3.06, 0.022, 214, 92, STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB
3667, 4yhyL, 0.6389, 3.00, 0.055, 210, 91, CRYSTAL STRUCTURE OF 309M3-B IN COMPLEX WITH TRIMETHYLATED LYS
3668, 4tqeL, 0.6389, 3.11, 0.054, 218, 93, STRUCTURE OF TAU PEPTIDE IN COMPLEX WITH TAU5 ANTIBODY FAB FRAGMENT
3669, 4jo3M, 0.6389, 2.91, 0.066, 214, 91, CRYSTAL STRUCTURE OF RABBIT MAB R20 FAB IN COMPLEX WITH V3 C-TERMINUS OF HIV-1 CONSENSUS B GP120
3670, 4hwbL, 0.6389, 3.22, 0.053, 212, 94, CRYSTAL STRUCTURE OF ECTODOMAIN 3 OF THE IL-13 RECEPTOR ALPHA 1 IN COMPLEX WITH A HUMAN NEUTRALIZING MONOCLONAL ANTIBODY FRAGMENT
3671, 4hcrL, 0.6389, 3.00, 0.055, 218, 91, CRYSTAL STRUCTURE OF HUMAN MADCAM-1 D1D2 COMPLEXED WITH FAB PF-547659
3672, 3wsqL, 0.6389, 3.06, 0.054, 215, 93, STRUCTURE OF HER2 WITH AN FAB
3673, 3d9aL, 0.6389, 2.98, 0.043, 213, 92, HIGH RESOLUTION CRYSTAL STRUCTURE STRUCTURE OF HYHEL10 FAB COMPLEXED TO HEN EGG LYSOZYME
3674, 3csyH, 0.6389, 2.74, 0.056, 216, 89, CRYSTAL STRUCTURE OF THE TRIMERIC PREFUSION EBOLA VIRUS GLYCOPROTEIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY FROM A HUMAN SURVIVOR
3675, 3bt2L, 0.6389, 2.98, 0.054, 211, 92, STRUCTURE OF UROKINASE RECEPTOR UROKINASE AND VITRONECTIN COMPLEX
3676, 2adfL, 0.6389, 2.95, 0.067, 209, 90, CRYSTAL STRUCTURE AND PARATOPE DETERMINATION OF 82D6A3 AN ANTITHROMBOTIC ANTIBODY DIRECTED AGAINST THE VON WILLEBRAND FACTOR A3-DOMAIN
3677, 1w72M, 0.6389, 2.71, 0.101, 210, 89, CRYSTAL STRUCTURE OF HLA-A1:MAGE-A1 IN COMPLEX WITH FAB- HYB3
3678, 1igfL, 0.6389, 3.06, 0.032, 219, 93, CRYSTAL STRUCTURES OF AN ANTIBODY TO A PEPTIDE AND ITS COMPLEX WITH PEPTIDE ANTIGEN AT 2.8 ANGSTROMS
3679, 6oe4F, 0.6388, 2.98, 0.056, 212, 90, PREFUSION RSV F MONOMER BOUND BY NEUTRALIZING ANTIBODY CR9501 
3680, 5usiB, 0.6388, 3.02, 0.054, 213, 92, STRUCTURE OF VACCINIA VIRUS D8 PROTEIN BOUND TO HUMAN FAB VV138
3681, 5tdpA, 0.6388, 3.07, 0.054, 213, 93, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-HER2 ANTIBODY 4D5 WITH REDESIGNED HEAVY AND LIGHT CHAIN INTERFACES
3682, 5mv4B, 0.6388, 2.92, 0.054, 217, 92, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED CII616-639 EPITOPE OF COLLAGEN TYPE II (PTM23)
3683, 5moiB, 0.6388, 2.96, 0.022, 191, 91, CRYSTAL STRUCTURE OF HUMAN IGE-FC EPSILON 3-4
3684, 4xmkM, 0.6388, 2.91, 0.067, 215, 90, CRYSTAL STRUCTURE OF FAB OF HIV-1 GP120 V3-SPECIFIC HUMAN MONOCLONAL ANTIBODY 2424 IN COMPLEX WITH JR-FL V3 PEPTIDE
3685, 4xcyD, 0.6388, 3.06, 0.054, 214, 92, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDYLGLYCEROL (06:0 PG)
3686, 4u6hD, 0.6388, 3.11, 0.054, 218, 93, VACCINIA L1/M12B9-FAB COMPLEX
3687, 4rbpL, 0.6388, 3.03, 0.055, 213, 91, CRYSTAL STRUCTURE OF HIV NEUTRALIZING ANTIBODY 2G12 IN COMPLEX WITH A BACTERIAL OLIGOSACCHARIDE ANALOG OF MAMMALIAN OLIGOMANOSE
3688, 4r7nJ, 0.6388, 2.69, 0.057, 211, 88, FAB C2E3
3689, 4hafB, 0.6388, 3.04, 0.132, 190, 91, CRYSTAL STRUCTURE OF FC-FRAGMENT OF HUMAN IGG2 ANTIBODY (PRIMITIVE CRYSTAL FORM)
3690, 4amkL, 0.6388, 2.70, 0.056, 210, 89, FAB FRAGMENT OF ANTIPORPHRIN ANTIBODY 13G10
3691, 2zuqE, 0.6388, 2.99, 0.043, 218, 93, CRYSTAL STRUCTURE OF DSBB-FAB COMPLEX
3692, 2ltqE, 0.6388, 2.99, 0.043, 218, 93, HIGH RESOLUTION STRUCTURE OF DSBB C41S BY JOINT CALCULATION WITH SOLID-STATE NMR AND X-RAY DATA
3693, 2fx8M, 0.6388, 3.00, 0.055, 214, 91, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH AN AIB-INDUCED PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41
3694, 2exwD, 0.6388, 2.90, 0.044, 211, 91, CRYSTAL STRUCTURE OF A ECCLC-FAB COMPLEX IN THE ABSENCE OF BOUND IONS
3695, 1yecL, 0.6388, 3.01, 0.043, 219, 92, STRUCTURE OF A CATALYTIC ANTIBODY IGG2A FAB FRAGMENT (D2.3)
3696, 1tpxC, 0.6388, 3.24, 0.053, 219, 94, OVINE RECOMBINANT PRP(114-234) ARQ VARIANT IN COMPLEX WITH THE FAB OF THE VRQ14 ANTIBODY
3697, 1p2cD, 0.6388, 3.03, 0.066, 211, 91, CRYSTAL STRUCTURE ANALYSIS OF AN ANTI-LYSOZYME ANTIBODY
3698, 6ca6A, 0.6387, 2.94, 0.056, 211, 90, CRYSTAL STRUCTURE OF PCT64_35S; A BROADLY NEUTRALIZING ANTI-HIV ANTIBODY. 
3699, 5y9kL, 0.6387, 2.73, 0.101, 209, 89, STRUCTURE OF THE BELIMUMAB FAB FRAGMENT
3700, 5y9fW, 0.6387, 3.08, 0.043, 219, 93, CRYSTAL STRUCTURE OF HPV59 PENTAMER IN COMPLEX WITH THE FAB FRAGMENT OF ANTIBODY 28F10
3701, 5ushL, 0.6387, 2.78, 0.090, 212, 89, STRUCTURE OF VACCINIA VIRUS D8 PROTEIN BOUND TO HUMAN FAB VV66
3702, 5uqyO, 0.6387, 2.86, 0.056, 210, 89, CRYSTAL STRUCTURE OF MARBURG VIRUS GP IN COMPLEX WITH THE HUMAN SURVIVOR ANTIBODY MR78
3703, 5lspL, 0.6387, 2.76, 0.056, 212, 89, 107_A07 FAB IN COMPLEX WITH FRAGMENT OF THE MET RECEPTOR
3704, 5epmB, 0.6387, 2.99, 0.054, 218, 92, CERATOTOXIN VARIANT IN COMPLEX WITH SPECIFIC ANTIBODY FAB FRAGMENT
3705, 5e4eB, 0.6387, 2.73, 0.090, 183, 89, ENGINEERED INTERLEUKIN-13 BOUND TO RECEPTOR
3706, 5czkA, 0.6387, 2.92, 0.056, 587, 89, STRUCTURE OF E. COLI BETA-GLUCURONIDASE BOUND WITH A NOVEL POTENT INHIBITOR 1-((68-DIMETHYL-2-OXO-12-DIHYDROQUINOLIN-3-YL)METHYL)-1- (2-HYDROXYETHYL)-3-(4-HYDROXYPHENYL)THIOUREA
3707, 4r4bA, 0.6387, 2.87, 0.067, 210, 89, CRYSTAL STRUCTURE OF THE ANTI-HIV-1 ANTIBODY 2.2C
3708, 4nnpY, 0.6387, 2.99, 0.055, 213, 91, CRYSTAL STRUCTURE OF APO MANGANESE ABC TRANSPORTER MNTC FROM STAPHYLOCOCCUS AUREUS BOUND TO AN ANTAGONISTIC FAB FRAGMENT
3709, 4lsvL, 0.6387, 2.91, 0.056, 203, 90, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY 3BNC117 IN COMPLEX WITH HIV-1 CLADE C C1086 GP120
3710, 4hlzJ, 0.6387, 2.96, 0.044, 212, 91, CRYSTAL STRUCTURE OF FAB C179 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ
3711, 4hk3N, 0.6387, 2.72, 0.090, 210, 89, I2 FAB (UNBOUND) FROM CH65-CH67 LINEAGE
3712, 4cmhC, 0.6387, 3.10, 0.054, 213, 92, CRYSTAL STRUCTURE OF CD38 WITH A NOVEL CD38-TARGETING ANTIBODY SAR650984
3713, 3v0vL, 0.6387, 3.09, 0.054, 212, 92, FAB WN1 222-5 UNLIGANDED
3714, 3qumA, 0.6387, 3.25, 0.053, 218, 94, CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN (PSA) IN FAB SANDWICH WITH A HIGH AFFINITY AND A PCA SELECTIVE ANTIBODY
3715, 3hkfA, 0.6387, 2.72, 0.065, 205, 92, MURINE UNGLYCOSYLATED IGG FC FRAGMENT
3716, 3bgaA, 0.6387, 3.24, 0.059, 983, 101, CRYSTAL STRUCTURE OF BETA-GALACTOSIDASE FROM BACTEROIDES THETAIOTAOMICRON VPI-5482
3717, 3be1L, 0.6387, 2.92, 0.055, 216, 91, DUAL SPECIFIC BH1 FAB IN COMPLEX WITH THE EXTRACELLULAR DOMAIN OF HER2/ERBB-2
3718, 2r56L, 0.6387, 2.91, 0.067, 211, 90, CRYSTAL STRUCTURE OF A RECOMBINANT IGE FAB FRAGMENT IN COMPLEX WITH BOVINE BETA-LACTOGLOBULIN ALLERGEN
3719, 1nbzA, 0.6387, 3.22, 0.053, 214, 94, CRYSTAL STRUCTURE OF HYHEL-63 COMPLEXED WITH HEL MUTANT K97A
3720, 1c12A, 0.6387, 3.08, 0.054, 214, 93, INSIGHT IN ODORANT PERCEPTION: THE CRYSTAL STRUCTURE AND BINDING CHARACTERISTICS OF ANTIBODY FRAGMENTS DIRECTED AGAINST THE MUSK ODORANT TRASEOLIDE
3721, 6iebL, 0.6386, 2.76, 0.079, 207, 89, STRUCTURE OF RVFV GN AND HUMAN MONOCLONAL ANTIBODY R15 
3722, 6i04L, 0.6386, 3.00, 0.055, 212, 91, CRYSTAL STRUCTURE OF SEMA DOMAIN OF THE MET RECEPTOR IN COMPLEX WITH FAB 
3723, 6ghgB, 0.6386, 3.15, 0.054, 214, 92, VARIABLE HEAVY - VARIABLE LIGHT DOMAIN AND FAB-ARM CROSSMABS WITH CHARGED RESIDUE EXCHANGES 
3724, 6bpaC, 0.6386, 2.86, 0.055, 212, 91, PLASMODIUM VIVAX RETICULOCYTE BINDING PROTEIN 2B (PVRBP2B) BOUND TO MONOCLONAL ANTIBODY 3E9 
3725, 6ao0L, 0.6386, 2.88, 0.056, 213, 89, CAT192 FAB INSERTION MUTANT H2/L2
3726, 5jw5B, 0.6386, 3.01, 0.054, 206, 92, STRUCTURE OF MEDI8852 FAB FRAGMENT
3727, 5i30L, 0.6386, 2.83, 0.044, 212, 90, CRYSTAL STRUCTURE OF THE HUMAN ASTROVIRUS 2 NEUTRALIZING MONOCLONAL ANTIBODY PL-2 FAB FRAGMENT AT 1.9 A RESOLUTION
3728, 4xakL, 0.6386, 2.92, 0.056, 212, 90, CRYSTAL STRUCTURE OF POTENT NEUTRALIZING ANTIBODY M336 IN COMPLEX WITH MERS CO-V RBD
3729, 4rgnC, 0.6386, 3.01, 0.054, 213, 92, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO TWO NEUTRALIZING ANTIBODIES 14G8 AND 6D3
3730, 4i2xA, 0.6386, 3.03, 0.054, 214, 93, CRYSTAL STRUCTURE OF SIGNAL REGULATORY PROTEIN GAMMA (SIRP-GAMMA) IN COMPLEX WITH FABOX117
3731, 3ze2F, 0.6386, 3.08, 0.054, 214, 93, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
3732, 3v6fB, 0.6386, 2.87, 0.055, 219, 91, CRYSTAL STRUCTURE OF AN ANTI-HBV E-ANTIGEN MONOCLONAL FAB FRAGMENT (E6) UNBOUND
3733, 2q76A, 0.6386, 3.11, 0.043, 212, 92, MOUSE ANTI-HEN EGG WHITE LYSOZYME ANTIBODY F10.6.6 FAB FRAGMENT
3734, 2d03L, 0.6386, 3.10, 0.065, 217, 92, CRYSTAL STRUCTURE OF THE G91S MUTANT OF THE NNA7 FAB
3735, 2a9dA, 0.6386, 3.36, 0.083, 369, 96, CRYSTAL STRUCTURE OF RECOMBINANT CHICKEN SULFITE OXIDASE WITH ARG AT RESIDUE 161
3736, 1rziI, 0.6386, 2.97, 0.054, 211, 92, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 47E FAB
3737, 6i8sJ, 0.6385, 2.87, 0.056, 211, 89, DISCOVERY AND CHARACTERISATION OF AN ANTIBODY THAT SELECTIVELY MODULATES THE INHIBITORY ACTIVITY OF PLASMINOGEN ACTIVATOR INHIBITOR- 1 
3738, 6higL, 0.6385, 2.89, 0.056, 203, 89, HPD-1/NBO1A FAB COMPLEX 
3739, 6ea5L, 0.6385, 2.99, 0.054, 210, 92, STRUCTURE OF BDBV GPCL IN COMPLEX WITH THE PAN-EBOLAVIRUS MAB ADI- 15878 
3740, 6e62L, 0.6385, 2.73, 0.067, 213, 90, CRYSTAL STRUCTURE OF MALARIA TRANSMISSION-BLOCKING ANTIGEN PFS48/45 6C IN COMPLEX WITH ANTIBODY 85RF45.1 
3741, 6a67L, 0.6385, 2.84, 0.089, 212, 90, CRYSTAL STRUCTURE OF INFLUENZA A VIRUS H5 HEMAGGLUTININ GLOBULAR HEAD IN COMPLEX WITH THE FAB OF ANTIBODY FLD21.140 
3742, 5ijkC, 0.6385, 2.74, 0.056, 218, 89, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E03 FAB FRAGMENT IN COMPLEX OF PEPTIDE PLQPEQPFP
3743, 5i1eL, 0.6385, 3.08, 0.066, 211, 91, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-53/IGKV1-39
3744, 5cd5D, 0.6385, 2.88, 0.056, 207, 89, CRYSTAL STRUCTURE OF AN IMMATURE VRC01-CLASS ANTIBODY DRVIA7 FROM A CHINESE DONOR BOUND TO CLADE A/E HIV-1 GP120 CORE
3745, 5bk3D, 0.6385, 2.88, 0.045, 217, 89, CRYSTAL STRUCTURE OF THE NEUTRALIZING ANTI-CIRCUMSPOROZOITE PROTEIN 580 ANTIBODY
3746, 4z5rL, 0.6385, 3.02, 0.054, 217, 92, RONTALIZUMAB FAB BOUND TO INTERFERON-A2
3747, 4yc2L, 0.6385, 2.74, 0.067, 210, 89, CRYSTAL STRUCTURE OF THE STABILIZED INNER DOMAIN OF CLADE A/E HIV-1 GP120 FROM E. COLI IN COMPLEX WITH THE ANTIBODY A32.
3748, 4xc1L, 0.6385, 3.01, 0.054, 214, 92, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH ITS PEPTIDE EPITOPE ON HIV-1 GP41: CRYSTALS CRYOPROTECTED WITH SN-GLYCEROL 3- PHOSPHATE
3749, 4x0kL, 0.6385, 3.20, 0.064, 226, 94, ENGINEERED FAB FRAGMENT SPECIFIC FOR EYMPME (EE) PEPTIDE
3750, 4u0rC, 0.6385, 3.14, 0.054, 217, 93, PLASMODIUM FALCIPARUM RETICULOCYTE-BINDING PROTEIN HOMOLOGUE 5 (PFRH5) BOUND TO MONOCLONAL ANTIBODY 9AD4
3751, 4mxvX, 0.6385, 2.68, 0.057, 211, 88, STRUCTURE OF LYMPHOTOXIN ALPHA BOUND TO ANTI-LTA FAB
3752, 4kq3L, 0.6385, 2.92, 0.056, 211, 90, CRYSTAL STRUCTURE OF ANTI-IL-17A ANTIBODY CNTO3186
3753, 3obaC, 0.6385, 3.30, 0.061, 1024, 98, STRUCTURE OF THE BETA-GALACTOSIDASE FROM KLUYVEROMYCES LACTIS
3754, 3obaB, 0.6385, 3.30, 0.061, 1024, 98, STRUCTURE OF THE BETA-GALACTOSIDASE FROM KLUYVEROMYCES LACTIS
3755, 3obaA, 0.6385, 3.30, 0.061, 1024, 98, STRUCTURE OF THE BETA-GALACTOSIDASE FROM KLUYVEROMYCES LACTIS
3756, 3b2uU, 0.6385, 2.90, 0.055, 213, 91, CRYSTAL STRUCTURE OF ISOLATED DOMAIN III OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8
3757, 3b2uO, 0.6385, 3.02, 0.055, 213, 91, CRYSTAL STRUCTURE OF ISOLATED DOMAIN III OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8
3758, 1yefL, 0.6385, 3.03, 0.043, 219, 92, STRUCTURE OF IGG2A FAB FRAGMENT (D2.3) COMPLEXED WITH SUBSTRATE ANALOGUE
3759, 1mhpL, 0.6385, 3.10, 0.054, 212, 93, CRYSTAL STRUCTURE OF A CHIMERIC ALPHA1 INTEGRIN I-DOMAIN IN COMPLEX WITH THE FAB FRAGMENT OF A HUMANIZED NEUTRALIZING ANTIBODY
3760, 1igfM, 0.6385, 3.01, 0.054, 219, 93, CRYSTAL STRUCTURES OF AN ANTIBODY TO A PEPTIDE AND ITS COMPLEX WITH PEPTIDE ANTIGEN AT 2.8 ANGSTROMS
3761, 6medD, 0.6384, 2.77, 0.056, 212, 89, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
3762, 6d7fC, 0.6384, 2.66, 0.044, 579, 90, BACTEROIDES UNIFORMIS BETA-GLUCURONIDASE 1 BOUND TO THIOPHENYL-BETA-D- GLUCURONIDE 
3763, 6d01B, 0.6384, 2.78, 0.056, 212, 90, CRYSTAL STRUCTURE OF 1210 FAB IN COMPLEX WITH CIRCUMSPOROZOITE PROTEIN NANP5 
3764, 6apdI, 0.6384, 2.92, 0.056, 212, 89, CRYSTAL STRUCTURE OF RSV F BOUND BY AM22 AND THE INFANT ANTIBODY ADI- 19425
3765, 5w1mE, 0.6384, 3.06, 0.054, 221, 92, MACV GP1 CR1-07 FAB COMPLEX 
3766, 5vcoB, 0.6384, 3.40, 0.042, 215, 96, THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 10B9
3767, 5truL, 0.6384, 2.98, 0.056, 213, 90, STRUCTURE OF THE FIRST-IN-CLASS CHECKPOINT INHIBITOR IPILIMUMAB BOUND TO HUMAN CTLA-4
3768, 5iq9L, 0.6384, 2.73, 0.056, 210, 89, CRYSTAL STRUCTURE OF 10E8V4 FAB IN COMPLEX WITH AN HIV-1 GP41 PEPTIDE.
3769, 5i1lA, 0.6384, 3.19, 0.065, 219, 92, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV5-51/IGKV4-1
3770, 5cjxC, 0.6384, 3.09, 0.054, 214, 92, CRYSTAL STRUCTURE OF 8ANC195 FAB IN COMPLEX WITH BG505 SOSIP.664 HIV-1 ENV TRIMER
3771, 4z7qL, 0.6384, 3.01, 0.054, 214, 92, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV-NH2 PEPTIDE
3772, 4xceD, 0.6384, 2.99, 0.055, 214, 91, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB CRYSTALIZED IN THE PRESENCE OF PHOSPHATIDYLCHOLINE (06:0 PC); C2 SPACE GROUP
3773, 4rrpA, 0.6384, 3.03, 0.055, 213, 91, CRYSTAL STRUCTURE OF THE FAB COMPLEXED WITH ANTIGEN ASF1P NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET PDR16
3774, 4pp2B, 0.6384, 3.40, 0.042, 215, 96, THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 10B9
3775, 3ze2L, 0.6384, 3.03, 0.054, 214, 93, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
3776, 3wknN, 0.6384, 3.06, 0.052, 210, 96, CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG
3777, 1tqcC, 0.6384, 3.24, 0.053, 219, 94, OVINE RECOMBINANT PRP(114-234) ARR VARIANT IN COMPLEX WITH THE VRQ14 FAB FRAGMENT (IGG2A)
3778, 1sm3L, 0.6384, 2.74, 0.101, 210, 89, CRYSTAL STRUCTURE OF THE TUMOR SPECIFIC ANTIBODY SM3 COMPLEX WITH ITS PEPTIDE EPITOPE
3779, 6bzvH, 0.6383, 2.97, 0.056, 215, 90, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE GL PRECURSOR OF THE BROADLY NEUTRALIZING ANTIBODY 19B3 
3780, 5nuzB, 0.6383, 3.00, 0.054, 218, 92, JUNIN VIRUS GP1 GLYCOPROTEIN IN COMPLEX WITH AN ANTIBODY FAB FRAGMENT
3781, 5e8eA, 0.6383, 3.08, 0.065, 215, 93, CRYSTAL STRUCTURE OF THROMBIN BOUND TO AN EXOSITE 1-SPECIFIC IGA FAB
3782, 4whyN, 0.6383, 2.94, 0.044, 215, 90, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11 P21 CRYSTAL FORM
3783, 4rqqL, 0.6383, 2.90, 0.056, 215, 90, CRYSTAL STRUCTURE OF HUMAN FAB PGDM1400 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
3784, 4lluD, 0.6383, 2.75, 0.090, 206, 89, STRUCTURE OF PERTUZUMAB FAB WITH LIGHT CHAIN CLAMBDA AT 2.16A
3785, 4kphL, 0.6383, 2.98, 0.055, 209, 91, STRUCTURE OF THE FAB FRAGMENT OF N62 A PROTECTIVE MONOCLONAL ANTIBODY TO THE NONREDUCING END OF FRANCISELLA TULARENSIS O-ANTIGEN
3786, 4fp8M, 0.6383, 3.03, 0.054, 213, 92, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ HA1 SUBUNIT
3787, 4evnB, 0.6383, 2.84, 0.066, 213, 91, CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN)
3788, 3ubxL, 0.6383, 3.21, 0.043, 214, 94, CRYSTAL STRUCTURE OF THE MOUSE CD1D-C20:2-AGALCER-L363 MAB FAB COMPLEX
3789, 3ubxI, 0.6383, 3.21, 0.043, 214, 94, CRYSTAL STRUCTURE OF THE MOUSE CD1D-C20:2-AGALCER-L363 MAB FAB COMPLEX
3790, 2y7qD, 0.6383, 3.26, 0.062, 290, 96, THE HIGH-AFFINITY COMPLEX BETWEEN IGE AND ITS RECEPTOR FC EPSILON RI
3791, 2wubQ, 0.6383, 2.99, 0.065, 214, 92, CRYSTAL STRUCTURE OF HGFA IN COMPLEX WITH THE ALLOSTERIC NON-INHIBITORY ANTIBODY FAB40.DELTATRP
3792, 2r4rL, 0.6383, 3.08, 0.053, 214, 94, CRYSTAL STRUCTURE OF THE HUMAN BETA2 ADRENOCEPTOR
3793, 1xgrA, 0.6383, 3.21, 0.053, 215, 94, STRUCTURE FOR ANTIBODY HYHEL-63 Y33I MUTANT COMPLEXED WITH HEN EGG LYSOZYME
3794, 1rulL, 0.6383, 3.04, 0.054, 218, 93, CRYSTAL STRUCTURE (D) OF U.V.-IRRADIATED CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 5.6 WITH A DATA SET COLLECTED AT SSRL BEAMLINE 11-1.
3795, 1nbyA, 0.6383, 3.05, 0.054, 214, 93, CRYSTAL STRUCTURE OF HYHEL-63 COMPLEXED WITH HEL MUTANT K96A
3796, 1lk3M, 0.6383, 2.92, 0.044, 210, 90, ENGINEERED HUMAN INTERLEUKIN-10 MONOMER COMPLEXED TO 9D7 FAB FRAGMENT
3797, 6mtsL, 0.6382, 2.83, 0.089, 212, 90, CRYSTAL STRUCTURE OF VRC43.03 FAB 
3798, 6dcaO, 0.6382, 2.87, 0.044, 215, 90, FAB/EPITOPE COMPLEX OF MOUSE MONOCLONAL ANTIBODY 6B2 TARGETING A NON- PHOSPHORYLATED TAU EPITOPE. 
3799, 6dcaN, 0.6382, 2.81, 0.044, 215, 90, FAB/EPITOPE COMPLEX OF MOUSE MONOCLONAL ANTIBODY 6B2 TARGETING A NON- PHOSPHORYLATED TAU EPITOPE. 
3800, 6b70F, 0.6382, 3.07, 0.077, 211, 91, CRYO-EM STRUCTURE OF HUMAN INSULIN DEGRADING ENZYME IN COMPLEX WITH FAB H11-E HEAVY CHAIN FAB H11-E LIGHT CHAIN AND INSULIN
3801, 5wkoL, 0.6382, 2.95, 0.056, 213, 90, CRYSTAL STRUCTURE OF ANTIBODY 27F3 RECOGNIZING THE HA FROM A/CALIFORNIA/04/2009 (H1N1) INFLUENZA VIRUS
3802, 5mtlB, 0.6382, 2.73, 0.056, 198, 89, CRYSTAL STRUCTURE OF AN AMYLOIDOGENIC LIGHT CHAIN
3803, 5mp1D, 0.6382, 2.96, 0.054, 218, 92, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 7.5 
3804, 5hdbL, 0.6382, 3.01, 0.054, 214, 92, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH RO-435054
3805, 5dd6L, 0.6382, 3.09, 0.065, 213, 92, CRYSTAL STRUCTURES IN AN ANTI-HIV ANTIBODY LINEAGE FROM IMMUNIZATION OF RHESUS MACAQUES
3806, 5bk2L, 0.6382, 3.08, 0.065, 216, 93, CRYSTAL STRUCTURE OF MALTOSE BINDING PROTEIN IN COMPLEX WITH A PERISTERIC SYNTHETIC ANTIBODY
3807, 5b71C, 0.6382, 2.90, 0.056, 214, 89, CRYSTAL STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH SKY59
3808, 4z7qF, 0.6382, 3.23, 0.053, 214, 94, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV-NH2 PEPTIDE
3809, 4rauA, 0.6382, 3.08, 0.054, 212, 92, CRYSTAL STRUCTURE OF RTOFAB IN COMPLEX WITH HUMAN PF4
3810, 4nzuL, 0.6382, 3.05, 0.066, 211, 91, CRYSTAL STRUCTURE OF THE PRIMARY MONOCLONAL ANTIBODY 13PL FAB  FROM A MULTIPLE MYELOMA PATIENT
3811, 4nhhQ, 0.6382, 2.95, 0.056, 211, 90, STRUCTURE OF 2G12 IGG DIMER
3812, 4nhhL, 0.6382, 2.95, 0.056, 211, 90, STRUCTURE OF 2G12 IGG DIMER
3813, 4nhhG, 0.6382, 2.95, 0.056, 211, 90, STRUCTURE OF 2G12 IGG DIMER
3814, 4fqqC, 0.6382, 2.74, 0.090, 210, 89, CRYSTAL STRUCTURE OF GERMLINE ANTIBODY PGT121-GL FAB
3815, 3ze1L, 0.6382, 3.00, 0.054, 214, 92, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
3816, 3t3mL, 0.6382, 3.13, 0.054, 214, 93, A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
3817, 3obaD, 0.6382, 3.30, 0.061, 1024, 98, STRUCTURE OF THE BETA-GALACTOSIDASE FROM KLUYVEROMYCES LACTIS
3818, 3b2uD, 0.6382, 2.86, 0.056, 213, 90, CRYSTAL STRUCTURE OF ISOLATED DOMAIN III OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8
3819, 2r9hD, 0.6382, 2.91, 0.044, 211, 91, CRYSTAL STRUCTURE OF Q207C MUTANT OF CLC-EC1 IN COMPLEX WITH FAB
3820, 2o5xL, 0.6382, 3.02, 0.054, 218, 92, CRYSTAL STRUCTURE OF 1E9 LEUH47TRP/ARGH100TRP AN ENGINEERED DIELS- ALDERASE FAB WITH NM STEROID-BINDING AFFINITY
3821, 1tzgL, 0.6382, 3.01, 0.054, 214, 92, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH A 13-RESIDUE PEPTIDE CONTAINING THE 4E10 EPITOPE ON GP41
3822, 1rziC, 0.6382, 2.92, 0.055, 212, 91, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 47E FAB
3823, 1op3L, 0.6382, 2.95, 0.056, 211, 90, CRYSTAL STRUCTURE OF FAB 2G12 BOUND TO MAN1->2MAN
3824, 1mcjA, 0.6382, 2.91, 0.065, 216, 92, PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
3825, 1cloL, 0.6382, 3.16, 0.043, 213, 94, ANTI-CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY A5B7
3826, 6flcA, 0.6381, 2.87, 0.044, 211, 90, 2C8 FAB BOUND TO EDIII OF DENV 2 
3827, 6ea7L, 0.6381, 2.98, 0.065, 210, 92, STRUCTURE OF EBOV GPCL IN COMPLEX WITH THE PAN-EBOLAVIRUS MAB ADI- 15878 
3828, 6co3L, 0.6381, 2.89, 0.056, 211, 89, ADUCANUMAB ABETA COMPLEX 
3829, 5kanL, 0.6381, 2.83, 0.055, 214, 91, CRYSTAL STRUCTURE OF MULTIDONOR HV1-18-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 16.G.07 IN COMPLEX WITH A/HONG KONG/1-4-MA21- 1/1968 (H3N2) HEMAGGLUTININ
3830, 5k9oL, 0.6381, 3.08, 0.065, 217, 93, CRYSTAL STRUCTURE OF MULTIDONOR HV1-18+HD3-9 CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 31.B.09 IN COMPLEX WITH HEMAGGLUTININ H1 A/CALIFORNIA/04/2009
3831, 5k9oB, 0.6381, 3.08, 0.065, 213, 93, CRYSTAL STRUCTURE OF MULTIDONOR HV1-18+HD3-9 CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 31.B.09 IN COMPLEX WITH HEMAGGLUTININ H1 A/CALIFORNIA/04/2009
3832, 5drzA, 0.6381, 3.05, 0.054, 218, 92, CRYSTAL STRUCTURE OF ANTI-HIV-1 ANTIBODY F240 FAB IN COMPLEX WITH GP41 PEPTIDE
3833, 4rgnL, 0.6381, 3.01, 0.054, 213, 92, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO TWO NEUTRALIZING ANTIBODIES 14G8 AND 6D3
3834, 4rauS, 0.6381, 3.08, 0.054, 212, 92, CRYSTAL STRUCTURE OF RTOFAB IN COMPLEX WITH HUMAN PF4
3835, 4qnpL, 0.6381, 2.99, 0.055, 211, 91, CRYSTAL STRUCTURE OF THE 2009 PANDEMIC H1N1 INFLUENZA VIRUS NEURAMINIDASE WITH A NEUTRALIZING ANTIBODY
3836, 3q3gF, 0.6381, 3.03, 0.043, 220, 93, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
3837, 2r4sL, 0.6381, 3.10, 0.053, 214, 94, CRYSTAL STRUCTURE OF THE HUMAN BETA2 ADRENOCEPTOR
3838, 2hffA, 0.6381, 2.92, 0.043, 213, 92, CRYSTAL STRUCTURE OF CB2 FAB
3839, 2erjB, 0.6381, 3.36, 0.054, 204, 93, CRYSTAL STRUCTURE OF THE HETEROTRIMERIC INTERLEUKIN-2 RECEPTOR IN COMPLEX WITH INTERLEUKIN-2
3840, 1tzhL, 0.6381, 2.76, 0.056, 210, 89, CRYSTAL STRUCTURE OF THE FAB YADS1 COMPLEXED WITH H-VEGF
3841, 1mpaL, 0.6381, 3.23, 0.043, 219, 94, BACTERICIDAL ANTIBODY AGAINST NEISSERIA MENINGITIDIS
3842, 1mlbA, 0.6381, 3.05, 0.054, 214, 93, MONOCLONAL ANTIBODY FAB D44.1 RAISED AGAINST CHICKEN EGG-WHITE LYSOZYME
3843, 12e8M, 0.6381, 3.03, 0.054, 214, 93, 2E8 FAB FRAGMENT
3844, 6mubK, 0.6380, 2.85, 0.055, 213, 91, ANTI-HIV-1 FAB 2G12 + MAN5 RE-REFINEMENT 
3845, 6m87I, 0.6380, 2.86, 0.044, 207, 90, FAB 10A6 IN COMPLEX WITH MPTS 
3846, 6cdmB, 0.6380, 2.77, 0.056, 218, 90, STRUCTURE OF VACCINE-ELICITED HIV-1 NEUTRALIZING ANTIBODY VFP7.04 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519 
3847, 6b3mD, 0.6380, 3.07, 0.054, 214, 92, THE CRYSTAL STRUCTURE OF A BROADLY-REACTIVE HUMAN ANTI-HEMAGGLUTININ STALK ANTIBODY (70-1F02) IN COMPLEX WITH H5 HEMAGGLUTININ 
3848, 5fykE, 0.6380, 2.90, 0.055, 213, 91, CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE B JR-FL SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122 35O22 AND VRC01
3849, 5bvjG, 0.6380, 2.90, 0.055, 214, 91, THE MOLECULAR MODE OF ACTION AND SPECIES SPECIFICITY OF CANAKINUMAB A HUMAN MONOCLONAL ANTIBODY NEUTRALIZING IL-1BETA
3850, 4yhpF, 0.6380, 2.77, 0.056, 211, 89, CRYSTAL STRUCTURE OF 309M3-B FAB IN COMPLEX WITH H3K9ME3 PEPTIDE
3851, 3qpqL, 0.6380, 3.03, 0.054, 215, 93, CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB
3852, 3bkyL, 0.6380, 3.02, 0.054, 213, 92, CRYSTAL STRUCTURE OF CHIMERIC ANTIBODY C2H7 FAB IN COMPLEX WITH A CD20 PEPTIDE
3853, 2ny6C, 0.6380, 2.95, 0.056, 214, 90, HIV-1 GP120 ENVELOPE GLYCOPROTEIN (M95W W96C I109C T123C T257S V275CS334A S375W Q428C G431C) COMPLEXED WITH CD4 AND ANTIBODY 17B
3854, 1tzhA, 0.6380, 2.86, 0.056, 210, 89, CRYSTAL STRUCTURE OF THE FAB YADS1 COMPLEXED WITH H-VEGF
3855, 1pg7Y, 0.6380, 2.67, 0.045, 210, 88, MURINE 6A6 FAB IN COMPLEX WITH HUMANIZED ANTI-TISSUE FACTOR D3H44 FAB
3856, 1otsD, 0.6380, 2.91, 0.044, 211, 91, STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL AND FAB COMPLEX
3857, 1ggiL, 0.6380, 2.90, 0.056, 215, 90, CRYSTAL STRUCTURE OF AN HIV-1 NEUTRALIZING ANTIBODY 50.1 IN COMPLEX WITH ITS V3 LOOP PEPTIDE ANTIGEN
3858, 5y9fO, 0.6379, 3.04, 0.043, 218, 92, CRYSTAL STRUCTURE OF HPV59 PENTAMER IN COMPLEX WITH THE FAB FRAGMENT OF ANTIBODY 28F10
3859, 5vz1A, 0.6379, 2.99, 0.065, 200, 92, CRYSTAL STRUCTURE OF THE APO ANTIBODY FRAGMENT (FAB) RAISED AGAINST C- TERMINAL DOMAIN OF EBOLA NUCLEOPROTEIN (EBOV; TAFV; BDBV STRAINS) 
3860, 5myxC, 0.6379, 2.93, 0.054, 218, 92, STRUCTURE OF PYROGLUTAMATE-ABETA-SPECIFIC FAB C 24 IN COMPLEX WITH HUMAN ABETA-PE3-18
3861, 5ig7E, 0.6379, 2.72, 0.090, 213, 89, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E01 FAB FRAGMENT IN COMPLEX OF PEPTIDE PLQPQQPFP
3862, 4xwoR, 0.6379, 3.14, 0.053, 216, 94, STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF SEC22
3863, 4xbpF, 0.6379, 2.94, 0.056, 213, 90, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB CRYSTALIZED IN THE PRESENCE OF PHOSPHATIDYLETHANOLAMINE (06:0 PE)
3864, 4rfeD, 0.6379, 2.75, 0.090, 212, 89, CRYSTAL STRUCTURE OF ADCC-POTENT ANTI-HIV-1 RHESUS MACAQUE ANTIBODY JR4 FAB
3865, 4qwwE, 0.6379, 3.14, 0.054, 212, 93, CRYSTAL STRUCTURE OF THE FAB410-BFACHE COMPLEX
3866, 3haeN, 0.6379, 2.73, 0.090, 211, 89, RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES
3867, 2g5bA, 0.6379, 2.94, 0.055, 217, 91, CRYSTAL STRUCTURE OF THE ANTI-BAX MONOCLONAL ANTIBODY 6A7 AND A BAX PEPTIDE.
3868, 2agjH, 0.6379, 3.17, 0.065, 225, 93, CRYSTAL STRUCTURE OF A GLYCOSYLATED FAB FROM AN IGM CRYOGLOBULIN WITH PROPERTIES OF A NATURAL PROTEOLYTIC ANTIBODY
3869, 1ob1D, 0.6379, 3.06, 0.043, 215, 93, CRYSTAL STRUCTURE OF A FAB COMPLEX WHITH PLASMODIUM FALCIPARUM MSP1-19
3870, 1fl6L, 0.6379, 2.98, 0.056, 217, 90, THE HAPTEN COMPLEXED GERMLINE PRECURSOR TO SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4
3871, 1faiL, 0.6379, 3.07, 0.054, 214, 93, THREE-DIMENSIONAL STRUCTURE OF TWO CRYSTAL FORMS OF FAB R19.9 FROM A MONOCLONAL ANTI-ARSONATE ANTIBODY
3872, 6mekL, 0.6378, 2.83, 0.055, 213, 91, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
3873, 6h06L, 0.6378, 3.02, 0.054, 218, 92, FAB CBTAU-22.1 IN COMPLEX WITH TAU PEPTIDE V1088-5 
3874, 6ev1B, 0.6378, 2.71, 0.057, 210, 88, CRYSTAL STRUCTURE OF ANTIBODY AGAINST SCHIZOPHYLLAN 
3875, 6dwiI, 0.6378, 2.72, 0.057, 211, 88, STRUCTURE OF THE 4462 ANTIBODY FAB FRAGMENT BOUND TO A STAPHYLOCOCCUS AUREUS WALL TECHOIC ACID ANALOG 
3876, 6d6wD, 0.6378, 2.66, 0.044, 579, 90, BACTEROIDES UNIFORMIS BETA-GLUCURONIDASE 1 BOUND TO GLUCURONATE 
3877, 6d0xB, 0.6378, 2.78, 0.056, 211, 89, CRYSTAL STRUCTURE OF CHIMERIC H.2140 / K.1210 FAB IN COMPLEX WITH CIRCUMSPOROZOITE PROTEIN NANP3 
3878, 6bb4M, 0.6378, 3.00, 0.055, 211, 91, FAB/EPITOPE COMPLEX OF MOUSE MONOCLONAL ANTIBODY C5.2 TARGETING A PHOSPHO-TAU EPITOPE. 
3879, 5vcoD, 0.6378, 3.40, 0.042, 219, 96, THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 10B9
3880, 5ijkD, 0.6378, 2.73, 0.056, 218, 89, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E03 FAB FRAGMENT IN COMPLEX OF PEPTIDE PLQPEQPFP
3881, 5g64A, 0.6378, 3.23, 0.064, 308, 94, THE COMPLEX BETWEEN HUMAN IGE-FC AND TWO ANTI-IGE FAB FRAGMENTS
3882, 5dqdL, 0.6378, 3.06, 0.054, 217, 93, STRUCTURE OF S55-5 FAB IN COMPLEX WITH LIPID A CARBOHYDRATE BACKBONE
3883, 4rfeF, 0.6378, 2.74, 0.090, 212, 89, CRYSTAL STRUCTURE OF ADCC-POTENT ANTI-HIV-1 RHESUS MACAQUE ANTIBODY JR4 FAB
3884, 4qwwC, 0.6378, 3.14, 0.054, 212, 93, CRYSTAL STRUCTURE OF THE FAB410-BFACHE COMPLEX
3885, 4pp2D, 0.6378, 3.40, 0.042, 219, 96, THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 10B9
3886, 4mxvE, 0.6378, 2.92, 0.056, 211, 90, STRUCTURE OF LYMPHOTOXIN ALPHA BOUND TO ANTI-LTA FAB
3887, 4jpiB, 0.6378, 2.97, 0.056, 207, 90, CRYSTAL STRUCTURE OF A PUTATIVE VRC01 GERMLINE PRECURSOR FAB
3888, 3u9pL, 0.6378, 2.67, 0.034, 212, 89, CRYSTAL STRUCTURE OF MURINE SIDEROCALIN IN COMPLEX WITH AN FAB FRAGMENT
3889, 3qa3F, 0.6378, 3.02, 0.043, 220, 93, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
3890, 3nfsL, 0.6378, 2.85, 0.056, 212, 90, CRYSTAL STRUCTURE THE FAB FRAGMENT OF THERAPEUTIC ANTIBODY DACLIZUMAB
3891, 2g5bG, 0.6378, 2.93, 0.055, 217, 91, CRYSTAL STRUCTURE OF THE ANTI-BAX MONOCLONAL ANTIBODY 6A7 AND A BAX PEPTIDE.
3892, 2g5bE, 0.6378, 2.93, 0.055, 217, 91, CRYSTAL STRUCTURE OF THE ANTI-BAX MONOCLONAL ANTIBODY 6A7 AND A BAX PEPTIDE.
3893, 2g5bC, 0.6378, 2.94, 0.055, 217, 91, CRYSTAL STRUCTURE OF THE ANTI-BAX MONOCLONAL ANTIBODY 6A7 AND A BAX PEPTIDE.
3894, 1lk3L, 0.6378, 2.92, 0.044, 210, 90, ENGINEERED HUMAN INTERLEUKIN-10 MONOMER COMPLEXED TO 9D7 FAB FRAGMENT
3895, 6ev1H, 0.6377, 2.81, 0.056, 211, 90, CRYSTAL STRUCTURE OF ANTIBODY AGAINST SCHIZOPHYLLAN 
3896, 6cnrL, 0.6377, 2.71, 0.057, 211, 88, ADUCANUMAB APO FAB 
3897, 6apdG, 0.6377, 3.09, 0.065, 215, 93, CRYSTAL STRUCTURE OF RSV F BOUND BY AM22 AND THE INFANT ANTIBODY ADI- 19425
3898, 5vyfL, 0.6377, 3.04, 0.054, 213, 92, STRUCTURE OF SINGLE CHAIN FEL D 1 BOUND TO A NEUTRALIZING ANTIBODY
3899, 5mp1L, 0.6377, 3.01, 0.054, 218, 92, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 7.5 
3900, 5f3hB, 0.6377, 2.79, 0.056, 212, 90, STRUCTURE OF MYOSTATIN IN COMPLEX WITH HUMANIZED RK35 ANTIBODY
3901, 4zypI, 0.6377, 2.76, 0.056, 213, 89, CRYSTAL STRUCTURE OF MOTAVIZUMAB AND QUATERNARY-SPECIFIC RSV- NEUTRALIZING HUMAN ANTIBODY AM14 IN COMPLEX WITH PREFUSION RSV F GLYCOPROTEIN
3902, 4utaM, 0.6377, 3.05, 0.054, 213, 92, CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE1 C8
3903, 4rauM, 0.6377, 3.10, 0.054, 212, 92, CRYSTAL STRUCTURE OF RTOFAB IN COMPLEX WITH HUMAN PF4
3904, 4r4nO, 0.6377, 2.88, 0.056, 210, 89, CRYSTAL STRUCTURE OF THE ANTI-HIV-1 ANTIBODY 2.2C IN COMPLEX WITH HIV- 1 93UG037 GP120
3905, 4qciL, 0.6377, 2.76, 0.079, 203, 89, PDGF-B BLOCKING ANTIBODY BOUND TO PDGF-BB
3906, 4fg6D, 0.6377, 2.90, 0.044, 211, 91, STRUCTURE OF ECCLC E148A MUTANT IN GLUTAMATE
3907, 4am0B, 0.6377, 2.96, 0.055, 212, 91, STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12
3908, 4aehL, 0.6377, 3.04, 0.055, 211, 91, CRYSTAL STRUCTURE OF THE ANTI-AAHI FAB9C2 ANTIBODY
3909, 3p11L, 0.6377, 3.24, 0.076, 211, 92, ANTI-EGFR/HER3 FAB DL11 IN COMPLEX WITH DOMAINS I-III OF THE HER3 EXTRACELLULAR REGION
3910, 3eotL, 0.6377, 2.93, 0.054, 214, 92, CRYSTAL STRUCTURE OF LAC031 AN ENGINEERED ANTI-VLA1 FAB
3911, 2fx7L, 0.6377, 3.02, 0.054, 214, 92, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH A 16-RESIDUE PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41
3912, 2a6iA, 0.6377, 2.81, 0.055, 214, 91, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-ARSONATE GERMLINE ANTIBODY 36-65 IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE KLASIPTHTSPL
3913, 1yymL, 0.6377, 2.78, 0.056, 214, 89, CRYSTAL STRUCTURE OF F23 A SCORPION-TOXIN MIMIC OF CD4 IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
3914, 1yylL, 0.6377, 2.78, 0.056, 214, 89, CRYSTAL STRUCTURE OF CD4M33 A SCORPION-TOXIN MIMIC OF CD4 IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
3915, 1cgsL, 0.6377, 3.11, 0.043, 219, 93, LOCAL AND TRANSMITTED CONFORMATIONAL CHANGES ON COMPLEXATION OF AN ANTI-SWEETENER FAB
3916, 1cbvL, 0.6377, 3.00, 0.043, 219, 93, AN AUTOANTIBODY TO SINGLE-STRANDED DNA: COMPARISON OF THE THREE- DIMENSIONAL STRUCTURES OF THE UNLIGANDED FAB AND A DEOXYNUCLEOTIDE- FAB COMPLEX
3917, 6flcL, 0.6376, 2.94, 0.044, 212, 91, 2C8 FAB BOUND TO EDIII OF DENV 2 
3918, 6b3mP, 0.6376, 3.00, 0.055, 213, 91, THE CRYSTAL STRUCTURE OF A BROADLY-REACTIVE HUMAN ANTI-HEMAGGLUTININ STALK ANTIBODY (70-1F02) IN COMPLEX WITH H5 HEMAGGLUTININ 
3919, 5uemL, 0.6376, 2.89, 0.056, 213, 89, CRYSTAL STRUCTURE OF 354NC37 FAB IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057 GP120
3920, 5tlkC, 0.6376, 2.88, 0.056, 215, 89, COMPLEX BETWEEN HUMAN CD27 AND FAB FRAGMENTS OF ANTIBODIES M2177 AND H2191
3921, 5kanI, 0.6376, 3.09, 0.054, 214, 93, CRYSTAL STRUCTURE OF MULTIDONOR HV1-18-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 16.G.07 IN COMPLEX WITH A/HONG KONG/1-4-MA21- 1/1968 (H3N2) HEMAGGLUTININ
3922, 5eoqL, 0.6376, 3.02, 0.043, 218, 92, STRUCTURE OF THE MURINE FAB 1G6 BOUND TO THE VACCINIA VIRUS A27 PEPTIDE 31-40
3923, 4yblL, 0.6376, 2.77, 0.067, 210, 89, CRYSTAL STRUCTURE OF THE STABILIZED INNER DOMAIN OF CLADE A/E HIV-1 GP120 IN COMPLEX WITH THE ADCC MEDIATING ANTI-HIV-1 ANTIBODY A32
3924, 4xgzV, 0.6376, 2.88, 0.054, 210, 92, CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD2 MOTIF IN COMPLEX WITH FAB FRAGMENT
3925, 4kaqL, 0.6376, 3.05, 0.054, 211, 93, STRUCTURE OF RITUXIMAB FAB
3926, 4g5zL, 0.6376, 2.94, 0.056, 212, 90, CRYSTAL STRUCTURE OF THE THERAPEUTICAL ANTIBODY FRAGMENT OF CANAKINUMAB IN ITS UNBOUND STATE
3927, 3wjjB, 0.6376, 2.89, 0.053, 206, 94, CRYSTAL STRUCTURE OF IIB SELECTIVE FC VARIANT FC(P238D) IN COMPLEX WITH FCGRIIB
3928, 3wd5L, 0.6376, 2.99, 0.054, 213, 92, CRYSTAL STRUCTURE OF TNFALPHA IN COMPLEX WITH ADALIMUMAB FAB FRAGMENT
3929, 3utzD, 0.6376, 2.87, 0.056, 212, 89, ENDOGENOUS-LIKE INHIBITORY ANTIBODIES TARGETING ACTIVATED METALLOPROTEINASE MOTIFS SHOW THERAPEUTIC POTENTIAL
3930, 3ujtM, 0.6376, 2.84, 0.044, 217, 90, STRUCTURE OF THE FAB FRAGMENT OF AB-52 AN ANTIBODY THAT BINDS THE O- ANTIGEN OF FRANCISELLA TULARENSIS
3931, 3piqB, 0.6376, 2.82, 0.090, 209, 89, CRYSTAL STRUCTURE OF HUMAN 2909 FAB A QUATERNARY STRUCTURE-SPECIFIC ANTIBODY AGAINST HIV-1
3932, 2jb6L, 0.6376, 2.76, 0.090, 210, 89, FAB FRAGMENT IN COMPLEX WITH SMALL MOLECULE HAPTEN CRYSTAL FORM-2
3933, 2ht2D, 0.6376, 2.93, 0.044, 211, 91, STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445H MUTANT AND FAB COMPLEX
3934, 1za6G, 0.6376, 3.22, 0.054, 220, 93, THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY
3935, 1yegL, 0.6376, 3.29, 0.043, 219, 94, STRUCTURE OF IGG2A FAB FRAGMENT (D2.3) COMPLEXED WITH REACTION PRODUCT
3936, 1w72L, 0.6376, 2.74, 0.101, 210, 89, CRYSTAL STRUCTURE OF HLA-A1:MAGE-A1 IN COMPLEX WITH FAB- HYB3
3937, 1ndmA, 0.6376, 3.21, 0.053, 214, 94, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTIBODY HYHEL-26 COMPLEXED WITH LYSOZYME
3938, 6bi0L, 0.6375, 3.11, 0.054, 212, 92, TRASTUZUMAB FAB N158A D185A K190A (LIGHT CHAIN) TRIPLE MUTANT.
3939, 5mv4D, 0.6375, 2.93, 0.054, 217, 92, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED CII616-639 EPITOPE OF COLLAGEN TYPE II (PTM23)
3940, 5f7eL, 0.6375, 2.96, 0.056, 207, 90, CRYSTAL STRUCTURE OF GERM-LINE PRECURSOR OF 3BNC60 FAB
3941, 5d96B, 0.6375, 3.18, 0.053, 214, 94, OXIDOREDUCTASE FRAGMENT OF MOUSE QSOX1 IN COMPLEX WITH A FAB FRAGMENT FROM AN ANTIBODY TARGETING MOUSE AND HUMAN QSOX1
3942, 4zykB, 0.6375, 3.02, 0.054, 214, 92, CRYSTAL STRUCTURE OF QUATERNARY-SPECIFIC RSV-NEUTRALIZING HUMAN ANTIBODY AM14
3943, 4zffL, 0.6375, 2.86, 0.056, 213, 90, DUAL-ACTING FAB 5A12 IN COMPLEX WITH VEGF
3944, 4wfeD, 0.6375, 3.11, 0.054, 211, 92, HUMAN TRAAK K+ CHANNEL IN A K+ BOUND CONDUCTIVE CONFORMATION
3945, 4tnwZ, 0.6375, 2.89, 0.055, 215, 91, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
3946, 4s1dP, 0.6375, 2.97, 0.056, 210, 90, STRUCTURE OF IGG1 FAB FRAGMENT IN COMPLEX WITH BIOTINCYTIDINAMIDE
3947, 4rrpD, 0.6375, 3.12, 0.054, 214, 93, CRYSTAL STRUCTURE OF THE FAB COMPLEXED WITH ANTIGEN ASF1P NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET PDR16
3948, 4pb0L, 0.6375, 2.94, 0.056, 216, 90, STRUCTURE OF THE FAB FRAGMENT OF THE ANTI-FRANCISELLA TULARENSIS GROEL ANTIBODY AB53
3949, 4ongL, 0.6375, 2.82, 0.045, 214, 89, FAB FRAGMENT OF 3D6 IN COMPLEX WITH AMYLOID BETA 1-40
3950, 4j4pB, 0.6375, 3.39, 0.071, 317, 98, THE COMPLEX OF HUMAN IGE-FC WITH TWO BOUND FAB FRAGMENTS
3951, 3tt3L, 0.6375, 2.93, 0.044, 216, 91, CRYSTAL STRUCTURE OF LEUT IN THE INWARD-OPEN CONFORMATION IN COMPLEX WITH FAB
3952, 3eyqC, 0.6375, 2.88, 0.067, 212, 89, CRYSTAL STRUCTURE OF MJ5 FAB A GERMLINE ANTIBODY VARIANT OF ANTI-HUMAN CYTOMEGALOVIRUS ANTIBODY 8F9
3953, 1yymQ, 0.6375, 2.78, 0.056, 214, 89, CRYSTAL STRUCTURE OF F23 A SCORPION-TOXIN MIMIC OF CD4 IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
3954, 1yejL, 0.6375, 3.13, 0.043, 219, 93, CATALYTIC ANTIBODY COMPLEX
3955, 1rziK, 0.6375, 3.05, 0.065, 211, 92, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 47E FAB
3956, 1fn4A, 0.6375, 3.18, 0.032, 211, 93, CRYSTAL STRUCTURE OF FAB198 AN EFFICIENT PROTECTOR OF ACETYLCHOLINE RECEPTOR AGAINST MYASTHENOGENIC ANTIBODIES
3957, 6fgbL, 0.6374, 3.10, 0.065, 219, 93, HUMAN FCRN EXTRA-CELLULAR DOMAIN COMPLEXED WITH FAB FRAGMENT OF ROZANOLIXIZUMAB 
3958, 6dw2A, 0.6374, 3.04, 0.054, 213, 92, STRUCTURE OF THE 6078 ANTIBODY FAB FRAGMENT BOUND TO A STAPHYLOCOCCUS AUREUS WALL TECHOIC ACID ANALOG 
3959, 5xhgA, 0.6374, 3.03, 0.055, 213, 91, CRYSTAL STRUCTURE OF TRASTUZUMAB FAB FRAGMENT BEARING NE-(O- AZIDOBENZYLOXYCARBONYL)-L-LYSINE
3960, 5m6aD, 0.6374, 2.73, 0.067, 212, 89, CRYSTAL STRUCTURE OF CARDIOTOXIC BENCE-JONES LIGHT CHAIN DIMER H9
3961, 5f89B, 0.6374, 2.87, 0.077, 222, 91, STRUCTURE OF THE UNLIGANDED FAB FROM HIV-1 NEUTRALISING ANTIBODY CAP248-2B THAT BINDS TO THE GP120 C-TERMINUS - GP41 INTERFACE
3962, 4ygvB, 0.6374, 2.98, 0.065, 218, 92, REVERSAL AGENT FOR DABIGATRAN
3963, 4xnmA, 0.6374, 2.89, 0.089, 208, 90, ANTIBODY INFLUENZA H5 COMPLEX
3964, 4whtF, 0.6374, 3.04, 0.044, 215, 91, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11 P1 CRYSTAL FORM
3965, 4wffD, 0.6374, 2.91, 0.044, 211, 91, HUMAN TRAAK K+ CHANNEL IN A K+ BOUND NONCONDUCTIVE CONFORMATION
3966, 4r7nF, 0.6374, 2.89, 0.056, 211, 89, FAB C2E3
3967, 4nhhN, 0.6374, 2.90, 0.054, 206, 93, STRUCTURE OF 2G12 IGG DIMER
3968, 4nhhD, 0.6374, 2.90, 0.054, 206, 93, STRUCTURE OF 2G12 IGG DIMER
3969, 4nhhB, 0.6374, 2.90, 0.054, 206, 93, STRUCTURE OF 2G12 IGG DIMER
3970, 4nhgY, 0.6374, 2.90, 0.054, 206, 93, CRYSTAL STRUCTURE OF 2G12 IGG DIMER
3971, 4nhgP, 0.6374, 2.90, 0.054, 206, 93, CRYSTAL STRUCTURE OF 2G12 IGG DIMER
3972, 4nhgN, 0.6374, 2.90, 0.054, 206, 93, CRYSTAL STRUCTURE OF 2G12 IGG DIMER
3973, 4jzoF, 0.6374, 2.96, 0.056, 210, 90, THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING HUMAN ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 FAB FRAGMENT HC84-27
3974, 4jlrL, 0.6374, 2.72, 0.057, 210, 88, CRYSTAL STRUCTURE OF A DESIGNED RESPIRATORY SYNCYTIAL VIRUS IMMUNOGEN IN COMPLEX WITH MOTAVIZUMAB
3975, 4jlrB, 0.6374, 2.71, 0.057, 210, 88, CRYSTAL STRUCTURE OF A DESIGNED RESPIRATORY SYNCYTIAL VIRUS IMMUNOGEN IN COMPLEX WITH MOTAVIZUMAB
3976, 3mmeL, 0.6374, 2.86, 0.089, 211, 90, STRUCTURE AND FUNCTIONAL DISSECTION OF PG16 AN ANTIBODY WITH BROAD AND POTENT NEUTRALIZATION OF HIV-1
3977, 1pg7L, 0.6374, 3.03, 0.055, 213, 91, MURINE 6A6 FAB IN COMPLEX WITH HUMANIZED ANTI-TISSUE FACTOR D3H44 FAB
3978, 1mfdL, 0.6374, 2.81, 0.056, 212, 90, THE SOLUTION STRUCTURE OF A TRISACCHARIDE-ANTIBODY COMPLEX: COMPARISON OF NMR MEASUREMENTS WITH A CRYSTAL STRUCTURE
3979, 1h3xB, 0.6374, 2.90, 0.054, 206, 93, CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENTGLYCOFORM (G0F)2
3980, 1f3dJ, 0.6374, 3.02, 0.054, 218, 92, CATALYTIC ANTIBODY 4B2 IN COMPLEX WITH ITS AMIDINIUM HAPTEN.
3981, 6e63C, 0.6373, 2.74, 0.090, 212, 89, CRYSTAL STRUCTURE OF MALARIA TRANSMISSION-BLOCKING ANTIGEN PFS48/45 6C IN COMPLEX WITH ANTIBODY TB31F 
3982, 6d7fA, 0.6373, 2.66, 0.044, 579, 90, BACTEROIDES UNIFORMIS BETA-GLUCURONIDASE 1 BOUND TO THIOPHENYL-BETA-D- GLUCURONIDE 
3983, 5n7wB, 0.6373, 2.74, 0.090, 210, 89, COMPUTATIONALLY DESIGNED FUNCTIONAL ANTIBODY 
3984, 5mp5F, 0.6373, 3.03, 0.055, 216, 91, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 6.5 
3985, 5kzcD, 0.6373, 3.08, 0.054, 209, 93, CRYSTAL STRUCTURE OF AN HIV-1 GP120 ENGINEERED OUTER DOMAIN WITH A MAN9 GLYCAN AT POSITION N276 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODY VRC01
3986, 5iq9B, 0.6373, 2.74, 0.056, 210, 89, CRYSTAL STRUCTURE OF 10E8V4 FAB IN COMPLEX WITH AN HIV-1 GP41 PEPTIDE.
3987, 5hsfA, 0.6373, 3.04, 0.109, 105, 92, 1.52 ANGSTROM CRYSTAL STRUCTURE OF FC FRAGMENT OF HUMAN IGG1.
3988, 4webL, 0.6373, 2.89, 0.056, 217, 90, STRUCTURE OF THE CORE ECTODOMAIN OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN 2
3989, 4eneD, 0.6373, 2.89, 0.044, 211, 91, STRUCTURE OF THE N- AND C-TERMINAL TRIMMED CLC-EC1 CL-/H+ ANTIPORTER AND FAB COMPLEX
3990, 4am0F, 0.6373, 2.96, 0.044, 212, 91, STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12
3991, 3wheX, 0.6373, 2.74, 0.090, 212, 89, A NEW CONSERVED NEUTRALIZING EPITOPE AT THE GLOBULAR HEAD OF HEMAGGLUTININ IN H3N2 INFLUENZA VIRUSES
3992, 3wheV, 0.6373, 2.74, 0.090, 212, 89, A NEW CONSERVED NEUTRALIZING EPITOPE AT THE GLOBULAR HEAD OF HEMAGGLUTININ IN H3N2 INFLUENZA VIRUSES
3993, 3whe8, 0.6373, 2.74, 0.090, 212, 89, A NEW CONSERVED NEUTRALIZING EPITOPE AT THE GLOBULAR HEAD OF HEMAGGLUTININ IN H3N2 INFLUENZA VIRUSES
3994, 3whe2, 0.6373, 2.74, 0.090, 212, 89, A NEW CONSERVED NEUTRALIZING EPITOPE AT THE GLOBULAR HEAD OF HEMAGGLUTININ IN H3N2 INFLUENZA VIRUSES
3995, 3nifL, 0.6373, 3.04, 0.043, 214, 93, THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
3996, 3cfdL, 0.6373, 2.97, 0.054, 213, 92, PURPLE-FLUORESCENT ANTIBODY EP2-25C10 IN COMPLEX WITH ITS STILBENE HAPTEN
3997, 2fjgA, 0.6373, 2.75, 0.056, 211, 89, STRUCTURE OF THE G6 FAB A PHAGE DERIVED FAB FRAGMENT IN COMPLEX WITH VEGF
3998, 2a1wL, 0.6373, 3.02, 0.055, 216, 91, ANTI-COCAINE ANTIBODY 7.5.21 CRYSTAL FORM I
3999, 1v7nM, 0.6373, 3.02, 0.054, 212, 93, HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB
4000, 1oakL, 0.6373, 3.08, 0.054, 212, 92, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR (VWF) A1 DOMAIN IN COMPLEX WITH THE FUNCTION BLOCKING NMC-4 FAB
4001, 6b5lL, 0.6372, 2.94, 0.055, 218, 91, STRUCTURE OF PFCSP PEPTIDE 20 WITH HUMAN PROTECTIVE ANTIBODY CIS43
4002, 5cwsA, 0.6372, 2.96, 0.056, 208, 90, CRYSTAL STRUCTURE OF THE INTACT CHAETOMIUM THERMOPHILUM NSP1-NUP49- NUP57 CHANNEL NUCLEOPORIN HETEROTRIMER BOUND TO ITS NIC96 NUCLEAR PORE COMPLEX ATTACHMENT SITE
4003, 4zs6L, 0.6372, 2.91, 0.056, 210, 89, RECEPTOR BINDING DOMAIN AND FAB COMPLEX
4004, 4z0bL, 0.6372, 3.09, 0.043, 202, 94, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-OFLOXACIN ANTIBODY AND EXPLORATION ITS RECEPTOR BINDING SITE
4005, 4janL, 0.6372, 2.82, 0.078, 206, 90, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH103 IN COMPLEX WITH HIV-1 GP120
4006, 4c2iL, 0.6372, 2.67, 0.067, 211, 89, CRYO-EM STRUCTURE OF DENGUE VIRUS SEROTYPE 1 COMPLEXED WITH FAB FRAGMENTS OF HUMAN ANTIBODY 1F4
4007, 3wheN, 0.6372, 2.74, 0.090, 212, 89, A NEW CONSERVED NEUTRALIZING EPITOPE AT THE GLOBULAR HEAD OF HEMAGGLUTININ IN H3N2 INFLUENZA VIRUSES
4008, 3whe6, 0.6372, 2.74, 0.090, 212, 89, A NEW CONSERVED NEUTRALIZING EPITOPE AT THE GLOBULAR HEAD OF HEMAGGLUTININ IN H3N2 INFLUENZA VIRUSES
4009, 3whe4, 0.6372, 2.74, 0.090, 212, 89, A NEW CONSERVED NEUTRALIZING EPITOPE AT THE GLOBULAR HEAD OF HEMAGGLUTININ IN H3N2 INFLUENZA VIRUSES
4010, 3whe0, 0.6372, 2.74, 0.090, 212, 89, A NEW CONSERVED NEUTRALIZING EPITOPE AT THE GLOBULAR HEAD OF HEMAGGLUTININ IN H3N2 INFLUENZA VIRUSES
4011, 3kymG, 0.6372, 3.12, 0.054, 213, 92, CRYSTAL STRUCTURE OF LI33 IGG2 DI-FAB
4012, 3hi6Y, 0.6372, 2.70, 0.057, 209, 88, CRYSTAL STRUCTURE OF INTERMEDIATE AFFINITY I DOMAIN OF INTEGRIN LFA-1 WITH THE FAB FRAGMENT OF ITS ANTIBODY AL-57
4013, 2w9dL, 0.6372, 2.95, 0.055, 210, 91, STRUCTURE OF FAB FRAGMENT OF THE ICSM 18 - ANTI-PRP THERAPEUTIC ANTIBODY   AT 1.57 A RESOLUTION.
4014, 2r56M, 0.6372, 2.93, 0.067, 211, 90, CRYSTAL STRUCTURE OF A RECOMBINANT IGE FAB FRAGMENT IN COMPLEX WITH BOVINE BETA-LACTOGLOBULIN ALLERGEN
4015, 2o5zL, 0.6372, 3.02, 0.054, 218, 92, CRYSTAL STRUCTURE OF THE 1E9 LEUH47TRP/ARGH100TRP FAB 5-BETA- ANDROSTANE-317-DIONE COMPLEX
4016, 2jb6A, 0.6372, 2.77, 0.090, 211, 89, FAB FRAGMENT IN COMPLEX WITH SMALL MOLECULE HAPTEN CRYSTAL FORM-2
4017, 1kc5L, 0.6372, 3.09, 0.054, 214, 93, CRYSTAL STRUCTURE OF ANTIBODY PC287 IN COMPLEX WITH PS1 PEPTIDE
4018, 1bbjL, 0.6372, 2.67, 0.057, 211, 88, CRYSTAL STRUCTURE OF A CHIMERIC FAB  FRAGMENT OF AN ANTIBODY BINDING TUMOUR CELLS
4019, 1bbjA, 0.6372, 2.67, 0.057, 211, 88, CRYSTAL STRUCTURE OF A CHIMERIC FAB  FRAGMENT OF AN ANTIBODY BINDING TUMOUR CELLS
4020, 6ea7N, 0.6371, 3.04, 0.054, 211, 92, STRUCTURE OF EBOV GPCL IN COMPLEX WITH THE PAN-EBOLAVIRUS MAB ADI- 15878 
4021, 6db5L, 0.6371, 2.86, 0.089, 211, 90, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB TA6 IN COMPLEX WITH A HIV-1 GP120 V3 PEPTIDE FROM NY5 STRAIN 
4022, 6d6wB, 0.6371, 2.67, 0.044, 579, 90, BACTEROIDES UNIFORMIS BETA-GLUCURONIDASE 1 BOUND TO GLUCURONATE 
4023, 6b3mJ, 0.6371, 3.08, 0.054, 214, 92, THE CRYSTAL STRUCTURE OF A BROADLY-REACTIVE HUMAN ANTI-HEMAGGLUTININ STALK ANTIBODY (70-1F02) IN COMPLEX WITH H5 HEMAGGLUTININ 
4024, 5tlkG, 0.6371, 3.07, 0.066, 215, 91, COMPLEX BETWEEN HUMAN CD27 AND FAB FRAGMENTS OF ANTIBODIES M2177 AND H2191
4025, 5ewiL, 0.6371, 2.89, 0.056, 217, 89, CRYSTAL STRUCTURE OF THE HUMAN FAB VRC38.01 AN HIV-1 V1V2-DIRECTED NEUTRALIZING ANTIBODY ISOLATED FROM DONOR N90
4026, 5czkB, 0.6371, 2.91, 0.056, 588, 89, STRUCTURE OF E. COLI BETA-GLUCURONIDASE BOUND WITH A NOVEL POTENT INHIBITOR 1-((68-DIMETHYL-2-OXO-12-DIHYDROQUINOLIN-3-YL)METHYL)-1- (2-HYDROXYETHYL)-3-(4-HYDROXYPHENYL)THIOUREA
4027, 5cp7C, 0.6371, 2.94, 0.043, 218, 92, CRYSTAL STRUCTURE OF AN ANTIGEN-BINDING FRAGMENT OF MONOCLONAL ANTIBODY AGAINST SULFONAMIDES
4028, 5bvpL, 0.6371, 2.96, 0.055, 213, 91, THE MOLECULAR MODE OF ACTION AND SPECIES SPECIFICITY OF CANAKINUMAB A HUMAN MONOCLONAL ANTIBODY NEUTRALIZING IL-1BETA
4029, 5a8hO, 0.6371, 2.90, 0.056, 214, 90, CRYO-ET SUBTOMOGRAM AVERAGING OF BG505 SOSIP.664 IN COMPLEX WITH SCD4 17B AND 8ANC195
4030, 5a8hI, 0.6371, 2.90, 0.056, 214, 90, CRYO-ET SUBTOMOGRAM AVERAGING OF BG505 SOSIP.664 IN COMPLEX WITH SCD4 17B AND 8ANC195
4031, 5a8hC, 0.6371, 2.90, 0.056, 214, 90, CRYO-ET SUBTOMOGRAM AVERAGING OF BG505 SOSIP.664 IN COMPLEX WITH SCD4 17B AND 8ANC195
4032, 5a7xK, 0.6371, 2.90, 0.056, 214, 90, NEGATIVE STAIN EM OF BG505 SOSIP.664 IN COMPLEX WITH SCD4 17B AND 8ANC195
4033, 5a7xG, 0.6371, 2.90, 0.056, 214, 90, NEGATIVE STAIN EM OF BG505 SOSIP.664 IN COMPLEX WITH SCD4 17B AND 8ANC195
4034, 5a7xC, 0.6371, 2.90, 0.056, 214, 90, NEGATIVE STAIN EM OF BG505 SOSIP.664 IN COMPLEX WITH SCD4 17B AND 8ANC195
4035, 4yhpB, 0.6371, 2.85, 0.056, 212, 90, CRYSTAL STRUCTURE OF 309M3-B FAB IN COMPLEX WITH H3K9ME3 PEPTIDE
4036, 4kk9D, 0.6371, 2.89, 0.044, 211, 91, STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE AND 2MM BROMIDE
4037, 3wheZ, 0.6371, 2.74, 0.090, 212, 89, A NEW CONSERVED NEUTRALIZING EPITOPE AT THE GLOBULAR HEAD OF HEMAGGLUTININ IN H3N2 INFLUENZA VIRUSES
4038, 3wheR, 0.6371, 2.74, 0.090, 212, 89, A NEW CONSERVED NEUTRALIZING EPITOPE AT THE GLOBULAR HEAD OF HEMAGGLUTININ IN H3N2 INFLUENZA VIRUSES
4039, 3wheP, 0.6371, 2.74, 0.090, 212, 89, A NEW CONSERVED NEUTRALIZING EPITOPE AT THE GLOBULAR HEAD OF HEMAGGLUTININ IN H3N2 INFLUENZA VIRUSES
4040, 3b2uR, 0.6371, 2.88, 0.055, 213, 91, CRYSTAL STRUCTURE OF ISOLATED DOMAIN III OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8
4041, 2v7nG, 0.6371, 2.99, 0.056, 212, 90, UNUSUAL TWINNING IN CRYSTALS OF THE CITS BINDING ANTIBODY FAB FRAGMENT F3P4
4042, 1xcqG, 0.6371, 3.12, 0.054, 219, 93, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55AL57HY64W) IN SPACE GROUP P21
4043, 1rzkL, 0.6371, 2.90, 0.056, 214, 90, HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
4044, 1iqwL, 0.6371, 2.90, 0.044, 215, 90, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE MOUSE ANTI- HUMAN FAS ANTIBODY HFE7A
4045, 6mtqL, 0.6370, 2.88, 0.056, 212, 89, CRYSTAL STRUCTURE OF VRC42.N1 FAB IN COMPLEX WITH T117-F MPER SCAFFOLD 
4046, 5vqmC, 0.6370, 3.24, 0.064, 214, 94, CLOSTRIDIUM DIFFICILE TCDB-GTD BOUND TO PA41 FAB
4047, 5vodL, 0.6370, 2.97, 0.043, 221, 92, CRYSTAL STRUCTURE OF HCMV PENTAMER IN COMPLEX WITH NEUTRALIZING ANTIBODY 9I6
4048, 5eziL, 0.6370, 3.18, 0.043, 214, 93, CRYSTAL STRUCTURE OF FAB OF PARASITE INVASION INHIBITORY ANTIBODY C1 - HEXAGONAL FORM
4049, 5bk5C, 0.6370, 3.05, 0.055, 217, 91, CRYSTAL STRUCTURE OF THE ANTI-CIRCUMSPOROZOITE PROTEIN 663 GERMLINE ANTIBODY
4050, 4yhiB, 0.6370, 3.03, 0.065, 219, 93, REVERSAL AGENT FOR DABIGATRAN
4051, 4xgzL, 0.6370, 3.02, 0.065, 209, 92, CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD2 MOTIF IN COMPLEX WITH FAB FRAGMENT
4052, 4xc3L, 0.6370, 3.02, 0.054, 213, 92, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH ITS PEPTIDE EPITOPE ON HIV-1 GP41; CRYSTALS CRYOPROTECTED WITH RAC-GLYCEROL 1- PHOSPHATE
4053, 4xbpB, 0.6370, 2.98, 0.055, 214, 91, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB CRYSTALIZED IN THE PRESENCE OF PHOSPHATIDYLETHANOLAMINE (06:0 PE)
4054, 4rauV, 0.6370, 3.09, 0.054, 212, 92, CRYSTAL STRUCTURE OF RTOFAB IN COMPLEX WITH HUMAN PF4
4055, 4jzoH, 0.6370, 2.97, 0.056, 210, 90, THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING HUMAN ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 FAB FRAGMENT HC84-27
4056, 3wheT, 0.6370, 2.74, 0.090, 212, 89, A NEW CONSERVED NEUTRALIZING EPITOPE AT THE GLOBULAR HEAD OF HEMAGGLUTININ IN H3N2 INFLUENZA VIRUSES
4057, 3piqK, 0.6370, 2.81, 0.090, 208, 89, CRYSTAL STRUCTURE OF HUMAN 2909 FAB A QUATERNARY STRUCTURE-SPECIFIC ANTIBODY AGAINST HIV-1
4058, 5zmjL, 0.6369, 2.75, 0.090, 211, 89, CRYSTAL STRUCTURE OF THE FAB REGION OF A NEUTRALIZING FULLY HUMAN ANTIBODY AGAINST GM-CSF 
4059, 5x8lM, 0.6369, 2.98, 0.066, 213, 91, PD-L1 IN COMPLEX WITH ATEZOLIZUMAB
4060, 5u3lB, 0.6369, 2.96, 0.056, 213, 90, CRYSTAL STRUCTURE OF DH511.2 FAB IN COMPLEX WITH HIV-1 GP41 MPER 670- 683 PEPTIDE
4061, 5e2vL, 0.6369, 2.87, 0.056, 216, 89, ANTI-TAU AT8 FAB WITH DOUBLY PHOSPHORYLATED TAU PEPTIDE
4062, 5d93B, 0.6369, 3.05, 0.054, 212, 92, OXIDOREDUCTASE FRAGMENT OF MOUSE QSOX1 IN COMPLEX WITH A FAB FRAGMENT FROM A MOUSE QSOX1-SPECIFIC ANTIBODY
4063, 5cjqL, 0.6369, 2.71, 0.090, 211, 89, CRYSTAL STRUCTURE OF A TRIMERIC INFLUENZA HEMAGGLUTININ STEM IN COMPLEX WITH AN BROADLY NEUTRALIZING ANTIBODY CR9114
4064, 5c8jF, 0.6369, 2.85, 0.056, 213, 90, A YIDC-LIKE PROTEIN IN THE ARCHAEAL PLASMA MEMBRANE
4065, 4kroC, 0.6369, 2.88, 0.056, 211, 89, NANOBODY/VHH DOMAIN EGA1 IN COMPLEX WITH THE EXTRACELLULAR REGION OF EGFR
4066, 4jhwL, 0.6369, 2.92, 0.056, 211, 89, CRYSTAL STRUCTURE OF RESPIRATORY SYNCYTIAL VIRUS FUSION GLYCOPROTEIN STABILIZED IN THE PREFUSION CONFORMATION BY HUMAN ANTIBODY D25
4067, 3ztjJ, 0.6369, 3.13, 0.065, 216, 92, STRUCTURE OF INFLUENZA A NEUTRALIZING ANTIBODY SELECTED FROM CULTURES OF SINGLE HUMAN PLASMA CELLS IN COMPLEX WITH HUMAN H3 INFLUENZA HAEMAGGLUTININ.
4068, 3t2nL, 0.6369, 2.75, 0.090, 211, 89, HUMAN HEPSIN PROTEASE IN COMPLEX WITH THE FAB FRAGMENT OF AN INHIBITORY ANTIBODY
4069, 3sgdI, 0.6369, 3.00, 0.054, 218, 92, CRYSTAL STRUCTURE OF THE MOUSE MAB 17.2
4070, 3kymE, 0.6369, 2.83, 0.056, 213, 90, CRYSTAL STRUCTURE OF LI33 IGG2 DI-FAB
4071, 3kymC, 0.6369, 2.86, 0.056, 213, 90, CRYSTAL STRUCTURE OF LI33 IGG2 DI-FAB
4072, 3hc3L, 0.6369, 3.11, 0.054, 213, 92, BHA10 IGG1 FAB DOUBLE MUTANT VARIANT - ANTIBODY DIRECTED AT HUMAN LTBR
4073, 2fedD, 0.6369, 2.93, 0.044, 211, 91, STRUCTURE OF THE E203Q MUTANT OF THE CL-/H+ EXCHANGER CLC- EC1 FROM E.COLI
4074, 2ai0L, 0.6369, 3.01, 0.054, 217, 92, ANTI-COCAINE ANTIBODY 7.5.21 CRYSTAL FORM III
4075, 1fe8N, 0.6369, 3.03, 0.055, 211, 91, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A FAB FRAGMENT OF IGG RU5 THAT INHIBITS COLLAGEN BINDING
4076, 6iuvL, 0.6368, 2.97, 0.056, 215, 90, CRYSTAL STRUCTURE OF INFLUENZA A VIRUS H5 HEMAGGLUTININ GLOBULAR HEAD IN COMPLEX WITH THE FAB OF ANTIBODY 3C11 
4077, 5wk3T, 0.6368, 2.99, 0.055, 218, 91, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CCL17 AND M116 FAB
4078, 5nhwL, 0.6368, 2.99, 0.087, 215, 92, CRYSTAL STRUCTURE OF THE BIMAGRUMAB FAB
4079, 5hd8D, 0.6368, 2.89, 0.044, 211, 91, CRYSTAL STRUCTURE OF DISULFIDE CROSS-LINKED D417C CLC-EC1
4080, 5b4mD, 0.6368, 3.04, 0.054, 218, 93, CRYSTAL STRUCTURE OF AN FAB AGAINST HUMAN INFLUENZA A
4081, 4rgmL, 0.6368, 3.00, 0.054, 213, 92, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO THE NEUTRALIZING ANTIBODY 20B1
4082, 4gayB, 0.6368, 3.03, 0.055, 216, 91, STRUCTURE OF THE BROADLY NEUTRALIZING ANTIBODY AP33
4083, 4at6D, 0.6368, 2.72, 0.078, 212, 90, FAB FRAGMENT OF ANTIPORPHYRIN ANTIBODY 14H7
4084, 4am0L, 0.6368, 2.96, 0.044, 212, 91, STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12
4085, 3q6gL, 0.6368, 2.76, 0.090, 209, 89, CRYSTAL STRUCTURE OF FAB OF RHESUS MAB 2.5B SPECIFIC FOR QUATERNARY NEUTRALIZING EPITOPE OF HIV-1 GP120
4086, 3mnzA, 0.6368, 3.03, 0.054, 220, 92, CRYSTAL STRUCTURE OF THE NON-NEUTRALIZING HIV ANTIBODY 13H11 FAB FRAGMENT WITH A GP41 MPER-DERIVED PEPTIDE BEARING ALA SUBSTITUTIONS IN A HELICAL CONFORMATION
4087, 3ixtL, 0.6368, 3.00, 0.066, 211, 91, CRYSTAL STRUCTURE OF MOTAVIZUMAB FAB BOUND TO PEPTIDE EPITOPE
4088, 3hc4L, 0.6368, 3.12, 0.054, 213, 92, BHA10 IGG1 FAB QUADRUPLE MUTANT VARIANT - ANTIBODY DIRECTED AT HUMAN LTBR
4089, 2xqbL, 0.6368, 2.67, 0.056, 202, 89, CRYSTAL STRUCTURE OF ANTI-IL-15 ANTIBODY IN COMPLEX WITH HUMAN IL-15
4090, 1fptL, 0.6368, 3.04, 0.043, 219, 93, THREE-DIMENSIONAL STRUCTURE OF THE COMPLEX BETWEEN THE FAB FRAGMENT OF AN NEUTRALIZING ANTIBODY FOR TYPE 1 POLIOVIRUS AND ITS VIRAL EPITOPE
4091, 1deeB, 0.6368, 2.89, 0.089, 223, 90, CRYSTAL STRUCTURE AT 2.7A RESOLUTION OF A COMPLEX BETWEEN A STAPHYLOCOCCUS AUREUS DOMAIN AND A FAB FRAGMENT OF A HUMAN IGM ANTIBODY
4092, 6bt3A, 0.6367, 3.37, 0.043, 220, 94, HIGH-RESOLUTION STRUCTURE ANALYSIS OF ANTIBODY V5 CONFORMATIONAL EPITOPE ON HUMAN PAPILLOMAVIRUS 16
4093, 6ayzD, 0.6367, 3.04, 0.055, 211, 91, CRYSTAL STRUCTURE OF ASF1-FAB 12E COMPLEX
4094, 5v4eB, 0.6367, 2.79, 0.124, 186, 89, ENGINEERED HUMAN IGG FC DOMAIN GLYCO801 (FC801)
4095, 5nphL, 0.6367, 3.13, 0.054, 214, 93, STRUCTURE OF THE HEPATITIS C VIRUS STRAIN J4 GLYCOPROTEIN E2 ANTIGENIC REGION 532-540 BOUND TO THE FAB FRAGMENT OF THE NON-NEUTRALIZING ANTIBODY DAO5
4096, 4yhpD, 0.6367, 2.76, 0.056, 213, 89, CRYSTAL STRUCTURE OF 309M3-B FAB IN COMPLEX WITH H3K9ME3 PEPTIDE
4097, 4xwoD, 0.6367, 2.87, 0.055, 216, 91, STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF SEC22
4098, 4rauG, 0.6367, 3.10, 0.054, 212, 92, CRYSTAL STRUCTURE OF RTOFAB IN COMPLEX WITH HUMAN PF4
4099, 4kkaD, 0.6367, 2.90, 0.044, 211, 91, STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE AND 20MM BROMIDE
4100, 3piqL, 0.6367, 2.83, 0.090, 209, 89, CRYSTAL STRUCTURE OF HUMAN 2909 FAB A QUATERNARY STRUCTURE-SPECIFIC ANTIBODY AGAINST HIV-1
4101, 2vxtL, 0.6367, 2.84, 0.055, 213, 91, CRYSTAL STRUCTURE OF HUMAN IL-18 COMPLEXED TO MURINE REFERENCE ANTIBODY 125-2H FAB
4102, 2ny0C, 0.6367, 2.98, 0.056, 214, 90, HIV-1 GP120 ENVELOPE GLYCOPROTEIN (M95W W96C T257S V275C S334A S375W A433M) COMPLEXED WITH CD4 AND ANTIBODY 17B
4103, 2a6kL, 0.6367, 2.95, 0.054, 214, 92, CRYSTAL STRUCTURE ANALYSIS OF THE GERMLINE ANTIBODY 36-65 FAB IN COMPLEX WITH THE DODECAPEPTIDE SLGDNLTNHNLR
4104, 1yntC, 0.6367, 3.02, 0.043, 213, 92, STRUCTURE OF THE IMMUNODOMINANT EPITOPE DISPLAYED BY THE SURFACE ANTIGEN 1 (SAG1) OF TOXOPLASMA GONDII COMPLEXED TO A MONOCLONAL ANTIBODY
4105, 1yntA, 0.6367, 3.02, 0.043, 213, 92, STRUCTURE OF THE IMMUNODOMINANT EPITOPE DISPLAYED BY THE SURFACE ANTIGEN 1 (SAG1) OF TOXOPLASMA GONDII COMPLEXED TO A MONOCLONAL ANTIBODY
4106, 1mfbL, 0.6367, 2.81, 0.056, 212, 90, HIGH RESOLUTION STRUCTURES OF ANTIBODY FAB FRAGMENT COMPLEXED WITH CELL-SURFACE OLIGOSACCHARIDE OF PATHOGENIC SALMONELLA
4107, 1gpoM, 0.6367, 2.99, 0.033, 218, 92, CRYSTAL STRUCTURE OF THE RATIONALLY DESIGNED ANTIBODY M41 AS A FAB FRAGMENT
4108, 1gafL, 0.6367, 2.87, 0.055, 214, 91, 48G7 HYBRIDOMA LINE FAB COMPLEXED WITH HAPTEN 5-(PARA- NITROPHENYL PHOSPHONATE)-PENTANOIC ACID
4109, 1c5dB, 0.6367, 3.29, 0.084, 215, 95, THE CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A RAT MONOCLONAL ANTIBODY AGAINST THE MAIN IMMUNOGENIC REGION OF THE HUMAN MUSCLE ACETYLCHOLINE RECEPTOR
4110, 1blnA, 0.6367, 3.03, 0.044, 214, 90, ANTI-P-GLYCOPROTEIN FAB MRK-16
4111, 6r2sA, 0.6366, 3.02, 0.054, 213, 92, THE STRUCTURE OF PLASMODIUM VIVAX DUFFY BINDING PROTEIN (PVDBP) BOUND TO HUMAN ANTIBODY DB9 
4112, 6eljL, 0.6366, 2.94, 0.056, 212, 90, FAB FRAGMENT. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN ANTIBODY DRUG DISCOVERY
4113, 6cdmE, 0.6366, 3.03, 0.054, 218, 92, STRUCTURE OF VACCINE-ELICITED HIV-1 NEUTRALIZING ANTIBODY VFP7.04 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519 
4114, 5xajB, 0.6366, 3.11, 0.054, 214, 93, STRUCTURAL MIMICRY OF THE DENGUE VIRUS ENVELOPE GLYCOPROTEIN REVEALED BY THE CRYSTALLOGRAPHIC STUDY OF AN IDIOTYPE-ANTI-IDIOTYPE FAB COMPLEX.
4115, 5tgbB, 0.6366, 2.90, 0.056, 207, 89, STRUCTURE OF CHIMERIC 02-CB FAB A VRC01-LIKE GERMLINE ANTIBODY
4116, 5muhA, 0.6366, 2.74, 0.090, 194, 89, CRYSTAL STRUCTURE OF AN AMYLOIDOGENIC LIGHT CHAIN DIMER H7
4117, 5h35G, 0.6366, 3.07, 0.054, 217, 92, CRYSTAL STRUCTURES OF THE TRIC TRIMERIC INTRACELLULAR CATION CHANNEL ORTHOLOGUE FROM SULFOLOBUS SOLFATARICUS
4118, 5cckL, 0.6366, 2.76, 0.090, 210, 89, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 BROADLY NEUTRALIZING ANTIBODY 3BC315 FAB
4119, 4xmkN, 0.6366, 2.81, 0.057, 213, 88, CRYSTAL STRUCTURE OF FAB OF HIV-1 GP120 V3-SPECIFIC HUMAN MONOCLONAL ANTIBODY 2424 IN COMPLEX WITH JR-FL V3 PEPTIDE
4120, 4xbpD, 0.6366, 3.01, 0.055, 214, 91, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB CRYSTALIZED IN THE PRESENCE OF PHOSPHATIDYLETHANOLAMINE (06:0 PE)
4121, 4r4nG, 0.6366, 2.71, 0.057, 210, 88, CRYSTAL STRUCTURE OF THE ANTI-HIV-1 ANTIBODY 2.2C IN COMPLEX WITH HIV- 1 93UG037 GP120
4122, 4nquA, 0.6366, 2.94, 0.043, 208, 93, ANTI-PARALLEL FC-KNOB (T366W) HOMODIMER
4123, 3x2dC, 0.6366, 2.69, 0.056, 211, 89, CRYSTAL STRUCTURE OF MARBURG VIRUS GP IN COMPLEX WITH THE HUMAN SURVIVOR ANTIBODY MR78
4124, 3qpqI, 0.6366, 3.01, 0.054, 215, 92, CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB
4125, 2ht4D, 0.6366, 2.91, 0.044, 211, 91, STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445W MUTANT AND FAB COMPLEX
4126, 1uz8L, 0.6366, 2.95, 0.054, 218, 92, ANTI-LEWIS X FAB FRAGMENT IN COMPLEX WITH LEWIS X
4127, 1deeF, 0.6366, 2.89, 0.089, 223, 90, CRYSTAL STRUCTURE AT 2.7A RESOLUTION OF A COMPLEX BETWEEN A STAPHYLOCOCCUS AUREUS DOMAIN AND A FAB FRAGMENT OF A HUMAN IGM ANTIBODY
4128, 1blnC, 0.6366, 3.03, 0.044, 214, 90, ANTI-P-GLYCOPROTEIN FAB MRK-16
4129, 5wk3V, 0.6365, 2.89, 0.056, 216, 89, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CCL17 AND M116 FAB
4130, 5vshF, 0.6365, 2.92, 0.067, 211, 90, CH1/CLAMBDA FAB BASED ON PERTUZUMAB
4131, 5i16L, 0.6365, 2.89, 0.056, 211, 89, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV1-69/IGKV3-11
4132, 4u6hB, 0.6365, 3.09, 0.054, 217, 92, VACCINIA L1/M12B9-FAB COMPLEX
4133, 4rauJ, 0.6365, 3.10, 0.054, 212, 92, CRYSTAL STRUCTURE OF RTOFAB IN COMPLEX WITH HUMAN PF4
4134, 4hiiA, 0.6365, 2.90, 0.067, 212, 89, ANTI-STREPTOCOCCUS PNEUMONIAE 23F FAB 023.102 WITH BOUND RHAMNOSE- GALACTOSE
4135, 4hc1N, 0.6365, 2.95, 0.054, 213, 92, CRYSTAL STRUCTURE OF A LOOP DELETED MUTANT OF HUMAN MADCAM-1 D1D2 COMPLEXED WITH FAB 10G3
4136, 3qegL, 0.6365, 2.98, 0.056, 213, 90, CRYSTAL STRUCTURE OF HUMAN N12-I2 FAB AN ADCC AND NEUTRALIZING ANTI- HIV-1 ENV ANTIBODY
4137, 3j70S, 0.6365, 2.88, 0.056, 210, 90, MODEL OF GP120 INCLUDING VARIABLE REGIONS IN COMPLEX WITH CD4 AND 17B
4138, 3j70N, 0.6365, 2.88, 0.056, 210, 90, MODEL OF GP120 INCLUDING VARIABLE REGIONS IN COMPLEX WITH CD4 AND 17B
4139, 3j70B, 0.6365, 2.88, 0.056, 210, 90, MODEL OF GP120 INCLUDING VARIABLE REGIONS IN COMPLEX WITH CD4 AND 17B
4140, 3j3pL, 0.6365, 3.05, 0.043, 219, 93, CONFORMATIONAL SHIFT OF A MAJOR POLIOVIRUS ANTIGEN CONFIRMED BY IMMUNO-CRYOGENIC ELECTRON MICROSCOPY: 135S POLIOVIRUS AND C3-FAB COMPLEX
4141, 3cm9O, 0.6365, 3.10, 0.065, 214, 93, SOLUTION STRUCTURE OF HUMAN SIGA2
4142, 3cm9M, 0.6365, 3.10, 0.065, 214, 93, SOLUTION STRUCTURE OF HUMAN SIGA2
4143, 2feeO, 0.6365, 2.92, 0.044, 211, 91, STRUCTURE OF THE CL-/H+ EXCHANGER CLC-EC1 FROM E.COLI IN NABR
4144, 1yeiL, 0.6365, 3.14, 0.043, 219, 93, CATALYTIC ANTIBODY D2.3 COMPLEX
4145, 1xf3A, 0.6365, 3.00, 0.055, 213, 91, STRUCTURE OF LIGAND-FREE FAB DNA-1 IN SPACE GROUP P65
4146, 1rfdL, 0.6365, 3.01, 0.054, 218, 92, ANTI-COCAINE ANTIBODY M82G2
4147, 6obdL, 0.6364, 2.78, 0.056, 216, 89, CRYSTAL STRUCTURE OF ANTI-GLD52 FAB COMPLEX WITH HUMAN GLD52 PEPTIDE MIMETIC 
4148, 6mtpB, 0.6364, 3.10, 0.054, 214, 92, CRYSTAL STRUCTURE OF VRC42.04 FAB IN COMPLEX WITH GP41 PEPTIDE 
4149, 6b3mW, 0.6364, 3.09, 0.054, 214, 92, THE CRYSTAL STRUCTURE OF A BROADLY-REACTIVE HUMAN ANTI-HEMAGGLUTININ STALK ANTIBODY (70-1F02) IN COMPLEX WITH H5 HEMAGGLUTININ 
4150, 5yslD, 0.6364, 3.01, 0.055, 213, 91, CRYSTAL STRUCTURE OF ANTIBODY 1H1 FAB
4151, 5whkL, 0.6364, 2.77, 0.090, 212, 89, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTIBODY DX-2507 BOUND TO FCRN- B2M
4152, 5ob5L, 0.6364, 2.81, 0.056, 213, 90, FAB COMPLEX WITH GROBETA. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION-MAKING IN ANTIBODY DRUG DISCOVERY.
4153, 4wffF, 0.6364, 2.90, 0.044, 211, 91, HUMAN TRAAK K+ CHANNEL IN A K+ BOUND NONCONDUCTIVE CONFORMATION
4154, 4wfeF, 0.6364, 2.91, 0.044, 211, 91, HUMAN TRAAK K+ CHANNEL IN A K+ BOUND CONDUCTIVE CONFORMATION
4155, 4r4nK, 0.6364, 2.98, 0.056, 210, 90, CRYSTAL STRUCTURE OF THE ANTI-HIV-1 ANTIBODY 2.2C IN COMPLEX WITH HIV- 1 93UG037 GP120
4156, 4r4fL, 0.6364, 2.72, 0.057, 208, 88, CRYSTAL STRUCTURE OF NON-NEUTRALIZING A32-LIKE ANTIBODY 2.2C IN COMPLEX WITH HIV-1 YU2 GP120
4157, 4pljL, 0.6364, 2.94, 0.055, 212, 91, HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE IV) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12
4158, 4mqxD, 0.6364, 2.91, 0.044, 211, 91, CLC-EC1 FAB COMPLEX CYSLESS A399C-A432C MUTANT
4159, 4m93L, 0.6364, 3.12, 0.054, 218, 93, UNLIGANDED 2 CRYSTAL STRUCTURE OF S25-26 FAB
4160, 4g80B, 0.6364, 2.89, 0.056, 211, 89, CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (WT 3.8 A)
4161, 3d69A, 0.6364, 2.82, 0.067, 211, 90, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF AN ANTI-FACTOR IX ANTIBODY 10C12
4162, 2r1wA, 0.6364, 2.88, 0.055, 216, 91, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
4163, 2hlfD, 0.6364, 2.91, 0.044, 211, 91, STRUCTURE OF THE ESCHERICHIS COLI CLC CHLORIDE CHANNEL Y445E MUTANT AND FAB COMPLEX
4164, 2h9gA, 0.6364, 2.72, 0.057, 211, 88, CRYSTAL STRUCTURE OF PHAGE DERIVED FAB BDF1 WITH HUMAN DEATH RECEPTOR 5 (DR5)
4165, 1yekL, 0.6364, 3.14, 0.043, 219, 93, CATALYTIC ANTIBODY D2.3 COMPLEX
4166, 1qygL, 0.6364, 3.14, 0.054, 218, 93, ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH BENZOYLECGONINE
4167, 1lo4L, 0.6364, 2.98, 0.055, 217, 91, RETRO-DIELS-ALDERASE CATALYTIC ANTIBODY 9D9
4168, 6ncyA, 0.6363, 2.77, 0.033, 585, 91, CRYSTAL STRUCTURE OF HYBRID BETA-GLUCURONIDASE/BETA-GALACTURONIDASE FROM FUSICATENIBACTER SACCHARIVORANS 
4169, 6mtoL, 0.6363, 2.88, 0.056, 212, 89, CRYSTAL STRUCTURE OF VRC42.01 FAB IN COMPLEX WITH T117-F MPER SCAFFOLD 
4170, 6e56I, 0.6363, 2.90, 0.056, 212, 89, HUMAN ANTIBODY H2214 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ A/AICHI/2/1968 (X-31) (H3N2) 
4171, 6d6wA, 0.6363, 2.67, 0.044, 579, 90, BACTEROIDES UNIFORMIS BETA-GLUCURONIDASE 1 BOUND TO GLUCURONATE 
4172, 6d1nA, 0.6363, 2.71, 0.044, 579, 91, APO STRUCTURE OF BACTEROIDES UNIFORMIS BETA-GLUCURONIDASE 1 
4173, 6d0uD, 0.6363, 2.85, 0.056, 213, 90, CRYSTAL STRUCTURE OF C05 V110P/A117E MUTANT BOUND TO H3 INFLUENZA HEMAGGLUTININ; HA1 SUBUNIT 
4174, 6bt3G, 0.6363, 3.45, 0.043, 220, 94, HIGH-RESOLUTION STRUCTURE ANALYSIS OF ANTIBODY V5 CONFORMATIONAL EPITOPE ON HUMAN PAPILLOMAVIRUS 16
4175, 6bt3C, 0.6363, 3.45, 0.043, 220, 94, HIGH-RESOLUTION STRUCTURE ANALYSIS OF ANTIBODY V5 CONFORMATIONAL EPITOPE ON HUMAN PAPILLOMAVIRUS 16
4176, 5yslB, 0.6363, 3.00, 0.055, 213, 91, CRYSTAL STRUCTURE OF ANTIBODY 1H1 FAB
4177, 5x5xL, 0.6363, 2.89, 0.056, 217, 89, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-OSTEOCALCIN C-TERMINAL PEPTIDE ANTIBODY KTM219
4178, 5hbtC, 0.6363, 3.01, 0.043, 212, 92, COMPLEX STRUCTURE OF FAB35 AND HUMAN NACHR ALPHA1
4179, 5fehA, 0.6363, 3.02, 0.054, 212, 92, CRYSTAL STRUCTURE OF PCT64_35B A BROADLY NEUTRALIZING ANTI-HIV ANTIBODY
4180, 4n90E, 0.6363, 2.94, 0.055, 214, 91, CRYSTAL STRUCTURE OF TERNARY COMPLEX OF TRAIL DR5 AND FAB FRAGMENT FROM A DR5 AGONIST ANTIBODY
4181, 4m1gL, 0.6363, 3.11, 0.054, 214, 93, STRUCTURE OF MURINE IGG2A A27D7-FAB IN COMPLEX WITH VACCINIA ANTIGEN A33R AT THE RESOLUTION OF 1.6 ANGSTROMS
4182, 4lssL, 0.6363, 3.24, 0.064, 208, 94, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC01 IN COMPLEX WITH HIV-1 CLADE A STRAIN KER_2018_11 GP120
4183, 3we6B, 0.6363, 3.06, 0.054, 217, 92, CRYSTAL STRUCTURE OF ANTI-PROSTAGLANDIN E2 FAB FRAGMENT
4184, 3u7yL, 0.6363, 3.10, 0.065, 208, 93, STRUCTURE OF NIH45-46 FAB IN COMPLEX WITH GP120 OF 93TH057 HIV
4185, 3pjsA, 0.6363, 3.16, 0.065, 215, 93, MECHANISM OF ACTIVATION GATING IN THE FULL-LENGTH KCSA K+ CHANNEL
4186, 2uylV, 0.6363, 2.88, 0.056, 216, 90, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
4187, 2j6eL, 0.6363, 2.96, 0.077, 213, 91, CRYSTAL STRUCTURE OF AN AUTOIMMUNE COMPLEX BETWEEN A HUMAN IGM RHEUMATOID FACTOR AND IGG1 FC REVEALS A NOVEL FC EPITOPE AND EVIDENCE FOR AFFINITY MATURATION
4188, 1c5dH, 0.6363, 3.26, 0.084, 214, 95, THE CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A RAT MONOCLONAL ANTIBODY AGAINST THE MAIN IMMUNOGENIC REGION OF THE HUMAN MUSCLE ACETYLCHOLINE RECEPTOR
4189, 6mekG, 0.6362, 2.76, 0.079, 212, 89, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
4190, 6mekD, 0.6362, 2.82, 0.056, 213, 90, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
4191, 6d6wC, 0.6362, 2.67, 0.044, 579, 90, BACTEROIDES UNIFORMIS BETA-GLUCURONIDASE 1 BOUND TO GLUCURONATE 
4192, 6bhzL, 0.6362, 2.86, 0.055, 213, 91, TRASTUZUMAB FAB D185A (LIGHT CHAIN) MUTANT.
4193, 5weqA, 0.6362, 2.78, 0.056, 211, 89, THE CRYSTAL STRUCTURE OF A MR78 MUTANT 
4194, 5v4eC, 0.6362, 3.04, 0.110, 162, 91, ENGINEERED HUMAN IGG FC DOMAIN GLYCO801 (FC801)
4195, 5t6pC, 0.6362, 2.82, 0.044, 216, 90, CRYSTAL STRUCTURE OF THERAPEUTIC MAB AR20.5 IN COMPLEX WITH MUC1 PEPTIDE
4196, 5mv4M, 0.6362, 3.01, 0.054, 217, 92, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED CII616-639 EPITOPE OF COLLAGEN TYPE II (PTM23)
4197, 5kn5E, 0.6362, 2.92, 0.056, 216, 89, TGFALPHA/EPIREGULIN COMPLEX WITH NEUTRALIZING ANTIBODY LY3016859
4198, 5dq9L, 0.6362, 2.84, 0.045, 212, 88, STRUCTURE OF S55-3 FAB IN COMPLEX WITH LIPID A
4199, 4rauP, 0.6362, 3.10, 0.054, 212, 92, CRYSTAL STRUCTURE OF RTOFAB IN COMPLEX WITH HUMAN PF4
4200, 4r7nL, 0.6362, 2.91, 0.056, 211, 89, FAB C2E3
4201, 4okvD, 0.6362, 2.97, 0.054, 218, 92, CRYSTAL STRUCTURE OF ANOPHELINE ANTI-PLATELET PROTEIN WITH FAB ANTIBODY
4202, 4odvL, 0.6362, 2.99, 0.055, 214, 91, FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY A6 IN COMPLEX WITH LIPID A CARBOHYDRATE BACKBONE
4203, 4kklD, 0.6362, 2.91, 0.044, 211, 91, STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTA NC CONSTRUCT IN 100MM FLUORIDE
4204, 4kk5D, 0.6362, 2.91, 0.044, 211, 91, STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN 20MM FLUORIDE AND 20MM BROMIDE
4205, 4jdtL, 0.6362, 2.98, 0.055, 206, 91, CRYSTAL STRUCTURE OF CHIMERIC GERM-LINE PRECURSOR OF NIH45-46 FAB IN COMPLEX WITH GP120 OF 93TH057 HIV-1
4206, 4fg6F, 0.6362, 2.91, 0.044, 211, 91, STRUCTURE OF ECCLC E148A MUTANT IN GLUTAMATE
4207, 4bh7A, 0.6362, 2.83, 0.055, 214, 91, CRYSTAL STRUCTURE OF GERMLINE ANTIBODY 36-65 IN COMPLEX WITH PEPTIDE PPYPAWHAPGNI
4208, 3detD, 0.6362, 2.91, 0.044, 211, 91, STRUCTURE OF THE E148A Y445A DOUBLY UNGATED MUTANT OF E.COLI CLC_EC1 CL-/H+ ANTIPORTER
4209, 3cfdA, 0.6362, 2.97, 0.054, 213, 92, PURPLE-FLUORESCENT ANTIBODY EP2-25C10 IN COMPLEX WITH ITS STILBENE HAPTEN
4210, 2xknA, 0.6362, 2.97, 0.055, 213, 91, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE ANTI-EGFR ANTIBODY 7A7
4211, 1v7nN, 0.6362, 2.96, 0.054, 212, 92, HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB
4212, 6h0eD, 0.6361, 2.98, 0.055, 217, 91, FAB DMCBTAU-22.1 IN COMPLEX WITH TAU PEPTIDE V1088-23 
4213, 6dcaL, 0.6361, 2.83, 0.044, 215, 90, FAB/EPITOPE COMPLEX OF MOUSE MONOCLONAL ANTIBODY 6B2 TARGETING A NON- PHOSPHORYLATED TAU EPITOPE. 
4214, 5t4zB, 0.6361, 2.83, 0.079, 210, 89, STRUCTURE OF THE ANTI-HIV ANTIBODY DH501 THAT BINDS GP120 V3 GLYCAN AND THE BASE OF V3 WITH FREE MAN9 GLYCAN
4215, 5o4eC, 0.6361, 3.15, 0.120, 181, 92, CRYSTAL STRUCTURE OF VEGF IN COMPLEX WITH HETERODIMERIC FCAB JANUSCT6
4216, 5albL, 0.6361, 2.76, 0.090, 210, 89, TICAGRELOR ANTIDOTE CANDIDATE MEDI2452 IN COMPLEX WITH TICAGRELOR
4217, 4xcfL, 0.6361, 3.03, 0.054, 214, 92, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH ITS PEPTIDE EPITOPE ON HIV-1 GP41; CRYSTALS CRYOPROTECTED WITH PHOSPHATIDYLCHOLINE (03:0 PC)
4218, 4r7nT, 0.6361, 2.89, 0.056, 211, 89, FAB C2E3
4219, 4nrxE, 0.6361, 2.99, 0.056, 211, 90, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66 IN COMPLEX WITH GP41 MPER PEPTIDE
4220, 3w9dB, 0.6361, 3.00, 0.056, 212, 90, STRUCTURE OF HUMAN MONOCLONAL ANTIBODY E317 FAB
4221, 3u9uD, 0.6361, 3.06, 0.043, 219, 93, CRYSTAL STRUCTURE OF EXTRACELLULAR DOMAIN OF HUMAN ERBB4/HER4 IN COMPLEX WITH THE FAB FRAGMENT OF MAB1479
4222, 3ls4L, 0.6361, 3.10, 0.054, 215, 93, CRYSTAL STRUCTURE OF ANTI-TETRAHYDROCANNABINOL FAB FRAGMENT IN COMPLEX WITH THC
4223, 1nbvL, 0.6361, 3.01, 0.043, 219, 93, AN AUTOANTIBODY TO SINGLE-STRANDED DNA: COMPARISON OF THE THREE-DIMENSIONAL STRUCTURES OF THE UNLIGANDED FAB AND A DEOXYNUCLEOTIDE-FAB COMPLEX
4224, 6bzuD, 0.6360, 3.03, 0.055, 214, 91, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 19B3 
4225, 5wk3P, 0.6360, 2.90, 0.056, 217, 89, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CCL17 AND M116 FAB
4226, 5kn5B, 0.6360, 2.90, 0.056, 216, 89, TGFALPHA/EPIREGULIN COMPLEX WITH NEUTRALIZING ANTIBODY LY3016859
4227, 5k3xB, 0.6360, 3.13, 0.082, 345, 97, CRYSTAL STRUCTURE OF THE SULFITE DEHYDROGENASE SORT R78K MUTANT FROM SINORHIZOBIUM MELILOTI
4228, 5i1iL, 0.6360, 3.03, 0.054, 219, 92, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-53/IGKV4-1
4229, 4r7nD, 0.6360, 2.74, 0.057, 211, 88, FAB C2E3
4230, 4r4nX, 0.6360, 2.91, 0.056, 210, 89, CRYSTAL STRUCTURE OF THE ANTI-HIV-1 ANTIBODY 2.2C IN COMPLEX WITH HIV- 1 93UG037 GP120
4231, 4hijA, 0.6360, 2.89, 0.067, 209, 89, ANTI-STREPTOCOCCUS PNEUMONIAE 23F FAB 023.102 WITH BOUND L-RHAMNOSE- (1-2)-ALPHA-D-GALACTOSE-(3-O)-PHOSPHATE-2-GLYCEROL
4232, 4dz8B, 0.6360, 2.85, 0.054, 205, 92, HUMAN IGG1 FC FRAGMENT HETERODIMER
4233, 3nifF, 0.6360, 3.12, 0.054, 214, 93, THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
4234, 3nidF, 0.6360, 3.11, 0.054, 214, 93, THE CLOSED HEADPIECE OF INTEGRIN ALPHAIIB BETA3 AND ITS COMPLEX WITH AN ALPAHIIB BETA3 -SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
4235, 3haeG, 0.6360, 2.75, 0.090, 211, 89, RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES
4236, 3cmgA, 0.6360, 3.23, 0.099, 661, 101, CRYSTAL STRUCTURE OF PUTATIVE BETA-GALACTOSIDASE FROM BACTEROIDES FRAGILIS
4237, 2vq1A, 0.6360, 2.84, 0.056, 216, 90, ANTI TRIMERIC LEWIS X FAB54-5C10-A
4238, 2uylM, 0.6360, 2.87, 0.056, 216, 90, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
4239, 1lilA, 0.6360, 2.88, 0.066, 212, 91, BENCE JONES PROTEIN CLE A LAMBDA III IMMUNOGLOBULIN LIGHT- CHAIN DIMER
4240, 1kcuL, 0.6360, 3.08, 0.054, 214, 93, CRYSTAL STRUCTURE OF ANTIBODY PC287
4241, 1jn6A, 0.6360, 2.52, 0.057, 206, 87, CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES
4242, 1deeD, 0.6360, 2.90, 0.089, 223, 90, CRYSTAL STRUCTURE AT 2.7A RESOLUTION OF A COMPLEX BETWEEN A STAPHYLOCOCCUS AUREUS DOMAIN AND A FAB FRAGMENT OF A HUMAN IGM ANTIBODY
4243, 5viyI, 0.6359, 3.22, 0.065, 213, 92, BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195
4244, 5viyG, 0.6359, 3.22, 0.065, 212, 92, BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195
4245, 5mv3V, 0.6359, 3.25, 0.064, 218, 94, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
4246, 5mi0C, 0.6359, 3.13, 0.054, 217, 93, A THERMALLY STABILISED VERSION OF PLASMODIUM FALCIPARUM RH5
4247, 5dyoB, 0.6359, 3.02, 0.054, 218, 92, FAB43.1 COMPLEX WITH FLOURESCEIN
4248, 4xwoP, 0.6359, 3.11, 0.054, 216, 93, STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF SEC22
4249, 4xnmL, 0.6359, 2.89, 0.089, 208, 90, ANTIBODY INFLUENZA H5 COMPLEX
4250, 4krpC, 0.6359, 2.90, 0.056, 211, 89, NANOBODY/VHH DOMAIN 9G8 IN COMPLEX WITH THE EXTRACELLULAR REGION OF EGFR
4251, 3vi4L, 0.6359, 2.98, 0.055, 219, 91, CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE IN COMPLEX WITH RGD PEPTIDE
4252, 2ojzL, 0.6359, 3.05, 0.054, 218, 92, ANTI-DNA ANTIBODY ED10
4253, 1d5iL, 0.6359, 2.71, 0.057, 211, 88, UNLIGANDED GERMLINE PRECURSOR OF AN OXY-COPE CATALYTIC ANTIBODY
4254, 6n81D, 0.6358, 2.90, 0.056, 211, 89, CRYSTAL STRUCTURE OF GII.4 2002 NOROVIRUS P DOMAIN IN COMPLEX WITH CROSS-REACTIVE HUMAN ANTIBODY A1227 
4255, 5durD, 0.6358, 2.74, 0.090, 212, 89, INFLUENZA A VIRUS H5 HEMAGGLUTININ GLOBULAR HEAD IN COMPLEX WITH ANTIBODY 100F4
4256, 4rauD, 0.6358, 3.11, 0.054, 212, 92, CRYSTAL STRUCTURE OF RTOFAB IN COMPLEX WITH HUMAN PF4
4257, 4r7nB, 0.6358, 2.91, 0.056, 211, 89, FAB C2E3
4258, 4ocyH, 0.6358, 3.43, 0.021, 210, 95, FAB FOR METHOTREXATE (UNBOUND APO)
4259, 4nztL, 0.6358, 2.87, 0.089, 212, 90, CRYSTAL STRUCTURE OF THE ANTIBODY-BINDING REGION OF PROTEIN M (PROTEIN M TD) IN COMPLEX WITH ANTI-INFLEUNZA HEMAGGLUTININ ANTIBODY CR9114 FAB
4260, 4khtL, 0.6358, 2.80, 0.079, 209, 89, TRIPLE HELIX BUNDLE OF GP41 COMPLEXED WITH FAB 8066
4261, 4gmsN, 0.6358, 3.04, 0.043, 213, 92, CRYSTAL STRUCTURE OF HETEROSUBTYPIC FAB S139/1 IN COMPLEX WITH INFLUENZA A H3 HEMAGGLUTININ
4262, 3qehD, 0.6358, 2.91, 0.056, 215, 90, CRYSTAL STRUCTURE OF HUMAN N12-I15 AN ADCC AND NON-NEUTRALIZING ANTI- HIV-1 ENV ANTIBODY
4263, 3ob0K, 0.6358, 3.04, 0.054, 213, 92, A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY
4264, 3kykL, 0.6358, 2.71, 0.057, 211, 88, CRYSTAL STRUCTURE OF LI33 IGG1 FAB
4265, 3g6aL, 0.6358, 2.78, 0.067, 210, 90, CRYSTAL STRUCTURE OF ANTI-IL-13 ANTIBODY CNTO607
4266, 1igiL, 0.6358, 3.08, 0.054, 218, 92, 26-10 FAB:DIGOXIN COMPLEX-AFFINITY AND SPECIFICITY DUE TO SURFACE COMPLEMENTARITY
4267, 1a3lL, 0.6358, 3.00, 0.055, 217, 91, CATALYSIS OF A DISFAVORED REACTION: AN ANTIBODY EXO DIELS- ALDERASE-TSA-INHIBITOR COMPLEX AT 1.95 A RESOLUTION
4268, 6me1D, 0.6357, 2.81, 0.056, 212, 89, CRYSTAL STRUCTURE OF THE CLADE B ISOLATE B41 MUTANT FUSION PEPTIDE (RESIDUES 512-521) IN COMPLEX WITH VRC34.01 
4269, 6didH, 0.6357, 2.78, 0.067, 217, 90, HIV ENV BG505 SOSIP WITH POLYCLONAL FABS FROM IMMUNIZED RABBIT  3417 POST-BOOST 1 
4270, 6didE, 0.6357, 2.78, 0.067, 217, 90, HIV ENV BG505 SOSIP WITH POLYCLONAL FABS FROM IMMUNIZED RABBIT  3417 POST-BOOST 1 
4271, 6didC, 0.6357, 2.78, 0.067, 217, 90, HIV ENV BG505 SOSIP WITH POLYCLONAL FABS FROM IMMUNIZED RABBIT  3417 POST-BOOST 1 
4272, 5y11B, 0.6357, 3.07, 0.054, 215, 92, SFTSV GN WITH NEUTRALIZING ANTIBODY MAB4-5
4273, 5m5eB, 0.6357, 3.07, 0.067, 203, 90, CRYSTAL STRUCTURE OF A INTERLEUKIN-2 VARIANT IN COMPLEX WITH INTERLEUKIN-2 RECEPTOR
4274, 5j3dL, 0.6357, 3.05, 0.054, 215, 92, CRYSTAL STRUCTURE OF HUMAN FAB 14N4 IN COMPLEX WITH POST-FUSION RSV F
4275, 5ifhL, 0.6357, 2.82, 0.089, 211, 90, CRYSTAL STRUCTURE OF THE BCR FAB FRAGMENT FROM SUBSET  2 CASE P11475
4276, 4yhpL, 0.6357, 2.98, 0.056, 213, 90, CRYSTAL STRUCTURE OF 309M3-B FAB IN COMPLEX WITH H3K9ME3 PEPTIDE
4277, 4q7dA, 0.6357, 3.10, 0.121, 207, 91, WILD TYPE FC (WTFC)
4278, 4lriB, 0.6357, 3.04, 0.055, 217, 91, ANTI CMV FAB FRAGMENT
4279, 4leoB, 0.6357, 3.07, 0.054, 219, 92, CRYSTAL STRUCTURE OF ANTI-HER3 FAB RG7116 IN COMPLEX WITH THE EXTRACELLULAR DOMAINS OF HUMAN HER3 (ERBB3)
4280, 4jhaL, 0.6357, 2.90, 0.056, 211, 89, CRYSTAL STRUCTURE OF RSV-NEUTRALIZING HUMAN ANTIBODY D25
4281, 4g7yL, 0.6357, 2.70, 0.057, 211, 88, CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (R217E 2.8 A)
4282, 4cadD, 0.6357, 3.00, 0.044, 211, 91, MECHANISM OF FARNESYLATED CAAX PROTEIN PROCESSING BY THE INTEGRAL MEMBRANE PROTEASE RCE1
4283, 3vi3E, 0.6357, 3.02, 0.054, 219, 92, CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE (LIGAND-FREE FORM)
4284, 3ngbK, 0.6357, 3.13, 0.065, 210, 93, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC01 IN COMPLEX WITH HIV-1 GP120
4285, 3kj6L, 0.6357, 3.13, 0.053, 214, 94, CRYSTAL STRUCTURE OF A METHYLATED BETA2 ADRENERGIC RECEPTOR- FAB COMPLEX
4286, 3iu3D, 0.6357, 3.05, 0.055, 209, 91, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THERAPEUTIC ANTIBODY BASILIXIMAB IN COMPLEX WITH IL-2RA (CD25) ECTODOMAIN
4287, 1tqbC, 0.6357, 3.12, 0.054, 219, 93, OVINE RECOMBINANT PRP(114-234) VRQ VARIANT IN COMPLEX WITH THE FAB OF THE VRQ14 ANTIBODY
4288, 1t4kC, 0.6357, 3.03, 0.054, 217, 92, CRYSTAL STRUCTURE OF UNLIGANDED ALDOLASE ANTIBODY 93F3 FAB
4289, 1mrfL, 0.6357, 2.93, 0.033, 216, 90, PREPARATION CHARACTERIZATION AND CRYSTALLIZATION OF AN ANTIBODY FAB FRAGMENT THAT RECOGNIZES RNA. CRYSTAL STRUCTURES OF NATIVE FAB AND THREE FAB-MONONUCLEOTIDE COMPLEXES
4290, 1f6aB, 0.6357, 3.18, 0.091, 217, 99, STRUCTURE OF THE HUMAN IGE-FC BOUND TO ITS HIGH AFFINITY RECEPTOR FC(EPSILON)RI(ALPHA)
4291, 1b6dB, 0.6357, 2.92, 0.044, 212, 90, BENCE JONES PROTEIN DEL: AN ENTIRE IMMUNOGLOBULIN KAPPA LIGHT-CHAIN DIMER
4292, 6ev1D, 0.6356, 2.71, 0.057, 210, 88, CRYSTAL STRUCTURE OF ANTIBODY AGAINST SCHIZOPHYLLAN 
4293, 6cxyL, 0.6356, 2.87, 0.056, 217, 90, CRYSTAL STRUCTURE OF HUMAN E-CADHERIN BOUND BY MOUSE MONOCLONAL ANTIBODY FAB MAB-1_19A11 
4294, 6cjkC, 0.6356, 2.78, 0.067, 217, 90, ANTI HIV FAB 10A 
4295, 5xhgC, 0.6356, 3.11, 0.054, 214, 93, CRYSTAL STRUCTURE OF TRASTUZUMAB FAB FRAGMENT BEARING NE-(O- AZIDOBENZYLOXYCARBONYL)-L-LYSINE
4296, 5w5zL, 0.6356, 3.04, 0.043, 212, 92, CRYSTAL STRUCTURE OF BAXP168G IN COMPLEX WITH AN ACTIVATING ANTIBODY AT HIGH RESOLUTION 
4297, 5w38B, 0.6356, 3.00, 0.053, 209, 95, 1.80A RESOLUTION STRUCTURE OF HUMAN IGG3 FC (N392K)
4298, 5fuzL, 0.6356, 3.04, 0.054, 216, 92, EXTENDING THE HALF-LIFE OF A FAB FRAGMENT THROUGH GENERATION OF A HUMANISED ANTI-HUMAN SERUM ALBUMIN (HSA) FV DOMAIN: AN INVESTIGATION INTO THE CORRELATION BETWEEN AFFINITY AND SERUM HALF-LIFE
4299, 5d8jL, 0.6356, 2.97, 0.055, 214, 91, DEVELOPMENT OF A THERAPEUTIC MONOCLONAL ANTIBODY TARGETING SECRETED AP2 TO TREAT TYPE 2 DIABETES.
4300, 4zxbB, 0.6356, 2.94, 0.054, 218, 92, STRUCTURE OF THE HUMAN INSULIN RECEPTOR ECTODOMAIN IRDELTABETA CONSTRUCT IN COMPLEX WITH FOUR FAB MOLECULES
4301, 4xbeL, 0.6356, 3.03, 0.054, 214, 92, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH ITS PEPTIDE EPITOPE ON HIV-1 GP41: CRYSTALS CRYOPROTECTED WITH SPHINGOMYELIN (02:0 SM (D18:1/2:0)).
4302, 4tujD, 0.6356, 2.93, 0.056, 217, 90, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY AGAINST NEUROBLASTOMA ASSOCIATED ANTIGEN.
4303, 4rfeB, 0.6356, 2.76, 0.090, 210, 89, CRYSTAL STRUCTURE OF ADCC-POTENT ANTI-HIV-1 RHESUS MACAQUE ANTIBODY JR4 FAB
4304, 4r7dL, 0.6356, 2.70, 0.057, 211, 88, FAB HU 15C1
4305, 4r4nU, 0.6356, 2.73, 0.057, 210, 88, CRYSTAL STRUCTURE OF THE ANTI-HIV-1 ANTIBODY 2.2C IN COMPLEX WITH HIV- 1 93UG037 GP120
4306, 4fp8L, 0.6356, 3.01, 0.065, 213, 92, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ HA1 SUBUNIT
4307, 3t2nM, 0.6356, 2.80, 0.067, 212, 90, HUMAN HEPSIN PROTEASE IN COMPLEX WITH THE FAB FRAGMENT OF AN INHIBITORY ANTIBODY
4308, 3o2dL, 0.6356, 2.71, 0.057, 216, 88, CRYSTAL STRUCTURE OF HIV-1 PRIMARY RECEPTOR CD4 IN COMPLEX WITH A POTENT ANTIVIRAL ANTIBODY
4309, 3cfbL, 0.6356, 3.15, 0.054, 218, 93, HIGH-RESOLUTION STRUCTURE OF BLUE FLUORESCENT ANTIBODY EP2-19G2 IN COMPLEX WITH STILBENE HAPTEN AT 100K
4310, 2gk0L, 0.6356, 2.96, 0.055, 217, 91, STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 13G5 FROM A TWINNED CRYSTAL IN SPACE GROUP C2
4311, 6eyoB, 0.6355, 3.27, 0.090, 309, 100, STRUCTURE OF EXTENDED IGE-FC IN COMPLEX WITH TWO ANTI-IGE FABS 
4312, 5ikcA, 0.6355, 2.97, 0.054, 213, 92, X-RAY STRUCTURE OF THE N-TERMINAL DOMAIN OF HUMAN DOUBLECORTIN IN COMPLEX WITH FAB
4313, 4xnqL, 0.6355, 2.88, 0.089, 208, 90, ANTIBODY HEMAGGLUTININ COMPLEXES
4314, 4xawL, 0.6355, 3.03, 0.054, 214, 92, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH ITS PEPTIDE EPITOPE ON HIV-1 GP41: CRYSTALS CRYOPROTECTED WITH PHOSPHATIDIC ACID (08:0 PA)
4315, 4r4nD, 0.6355, 2.99, 0.056, 210, 90, CRYSTAL STRUCTURE OF THE ANTI-HIV-1 ANTIBODY 2.2C IN COMPLEX WITH HIV- 1 93UG037 GP120
4316, 4jm2C, 0.6355, 2.80, 0.056, 214, 90, CRYSTAL STRUCTURE OF PGT 135 FAB IN COMPLEX WITH GP120 CORE PROTEIN FROM HIV-1 STRAIN JR-FL BOUND TO CD4 AND 17B FAB
4317, 4j1uE, 0.6355, 2.91, 0.056, 214, 90, CRYSTAL STRUCTURE OF ANTIBODY 93F3 UNSTABLE VARIANT
4318, 4dn3L, 0.6355, 2.89, 0.056, 214, 90, CRYSTAL STRUCTURE OF ANTI-MCP-1 ANTIBODY CNTO888
4319, 3wifB, 0.6355, 3.06, 0.055, 216, 91, CRYSTAL STRUCTURE OF ANTI-PROSTAGLANDIN E2 FAB FRAGMENT 9CL-PGF2BETA COMPLEX
4320, 3t3pF, 0.6355, 3.23, 0.053, 214, 94, A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
4321, 3mxwL, 0.6355, 2.79, 0.056, 212, 89, CRYSTAL STRUCTURE SONIC HEDGEHOG BOUND TO THE 5E1 FAB FRAGMENT
4322, 2uylX, 0.6355, 2.87, 0.056, 216, 90, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
4323, 2fjfJ, 0.6355, 2.90, 0.056, 211, 89, STRUCTURE OF THE G6 FAB A PHAGE DERIVED VEGF BINDING FAB
4324, 2fjfC, 0.6355, 2.98, 0.056, 211, 90, STRUCTURE OF THE G6 FAB A PHAGE DERIVED VEGF BINDING FAB
4325, 6dwiG, 0.6354, 2.74, 0.057, 211, 88, STRUCTURE OF THE 4462 ANTIBODY FAB FRAGMENT BOUND TO A STAPHYLOCOCCUS AUREUS WALL TECHOIC ACID ANALOG 
4326, 6d1nB, 0.6354, 2.71, 0.055, 579, 91, APO STRUCTURE OF BACTEROIDES UNIFORMIS BETA-GLUCURONIDASE 1 
4327, 5w23N, 0.6354, 2.90, 0.044, 215, 90, CRYSTAL STRUCTURE OF RSV F IN COMPLEX WITH 5C4 FAB
4328, 5uddT, 0.6354, 2.74, 0.057, 211, 88, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
4329, 4zypO, 0.6354, 3.03, 0.066, 211, 91, CRYSTAL STRUCTURE OF MOTAVIZUMAB AND QUATERNARY-SPECIFIC RSV- NEUTRALIZING HUMAN ANTIBODY AM14 IN COMPLEX WITH PREFUSION RSV F GLYCOPROTEIN
4330, 4whtJ, 0.6354, 2.95, 0.044, 215, 90, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11 P1 CRYSTAL FORM
4331, 4pozD, 0.6354, 3.43, 0.031, 215, 96, FAB FRAGMENT OF DER P 1 SPECIFIC ANTIBODY 10B9
4332, 4imlA, 0.6354, 3.06, 0.044, 234, 91, CROSSFAB BINDING TO HUMAN ANGIOPOIETIN 2
4333, 3piqF, 0.6354, 2.83, 0.090, 208, 89, CRYSTAL STRUCTURE OF HUMAN 2909 FAB A QUATERNARY STRUCTURE-SPECIFIC ANTIBODY AGAINST HIV-1
4334, 3o2vL, 0.6354, 3.04, 0.054, 218, 92, CRYSTAL STRUCTURE OF 1E9 PHEL89SER/LEUH47TRP/METH100BPHE AN ENGINEERED DIELS-ALDERASE FAB WITH MODIFIED SPECIFICITY AND CATALYTIC ACTIVITY
4335, 3nfpL, 0.6354, 2.90, 0.055, 212, 91, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THERAPEUTIC ANTIBODY DACLIZUMAB IN COMPLEX WITH IL-2RA (CD25) ECTODOMAIN
4336, 2h2pF, 0.6354, 3.13, 0.054, 211, 92, CRYSTAL STRUCTURE OF CLC-EC1 IN COMPLEX WITH FAB FRAGMENT IN SECN-
4337, 1mexL, 0.6354, 3.04, 0.054, 213, 92, ANTIBODY CATALYSIS OF A BIMOLECULAR CYCLOADDITION REACTION
4338, 6mlkL, 0.6353, 2.73, 0.057, 217, 88, STRUCTURE OF THIOESTERASE FROM DEBS WITH A THIOESTERASE-SPECIFIC ANTIBODY 
4339, 6e5pT, 0.6353, 3.06, 0.054, 212, 92, BACKBONE MODEL BASED ON CRYO-EM MAP AT 8.5 A OF DOMAIN-SWAPPED; GLYCAN-REACTIVE; NEUTRALIZING ANTIBODY 2G12 BOUND TO HIV-1 ENV BG505 DS-SOSIP; WHICH WAS ALSO BOUND TO CD4-BINDING SITE ANTIBODY VRC03 
4340, 6e5pL, 0.6353, 3.06, 0.054, 212, 92, BACKBONE MODEL BASED ON CRYO-EM MAP AT 8.5 A OF DOMAIN-SWAPPED; GLYCAN-REACTIVE; NEUTRALIZING ANTIBODY 2G12 BOUND TO HIV-1 ENV BG505 DS-SOSIP; WHICH WAS ALSO BOUND TO CD4-BINDING SITE ANTIBODY VRC03 
4341, 6e5p4, 0.6353, 3.06, 0.054, 212, 92, BACKBONE MODEL BASED ON CRYO-EM MAP AT 8.5 A OF DOMAIN-SWAPPED; GLYCAN-REACTIVE; NEUTRALIZING ANTIBODY 2G12 BOUND TO HIV-1 ENV BG505 DS-SOSIP; WHICH WAS ALSO BOUND TO CD4-BINDING SITE ANTIBODY VRC03 
4342, 5vjqD, 0.6353, 3.02, 0.054, 213, 92, COMPLEX BETWEEN HYHEL10 FAB FRAGMENT HEAVY CHAIN MUTANT (I29F; S52T; Y53F) AND PEKIN DUCK EGG LYSOZYME ISOFORM I (DEL-I) 
4343, 5v6lL, 0.6353, 2.71, 0.067, 215, 90, CRYSTAL STRUCTURE OF RABBIT ANTI-HIV-1 GP120 V3 FAB 10A37 IN COMPLEX WITH V3 PEPTIDE JR-FL
4344, 5udcL, 0.6353, 2.99, 0.056, 211, 90, CRYSTAL STRUCTURE OF RSV F A2 BOUND TO MEDI8897
4345, 5jqdA, 0.6353, 2.99, 0.055, 214, 91, ANTIBODY FAB FRAGMENT
4346, 5i8cB, 0.6353, 2.81, 0.056, 212, 89, CRYSTAL STRUCTURE OF HIV-1 CLADE A BG505 FUSION PEPTIDE (RESIDUE 512- 520) IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODY VRC34.01 FAB
4347, 4jpvL, 0.6353, 2.86, 0.056, 204, 90, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY 3BNC117 IN COMPLEX WITH HIV-1 GP120
4348, 4g80H, 0.6353, 2.72, 0.057, 211, 88, CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (WT 3.8 A)
4349, 4g80F, 0.6353, 2.90, 0.056, 211, 89, CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (WT 3.8 A)
4350, 3bpcA, 0.6353, 3.01, 0.054, 216, 92, CO-CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH 5-DEOXY-4- EPI-23-DEHYDRO KDO (4.8) KDO
4351, 2y6sC, 0.6353, 3.02, 0.043, 217, 92, STRUCTURE OF AN EBOLAVIRUS-PROTECTIVE ANTIBODY IN COMPLEX WITH ITS MUCIN-DOMAIN LINEAR EPITOPE
4352, 2h9gL, 0.6353, 2.73, 0.057, 211, 88, CRYSTAL STRUCTURE OF PHAGE DERIVED FAB BDF1 WITH HUMAN DEATH RECEPTOR 5 (DR5)
4353, 2bmkA, 0.6353, 3.23, 0.043, 213, 94, FAB FRAGMENT OF PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH PHOSPHOPYRIDOXYL-D-ALANINE
4354, 1op5L, 0.6353, 3.06, 0.054, 212, 92, CRYSTAL STRUCTURE OF FAB 2G12 BOUND TO MAN9GLCNAC2
4355, 1igyA, 0.6353, 3.16, 0.053, 213, 94, STRUCTURE OF IMMUNOGLOBULIN
4356, 1fvdA, 0.6353, 3.07, 0.065, 214, 93, X-RAY STRUCTURES OF THE ANTIGEN-BINDING DOMAINS FROM THREE VARIANTS OF HUMANIZED ANTI-P185-HER2 ANTIBODY 4D5 AND COMPARISON WITH MOLECULAR MODELING
4357, 6n81L, 0.6352, 2.91, 0.056, 211, 89, CRYSTAL STRUCTURE OF GII.4 2002 NOROVIRUS P DOMAIN IN COMPLEX WITH CROSS-REACTIVE HUMAN ANTIBODY A1227 
4358, 6bpcC, 0.6352, 2.91, 0.044, 212, 91, PLASMODIUM VIVAX RETICULOCYTE BINDING PROTEIN 2B (PVRBP2B) BOUND TO MONOCLONAL ANTIBODY 4F7 
4359, 6bckL, 0.6352, 2.79, 0.090, 199, 89, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY N49P7 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057 GP120 CORE. 
4360, 5kzpI, 0.6352, 3.18, 0.065, 212, 92, STRUCTURE OF THE HCV1-C1 ANTIBODY-ANTIGEN COMPLEX
4361, 5esaB, 0.6352, 3.00, 0.043, 212, 92, CRYSTAL STRUCTURE OF ANTI-HCV E2 ANTIBODY HC84-26
4362, 4xrcL, 0.6352, 2.88, 0.089, 208, 90, ANTIBODY HEMAGGLUTININ COMPLEXES
4363, 4lriA, 0.6352, 3.01, 0.055, 217, 91, ANTI CMV FAB FRAGMENT
4364, 4g6aH, 0.6352, 3.40, 0.031, 221, 96, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY AP33
4365, 3qwoB, 0.6352, 2.95, 0.056, 210, 90, CRYSTAL STRUCTURE OF A MOTAVIZUMAB EPITOPE-SCAFFOLD BOUND TO MOTAVIZUMAB FAB
4366, 2y6sL, 0.6352, 3.02, 0.043, 217, 92, STRUCTURE OF AN EBOLAVIRUS-PROTECTIVE ANTIBODY IN COMPLEX WITH ITS MUCIN-DOMAIN LINEAR EPITOPE
4367, 2htlD, 0.6352, 2.91, 0.044, 211, 91, STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445F MUTANT AND FAB COMPLEX
4368, 25c8L, 0.6352, 2.96, 0.056, 212, 89, CATALYTIC ANTIBODY 5C8 FAB-HAPTEN COMPLEX
4369, 6okqB, 0.6351, 2.79, 0.056, 210, 90, CRYSTAL STRUCTURE OF THE SF12 FAB 
4370, 5vjqH, 0.6351, 2.91, 0.055, 212, 91, COMPLEX BETWEEN HYHEL10 FAB FRAGMENT HEAVY CHAIN MUTANT (I29F; S52T; Y53F) AND PEKIN DUCK EGG LYSOZYME ISOFORM I (DEL-I) 
4371, 5i15L, 0.6351, 2.86, 0.055, 214, 91, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV1-69/IGKV1-39
4372, 5hdbF, 0.6351, 3.24, 0.053, 214, 94, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH RO-435054
4373, 5ggrB, 0.6351, 2.84, 0.056, 212, 90, PD-1 IN COMPLEX WITH NIVOLUMAB FAB
4374, 5c8jH, 0.6351, 2.88, 0.056, 213, 90, A YIDC-LIKE PROTEIN IN THE ARCHAEAL PLASMA MEMBRANE
4375, 5c0nL, 0.6351, 2.96, 0.056, 216, 90, DEVELOPMENT OF A MONOCLONAL ANTIBODY TARGETING SECRETED AP2 TO TREAT DIABETES AND FATTY LIVER DISEASE
4376, 5anmG, 0.6351, 3.06, 0.022, 211, 92, CRYSTAL STRUCTURE OF IGE FC IN COMPLEX WITH A NEUTRALIZING ANTIBODY
4377, 4zypL, 0.6351, 2.82, 0.056, 211, 89, CRYSTAL STRUCTURE OF MOTAVIZUMAB AND QUATERNARY-SPECIFIC RSV- NEUTRALIZING HUMAN ANTIBODY AM14 IN COMPLEX WITH PREFUSION RSV F GLYCOPROTEIN
4378, 4wfgD, 0.6351, 2.93, 0.044, 211, 91, HUMAN TRAAK K+ CHANNEL IN A TL+ BOUND CONDUCTIVE CONFORMATION
4379, 4kk6D, 0.6351, 2.90, 0.044, 211, 91, STRUCTURE OF CLC-EC1 DELTANC CONSTRUCT IN 20MM BROMIDE
4380, 4cadA, 0.6351, 2.99, 0.044, 211, 91, MECHANISM OF FARNESYLATED CAAX PROTEIN PROCESSING BY THE INTEGRAL MEMBRANE PROTEASE RCE1
4381, 3f8uB, 0.6351, 3.32, 0.064, 361, 94, TAPASIN/ERP57 HETERODIMER
4382, 3baeL, 0.6351, 3.07, 0.054, 218, 92, CRYSTAL STRUCTURE OF FAB WO2 BOUND TO THE N TERMINAL DOMAIN OF AMYLOID BETA PEPTIDE (1-28)
4383, 2fjfE, 0.6351, 2.94, 0.056, 211, 90, STRUCTURE OF THE G6 FAB A PHAGE DERIVED VEGF BINDING FAB
4384, 6d89D, 0.6350, 2.66, 0.044, 571, 90, BACTEROIDES UNIFORMIS BETA-GLUCURONIDASE 1 WITH N-TERMINAL LOOP DELETION 
4385, 6bzyL, 0.6350, 2.76, 0.056, 215, 89, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE 22D11 BROADLY NEUTRALIZING ANTIBODY 
4386, 6aniL, 0.6350, 3.08, 0.055, 210, 91, COLTUXIMAB FAB IN COMPLEX WITH ANTI-KAPPA VHH DOMAIN
4387, 5vcoA, 0.6350, 3.06, 0.055, 211, 91, THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 10B9
4388, 5fylL, 0.6350, 2.82, 0.067, 210, 90, CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122 AND 35O22
4389, 5f9wL, 0.6350, 2.91, 0.056, 210, 89, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING VH1-46 GERMLINE-DERIVED CD4- BINDING SITE-DIRECTED ANTIBODY CH235 IN COMPLEX WITH HIV-1 CLADE A/E 93TH057 GP120
4390, 5bk3B, 0.6350, 2.72, 0.057, 217, 88, CRYSTAL STRUCTURE OF THE NEUTRALIZING ANTI-CIRCUMSPOROZOITE PROTEIN 580 ANTIBODY
4391, 4pp2A, 0.6350, 3.06, 0.055, 211, 91, THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 10B9
4392, 4npyA, 0.6350, 2.76, 0.090, 211, 89, CRYSTAL STRUCTURE OF GERMLINE FAB PGT121 A PUTATIVE PRECURSOR OF THE BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
4393, 3piqD, 0.6350, 2.85, 0.090, 208, 89, CRYSTAL STRUCTURE OF HUMAN 2909 FAB A QUATERNARY STRUCTURE-SPECIFIC ANTIBODY AGAINST HIV-1
4394, 3c5sA, 0.6350, 3.04, 0.043, 218, 92, CRYSTAL STRUCTURE OF MONOCLONAL FAB F22-4 SPECIFIC FOR SHIGELLA FLEXNERI 2A O-AG
4395, 2fecL, 0.6350, 2.96, 0.044, 211, 91, STRUCTURE OF THE E203Q MUTANT OF THE CL-/H+ EXCHANGER CLC- EC1 FROM E.COLI
4396, 1ogpF, 0.6350, 3.07, 0.043, 388, 94, THE CRYSTAL STRUCTURE OF PLANT SULFITE OXIDASE PROVIDES INSIGHT INTO SULFITE OXIDATION IN PLANTS AND ANIMALS
4397, 1mfcL, 0.6350, 2.83, 0.056, 212, 90, HIGH RESOLUTION STRUCTURES OF ANTIBODY FAB FRAGMENT COMPLEXED WITH CELL-SURFACE OLIGOSACCHARIDE OF PATHOGENIC SALMONELLA
4398, 1fn4C, 0.6350, 3.04, 0.022, 211, 92, CRYSTAL STRUCTURE OF FAB198 AN EFFICIENT PROTECTOR OF ACETYLCHOLINE RECEPTOR AGAINST MYASTHENOGENIC ANTIBODIES
4399, 1egjL, 0.6350, 3.02, 0.055, 215, 91, DOMAIN 4 OF THE BETA COMMON CHAIN IN COMPLEX WITH AN ANTIBODY
4400, 6okqC, 0.6349, 2.80, 0.056, 210, 90, CRYSTAL STRUCTURE OF THE SF12 FAB 
4401, 5xxyL, 0.6349, 2.96, 0.056, 211, 90, COMPLEX STRUCTURE OF PD-L1 WITH ATEZOLIZUMAB FAB
4402, 4nylD, 0.6349, 2.70, 0.057, 211, 88, CRYSTAL STRUCTURE OF ADALIMUMAB FAB FRAGMENT
4403, 4k3jL, 0.6349, 3.06, 0.067, 217, 90, CRYSTAL STRUCTURE OF ONARTUZUMAB FAB IN COMPLEX WITH MET AND HGF-BETA
4404, 4i9wD, 0.6349, 2.93, 0.044, 211, 91, HUMAN TWO PORE DOMAIN K+ CHANNEL TRAAK (K2P4.1) - FAB COMPLEX STRUCTURE
4405, 4hk0B, 0.6349, 2.76, 0.090, 210, 89, UCA FAB (UNBOUND) FROM CH65-CH67 LINEAGE
4406, 3qehB, 0.6349, 2.94, 0.056, 215, 90, CRYSTAL STRUCTURE OF HUMAN N12-I15 AN ADCC AND NON-NEUTRALIZING ANTI- HIV-1 ENV ANTIBODY
4407, 3piqI, 0.6349, 2.83, 0.090, 208, 89, CRYSTAL STRUCTURE OF HUMAN 2909 FAB A QUATERNARY STRUCTURE-SPECIFIC ANTIBODY AGAINST HIV-1
4408, 6eyoA, 0.6348, 3.28, 0.090, 307, 100, STRUCTURE OF EXTENDED IGE-FC IN COMPLEX WITH TWO ANTI-IGE FABS 
4409, 6bitL, 0.6348, 3.08, 0.055, 210, 91, SIRPALPHA ANTIBODY COMPLEX
4410, 5iesL, 0.6348, 2.81, 0.056, 206, 89, CRYSTAL STRUCTURE OF VRC01C-HUGL2 FAB FROM AN HIV-1 NAIVE DONOR IN COMPLEX WITH WITH A GERMLINE-TARGETING GP120 ENGINEERED OUTER DOMAIN EOD-GT8 AT 2.16 A
4411, 5b4mL, 0.6348, 3.05, 0.054, 218, 93, CRYSTAL STRUCTURE OF AN FAB AGAINST HUMAN INFLUENZA A
4412, 5aumL, 0.6348, 2.91, 0.044, 216, 90, CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH THE LIGAND PEPTIDE
4413, 4ojfL, 0.6348, 2.88, 0.055, 219, 91, HUMANISED 3D6 FAB COMPLEXED TO AMYLOID BETA 1-8
4414, 4m43L, 0.6348, 3.00, 0.055, 213, 91, CRYSTAL STRUCTURE OF ANTI-RABIES GLYCOPROTEIN FAB 523-11
4415, 4kjwD, 0.6348, 2.93, 0.044, 211, 91, STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE AND 20MM BROMIDE
4416, 4g80D, 0.6348, 2.71, 0.057, 211, 88, CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (WT 3.8 A)
4417, 3c6sG, 0.6348, 3.06, 0.055, 216, 91, CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A SHIGELLA FLEXNERI 2A O-AG PENTADECASACCHARIDE
4418, 35c8L, 0.6348, 3.00, 0.056, 212, 90, CATALYTIC ANTIBODY 5C8 FAB-INHIBITOR COMPLEX
4419, 2htkF, 0.6348, 2.94, 0.044, 211, 91, STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445A MUTANT AND FAB COMPLEX
4420, 2fedF, 0.6348, 2.96, 0.044, 211, 91, STRUCTURE OF THE E203Q MUTANT OF THE CL-/H+ EXCHANGER CLC- EC1 FROM E.COLI
4421, 1ncbL, 0.6348, 2.86, 0.044, 214, 91, CRYSTAL STRUCTURES OF TWO MUTANT NEURAMINIDASE-ANTIBODY COMPLEXES WITH AMINO ACID SUBSTITUTIONS IN THE INTERFACE
4422, 6ed2A, 0.6347, 2.71, 0.056, 591, 89, FAECALIBACTERIUM PRAUSNITZII BETA-GLUCURONIDASE 
4423, 5xbmD, 0.6347, 3.10, 0.054, 209, 92, STRUCTURE OF SCARB2-JL2 COMPLEX 
4424, 5w1mC, 0.6347, 2.89, 0.055, 221, 91, MACV GP1 CR1-07 FAB COMPLEX 
4425, 5uqyC, 0.6347, 2.77, 0.056, 210, 89, CRYSTAL STRUCTURE OF MARBURG VIRUS GP IN COMPLEX WITH THE HUMAN SURVIVOR ANTIBODY MR78
4426, 5tppL, 0.6347, 2.70, 0.067, 212, 90, CRYSTAL STRUCTURE OF DH270.5 (UNLIGANDED) FROM THE DH270 BROADLY NEUTRALIZING N332-GLYCAN DEPENDENT LINEAGE
4427, 5mtlC, 0.6347, 2.80, 0.090, 206, 89, CRYSTAL STRUCTURE OF AN AMYLOIDOGENIC LIGHT CHAIN
4428, 5hsfB, 0.6347, 3.01, 0.121, 108, 91, 1.52 ANGSTROM CRYSTAL STRUCTURE OF FC FRAGMENT OF HUMAN IGG1.
4429, 5f9wC, 0.6347, 2.90, 0.056, 210, 89, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING VH1-46 GERMLINE-DERIVED CD4- BINDING SITE-DIRECTED ANTIBODY CH235 IN COMPLEX WITH HIV-1 CLADE A/E 93TH057 GP120
4430, 5esvL, 0.6347, 3.03, 0.065, 214, 92, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH03 ISOLATED FROM DONOR CH0219 IN COMPLEX WITH SCAFFOLDED TRIMERIC HIV-1 ENV V1V2 DOMAIN FROM THE CLADE C SUPERINFECTING STRAIN OF DONOR CAP256.
4431, 4x98B, 0.6347, 2.95, 0.066, 204, 91, IMMUNOGLOBULIN FC HETERODIMER VARIANT
4432, 4r96L, 0.6347, 3.15, 0.054, 221, 93, STRUCTURE OF A LLAMA GLAMA FAB 48A2 AGAINST HUMAN CMET
4433, 3zdyL, 0.6347, 3.05, 0.054, 214, 92, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
4434, 3vw3L, 0.6347, 2.87, 0.044, 215, 91, ANTIBODY 64M-5 FAB IN COMPLEX WITH A DOUBLE-STRANDED DNA (6-4) PHOTOPRODUCT
4435, 2j6eB, 0.6347, 2.95, 0.054, 208, 93, CRYSTAL STRUCTURE OF AN AUTOIMMUNE COMPLEX BETWEEN A HUMAN IGM RHEUMATOID FACTOR AND IGG1 FC REVEALS A NOVEL FC EPITOPE AND EVIDENCE FOR AFFINITY MATURATION
4436, 2fjfL, 0.6347, 2.74, 0.057, 211, 88, STRUCTURE OF THE G6 FAB A PHAGE DERIVED VEGF BINDING FAB
4437, 1fbiP, 0.6347, 2.88, 0.056, 214, 90, CRYSTAL STRUCTURE OF A CROSS-REACTION COMPLEX BETWEEN FAB F9.13.7 AND GUINEA-FOWL LYSOZYME
4438, 6bt3E, 0.6346, 3.23, 0.043, 220, 93, HIGH-RESOLUTION STRUCTURE ANALYSIS OF ANTIBODY V5 CONFORMATIONAL EPITOPE ON HUMAN PAPILLOMAVIRUS 16
4439, 6bpdB, 0.6346, 2.96, 0.056, 210, 90, PLASMODIUM VIVAX INVASION BLOCKING MONOCLONAL ANTIBODY 10B12 
4440, 5w42L, 0.6346, 3.04, 0.055, 212, 91, CRYSTAL STRUCTURE OF HUMAN MONOCLONAL ANTIBODY H3V-47 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/MINNESOTA/11/2010 (H3N2) 
4441, 5cd3F, 0.6346, 2.91, 0.056, 206, 89, STRUCTURE OF IMMATURE VRC01-CLASS ANTIBODY DRVIA7
4442, 5bk3L, 0.6346, 2.71, 0.057, 217, 88, CRYSTAL STRUCTURE OF THE NEUTRALIZING ANTI-CIRCUMSPOROZOITE PROTEIN 580 ANTIBODY
4443, 4xx1G, 0.6346, 2.84, 0.089, 210, 90, LOW RESOLUTION STRUCTURE OF LCAT IN COMPLEX WITH FAB1
4444, 4xbgB, 0.6346, 3.00, 0.055, 214, 91, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA): 2.73 A RESOLUTION
4445, 3utzA, 0.6346, 2.94, 0.056, 215, 90, ENDOGENOUS-LIKE INHIBITORY ANTIBODIES TARGETING ACTIVATED METALLOPROTEINASE MOTIFS SHOW THERAPEUTIC POTENTIAL
4446, 3mltA, 0.6346, 2.81, 0.056, 215, 90, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A UG1033 V3 PEPTIDE
4447, 2qr0M, 0.6346, 2.92, 0.056, 213, 89, STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS
4448, 2ddqL, 0.6346, 2.99, 0.043, 218, 92, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A R310 ANTIBODY COMPLEXED WITH (R)-HNE-HISTIDINE ADDUCT
4449, 1yjdL, 0.6346, 3.10, 0.054, 212, 92, CRYSTAL STRUCTURE OF HUMAN CD28 IN COMPLEX WITH THE FAB FRAGMENT OF A MITOGENIC ANTIBODY (5.11A1)
4450, 1orsA, 0.6346, 3.20, 0.053, 214, 94, X-RAY STRUCTURE OF THE KVAP POTASSIUM CHANNEL VOLTAGE SENSOR IN COMPLEX WITH AN FAB
4451, 1fvdC, 0.6346, 3.09, 0.054, 214, 93, X-RAY STRUCTURES OF THE ANTIGEN-BINDING DOMAINS FROM THREE VARIANTS OF HUMANIZED ANTI-P185-HER2 ANTIBODY 4D5 AND COMPARISON WITH MOLECULAR MODELING
4452, 5vgjL, 0.6345, 2.73, 0.057, 217, 88, CRYSTAL STRUCTURE OF THE HUMAN FAB VRC38.01 AN HIV-1 V1V2-DIRECTED NEUTRALIZING ANTIBODY ISOLATED FROM DONOR N90 BOUND TO A SCAFFOLDED WITO V1V2 DOMAIN
4453, 5uddS, 0.6345, 2.75, 0.057, 211, 88, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
4454, 5tfsL, 0.6345, 2.77, 0.056, 207, 89, STRUCTURE OF CHIMERIC 02-K FAB A VRC01-LIKE GERMLINE ANTIBODY
4455, 5nj6L, 0.6345, 3.17, 0.054, 213, 92, CRYSTAL STRUCTURE OF A THERMOSTABILISED HUMAN PROTEASE-ACTIVATED RECEPTOR-2 (PAR2) IN TERNARY COMPLEX WITH FAB3949 AND AZ7188 AT 4.0 ANGSTROM RESOLUTION
4456, 4yo0B, 0.6345, 2.73, 0.067, 209, 89, CRYSTAL STRUCTURE OF MONOCLONAL ANTI-HUMAN PODOPLANIN ANTIBODY NZ-1 WITH BOUND PA PEPTIDE
4457, 4tulL, 0.6345, 3.15, 0.043, 218, 92, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY AGAINST NEUROBLASTOMA ASSOCIATED ANTIGEN.
4458, 4ouuA, 0.6345, 3.03, 0.055, 217, 91, ANTI-MT1-MMP MONOCLONAL ANTIBODY
4459, 4f2mD, 0.6345, 3.06, 0.055, 211, 91, CRYSTAL STRUCTURE OF A TGEV CORONAVIRUS SPIKE FRAGMENT IN COMPLEX WITH THE TGEV NEUTRALIZING MONOCLONAL ANTIBODY 1AF10
4460, 3x2dK, 0.6345, 2.92, 0.056, 211, 90, CRYSTAL STRUCTURE OF MARBURG VIRUS GP IN COMPLEX WITH THE HUMAN SURVIVOR ANTIBODY MR78
4461, 3cfeA, 0.6345, 2.99, 0.054, 213, 92, CRYSTAL STRUCTURE OF PURPLE-FLUORESCENT ANTIBODY EP2-25C10
4462, 3c09L, 0.6345, 3.02, 0.056, 211, 90, CRYSTAL STRUCTURE THE FAB FRAGMENT OF MATUZUMAB (FAB72000) IN COMPLEX WITH DOMAIN III OF THE EXTRACELLULAR REGION OF EGFR
4463, 2vl5B, 0.6345, 2.97, 0.054, 217, 92, STRUCTURE OF ANTI-COLLAGEN TYPE II FAB CIIC1
4464, 2qr0E, 0.6345, 2.92, 0.056, 213, 89, STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS
4465, 1g9nL, 0.6345, 3.15, 0.054, 214, 92, HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
4466, 1fveC, 0.6345, 3.08, 0.054, 214, 93, X-RAY STRUCTURES OF THE ANTIGEN-BINDING DOMAINS FROM THREE VARIANTS OF HUMANIZED ANTI-P185-HER2 ANTIBODY 4D5 AND COMPARISON WITH MOLECULAR MODELING
4467, 15c8L, 0.6345, 3.13, 0.054, 213, 92, CATALYTIC ANTIBODY 5C8 FREE FAB
4468, 6ml8L, 0.6344, 2.99, 0.056, 212, 90, CRYSTAL STRUCTURE OF HEMAGGLUTININ FROM H1N1 INFLUENZA A VIRUS A/DENVER/57 BOUND TO THE C05 ANTIBODY 
4469, 6fn1B, 0.6344, 2.91, 0.043, 220, 92, ZOSUQUIDAR AND UIC2 FAB COMPLEX OF HUMAN-MOUSE CHIMERIC ABCB1 (ABCB1HM)
4470, 6flbL, 0.6344, 2.94, 0.044, 216, 91, 3H5 FAB BOUND TO EDIII OF DENV 2 XTAL FORM 2 
4471, 6b3mU, 0.6344, 3.10, 0.054, 214, 92, THE CRYSTAL STRUCTURE OF A BROADLY-REACTIVE HUMAN ANTI-HEMAGGLUTININ STALK ANTIBODY (70-1F02) IN COMPLEX WITH H5 HEMAGGLUTININ 
4472, 5uxqB, 0.6344, 3.07, 0.054, 217, 92, STRUCTURE OF ANTI-HIV TRIMER APEX ANTIBODY PGT143
4473, 5tihL, 0.6344, 2.96, 0.044, 212, 91, STRUCTURAL BASIS FOR INHIBITION OF ERYTHROCYTE INVASION BY ANTIBODIES TO PLASMODIUM FALCIPARUM PROTEIN CYRPA
4474, 4kkcD, 0.6344, 2.92, 0.044, 211, 91, STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 20MM BROMIDE
4475, 3fo2L, 0.6344, 2.73, 0.057, 216, 88, CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (GLU(L39)GLN MUTANT)
4476, 2fatL, 0.6344, 3.10, 0.054, 212, 93, AN ANTI-UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR (UPAR) ANTIBODY: CRYSTAL STRUCTURE AND BINDING EPITOPE
4477, 1a3rL, 0.6344, 3.12, 0.054, 220, 93, FAB FRAGMENT (ANTIBODY 8F5) COMPLEXED WITH PEPTIDE FROM HUMAN RHINOVIRUS (SEROTYPE 2) VIRAL CAPSID PROTEIN VP2 (RESIDUES 156-170)
4478, 5wk3R, 0.6343, 2.91, 0.056, 217, 89, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CCL17 AND M116 FAB
4479, 5ueaL, 0.6343, 2.73, 0.057, 211, 88, STRUCTURE OF ANTIGEN-FAB COMPLEX WITH HISTONE CHAPERONE ASF1
4480, 5ezoL, 0.6343, 2.95, 0.054, 213, 92, CRYSTAL STRUCTURE OF PFCYRPA IN COMPLEX WITH AN INVASION-INHIBITORY ANTIBODY FAB.
4481, 4ydvL, 0.6343, 2.90, 0.067, 206, 89, STRUCTURE OF THE ANTIBODY 7B2 THAT CAPTURES HIV-1 VIRIONS
4482, 4wfhF, 0.6343, 2.92, 0.044, 211, 91, HUMAN TRAAK K+ CHANNEL IN A TL+ BOUND NONCONDUCTIVE CONFORMATION
4483, 4wfhD, 0.6343, 2.93, 0.044, 211, 91, HUMAN TRAAK K+ CHANNEL IN A TL+ BOUND NONCONDUCTIVE CONFORMATION
4484, 4ttdL, 0.6343, 2.89, 0.089, 214, 90, STRUCTURE OF A LYSOZYME ANTIBODY COMPLEX
4485, 4n90I, 0.6343, 2.93, 0.055, 214, 91, CRYSTAL STRUCTURE OF TERNARY COMPLEX OF TRAIL DR5 AND FAB FRAGMENT FROM A DR5 AGONIST ANTIBODY
4486, 4jy6A, 0.6343, 2.88, 0.078, 208, 90, CRYSTAL STRUCTURE OF HUMAN FAB PGT123 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
4487, 4i9wF, 0.6343, 2.93, 0.044, 211, 91, HUMAN TWO PORE DOMAIN K+ CHANNEL TRAAK (K2P4.1) - FAB COMPLEX STRUCTURE
4488, 4gs7C, 0.6343, 2.78, 0.135, 193, 89, STRUCTURE OF THE INTERLEUKIN-15 QUATERNARY COMPLEX
4489, 3cfeL, 0.6343, 2.99, 0.054, 213, 92, CRYSTAL STRUCTURE OF PURPLE-FLUORESCENT ANTIBODY EP2-25C10
4490, 2o5yL, 0.6343, 3.04, 0.054, 218, 92, CRYSTAL STRUCTURE OF THE 1E9 LEUH47TRP/ARGH100TRP FAB PROGESTERONE COMPLEX
4491, 6iccL, 0.6342, 3.02, 0.054, 213, 93, THE NZ-1 FAB COMPLEXED WITH THE PDZ TANDEM FRAGMENT OF A. AEOLICUS S2P HOMOLOG WITH THE PA12 TAG INSERTED BETWEEN THE RESIDUES 181 AND 186 
4492, 5z1aA, 0.6342, 3.25, 0.099, 655, 101, THE CRYSTAL STRUCTURE OF BACTEROIDES FRAGILIS BETA-GLUCURONIDASE IN COMPLEX WITH URONIC ISOFAGOMINE 
4493, 5uqyK, 0.6342, 2.91, 0.056, 210, 89, CRYSTAL STRUCTURE OF MARBURG VIRUS GP IN COMPLEX WITH THE HUMAN SURVIVOR ANTIBODY MR78
4494, 5t5nH, 0.6342, 3.02, 0.055, 212, 91, CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1 (BEST1) TRIPLE MUTANT: I76A F80A F84A; IN COMPLEX WITH AN FAB ANTIBODY FRAGMENT CHLORIDE AND CALCIUM
4495, 5my4A, 0.6342, 2.87, 0.055, 218, 91, STRUCTURE OF PYROGLUTAMATE-ABETA-SPECIFIC FAB C 17 IN COMPLEX WITH HUMAN ABETA-PE3-12PEGB
4496, 5eu7C, 0.6342, 2.93, 0.056, 211, 89, CRYSTAL STRUCTURE OF HIV-1 INTEGRASE CATALYTIC CORE IN COMPLEX WITH FAB
4497, 5cipB, 0.6342, 2.91, 0.056, 212, 89, CRYSTAL STRUCTURE OF UNBOUND 4E10
4498, 4xnzF, 0.6342, 2.83, 0.056, 206, 89, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC06B IN COMPLEX WITH HIV-1 CLADE A/E STRAIN 93TH057 GP120
4499, 4nccL, 0.6342, 3.02, 0.055, 211, 91, NEUTRALIZING ANTIBODY TO MURINE NOROVIRUS
4500, 3qumC, 0.6342, 3.12, 0.054, 218, 93, CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN (PSA) IN FAB SANDWICH WITH A HIGH AFFINITY AND A PCA SELECTIVE ANTIBODY
4501, 3o6mL, 0.6342, 2.95, 0.056, 216, 90, ANTI-TAT HIV 11H6H1 FAB  COMPLEXED WITH A 9-MER TAT PEPTIDE
4502, 3ietC, 0.6342, 3.07, 0.065, 217, 92, CRYSTAL STRUCTURE OF 237MAB WITH ANTIGEN
4503, 2pcpC, 0.6342, 2.91, 0.044, 216, 90, ANTIBODY FAB COMPLEXED WITH PHENCYCLIDINE
4504, 2htlF, 0.6342, 2.93, 0.044, 211, 91, STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445F MUTANT AND FAB COMPLEX
4505, 2h1pL, 0.6342, 3.12, 0.043, 219, 93, THE THREE-DIMENSIONAL STRUCTURES OF A POLYSACCHARIDE BINDING ANTIBODY TO CRYPTOCOCCUS NEOFORMANS AND ITS COMPLEX WITH A PEPTIDE FROM A PHAGE DISPLAY LIBRARY: IMPLICATIONS FOR THE IDENTIFICATION OF PEPTIDE MIMOTOPES
4506, 1rurL, 0.6342, 2.98, 0.055, 217, 91, CRYSTAL STRUCTURE (I) OF NATIVE DIELS-ALDER ANTIBODY 13G5 FAB AT PH 8.0 WITH A DATA SET COLLECTED AT SSRL BEAMLINE 9- 1.
4507, 6ellB, 0.6341, 3.07, 0.054, 213, 92, FAB FRAGMENT. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN ANTIBODY DRUG DISCOVERY
4508, 6d9gD, 0.6341, 3.04, 0.055, 216, 91, X-RAY STRUCTURE OF THE FAB FRAGMENT OF 15B8; A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR THE HUMAN SEROTONIN TRANSPORTER 
4509, 6d11B, 0.6341, 3.02, 0.055, 211, 91, CRYSTAL STRUCTURE OF 1450 FAB IN COMPLEX WITH CIRCUMSPOROZOITE PROTEIN NANP5 
4510, 6c5jL, 0.6341, 2.95, 0.055, 217, 91, S25-23 FAB IN COMPLEX WITH CHLAMYDIACEAE LPS (CRYSTAL FORM 1) 
4511, 4ydvA, 0.6341, 2.90, 0.067, 206, 89, STRUCTURE OF THE ANTIBODY 7B2 THAT CAPTURES HIV-1 VIRIONS
4512, 4xcyL, 0.6341, 3.08, 0.054, 214, 92, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDYLGLYCEROL (06:0 PG)
4513, 4rdqL, 0.6341, 2.97, 0.044, 212, 91, CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1 FROM CHICKEN IN COMPLEX WITH FAB ANTIBODY FRAGMENTS CHLORIDE AND CALCIUM
4514, 3oazL, 0.6341, 2.86, 0.056, 213, 90, A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY
4515, 3eyuL, 0.6341, 3.05, 0.054, 218, 92, PFA1 FAB FRAGMENT COMPLEXED WITH ROR2(518-525)
4516, 1yylQ, 0.6341, 2.82, 0.056, 214, 89, CRYSTAL STRUCTURE OF CD4M33 A SCORPION-TOXIN MIMIC OF CD4 IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
4517, 1a4kA, 0.6341, 2.94, 0.056, 216, 90, DIELS ALDER CATALYTIC ANTIBODY WITH TRANSITION STATE ANALOGUE
4518, 6eljB, 0.6340, 3.05, 0.054, 213, 92, FAB FRAGMENT. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN ANTIBODY DRUG DISCOVERY
4519, 6dwiK, 0.6340, 2.85, 0.056, 211, 89, STRUCTURE OF THE 4462 ANTIBODY FAB FRAGMENT BOUND TO A STAPHYLOCOCCUS AUREUS WALL TECHOIC ACID ANALOG 
4520, 6dl8B, 0.6340, 2.92, 0.056, 197, 90, CRYSTAL STRUCTURE OF AN INFLUENZA A HEMAGGLUTININ ANTIBODY FAB VARIANT CH67:1203D4 CHIMERA 
4521, 5m76B, 0.6340, 2.80, 0.067, 211, 90, CRYSTAL STRUCTURE OF CARDIOTOXIC BENCE-JONES LIGHT CHAIN DIMER H10
4522, 5jxeC, 0.6340, 2.90, 0.056, 215, 89, HUMAN PD-1 ECTODOMAIN COMPLEXED WITH PEMBROLIZUMAB FAB
4523, 5f89L, 0.6340, 2.86, 0.078, 221, 90, STRUCTURE OF THE UNLIGANDED FAB FROM HIV-1 NEUTRALISING ANTIBODY CAP248-2B THAT BINDS TO THE GP120 C-TERMINUS - GP41 INTERFACE
4524, 5f3hD, 0.6340, 2.91, 0.056, 211, 89, STRUCTURE OF MYOSTATIN IN COMPLEX WITH HUMANIZED RK35 ANTIBODY
4525, 4ynyD, 0.6340, 2.76, 0.079, 209, 89, CRYSTAL STRUCTURE OF MONOCLONAL ANTI-HUMAN PODOPLANIN ANTIBODY NZ-1
4526, 4wi4A, 0.6340, 2.94, 0.133, 205, 90, STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION S254A
4527, 4qt5A, 0.6340, 2.77, 0.056, 216, 89, CRYSTAL STRUCTURE OF 3BD10: A MONOCLONAL ANTIBODY AGAINST THE TSH RECEPTOR
4528, 4bklB, 0.6340, 2.96, 0.044, 216, 91, CRYSTAL STRUCTURE OF THE ARTHRITOGENIC ANTIBODY M2139 (FAB FRAGMENT) IN COMPLEX WITH THE TRIPLE-HELICAL J1 PEPTIDE
4529, 3v4vL, 0.6340, 3.01, 0.055, 217, 91, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1 AND RO0505376
4530, 3v0vB, 0.6340, 3.14, 0.054, 212, 92, FAB WN1 222-5 UNLIGANDED
4531, 3npsC, 0.6340, 3.07, 0.055, 211, 91, CRYSTAL STRUCTURE OF MEMBRANE-TYPE SERINE PROTEASE 1 (MT-SP1) IN COMPLEX WITH THE FAB INHIBITOR S4
4532, 3inuL, 0.6340, 2.89, 0.056, 217, 89, CRYSTAL STRUCTURE OF AN UNBOUND KZ52 NEUTRALIZING ANTI-EBOLAVIRUS ANTIBODY.
4533, 3ejzD, 0.6340, 3.09, 0.054, 211, 92, STRUCTURE OF E203V MUTANT E.COLI CL-/H+ EXCHANGER CLC-EC1
4534, 2fecO, 0.6340, 2.96, 0.044, 211, 91, STRUCTURE OF THE E203Q MUTANT OF THE CL-/H+ EXCHANGER CLC- EC1 FROM E.COLI
4535, 1mcwM, 0.6340, 3.07, 0.054, 215, 93, THREE-DIMENSIONAL STRUCTURE OF A HYBRID LIGHT CHAIN DIMER. PROTEIN ENGINEERING OF A BINDING CAVITY
4536, 1fe8J, 0.6340, 3.27, 0.043, 210, 94, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A FAB FRAGMENT OF IGG RU5 THAT INHIBITS COLLAGEN BINDING
4537, 5mu0N, 0.6339, 3.08, 0.055, 215, 91, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (IA03)
4538, 5mhrG, 0.6339, 3.10, 0.055, 211, 91, T3D REOVIRUS SIGMA1 COMPLEXED WITH 9BG5 FAB FRAGMENTS
4539, 5cd3B, 0.6339, 2.91, 0.056, 206, 89, STRUCTURE OF IMMATURE VRC01-CLASS ANTIBODY DRVIA7
4540, 4tujB, 0.6339, 2.96, 0.044, 217, 90, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY AGAINST NEUROBLASTOMA ASSOCIATED ANTIGEN.
4541, 4r4nL, 0.6339, 2.74, 0.057, 210, 88, CRYSTAL STRUCTURE OF THE ANTI-HIV-1 ANTIBODY 2.2C IN COMPLEX WITH HIV- 1 93UG037 GP120
4542, 4oduL, 0.6339, 2.92, 0.055, 212, 91, UNLIGANDED FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY S1-15
4543, 3ztjL, 0.6339, 3.00, 0.066, 216, 91, STRUCTURE OF INFLUENZA A NEUTRALIZING ANTIBODY SELECTED FROM CULTURES OF SINGLE HUMAN PLASMA CELLS IN COMPLEX WITH HUMAN H3 INFLUENZA HAEMAGGLUTININ.
4544, 3aazA, 0.6339, 3.30, 0.063, 228, 95, CRYSTAL STRUCTURE OF THE HUMANIZED RECOMBINANT FAB FRAGMENT OF A MURINE; ANTIBODY
4545, 2fx8N, 0.6339, 2.99, 0.055, 214, 91, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH AN AIB-INDUCED PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41
4546, 2ak1L, 0.6339, 3.08, 0.055, 216, 91, CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB  IN COMPLEX WITH BENZOIC ACID
4547, 1t66L, 0.6339, 3.13, 0.043, 219, 93, THE STRUCTURE OF FAB WITH INTERMEDIATE AFFINITY FOR FLUORESCEIN.
4548, 1t4kD, 0.6339, 3.28, 0.063, 217, 95, CRYSTAL STRUCTURE OF UNLIGANDED ALDOLASE ANTIBODY 93F3 FAB
4549, 1q72L, 0.6339, 3.03, 0.054, 218, 92, ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH COCAINE
4550, 1figL, 0.6339, 3.23, 0.053, 215, 94, ROUTES TO CATALYSIS: STRUCTURE OF A CATALYTIC ANTIBODY AND COMPARISON WITH ITS NATURAL COUNTERPART
4551, 4xcnB, 0.6338, 3.00, 0.055, 214, 91, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA); 2.9 A RESOLUTION
4552, 4mhjX, 0.6338, 3.04, 0.054, 216, 92, CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/GOOSE/GUANGDONG/1/96 (H5N1)
4553, 4mhjE, 0.6338, 3.04, 0.054, 216, 92, CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/GOOSE/GUANGDONG/1/96 (H5N1)
4554, 4mhhL, 0.6338, 3.04, 0.054, 217, 92, CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/VIET NAM/1203/2004 (H5N1)
4555, 4mhhI, 0.6338, 3.00, 0.054, 217, 92, CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/VIET NAM/1203/2004 (H5N1)
4556, 3zl4H, 0.6338, 3.13, 0.043, 231, 93, ANTIBODY STRUCTURAL ORGANIZATION: ROLE OF KAPPA -  LAMBDA CHAIN CONSTANT DOMAIN SWITCH IN CATALYTIC FUNCTIONALITY
4557, 3whxB, 0.6338, 3.06, 0.055, 216, 91, CRYSTAL STRUCTURE OF ANTI-PROSTAGLANDIN E2 FAB FRAGMENT PGE1 COMPLEX
4558, 2r0wL, 0.6338, 3.18, 0.054, 218, 93, PFA2 FAB COMPLEXED WITH ABETA1-8
4559, 2ojzM, 0.6338, 3.06, 0.054, 218, 92, ANTI-DNA ANTIBODY ED10
4560, 1mhhC, 0.6338, 3.05, 0.054, 219, 92, ANTIBODY-ANTIGEN COMPLEX
4561, 1hilA, 0.6338, 2.93, 0.056, 217, 90, STRUCTURAL EVIDENCE FOR INDUCED FIT AS A MECHANISM FOR ANTIGEN-ANTIBODY RECOGNITION
4562, 6ea5N, 0.6337, 3.08, 0.054, 212, 92, STRUCTURE OF BDBV GPCL IN COMPLEX WITH THE PAN-EBOLAVIRUS MAB ADI- 15878 
4563, 5tztB, 0.6337, 2.88, 0.055, 218, 91, CRYSTAL STRUCTURE OF HUMAN CD47 ECD BOUND TO FAB OF C47B161
4564, 5tkjH, 0.6337, 2.98, 0.056, 216, 90, STRUCTURE OF VACCINE-ELICITED DIVERSE HIV-1 NEUTRALIZING ANTIBODY VFP1.01 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519
4565, 5l0qE, 0.6337, 3.15, 0.054, 212, 92, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN ADAM10 D+C DOMAIN AND A CONFORMATION SPECIFIC MAB 8C7.
4566, 5e2wL, 0.6337, 2.89, 0.056, 216, 89, ANTI-TAU AT8 FAB WITH TRIPLY PHOSPHORYLATED TAU PEPTIDE
4567, 5dd0L, 0.6337, 2.81, 0.067, 211, 89, CRYSTAL STRUCTURES IN AN ANTI-HIV ANTIBODY LINEAGE FROM IMMUNIZATION OF RHESUS MACAQUES
4568, 5cipL, 0.6337, 2.92, 0.056, 212, 89, CRYSTAL STRUCTURE OF UNBOUND 4E10
4569, 4yk4B, 0.6337, 2.77, 0.056, 211, 89, HUMAN ANTIBODY 641 I-9 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ H1 SOLOMON ISLANDS/03/2006
4570, 4r4bL, 0.6337, 3.01, 0.056, 210, 90, CRYSTAL STRUCTURE OF THE ANTI-HIV-1 ANTIBODY 2.2C
4571, 4ocxH, 0.6337, 3.40, 0.021, 210, 95, FAB COMPLEX WITH METHOTREXATE
4572, 4gt7D, 0.6337, 3.34, 0.073, 213, 96, AN ENGINEERED DISULFIDE BOND REVERSIBLY TRAPS THE IGE-FC3-4 IN A CLOSED NON-RECEPTOR BINDING CONFORMATION
4573, 4etqB, 0.6337, 2.87, 0.055, 212, 91, VACCINIA VIRUS D8L IMV ENVELOPE PROTEIN IN COMPLEX WITH FAB OF MURINE IGG2A LA5
4574, 3u2sB, 0.6337, 2.75, 0.067, 211, 89, CRYSTAL STRUCTURE OF PG9 FAB IN COMPLEX WITH V1V2 REGION FROM HIV-1 STRAIN ZM109
4575, 3pnwD, 0.6337, 2.79, 0.056, 213, 89, CRYSTAL STRUCTURE OF THE TUDOR DOMAIN OF HUMAN TDRD3 IN COMPLEX WITH AN ANTI-TDRD3 FAB
4576, 3d69L, 0.6337, 2.85, 0.067, 211, 90, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF AN ANTI-FACTOR IX ANTIBODY 10C12
4577, 1zluK, 0.6337, 2.99, 0.056, 209, 90, FAB 2G12 + MAN5
4578, 1fgnL, 0.6337, 3.12, 0.043, 214, 93, MONOCLONAL MURINE ANTIBODY 5G9-ANTI-HUMAN TISSUE FACTOR
4579, 6nczF, 0.6336, 2.78, 0.033, 589, 91, CRYSTAL STRUCTURE OF HYBRID BETA-GLUCURONIDASE/BETA-GALACTURONIDASE FROM FUSICATENIBACTER SACCHARIVORANS BOUND TO PHENYL-THIO-BETA-D- GLUCURONIDE 
4580, 5wduI, 0.6336, 2.71, 0.045, 207, 88, HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB 35O22 FAB AND NIH45-46 SCFV
4581, 5vyfA, 0.6336, 2.75, 0.057, 211, 88, STRUCTURE OF SINGLE CHAIN FEL D 1 BOUND TO A NEUTRALIZING ANTIBODY
4582, 5vicL, 0.6336, 2.94, 0.056, 211, 90, CRYSTAL STRUCTURE OF ANTI-ZIKA ANTIBODY Z004 BOUND TO DENV-1 ENVELOPE PROTEIN DIII
4583, 4s2sL, 0.6336, 2.92, 0.056, 217, 89, CRYSTAL STRUCTURE OF FAB FRAGMENT OF MONOCLONAL ANTIBODY ROAB13
4584, 4mhjQ, 0.6336, 3.04, 0.054, 215, 92, CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/GOOSE/GUANGDONG/1/96 (H5N1)
4585, 4jm2B, 0.6336, 3.14, 0.054, 214, 93, CRYSTAL STRUCTURE OF PGT 135 FAB IN COMPLEX WITH GP120 CORE PROTEIN FROM HIV-1 STRAIN JR-FL BOUND TO CD4 AND 17B FAB
4586, 3k4dB, 0.6336, 2.96, 0.056, 596, 89, CRYSTAL STRUCTURE OF E. COLI BETA-GLUCURONIDASE WITH THE GLUCARO-D- LACTAM INHIBITOR BOUND
4587, 3cmoL, 0.6336, 3.06, 0.055, 210, 91, HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ18
4588, 2z91B, 0.6336, 3.17, 0.043, 211, 92, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY 10C9
4589, 2or9L, 0.6336, 2.91, 0.044, 216, 91, THE STRUCTURE OF THE ANTI-C-MYC ANTIBODY 9E10 FAB FRAGMENT/EPITOPE PEPTIDE COMPLEX REVEALS A NOVEL BINDING MODE DOMINATED BY THE HEAVY CHAIN HYPERVARIABLE LOOPS
4590, 2fjgL, 0.6336, 2.90, 0.045, 211, 89, STRUCTURE OF THE G6 FAB A PHAGE DERIVED FAB FRAGMENT IN COMPLEX WITH VEGF
4591, 1t4kB, 0.6336, 3.30, 0.063, 217, 95, CRYSTAL STRUCTURE OF UNLIGANDED ALDOLASE ANTIBODY 93F3 FAB
4592, 1rivL, 0.6336, 3.18, 0.054, 218, 93, ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH META- OXYBENZOYLECGONINE
4593, 1ogpA, 0.6336, 3.14, 0.053, 388, 95, THE CRYSTAL STRUCTURE OF PLANT SULFITE OXIDASE PROVIDES INSIGHT INTO SULFITE OXIDATION IN PLANTS AND ANIMALS
4594, 6dwiA, 0.6335, 2.75, 0.057, 211, 88, STRUCTURE OF THE 4462 ANTIBODY FAB FRAGMENT BOUND TO A STAPHYLOCOCCUS AUREUS WALL TECHOIC ACID ANALOG 
4595, 5ubxA, 0.6335, 2.88, 0.125, 191, 88, CRYSTAL STRUCTURE OF A MUTANT MIGG2B FC HETERODIMER IN COMPLEX WITH PROTEIN A PEPTIDE ANALOG Z34C
4596, 5t5nL, 0.6335, 2.97, 0.044, 212, 91, CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1 (BEST1) TRIPLE MUTANT: I76A F80A F84A; IN COMPLEX WITH AN FAB ANTIBODY FRAGMENT CHLORIDE AND CALCIUM
4597, 5fecB, 0.6335, 3.00, 0.055, 209, 91, CRYSTAL STRUCTURE OF 3BNC60 FAB GERMLINE PRECURSOR IN COMPLEX WITH 426C.TM4DELTAV1-3 GP120
4598, 5aumB, 0.6335, 2.96, 0.033, 216, 90, CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH THE LIGAND PEPTIDE
4599, 4zfgL, 0.6335, 3.02, 0.056, 213, 90, DUAL-SPECIFICITY FAB 5A12 IN COMPLEX WITH ANGIOPOIETIN 2
4600, 4wwiE, 0.6335, 2.80, 0.112, 179, 89, CRYSTAL STRUCTURE OF THE C DOMAIN OF STAPHYLOCOCCAL PROTEIN A IN COMPLEX WITH THE FC FRAGMENT OF HUMAN IGG AT 2.3 ANGSTROM RESOLUTION
4601, 4rqqA, 0.6335, 2.95, 0.056, 215, 90, CRYSTAL STRUCTURE OF HUMAN FAB PGDM1400 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
4602, 4kuzL, 0.6335, 2.88, 0.056, 216, 89, CRYSTAL STRUCTURE OF ANTI-EMMPRIN ANTIBODY 4A5 FAB IN TRIGONAL FORM
4603, 3vg0H, 0.6335, 3.38, 0.094, 219, 96, ANTIBODY FAB FRAGMENT
4604, 3cm9N, 0.6335, 3.14, 0.065, 214, 93, SOLUTION STRUCTURE OF HUMAN SIGA2
4605, 3cm9L, 0.6335, 3.14, 0.065, 214, 93, SOLUTION STRUCTURE OF HUMAN SIGA2
4606, 2i60L, 0.6335, 3.03, 0.066, 214, 91, CRYSTAL STRUCTURE OF [PHE23]M47 A SCORPION-TOXIN MIMIC OF CD4 IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
4607, 2erjF, 0.6335, 3.06, 0.079, 201, 89, CRYSTAL STRUCTURE OF THE HETEROTRIMERIC INTERLEUKIN-2 RECEPTOR IN COMPLEX WITH INTERLEUKIN-2
4608, 1nfdB, 0.6335, 3.10, 0.084, 239, 95, AN ALPHA-BETA T CELL RECEPTOR (TCR) HETERODIMER IN COMPLEX WITH AN ANTI-TCR FAB FRAGMENT DERIVED FROM A MITOGENIC ANTIBODY
4609, 1kegL, 0.6335, 3.00, 0.044, 216, 91, ANTIBODY 64M-2 FAB COMPLEXED WITH DTT(6-4)TT
4610, 6nczA, 0.6334, 2.77, 0.033, 588, 91, CRYSTAL STRUCTURE OF HYBRID BETA-GLUCURONIDASE/BETA-GALACTURONIDASE FROM FUSICATENIBACTER SACCHARIVORANS BOUND TO PHENYL-THIO-BETA-D- GLUCURONIDE 
4611, 6eleB, 0.6334, 2.97, 0.055, 213, 91, FAB FRAGMENT. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN ANTIBODY DRUG DISCOVERY
4612, 5tlkA, 0.6334, 2.73, 0.057, 215, 88, COMPLEX BETWEEN HUMAN CD27 AND FAB FRAGMENTS OF ANTIBODIES M2177 AND H2191
4613, 5t5nF, 0.6334, 3.15, 0.054, 212, 92, CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1 (BEST1) TRIPLE MUTANT: I76A F80A F84A; IN COMPLEX WITH AN FAB ANTIBODY FRAGMENT CHLORIDE AND CALCIUM
4614, 4zxbA, 0.6334, 3.30, 0.042, 214, 95, STRUCTURE OF THE HUMAN INSULIN RECEPTOR ECTODOMAIN IRDELTABETA CONSTRUCT IN COMPLEX WITH FOUR FAB MOLECULES
4615, 3ifnL, 0.6334, 3.31, 0.053, 219, 95, X-RAY STRUCTURE OF AMYLOID BETA PEPTIDE:ANTIBODY (ABETA1-40:12A11) COMPLEX
4616, 2w59A, 0.6334, 2.97, 0.044, 215, 91, STRUCTURE OF AN AVIAN IGY-FC 3-4 FRAGMENT
4617, 2i5yL, 0.6334, 3.02, 0.066, 214, 91, CRYSTAL STRUCTURE OF CD4M47 A SCORPION-TOXIN MIMIC OF CD4 IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
4618, 2hlfF, 0.6334, 2.94, 0.044, 211, 91, STRUCTURE OF THE ESCHERICHIS COLI CLC CHLORIDE CHANNEL Y445E MUTANT AND FAB COMPLEX
4619, 1t2qL, 0.6334, 3.04, 0.055, 217, 91, THE CRYSTAL STRUCTURE OF AN NNA7 FAB THAT RECOGNIZES AN N-TYPE BLOOD GROUP ANTIGEN
4620, 1ogpE, 0.6334, 3.13, 0.053, 388, 95, THE CRYSTAL STRUCTURE OF PLANT SULFITE OXIDASE PROVIDES INSIGHT INTO SULFITE OXIDATION IN PLANTS AND ANIMALS
4621, 6rcvD, 0.6333, 2.78, 0.057, 210, 88, PFRH5 BOUND TO MONOCLONAL ANTIBODIES R5.011 AND R5.016 
4622, 5jhlL, 0.6333, 2.96, 0.056, 211, 90, CRYSTAL STRUCTURE OF ZIKA VIRUS ENVELOPE PROTEIN IN COMPLEX WITH A FLAVIVIRUS BROADLY-PROTECTIVE ANTIBODY
4623, 4uokL, 0.6333, 2.93, 0.056, 215, 90, ELECTRON CRYO-MICROSCOPY OF VENEZUELAN EQUINE ENCEPHALITIS VIRUS TC-83 IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB 3B4C-4
4624, 4kk5F, 0.6333, 2.93, 0.044, 211, 91, STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN 20MM FLUORIDE AND 20MM BROMIDE
4625, 3nfpB, 0.6333, 2.92, 0.056, 212, 90, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THERAPEUTIC ANTIBODY DACLIZUMAB IN COMPLEX WITH IL-2RA (CD25) ECTODOMAIN
4626, 3aazH, 0.6333, 3.31, 0.063, 229, 95, CRYSTAL STRUCTURE OF THE HUMANIZED RECOMBINANT FAB FRAGMENT OF A MURINE; ANTIBODY
4627, 2xknC, 0.6333, 3.07, 0.054, 213, 92, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE ANTI-EGFR ANTIBODY 7A7
4628, 2i5yQ, 0.6333, 3.00, 0.066, 214, 91, CRYSTAL STRUCTURE OF CD4M47 A SCORPION-TOXIN MIMIC OF CD4 IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
4629, 1ogpD, 0.6333, 3.14, 0.053, 388, 95, THE CRYSTAL STRUCTURE OF PLANT SULFITE OXIDASE PROVIDES INSIGHT INTO SULFITE OXIDATION IN PLANTS AND ANIMALS
4630, 1ogpC, 0.6333, 3.14, 0.053, 388, 95, THE CRYSTAL STRUCTURE OF PLANT SULFITE OXIDASE PROVIDES INSIGHT INTO SULFITE OXIDATION IN PLANTS AND ANIMALS
4631, 1c12B, 0.6333, 3.32, 0.032, 220, 94, INSIGHT IN ODORANT PERCEPTION: THE CRYSTAL STRUCTURE AND BINDING CHARACTERISTICS OF ANTIBODY FRAGMENTS DIRECTED AGAINST THE MUSK ODORANT TRASEOLIDE
4632, 6d41A, 0.6332, 2.73, 0.055, 579, 91, BACTERIODES UNIFORMIS BETA-GLUCURONIDASE 1 BOUND TO D-GLUCARO-1;5- LACTONE 
4633, 5ueaB, 0.6332, 2.91, 0.067, 211, 89, STRUCTURE OF ANTIGEN-FAB COMPLEX WITH HISTONE CHAPERONE ASF1
4634, 5l0qB, 0.6332, 3.14, 0.054, 212, 92, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN ADAM10 D+C DOMAIN AND A CONFORMATION SPECIFIC MAB 8C7.
4635, 5jorE, 0.6332, 2.99, 0.044, 217, 91, CRYSTAL STRUCTURE OF UNBOUND ANTI-GLYCAN ANTIBODY FAB14.22 AT 2.2 A
4636, 4whtR, 0.6332, 2.99, 0.044, 215, 90, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11 P1 CRYSTAL FORM
4637, 4whtB, 0.6332, 2.98, 0.044, 215, 90, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11 P1 CRYSTAL FORM
4638, 4wfgF, 0.6332, 2.94, 0.044, 211, 91, HUMAN TRAAK K+ CHANNEL IN A TL+ BOUND CONDUCTIVE CONFORMATION
4639, 4tnvN, 0.6332, 2.81, 0.056, 211, 89, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
4640, 4kjpD, 0.6332, 2.95, 0.044, 211, 91, STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN THE ABSENCE OF HALIDE
4641, 4hfwA, 0.6332, 2.91, 0.056, 210, 90, ANTI ROTAVIRUS ANTIBODY
4642, 3hzyA, 0.6332, 2.98, 0.056, 215, 90, CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO(2.4)KDO
4643, 2vl5D, 0.6332, 3.13, 0.054, 216, 92, STRUCTURE OF ANTI-COLLAGEN TYPE II FAB CIIC1
4644, 1r70C, 0.6332, 3.15, 0.054, 214, 93, MODEL OF HUMAN IGA2 DETERMINED BY SOLUTION SCATTERING CURVE FITTING AND HOMOLOGY MODELLING
4645, 1a4jA, 0.6332, 3.02, 0.056, 217, 90, DIELS ALDER CATALYTIC ANTIBODY GERMLINE PRECURSOR
4646, 6eleL, 0.6331, 2.90, 0.056, 211, 89, FAB FRAGMENT. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN ANTIBODY DRUG DISCOVERY
4647, 5vcoC, 0.6331, 3.09, 0.055, 211, 91, THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 10B9
4648, 4r7dF, 0.6331, 3.00, 0.055, 211, 91, FAB HU 15C1
4649, 4qt5L, 0.6331, 2.96, 0.056, 216, 90, CRYSTAL STRUCTURE OF 3BD10: A MONOCLONAL ANTIBODY AGAINST THE TSH RECEPTOR
4650, 4ptuA, 0.6331, 2.76, 0.057, 212, 88, CRYSTAL STRUCTURE OF ANTI-23F STREP FAB C05 WITH RHAMNOSE
4651, 4pp2C, 0.6331, 3.09, 0.055, 211, 91, THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 10B9
4652, 4lvnC, 0.6331, 3.43, 0.032, 216, 95, CRYSTAL STRUCTURE OF PFSUB1-PRODOMAIN-NIMP.M7 FAB COMPLEX
4653, 2pcpA, 0.6331, 2.89, 0.056, 216, 90, ANTIBODY FAB COMPLEXED WITH PHENCYCLIDINE
4654, 2f58H, 0.6331, 3.36, 0.021, 228, 95, IGG1 FAB FRAGMENT (58.2) COMPLEX WITH 12-RESIDUE CYCLIC PEPTIDE (INCLUDING RESIDUES 315-324 OF HIV-1 GP120) (MN ISOLATE)
4655, 1hilC, 0.6331, 2.93, 0.056, 217, 90, STRUCTURAL EVIDENCE FOR INDUCED FIT AS A MECHANISM FOR ANTIGEN-ANTIBODY RECOGNITION
4656, 1dbkL, 0.6331, 2.91, 0.056, 216, 89, MOLECULAR BASIS OF CROSS-REACTIVITY AND THE LIMITS OF ANTIBODY-ANTIGEN COMPLEMENTARITY
4657, 6m87K, 0.6330, 2.88, 0.044, 206, 90, FAB 10A6 IN COMPLEX WITH MPTS 
4658, 5xqwL, 0.6330, 2.93, 0.044, 211, 90, CATALYTIC ANTIBODY 7B9 
4659, 5t5fL, 0.6330, 2.95, 0.044, 216, 90, NEISSERIA MENINGITIDIS FACTOR H BINDING PROTEIN IN COMPLEX WITH MONOCLONAL ANTIBODY JAR5
4660, 5n2kO, 0.6330, 2.73, 0.080, 210, 88, STRUCTURE OF UNBOUND BRIAKINUMAB FAB
4661, 4r7nN, 0.6330, 2.96, 0.056, 211, 90, FAB C2E3
4662, 4nm8M, 0.6330, 2.99, 0.056, 217, 90, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR8043 BOUND TO H3 INFLUENZA HEMAGGLUTININ
4663, 4hihA, 0.6330, 2.94, 0.056, 212, 89, ANTI-STREPTOCOCCUS PNEUMONIAE 23F FAB 023.102 WITH BOUND RHAMNOSE.
4664, 4a6yA, 0.6330, 2.84, 0.090, 211, 89, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-(4-HYDROXY-3- NITROPHENYL)-ACETYL MURINE GERMLINE ANTIBODY BBE6.12H3
4665, 3jabR, 0.6330, 3.18, 0.053, 214, 94, DOMAIN ORGANIZATION AND CONFORMATIONAL PLASTICITY OF THE G PROTEIN EFFECTOR PDE6
4666, 3jabL, 0.6330, 3.18, 0.053, 214, 94, DOMAIN ORGANIZATION AND CONFORMATIONAL PLASTICITY OF THE G PROTEIN EFFECTOR PDE6
4667, 1r70A, 0.6330, 3.15, 0.065, 214, 93, MODEL OF HUMAN IGA2 DETERMINED BY SOLUTION SCATTERING CURVE FITTING AND HOMOLOGY MODELLING
4668, 12e8L, 0.6330, 3.18, 0.053, 214, 94, 2E8 FAB FRAGMENT
4669, 6nczC, 0.6329, 2.77, 0.033, 589, 91, CRYSTAL STRUCTURE OF HYBRID BETA-GLUCURONIDASE/BETA-GALACTURONIDASE FROM FUSICATENIBACTER SACCHARIVORANS BOUND TO PHENYL-THIO-BETA-D- GLUCURONIDE 
4670, 6aq7L, 0.6329, 3.11, 0.054, 216, 92, STRUCTURE OF POM6 FAB FRAGMENT COMPLEXED WITH MOUSE PRPC
4671, 6al1L, 0.6329, 2.82, 0.079, 209, 89, THE NZ-1 FAB COMPLEXED WITH THE PDZ TANDEM FRAGMENT OF A. AEOLICUS S2P HOMOLOG WITH THE PA12 TAG INSERTED BETWEEN THE RESIDUES 181 AND 184 
4672, 5t5nN, 0.6329, 3.16, 0.054, 212, 92, CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1 (BEST1) TRIPLE MUTANT: I76A F80A F84A; IN COMPLEX WITH AN FAB ANTIBODY FRAGMENT CHLORIDE AND CALCIUM
4673, 5bmfL, 0.6329, 2.94, 0.056, 216, 89, CRYSTAL STRUCTURE OF A THEOPHYLLINE BINDING ANTIBODY FAB FRAGMENT
4674, 4pttA, 0.6329, 2.96, 0.056, 213, 89, CRYSTAL STRUCTURE OF ANTI-23F STREP FAB C05
4675, 4mhjL, 0.6329, 3.07, 0.054, 215, 92, CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/GOOSE/GUANGDONG/1/96 (H5N1)
4676, 3v4pL, 0.6329, 3.02, 0.055, 217, 91, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1
4677, 2y36L, 0.6329, 2.77, 0.056, 211, 89, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-(4-HYDROXY-3- NITROPHENYL)- ACETYL MURINE GERMLINE ANTIBODY BBE6.12H3 FAB FRAGMENT IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE DLWTTAIPTIPS
4678, 2fr4A, 0.6329, 3.16, 0.054, 213, 93, STRUCTURE OF FAB DNA-1 COMPLEXED WITH A STEM-LOOP DNA LIGAND
4679, 2fjfA, 0.6329, 2.96, 0.056, 211, 90, STRUCTURE OF THE G6 FAB A PHAGE DERIVED VEGF BINDING FAB
4680, 2feeL, 0.6329, 2.96, 0.044, 211, 91, STRUCTURE OF THE CL-/H+ EXCHANGER CLC-EC1 FROM E.COLI IN NABR
4681, 1zlwL, 0.6329, 2.90, 0.056, 209, 89, FAB 2G12 + MAN8
4682, 1seqL, 0.6329, 2.87, 0.056, 208, 89, FAB MNAC13
4683, 1rziE, 0.6329, 2.86, 0.055, 211, 91, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 47E FAB
4684, 6i8sL, 0.6328, 2.92, 0.056, 211, 89, DISCOVERY AND CHARACTERISATION OF AN ANTIBODY THAT SELECTIVELY MODULATES THE INHIBITORY ACTIVITY OF PLASMINOGEN ACTIVATOR INHIBITOR- 1 
4685, 6al0L, 0.6328, 3.09, 0.043, 213, 93, THE NZ-1 FAB COMPLEXED WITH THE PDZ TANDEM FRAGMENT OF A. AEOLICUS S2P HOMOLOG WITH THE PA12 TAG INSERTED BETWEEN THE RESIDUES 263 AND 267 
4686, 5uekL, 0.6328, 2.94, 0.056, 209, 89, STRUCTURE OF ANTIGEN-FAB 12E COMPLEX WITH HISTONE CHAPERONE ASF1
4687, 5kzcL, 0.6328, 2.75, 0.057, 206, 88, CRYSTAL STRUCTURE OF AN HIV-1 GP120 ENGINEERED OUTER DOMAIN WITH A MAN9 GLYCAN AT POSITION N276 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODY VRC01
4688, 5kanK, 0.6328, 3.14, 0.065, 214, 93, CRYSTAL STRUCTURE OF MULTIDONOR HV1-18-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 16.G.07 IN COMPLEX WITH A/HONG KONG/1-4-MA21- 1/1968 (H3N2) HEMAGGLUTININ
4689, 5f3hH, 0.6328, 2.93, 0.056, 211, 89, STRUCTURE OF MYOSTATIN IN COMPLEX WITH HUMANIZED RK35 ANTIBODY
4690, 4yhoL, 0.6328, 3.10, 0.054, 219, 93, REVERSAL AGENT FOR DABIGATRAN
4691, 4rdqF, 0.6328, 3.16, 0.054, 212, 92, CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1 FROM CHICKEN IN COMPLEX WITH FAB ANTIBODY FRAGMENTS CHLORIDE AND CALCIUM
4692, 4r4hL, 0.6328, 2.92, 0.056, 210, 89, CRYSTAL STRUCTURE OF NON-NEUTRALIZING A32-LIKE ANTIBODY 2.2C IN COMPLEX WITH HIV-1 ENV GP120
4693, 4np4L, 0.6328, 2.81, 0.056, 213, 89, CLOSTRIDIUM DIFFICILE TOXIN B CROP DOMAIN IN COMPLEX WITH FAB DOMAINS OF NEUTRALIZING ANTIBODY BEZLOTOXUMAB
4694, 3b9kH, 0.6328, 3.32, 0.011, 214, 94, CRYSTAL STRUCTURE OF CD8ALPHA-BETA IN COMPLEX WITH YTS 156.7 FAB
4695, 2iffL, 0.6328, 3.23, 0.043, 212, 93, STRUCTURE OF AN ANTIBODY-LYSOZYME COMPLEX: EFFECT OF A CONSERVATIVE MUTATION
4696, 2hh0L, 0.6328, 2.97, 0.056, 210, 90, STRUCTURE OF AN ANTI-PRP FAB P-CLONE IN COMPLEX WITH ITS COGNATE BOVINE PEPTIDE EPITOPE.
4697, 1rziA, 0.6328, 3.04, 0.065, 211, 92, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 47E FAB
4698, 6bzuG, 0.6327, 3.30, 0.053, 220, 95, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 19B3 
4699, 5i1gL, 0.6327, 2.96, 0.056, 211, 90, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-53/IGKV3-11
4700, 5dyoL, 0.6327, 3.09, 0.055, 216, 91, FAB43.1 COMPLEX WITH FLOURESCEIN
4701, 4yk4Y, 0.6327, 2.74, 0.057, 211, 88, HUMAN ANTIBODY 641 I-9 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ H1 SOLOMON ISLANDS/03/2006
4702, 4i77H, 0.6327, 3.40, 0.042, 219, 95, LEBRIKIZUMAB FAB BOUND TO IL-13
4703, 4hfwL, 0.6327, 2.90, 0.055, 212, 91, ANTI ROTAVIRUS ANTIBODY
4704, 2w65B, 0.6327, 3.01, 0.055, 217, 91, ANTI CITRULLINATED COLLAGEN TYPE 2 ANTIBODY ACC4 IN COMPLEX WITH A CITRULLINATED PEPTIDE
4705, 2ajxL, 0.6327, 3.08, 0.055, 216, 91, CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB  IN COMPLEX WITH TRANSITION STATE ANALOG
4706, 1zanH, 0.6327, 3.31, 0.043, 216, 94, CRYSTAL STRUCTURE OF ANTI-NGF AD11 FAB
4707, 1yy9C, 0.6327, 2.91, 0.056, 211, 89, STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF CETUXIMAB/ERBITUX/IMC- C225
4708, 1otsF, 0.6327, 2.94, 0.044, 211, 91, STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL AND FAB COMPLEX
4709, 6rcuD, 0.6326, 3.26, 0.065, 210, 93, PFRH5 BOUND TO MONOCLONAL ANTIBODIES R5.004 AND R5.016 
4710, 6iebF, 0.6326, 2.81, 0.090, 204, 89, STRUCTURE OF RVFV GN AND HUMAN MONOCLONAL ANTIBODY R15 
4711, 6d9wL, 0.6326, 3.10, 0.065, 213, 93, CRYSTAL STRUCTURE OF DEINOCOCCUS RADIODURANS MNTH; AN NRAMP-FAMILY TRANSITION METAL TRANSPORTER; IN THE INWARD-OPEN APO STATE 
4712, 6c5hL, 0.6326, 3.12, 0.055, 216, 91, S25-5 FAB IN COMPLEX WITH CHLAMYDIACEAE-SPECIFIC LPS ANTIGEN 
4713, 5ggqL, 0.6326, 2.81, 0.056, 211, 89, CRYSTAL STRUCTURE OF NIVOLUMAB FAB FRAGMENT
4714, 4ttdD, 0.6326, 2.89, 0.089, 214, 90, STRUCTURE OF A LYSOZYME ANTIBODY COMPLEX
4715, 4rdqN, 0.6326, 3.17, 0.054, 212, 92, CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1 FROM CHICKEN IN COMPLEX WITH FAB ANTIBODY FRAGMENTS CHLORIDE AND CALCIUM
4716, 4m93C, 0.6326, 3.13, 0.054, 218, 93, UNLIGANDED 2 CRYSTAL STRUCTURE OF S25-26 FAB
4717, 4kjwF, 0.6326, 2.95, 0.044, 211, 91, STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE AND 20MM BROMIDE
4718, 4jpiL, 0.6326, 2.93, 0.056, 206, 89, CRYSTAL STRUCTURE OF A PUTATIVE VRC01 GERMLINE PRECURSOR FAB
4719, 3v4vN, 0.6326, 3.02, 0.055, 217, 91, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1 AND RO0505376
4720, 3c6sA, 0.6326, 3.09, 0.055, 216, 91, CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A SHIGELLA FLEXNERI 2A O-AG PENTADECASACCHARIDE
4721, 3bszL, 0.6326, 2.95, 0.056, 215, 90, CRYSTAL STRUCTURE OF THE TRANSTHYRETIN-RETINOL BINDING PROTEIN-FAB COMPLEX
4722, 2zuqB, 0.6326, 2.97, 0.043, 218, 93, CRYSTAL STRUCTURE OF DSBB-FAB COMPLEX
4723, 2ltqB, 0.6326, 2.97, 0.043, 218, 93, HIGH RESOLUTION STRUCTURE OF DSBB C41S BY JOINT CALCULATION WITH SOLID-STATE NMR AND X-RAY DATA
4724, 2erjC, 0.6326, 2.82, 0.100, 195, 90, CRYSTAL STRUCTURE OF THE HETEROTRIMERIC INTERLEUKIN-2 RECEPTOR IN COMPLEX WITH INTERLEUKIN-2
4725, 2ck0L, 0.6326, 2.95, 0.056, 216, 90, ANTI-ANTI-IDIOTYPIC ANTIBODY AGAINST HUMAN ANGIOTENSIN II COMPLEX WITH A SYNTHETIC CYCLIC PEPTIDE
4726, 1ggbL, 0.6326, 2.91, 0.056, 215, 89, MAJOR ANTIGEN-INDUCED DOMAIN REARRANGEMENTS IN AN ANTIBODY
4727, 6rcvI, 0.6325, 2.78, 0.057, 210, 88, PFRH5 BOUND TO MONOCLONAL ANTIBODIES R5.011 AND R5.016 
4728, 6rcsB, 0.6325, 3.08, 0.065, 197, 92, PFRH5-BINDING MONOCLONAL ANTIBODY R5.016 
4729, 6nczE, 0.6325, 2.78, 0.033, 589, 91, CRYSTAL STRUCTURE OF HYBRID BETA-GLUCURONIDASE/BETA-GALACTURONIDASE FROM FUSICATENIBACTER SACCHARIVORANS BOUND TO PHENYL-THIO-BETA-D- GLUCURONIDE 
4730, 6mttL, 0.6325, 2.90, 0.056, 211, 89, CRYSTAL STRUCTURE OF VRC46.01 FAB IN COMPLEX WITH GP41 PEPTIDE 
4731, 6mefL, 0.6325, 2.98, 0.055, 212, 91, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
4732, 6bzyH, 0.6325, 3.32, 0.053, 214, 95, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE 22D11 BROADLY NEUTRALIZING ANTIBODY 
4733, 5x8lO, 0.6325, 3.19, 0.065, 213, 93, PD-L1 IN COMPLEX WITH ATEZOLIZUMAB
4734, 5w5xL, 0.6325, 3.06, 0.043, 212, 92, CRYSTAL STRUCTURE OF BAXP168G IN COMPLEX WITH AN ACTIVATING ANTIBODY 
4735, 5t1dL, 0.6325, 3.15, 0.054, 217, 92, CRYSTAL STRUCTURE OF EBV GHGL/GP42/E1D1 COMPLEX
4736, 5mojB, 0.6325, 3.01, 0.022, 197, 91, CRYSTAL STRUCTURE OF IGE-FC EPSILON 3-4
4737, 5ifaL, 0.6325, 2.74, 0.057, 207, 88, CRYSTAL STRUCTURE OF UNBOUND VRC01C-HUGL2 FAB FROM AN HIV-1 NAIVE DONOR AT 1.82 A
4738, 5i5kY, 0.6325, 3.20, 0.075, 213, 93, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH ECULIZUMAB
4739, 5drzL, 0.6325, 2.74, 0.057, 216, 88, CRYSTAL STRUCTURE OF ANTI-HIV-1 ANTIBODY F240 FAB IN COMPLEX WITH GP41 PEPTIDE
4740, 4rdqH, 0.6325, 3.16, 0.054, 212, 92, CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1 FROM CHICKEN IN COMPLEX WITH FAB ANTIBODY FRAGMENTS CHLORIDE AND CALCIUM
4741, 3or7B, 0.6325, 3.17, 0.054, 212, 92, ON THE STRUCTURAL BASIS OF MODAL GATING BEHAVIOR IN K+CHANNELS - E71I
4742, 3o45A, 0.6325, 3.27, 0.032, 220, 94, CRYSTAL STRUCTURE OF 101F FAB BOUND TO 17-MER PEPTIDE EPITOPE
4743, 2z92B, 0.6325, 3.10, 0.055, 210, 91, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY 10C9 IN COMPLEX WITH CTX3C_ABCDE
4744, 2jixA, 0.6325, 2.83, 0.056, 214, 90, CRYSTAL STRUCTURE OF ABT-007 FAB FRAGMENT WITH THE SOLUBLE DOMAIN OF EPO RECEPTOR
4745, 2fjhA, 0.6325, 2.75, 0.057, 211, 88, STRUCTURE OF THE B20-4 FAB A PHAGE DERIVED FAB FRAGMENT IN COMPLEX WITH VEGF
4746, 1xcqC, 0.6325, 3.16, 0.054, 220, 92, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55AL57HY64W) IN SPACE GROUP P21
4747, 1t4kA, 0.6325, 3.00, 0.055, 217, 91, CRYSTAL STRUCTURE OF UNLIGANDED ALDOLASE ANTIBODY 93F3 FAB
4748, 6b5mL, 0.6324, 2.95, 0.056, 217, 90, STRUCTURE OF PFCSP PEPTIDE 21 WITH HUMAN PROTECTIVE ANTIBODY CIS43
4749, 5umiL, 0.6324, 3.06, 0.054, 210, 92, CLOSTRIDIUM DIFFICILE TCDA-CROPS BOUND TO PA50 FAB
4750, 5i5kL, 0.6324, 3.26, 0.075, 213, 93, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH ECULIZUMAB
4751, 5f9oL, 0.6324, 2.96, 0.056, 210, 89, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING VH1-46 GERMLINE-DERIVED CD4- BINDING SITE-DIRECTED ANTIBODY CH235.09 IN COMPLEX WITH HIV-1 CLADE A/E 93TH057 GP120
4752, 4whtD, 0.6324, 3.00, 0.033, 216, 91, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11 P1 CRYSTAL FORM
4753, 4kk9F, 0.6324, 2.96, 0.044, 211, 91, STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE AND 2MM BROMIDE
4754, 3wfhB, 0.6324, 3.05, 0.055, 216, 91, CRYSTAL STRUCTURE OF ANTI-PROSTAGLANDIN E2 FAB FRAGMENT PGE2 COMPLEX
4755, 3utzE, 0.6324, 2.97, 0.067, 212, 90, ENDOGENOUS-LIKE INHIBITORY ANTIBODIES TARGETING ACTIVATED METALLOPROTEINASE MOTIFS SHOW THERAPEUTIC POTENTIAL
4756, 3tclL, 0.6324, 3.00, 0.066, 214, 91, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY CH04
4757, 2f19L, 0.6324, 3.23, 0.053, 214, 94, THREE-DIMENSIONAL STRUCTURE OF TWO CRYSTAL FORMS OF FAB R19.9 FROM A MONOCLONAL ANTI-ARSONATE ANTIBODY
4758, 1riuL, 0.6324, 3.18, 0.054, 218, 93, ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH NORBENZOYLECGONINE
4759, 1fe8I, 0.6324, 3.30, 0.043, 210, 94, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A FAB FRAGMENT OF IGG RU5 THAT INHIBITS COLLAGEN BINDING
4760, 1a4jL, 0.6324, 3.01, 0.056, 217, 90, DIELS ALDER CATALYTIC ANTIBODY GERMLINE PRECURSOR
4761, 6iuvD, 0.6323, 2.74, 0.057, 215, 88, CRYSTAL STRUCTURE OF INFLUENZA A VIRUS H5 HEMAGGLUTININ GLOBULAR HEAD IN COMPLEX WITH THE FAB OF ANTIBODY 3C11 
4762, 6az2E, 0.6323, 2.86, 0.057, 210, 88, CRYSTAL STRUCTURE OF ASF1-FAB 12E COMPLEX
4763, 5vshD, 0.6323, 2.96, 0.067, 211, 90, CH1/CLAMBDA FAB BASED ON PERTUZUMAB
4764, 5fecL, 0.6323, 2.94, 0.056, 202, 89, CRYSTAL STRUCTURE OF 3BNC60 FAB GERMLINE PRECURSOR IN COMPLEX WITH 426C.TM4DELTAV1-3 GP120
4765, 5f3hF, 0.6323, 2.94, 0.056, 211, 89, STRUCTURE OF MYOSTATIN IN COMPLEX WITH HUMANIZED RK35 ANTIBODY
4766, 4py7J, 0.6323, 3.11, 0.055, 212, 91, CRYSTAL STRUCTURE OF FAB 3.1
4767, 3v4pN, 0.6323, 3.02, 0.055, 217, 91, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1
4768, 3f12A, 0.6323, 2.90, 0.045, 211, 89, GERMLINE V-GENES SCULPT THE BINDING SITE OF A FAMILY OF ANTIBODIES NEUTRALIZING HUMAN CYTOMEGALOVIRUS
4769, 3detF, 0.6323, 2.96, 0.044, 211, 91, STRUCTURE OF THE E148A Y445A DOUBLY UNGATED MUTANT OF E.COLI CLC_EC1 CL-/H+ ANTIPORTER
4770, 3b9kD, 0.6323, 3.30, 0.011, 214, 93, CRYSTAL STRUCTURE OF CD8ALPHA-BETA IN COMPLEX WITH YTS 156.7 FAB
4771, 2z91D, 0.6323, 2.93, 0.056, 208, 90, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY 10C9
4772, 1a6tA, 0.6323, 3.00, 0.056, 210, 90, FAB FRAGMENT OF MAB1-IA MONOCLONAL ANTIBODY TO HUMAN RHINOVIRUS 14 NIM-IA SITE
4773, 5uqyG, 0.6322, 2.79, 0.056, 210, 89, CRYSTAL STRUCTURE OF MARBURG VIRUS GP IN COMPLEX WITH THE HUMAN SURVIVOR ANTIBODY MR78
4774, 5n4gL, 0.6322, 2.80, 0.056, 216, 89, HUMAN FAB FRAGMENT 12E1 AGAINST NHBA FROM NEISSERIA MENINGITIDIS
4775, 5i16A, 0.6322, 2.92, 0.056, 211, 89, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV1-69/IGKV3-11
4776, 4yueH, 0.6322, 3.44, 0.042, 223, 96, MOUSE IL-2 BOUND TO S4B6 FAB FRAGMENT
4777, 4rdqJ, 0.6322, 3.03, 0.055, 212, 91, CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1 FROM CHICKEN IN COMPLEX WITH FAB ANTIBODY FRAGMENTS CHLORIDE AND CALCIUM
4778, 4o02L, 0.6322, 3.08, 0.043, 214, 92, ALPHAVBETA3 INTEGRIN IN COMPLEX WITH MONOCLONAL ANTIBODY FAB FRAGMENT.
4779, 3ra7M, 0.6322, 2.97, 0.056, 211, 90, BISPECIFIC DIGOXIGENIN BINDING ANTIBODIES FOR TARGETED PAYLOAD DELIVERY
4780, 3kymA, 0.6322, 3.10, 0.054, 213, 92, CRYSTAL STRUCTURE OF LI33 IGG2 DI-FAB
4781, 3bgfC, 0.6322, 2.96, 0.056, 210, 90, X-RAY CRYSTAL STRUCTURE OF THE SARS CORONAVIRUS SPIKE RECEPTOR BINDING DOMAIN IN COMPLEX WITH F26G19 FAB
4782, 32c2B, 0.6322, 3.29, 0.043, 218, 94, STRUCTURE OF AN ACTIVITY SUPPRESSING FAB FRAGMENT TO CYTOCHROME P450 AROMATASE
4783, 2w59B, 0.6322, 3.14, 0.033, 214, 92, STRUCTURE OF AN AVIAN IGY-FC 3-4 FRAGMENT
4784, 2fx9M, 0.6322, 3.03, 0.055, 214, 91, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH A THIOETHER-LINKED PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41
4785, 2fjfG, 0.6322, 2.95, 0.056, 211, 89, STRUCTURE OF THE G6 FAB A PHAGE DERIVED VEGF BINDING FAB
4786, 1t66C, 0.6322, 3.12, 0.043, 219, 93, THE STRUCTURE OF FAB WITH INTERMEDIATE AFFINITY FOR FLUORESCEIN.
4787, 1ruqL, 0.6322, 3.04, 0.055, 217, 91, CRYSTAL STRUCTURE (H) OF U.V.-IRRADIATED DIELS-ALDER ANTIBODY 13G5 FAB AT PH 8.0 WITH A DATA SET COLLECTED IN HOUSE.
4788, 1ggiM, 0.6322, 2.86, 0.045, 215, 89, CRYSTAL STRUCTURE OF AN HIV-1 NEUTRALIZING ANTIBODY 50.1 IN COMPLEX WITH ITS V3 LOOP PEPTIDE ANTIGEN
4789, 1cfsA, 0.6322, 3.32, 0.053, 214, 94, ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH AN EPITOPE-UNRELATED PEPTIDE
4790, 5vjoD, 0.6321, 2.98, 0.056, 211, 90, COMPLEX BETWEEN HYHEL10 FAB FRAGMENT HEAVY CHAIN MUTANT I29F AND PEKIN DUCK EGG LYSOZYME ISOFORM I (DEL-I) 
4791, 4zypM, 0.6321, 3.05, 0.066, 211, 91, CRYSTAL STRUCTURE OF MOTAVIZUMAB AND QUATERNARY-SPECIFIC RSV- NEUTRALIZING HUMAN ANTIBODY AM14 IN COMPLEX WITH PREFUSION RSV F GLYCOPROTEIN
4792, 4py7B, 0.6321, 3.01, 0.056, 212, 90, CRYSTAL STRUCTURE OF FAB 3.1
4793, 4o9hH, 0.6321, 3.13, 0.043, 200, 93, STRUCTURE OF INTERLEUKIN-6 IN COMPLEX WITH A CAMELID FAB FRAGMENT
4794, 4kjpF, 0.6321, 2.94, 0.055, 211, 91, STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN THE ABSENCE OF HALIDE
4795, 4hiiC, 0.6321, 2.99, 0.056, 205, 90, ANTI-STREPTOCOCCUS PNEUMONIAE 23F FAB 023.102 WITH BOUND RHAMNOSE- GALACTOSE
4796, 4gw4L, 0.6321, 3.02, 0.067, 198, 89, CRYSTAL STRUCTURE OF 3BNC60 FAB WITH P61A MUTATION
4797, 4grgD, 0.6321, 3.41, 0.062, 213, 97, CRYSTAL STRUCTURE OF IGE COMPLEXED WITH E2_79 AN ANTI-IGE INHIBITOR
4798, 3bjlB, 0.6321, 3.04, 0.065, 215, 93, LOC A LAMBDA 1 TYPE LIGHT-CHAIN DIMER (BENCE-JONES PROTEIN) CRYSTALLIZED IN AMMONIUM SULFATE
4799, 1frgL, 0.6321, 3.06, 0.055, 217, 91, CRYSTAL STRUCTURE SEQUENCE AND EPITOPE MAPPING OF A PEPTIDE COMPLEX OF AN ANTI-INFLUENZA HA PEPTIDE ANTIBODY FAB 26(SLASH)9: FINE-TUNING ANTIBODY SPECIFICITY
4800, 6iutL, 0.6320, 2.85, 0.056, 214, 89, CRYSTAL STRUCTURE OF INFLUENZA A VIRUS H5 HEMAGGLUTININ GLOBULAR HEAD IN COMPLEX WITH THE FAB OF ANTIBODY AVFLUIGG01 
4801, 6bhqB, 0.6320, 2.97, 0.121, 199, 91, MOUSE IMMUNOGLOBULIN G 2C FC FRAGMENT WITH COMPLEX-TYPE GLYCAN
4802, 5vl3D, 0.6320, 2.94, 0.056, 216, 89, CD22 D1-D3 IN COMPLEX WITH THERAPEUTIC FAB EPRATUZUMAB
4803, 5hysF, 0.6320, 2.97, 0.056, 215, 90, STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB
4804, 5e2tL, 0.6320, 2.74, 0.057, 216, 88, CRYSTAL STRUCTURE OF ANTI-TAU ANTIBODY AT8 FAB
4805, 4yr6E, 0.6320, 3.09, 0.055, 211, 91, FAB FRAGMENT OF 5G6 IN COMPLEX WITH EPITOPE PEPTIDE
4806, 4kkbD, 0.6320, 2.96, 0.044, 211, 91, STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 20MM FLUORIDE AND 20MM BROMIDE
4807, 3qg6L, 0.6320, 3.08, 0.054, 218, 92, STRUCTURAL BASIS FOR LIGAND RECOGNITION AND DISCRIMINATION OF A QUORUM QUENCHING ANTIBODY
4808, 3ijyA, 0.6320, 2.90, 0.056, 215, 90, STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)KDO
4809, 2r9hF, 0.6320, 2.97, 0.044, 211, 91, CRYSTAL STRUCTURE OF Q207C MUTANT OF CLC-EC1 IN COMPLEX WITH FAB
4810, 2fjfS, 0.6320, 2.94, 0.056, 211, 89, STRUCTURE OF THE G6 FAB A PHAGE DERIVED VEGF BINDING FAB
4811, 2ajvL, 0.6320, 3.09, 0.055, 216, 91, CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB  IN COMPLEX WITH COCAINE
4812, 1ottD, 0.6320, 2.95, 0.044, 211, 91, STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL E148A MUTANT AND FAB COMPLEX
4813, 1mrdL, 0.6320, 2.95, 0.044, 216, 90, PREPARATION CHARACTERIZATION AND CRYSTALLIZATION OF AN ANTIBODY FAB FRAGMENT THAT RECOGNIZES RNA. CRYSTAL STRUCTURES OF NATIVE FAB AND THREE FAB-MONONUCLEOTIDE COMPLEXES
4814, 6emjB, 0.6319, 2.98, 0.055, 213, 91, FAB FRAGMENT. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN ANTIBODY DRUG DISCOVERY
4815, 6d7fE, 0.6319, 2.70, 0.044, 579, 90, BACTEROIDES UNIFORMIS BETA-GLUCURONIDASE 1 BOUND TO THIOPHENYL-BETA-D- GLUCURONIDE 
4816, 5wttB, 0.6319, 3.12, 0.055, 216, 91, STRUCTURE OF THE 093G9 FAB IN COMPLEX WITH THE EPITOPE PEPTIDE
4817, 5uddU, 0.6319, 2.69, 0.057, 208, 87, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
4818, 5tljC, 0.6319, 3.12, 0.055, 215, 91, COMPLEX BETWEEN HUMAN CD27 AND FAB FRAGMENTS OF ANTIBODIES M2177 AND M2191
4819, 4xnqA, 0.6319, 2.93, 0.089, 208, 90, ANTIBODY HEMAGGLUTININ COMPLEXES
4820, 4r7nH, 0.6319, 2.97, 0.056, 211, 90, FAB C2E3
4821, 4mxwV, 0.6319, 2.93, 0.056, 211, 89, STRUCTURE OF HETEROTRIMERIC LYMPHOTOXIN LTA1B2 BOUND TO LYMPHOTOXIN BETA RECEPTOR LTBR AND ANTI-LTA FAB
4822, 4kkcF, 0.6319, 2.94, 0.044, 211, 91, STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 20MM BROMIDE
4823, 4hieA, 0.6319, 2.95, 0.056, 212, 89, ANTI-STREPTOCOCCUS PNEUMONIAE 23F FAB 023.102
4824, 3q6gM, 0.6319, 2.85, 0.090, 209, 89, CRYSTAL STRUCTURE OF FAB OF RHESUS MAB 2.5B SPECIFIC FOR QUATERNARY NEUTRALIZING EPITOPE OF HIV-1 GP120
4825, 3hfmL, 0.6319, 3.03, 0.043, 214, 93, STRUCTURE OF AN ANTIBODY-ANTIGEN COMPLEX. CRYSTAL STRUCTURE OF THE HY/HEL-10 FAB-LYSOZYME COMPLEX
4826, 3bkjL, 0.6319, 3.03, 0.055, 218, 91, CRYSTAL STRUCTURE OF FAB WO2 BOUND TO THE N TERMINAL DOMAIN OF AMYLOID BETA PEPTIDE (1-16)
4827, 2dwdB, 0.6319, 3.24, 0.054, 212, 93, CRYSTAL STRUCTURE OF KCSA-FAB-TBA COMPLEX IN TL+
4828, 1ngpL, 0.6319, 2.78, 0.056, 211, 89, N1G9 (IGG1-LAMBDA) FAB FRAGMENT COMPLEXED WITH (4-HYDROXY-3- NITROPHENYL) ACETATE
4829, 1axsL, 0.6319, 2.76, 0.057, 211, 88, MATURE OXY-COPE CATALYTIC ANTIBODY WITH HAPTEN
4830, 6bzvE, 0.6318, 3.32, 0.053, 218, 95, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE GL PRECURSOR OF THE BROADLY NEUTRALIZING ANTIBODY 19B3 
4831, 5vphC, 0.6318, 3.11, 0.055, 211, 91, CRYSTAL STRUCTURE OF DER P 1 COMPLEXED WITH FAB 4C1
4832, 5jofB, 0.6318, 3.06, 0.054, 210, 92, CRYSTAL STRUCTURE OF VRC03 GHVGLV ANTIGEN-BINDING FRAGMENT.
4833, 3rvxC, 0.6318, 3.11, 0.055, 211, 91, CRYSTAL STRUCTURE OF DER P 1 COMPLEXED WITH FAB 4C1
4834, 3rifM, 0.6318, 2.78, 0.057, 210, 88, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND GLUTAMATE.
4835, 3pnwA, 0.6318, 2.94, 0.056, 213, 89, CRYSTAL STRUCTURE OF THE TUDOR DOMAIN OF HUMAN TDRD3 IN COMPLEX WITH AN ANTI-TDRD3 FAB
4836, 3eyvL, 0.6318, 2.75, 0.057, 216, 88, ANTI-LEWIS Y FAB FRAGMENT WITH LEWIS Y ANTIGEN IN THE PRESENCE OF ZINC IONS
4837, 2gsiC, 0.6318, 3.09, 0.055, 215, 91, CRYSTAL STRUCTURE OF A MURINE FAB IN COMPLEX WITH AN 11 RESIDUE PEPTIDE DERIVED FROM STAPHYLOCOCCAL NUCLEASE
4838, 5nyxN, 0.6317, 3.02, 0.056, 210, 90, HUMAN FAB FRAGMENT 5H2 AGAINST NHBA FROM NEISSERIA MENINGITIDIS 
4839, 4ynyB, 0.6317, 2.95, 0.056, 209, 90, CRYSTAL STRUCTURE OF MONOCLONAL ANTI-HUMAN PODOPLANIN ANTIBODY NZ-1
4840, 4xwoV, 0.6317, 3.14, 0.054, 215, 93, STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF SEC22
4841, 4rfnC, 0.6317, 2.80, 0.067, 210, 89, CRYSTAL STRUCTURE OF ADCC-POTENT RHESUS MACAQUE ANTIBODY JR4 IN COMPLEX WITH HIV-1 CLADE A/E GP120 AND M48
4842, 4mxwL, 0.6317, 2.93, 0.056, 211, 89, STRUCTURE OF HETEROTRIMERIC LYMPHOTOXIN LTA1B2 BOUND TO LYMPHOTOXIN BETA RECEPTOR LTBR AND ANTI-LTA FAB
4843, 3l7fA, 0.6317, 3.08, 0.054, 213, 92, STRUCTURE OF IL-13 ANTIBODY H2L6 A HUMANIZED VARIANT OF C836
4844, 3fo0L, 0.6317, 3.03, 0.056, 216, 90, CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (WILD-TYPE)
4845, 3bszM, 0.6317, 2.96, 0.056, 215, 90, CRYSTAL STRUCTURE OF THE TRANSTHYRETIN-RETINOL BINDING PROTEIN-FAB COMPLEX
4846, 1mcwW, 0.6317, 2.95, 0.065, 215, 92, THREE-DIMENSIONAL STRUCTURE OF A HYBRID LIGHT CHAIN DIMER. PROTEIN ENGINEERING OF A BINDING CAVITY
4847, 6ncwA, 0.6316, 3.02, 0.108, 561, 93, CRYSTAL STRUCTURE OF A GH2 BETA-GALACTURONIDASE FROM EISENBERGIELLA TAYI BOUND TO GLYCEROL 
4848, 6bzvG, 0.6316, 3.33, 0.042, 221, 95, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE GL PRECURSOR OF THE BROADLY NEUTRALIZING ANTIBODY 19B3 
4849, 6bpcF, 0.6316, 3.13, 0.054, 211, 92, PLASMODIUM VIVAX RETICULOCYTE BINDING PROTEIN 2B (PVRBP2B) BOUND TO MONOCLONAL ANTIBODY 4F7 
4850, 6azxD, 0.6316, 2.73, 0.057, 215, 88, CRYSTAL STRUCTURE OF THE NEUTRALIZING ANTI-CIRCUMSPOROZOITE PROTEIN 663 ANTIBODY
4851, 5t5nJ, 0.6316, 2.97, 0.044, 212, 91, CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1 (BEST1) TRIPLE MUTANT: I76A F80A F84A; IN COMPLEX WITH AN FAB ANTIBODY FRAGMENT CHLORIDE AND CALCIUM
4852, 5gjsL, 0.6316, 2.58, 0.057, 207, 87, CRYSTAL STRUCTURE OF H1 HEMAGGLUTININ FROM A/CALIFORNIA/04/2009 IN COMPLEX WITH A NEUTRALIZING ANTIBODY 3E1
4853, 4od2A, 0.6316, 2.81, 0.090, 209, 89, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF AN ANTI-DR5 ANTIBODY BOUND TO DR5
4854, 3r19A, 0.6316, 3.36, 0.062, 372, 97, CHICKEN SULFITE OXIDASE TRIPLE MUTANT WITH ALTERED ACTIVITY AND SUBSTRATE AFFINITY
4855, 3qo0B, 0.6316, 3.36, 0.074, 220, 95, MONOCLINIC FORM OF IGG1 FAB FRAGMENT (IN COMPLEX WITH ANTIGENIC PEPTIDE) SHARING SAME FV AS IGA
4856, 3lpfB, 0.6316, 2.88, 0.056, 590, 89, STRUCTURE OF E. COLI BETA-GLUCURONIDASE BOUND WITH A NOVEL POTENT INHIBITOR 1-((67-DIMETHYL-2-OXO-12-DIHYDROQUINOLIN-3-YL)METHYL)-1- (2-HYDROXYETHYL)-3-(3-METHOXYPHENYL)THIOUREA
4857, 2ypvL, 0.6316, 2.99, 0.055, 212, 91, CRYSTAL STRUCTURE OF THE MENINGOCOCCAL VACCINE ANTIGEN FACTOR H BINDING PROTEIN IN COMPLEX WITH A BACTERICIDAL ANTIBODY
4858, 2fjfO, 0.6316, 2.75, 0.057, 211, 88, STRUCTURE OF THE G6 FAB A PHAGE DERIVED VEGF BINDING FAB
4859, 1ncdL, 0.6316, 3.05, 0.043, 214, 92, REFINED CRYSTAL STRUCTURE OF THE INFLUENZA VIRUS N9 NEURAMINIDASE-NC41 FAB COMPLEX
4860, 6i8sI, 0.6315, 2.95, 0.056, 211, 89, DISCOVERY AND CHARACTERISATION OF AN ANTIBODY THAT SELECTIVELY MODULATES THE INHIBITORY ACTIVITY OF PLASMINOGEN ACTIVATOR INHIBITOR- 1 
4861, 6bzvA, 0.6315, 3.33, 0.053, 218, 95, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE GL PRECURSOR OF THE BROADLY NEUTRALIZING ANTIBODY 19B3 
4862, 5uddQ, 0.6315, 2.75, 0.057, 211, 88, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
4863, 5ubxB, 0.6315, 2.87, 0.133, 201, 90, CRYSTAL STRUCTURE OF A MUTANT MIGG2B FC HETERODIMER IN COMPLEX WITH PROTEIN A PEPTIDE ANALOG Z34C
4864, 5t0yL, 0.6315, 3.27, 0.054, 212, 93, 2A10 ANTIBODY FAB FRAGMENT
4865, 5m5eC, 0.6315, 2.77, 0.112, 193, 89, CRYSTAL STRUCTURE OF A INTERLEUKIN-2 VARIANT IN COMPLEX WITH INTERLEUKIN-2 RECEPTOR
4866, 4gagH, 0.6315, 3.41, 0.031, 212, 96, STRUCTURE OF THE BROADLY NEUTRALIZING ANTIBODY AP33 IN COMPLEX WITH ITS HCV EPITOPE (E2 RESIDUES 412-423)
4867, 3wiiM, 0.6315, 3.07, 0.044, 213, 91, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF B2212A A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1.
4868, 3riaL, 0.6315, 2.79, 0.080, 210, 88, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND IODIDE.
4869, 3rhwL, 0.6315, 2.79, 0.080, 210, 88, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND IVERMECTIN
4870, 3nz8B, 0.6315, 3.17, 0.054, 217, 92, CRYSTAL STRUCTURE OF THE HIV-2 NEUTRALIZING FAB FRAGMENT 7C8
4871, 2p7tB, 0.6315, 3.25, 0.054, 212, 93, CRYSTAL STRUCTURE OF KCSA MUTANT
4872, 1mceA, 0.6315, 2.90, 0.054, 216, 92, PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
4873, 6db7I, 0.6314, 3.46, 0.042, 233, 96, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 1334 IN COMPLEX WITH A HIV-1 GP120 V3 PEPTIDE FROM MN STRAIN 
4874, 6d11D, 0.6314, 2.82, 0.056, 211, 89, CRYSTAL STRUCTURE OF 1450 FAB IN COMPLEX WITH CIRCUMSPOROZOITE PROTEIN NANP5 
4875, 6bzvC, 0.6314, 3.33, 0.042, 218, 95, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE GL PRECURSOR OF THE BROADLY NEUTRALIZING ANTIBODY 19B3 
4876, 5iieL, 0.6314, 2.82, 0.079, 211, 89, STRUCTURE OF THE UNLIGANDED ANTI-HIV ANTIBODY DH501 THAT BINDS GP120 V3 GLYCAN AND THE BASE OF V3
4877, 3pnwJ, 0.6314, 2.76, 0.057, 213, 88, CRYSTAL STRUCTURE OF THE TUDOR DOMAIN OF HUMAN TDRD3 IN COMPLEX WITH AN ANTI-TDRD3 FAB
4878, 3o45H, 0.6314, 3.35, 0.042, 220, 95, CRYSTAL STRUCTURE OF 101F FAB BOUND TO 17-MER PEPTIDE EPITOPE
4879, 2ht2F, 0.6314, 2.98, 0.044, 211, 91, STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445H MUTANT AND FAB COMPLEX
4880, 2fjfW, 0.6314, 2.99, 0.067, 211, 90, STRUCTURE OF THE G6 FAB A PHAGE DERIVED VEGF BINDING FAB
4881, 2adiA, 0.6314, 3.11, 0.055, 211, 91, CRYSTAL STRUCTURE OF MONOCLONAL ANTI-CD4 ANTIBODY Q425 IN COMPLEX WITH BARIUM
4882, 1nccL, 0.6314, 2.89, 0.044, 214, 91, CRYSTAL STRUCTURES OF TWO MUTANT NEURAMINIDASE-ANTIBODY COMPLEXES WITH AMINO ACID SUBSTITUTIONS IN THE INTERFACE
4883, 6n5bL, 0.6313, 2.78, 0.068, 211, 88, BROADLY PROTECTIVE ANTIBODIES DIRECTED TO A SUBDOMINANT INFLUENZA HEMAGGLUTININ EPITOPE 
4884, 6ewbI, 0.6313, 3.11, 0.055, 211, 91, CRYSTAL STRUCTURE OF GII.4 UNSW 2012 P DOMAIN IN COMPLEX WITH FAB 10E9 
4885, 6bpbB, 0.6313, 3.11, 0.054, 209, 92, PLASMODIUM VIVAX INVASION BLOCKING MONOCLONAL ANTIBODY 4F7 
4886, 5cinL, 0.6313, 2.92, 0.056, 212, 89, CRYSTAL STRUCTURE OF NON-NEUTRALIZING VERSION OF 4E10 (DELTALOOP) WITH EPITOPE BOUND
4887, 4jdvL, 0.6313, 3.08, 0.054, 209, 92, CRYSTAL STRUCTURE OF GERM-LINE PRECURSOR OF NIH45-46 FAB
4888, 3wlwL, 0.6313, 2.93, 0.043, 217, 92, MOLECULAR ARCHITECTURE OF THE ERBB2 EXTRACELLULAR DOMAIN HOMODIMER
4889, 3bn9E, 0.6313, 3.00, 0.056, 211, 90, CRYSTAL STRUCTURE OF MT-SP1 IN COMPLEX WITH FAB INHIBITOR E2
4890, 1wc7A, 0.6313, 3.20, 0.054, 212, 93, FAB FRAGMENT OF PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH PHOSPHOPYRIDOXYL-L-ALANINE
4891, 5vjoB, 0.6312, 3.10, 0.055, 211, 91, COMPLEX BETWEEN HYHEL10 FAB FRAGMENT HEAVY CHAIN MUTANT I29F AND PEKIN DUCK EGG LYSOZYME ISOFORM I (DEL-I) 
4892, 5tpsB, 0.6312, 2.97, 0.111, 192, 90, STRUCTURE OF A FC HETERODIMER
4893, 5d1qD, 0.6312, 2.79, 0.056, 214, 90, ISDB NEAT2 BOUND BY CLONE D2-06
4894, 4mqxF, 0.6312, 2.95, 0.044, 211, 91, CLC-EC1 FAB COMPLEX CYSLESS A399C-A432C MUTANT
4895, 4jo4L, 0.6312, 2.92, 0.066, 214, 91, CRYSTAL STRUCTURE OF RABBIT MAB R20 FAB
4896, 4hhaA, 0.6312, 3.09, 0.054, 212, 92, ANTI-HUMAN CYTOMEGALOVIRUS (HCMV) FAB KE5 WITH EPITOPE PEPTIDE AD-2S1
4897, 3qg6A, 0.6312, 3.09, 0.054, 218, 92, STRUCTURAL BASIS FOR LIGAND RECOGNITION AND DISCRIMINATION OF A QUORUM QUENCHING ANTIBODY
4898, 3lpgB, 0.6312, 2.94, 0.056, 590, 90, STRUCTURE OF E. COLI BETA-GLUCURONIDASE BOUND WITH A NOVEL POTENT INHIBITOR 3-(2-FLUOROPHENYL)-1-(2-HYDROXYETHYL)-1-((6-METHYL-2-OXO-1 2-DIHYDROQUINOLIN-3-YL)METHYL)UREA
4899, 1fh5L, 0.6312, 3.19, 0.054, 213, 93, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE MONOCLONAL ANTIBODY MAK33
4900, 6mwxP, 0.6311, 2.81, 0.056, 211, 89, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-69 ANTIBODY 
4901, 6mwxL, 0.6311, 2.81, 0.056, 211, 89, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-69 ANTIBODY 
4902, 6mwxH, 0.6311, 2.81, 0.056, 211, 89, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-69 ANTIBODY 
4903, 6mwxD, 0.6311, 2.81, 0.056, 211, 89, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-69 ANTIBODY 
4904, 6mwvP, 0.6311, 2.81, 0.056, 211, 89, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-58 ANTIBODY 
4905, 6mwvL, 0.6311, 2.81, 0.056, 211, 89, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-58 ANTIBODY 
4906, 6mwvH, 0.6311, 2.81, 0.056, 211, 89, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-58 ANTIBODY 
4907, 6mwvD, 0.6311, 2.81, 0.056, 211, 89, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-58 ANTIBODY 
4908, 6mwcP, 0.6311, 2.81, 0.056, 211, 89, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-5 ANTIBODY 
4909, 6mwcL, 0.6311, 2.81, 0.056, 211, 89, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-5 ANTIBODY 
4910, 6mwcH, 0.6311, 2.81, 0.056, 211, 89, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-5 ANTIBODY 
4911, 6mwcD, 0.6311, 2.81, 0.056, 211, 89, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-5 ANTIBODY 
4912, 6mw9P, 0.6311, 2.81, 0.056, 211, 89, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-3 ANTIBODY 
4913, 6mw9L, 0.6311, 2.81, 0.056, 211, 89, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-3 ANTIBODY 
4914, 6mw9H, 0.6311, 2.81, 0.056, 211, 89, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-3 ANTIBODY 
4915, 6mw9D, 0.6311, 2.81, 0.056, 211, 89, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-3 ANTIBODY 
4916, 6muiP, 0.6311, 2.81, 0.056, 211, 89, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-42 ANTIBODY 
4917, 6muiL, 0.6311, 2.81, 0.056, 211, 89, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-42 ANTIBODY 
4918, 6muiH, 0.6311, 2.81, 0.056, 211, 89, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-42 ANTIBODY 
4919, 6muiD, 0.6311, 2.81, 0.056, 211, 89, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-42 ANTIBODY 
4920, 5udcC, 0.6311, 2.81, 0.057, 211, 88, CRYSTAL STRUCTURE OF RSV F A2 BOUND TO MEDI8897
4921, 5anyP, 0.6311, 2.81, 0.056, 211, 89, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VIRUS IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK265
4922, 5anyO, 0.6311, 2.81, 0.056, 211, 89, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VIRUS IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK265
4923, 5anyN, 0.6311, 2.81, 0.056, 211, 89, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VIRUS IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK265
4924, 5anyM, 0.6311, 2.81, 0.056, 211, 89, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VIRUS IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK265
4925, 4xrcA, 0.6311, 2.95, 0.089, 208, 90, ANTIBODY HEMAGGLUTININ COMPLEXES
4926, 4mxvL, 0.6311, 2.99, 0.044, 211, 90, STRUCTURE OF LYMPHOTOXIN ALPHA BOUND TO ANTI-LTA FAB
4927, 4louF, 0.6311, 2.97, 0.044, 211, 91, STRUCTURE OF THE E148Q MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN THE ABSENCE OF HALIDE
4928, 4kk8F, 0.6311, 2.96, 0.044, 211, 91, STRUCTURE OF THE E148Q MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE
4929, 4at6I, 0.6311, 2.98, 0.044, 212, 91, FAB FRAGMENT OF ANTIPORPHYRIN ANTIBODY 14H7
4930, 4acpA, 0.6311, 3.00, 0.111, 198, 90, DEACTIVATION OF HUMAN IGG1 FC BY ENDOGLYCOSIDASE TREATMENT
4931, 43c9B, 0.6311, 3.25, 0.065, 118, 93, CRYSTALLOGRAPHIC STRUCTURE OF THE ESTEROLYTIC AND AMIDOLYTIC 43C9 ANTIBODY
4932, 1qkzL, 0.6311, 3.01, 0.043, 214, 92, FAB FRAGMENT (MN14C11.6) IN COMPLEX WITH A PEPTIDE ANTIGEN DERIVED FROM NEISSERIA MENINGITIDIS P1.7 SEROSUBTYPE ANTIGEN AND DOMAIN II FROM STREPTOCOCCAL PROTEIN G
4933, 1kemL, 0.6311, 2.99, 0.044, 217, 91, CATALYTIC ANTIBODY 28B4 FAB FRAGMENT
4934, 1fe8H, 0.6311, 3.31, 0.032, 210, 94, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A FAB FRAGMENT OF IGG RU5 THAT INHIBITS COLLAGEN BINDING
4935, 6nczB, 0.6310, 2.78, 0.033, 588, 91, CRYSTAL STRUCTURE OF HYBRID BETA-GLUCURONIDASE/BETA-GALACTURONIDASE FROM FUSICATENIBACTER SACCHARIVORANS BOUND TO PHENYL-THIO-BETA-D- GLUCURONIDE 
4936, 5x08L, 0.6310, 2.93, 0.056, 212, 89, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY 4E10 MUTANT NPRO WITH PEPTIDE BOUND
4937, 5tkjK, 0.6310, 2.99, 0.056, 216, 90, STRUCTURE OF VACCINE-ELICITED DIVERSE HIV-1 NEUTRALIZING ANTIBODY VFP1.01 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519
4938, 4zpvL, 0.6310, 3.12, 0.054, 212, 92, STRUCTURE OF MERS-CORONAVIRUS SPIKE RECEPTOR-BINDING DOMAIN (ENGLAND1 STRAIN) IN COMPLEX WITH VACCINE-ELICITED MURINE NEUTRALIZING ANTIBODY D12 (CRYSTAL FORM 2)
4939, 4wy7L, 0.6310, 2.92, 0.056, 212, 89, CRYSTAL STRUCTURE OF RECOMBINANT 4E10 EXPRESSED IN ESCHERICHIA COLI WITH EPITOPE BOUND
4940, 4whtP, 0.6310, 3.00, 0.044, 215, 90, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11 P1 CRYSTAL FORM
4941, 4j1uA, 0.6310, 2.85, 0.057, 210, 88, CRYSTAL STRUCTURE OF ANTIBODY 93F3 UNSTABLE VARIANT
4942, 3uc0M, 0.6310, 2.75, 0.057, 211, 88, CRYSTAL STRUCTURE OF DOMAIN I OF THE ENVELOPE GLYCOPROTEIN ECTODOMAIN FROM DENGUE VIRUS SEROTYPE 4 IN COMPLEX WITH THE FAB FRAGMENT OF THE CHIMPANZEE MONOCLONAL ANTIBODY 5H2
4943, 3rifL, 0.6310, 2.79, 0.080, 210, 88, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND GLUTAMATE.
4944, 3pqyO, 0.6310, 3.13, 0.064, 240, 94, CRYSTAL STRUCTURE OF 6218 TCR IN COMPLEX WITH THE H2DB-PA224
4945, 1ngqL, 0.6310, 2.81, 0.056, 211, 89, N1G9 (IGG1-LAMBDA) FAB FRAGMENT
4946, 6nczD, 0.6309, 2.78, 0.033, 589, 91, CRYSTAL STRUCTURE OF HYBRID BETA-GLUCURONIDASE/BETA-GALACTURONIDASE FROM FUSICATENIBACTER SACCHARIVORANS BOUND TO PHENYL-THIO-BETA-D- GLUCURONIDE 
4947, 6ncwD, 0.6309, 2.96, 0.042, 560, 95, CRYSTAL STRUCTURE OF A GH2 BETA-GALACTURONIDASE FROM EISENBERGIELLA TAYI BOUND TO GLYCEROL 
4948, 5kteL, 0.6309, 3.11, 0.065, 213, 93, CRYSTAL STRUCTURE OF DEINOCOCCUS RADIODURANS MNTH AN NRAMP-FAMILY TRANSITION METAL TRANSPORTER
4949, 4lvoC, 0.6309, 3.46, 0.032, 214, 95, CRYSTAL STRUCTURE OF PFSUB1-PRODOMAIN-NIMP.M7 FAB COMPLEX WITH ADDED CACL2
4950, 4hj0D, 0.6309, 2.87, 0.067, 211, 89, CRYSTAL STRUCTURE OF THE HUMAN GIPR ECD IN COMPLEX WITH GIPG013 FAB AT 3-A RESOLUTION
4951, 3v0wL, 0.6309, 3.07, 0.055, 211, 91, CRYSTAL STRUCTURE OF FAB WN1 222-5 IN COMPLEX WITH LPS
4952, 3qwoL, 0.6309, 2.77, 0.057, 210, 88, CRYSTAL STRUCTURE OF A MOTAVIZUMAB EPITOPE-SCAFFOLD BOUND TO MOTAVIZUMAB FAB
4953, 3mclL, 0.6309, 3.05, 0.056, 209, 90, ANTI-BETA-AMYLOID ANTIBODY C706 FAB IN SPACE GROUP P21
4954, 3k4aA, 0.6309, 2.87, 0.057, 584, 88, CRYSTAL STRUCTURE OF SELENOMETHIONINE SUBSTITUTED E. COLI BETA- GLUCURONIDASE
4955, 2b2xL, 0.6309, 2.98, 0.056, 210, 90, VLA1 RDELTAH I-DOMAIN COMPLEXED WITH A QUADRUPLE MUTANT OF THE AQC2 FAB
4956, 1tetL, 0.6309, 3.15, 0.066, 216, 91, CRYSTAL STRUCTURE OF AN ANTICHOLERA TOXIN PEPTIDE COMPLEX AT 2.3 ANGSTROMS
4957, 1n6qL, 0.6309, 2.97, 0.056, 211, 90, HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO PRE- TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX N)
4958, 1iaiM, 0.6309, 3.05, 0.054, 215, 92, IDIOTYPE-ANTI-IDIOTYPE FAB COMPLEX
4959, 1axsA, 0.6309, 2.77, 0.057, 211, 88, MATURE OXY-COPE CATALYTIC ANTIBODY WITH HAPTEN
4960, 6qn8J, 0.6308, 3.21, 0.022, 227, 93, STRUCTURE OF BOVINE ANTI-RSV FAB B13 
4961, 6faxL, 0.6308, 2.94, 0.056, 211, 89, COMPLEX OF HUMAN CD40 ECTODOMAIN WITH LOB 7.4 FAB
4962, 5wavB, 0.6308, 2.88, 0.054, 207, 92, FC ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION-MAKING IN ANTIBODY DRUG DISCOVERY.
4963, 5dq9B, 0.6308, 2.85, 0.045, 212, 88, STRUCTURE OF S55-3 FAB IN COMPLEX WITH LIPID A
4964, 5cilL, 0.6308, 2.92, 0.056, 212, 89, CRYSTAL STRUCTURE OF NON-NEUTRALIZING VERSION OF 4E10 (WDWD) WITH EPITOPE BOUND
4965, 4mhhK, 0.6308, 3.06, 0.054, 217, 92, CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/VIET NAM/1203/2004 (H5N1)
4966, 3vg9B, 0.6308, 3.01, 0.044, 212, 91, CRYSTAL STRUCTURE OF HUMAN ADENOSINE A2A RECEPTOR WITH AN ALLOSTERIC INVERSE-AGONIST ANTIBODY AT 2.7 A RESOLUTION
4967, 3tnmL, 0.6308, 2.81, 0.090, 210, 89, CRYSTAL STRUCTURE OF A32 FAB AN ADCC MEDIATING ANTI-HIV-1 ANTIBODY
4968, 3riaM, 0.6308, 2.79, 0.057, 210, 88, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND IODIDE.
4969, 3rhwM, 0.6308, 2.79, 0.057, 210, 88, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND IVERMECTIN
4970, 3o41A, 0.6308, 3.29, 0.032, 217, 94, CRYSTAL STRUCTURE OF 101F FAB BOUND TO 15-MER PEPTIDE EPITOPE
4971, 3hmwL, 0.6308, 2.90, 0.055, 214, 91, CRYSTAL STRUCTURE OF USTEKINUMAB FAB
4972, 3ejzF, 0.6308, 2.98, 0.044, 211, 91, STRUCTURE OF E203V MUTANT E.COLI CL-/H+ EXCHANGER CLC-EC1
4973, 2mcpL, 0.6308, 3.16, 0.043, 220, 93, REFINED CRYSTAL STRUCTURE OF THE MC/PC603 FAB-PHOSPHOCHOLINE COMPLEX AT 3.1 ANGSTROMS RESOLUTION
4974, 2exyD, 0.6308, 2.96, 0.044, 211, 91, CRYSTAL STRUCTURE OF THE E148Q MUTANT OF ECCLC FAB COMPLEXED IN ABSENCE OF BOUND IONS
4975, 2esvE, 0.6308, 3.14, 0.064, 240, 94, STRUCTURE OF THE HLA-E-VMAPRTLIL/KK50.4 TCR COMPLEX
4976, 6mftL, 0.6307, 3.04, 0.055, 208, 91, CRYSTAL STRUCTURE OF GLYCOSYLATED 426C HIV-1 GP120 CORE G459C IN COMPLEX WITH GLVRC01 A60C HEAVY CHAIN 
4977, 6emjL, 0.6307, 2.91, 0.056, 211, 89, FAB FRAGMENT. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN ANTIBODY DRUG DISCOVERY
4978, 6amjL, 0.6307, 3.03, 0.056, 211, 90, CAT192 FAB WILD TYPE
4979, 5wuxB, 0.6307, 3.12, 0.055, 212, 91, TNFALPHA-CERTOLIZUMAB FAB
4980, 5trul, 0.6307, 2.94, 0.056, 212, 89, STRUCTURE OF THE FIRST-IN-CLASS CHECKPOINT INHIBITOR IPILIMUMAB BOUND TO HUMAN CTLA-4
4981, 5hd8F, 0.6307, 2.97, 0.044, 211, 91, CRYSTAL STRUCTURE OF DISULFIDE CROSS-LINKED D417C CLC-EC1
4982, 4zncF, 0.6307, 3.19, 0.120, 195, 92, FC FRAGMENT OF HUMAN IGG IN COMPLEX WITH THE C DOMAIN OF STAPHYLOCOCCAL PROTEIN A MUTANT - Q9W
4983, 4qgtA, 0.6307, 2.89, 0.054, 205, 93, THE CRYSTAL STRUCTURE OF HUMAN IGG FC DOMAIN WITH ENHANCED AROMATIC SEQUON
4984, 4j8rA, 0.6307, 3.04, 0.055, 209, 91, STRUCTURE OF AN OCTAPEPTIDE REPEAT OF THE PRION PROTEIN BOUND TO THE POM2 FAB ANTIBODY FRAGMENT
4985, 1mrcL, 0.6307, 2.96, 0.033, 216, 90, PREPARATION CHARACTERIZATION AND CRYSTALLIZATION OF AN ANTIBODY FAB FRAGMENT THAT RECOGNIZES RNA. CRYSTAL STRUCTURES OF NATIVE FAB AND THREE FAB-MONONUCLEOTIDE COMPLEXES
4986, 1ck0L, 0.6307, 3.01, 0.056, 216, 90, ANTI-ANTI-IDIOTYPIC ANTIBODY AGAINST HUMAN ANGIOTENSIN II UNLIGANDED FORM
4987, 5tf1L, 0.6306, 2.94, 0.056, 207, 89, STRUCTURE OF CHIMERIC 02-CC FAB A VRC01-LIKE GERMLINE ANTIBODY
4988, 5girB, 0.6306, 2.96, 0.056, 211, 90, CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH ITS LIGAND PEPTIDE
4989, 4yueL, 0.6306, 3.03, 0.055, 214, 91, MOUSE IL-2 BOUND TO S4B6 FAB FRAGMENT
4990, 4s2sB, 0.6306, 3.00, 0.056, 217, 90, CRYSTAL STRUCTURE OF FAB FRAGMENT OF MONOCLONAL ANTIBODY ROAB13
4991, 3vi3L, 0.6306, 3.12, 0.054, 219, 93, CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE (LIGAND-FREE FORM)
4992, 3v6oC, 0.6306, 3.30, 0.095, 219, 95, LEPTIN RECEPTOR-ANTIBODY COMPLEX
4993, 3kprE, 0.6306, 3.15, 0.074, 241, 94, CRYSTAL STRUCTURE OF THE LC13 TCR IN COMPLEX WITH HLA B*4405 BOUND TO EEYLKAWTF A MIMOTOPE
4994, 2iq9H, 0.6306, 3.30, 0.022, 221, 93, PFA2 FAB FRAGMENT TRICLINIC APO FORM
4995, 2gsiE, 0.6306, 2.94, 0.056, 215, 90, CRYSTAL STRUCTURE OF A MURINE FAB IN COMPLEX WITH AN 11 RESIDUE PEPTIDE DERIVED FROM STAPHYLOCOCCAL NUCLEASE
4996, 2gsiA, 0.6306, 3.09, 0.044, 215, 91, CRYSTAL STRUCTURE OF A MURINE FAB IN COMPLEX WITH AN 11 RESIDUE PEPTIDE DERIVED FROM STAPHYLOCOCCAL NUCLEASE
4997, 1otuD, 0.6306, 2.96, 0.044, 211, 91, STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL E148Q MUTANT AND FAB COMPLEX
4998, 1fveA, 0.6306, 3.16, 0.054, 214, 93, X-RAY STRUCTURES OF THE ANTIGEN-BINDING DOMAINS FROM THREE VARIANTS OF HUMANIZED ANTI-P185-HER2 ANTIBODY 4D5 AND COMPARISON WITH MOLECULAR MODELING
4999, 6mnoB, 0.6305, 3.04, 0.065, 239, 93, 6235 TCR BOUND TO I-AB PADI4 
5000, 6dwcA, 0.6305, 3.04, 0.044, 217, 90, STRUCTURE OF THE APO 4497 ANTIBODY FAB FRAGMENT 
